Citrus Sinensis ID: 010231
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 514 | 2.2.26 [Sep-21-2011] | |||||||
| Q39008 | 608 | Mitogen-activated protein | yes | no | 0.891 | 0.753 | 0.507 | 1e-105 | |
| Q9SZ67 | 1895 | Probable WRKY transcripti | no | no | 0.474 | 0.128 | 0.555 | 6e-68 | |
| O22040 | 666 | Mitogen-activated protein | no | no | 0.285 | 0.220 | 0.467 | 1e-32 | |
| Q9FZ36 | 651 | Mitogen-activated protein | no | no | 0.285 | 0.225 | 0.460 | 1e-32 | |
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.289 | 0.158 | 0.450 | 9e-31 | |
| Q61083 | 619 | Mitogen-activated protein | yes | no | 0.317 | 0.263 | 0.449 | 5e-30 | |
| O22042 | 651 | Mitogen-activated protein | no | no | 0.284 | 0.224 | 0.437 | 1e-29 | |
| Q9Y2U5 | 619 | Mitogen-activated protein | yes | no | 0.313 | 0.260 | 0.454 | 4e-29 | |
| E9Q3S4 | 1311 | Mitogen-activated protein | no | no | 0.287 | 0.112 | 0.44 | 6e-29 | |
| P28829 | 659 | Protein kinase byr2 OS=Sc | yes | no | 0.284 | 0.221 | 0.450 | 8e-28 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 382 bits (980), Expect = e-105, Method: Compositional matrix adjust.
Identities = 250/493 (50%), Positives = 316/493 (64%), Gaps = 35/493 (7%)
Query: 6 RFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSL--DDSSSSSSLITR 63
R L+ +KS G+ D + + RLERR+AA++I YD AS SSS D S S+SSL+TR
Sbjct: 3 RILARMKKSTGRRGGD-KNITPVRRLERRDAARNINYDAASCSSSSAEDLSVSTSSLMTR 61
Query: 64 SLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQ 123
SL+ + TSFRI G GE +RI RSLG+SGP+D AI AWEA K RS+SD++ R +
Sbjct: 62 SLEFPEPTSFRIGGGVGEMDRIYRSLGVSGPDDLAISFDAWEACKKRSSSDVVNRFKSFD 121
Query: 124 LDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETEL-----TRTKLTQVAELSC---R 175
LD +++ + +G VVG D ++ V+ ++ +E T+L+++ L R
Sbjct: 122 LDKVRDQDLSEEGPSGVVVGS--DSMNHKVQGQDLSEAGPSGGIVTELSEIGNLITPVDR 179
Query: 176 ASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKG-------IKGVRPPLLKPPPGM 228
G + VME T + +S V +N V IKG+RPP+LKPPP M
Sbjct: 180 LVADGVVENRRVMERTPT----IVKSKGYLVPNNVVAVGVGVGGGIKGLRPPVLKPPPAM 235
Query: 229 RQPVIDNACSTWDILRDFAPKDGI---TPSSVMNDRALSSSSDDEDNEKEGEEADRAIVK 285
++P ID+ S+WD L FAP + + + SS ++ E+ + E R I
Sbjct: 236 KRPPIDHRGSSWDFLTHFAPSETVKRPSSSSSSSEDGCDEEEGKEEEAEAEEMGARFIQL 295
Query: 286 EEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSV 345
+ D E+CSFTT +E DSSST + S I P+G IIT WQKG LLGRGSFGSV
Sbjct: 296 GDTAD----ETCSFTT-NEGDSSSTVSN-TSPIYPDG--GAIITSWQKGQLLGRGSFGSV 347
Query: 346 YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405
YEGIS DG FFAVKEVSLLDQGSQA++ I QLE EI LLS+ +H+NIV+Y GT KD S L
Sbjct: 348 YEGISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNL 407
Query: 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465
YIFLELVT+GSLL LYQRY LRDS VS YTRQIL GLKYLHD+ +HRDIKCANILVDAN
Sbjct: 408 YIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDAN 467
Query: 466 GSVKLADFGLAKV 478
G+VKLADFGLAKV
Sbjct: 468 GAVKLADFGLAKV 480
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (660), Expect = 6e-68, Method: Compositional matrix adjust.
Identities = 150/270 (55%), Positives = 177/270 (65%), Gaps = 26/270 (9%)
Query: 214 IKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNE 273
IKG+RPP+L+ P M+ I STWD + FAP + + P S ++ +E
Sbjct: 1527 IKGLRPPVLQLQPAMKLSHIPRG-STWDFVTHFAPPETVAPPSSSSEAREEEVETEETGA 1585
Query: 274 KEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISP----NGRFKRIIT 329
D+ E+CSFT ++ DSS T +SN SP G F IT
Sbjct: 1586 MFIPLGDK-------------ETCSFTV-NKGDSSRT----ISNTSPIYASEGSF---IT 1624
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
WQKG LLGRGS GSVYEGIS DG FFA KEVSLLDQGSQA + I Q+E IALLS+ +H
Sbjct: 1625 CWQKGQLLGRGSLGSVYEGISADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQH 1684
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+NIV+Y GT KDES LYIFLELVT+GSL LYQR L DS VS YTRQIL GLKYLHD+
Sbjct: 1685 QNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKG 1744
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVF 479
+HR+IKCAN+LVDANG+VKLADFGLAKV
Sbjct: 1745 FIHRNIKCANVLVDANGTVKLADFGLAKVM 1774
|
Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) |
| >sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 141 bits (355), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 71/152 (46%), Positives = 101/152 (66%), Gaps = 5/152 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL---LDQGSQAKQSISQLEQEIALLSR 386
W+KG L+GRG+FG+VY G++ D G AVK+V + + + I +LE+E+ LL
Sbjct: 69 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 445
H NIV+Y GT +++ L I LE V GS+ +L +++ +S V YTRQ+LLGL+YL
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYL 188
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
H+ ++HRDIK ANILVD G +KLADFG +K
Sbjct: 189 HNHAIMHRDIKGANILVDNKGCIKLADFGASK 220
|
May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 141 bits (355), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 70/152 (46%), Positives = 102/152 (67%), Gaps = 5/152 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS---ISQLEQEIALLSR 386
W+KG L+GRG+FG+VY G++ D G AVK+V + + +++ I +LE+E+ LL
Sbjct: 68 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKN 127
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYL 445
H NIV+Y GT +++ L I LE V GS+ +L +++ +S V YT Q+LLGL+YL
Sbjct: 128 LSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEYL 187
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
H+ ++HRDIK ANILVD G +KLADFG +K
Sbjct: 188 HNHAIMHRDIKGANILVDNQGCIKLADFGASK 219
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function description |
|---|
Score = 135 bits (339), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 69/153 (45%), Positives = 100/153 (65%), Gaps = 4/153 (2%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRF 387
WQKG +LGRG +GSVY G++ D G FAVK++ ++D S + K I +EI ++
Sbjct: 170 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 229
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
H+NIV+Y GT D+S L +FLE + GS+ +L ++ ++ + YT+QIL GL +LH
Sbjct: 230 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 289
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
++HRDIK ANIL+D G VKL+DFG +K F
Sbjct: 290 ANSIIHRDIKGANILIDTKGIVKLSDFGCSKSF 322
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q61083|M3K2_MOUSE Mitogen-activated protein kinase kinase kinase 2 OS=Mus musculus GN=Map3k2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 132 bits (333), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 75/167 (44%), Positives = 99/167 (59%), Gaps = 4/167 (2%)
Query: 315 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 373
+++ISP R R T W+ G LLG+G+FG VY D G AVK+V + + +
Sbjct: 340 VTDISPPSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFNPESPETSKE 399
Query: 374 ISQLEQEIALLSRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
++ LE EI LL HE IVQYYG D E L IF+EL GS+ + + Y L ++
Sbjct: 400 VNALECEIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMELSPGGSIKDQLKAYGALTENV 459
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
YTRQIL G+ YLH +VHRDIK ANIL D+ G++KL DFG +K
Sbjct: 460 TRKYTRQILEGVHYLHSNMIVHRDIKGANILRDSTGNIKLGDFGASK 506
|
Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7. Plays a role in caveolae kiss-and-run dynamics. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 131 bits (330), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 67/153 (43%), Positives = 101/153 (66%), Gaps = 7/153 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 385
W+KG+L+G G+FG VY G++ D G A+K+V L+ S +K+ I +LE+E+ LL
Sbjct: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAIKQV-LIAPSSASKEKTQGHIRELEEEVQLLK 126
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
H NIV+Y GT ++ L I +E V GS+ +L +++ + + YT+Q+LLGL+Y
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEY 186
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
LH+ ++HRDIK ANILVD G ++LADFG +K
Sbjct: 187 LHNNGIMHRDIKGANILVDNKGCIRLADFGASK 219
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 129 bits (325), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 75/165 (45%), Positives = 96/165 (58%), Gaps = 4/165 (2%)
Query: 317 NISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSIS 375
+ISP R R T W+ G LLG+G+FG VY D G AVK+V + + ++
Sbjct: 342 DISPPSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVN 401
Query: 376 QLEQEIALLSRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVS 432
LE EI LL HE IVQYYG D E L IF+E + GS+ + + Y L ++
Sbjct: 402 ALECEIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGALTENVTR 461
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
YTRQIL G+ YLH +VHRDIK ANIL D+ G+VKL DFG +K
Sbjct: 462 KYTRQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASK 506
|
Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 129 bits (324), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 66/150 (44%), Positives = 96/150 (64%), Gaps = 2/150 (1%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE 388
+W KG++LGRG++G+VY G++ G AVK+V+L A ++ +L++E+ LL +
Sbjct: 1043 FWTKGEILGRGAYGTVYCGLTSLGQLIAVKQVALDTSDKLATEKEYRKLQEEVDLLKALK 1102
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD 447
H NIV Y GT +E+ L IF+E V GS+ ++ R+ L + YTRQIL G+ YLHD
Sbjct: 1103 HVNIVAYLGTCLEENTLSIFMEFVPGGSISSIINRFGPLPEMVFCKYTRQILQGVAYLHD 1162
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477
VVHRDIK N+++ G +KL DFG AK
Sbjct: 1163 NCVVHRDIKGNNVMLMPTGIIKLIDFGCAK 1192
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (314), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 69/153 (45%), Positives = 96/153 (62%), Gaps = 7/153 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAK----QSISQLEQEIALLS 385
W +G L+G GSFG VY G+ + G AVK+V +LD S++K + + L EIALL
Sbjct: 394 WIRGALIGSGSFGQVYLGMNASSGELMAVKQV-ILDSVSESKDRHAKLLDALAGEIALLQ 452
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
HE+IVQY G++ + L IFLE V GS+ L Y ++ V + +Q L GL+Y
Sbjct: 453 ELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIKQTLKGLEY 512
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
LH + +VHRDIK ANILVD G +K++DFG++K
Sbjct: 513 LHSRGIVHRDIKGANILVDNKGKIKISDFGISK 545
|
Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 514 | ||||||
| 255545546 | 555 | Mitogen-activated protein kinase kinase | 0.807 | 0.747 | 0.637 | 1e-149 | |
| 356509460 | 566 | PREDICTED: mitogen-activated protein kin | 0.821 | 0.745 | 0.570 | 1e-137 | |
| 224082218 | 548 | predicted protein [Populus trichocarpa] | 0.809 | 0.759 | 0.630 | 1e-130 | |
| 356552843 | 590 | PREDICTED: mitogen-activated protein kin | 0.834 | 0.727 | 0.546 | 1e-128 | |
| 357489127 | 593 | Mitogen-activated protein kinase kinase | 0.898 | 0.779 | 0.572 | 1e-127 | |
| 32400274 | 592 | putative mitogen-activated protein kinas | 0.892 | 0.775 | 0.566 | 1e-124 | |
| 356518515 | 555 | PREDICTED: mitogen-activated protein kin | 0.813 | 0.753 | 0.587 | 1e-124 | |
| 225459451 | 567 | PREDICTED: mitogen-activated protein kin | 0.842 | 0.763 | 0.559 | 1e-121 | |
| 449445122 | 565 | PREDICTED: mitogen-activated protein kin | 0.828 | 0.753 | 0.553 | 1e-120 | |
| 224066881 | 558 | predicted protein [Populus trichocarpa] | 0.811 | 0.747 | 0.623 | 1e-120 |
| >gi|255545546|ref|XP_002513833.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223546919|gb|EEF48416.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1373), Expect = e-149, Method: Compositional matrix adjust.
Identities = 302/474 (63%), Positives = 341/474 (71%), Gaps = 59/474 (12%)
Query: 20 MDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVE 79
MDP+ R +PRLERRNAAKHIEYD S+ SSLD SS SSSL+TRSLDL + TSFRIEG +
Sbjct: 1 MDPKNGRSRPRLERRNAAKHIEYDATSSFSSLDASSCSSSLVTRSLDLPEGTSFRIEGTD 60
Query: 80 GEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAG 139
GEF+RICRS+GL+GPEDF IP AAWEA K RSASDLLPRSRL D+ + E +
Sbjct: 61 GEFDRICRSIGLTGPEDFEIPTAAWEAMKVRSASDLLPRSRLYVSDSPR-IAEAKHKEQE 119
Query: 140 AVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLA 199
ELC RV D VR + TELT+ K QV + SG G
Sbjct: 120 QEKSELCARVLDTVRTDDSTELTQEK--QVQPVKLNVSGGG------------------- 158
Query: 200 ESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMN 259
IKGVRPPLLKPPP M PVID CSTWDILRDFAP++ S ++
Sbjct: 159 --------------IKGVRPPLLKPPPSMTLPVIDKCCSTWDILRDFAPENDRRSSMLIA 204
Query: 260 DRALSSSSDDEDNEKEGEEADRAIVKEEEDDM---------------VLSESCSFTTEHE 304
+ LSS DDE EE AI K EE++ VLSESCSFTT ++
Sbjct: 205 EGGLSS--DDE------EEVAAAINKGEEEEEEEDDDDNLSRIREIGVLSESCSFTTSND 256
Query: 305 DDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL 364
DDSSSTTTE MSNISP+ RF+R+I+ W+KGDLLGRGSFGSVYEGI+ DGFFFA+KEVSLL
Sbjct: 257 DDSSSTTTELMSNISPHERFRRMISDWEKGDLLGRGSFGSVYEGIAHDGFFFAIKEVSLL 316
Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY 424
DQGSQ KQSI QLEQEIALLS+FEHENIV+YYGTDKD+S LYIFLELVT+GSL+NLYQRY
Sbjct: 317 DQGSQGKQSIYQLEQEIALLSQFEHENIVRYYGTDKDDSNLYIFLELVTQGSLMNLYQRY 376
Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
HLRDSQVSAYTRQIL GLKYLHD++VVHRDIKCANILVDA+GSVKLADFGLAK
Sbjct: 377 HLRDSQVSAYTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADFGLAKA 430
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356509460|ref|XP_003523467.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1276), Expect = e-137, Method: Compositional matrix adjust.
Identities = 283/496 (57%), Positives = 339/496 (68%), Gaps = 74/496 (14%)
Query: 1 MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHI--EYDVASTSSSLDDSSSSS 58
MH+L R PR+++ MD + R+KP+LERRNA K+ EYDV S S S
Sbjct: 1 MHYLSRIFEPRKQTK---TMDRKNPRRKPKLERRNALKYSSSEYDVVS-------SPSDD 50
Query: 59 SLITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPR 118
+L TRS++ DRTSFRIEGVEGEF+RICRSLGLSGPEDFAIPAAAWEA K RS+SD+LPR
Sbjct: 51 TLYTRSMEFYDRTSFRIEGVEGEFDRICRSLGLSGPEDFAIPAAAWEAMKFRSSSDILPR 110
Query: 119 SRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASG 178
+L LD +E VE E+++ ++ + AE +
Sbjct: 111 LKLDNLDIPEEDVE------------------------EESKVNEVRMFKSAEEGELSEN 146
Query: 179 AGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDN-AC 237
G +D++ V E E SSN GIKG+RPP+LKPPPG R V+D+ AC
Sbjct: 147 HGVSDSVRVREIDE--------------SSN---GIKGIRPPMLKPPPGTRVQVVDDSAC 189
Query: 238 STWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMV----- 292
S+WD+LRD AP+ G +N S+ + ++EGE + K EE+ V
Sbjct: 190 SSWDLLRDLAPQGG--EGLPLNH---SNEEREVAEKEEGEVGTKESPKREEEQNVDNAAR 244
Query: 293 -------LSESCSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIITY--WQKGDLLGRGSF 342
LSESCSF+T +EDDSSS+TT+P SN ISP GR KRIIT WQKG+ LG GSF
Sbjct: 245 IAEIVAGLSESCSFSTSNEDDSSSSTTDPRSNNISPQGRIKRIITAGSWQKGEFLGGGSF 304
Query: 343 GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402
GSVYEGISDDGFFFAVKEVSLLDQG+Q KQS+ QLEQEIALLS+FEH+NIVQYYGT+ D+
Sbjct: 305 GSVYEGISDDGFFFAVKEVSLLDQGTQGKQSVYQLEQEIALLSQFEHDNIVQYYGTEMDQ 364
Query: 403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV 462
SKLYIFLELVTKGSL +LYQ+Y LRDSQVSAYTRQIL GLKYLHD++VVHRDIKCANILV
Sbjct: 365 SKLYIFLELVTKGSLRSLYQKYTLRDSQVSAYTRQILHGLKYLHDRNVVHRDIKCANILV 424
Query: 463 DANGSVKLADFGLAKV 478
DA+GSVKLADFGLAK
Sbjct: 425 DASGSVKLADFGLAKA 440
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082218|ref|XP_002306607.1| predicted protein [Populus trichocarpa] gi|222856056|gb|EEE93603.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 470 bits (1210), Expect = e-130, Method: Compositional matrix adjust.
Identities = 306/485 (63%), Positives = 346/485 (71%), Gaps = 69/485 (14%)
Query: 1 MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSL 60
MHHLP+FL+ ++K++ +MDP+ R+ RLERRNA KHI+YD A+ S S D SSSSSL
Sbjct: 1 MHHLPQFLTRKKKTS---SMDPKNRRRP-RLERRNALKHIDYD-ATPSFSSLDDSSSSSL 55
Query: 61 ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSR 120
TRSLDL DRTSFRIEG EGE +RICRSLGLSGPEDFAIPAAAWEA K RSASDLL RSR
Sbjct: 56 FTRSLDLPDRTSFRIEGTEGELDRICRSLGLSGPEDFAIPAAAWEAMKARSASDLLRRSR 115
Query: 121 L------KQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSC 174
L K + K VE + ELC V VR+R+ + T+L ++
Sbjct: 116 LLGPDSPKAAEEFKAIVEMTNQQEER---ELCAGVLKSVRVRDSS----TELNTCHDI-- 166
Query: 175 RASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVID 234
+N ++V GIKG RPPLLKPPP M PVID
Sbjct: 167 ------DNRGVSV-------------------------GIKGPRPPLLKPPPSMTLPVID 195
Query: 235 NACSTWDILRDFAPK-DGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVL 293
CSTWD+ RDFAP+ DG+ V N++ SS DD+ E+ + D A
Sbjct: 196 KECSTWDLFRDFAPENDGV----VNNNKEFSSGDDDDGRERRPQVIDAA----------- 240
Query: 294 SESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDG 353
SCSFTT ++DDSSS+TTEPMSNISPN RF+R IT W+KG+LLGRGSFGSVYEGISDDG
Sbjct: 241 --SCSFTTSNDDDSSSSTTEPMSNISPNLRFRRSITDWEKGELLGRGSFGSVYEGISDDG 298
Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
FFFAVKEVSLLDQGSQ KQSI QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT
Sbjct: 299 FFFAVKEVSLLDQGSQGKQSIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 358
Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
KGSLL LYQRY+LRDSQVSAYTRQIL GLKYLHDQ+VVHRDIKCAN+LVDANGSVKLADF
Sbjct: 359 KGSLLKLYQRYNLRDSQVSAYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLADF 418
Query: 474 GLAKV 478
GLAK
Sbjct: 419 GLAKA 423
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356552843|ref|XP_003544772.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1197), Expect = e-128, Method: Compositional matrix adjust.
Identities = 281/514 (54%), Positives = 338/514 (65%), Gaps = 85/514 (16%)
Query: 1 MHHLPRFLSPREKSAGKAAMDP--------RKMRQKPRLERRNAAKHIEYDVASTSSSLD 52
M+HLPR R+K A + MDP K Q+P+LERRNAAKH EYD S SS D
Sbjct: 1 MNHLPRIFGNRKKQA--SDMDPTKKKKKSKGKKHQQPKLERRNAAKHFEYDAGSLCSSRD 58
Query: 53 DSSSSSSL-----ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEAR 107
+ +S+S TRS++L DR SFRIEGVEGEF++ICRSLGLSGPEDF+IPAAAWEA
Sbjct: 59 EYDASTSSSSSLHCTRSMELFDRKSFRIEGVEGEFDQICRSLGLSGPEDFSIPAAAWEAM 118
Query: 108 KNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLT 167
K R +SDLLP R+ G E + +
Sbjct: 119 KLRCSSDLLP---------------RRPKHGGEEE-----------EFDEEPKEKEKEEV 152
Query: 168 QVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPG 227
++A L + D V++ +P AESS CC GIKG RPP+LKPPPG
Sbjct: 153 EIAVLE-------SEDRARVLDECVVP----AESSGCC------GGIKGFRPPMLKPPPG 195
Query: 228 MRQPVIDNA-CSTWDILRDFAPK-DGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVK 285
+R V+D+A CSTWD++RDFAPK +G S + +SSDDED+ + E+ + +
Sbjct: 196 VRVSVVDDATCSTWDLMRDFAPKGEGGGKDSYVE----LNSSDDEDDHEREEKEEEEEEE 251
Query: 286 EEEDDMV------------------LSESCSFTTEHEDDSSSTTTEPMSN-ISPNGRFKR 326
EEE ++ + + F+T +EDDSSST+T P SN ISPNGR KR
Sbjct: 252 EEEGEVGGVRVESVEEENAAAIAEIVGDFSGFSTSNEDDSSSTSTGPRSNNISPNGRIKR 311
Query: 327 IITY--WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
+IT WQKG+LLGRGSFGSVYEGIS+DGFFFAVKEVSLLDQG+Q +QS+ QLEQEIALL
Sbjct: 312 VITAGNWQKGELLGRGSFGSVYEGISEDGFFFAVKEVSLLDQGNQGRQSVYQLEQEIALL 371
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
S+FEHENIVQY GT+ D S LYIF+ELVTKGSL NLYQRY+LRDSQVSAYTRQIL GLKY
Sbjct: 372 SQFEHENIVQYIGTEMDASNLYIFIELVTKGSLRNLYQRYNLRDSQVSAYTRQILHGLKY 431
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
LHD+++VHRDIKCANILVDANGSVKLADFGLAK
Sbjct: 432 LHDRNIVHRDIKCANILVDANGSVKLADFGLAKA 465
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357489127|ref|XP_003614851.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355516186|gb|AES97809.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 460 bits (1183), Expect = e-127, Method: Compositional matrix adjust.
Identities = 278/486 (57%), Positives = 338/486 (69%), Gaps = 24/486 (4%)
Query: 1 MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSS- 59
M+HLPR R KS M+ +K +Q P+L+RRNA K+ YD +SSS + S S SS
Sbjct: 1 MNHLPRIFGYRNKST--TEMNSKKKKQ-PKLQRRNAVKNFNYDAQPSSSSPESSESVSSS 57
Query: 60 -LITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPR 118
L TRS+D DR SFR+EGV+GEF+ ICRSLGL+GPEDF+IPAAAWEA K RS+SD+LPR
Sbjct: 58 ILCTRSMDFYDRKSFRVEGVDGEFDIICRSLGLNGPEDFSIPAAAWEAMKVRSSSDVLPR 117
Query: 119 SRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASG 178
+ + D K V + D G V E DRV +VR + E + +S R S
Sbjct: 118 LNVTEFDETK--VSDEIDEVGVV--ECDDRV--LVR-DSPAESSVGDSGGEVNVSIRDSP 170
Query: 179 AGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACS 238
A ++ E + G E+S+C S GIKG+RPP+LKPPPG+R V+D+ CS
Sbjct: 171 AESSGCCTGGEI-RVSVRGFDETSSCSTGSG---GIKGIRPPMLKPPPGVRVSVVDDTCS 226
Query: 239 TWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMV--LSES 296
TWDILRDFAP+ + D+ + + E +E I +EE D++ S S
Sbjct: 227 TWDILRDFAPE---GEGKEREEEEEEEKVDEVEEKGEADEVGLKIEEEENGDIIGEFSRS 283
Query: 297 CSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIIT--YWQKGDLLGRGSFGSVYEGISDDG 353
CSFTT EDDSSSTTT+ SN ISPN R K +IT WQKG+LLGRGSFG+VYEGIS+DG
Sbjct: 284 CSFTTSQEDDSSSTTTDTRSNSISPNVRLKPVITPGSWQKGELLGRGSFGTVYEGISEDG 343
Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
FFFAVK+VSLLDQGSQ KQS+ QLE EIALLS+FEHENIV+Y GT+ DES LYIF+E VT
Sbjct: 344 FFFAVKQVSLLDQGSQGKQSVVQLEHEIALLSQFEHENIVRYIGTEMDESNLYIFIEFVT 403
Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
KGSLL+LY+RY LRDSQVSAYTRQIL GLKYLHD+++VHRDIKCANILVDANGSVK+ADF
Sbjct: 404 KGSLLSLYRRYKLRDSQVSAYTRQILHGLKYLHDRNIVHRDIKCANILVDANGSVKVADF 463
Query: 474 GLAKVF 479
GLAK
Sbjct: 464 GLAKAI 469
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|32400274|emb|CAE00640.1| putative mitogen-activated protein kinase 1 [Medicago sativa] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1159), Expect = e-124, Method: Compositional matrix adjust.
Identities = 274/484 (56%), Positives = 329/484 (67%), Gaps = 25/484 (5%)
Query: 1 MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSS- 59
M+HLPR R KS M+ +K +Q P+L+RRNA K+ YD +SSS + S S+SS
Sbjct: 1 MNHLPRIFGYRNKST--TEMNSKKKKQ-PKLQRRNAVKNFNYDAQPSSSSPESSESASSS 57
Query: 60 ---LITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLL 116
L TRS+D DR SFR+EGV+GEF+ ICRSLGL+GPEDF+IPAAAWEA K RS+SD+L
Sbjct: 58 ASILCTRSMDFHDRKSFRVEGVDGEFDIICRSLGLNGPEDFSIPAAAWEAMKFRSSSDVL 117
Query: 117 PRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRA 176
PR + + D K + E D G V CD D V +R+ + V S R
Sbjct: 118 PRLNVSEFDETKTSGE--IDQVGVVD---CD---DRVLVRDSPAESSGGEVNV---SIRD 166
Query: 177 SGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNA 236
S A ++ E +P G E+S C S GIKG+RPP+LKPPPG+R V+D+
Sbjct: 167 SPAKSSGCCTGGEI-RVPVRGFDETSNCSTGSG---GIKGIRPPMLKPPPGVRVSVVDDT 222
Query: 237 CSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSES 296
CSTWDILRDFAP+ + +E E E + + S S
Sbjct: 223 CSTWDILRDFAPEGEGKEREEQEEEEEKVDEVEEKEEVGELELKVEEEENGDIIGEFSRS 282
Query: 297 CSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIIT--YWQKGDLLGRGSFGSVYEGISDDG 353
CSFTT EDDSSSTTT+ SN ISPN R K +IT WQKG+LLGRGSFG+VYEGIS+DG
Sbjct: 283 CSFTTSQEDDSSSTTTDTRSNSISPNVRLKPVITPGSWQKGELLGRGSFGTVYEGISEDG 342
Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
FFFAVK+VSLLDQGSQ KQS+ QLE EIALLS+FEHENIV+Y GT+ DES LYIF+E VT
Sbjct: 343 FFFAVKQVSLLDQGSQGKQSVVQLEHEIALLSQFEHENIVRYIGTEMDESNLYIFIEFVT 402
Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
KGSLL+LY+RY LRDSQVSAYTRQIL GLKYLHD+++VHRDIKCANILVDANGSVK+ADF
Sbjct: 403 KGSLLSLYRRYKLRDSQVSAYTRQILHGLKYLHDRNIVHRDIKCANILVDANGSVKVADF 462
Query: 474 GLAK 477
GLAK
Sbjct: 463 GLAK 466
|
Source: Medicago sativa Species: Medicago sativa Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356518515|ref|XP_003527924.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1157), Expect = e-124, Method: Compositional matrix adjust.
Identities = 276/470 (58%), Positives = 330/470 (70%), Gaps = 52/470 (11%)
Query: 20 MDPRKMRQKPRLERRNAAKHI--EYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEG 77
MD + R+KP+LERRNA K+ EYD S S S +L TRS++ DRTSFRIEG
Sbjct: 1 MDRKNPRRKPKLERRNALKYSSSEYDAGS-------SPSDDTLYTRSMEFYDRTSFRIEG 53
Query: 78 VEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDA 137
VEGEF+RICRSLGLSGPEDFAIPAAAWEA K R +SD+LPR + LD L D
Sbjct: 54 VEGEFDRICRSLGLSGPEDFAIPAAAWEAIKFRYSSDILPRLK---LDNL--------DI 102
Query: 138 AGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSG 197
GE +V++ + I N E KL++ + D+ +V +
Sbjct: 103 PEEEEGEEELKVNEDI-IVNSVE--EGKLSE-----------KHGDSSSVRVRVRVRVRE 148
Query: 198 LAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNA-CSTWDILRDFAPK--DGITP 254
+ ESS GIKG RPP+LKPPPG R V+D++ CSTWD+LRD AP+ +G+
Sbjct: 149 IDESST---------GIKGTRPPMLKPPPGARVQVVDDSTCSTWDLLRDLAPQGEEGLPL 199
Query: 255 SSVMNDRALSSSSDDEDNEKE-GEEADRAIVKEEEDDMV--LSESCSFTTEHEDDSSSTT 311
+ N+ ++ + EKE GE R K EE++ V LSESCSF+T +EDDSSS+T
Sbjct: 200 NRSENESEVAREVERGAVEKEEGEVGTRESPKREEEENVAGLSESCSFSTSNEDDSSSST 259
Query: 312 TEPM-SNISPNGRFKRIITY--WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS 368
T+P +NISP GR KRIIT WQKG+ LG GSFGSVYEGISDDGFFFAVKEVSLLDQG+
Sbjct: 260 TDPTSNNISPQGRIKRIITAESWQKGEFLGGGSFGSVYEGISDDGFFFAVKEVSLLDQGT 319
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
Q KQS+ QLEQEIALLS+FEHENIVQYYGT+ D+SKLYIFLELVTKGSL +LYQ+Y LRD
Sbjct: 320 QGKQSVYQLEQEIALLSQFEHENIVQYYGTEMDQSKLYIFLELVTKGSLRSLYQKYTLRD 379
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
SQVS+YTRQIL GLKYLHD++VVHRDIKCANILVDA+GSVKLADFGLAK
Sbjct: 380 SQVSSYTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADFGLAKA 429
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225459451|ref|XP_002284356.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 443 bits (1139), Expect = e-121, Method: Compositional matrix adjust.
Identities = 272/486 (55%), Positives = 325/486 (66%), Gaps = 53/486 (10%)
Query: 1 MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSL 60
MHHLPR ++S G M P++ +KP+LERRNA +HI+YD +++SSS S +L
Sbjct: 1 MHHLPRLFDYSKRSKG---MFPKQKPRKPKLERRNALRHIDYDASASSSSSS-FDDSLAL 56
Query: 61 ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSR 120
T+SLDLSDR+SFRI G EGE + ICRSLGLSGP++ +IP AAWEA K RS SD+LPR+R
Sbjct: 57 HTQSLDLSDRSSFRIHGTEGEVDEICRSLGLSGPDELSIPEAAWEAWKVRSNSDVLPRTR 116
Query: 121 LKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAG 180
+L + K E + VV +L D D V SC
Sbjct: 117 FNRLHSSKRK-ESEVKVDDGVVDDLADGFEDSV-------------------SC------ 150
Query: 181 NNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTW 240
+DA+ T S L+ S GIKGVRPP L PPP M PVI + CSTW
Sbjct: 151 -SDAIGRRRET----SELSSSRIVGGVGGCGGGIKGVRPPFLSPPPLMSLPVISDGCSTW 205
Query: 241 DILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEE------DDM-VL 293
DIL+ F P D SSV+ + SSS DDE D A+VK E+ D++ +L
Sbjct: 206 DILKSFGP-DADGGSSVVVEGG-SSSEDDE--------FDAALVKGEDVNGLRNDEIALL 255
Query: 294 SESCSFTT-EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD 352
SES SFTT ++DDSSSTTTEPMSNISPNG + T W KG LG GSFG+VYEG+S+D
Sbjct: 256 SESYSFTTTSNDDDSSSTTTEPMSNISPNGSLRPSFTNWMKGAFLGSGSFGTVYEGMSED 315
Query: 353 GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412
G FFAVKEVSLLDQGSQ KQS+ QLEQEI LLS+F+HENIVQY+GT KDESKLYIFLELV
Sbjct: 316 GIFFAVKEVSLLDQGSQGKQSLYQLEQEIDLLSQFQHENIVQYHGTAKDESKLYIFLELV 375
Query: 413 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472
TKGSL +LYQRY+L DSQ SAYTRQIL GL YLH+++V+HRDIKCANILV ANGSVKL+D
Sbjct: 376 TKGSLASLYQRYNLGDSQASAYTRQILHGLNYLHERNVIHRDIKCANILVGANGSVKLSD 435
Query: 473 FGLAKV 478
FGLAK
Sbjct: 436 FGLAKA 441
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445122|ref|XP_004140322.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Cucumis sativus] gi|449519384|ref|XP_004166715.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 439 bits (1130), Expect = e-120, Method: Compositional matrix adjust.
Identities = 270/488 (55%), Positives = 326/488 (66%), Gaps = 62/488 (12%)
Query: 1 MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSL 60
M+ LP+F SPR K + MDPRK+ KP+L R NAAK+I+YD S+SSS SS SL
Sbjct: 1 MNRLPQFFSPRNK---RKPMDPRKIPGKPKLGRLNAAKNIDYDAPSSSSS--LEDSSGSL 55
Query: 61 ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSR 120
TRS++ D +SFRI+G++GE + ICR+LGL+GP+DFAIP AWEARK RS+S+LLPRSR
Sbjct: 56 YTRSMENPDPSSFRIKGLDGEVDLICRTLGLAGPDDFAIPMEAWEARKVRSSSELLPRSR 115
Query: 121 LKQLDTLKETVERQSDAAGA-VVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGA 179
L +DT +T E D + ELC RV D VRI +L++TK T+ AEL+ R
Sbjct: 116 LYPMDTSPKTEEISEDKEDKEIQDELCRRVKDSVRI--SVDLSKTK-TEFAELNERR--- 169
Query: 180 GNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACST 239
+A ++ C S GI G RPPLLKPPP MR P DNA ST
Sbjct: 170 ------------------MATATGCSSRS----GINGARPPLLKPPPSMRLPNFDNAYST 207
Query: 240 WDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGE----------EADRAIVKEEED 289
WDIL+ FAP +DE E+ GE E + V+ E+
Sbjct: 208 WDILKGFAPL-----------------VEDEHQEEVGERVEPLVEVEGEGEGNTVRPVEN 250
Query: 290 DMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI 349
++ SFTT ++DDSSS+TTEP +NISPN R IIT W G LLGRGSFGSVYE I
Sbjct: 251 ASLIGSWGSFTTSNDDDSSSSTTEP-ANISPNMRVNPIITSWVLGRLLGRGSFGSVYEAI 309
Query: 350 SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409
S+DG FFA+KEVSLLD+ SQ +QSI QL+QEIALLS FEHENIVQYYGT D SKLYIFL
Sbjct: 310 SEDGTFFALKEVSLLDEDSQGRQSIYQLQQEIALLSEFEHENIVQYYGTHSDGSKLYIFL 369
Query: 410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469
ELV++GSL++LYQR L DS VSAYTRQIL GLKYLH+++V+HRDIKCANILVD NGSVK
Sbjct: 370 ELVSQGSLMSLYQRTSLMDSIVSAYTRQILSGLKYLHERNVIHRDIKCANILVDVNGSVK 429
Query: 470 LADFGLAK 477
LADFGLAK
Sbjct: 430 LADFGLAK 437
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066881|ref|XP_002302260.1| predicted protein [Populus trichocarpa] gi|222843986|gb|EEE81533.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 439 bits (1128), Expect = e-120, Method: Compositional matrix adjust.
Identities = 295/473 (62%), Positives = 340/473 (71%), Gaps = 56/473 (11%)
Query: 20 MDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVE 79
MDP+ R+ RLERRNA +H+ YD +TSSS SSSSL+++SLDL DRTSFRIEG E
Sbjct: 1 MDPKNRRRP-RLERRNALRHVAYD--ATSSSSSLDDSSSSLLSQSLDLPDRTSFRIEGTE 57
Query: 80 GEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAG 139
GEF+RI RSLGLSGPEDF+IP AAWEA K RSASD+LPRSRL D+ K E + G
Sbjct: 58 GEFDRIFRSLGLSGPEDFSIPEAAWEAMKVRSASDILPRSRLFGSDSPKAAEEAKVVVEG 117
Query: 140 AVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLA 199
EL RV + VR+R+ + T++ + AEL+ +N L V
Sbjct: 118 -TKSELHARVLNSVRVRDSS--TQSTQNEPAELN--KFRDADNRCLPV------------ 160
Query: 200 ESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMN 259
GIKG+RPPLLKPPP M PVID CSTWD+ RDFAP++ V+N
Sbjct: 161 -------------GIKGLRPPLLKPPPSMTLPVIDKECSTWDLFRDFAPEN----DRVVN 203
Query: 260 DRALSSSSD---------------DEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHE 304
+ S+ D D DN++E EE I + +VLSESCSF+T ++
Sbjct: 204 NNIESTYDDGEEEKEERREQVINADADNKREEEENLLRI----GETVVLSESCSFSTSND 259
Query: 305 DDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL 364
DDSSS+TTEPMSNISPN RF+R ITYW+KG+LLGRGSFGSVYEGISDDGFFFAVKEVSLL
Sbjct: 260 DDSSSSTTEPMSNISPNVRFRRAITYWEKGELLGRGSFGSVYEGISDDGFFFAVKEVSLL 319
Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY 424
DQGS+ KQSI QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL LYQRY
Sbjct: 320 DQGSKGKQSIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLQKLYQRY 379
Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+LRDSQVS+YTRQIL GLKYLHDQ+VVHRDIKCAN+LVDANGSVKLADFGLAK
Sbjct: 380 NLRDSQVSSYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLADFGLAK 432
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 514 | ||||||
| TAIR|locus:2133559 | 608 | MEKK1 "MAPK/ERK kinase kinase | 0.902 | 0.763 | 0.460 | 1e-91 | |
| TAIR|locus:2133539 | 773 | MAPKKK9 "mitogen-activated pro | 0.492 | 0.327 | 0.554 | 4.5e-82 | |
| TAIR|locus:2118116 | 1895 | WRKY19 [Arabidopsis thaliana ( | 0.342 | 0.092 | 0.659 | 3.6e-60 | |
| TAIR|locus:2133529 | 560 | MEKK3 "MAPK/ERK kinase kinase | 0.305 | 0.280 | 0.700 | 1.6e-55 | |
| TAIR|locus:2026674 | 883 | YDA "YODA" [Arabidopsis thalia | 0.285 | 0.166 | 0.536 | 2.9e-35 | |
| TAIR|locus:2174969 | 716 | MAPKKK5 "mitogen-activated pro | 0.284 | 0.203 | 0.529 | 5.1e-35 | |
| TAIR|locus:2024832 | 609 | MAP3KA "mitogen-activated prot | 0.285 | 0.241 | 0.503 | 3.2e-33 | |
| DICTYBASE|DDB_G0283265 | 1267 | mkkA "octicosapeptide/Phox/Bem | 0.285 | 0.116 | 0.450 | 8e-31 | |
| TAIR|locus:2035989 | 666 | NP1 "NPK1-related protein kina | 0.285 | 0.220 | 0.480 | 1.2e-30 | |
| TAIR|locus:2080394 | 651 | NP3 "NPK1-related protein kina | 0.284 | 0.224 | 0.437 | 2.6e-30 |
| TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 914 (326.8 bits), Expect = 1.0e-91, P = 1.0e-91
Identities = 226/491 (46%), Positives = 285/491 (58%)
Query: 4 LPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVAXXXXXXXXXXXXXXXXXX 63
+ R L+ +KS G+ D + + RLERR+AA++I YD A
Sbjct: 1 MDRILARMKKSTGRRGGD-KNITPVRRLERRDAARNINYDAASCSSSSAEDLSVSTSSLM 59
Query: 64 XXXXXXX--TSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRL 121
TSFRI G GE +RI RSLG+SGP+D AI AWEA K RS+SD++ R +
Sbjct: 60 TRSLEFPEPTSFRIGGGVGEMDRIYRSLGVSGPDDLAISFDAWEACKKRSSSDVVNRFKS 119
Query: 122 KQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTR-----TKLTQVAELSC-- 174
LD +++ + +G VVG D ++ V+ ++ +E T+L+++ L
Sbjct: 120 FDLDKVRDQDLSEEGPSGVVVGS--DSMNHKVQGQDLSEAGPSGGIVTELSEIGNLITPV 177
Query: 175 -RASGAGNNDALAVMETTE--LPPSG-LAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQ 230
R G + VME T + G L ++ V GIKG+RPP+LKPPP M++
Sbjct: 178 DRLVADGVVENRRVMERTPTIVKSKGYLVPNNVVAVGVGVGGGIKGLRPPVLKPPPAMKR 237
Query: 231 PVIDNACSTWDILRDFAPKDGI---TPSSVMNDRALXXXXXXXXXXXXXXXXXRAIVKEE 287
P ID+ S+WD L FAP + + + SS ++ R I +
Sbjct: 238 PPIDHRGSSWDFLTHFAPSETVKRPSSSSSSSEDGCDEEEGKEEEAEAEEMGARFIQLGD 297
Query: 288 EDDMVLSESCSFXXXXXXXXXXXXXXPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYE 347
D E+CSF S I P+G IIT WQKG LLGRGSFGSVYE
Sbjct: 298 TAD----ETCSFTTNEGDSSSTVSNT--SPIYPDGG--AIITSWQKGQLLGRGSFGSVYE 349
Query: 348 GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407
GIS DG FFAVKEVSLLDQGSQA++ I QLE EI LLS+ +H+NIV+Y GT KD S LYI
Sbjct: 350 GISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNLYI 409
Query: 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467
FLELVT+GSLL LYQRY LRDS VS YTRQIL GLKYLHD+ +HRDIKCANILVDANG+
Sbjct: 410 FLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDANGA 469
Query: 468 VKLADFGLAKV 478
VKLADFGLAKV
Sbjct: 470 VKLADFGLAKV 480
|
|
| TAIR|locus:2133539 MAPKKK9 "mitogen-activated protein kinase kinase kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 676 (243.0 bits), Expect = 4.5e-82, Sum P(2) = 4.5e-82
Identities = 153/276 (55%), Positives = 179/276 (64%)
Query: 212 KGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALXXXXXXXX 271
+GIKGVRP +LKPPP M+ P +D S+WDIL FAP I R
Sbjct: 387 RGIKGVRPSVLKPPPVMKLPPVDLPGSSWDILTHFAPDSEIV-------RRPSSSSSSEN 439
Query: 272 XXXXXXXXXRAIVKEEEDDMVLS------ESCSFXXXXXXXXXXXXXXPMSNISP---NG 322
+ KEE DM + E+CSF +SN SP +G
Sbjct: 440 GCDEEEAEDDKVEKEETGDMFIQLEDTTDEACSFTTNEGDSSST-----VSNTSPICVSG 494
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
I T WQKG LL +GSFGSVYE IS+DG FFAVKEVSLLDQGSQA++ I QLE EIA
Sbjct: 495 G--SINTSWQKGQLLRQGSFGSVYEAISEDGDFFAVKEVSLLDQGSQAQECIQQLEGEIA 552
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
LLS+ EH+NI++Y GTDKD S LYIFLELVT+GSLL LY+RY +RDS +S YT+QIL GL
Sbjct: 553 LLSQLEHQNILRYRGTDKDGSNLYIFLELVTQGSLLELYRRYQIRDSLISLYTKQILDGL 612
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
KYLH + +HRDIKCA ILVDANG+VKLADFGLAKV
Sbjct: 613 KYLHHKGFIHRDIKCATILVDANGTVKLADFGLAKV 648
|
|
| TAIR|locus:2118116 WRKY19 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 3.6e-60, Sum P(2) = 3.6e-60
Identities = 124/188 (65%), Positives = 138/188 (73%)
Query: 295 ESCSFXXXXXXXXXXXXXXPMSNISP----NGRFKRIITYWQKGDLLGRGSFGSVYEGIS 350
E+CSF +SN SP G F IT WQKG LLGRGS GSVYEGIS
Sbjct: 1594 ETCSFTVNKGDSSRT-----ISNTSPIYASEGSF---ITCWQKGQLLGRGSLGSVYEGIS 1645
Query: 351 DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410
DG FFA KEVSLLDQGSQA + I Q+E IALLS+ +H+NIV+Y GT KDES LYIFLE
Sbjct: 1646 ADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLE 1705
Query: 411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470
LVT+GSL LYQR L DS VS YTRQIL GLKYLHD+ +HR+IKCAN+LVDANG+VKL
Sbjct: 1706 LVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKL 1765
Query: 471 ADFGLAKV 478
ADFGLAKV
Sbjct: 1766 ADFGLAKV 1773
|
|
| TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 1.6e-55, Sum P(2) = 1.6e-55
Identities = 110/157 (70%), Positives = 127/157 (80%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
N R IT W KG LLGRGS+ SVYE IS+DG FFAVKEVSLLD+G QA++ I QLE E
Sbjct: 293 NFRKPEDITSWLKGQLLGRGSYASVYEAISEDGDFFAVKEVSLLDKGIQAQECIQQLEGE 352
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL 440
IALLS+ +H+NIV+Y GT KD SKLYIFLELVT+GS+ LY+RY L + VS YTRQIL
Sbjct: 353 IALLSQLQHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERYQLSYTVVSLYTRQILA 412
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
GL YLHD+ VHRDIKCAN+LVDANG+VKLADFGLA+
Sbjct: 413 GLNYLHDKGFVHRDIKCANMLVDANGTVKLADFGLAE 449
|
|
| TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 391 (142.7 bits), Expect = 2.9e-35, P = 2.9e-35
Identities = 80/149 (53%), Positives = 106/149 (71%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+KG LLG GSFG VY G S+ G A+KEV+L ++++S QL QEI++LSR H
Sbjct: 400 WKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRH 459
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
+NIVQYYG++ + KLYI+LE V+ GS+ L Q Y ++ + YT+QIL GL YLH +
Sbjct: 460 QNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYGQFGENAIRNYTQQILSGLAYLHAK 519
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK 477
+ VHRDIK ANILVD +G VK+ADFG+AK
Sbjct: 520 NTVHRDIKGANILVDPHGRVKVADFGMAK 548
|
|
| TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 373 (136.4 bits), Expect = 5.1e-35, Sum P(2) = 5.1e-35
Identities = 80/151 (52%), Positives = 104/151 (68%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+KG L+GRG+FGSVY S+ G A+KEV L ++ + I QLEQEI LLS +H
Sbjct: 346 WKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQH 405
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
NIVQY+G++ E + +I+LE V GS+ N Y R H + +S V +TR IL GL YLH
Sbjct: 406 PNIVQYFGSETVEDRFFIYLEYVHPGSI-NKYIRDHCGTMTESVVRNFTRHILSGLAYLH 464
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
++ VHRDIK AN+LVDA+G VKLADFG+AK
Sbjct: 465 NKKTVHRDIKGANLLVDASGVVKLADFGMAK 495
|
|
| TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 367 (134.2 bits), Expect = 3.2e-33, P = 3.2e-33
Identities = 75/149 (50%), Positives = 99/149 (66%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+KG LG G+FG VY G S+ G A+KEV ++ +K+ + QL QEI LL++ H
Sbjct: 214 WKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQLCH 273
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
NIVQYYG++ E L ++LE V+ GS+ L + Y + + YTRQIL GL YLH +
Sbjct: 274 PNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPVIQNYTRQILAGLAYLHGR 333
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK 477
+ VHRDIK ANILVD NG +KLADFG+AK
Sbjct: 334 NTVHRDIKGANILVDPNGEIKLADFGMAK 362
|
|
| DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 340 (124.7 bits), Expect = 8.0e-31, Sum P(2) = 8.0e-31
Identities = 68/151 (45%), Positives = 99/151 (65%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRF 387
WQKG +LGRG +GSVY G++ D G FAVK++ ++D S + K I +EI ++
Sbjct: 495 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 554
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLH 446
H+NIV+Y GT D+S L +FLE + GS+ +L ++ ++ + YT+QIL GL +LH
Sbjct: 555 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 614
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
++HRDIK ANIL+D G VKL+DFG +K
Sbjct: 615 ANSIIHRDIKGANILIDTKGIVKLSDFGCSK 645
|
|
| TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 345 (126.5 bits), Expect = 1.2e-30, P = 1.2e-30
Identities = 73/152 (48%), Positives = 102/152 (67%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ-GSQAKQS--ISQLEQEIALLSR 386
W+KG L+GRG+FG+VY G++ D G AVK+V + S+ K I +LE+E+ LL
Sbjct: 69 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 445
H NIV+Y GT +++ L I LE V GS+ +L +++ +S V YTRQ+LLGL+YL
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYL 188
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
H+ ++HRDIK ANILVD G +KLADFG +K
Sbjct: 189 HNHAIMHRDIKGANILVDNKGCIKLADFGASK 220
|
|
| TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 325 (119.5 bits), Expect = 2.6e-30, Sum P(2) = 2.6e-30
Identities = 67/153 (43%), Positives = 101/153 (66%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 385
W+KG+L+G G+FG VY G++ D G A+K+V L+ S +K+ I +LE+E+ LL
Sbjct: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAIKQV-LIAPSSASKEKTQGHIRELEEEVQLLK 126
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
H NIV+Y GT ++ L I +E V GS+ +L +++ + + YT+Q+LLGL+Y
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEY 186
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
LH+ ++HRDIK ANILVD G ++LADFG +K
Sbjct: 187 LHNNGIMHRDIKGANILVDNKGCIRLADFGASK 219
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39008 | M3K1_ARATH | 2, ., 7, ., 1, 1, ., 2, 5 | 0.5070 | 0.8910 | 0.7532 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 514 | |||
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-82 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-63 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-51 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-41 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-37 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-36 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-33 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-32 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-31 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-29 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-28 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-25 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-21 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-19 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-17 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-17 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-12 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-12 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 255 bits (652), Expect = 7e-82
Identities = 97/150 (64%), Positives = 118/150 (78%), Gaps = 2/150 (1%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+KG+LLG GSFGSVYEG++ DDG FFAVKEVSL D G ++++ QLEQEIALLS+ +H
Sbjct: 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
NIVQY GT+++E LYIFLELV GSL L ++Y + + YTRQILLGL+YLHD+
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ VHRDIK ANILVD NG VKLADFG+AK
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQ 151
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 2e-63
Identities = 80/151 (52%), Positives = 104/151 (68%), Gaps = 7/151 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W +G+LLGRGSFGSVY + D G AVK V L +++ + LE+EI +LS +H
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVEL---SGDSEEELEALEREIRILSSLQH 58
Query: 390 ENIVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
NIV+YYG+++DE K L IFLE V+ GSL +L +++ L + + YTRQIL GL YLH
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+VHRDIK ANILVD++G VKLADFG AK
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAK 149
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 8e-56
Identities = 70/147 (47%), Positives = 96/147 (65%), Gaps = 5/147 (3%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
Q GDL+GRG+FG VY+G++ + G F A+K++SL +A +SI Q EI LL +H
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQ---EIDLLKNLKHP 59
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
NIV+Y G+ + LYI LE GSL + +++ +S V+ Y Q+L GL YLH+Q
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA 476
V+HRDIK ANIL +G VKLADFG+A
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA 146
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 9e-51
Identities = 58/151 (38%), Positives = 87/151 (57%), Gaps = 6/151 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ + LG GSFG VY G A+K + + K+ ++ +EI +L + +H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKK----KKIKKDRERILREIKILKKLKH 56
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
NIV+ Y +DE KLY+ +E G L +L ++ L + + Y RQIL L+YLH +
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+VHRD+K NIL+D +G VKLADFGLA+
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQL 147
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 70/151 (46%), Positives = 95/151 (62%), Gaps = 2/151 (1%)
Query: 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
T W++G LLG+G+FG VY D G AVK+V + K+ ++ LE EI LL
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
+HE IVQYYG +D+ L IF+E + GS+ + + Y L ++ YTRQIL G++YLH
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+VHRDIK ANIL D+ G+VKL DFG +K
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 59/154 (38%), Positives = 82/154 (53%), Gaps = 5/154 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ LG GSFG+VY+ G AVK + + S+ Q +EI +L R H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQ---TARREIRILRRLSH 57
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
NIV+ +D+ LY+ +E G L + R L + + QIL GL+YLH
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
++HRD+K NIL+D NG VK+ADFGLAK L S
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS 151
|
Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 2e-41
Identities = 63/150 (42%), Positives = 91/150 (60%), Gaps = 5/150 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
WQ+G+ +G G+FG VY ++ D G AVKE+ + Q + K +I ++ E+ +L +H
Sbjct: 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRI--QDNDPK-TIKEIADEMKVLELLKH 58
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHDQ 448
N+V+YYG + K+YIF+E + G+L L + + D V YT Q+L GL YLH
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKV 478
+VHRDIK ANI +D NG +KL DFG A
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 9e-41
Identities = 53/156 (33%), Positives = 93/156 (59%), Gaps = 8/156 (5%)
Query: 330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
++ + +G+G FG VY+ G A+K + L ++K+ ++ EI +L + +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCK 55
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLH 446
H NIV+YYG+ + +L+I +E + GSL +L + + +SQ++ +++L GL+YLH
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
++HRDIK ANIL+ ++G VKL DFGL+ +
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 9e-41
Identities = 58/154 (37%), Positives = 85/154 (55%), Gaps = 8/154 (5%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G FG+VY G A+K + + + +L +EI +L + H NIV+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
YG +DE+ LY+ +E GSL +L + L + ++ QIL GL+YLH ++HR
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 454 DIKCANILVDA-NGSVKLADFGLAKVFLSSLDFD 486
D+K NIL+D+ NG VKLADFGL+K+ S
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL 150
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 72/153 (47%), Positives = 95/153 (62%), Gaps = 6/153 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 385
W KG L+G GSFGSVY G+ + G AVK+V L + +K + L +EIALL
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
+HENIVQY G+ D L IFLE V GS+ L Y ++ V + RQIL GL Y
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
LH++ ++HRDIK ANILVD G +K++DFG++K
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 9/157 (5%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G+GSFG VY DG + +KE+ L + + ++ E+ +L + H NI+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE---DALNEVKILKKLNHPNII 62
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ 448
+YY + +++ KL I +E G L ++ + Q+ + Q+ L LKYLH +
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
++HRDIK NI + +NG VKL DFG++KV S++D
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 9e-37
Identities = 57/146 (39%), Positives = 87/146 (59%), Gaps = 5/146 (3%)
Query: 332 QKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ +G+GSFG VY+ I A+K + L +A+ I ++QEI LS+
Sbjct: 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQCRSP 59
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
I +YYG+ SKL+I +E GS L+L + L ++ ++ R++LLGL+YLH++
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 451 VHRDIKCANILVDANGSVKLADFGLA 476
+HRDIK ANIL+ G VKLADFG++
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-36
Identities = 64/150 (42%), Positives = 99/150 (66%), Gaps = 4/150 (2%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ--AKQSISQLEQEIALLSRFE 388
W KG++LG+G++G+VY G+++ G AVK+V L D + A++ +L++E+ LL +
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVEL-DTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD 447
H NIVQY GT D++ + IF+E V GS+ ++ R+ L + YT+QIL G+ YLH+
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477
VVHRDIK N+++ NG +KL DFG A+
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 7e-36
Identities = 61/154 (39%), Positives = 91/154 (59%), Gaps = 7/154 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL----LDQGSQAKQSI-SQLEQEIALL 384
W KG+L+G+G++G VY ++ G AVK+V L + ++ + L EI L
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-VSAYTRQILLGLK 443
+H NIVQY G + E L IFLE V GS+ + + Y + Q V +T Q+L GL
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
YLH + ++HRD+K N+LVDA+G K++DFG++K
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 55/143 (38%), Positives = 81/143 (56%), Gaps = 8/143 (5%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G++G VY+ G A+K + L ++QEI++L H NIV Y
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAY 65
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+G+ KL+I +E GSL ++YQ R L + Q++ R+ L GL YLH+ +HR
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125
Query: 454 DIKCANILVDANGSVKLADFGLA 476
DIK ANIL+ +G VKLADFG++
Sbjct: 126 DIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 9e-34
Identities = 53/156 (33%), Positives = 90/156 (57%), Gaps = 7/156 (4%)
Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
++ +LG+GS G VY+ G +A+K++ + QL +E+ L E
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF----RKQLLRELKTLRSCESP 59
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH-DQ 448
+V+ YG E ++ I LE + GSL +L ++ + + ++ RQIL GL YLH +
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
++HRDIK +N+L+++ G VK+ADFG++KV ++LD
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 50/145 (34%), Positives = 85/145 (58%), Gaps = 10/145 (6%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+ LG GS+GSVY+ I + G A+K V + ++ + ++ +EI++L + + IV
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIV 61
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+YYG+ + L+I +E GS+ ++ + L + +++A Q L GL+YLH +
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121
Query: 452 HRDIKCANILVDANGSVKLADFGLA 476
HRDIK NIL++ G KLADFG++
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-33
Identities = 73/152 (48%), Positives = 94/152 (61%), Gaps = 6/152 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFE 388
W+ G LLGRG+FG VY +D G AVK+V D SQ + ++ LE EI LL
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPF-DPDSQETSKEVNALECEIQLLKNLR 62
Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYL 445
H+ IVQYYG D +E KL IF+E + GS+ + + Y L ++ YTRQIL G+ YL
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
H +VHRDIK ANIL D+ G+VKL DFG +K
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-33
Identities = 54/151 (35%), Positives = 91/151 (60%), Gaps = 6/151 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRF 387
W KG LG G+F S Y D G AVK+V+ + S ++ + + L +EI L++R
Sbjct: 2 WLKGQQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
H +I++ G ++S +F+E + GS+ +L +Y +++ + YT Q+L GL YLH
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 447 DQDVVHRDIKCANILVDANGS-VKLADFGLA 476
+ ++HRD+K AN+L+D+ G +++ADFG A
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-33
Identities = 49/153 (32%), Positives = 79/153 (51%), Gaps = 11/153 (7%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFF-----AVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
G LG G+FG VY+G AVK L + + +Q I + +E ++ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQ-IEEFLREARIMRK 57
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKY 444
+H N+V+ G +E LYI +E + G LL+ R L S + ++ QI G++Y
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
L ++ +HRD+ N LV N VK++DFGL++
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFF-----AVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ G LG G+FG VY+G AVK L +G+ ++ +E +++ +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK---TLKEGASEEEREE-FLEEASIMKK 57
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
H NIV+ G LYI E + G LL+ +++ L + QI G++Y
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
L ++ VHRD+ N LV N VK++DFGL++
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 70/153 (45%), Positives = 93/153 (60%), Gaps = 4/153 (2%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
T W+ G LLG+G+FG VY +D G AVK+V + + + ++ LE EI LL
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 388 EHENIVQYYGTDKD--ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
HE IVQYYG +D E L IF+E + GS+ + + Y L ++ YTRQIL G+ Y
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
LH +VHRDIK ANIL D+ G+VKL DFG +K
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 70/151 (46%), Positives = 92/151 (60%), Gaps = 4/151 (2%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W++G LLG+G+FG VY D G A K+V + + + +S LE EI LL +H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
E IVQYYG D+ E L IF+E + GS+ + + Y L +S YTRQIL G+ YLH
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+VHRDIK ANIL D+ G+VKL DFG +K
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 14/154 (9%)
Query: 333 KGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LG G+FG VY+G AVK + + ++Q I + +E ++ +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL----KEDASEQQIEEFLREARIMRKL 58
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLK 443
+H NIV+ G +E L I +E + G LL+ Y R + L S + ++ QI G++
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLD-YLRKNRPKELSLSDLLSFALQIARGME 117
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
YL ++ +HRD+ N LV N VK++DFGL++
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 58/164 (35%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+ +G+GSFG+V + DG KE +D G+ ++ QL E+ +L +H NIV
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKE---IDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 394 QYYGTDKDESK--LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLH 446
+YY D S LYI +E G L L Q+ ++ + + Q+LL L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 447 -----DQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
V+HRD+K ANI +DAN +VKL DFGLAK+ F
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 54/149 (36%), Positives = 86/149 (57%), Gaps = 12/149 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+K +G G+ G VY+ G A+K++ L KQ+ + EI ++ +H
Sbjct: 24 LEK---IGEGASGEVYKATDRATGKEVAIKKMRL------RKQNKELIINEILIMKDCKH 74
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
NIV YY + +L++ +E + GSL ++ + +R + Q++ R++L GL+YLH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLA 476
Q+V+HRDIK NIL+ +GSVKLADFG A
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 51/151 (33%), Positives = 82/151 (54%), Gaps = 9/151 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--LLDQGSQAKQSISQLEQEI-ALLSRFEH 389
G ++G GSF +V + +A+K + L + + K ++E+E+ L+ H
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--EKKVKYVKIEKEVLTRLNG--H 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 448
I++ Y T +DE LY LE G LL ++Y D + + Y +ILL L+YLH +
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
++HRD+K NIL+D + +K+ DFG AKV
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVL 152
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 6e-29
Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 335 DLLGRGSFGSVYEGISDDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG VY+G AVK + + +++ +E ++ + H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL----KEDASEEERKDFLKEARVMKKLGHP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL----------NLYQRYHLRDSQVSAYTRQILL 440
N+V+ G +E LY+ LE + G LL ++ L + ++ QI
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
G++YL + VHRD+ N LV + VK++DFGL++
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 60/148 (40%), Positives = 84/148 (56%), Gaps = 11/148 (7%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LG+G++G VY A+KE+ D + + L +EIAL S +H NIVQ
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-----RYVQPLHEEIALHSYLKHRNIVQ 69
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDV 450
Y G+D + IF+E V GSL L + + + YT+QIL GLKYLHD +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 451 VHRDIKCANILVDA-NGSVKLADFGLAK 477
VHRDIK N+LV+ +G VK++DFG +K
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSK 157
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 51/153 (33%), Positives = 79/153 (51%), Gaps = 11/153 (7%)
Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFE 388
+K + LG G++G VY+ G A+K++ L ++ I L +EI+LL +
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL----DNEEEGIPSTAL-REISLLKELK 56
Query: 389 HENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
H NIV+ E KLY+ E L+ L + + + Q+L GL Y H
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPG-PLSPNLIKSIMYQLLRGLAYCH 115
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
++HRD+K NIL++ +G +KLADFGLA+ F
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAF 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 15/162 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
+QK +G G++G VY+ G A+K++ L + K ++ +EI LL
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELN 56
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLK 443
H NI++ + + LY+ E + +LY+ + L +S + +Y Q+L GL
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
+ H ++HRD+K N+L++ G +KLADFGLA+ F S +
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 52/159 (32%), Positives = 85/159 (53%), Gaps = 15/159 (9%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ--SISQLEQEIALLSRFEHENIV 393
+G G++G VY+ + G A+K++ + K+ I+ + EI LL + H NIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM----ENEKEGFPITAIR-EIKLLQKLRHPNIV 61
Query: 394 QYYG--TDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+ T K + +Y+ E + G L + +SQ+ Y +Q+L GL+YLH
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDL 487
++HRDIK +NIL++ +G +KLADFGLA+ + D
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 52/152 (34%), Positives = 81/152 (53%), Gaps = 16/152 (10%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRF 387
LG GSFG V G ++A+K +S K I +L+Q E +L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILS--------KAKIVKLKQVEHVLNEKRILQSI 58
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLH 446
H +V YG+ +D+S LY+ +E V G L + ++ V+ Y Q++L L+YLH
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
D+V+RD+K N+L+D++G +K+ DFG AK
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR 150
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 54/157 (34%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEH 389
LG+GSFG V D G +A+K + K+ I + ++ E +LSR H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK--------KKKIIKRKEVEHTLTERNILSRINH 52
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
IV+ + + E KLY+ LE G L + L + + + Y +I+L L+YLH
Sbjct: 53 PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL 112
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
+++RD+K NIL+DA+G +KL DFGLAK S
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR 149
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 56/158 (35%), Positives = 92/158 (58%), Gaps = 8/158 (5%)
Query: 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
+ +Q+ +L+GRG++G+VY G G A+K ++L +S +++E+ALLS+
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINL----DTPDDDVSDIQREVALLSQL 56
Query: 388 EH---ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
NI +YYG+ +L+I +E GS+ L + + + +S R++L+ LKY
Sbjct: 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
+H V+HRDIK ANILV G+VKL DFG+A + +
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-26
Identities = 57/146 (39%), Positives = 94/146 (64%), Gaps = 3/146 (2%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ K + +G+GSFG V++GI D V + ++D +A+ I ++QEI +LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 62
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ +YYG+ ++KL+I +E + GS L+L + L ++Q++ R+IL GL YLH +
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 451 VHRDIKCANILVDANGSVKLADFGLA 476
+HRDIK AN+L+ +G VKLADFG+A
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 58/147 (39%), Positives = 91/147 (61%), Gaps = 5/147 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ K + +G+GSFG VY+GI + A+K + L +A+ I ++QEI +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
I +YYG+ +KL+I +E + GS L+L + L ++ ++ R+IL GL YLH +
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA 476
+HRDIK AN+L+ G VKLADFG+A
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 52/152 (34%), Positives = 81/152 (53%), Gaps = 8/152 (5%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
W+ LG G+FG VY+ + G F A K + + ++++ + EI +LS
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSE 58
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKY 444
+H NIV Y E+KL+I +E G+L ++ L + Q+ RQ+L L +
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
LH V+HRD+K NIL+ +G VKLADFG++
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 51/155 (32%), Positives = 88/155 (56%), Gaps = 10/155 (6%)
Query: 337 LGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G GSFG +Y + SD +KE+ L + K++ ++E+ LL++ +H NIV
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHC-VIKEIDLTKMPVKEKEAS---KKEVILLAKMKHPNIVT 63
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVV 451
++ + ++ +L+I +E G L+ R + Q+ ++ QI LGLK++HD+ ++
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123
Query: 452 HRDIKCANILVDANGSV-KLADFGLAKVFLSSLDF 485
HRDIK NI + NG V KL DFG+A+ S++
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 55/147 (37%), Positives = 90/147 (61%), Gaps = 5/147 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ K + +G+GSFG V++GI + A+K + L +A+ I ++QEI +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+ +YYG+ +KL+I +E + GS L+L + + Q++ ++IL GL YLH +
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA 476
+HRDIK AN+L+ G VKLADFG+A
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 51/158 (32%), Positives = 88/158 (55%), Gaps = 17/158 (10%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-----LSRFEHE 390
+G+GSFG V++ + D +A+K++ L +++ E+E A+ L++ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDL--------SKMNRREREEAIDEARVLAKLDSS 59
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHD 447
I++YY + D+ KL I +E G L L + L + QV + QILLGL +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
+ ++HRDIK N+ +DA +VK+ D G+AK+ + +F
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 49/150 (32%), Positives = 71/150 (47%), Gaps = 16/150 (10%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEH 389
LG G FG V FA+K V K+ I + Q E +L H
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVK--------KRHIVETGQQEHIFSEKEILEECNH 52
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
IV+ Y T KD+ +Y+ +E G L L R + Y ++L +YLH++
Sbjct: 53 PFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKV 478
+++RD+K N+L+D+NG VKL DFG AK
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKK 142
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 55/161 (34%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
KR + + ++ LG G FG V D V SL S +Q S E+EI
Sbjct: 3 KRHLKFIKQ---LGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREI 57
Query: 382 ALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQ 437
+L +HENIV+Y G L + +E + GSL + QR+ + ++ ++ Q
Sbjct: 58 EILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ 117
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
I G+ YL Q +HRD+ NILV++ VK++DFGLAKV
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 57/156 (36%), Positives = 85/156 (54%), Gaps = 21/156 (13%)
Query: 335 DLLGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSRF 387
LG+GS+GSVY + +SD F+A+KEV L S+SQ E+ EI +L+
Sbjct: 6 KKLGKGSYGSVYKVKRLSD-NQFYALKEVDL--------GSMSQKEREDAVNEIRILASV 56
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGL 442
H NI+ Y D +KL I +E G L + + + ++ Q+L GL
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ LH+Q ++HRD+K ANIL+ AN VK+ D G++KV
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 57/179 (31%), Positives = 88/179 (49%), Gaps = 10/179 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EH 389
++ LG GSFG VY D A+K ++ + + + + +EI +L+
Sbjct: 2 YRILRKLGEGSFGEVYLAR--DRKLVALKVLAK--KLESKSKEVERFLREIQILASLNHP 57
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYL 445
NIV+ Y +DE LY+ +E V GSL +L ++ L +S+ QIL L+YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 446 HDQDVVHRDIKCANILVDANGS-VKLADFGLAKVFLSSLDFDLLLIFSIFLNGCKFFLI 503
H + ++HRDIK NIL+D +G VKL DFGLAK+ + G ++
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
|
Length = 384 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 50/151 (33%), Positives = 82/151 (54%), Gaps = 8/151 (5%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G+G F VY+ I DG A+K+V + + AK L +EI LL + +H N+++Y
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCL-KEIDLLKQLDHPNVIKY 67
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ + ++L I LEL G L + Q+ + + + Y Q+ L+++H + +
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKVFLS 481
+HRDIK AN+ + A G VKL D GL + F S
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSS 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-23
Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EI-ALLSRFEH 389
LG G+FGSVY + + G A+K + K+ E+ E+ +L EH
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK---------KMKKKFYSWEECMNLREVKSLRKLNEH 57
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------SQVSAYTRQILLGLK 443
NIV+ ++ +LY E + NLYQ R S + + QIL GL
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
++H HRD+K N+LV VK+ADFGLA+
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G+ G V + G AVK + L + Q+ +E+ +L + IV +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRL----EINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQ-DVVH 452
YG + + I +E + GSL + + R + + +L GL YLH++ ++H
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124
Query: 453 RDIKCANILVDANGSVKLADFGLAKVFLSSL 483
RD+K +NILV++ G +KL DFG++ ++SL
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 19/156 (12%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ- 394
LG G+FG VY+ G A+K++ + ++ I+ L +EI +L + +H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITAL-REIKILKKLKHPNVVPL 72
Query: 395 ----YYGTDKDESKLYIFLELVT-------KGSLLNLYQRYHLRDSQVSAYTRQILLGLK 443
DK + K +VT G L N L +SQ+ Y Q+L G+
Sbjct: 73 IDMAVERPDKSKRKRGSVY-MVTPYMDHDLSGLLEN--PSVKLTESQIKCYMLQLLEGIN 129
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
YLH+ ++HRDIK ANIL+D G +K+ADFGLA+ +
Sbjct: 130 YLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 46/159 (28%), Positives = 85/159 (53%), Gaps = 19/159 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
++ +++G G++G VY+ G A+K + ++ + ++++E +L ++
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------EDEEEEIKEEYNILRKYSN 61
Query: 389 HENIVQYYGT------DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS----AYT-RQ 437
H NI +YG ++ +L++ +EL GS+ +L + + ++ AY R+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
L GL YLH+ V+HRDIK NIL+ N VKL DFG++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 47/144 (32%), Positives = 81/144 (56%), Gaps = 4/144 (2%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+ +G++G V+ G +A+K + D K + Q+ E +LS+ + +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
Y + + + LY+ +E + G L +L + D V+ Y +I+L L+YLH ++HRD
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 455 IKCANILVDANGSVKLADFGLAKV 478
+K NIL+D+NG +KL DFGL+KV
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKV 142
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 6e-23
Identities = 48/153 (31%), Positives = 86/153 (56%), Gaps = 9/153 (5%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G+ VY I + A+K + L + + S+ +L +E+ +S+ H N+V+Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 396 YGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
Y + +L++ + ++ GSLL++ Y R L ++ ++ +++L GL+YLH +
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124
Query: 452 HRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
HRDIK NIL+ +GSVK+ADFG++ D
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 12/156 (7%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G+ GSV + + + G FA+K ++ KQ + +E+ + + IV+Y
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ----ILRELEINKSCKSPYIVKY 64
Query: 396 YGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYLHDQ 448
YG D+ S + I +E GSL ++Y++ R ++ +L GL YLH +
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
++HRDIK +NIL+ G VKL DFG++ ++SL
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 53/162 (32%), Positives = 88/162 (54%), Gaps = 18/162 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRFE 388
++KG LG G++ VY+ + G A+K++ L + +AK I+ +EI LL +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKL-GERKEAKDGINFTALREIKLLQELK 60
Query: 389 HENI---VQYYGTDKDESKLYIF----LELVTK-GSLLNLYQRYHLRDSQVSAYTRQILL 440
H NI + +G + + ++ F LE V K S++ L + + +Y L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV-------LTPADIKSYMLMTLR 113
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
GL+YLH ++HRD+K N+L+ ++G +KLADFGLA+ F S
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 50/146 (34%), Positives = 76/146 (52%), Gaps = 9/146 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G + AVK L G+ + ++ QE ++ + H+ +VQ Y
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT---LKPGTMSPEA---FLQEAQIMKKLRHDKLVQLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+E +YI E ++KGSLL+ + LR Q+ QI G+ YL ++ +HR
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHR 127
Query: 454 DIKCANILVDANGSVKLADFGLAKVF 479
D+ NILV N K+ADFGLA++
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLI 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 56/162 (34%), Positives = 86/162 (53%), Gaps = 18/162 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL---SR 386
+++ +G G++G+VY+ + G F A+K+V + S+ +S L +EIALL
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV--PLSEEGIPLSTL-REIALLKQLES 57
Query: 387 FEHENIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQ 437
FEH NIV+ E KL + E V + L Y L + RQ
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD--LATYLSKCPKPGLPPETIKDLMRQ 115
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+L G+ +LH +VHRD+K NILV ++G VK+ADFGLA+++
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 9/147 (6%)
Query: 337 LGRGSFGS--VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
LG+G+FG +Y DD KEV+L + ++ EI +LS +H NI+
Sbjct: 8 LGKGAFGEATLYRRTEDDSLV-VWKEVNLTRLSEKERRDA---LNEIVILSLLQHPNIIA 63
Query: 395 YYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
YY D++ L I +E G+L + + + V Y QI+ + Y+H ++
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 452 HRDIKCANILVDANGSVKLADFGLAKV 478
HRDIK NI + G +KL DFG++K+
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKI 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 54/149 (36%), Positives = 89/149 (59%), Gaps = 7/149 (4%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G++G VY+ + + G A+K + L + + + ++QEI ++ +H NIV Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+G+ KL+I +E GSL ++Y L +SQ++ +R+ L GL YLH + +HRD
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131
Query: 455 IKCANILVDANGSVKLADFGLAKVFLSSL 483
IK ANIL+ NG VKLADFG++ +++
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATI 160
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 57/142 (40%), Positives = 83/142 (58%), Gaps = 7/142 (4%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G++G VY+ + G AVK + L + G S ++QEI ++ +H NIV Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL-EPGD----DFSLIQQEIFMVKECKHCNIVAY 71
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+G+ KL+I +E GSL ++Y L + Q++ R+ L GL YLH + +HRD
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131
Query: 455 IKCANILVDANGSVKLADFGLA 476
IK ANIL+ NG VKLADFG+A
Sbjct: 132 IKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 48/149 (32%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 338 GRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
G+G+FG V D FA+K ++ Q K S+ + E +L H +V +
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMN--KQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHL------RDSQVSAYTRQILLGLKYLHDQDV 450
+ +DE +Y+ ++L+ G L RYHL + QV + +I+L L+YLH + +
Sbjct: 67 YSFQDEENMYLVVDLLLGGDL-----RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKVF 479
+HRDIK NIL+D G V + DF +A
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKV 150
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 55/155 (35%), Positives = 86/155 (55%), Gaps = 11/155 (7%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
Y +K +LG G FG V Y+ +D G AVK + + +Q+ S ++EI +L
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL----KRECGQQNTSGWKKEINIL 60
Query: 385 SRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
HENIV+Y G +++ L + +E V GSL + ++ L +Q+ + +QI G+
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGM 120
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
YLH Q +HRD+ N+L+D + VK+ DFGLAK
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 15/152 (9%)
Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIV 393
+G G++G V + G A+K++S + AK+ + +EI LL HENI+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENII 62
Query: 394 Q----YYGTDKDE-SKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLH 446
++ + +YI EL + L+ + L D + + QIL GLKYLH
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTEL--METDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+V+HRD+K +NILV++N +K+ DFGLA+
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARG 152
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 49/146 (33%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+EG+ ++ AVK L G+ E ++ + H ++Q Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKT---LKPGTM---DPKDFLAEAQIMKKLRHPKLIQLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
E +YI EL+ GSLL Q L+ Q+ Q+ G+ YL Q+ +HR
Sbjct: 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127
Query: 454 DIKCANILVDANGSVKLADFGLAKVF 479
D+ N+LV N K+ADFGLA+V
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVI 153
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-21
Identities = 49/156 (31%), Positives = 93/156 (59%), Gaps = 13/156 (8%)
Query: 337 LGRGSFG-SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GSFG ++ +DG + +KE+++ + ++ + +E+A+LS +H NIVQY
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQY 64
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLR------DSQVSAYTRQILLGLKYLHDQD 449
+ ++ LYI ++ G +LY++ + + + Q+ + QI L LK++HD+
Sbjct: 65 QESFEENGNLYIVMDYCEGG---DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
++HRDIK NI + +G++KL DFG+A+V S+++
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 53/147 (36%), Positives = 84/147 (57%), Gaps = 7/147 (4%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G++G VY+G + G A+K++ L S+ + S +EI+LL +H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRL---ESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 396 YGTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
ES+LY+ E ++ K L +L + ++ V +Y QIL G+ + H + V+H
Sbjct: 65 QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124
Query: 453 RDIKCANILVDANGSVKLADFGLAKVF 479
RD+K N+L+D G +KLADFGLA+ F
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLARAF 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 46/151 (30%), Positives = 80/151 (52%), Gaps = 17/151 (11%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G G+ G V++ + G A+K+V+L L+ G +Q +EI L +H +V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-----NQALREIKALQACQHPYVV 62
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQ 448
+ S + +E + L + L ++QV +Y R +L G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPSD----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
++HRD+K AN+L+ A+G +K+ADFGLA++F
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLF 149
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 53/156 (33%), Positives = 90/156 (57%), Gaps = 14/156 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
+++ + LG G++ +VY+G + G A+KE+ L ++G+ S +EI+L+ +
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP-----STAIREISLMKELK 56
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLK 443
HENIV+ + E+KL + E + K L Y H L + V ++T Q+L G+
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ H+ V+HRD+K N+L++ G +KLADFGLA+ F
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+ G +G+G FG V G G AVK L D + A+ ++ E ++++ H N
Sbjct: 9 KLGATIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLA----EASVMTTLRHPN 61
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQ 448
+VQ G + LYI E + KGSL++ + R + +Q + + G++YL ++
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
+ VHRD+ N+LV + K++DFGLAK D
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 49/152 (32%), Positives = 84/152 (55%), Gaps = 6/152 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+QK + +G G++G VY+ + G A+K++ L D ++ S + +EI+LL H
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELNH 58
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
NIV+ E+KLY+ E + + ++ + + +Y Q+L GL + H
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
V+HRD+K N+L++ G++KLADFGLA+ F
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 8/153 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+QK + +G G++G VY+ G A+K++ L + + S + +EI+LL H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAI--REISLLKELNH 57
Query: 390 ENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
NIV+ E+KLY+ FL+L K + + L + +Y Q+L G+ Y H
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCH 116
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
V+HRD+K N+L+D G++KLADFGLA+ F
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 50/168 (29%), Positives = 87/168 (51%), Gaps = 17/168 (10%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
F ++ ++K +G+G+FG V++ A+K+V L++ + I+ L +EI
Sbjct: 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGF-PITAL-REIK 63
Query: 383 LLSRFEHENIVQYY--------GTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQV 431
+L +HEN+V ++ + Y+ E G L N ++ L S++
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL--SEI 121
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ +L GL Y+H ++HRD+K ANIL+ +G +KLADFGLA+ F
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 26/165 (15%)
Query: 338 GRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFEHENIV 393
GRG++G VY+ +G +A+K+ + ISQ +EIALL +HEN+V
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 394 QYYGT--DKDESKLYIFLELVTKGSLLNLYQ--RYH-------LRDSQVSAYTRQILLGL 442
+ + +Y+ + +L+Q ++H + S V + QIL G+
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKVFLSSL 483
YLH V+HRD+K ANILV G VK+ D GLA++F + L
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 12/152 (7%)
Query: 332 QKGDLLGRGSFGSVY---EGISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSR 386
+ ++GRG+FG V+ + D G +A+K + S + + +Q I+ + E +L+
Sbjct: 4 EVIKVIGRGAFGEVWLVRD--KDTGQVYAMKVLRKSDMIKRNQ----IAHVRAERDILAD 57
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 445
+ IV+ Y + +DE LY+ +E + G L+NL R + Y +++L L +
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
H +HRDIK NIL+DA+G +KLADFGL K
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 45/145 (31%), Positives = 76/145 (52%), Gaps = 7/145 (4%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++G G++G V + + G A+K+ + K++ + E+ +L + HENIV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVN 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ + +LY+ E V + +LL L + L V +Y Q+L + Y H +++H
Sbjct: 65 LKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123
Query: 453 RDIKCANILVDANGSVKLADFGLAK 477
RDIK NILV +G +KL DFG A+
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 52/159 (32%), Positives = 86/159 (54%), Gaps = 17/159 (10%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
+RI T +G G+FG V+ + IS ++A+K +++ + + KQ + E
Sbjct: 3 LERIKT-------VGTGTFGRVHLVRDRIS--EHYYALKVMAIPEV-IRLKQ-EQHVHNE 51
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQI 438
+L H I++ + T+ D+ LY+ +E V G L + Y R R S + Y +I
Sbjct: 52 KRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFS-YLRNSGRFSNSTGLFYASEI 110
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ L+YLH +++V+RD+K NIL+D G +KL DFG AK
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 55/152 (36%), Positives = 84/152 (55%), Gaps = 14/152 (9%)
Query: 336 LLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG+G+FGSV Y+ + D+ G AVK++ Q S A+ + E+EI +L +H+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKL----QHSTAEH-LRDFEREIEILKSLQHD 65
Query: 391 NIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLH 446
NIV+Y G L + +E + GSL + Q++ R ++ Y QI G++YL
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ VHRD+ NILV++ VK+ DFGL KV
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKV 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 46/145 (31%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+EG+ + A+K +L KQ ++E+ L R H++++ +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIK---ILKSDDLLKQQ--DFQKEVQALKRLRHKHLISLF 68
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHR 453
+YI EL+ KGSLL + + V++ Q+ G+ YL +Q+ +HR
Sbjct: 69 AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128
Query: 454 DIKCANILVDANGSVKLADFGLAKV 478
D+ NILV + K+ADFGLA++
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 52/152 (34%), Positives = 82/152 (53%), Gaps = 10/152 (6%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+GRG F VY DG A+K+V + D ++A+ + EI LL + H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPNVIK 66
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
YY + ++++L I LEL G L + Q+ + + V Y Q+ L+++H +
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVFLS 481
V+HRDIK AN+ + A G VKL D GL + F S
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 49/179 (27%), Positives = 96/179 (53%), Gaps = 8/179 (4%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLD 365
SSS+++ S + ++ ++ + +G G+ G+VY+ I G +A+K +
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI---- 107
Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH 425
G+ Q+ +EI +L H N+V+ + ++ + LE + GSL +
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THI 164
Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
+ ++ RQIL G+ YLH + +VHRDIK +N+L+++ +VK+ADFG++++ ++D
Sbjct: 165 ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223
|
Length = 353 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 44/150 (29%), Positives = 77/150 (51%), Gaps = 16/150 (10%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+ +G+G+FG VY+G+ AVK ++ + QE +L +++H NIV+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFL----QEAEILKQYDHPNIVK 56
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL-------LGLKYLHD 447
G + +YI +ELV GSLL LR + +++L G++YL
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLT-----FLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477
++ +HRD+ N LV N +K++DFG+++
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 15/156 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K + +G G++G+V++ + + A+K V L D + S +EI LL +H
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKH 58
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY------HLRDSQVSAYTRQILLGLK 443
+NIV+ Y + KL + E + ++Y + V ++ Q+L GL
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ H +V+HRD+K N+L++ NG +KLADFGLA+ F
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 9e-19
Identities = 43/149 (28%), Positives = 82/149 (55%), Gaps = 3/149 (2%)
Query: 339 RGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 397
+G+FGSVY G +FA+K + D ++ + + + E+ I ++ + E + + Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAKLYY 64
Query: 398 TDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
+ + + LY+ +E + G +L + L + Y +++LG++ LH + ++HRDIK
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124
Query: 457 CANILVDANGSVKLADFGLAKVFLSSLDF 485
N+L+D G +KL DFGL++ L + F
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLENKKF 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 50/156 (32%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G+FG VYEG D V +L + S+ +S E ++S+F H+NI
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDES--DFLMEALIMSKFNHQNI 71
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKY 444
V+ G + +I LEL+ G L + + R + S+ T + LL G KY
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAK 477
L + +HRDI N L+ G K+ADFG+A+
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 52/156 (33%), Positives = 82/156 (52%), Gaps = 12/156 (7%)
Query: 336 LLGRGSFGS---VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
++G GSFG V SD +A+KE+ L S + S +E LL++ +H NI
Sbjct: 7 VVGEGSFGRALLVQHVNSDQ--KYAMKEIRLPKSSSAVEDS----RKEAVLLAKMKHPNI 60
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQ-VSAYTRQILLGLKYLHDQD 449
V + + + + LYI +E G L+ QR L + + Q+ LG++++H++
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
V+HRDIK NI + NG VKL DFG A++ S +
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 14/157 (8%)
Query: 335 DLLGRGSFGSVY--EGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLS----R 386
+ LG G+FG VY ++ A+KE+++ G ++ + ++ ++ +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLG 441
H NIV+YY T + +LYI ++L+ L + ++ + ++ Q++L
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 442 LKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
L+YLH ++ +VHRD+ NI++ + V + DFGLAK
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 38/118 (32%), Positives = 67/118 (56%), Gaps = 5/118 (4%)
Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
AVK++ L Q Q L E+ ++ ++H NIV+ Y + +L++ +E + G+
Sbjct: 48 AVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102
Query: 417 LLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474
L ++ + + Q++ +L L +LH Q V+HRDIK +IL+ ++G VKL+DFG
Sbjct: 103 LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 47/145 (32%), Positives = 79/145 (54%), Gaps = 6/145 (4%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GSFG+VY A+K++S G Q+ + + +E+ L + H N ++Y
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
G E ++ +E L + +L ++++ L++ +++A L GL YLH + +HR
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHR 139
Query: 454 DIKCANILVDANGSVKLADFGLAKV 478
DIK NIL+ G+VKLADFG A +
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 15/162 (9%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
R +T ++K + +G G++G VY + G A+K+V + D + IS L +EI LL
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-DN-ERDGIPISSL-REITLL 60
Query: 385 SRFEHENIVQYYGTDKDESKLYIFL-------ELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
H NIV+ + IFL +L SLL+ +SQV Q
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDL---ASLLDNMPT-PFSESQVKCLMLQ 116
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+L GL+YLH+ ++HRD+K +N+L+ G +K+ADFGLA+ +
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 49/146 (33%), Positives = 82/146 (56%), Gaps = 6/146 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ + + +G+G+ G+VY I G A+K+++L Q K+ I EI ++ +H
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIIN---EILVMRENKH 75
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
NIV Y + +L++ +E + GSL ++ + + Q++A R+ L L++LH
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 135
Query: 450 VVHRDIKCANILVDANGSVKLADFGL 475
V+HRDIK NIL+ +GSVKL DFG
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 54/168 (32%), Positives = 89/168 (52%), Gaps = 17/168 (10%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
KR + + +G G++G VY+ D G A+K+V L + I+ + +EI +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAI-REIKI 59
Query: 384 LSRFEHENIVQYYG--TD--------KDESKLYIFLELVTKGSLLNLYQR--YHLRDSQV 431
L + H NIV TD KD+ Y+ E + L+ L + H + +
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
++ +Q+L GL Y H ++ +HRDIKC+NIL++ G +KLADFGLA+++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 51/153 (33%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 337 LGRGSFGSVY----EGISDDGFFFAVK---EVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
LG G++G V+ G D G +A+K + +++ + A+ + ++ Q + + R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTE-RQVLEAVRRCPF 66
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+V + + ++KL++ L+ V G L +LYQR H +S+V Y +I+L L +LH
Sbjct: 67 --LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481
+++RDIK NIL+D+ G V L DFGL+K FL+
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 6e-18
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 11/150 (7%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
G +G G FG VY+G+ ++ AVK S ++ + QE ++ +F+H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFL----QEAYIMRQFDH 66
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
+IV+ G + ++I +EL G L + Q +Y L + + Y+ Q+ L YL
Sbjct: 67 PHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ VHRDI N+LV + VKL DFGL++
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 22/155 (14%)
Query: 335 DLLGRGSFGSVYEGISDDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG GSFG V G AVK + + + +E A++ +HE
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK----SDKLSDIMDDFLKEAAIMHSLDHE 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--------YTRQILLGL 442
N+++ YG + + EL GSLL+ LR + Y QI G+
Sbjct: 57 NLIRLYGVVLTHPLMMVT-ELAPLGSLLD-----RLRKDALGHFLISTLCDYAVQIANGM 110
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+YL + +HRD+ NIL+ ++ VK+ DFGL +
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 50/163 (30%), Positives = 90/163 (55%), Gaps = 21/163 (12%)
Query: 330 YWQKGDLLGRGSFG---SVYEGISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLS 385
++ LG+G++G S + + A+K+++ + + AK+++ +E+ LL
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLR 56
Query: 386 RF-EHENIVQYYGTD----KDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTR 436
F H+NI Y D + ++LY++ EL+ +L+Q L D+ ++
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELME----ADLHQIIRSGQPLTDAHFQSFIY 112
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
QIL GLKY+H +V+HRD+K N+LV+A+ +K+ DFGLA+ F
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 48/150 (32%), Positives = 84/150 (56%), Gaps = 11/150 (7%)
Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G G++G V G A+K++S + + ++++ +EI +L RF+HENI+
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRFKHENII 66
Query: 394 QYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+ S +YI EL+ + L L + HL + + + QIL GLKY+H
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA 125
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKV 478
+V+HRD+K +N+L++ N +K+ DFGLA++
Sbjct: 126 NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 50/151 (33%), Positives = 79/151 (52%), Gaps = 14/151 (9%)
Query: 334 GDLLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G+ LG GSFG V G ++A+K L + + + + QE ++L H I
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIK--CLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS-----QVSA-YTRQILLGLKYLH 446
V + +DE+++Y LE V G L HLR + V+ Y +++L +YLH
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFT-----HLRKAGRFPNDVAKFYHAELVLAFEYLH 135
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+D+++RD+K N+L+D G VK+ DFG AK
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 48/148 (32%), Positives = 84/148 (56%), Gaps = 11/148 (7%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V+ + FFA+K +V L+D + + +E+ + L+ +EH
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLA-WEHP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
+ Y T + + L+ +E + G L+ Q H D + + Y +I+ GL++LH +
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK 477
+V+RD+K NIL+D +G +K+ADFG+ K
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 52/156 (33%), Positives = 88/156 (56%), Gaps = 12/156 (7%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENI 392
D LG+G++GSVY+ + G A+KE+ L LD+ +Q+ E+ +L + I
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-----FNQIIMELDILHKAVSPYI 61
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHDQ 448
V +YG E +Y+ +E + GSL LY + + + T ++ GLK+L ++
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
+++HRD+K N+LV+ NG VKL DFG++ ++SL
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 53/158 (33%), Positives = 84/158 (53%), Gaps = 22/158 (13%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG GS G V+ + SD AVK++ L D QS+ +EI ++ R +H+NIV+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKV 67
Query: 396 Y------GTDKDES--------KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 441
Y G+D E +YI E + + L N+ ++ L + + Q+L G
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLRG 126
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKV 478
LKY+H +V+HRD+K AN+ ++ V K+ DFGLA++
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 53/164 (32%), Positives = 74/164 (45%), Gaps = 28/164 (17%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKE----VSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
LG G+FG VYEG + D V L +G+ Q + +E L+S F H N
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPN 60
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL----------- 440
IV+ G YI +EL+ G LL+ +LRD++V + +L
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLS-----YLRDARVERFGPPLLTLKELLDICLDV 115
Query: 441 --GLKYLHDQDVVHRDIKCANILV-----DANGSVKLADFGLAK 477
G YL +HRD+ N LV DA+ VK+ DFGLA+
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 51/145 (35%), Positives = 80/145 (55%), Gaps = 6/145 (4%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GSFG+VY S AVK++S G Q + + +E+ L + +H N ++Y
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
G E ++ +E L + LL ++++ L++ +++A T L GL YLH +++HR
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 454 DIKCANILVDANGSVKLADFGLAKV 478
DIK NIL+ G VKLADFG A
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 45/151 (29%), Positives = 83/151 (54%), Gaps = 17/151 (11%)
Query: 336 LLGRGSFGSV----YEGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
+LG+GSFG V +G + +AVK +V L D + + E+ + L+
Sbjct: 2 VLGKGSFGKVLLAELKGTDE---LYAVKVLKKDVILQDDDVEC----TMTEKRVLALAG- 53
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLH 446
+H + Q + + + +L+ +E V G L+ QR + + Y +I+LGL++LH
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
++ +++RD+K N+L+D+ G +K+ADFG+ K
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 54/158 (34%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
F ++ TY +K D LG GS+ +VY+G S G A+KE+ L + +I +E +
Sbjct: 1 FGKLETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI----REAS 55
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQIL 439
LL +H NIV + + L + E + L Y L V + Q+L
Sbjct: 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD--LKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
GL Y H + V+HRD+K N+L+ G +KLADFGLA+
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 52/146 (35%), Positives = 79/146 (54%), Gaps = 12/146 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG+G FG V+ G + A+K L G+ + ++ QE ++ + HE +VQ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+E +YI E ++KGSLL+ +Y LR Q+ QI G+ Y+ + VH
Sbjct: 68 AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 453 RDIKCANILVDANGSVKLADFGLAKV 478
RD++ ANILV N K+ADFGLA++
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 51/152 (33%), Positives = 87/152 (57%), Gaps = 7/152 (4%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAK-QSISQLEQEIALLSRFEHE 390
+LG G++G V+ D G +A+K + +AK ++ E+ + R +
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-QSP 65
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+V + + E+KL++ L+ V+ G + +LYQR + + +V Y+ +I+L L++LH
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVFLS 481
+V+RDIK NIL+D+ G V L DFGL+K FLS
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 46/149 (30%), Positives = 81/149 (54%), Gaps = 6/149 (4%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+W+ LG G+FG VY+ + + A +V +D +++++ + EI +L+ +H
Sbjct: 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKV--ID--TKSEEELEDYMVEIDILASCDH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
NIV+ E+ L+I +E G++ + L L + Q+ +Q L L YLH+
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLA 476
++HRD+K NIL +G +KLADFG++
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 27/163 (16%)
Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG V+ G +D AVK + + + + + E+E LL+ F+HE
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL----KETASNDARKDFEREAELLTNFQHE 68
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAY 434
NIV++YG + + E + G L N + R H D SQ+
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
QI G+ YL Q VHRD+ N LV + VK+ DFG+++
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 51/147 (34%), Positives = 83/147 (56%), Gaps = 10/147 (6%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G GSFG+VY + D A+K++S G Q+ + + +E+ L R +H N +
Sbjct: 33 IGHGSFGAVY--FARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSI 88
Query: 394 QYYGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+Y G E ++ +E L + LL ++++ L++ +++A T L GL YLH +++
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 452 HRDIKCANILVDANGSVKLADFGLAKV 478
HRDIK NIL+ G VKLADFG A +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 50/145 (34%), Positives = 83/145 (57%), Gaps = 7/145 (4%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
L+G GS+G V + + G A+K+ L + + + I+ +EI +L + HEN+V
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAM--REIRMLKQLRHENLVN 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ + +LY+ E V ++L+ ++Y L +S+V Y QIL G+++ H +++H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123
Query: 453 RDIKCANILVDANGSVKLADFGLAK 477
RDIK NILV +G VKL DFG A+
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 1e-16
Identities = 51/153 (33%), Positives = 85/153 (55%), Gaps = 17/153 (11%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
+L+G G++G VY+G G A+K ++D ++ I +QEI +L ++ H NI
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEI---KQEINMLKKYSHHRNI 65
Query: 393 VQYYGT--DKD----ESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
YYG K+ + +L++ +E GS+ +L + L++ ++ R+IL GL
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
+LH V+HRDIK N+L+ N VKL DFG++
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 52/150 (34%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
LG G FG V Y+ D+ G AVK + G+ I+ L++EI +L HEN
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHEN 67
Query: 392 IVQYYG--TDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD 447
IV+Y G T+ + + + +E + GSL R + Q Y QI G+ YL
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ VHRD+ N+LV++ VK+ DFGL K
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 52/158 (32%), Positives = 88/158 (55%), Gaps = 12/158 (7%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
G+++G G FG+V +G G AVK + D +QA +E A++++ H+N+V
Sbjct: 11 GEIIGEGEFGAVLQG-EYTGQKVAVKNIKC-DVTAQA------FLEETAVMTKLHHKNLV 62
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ G LYI +EL++KG+L+N + R + Q+ ++ + G++YL + +
Sbjct: 63 RLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDLL 488
VHRD+ NILV +G K++DFGLA+V +D L
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL 159
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 332 QKGDLLGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
+K +LG G+FG+VY+G+ + V L ++ S ++ ++ E +++ +
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP--KANKEILDEAYVMASVD 67
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYL 445
H ++V+ G I +L+ G LL+ Y R H + + + QI G+ YL
Sbjct: 68 HPHVVRLLGICLSSQVQLI-TQLMPLGCLLD-YVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
++ +VHRD+ N+LV VK+ DFGLAK+
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 49/152 (32%), Positives = 82/152 (53%), Gaps = 6/152 (3%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GSFG+VY + A+K++S G Q+ + + +E+ L + H N +QY
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
G E ++ +E L + LL ++++ L++ +++A T L GL YLH +++HR
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 454 DIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
D+K NIL+ G VKL DFG A + + F
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 45/146 (30%), Positives = 75/146 (51%), Gaps = 8/146 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V G + A+K ++ +GS ++ + +E ++ + HE +VQ Y
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLY 65
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
G + +YI E ++ G LLN + + SQ+ + + G+ YL + +HRD
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRD 125
Query: 455 IKCANILVDANGSVKLADFGLAKVFL 480
+ N LVD G VK++DFGL++ L
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVL 151
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 10/152 (6%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQ-GSQAKQSISQLEQEIALLSRFEHENIVQ 394
+GRG F VY D A+K+V + + ++A+Q + EI LL + H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPNVIK 66
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
Y + ++++L I LEL G L + Q+ + + V Y Q+ ++++H +
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVFLS 481
V+HRDIK AN+ + A G VKL D GL + F S
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 48/162 (29%), Positives = 87/162 (53%), Gaps = 14/162 (8%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G+GS+G V DG + +K+++L + + +++ EQE LLS+ +H NIV Y
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA---EQEAQLLSQLKHPNIVAY 64
Query: 396 YGT-DKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQ 448
+ + ++ LYI + G +LY + L ++QV + QI + L+YLH++
Sbjct: 65 RESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDLLLI 490
++HRD+K N+ + +K+ D G+A+V + D LI
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 44/156 (28%), Positives = 85/156 (54%), Gaps = 18/156 (11%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G++G V I + G A+K++ D + AK+++ +E+ +L F+H+NI+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----RELKILRHFKHDNIIA 68
Query: 395 ----YYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLH 446
D +Y+ ++L+ +L+ H L + + + Q+L GLKY+H
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMES----DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
+V+HRD+K +N+LV+ + +++ DFG+A+ SS
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 56/155 (36%), Positives = 86/155 (55%), Gaps = 16/155 (10%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
+G G++G+VY+ G F A+K V + Q ++ +S + +E+ALL R F+H NI
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTV-REVALLKRLEAFDHPNI 64
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
V+ TD+ E+K+ + E V + + L+ L + RQ L GL +
Sbjct: 65 VRLMDVCATSRTDR-ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
LH +VHRD+K NILV + G VKLADFGLA+++
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 45/140 (32%), Positives = 75/140 (53%), Gaps = 6/140 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GS G V + G AVK++ L Q Q L E+ ++ ++HEN+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 82
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
Y + +L++ +E + G+L ++ + + Q++A +L L LH Q V+HRDI
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 456 KCANILVDANGSVKLADFGL 475
K +IL+ +G VKL+DFG
Sbjct: 143 KSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 17/153 (11%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
+++G G++G VY+G G A+K + + + + +++ EI +L ++ H NI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE------EIKLEINMLKKYSHHRNI 75
Query: 393 VQYYGTDKDES------KLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
YYG +S +L++ +E GS+ +L + L++ ++ R+IL GL
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
+LH V+HRDIK N+L+ N VKL DFG++
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 58/166 (34%), Positives = 88/166 (53%), Gaps = 22/166 (13%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
W+ + +G+G++G VY+ + DG AVK +LD S + I E E +L
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVK---ILDPISDVDEEI---EAEYNILQSLPN 77
Query: 389 HENIVQYYG----TDK-DESKLYIFLELVTKGS-------LLNLYQRYHLRDSQVSAYTR 436
H N+V++YG DK +L++ LEL GS LL QR L ++ +S
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYILY 135
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
LLGL++LH+ ++HRD+K NIL+ G VKL DFG++ S+
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+GRG+FG+V + + G AVK + + K+ + L+ ++ + IV+
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD---VVMRSSDCPYIVK 67
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYL-HD 447
+YG E +I +EL+ SL Y+ + + + L YL +
Sbjct: 68 FYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLA 476
++HRD+K +NIL+D NG++KL DFG++
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 50/144 (34%), Positives = 73/144 (50%), Gaps = 3/144 (2%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQ-SISQLEQEIALLSRFEHENIVQY 395
LG GSFG V + F V + ++ KQ + + E +L+ H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVA-IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
YG+ KDES LY+ LE V G +R + V Y QI+L +YL ++V+RD
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRD 156
Query: 455 IKCANILVDANGSVKLADFGLAKV 478
+K N+L+D +G +K+ DFG AKV
Sbjct: 157 LKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 8e-16
Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G A+K ++ +G+ ++ +E ++ + H N+VQ Y
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSED---DFIEEAKVMMKLSHPNLVQLY 65
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
G + ++I E + G LLN L +R L + + ++YL +HRD
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRD 125
Query: 455 IKCANILVDANGSVKLADFGLAKVFL 480
+ N LV + VK++DFGLA+ L
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVL 151
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 6/144 (4%)
Query: 337 LGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
LG G+FGSV +G+ G V V L Q A + +E +++++ +H IV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVA-VKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVR 60
Query: 395 YYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
G K E L + +EL G LL L +R + S + Q+ +G+ YL + VHR
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 454 DIKCANILVDANGSVKLADFGLAK 477
D+ N+L+ K++DFG+++
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K ++GRG+FG V+ D +K++ + + + + E +L H
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLSH 58
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLH 446
NI++YY ++ L I +E G+L Q L + + + QILL L ++H
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 447 DQDVVHRDIKCANILVDANGSV-KLADFGLAKVFLS 481
+ ++HRD+K NIL+D + V K+ DFG++K+ S
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 8/156 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+ LG G+FG VY+ + + G A K + +++++ + EI +L+ H
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYMVEIEILATCNH 68
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
IV+ G + KL+I +E G++ + L L + Q+ RQ+L L+YLH
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
++HRD+K N+L+ +G +KLADFG++ + +L
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 1e-15
Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 7/169 (4%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ 366
S E + +I G K+ T ++K +G+G+ G+VY + +EV++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMD----VATGQEVAIRQM 53
Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL 426
Q + + EI ++ ++ NIV Y + +L++ +E + GSL ++ +
Sbjct: 54 NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM 113
Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
+ Q++A R+ L L++LH V+HRDIK NIL+ +GSVKL DFG
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 53/166 (31%), Positives = 87/166 (52%), Gaps = 27/166 (16%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
F ++ TY K D LG G++ +VY+G ++D+ A+KE+ L + +I +E
Sbjct: 2 FGKLETY-IKLDKLGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEGAPCTAI----RE 54
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTK---------GSLLNLYQRYHLRDSQV 431
++LL +H NIV + E L + E + K G+ +N++ V
Sbjct: 55 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--------V 106
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ Q+L GL Y H + V+HRD+K N+L++ G +KLADFGLA+
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 46/145 (31%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G ++ AVK L G+ S+ +E L+ +H+ +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTM---SVQAFLEEANLMKTLQHDKLVRLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
E +YI E + KGSLL+ + + ++ ++ QI G+ Y+ ++ +HR
Sbjct: 68 AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127
Query: 454 DIKCANILVDANGSVKLADFGLAKV 478
D++ AN+LV + K+ADFGLA+V
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARV 152
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 52/164 (31%), Positives = 88/164 (53%), Gaps = 9/164 (5%)
Query: 313 EPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
E + +I G K+ T ++K +G+G+ G+VY I G A+K+++L Q +
Sbjct: 6 EKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK-- 60
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
+ EI ++ ++ NIV Y + +L++ +E + GSL ++ + + Q+
Sbjct: 61 ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
+A R+ L L +LH V+HRDIK NIL+ +GSVKL DFG
Sbjct: 118 AAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 44/145 (30%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LLG+G+FG V++G D AVK D + K + E +L +++H NIV+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKE-DLPQELK---IKFLSEARILKQYDHPNIVK 56
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
G +YI +ELV G L+ ++ L+ Q+ + G+ YL ++ +H
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 453 RDIKCANILVDANGSVKLADFGLAK 477
RD+ N LV N +K++DFG+++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 28/155 (18%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSRFE-H 389
+G G+F V + S G ++A+K K+ LEQ EI L R H
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK---------CMKKHFKSLEQVNNLREIQALRRLSPH 57
Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGL 442
NI++ D+ +L + EL+ +NLY ++ L + +V +Y Q+L L
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
++H + HRDIK NIL+ + +KLADFG +
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 11/148 (7%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V + FFA+K +V L D + + +E+ + L+ +EH
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVEC----TMVERRVLALA-WEHP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
+ + T + + L+ +E + G L+ Q D ++ Y +I+ GL++LH +
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK 477
+++RD+K N+L+D +G +K+ADFG+ K
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 36/115 (31%), Positives = 68/115 (59%), Gaps = 2/115 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
V ++D Q ++ + L E+ ++ ++H+N+V+ Y + +L++ +E + G+L ++
Sbjct: 51 VKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108
Query: 421 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
+ L + Q++ +L L YLH Q V+HRDIK +IL+ +G VKL+DFG
Sbjct: 109 VSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG+G FG V+ G + A+K L G+ ++ QE ++ + H+ +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKT---LKPGTMMPEA---FLQEAQIMKKLRHDKLVPLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+E +YI E + KGSLL+ + +L+ Q+ QI G+ Y+ + +HR
Sbjct: 68 AVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 454 DIKCANILVDANGSVKLADFGLAKV 478
D++ ANILV N K+ADFGLA++
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 47/146 (32%), Positives = 76/146 (52%), Gaps = 12/146 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G + AVK L G+ + +S +E ++ + H+ +VQ Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKT---LKPGTMSPES---FLEEAQIMKKLRHDKLVQLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+E +YI E ++KGSLL+ + R L+ + Q+ G+ Y+ + +H
Sbjct: 68 AVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERMNYIH 125
Query: 453 RDIKCANILVDANGSVKLADFGLAKV 478
RD++ ANILV K+ADFGLA++
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 51/147 (34%), Positives = 75/147 (51%), Gaps = 11/147 (7%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAV-KEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
L+GRG FG V E + D + V K+ LL A++++S E+E +LS
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPW 62
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQD 449
I Q +D+ LY+ +E G LL+L RY + Y +++L + +H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA 476
VHRDIK N+L+D G +KLADFG A
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSA 149
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 47/151 (31%), Positives = 83/151 (54%), Gaps = 5/151 (3%)
Query: 336 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+LG G++G V+ +S D G +A+K + +AK + + L +
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+V + + ++KL++ L+ + G L +L QR ++ +V Y+ +I+L L++LH +
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKVFLS 481
++RDIK NIL+D+NG V L DFGL+K F
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 51/162 (31%), Positives = 86/162 (53%), Gaps = 23/162 (14%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+GRG++G V S+ A+K+++ D AK+++ +EI LL +HEN++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68
Query: 395 YYGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLGLK 443
+ +YI EL+ +L+Q +R SQ + + Q+L GLK
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDT----DLHQI--IRSSQTLSDDHCQYFLYQLLRGLK 122
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
Y+H +V+HRD+K +N+L++AN +K+ DFGLA+ DF
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF 164
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 50/145 (34%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG GS+ +VY+GIS +G A+K +S+ + +I +E +LL +H NIV
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI----REASLLKGLKHANIVLL 68
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ + L E + L Y H L V + Q+L GL Y+H Q ++H
Sbjct: 69 HDIIHTKETLTFVFEYMHTD--LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 453 RDIKCANILVDANGSVKLADFGLAK 477
RD+K N+L+ G +KLADFGLA+
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 10/145 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G + A+K L QGS S E L+ + +H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKS---LKQGSM---SPEAFLAEANLMKQLQHPRLVRLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
E +YI E + GSL++ + L +++ QI G+ ++ ++ +HR
Sbjct: 68 AVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 454 DIKCANILVDANGSVKLADFGLAKV 478
D++ ANILV K+ADFGLA++
Sbjct: 127 DLRAANILVSETLCCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 39/119 (32%), Positives = 61/119 (51%), Gaps = 26/119 (21%)
Query: 380 EIALLSRF-EHENIVQYYGT-----DKDESKLYIFLEL--------VTKGSLLNLYQRYH 425
EI L +H NIV+ DKD +Y+ E + L ++++RY
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKD---IYLVFEYMETDLHAVIRANILEDVHKRYI 112
Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
+ Y Q+L LKY+H +V+HRD+K +NIL++++ VKLADFGLA+ +
Sbjct: 113 M-------Y--QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 52/156 (33%), Positives = 87/156 (55%), Gaps = 17/156 (10%)
Query: 337 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHEN 391
+G G++G V++ + + G F A+K V + Q + +S + +E+A+L FEH N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTI-REVAVLRHLETFEHPN 65
Query: 392 IVQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLK 443
+V+ + TD+ E+KL + E V + + L+ + + Q+L GL
Sbjct: 66 VVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+LH VVHRD+K NILV ++G +KLADFGLA+++
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 35/117 (29%), Positives = 67/117 (57%)
Query: 359 KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL 418
K+V++ + +Q L E+ ++ + HEN+V Y + +L++ +E + G+L
Sbjct: 48 KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
++ + + Q++ +L L YLH+Q V+HRDIK +IL+ ++G +KL+DFG
Sbjct: 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 51/164 (31%), Positives = 89/164 (54%), Gaps = 18/164 (10%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
W+ + +G+G++G V++ ++ +G AVK +LD + I E E +L +
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVK---ILDPIHDIDEEI---EAEYNILKALSD 73
Query: 389 HENIVQYYGT-----DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS----AYT-RQI 438
H N+V++YG K+ +L++ LEL GS+ +L + + R ++ AY +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
L+GL++LH +HRD+K NIL+ G VKL DFG++ S+
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 49/164 (29%), Positives = 89/164 (54%), Gaps = 9/164 (5%)
Query: 313 EPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAK 371
E + I G K+ T ++K +G+G+ G+V+ I G A+K+++L Q +
Sbjct: 6 EKLRTIVSIGDPKKKYTRYEK---IGQGASGTVFTAIDVATGQEVAIKQINL-----QKQ 57
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
+ EI ++ ++ NIV + + +L++ +E + GSL ++ + ++Q+
Sbjct: 58 PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI 117
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
+A R+ L L++LH V+HRDIK N+L+ +GSVKL DFG
Sbjct: 118 AAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 20/151 (13%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G +G VYEG+ AVK + + + + +E A++ +H N+VQ
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYLHD 447
G E YI E +T G+LL+ +LR+ +V+A QI ++YL
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKV 478
++ +HRD+ N LV N VK+ADFGL+++
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRL 153
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 51/161 (31%), Positives = 86/161 (53%), Gaps = 23/161 (14%)
Query: 331 WQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
++K + +G G++G VY+ ++++ A+K++ L +Q + S + +EI+LL
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNE--TIALKKIRL-EQEDEGVPSTAI--REISLLKEM 58
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--------VSAYTRQIL 439
+H NIV+ E +LY+ E L+L + H+ S + Y QIL
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 440 LGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKVF 479
G+ Y H V+HRD+K N+L+D ++KLADFGLA+ F
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153
|
Length = 294 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 23/159 (14%)
Query: 337 LGRGSFGSVYEGI-----SDDGFF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG+GSFG VYEG+ + A+K V+ + + + + E +++ F
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN----ENASMRERIEFLNEASVMKEFNCH 69
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ----VSAYTRQILL------ 440
++V+ G + +EL+ KG L + Y R +++ + T Q +
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKS-YLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
G+ YL + VHRD+ N +V + +VK+ DFG+ +
Sbjct: 129 ADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 36/107 (33%), Positives = 62/107 (57%), Gaps = 11/107 (10%)
Query: 380 EIALLSRFEHENIVQY----YGTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVS 432
EI +L + +H NIV G++ D K+Y+ +E V K + + Q + S+V
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQ--SEVK 109
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
Q+L G+ +LHD ++HRD+K +N+L++ G +K+ DFGLA+ +
Sbjct: 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 12/168 (7%)
Query: 330 YWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ--------- 379
Y QKG LG G++G V + + G A+K+V +++ + + +
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQI 438
E+ +++ +HENI+ + + + ++++ L + + L +SQV QI
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFD 486
L GL LH +HRD+ ANI +++ G K+ADFGLA+ + D
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
|
Length = 335 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G A+K + ++G+ +++ + E ++ + H +VQ Y
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIE---EAKVMMKLSHPKLVQLY 65
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
G + LYI E + G LLN L QR L + + + + G++YL +HRD
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125
Query: 455 IKCANILVDANGSVKLADFGLAKVFL 480
+ N LV + G VK++DFG+ + L
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVL 151
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 44/146 (30%), Positives = 78/146 (53%), Gaps = 4/146 (2%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++G+G+FG V D G +A+K +LL K ++ ++ E +L+ + +V
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHR 453
Y + +D LY+ +E + G L+ + +Y V+ Y + +L ++ +H +HR
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125
Query: 454 DIKCANILVDANGSVKLADFGLAKVF 479
DIK NIL+D G +KL+DFGL+ F
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 337 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+G G FG V G A+K L GS KQ + L E +++ +F+H NI
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKT---LKAGSSDKQRLDFL-TEASIMGQFDHPNI 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD 449
++ G + I E + GSL + + R + Q+ R I G+KYL + +
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKV 478
VHRD+ NILV++N K++DFGL++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRR 155
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
FK+I LLG+G G V+ + G FA+K + + + K EQEI
Sbjct: 2 HFKKI-------KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI 54
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQI 438
L+ +H + Y + + E+ L + ++ G L L QR L + Y ++
Sbjct: 55 --LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
LL L+YLH +V+RD+K NIL+ +G + L+DF L+K
Sbjct: 113 LLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK 151
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 50/151 (33%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K + LG GS+ +VY+G S +G A+K + L ++ +I +E +LL +H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI----REASLLKGLKH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
NIV + + L + E V L Y H L V + Q+L GL Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTD--LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ ++HRD+K N+L+ G +KLADFGLA+
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 61/194 (31%), Positives = 96/194 (49%), Gaps = 34/194 (17%)
Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS 362
ED+ + N SPN +K G+++G GSFG VYE I D A+K+V
Sbjct: 48 EDEDEEKMIDNDINRSPNKSYKL-------GNIIGNGSFGVVYEAICIDTSEKVAIKKVL 100
Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHENIV---QYYGTD---KDESKLYIFLELVTK-- 414
Q Q K +E+ ++ H NI+ YY T+ K+E IFL +V +
Sbjct: 101 ---QDPQYKN------RELLIMKNLNHINIIFLKDYYYTECFKKNEKN--IFLNVVMEFI 149
Query: 415 GSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-S 467
++ Y +++ R++ V Y+ Q+ L Y+H + + HRD+K N+L+D N +
Sbjct: 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT 209
Query: 468 VKLADFGLAKVFLS 481
+KL DFG AK L+
Sbjct: 210 LKLCDFGSAKNLLA 223
|
Length = 440 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 3/143 (2%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G+GSFG V DG F+AVK + + +Q E+ + LL +H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+ + + KLY L+ V G L QR + + Y +I L YLH ++++RD
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121
Query: 455 IKCANILVDANGSVKLADFGLAK 477
+K NIL+D+ G V L DFGL K
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 23/164 (14%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
F ++ TY K + LG G++ +V++G S A+KE+ L + +I +E++
Sbjct: 2 FGKMETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVS 56
Query: 383 LLSRFEHENIVQYYG---TDKDESKLYIFLELVTK------GSLLNLYQRYHLRDSQVSA 433
LL +H NIV + TDK + ++ +L+ K G++++++ V
Sbjct: 57 LLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN--------VKI 108
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ QIL GL Y H + V+HRD+K N+L++ G +KLADFGLA+
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 50/158 (31%), Positives = 86/158 (54%), Gaps = 11/158 (6%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
F ++ TY K D LG G++ +V++G S A+KE+ L + +I +E++
Sbjct: 1 FGKLETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVS 55
Query: 383 LLSRFEHENIVQYYG---TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
LL +H NIV + T++ + ++ +L+ K L N + + V + Q+L
Sbjct: 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN--VKIFMFQLL 113
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
GL Y H + ++HRD+K N+L++ G +KLADFGLA+
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V + + G +AVK +V L D + + E+ I L+R H
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT----EKRILSLAR-NHP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
+ Q Y + +L+ +E V G L+ Q+ D ++ Y +I L +LHD+
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK 477
+++RD+K N+L+D G KLADFG+ K
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 44/153 (28%), Positives = 86/153 (56%), Gaps = 21/153 (13%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V + G +FAVK +V L+D + + +E+ + L+ +E+
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVEC----TMVEKRVLALA-WENP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS------QVSAYTRQILLGLKY 444
+ Y T + + L+ +E + G L+ +H++D + + Y +I+ GL++
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLM-----FHIQDKGRFDLYRATFYAAEIVCGLQF 111
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
LH + +++RD+K N+++D +G +K+ADFG+ K
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 52/153 (33%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 333 KGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
K ++G G FG V+ GI G + L G KQ L E +++ +F H N
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFL-SEASIMGQFSHHN 67
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-----RQILLGLKYLH 446
I++ G I E + G+L + Y R H D + S+Y R I G+KYL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
D + VHRD+ NILV++N K++DFGL++V
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 46/144 (31%), Positives = 74/144 (51%), Gaps = 3/144 (2%)
Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++G+GSFG V DG F+AVK + + +Q+ E+ + LL +H +V
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+ + + KLY L+ V G L QR + + Y ++ + YLH ++++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 454 DIKCANILVDANGSVKLADFGLAK 477
D+K NIL+D+ G V L DFGL K
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 49/150 (32%), Positives = 81/150 (54%), Gaps = 12/150 (8%)
Query: 336 LLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEH 389
+LG+G +G V++ +D G FA+K +L + + + ++ + + E +L +H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMK---VLKKATIVRNQKDTAHTKAERNILEAVKH 59
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD 447
IV + KLY+ LE ++ G L +R + D+ Y +I L L++LH
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT-ACFYLSEISLALEHLHQ 118
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477
Q +++RD+K NIL+DA G VKL DFGL K
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 337 LGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQL--EQEIALL-SRFEH 389
LGRG FG V Y+ + +A+K +L A+ + L E+ I + H
Sbjct: 7 LGRGHFGKVLLAEYKKTGE---LYAIK--ALKKGDIIARDEVESLMCEKRIFETANSERH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+V + + E + +E G L+ + + Y ++LGL+YLH+
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK 477
+V+RD+K N+L+D G VK+ADFGL K
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCK 149
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 52/151 (34%), Positives = 83/151 (54%), Gaps = 15/151 (9%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--- 391
+G G+FG V+ ++D DG A+K+ + Q S ++ +E+ +L F+H+N
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKK---MPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 392 ---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD 447
I+Q D E ++Y+ EL+ + L + L V + QIL GLKYLH
Sbjct: 64 ALDILQPPHIDPFE-EIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKV 478
++HRDIK N+LV++N +K+ DFGLA+V
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 40/103 (38%), Positives = 56/103 (54%), Gaps = 6/103 (5%)
Query: 379 QEIALLSRFEHENIVQYYGTDKDESKL---YIFLELVTKGSLLNLYQRYHLRDSQVSAYT 435
+E+ LL HENI+ +D S L Y EL+ L L L + +
Sbjct: 58 RELKLLKHLRHENIISL--SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFL 114
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
QIL GLKY+H VVHRD+K +NIL++ N +K+ DFGLA++
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 34/120 (28%), Positives = 66/120 (55%), Gaps = 6/120 (5%)
Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
AVK+++L S +K+ + L+QEI + +H NI+ Y + +S+LY+ L+ GS
Sbjct: 29 AVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85
Query: 417 LLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
+L + + L + ++ + +L L Y+H + +HR +K ++IL+ +G V L+
Sbjct: 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 44/140 (31%), Positives = 73/140 (52%), Gaps = 3/140 (2%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
++GRG+FG V + V + LL + K+S S E + F + +VQ
Sbjct: 50 VIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+ +D+ LY+ +E + G L+NL Y + + YT +++L L +H +HRD
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 167
Query: 455 IKCANILVDANGSVKLADFG 474
+K N+L+D +G +KLADFG
Sbjct: 168 VKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 11/148 (7%)
Query: 336 LLGRGSFGSVYEGI---SDDGFFFAV--KEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V +D+ + V K+V L D + E+ I L+ +H
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDC----TMTEKRILALAA-KHP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQD 449
+ + + + +L+ +E V G L+ QR D S Y ++ L L +LH
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK 477
V++RD+K NIL+DA G KLADFG+ K
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 44/140 (31%), Positives = 74/140 (52%), Gaps = 3/140 (2%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
++GRG+FG V + V + LL + K+S S E + F + +VQ
Sbjct: 50 VIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+ +D+ LY+ +E + G L+NL Y + + YT +++L L +H ++HRD
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 167
Query: 455 IKCANILVDANGSVKLADFG 474
+K N+L+D +G +KLADFG
Sbjct: 168 VKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 10/148 (6%)
Query: 336 LLGRGSFGSVY-----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V+ G D G +A+K +L + + + + + E +L+ H
Sbjct: 3 VLGQGSFGKVFLVRKITG-PDAGQLYAMK---VLKKATLKVRDRVRTKMERDILAEVNHP 58
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
IV+ + + E KLY+ L+ + G L L + + V Y ++ L L +LH
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK 477
+++RD+K NIL+D G +KL DFGL+K
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 44/142 (30%), Positives = 77/142 (54%), Gaps = 7/142 (4%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
++GRG+FG V S +A+K +S + ++ + E++I ++ E I
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQ--VYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWI 105
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
VQ + +D+ LY+ +E + G L+NL Y + + YT +++L L +H +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH 165
Query: 453 RDIKCANILVDANGSVKLADFG 474
RD+K N+L+D +G +KLADFG
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 52/167 (31%), Positives = 76/167 (45%), Gaps = 27/167 (16%)
Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG V+ D AVK +L D A++ +E LL+ +HE
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 67
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------LRDSQVSAYT 435
+IV++YG + L + E + G L N + R H L SQ+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
+QI G+ YL Q VHRD+ N LV N VK+ DFG+++ S+
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 47/144 (32%), Positives = 78/144 (54%), Gaps = 4/144 (2%)
Query: 339 RGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 397
RG+FG VY G ++ +AVK V D + K + Q++ E L+ + IV Y
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMIN--KNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 398 TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRDIK 456
+ + + +Y+ +E + G + +L Y D +++ Y ++ L L YLH ++HRD+K
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 457 CANILVDANGSVKLADFGLAKVFL 480
N+L+ G +KL DFGL+KV L
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 13/158 (8%)
Query: 337 LGRGSFGSVY---EGISDDGFFFAV-KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG+GSFG+VY + + V KE+ + G Q QE LLS+ +H I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPV---GELNPNETVQANQEAQLLSKLDHPAI 64
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHD 447
V+++ + + I E L + L ++QV + Q+LLG+ Y+H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
+ ++HRD+K NI + N +K+ DFG++++ + S D
Sbjct: 125 RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDL 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 54/170 (31%), Positives = 78/170 (45%), Gaps = 30/170 (17%)
Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG V+ + D AVK +L D A++ ++E LL+ +HE
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 67
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------------SQVS 432
+IV++YG D L + E + G L N + R H D SQ+
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
QI G+ YL Q VHRD+ N LV AN VK+ DFG+++ S+
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 38/144 (26%), Positives = 71/144 (49%), Gaps = 5/144 (3%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GS+G V++ + + G A+K+ + K+ I+ +EI +L + +H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK-IAL--REIRMLKQLKHPNLVNL 65
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+ + KL++ E L L + + + + Q L + + H + +HRD
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRD 125
Query: 455 IKCANILVDANGSVKLADFGLAKV 478
+K NIL+ G +KL DFG A++
Sbjct: 126 VKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 10/145 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ + AVK + S+ E ++ +H+ +V+ +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVKLH 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHR 453
E +YI E + KGSLL+ + + ++ QI G+ ++ ++ +HR
Sbjct: 68 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 454 DIKCANILVDANGSVKLADFGLAKV 478
D++ ANILV A+ K+ADFGLA+V
Sbjct: 127 DLRAANILVSASLVCKIADFGLARV 151
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 51/148 (34%), Positives = 84/148 (56%), Gaps = 11/148 (7%)
Query: 336 LLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGS-QAKQSISQLEQE---IALLSRFEH 389
++GRG FG VY G +D G +A+K LD+ + KQ + E ++L+S +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
IV KL L+L+ G L +L Q ++++ Y +I+LGL+++H++
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLA 476
VV+RD+K ANIL+D +G V+++D GLA
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 47/150 (31%), Positives = 82/150 (54%), Gaps = 7/150 (4%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
+G+G+FG VY+ D +A+K +S + AK+ ++ E +L R E I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS--KKEIVAKKEVAHTIGERNILVRTLLDESPFI 58
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
V + + +S LY+ + ++ G L +L + + + Y +++L L++LH D+V
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 452 HRDIKCANILVDANGSVKLADFGLAKVFLS 481
+RD+K NIL+DA G + L DFGL+K L+
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLT 148
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 42/142 (29%), Positives = 75/142 (52%), Gaps = 4/142 (2%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V D G +A+K + D K+ ++ + E +L + +V+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVK 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+ + +D+ LY+ +E + G ++ L + L + Y + +L + +H +HR
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125
Query: 454 DIKCANILVDANGSVKLADFGL 475
DIK N+L+DA G VKL+DFGL
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI---SQLEQEIALLSRFEHENI 392
+G G++GSV + G AVK++S + QSI + +E+ LL +HEN+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 393 VQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
+ L F + LVT L N+ + L D V QIL GLKY+H
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 138
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477
D++HRD+K +N+ V+ + +K+ DFGLA+
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 4/150 (2%)
Query: 337 LGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G+GSFG V + D +A+K ++ ++ ++ E +L++ IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALK--TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQDVVHRD 454
+ + KLY+ L + G L + QR D S+ YT ++L L+ LH +V++RD
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 455 IKCANILVDANGSVKLADFGLAKVFLSSLD 484
+K NIL+D G + L DFGL K+ + D
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDD 148
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 46/153 (30%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
Q ++LG G+ G+VY+ AVK + L KQ +S+LE +L + +
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE----ILYKCDSP 59
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
I+ +YG E+++ I E + GSL ++Y++ + + + ++ GL YL +
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-DVYRK--IPEHVLGRIAVAVVKGLTYLWSLKI 116
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
+HRD+K +N+LV+ G VKL DFG++ ++S+
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQE------IALLSRFE 388
++G+GSFG V DG +AVK + Q K +++ EQ+ LL +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVL-------QKKIVLNRKEQKHIMAERNVLLKNVK 54
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
H +V + + + KLY L+ V G L +L + + + Y +I L YLH
Sbjct: 55 HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
++V+RD+K NIL+D+ G V L DFGL K ++ D
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 4/145 (2%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G+FG V D +A+K +L + + ++ ++ E +L+ ++E +V+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMK--TLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDVVHRD 454
Y + +D+ LY ++ + G +++L R + + Y ++ ++ +H +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 455 IKCANILVDANGSVKLADFGLAKVF 479
IK NIL+D +G +KL DFGL F
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 42/146 (28%), Positives = 78/146 (53%), Gaps = 4/146 (2%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V D G +A+K+ L K+ ++ + E +L+ ++ +V+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKK--LRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
Y + +DE+ LY+ +E + G ++ L + + + Y + +L + +H +HR
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125
Query: 454 DIKCANILVDANGSVKLADFGLAKVF 479
DIK N+L+DA G +KL+DFGL
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 9/145 (6%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+GRG+FG V+ G + D AVK L +AK QE +L ++ H NIV+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
G + +YI +ELV G L + L+ ++ G++YL + +H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 453 RDIKCANILVDANGSVKLADFGLAK 477
RD+ N LV +K++DFG+++
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 41/145 (28%), Positives = 78/145 (53%), Gaps = 4/145 (2%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G+FG V D +A+K +L + + ++ ++ E +L+ ++E +V+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMK--TLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
Y + +D+ LY ++ + G +++L R + ++ Y ++ L ++ +H +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 455 IKCANILVDANGSVKLADFGLAKVF 479
IK NIL+D +G +KL DFGL F
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 20/151 (13%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL--SRFEHENIV 393
LG+G FG V + G +A K++ + + ++ E++I SRF IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF----IV 56
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL--------RDSQVSAYTRQILLGLKYL 445
+ + L + + L+ G L +YH+ +++ Y QI+ GL++L
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDL-----KYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA 476
H + +V+RD+K N+L+D +G+V+++D GLA
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 336 LLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
++G G FG V G A+K L G KQ L E +++ +F+H N
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKT---LKAGYTEKQRRDFL-SEASIMGQFDHPN 66
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
I+ G + I E + GSL +++ Q+ R I G+KYL D
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVF 479
VHRD+ NILV++N K++DFGL++V
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 42/151 (27%), Positives = 80/151 (52%), Gaps = 17/151 (11%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAV--KEVSLLDQGSQAKQSISQLEQEI-ALLSR--F 387
+LG+GSFG V +D+ + + K+V + D + + +E+ + AL + F
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVEC----TMVEKRVLALPGKPPF 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
+ Q + + +LY +E V G L+ ++ Q ++ Y +I +GL +LH
Sbjct: 63 ----LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ +++RD+K N+++DA G +K+ADFG+ K
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 8/149 (5%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G+G +G V+ D G A+K + + + E +L+ + E +V+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK--KSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 396 YGTDKDESKLYIFLELVTKG---SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+D+ LY+ +E V G +LLN L + Y ++ + LH+ +H
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIH 124
Query: 453 RDIKCANILVDANGSVKLADFGLAKVFLS 481
RD+K N L+DA+G +KL DFGL+K ++
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSKGIVT 153
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 7/146 (4%)
Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEHENI 392
++G+GSFG V + F+AVK +L + + + K+ + + LL +H +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVK---VLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
V + + + KLY L+ + G L QR + + Y +I L YLH ++V
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 452 HRDIKCANILVDANGSVKLADFGLAK 477
+RD+K NIL+D+ G + L DFGL K
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 33/159 (20%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-------------EIAL 383
+G G++G V S D + K +I +L + E+ L
Sbjct: 23 VGSGAYGQV---------------CSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLE--LVTK--GSLLNLYQRYH-LRDSQVSAYTRQI 438
L +HEN++ S L F + LVT G+ LN + L D + QI
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQI 127
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
L GLKY+H ++HRD+K +NI V+ + +K+ DFGLA+
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 336 LLGRGSFGSVYEG--ISDDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
++G+G FG VY G I DG AVK ++ + + + Q +E ++ F H N
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----LEEVEQFLKEGIIMKDFSHPN 57
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYLH 446
++ G + S L + L + G L N + R + V + Q+ G++YL
Sbjct: 58 VLSLLGICLPSEGSPL-VVLPYMKHGDLRN-FIRSETHNPTVKDLIGFGLQVAKGMEYLA 115
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ VHRD+ N ++D + +VK+ADFGLA+
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 41/142 (28%), Positives = 75/142 (52%), Gaps = 4/142 (2%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V D G +A+K + D K+ + + E +L + +V+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVVK 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+ + +D+ LY+ +E + G ++ L + L + + Y + +L + +H +HR
Sbjct: 66 MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125
Query: 454 DIKCANILVDANGSVKLADFGL 475
DIK N+L+D+ G VKL+DFGL
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LGRG++G V + G AVK + + K+ + L+ I++ S + V +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD--ISMRSV-DCPYTVTF 65
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-----SAYTRQILLGLKYLHDQ-D 449
YG E ++I +E V SL Y++ + + + I+ L+YLH +
Sbjct: 66 YGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
V+HRD+K +N+L++ NG VKL DFG++ + S+
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 39/145 (26%), Positives = 76/145 (52%), Gaps = 4/145 (2%)
Query: 337 LGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G+FG V D +A+K + D + + ++ E +L+ ++E +V+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKAD--VLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
Y + +D+ LY ++ + G +++L R + + ++ Y ++ ++ +H +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 455 IKCANILVDANGSVKLADFGLAKVF 479
IK NIL+D +G +KL DFGL F
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 50/147 (34%), Positives = 82/147 (55%), Gaps = 9/147 (6%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGS-QAKQSISQLEQE---IALLSRFEHE 390
++GRG FG VY +D G +A+K LD+ + KQ + E ++L+S +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
IV KL L+L+ G L +L Q + ++ Y +I+LGL+++H++
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA 476
VV+RD+K ANIL+D +G V+++D GLA
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 335 DLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+++G G FG V G F A+K L G KQ L E +++ +F+H
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKT---LKSGYTEKQRRDFL-SEASIMGQFDHP 65
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILLGLKYL 445
NI+ G + I E + G+L + + D Q + R I G+KYL
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ + VHRD+ NILV++N K++DFGL++
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 43/150 (28%), Positives = 80/150 (53%), Gaps = 7/150 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
LG G+ GSV + K+V + AK S+ Q+ +E+ ++ IV +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD-QDVVHR 453
YG +E+ + + +E + GSL +Y++ + + ++ GL YL++ ++HR
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128
Query: 454 DIKCANILVDANGSVKLADFGLAKVFLSSL 483
DIK +NILV++ G +KL DFG++ ++S+
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSI 158
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 44/151 (29%), Positives = 81/151 (53%), Gaps = 9/151 (5%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQ 394
LG G+ G V + + G A K + L + K +I +Q+ +E+ +L IV
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHL-----EIKPAIRNQIIRELKVLHECNSPYIVG 63
Query: 395 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVH 452
+YG + ++ I +E + GSL L + + ++ + + +L GL YL ++ ++H
Sbjct: 64 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123
Query: 453 RDIKCANILVDANGSVKLADFGLAKVFLSSL 483
RD+K +NILV++ G +KL DFG++ + S+
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 20/152 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
+G G FG V+ G + A+K + + S +E ++ + H +VQ Y
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKYLHDQ 448
G + S + + E + G L + +LR +Q ++++ LL G+ YL
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSD-----YLR-AQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFL 480
+V+HRD+ N LV N VK++DFG+ + L
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 23/157 (14%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+++G+GS+G V I + G A+K++ + + S A +++ +EI LL H +I
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA----TRILREIKLLRLLRHPDI 61
Query: 393 VQ----YYGTDKDESK-LYIFLELVTKGSLLNLYQRYHLRDS------QVSAYTRQILLG 441
V+ + E K +Y+ EL+ +L+Q D Q Y Q+L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHHQFFLY--QLLRA 115
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
LKY+H +V HRD+K NIL +A+ +K+ DFGLA+V
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 332 QKGDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSR 386
G LG G+FG V E G+S AV +V++ A S + L E+ ++S
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSD---AVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 387 F-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILL 440
HENIV G + + E G LLN +R R+S ++ +++ Q+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAK 152
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
G+ +L ++ +HRD+ N+L+ VK+ DFGLA+
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 22/166 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
G LG G FG V GI D AV + + ++ +S L E+ ++ +
Sbjct: 20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVS---- 432
H+NI+ G + LY+ +E +KG+L Y + D Q++
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 433 -AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ T Q+ G++YL Q +HRD+ N+LV N +K+ADFGLA+
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 8e-11
Identities = 31/90 (34%), Positives = 53/90 (58%), Gaps = 1/90 (1%)
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
H +V + + ES+L+ +E V G L+ QR L + Y+ +I L L YLH+
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ +++RD+K N+L+D+ G +KL D+G+ K
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 337 LGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+G+G+FG V++ G+ F V V +L + + A + ++E AL++ F+H NI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVA-VKMLKEEASA-DMQADFQREAALMAEFDHPNI 70
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR------------------YHLRDSQVS-- 432
V+ G + + E + G L + L +S
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 433 ---AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+Q+ G+ YL ++ VHRD+ N LV N VK+ADFGL++
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 26/155 (16%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFE 388
LLG+G+FG V E + G ++A+K EV + AK ++ E +L
Sbjct: 2 LLGKGTFGKVILVREKAT--GKYYAMKILKKEVII------AKDEVAHTLTESRVLQNTR 53
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLGL 442
H + + + +L +E G L +HL +V + Y +I+ L
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSAL 108
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
YLH DVV+RD+K N+++D +G +K+ DFGL K
Sbjct: 109 GYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 51/179 (28%), Positives = 78/179 (43%), Gaps = 33/179 (18%)
Query: 327 IITYWQKGDLLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
I+ W+ LG G+FG V+ D AVK +L + A+Q ++E
Sbjct: 7 IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 57
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------ 428
LL+ +H++IV++YG + L + E + G L N + R H D
Sbjct: 58 AELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAP 116
Query: 429 -----SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
Q+ A QI G+ YL VHRD+ N LV VK+ DFG+++ S+
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 175
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 21/162 (12%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
D++G G+FG V + I DG + + S+ E+ +L + H NI
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNI 70
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYT 435
+ G + LY+ +E G+LL+ ++ L Q+ +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ G+ YL + +HRD+ NILV N K+ADFGL++
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 41/142 (28%), Positives = 77/142 (54%), Gaps = 5/142 (3%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V + + G +A+K ++ + +A+ + + E+++ L + I
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV--LVNGDRRWITN 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ +DE+ LY+ ++ G LL L ++ L + Y +++L + +H VH
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125
Query: 453 RDIKCANILVDANGSVKLADFG 474
RDIK N+L+D NG ++LADFG
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 337 LGRGSFGSVY----EGISD----DGFFFAVKEVSLL--------DQGSQAKQSISQLEQE 380
LG G FG V+ +G+ D + +L D A++ +E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED---FLKE 69
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR---- 436
+ +LSR NI + G + L + +E + G L Q++ S ++ ++
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 437 --------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474
QI G++YL + VHRD+ N LV N ++K+ADFG
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 41/145 (28%), Positives = 76/145 (52%), Gaps = 7/145 (4%)
Query: 336 LLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++G G++G V + + A+K+ ++ + K++ + E+ +L + ENIV+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR---ELKMLRTLKQENIVE 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ KLY+ E V K ++L L + + +V +Y Q++ + + H D+VH
Sbjct: 65 LKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123
Query: 453 RDIKCANILVDANGSVKLADFGLAK 477
RDIK N+L+ N +KL DFG A+
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 41/142 (28%), Positives = 78/142 (54%), Gaps = 5/142 (3%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V + + FA+K ++ + +A+ + + E+++ L +++ I
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDNQWITT 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQDVVH 452
+ +DE+ LY+ ++ G LL L ++ R + Y ++++ + +H VH
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125
Query: 453 RDIKCANILVDANGSVKLADFG 474
RDIK NIL+D NG ++LADFG
Sbjct: 126 RDIKPDNILMDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 54/170 (31%), Positives = 83/170 (48%), Gaps = 27/170 (15%)
Query: 333 KGDLLGRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+G +GRG++G VY+ DG +A+K++ +G+ S + EIALL +H
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACR---EIALLRELKH 57
Query: 390 ENIV--QYYGTDKDESKLYIFLELVT----------KGSLLNLYQRYHLRDSQVSAYTRQ 437
N++ Q + K+++ + + S N + L S V + Q
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQ 116
Query: 438 ILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKVFLSSL 483
IL G+ YLH V+HRD+K ANILV G VK+AD G A++F S L
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 40/142 (28%), Positives = 75/142 (52%), Gaps = 5/142 (3%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V + +A+K ++ + +A+ + + E+ + L + + I
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV--LVNGDCQWITT 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ +DE+ LY+ ++ G LL L ++ L + Y +++L + +H VH
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125
Query: 453 RDIKCANILVDANGSVKLADFG 474
RDIK N+L+D NG ++LADFG
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 36/182 (19%)
Query: 325 KRIITYWQKGDLLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQA---------- 370
++ +T+ +K LG G FG V+ EG+ F K+ SL G+Q
Sbjct: 4 RKRLTFKEK---LGEGQFGEVHLCEAEGMEK----FMDKDFSLDVSGNQPVLVAVKMLRE 56
Query: 371 ---KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR 427
K + + +EI ++SR + NI++ L + E + G L R+ +
Sbjct: 57 DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQ 116
Query: 428 DSQVSAYTR------------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
++ A QI G+KYL + VHRD+ N LV N ++K+ADFG+
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 476 AK 477
++
Sbjct: 177 SR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 29/77 (37%), Positives = 49/77 (63%), Gaps = 1/77 (1%)
Query: 402 ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460
ES+L+ +E V+ G L+ QR L + Y+ +I L L +LH++ +++RD+K N+
Sbjct: 68 ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127
Query: 461 LVDANGSVKLADFGLAK 477
L+DA G +KL D+G+ K
Sbjct: 128 LLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 23/163 (14%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
D++G G+FG V + I DG + + S+ E E+ L H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNII 59
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAYTRQILL- 440
G + LY+ +E G+LL+ + + S +S ++Q+L
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS--SQQLLHF 117
Query: 441 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
G+ YL + +HRD+ NILV N K+ADFGL++
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 12/152 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
+G+G FG V G G AVK + D +QA E +++++ H N+VQ
Sbjct: 14 IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 65
Query: 397 GTD-KDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
G +++ LYI E + KGSL++ + R L + ++ + ++YL + VH
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVH 125
Query: 453 RDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
RD+ N+LV + K++DFGL K S+ D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 39/142 (27%), Positives = 72/142 (50%), Gaps = 2/142 (1%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G+FG+V +G+ V +L + +L +E ++ + ++ IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
G + ES + +EL G L Q+ H+ + ++ Q+ +G+KYL + + VHRD+
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121
Query: 456 KCANILVDANGSVKLADFGLAK 477
N+L+ K++DFGL+K
Sbjct: 122 AARNVLLVTQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
D++G G+FG V I DG L + S+ E E+ L H NI+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV-LCKLGHHPNII 66
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ---------VSAYTRQILL---- 440
G ++ LYI +E G+LL+ ++ + ++ S T Q LL
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 441 ----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
G++YL ++ +HRD+ N+LV N + K+ADFGL++
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
G +LG+G FGSV E S+DG F V V +L + I + +E A + F+H N
Sbjct: 4 GRMLGKGEFGSVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEFLREAACMKEFDHPN 62
Query: 392 IVQYYGTD---KDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL----- 440
+++ G + + +L I L + G L + + + Q L+
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL-PLQTLVRFMID 121
Query: 441 ---GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481
G++YL ++ +HRD+ N +++ N +V +ADFGL+K S
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LLG+G+FG V E + G ++A+K L + AK ++ E +L H +
Sbjct: 2 LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ +L +E G L +L + + + Y +I+ L+YLH +DVV
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 452 HRDIKCANILVDANGSVKLADFGLAK 477
+RDIK N+++D +G +K+ DFGL K
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 41/151 (27%), Positives = 79/151 (52%), Gaps = 17/151 (11%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
+LG+GSFG V +G + +A+K +V + D + + +E+ + LS
Sbjct: 7 VLGKGSFGKVMLAERKGTDE---LYAIKILKKDVVIQDDDVEC----TMVEKRVLALSG- 58
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
+ + Q + + +LY +E V G L+ + Q ++ Y +I +GL +LH
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ +++RD+K N+++D+ G +K+ADFG+ K
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 10/146 (6%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG+G FG V + + G +A K++ ++ + ++ LE+EI L + IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQDV 450
+ ++ L + + L+ G L Y Y+ L +V Y+ QI G+ +LH D+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116
Query: 451 VHRDIKCANILVDANGSVKLADFGLA 476
V+RD+K N+L+D G+ +L+D GLA
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 27/79 (34%), Positives = 49/79 (62%), Gaps = 1/79 (1%)
Query: 400 KDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458
+ S+L++ +E V G L+ QR L + Y +I + L +LH++ +++RD+K
Sbjct: 66 QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125
Query: 459 NILVDANGSVKLADFGLAK 477
N+L+DA+G +KL D+G+ K
Sbjct: 126 NVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 34/113 (30%), Positives = 60/113 (53%), Gaps = 5/113 (4%)
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL-----LNLYQRYHLRDSQVSAY 434
E+ L+ +H IV+++ K + KL + +E + G L L + ++ +V
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDL 487
QI+L L +H + ++HRD+K ANI + G +KL DFG +K + S+ D+
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
|
Length = 478 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 38/114 (33%), Positives = 61/114 (53%), Gaps = 13/114 (11%)
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDS 429
QLE EI L R HENI++ + E+ Y ++T+ +LY + + +D
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTY----MITQKYDFDLYSFMYDEAFDWKDR 263
Query: 430 ----QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
Q A +Q+L ++Y+HD+ ++HRDIK NI ++ +G + L DFG A F
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
|
Length = 501 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 27/170 (15%)
Query: 333 KGDLLGRGSFGSVYEGISDDGFF---FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+G +GRG++G VY+ DG +A+K++ +G+ S + EIALL +H
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACR---EIALLRELKH 57
Query: 390 ENIV--QYYGTDKDESKLYIFLELVT----------KGSLLNLYQRYHLRDSQVSAYTRQ 437
N++ Q + K+++ + + S N + L V + Q
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQ 116
Query: 438 ILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKVFLSSL 483
IL G+ YLH V+HRD+K ANILV G VK+AD G A++F S L
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 40/148 (27%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 336 LLGRGSFGSVY-EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V +A+K +V + D + + +E+ + L + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC----TMVEKRV-LALQDKPP 61
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
+ Q + + +LY +E V G L+ Q+ ++ Q Y +I +GL +LH +
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK 477
+++RD+K N+++D+ G +K+ADFG+ K
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 45/150 (30%), Positives = 79/150 (52%), Gaps = 4/150 (2%)
Query: 336 LLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
L+ G++G+VY + FA+K+++ Q + I Q+ E +L+ E+ +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKIN--KQNLILRNQIQQVFVERDILTFAENPFVVS 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+ + + + L + +E V G L + L Y + +L L+YLH+ +VHR
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHR 125
Query: 454 DIKCANILVDANGSVKLADFGLAKVFLSSL 483
D+K N+L+ + G +KL DFGL+K+ L SL
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 46/177 (25%)
Query: 331 WQKGDLLGRGSFGSVY----------------------EGISDDGFFFAVKEVSLLDQGS 368
++K + +G G++G VY EGI A++E+SLL
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPT----ALREISLL---- 54
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYH- 425
Q +S+ + LL V++ + LY+ E + ++ R
Sbjct: 55 ---QMLSESIYIVRLLD-------VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG 104
Query: 426 --LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKVF 479
L + ++ Q+L G+ + H V+HRD+K N+LVD G +K+AD GL + F
Sbjct: 105 RPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+K LLG G FG+V++GI +G + Q +Q+ ++ + + +H
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----QVSAYTRQILLGLKYLH 446
IV+ G S L + +L GSLL+ + R H RDS ++ + QI G+ YL
Sbjct: 70 YIVRLLGICPGAS-LQLVTQLSPLGSLLD-HVRQH-RDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLA 476
+ +VHR++ NIL+ ++ V++ADFG+A
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 47/161 (29%), Positives = 85/161 (52%), Gaps = 18/161 (11%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQG-SQAKQSISQLEQEIALL 384
++ +Q+ +G G+ G V G AVK++S Q + AK++ +E+ LL
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY----RELVLL 74
Query: 385 SRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTR 436
H+NI+ + ++ +Y+ +EL+ NL Q H L ++S
Sbjct: 75 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIHMELDHERMSYLLY 130
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
Q+L G+K+LH ++HRD+K +NI+V ++ ++K+ DFGLA+
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 39/155 (25%), Positives = 86/155 (55%), Gaps = 6/155 (3%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIALLSR 386
T ++ +LG G+FG+VY+GI +G + + +L++ + K ++ +++ + +++
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-IMAS 65
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
+H ++V+ G + + + +L+ G LL+ + ++ + + QI G+ Y
Sbjct: 66 MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
L ++ +VHRD+ N+LV + VK+ DFGLA++
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 39/158 (24%), Positives = 62/158 (39%), Gaps = 20/158 (12%)
Query: 336 LLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
LGRG FG V+ VK + + S+ +E+ + + H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD----ENLQSEFRRELDMFRKLSH 67
Query: 390 ENIVQYYGTDKDESKLYIFLE----------LVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
+N+V+ G ++ Y+ LE L S + L Q A QI
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
LG+ +L + VHRD+ N LV + VK++ L+K
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G++GSV I G A+K++S + Q++ + +E+ LL +HEN++
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLS---RPFQSEIFAKRAYRELTLLKHMQHENVIG 78
Query: 395 YYGTDKDESKLYIFLE--LVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
F + LV +L + + L + +V Q+L GLKY+H +
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138
Query: 451 VHRDIKCANILVDANGSVKLADFGLAK 477
+HRD+K N+ V+ + +K+ DFGLA+
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 43/168 (25%), Positives = 74/168 (44%), Gaps = 28/168 (16%)
Query: 334 GDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
G LG G+FG V G+ + V V +L + ++ +S L E+ ++ +
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVA-VKML-KDDATEKDLSDLVSEMEMMKMIGK 74
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-------------------LNLYQRYHLRDS 429
H+NI+ G E LY+ +E G+L + +D
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
AY Q+ G+++L + +HRD+ N+LV + +K+ADFGLA+
Sbjct: 135 VSFAY--QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 32/107 (29%), Positives = 60/107 (56%), Gaps = 12/107 (11%)
Query: 379 QEIALLSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQ 430
+E+ L+ H+NI+ + ++ +Y+ +EL+ NL Q L +
Sbjct: 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMDLDHER 119
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+S Q+L G+K+LH ++HRD+K +NI+V ++ ++K+ DFGLA+
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 40/151 (26%), Positives = 76/151 (50%), Gaps = 18/151 (11%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG+G FG V + G +A K+++ + + +E+ I L++ IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRI--LAKVHSRFIVSL 58
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH----------LRDSQVSAYTRQILLGLKYL 445
+ ++ L + + ++ G L RYH + + YT QI+ GL++L
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDL-----RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA 476
H + +++RD+K N+L+D +G+V+++D GLA
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LLG+G+FG V E S G ++A+K L + AK ++ E +L H +
Sbjct: 2 LLGKGTFGKVILVREKAS--GKYYAMK--ILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ + + +L +E V G L +L + + + Y +I+ L YLH +V
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117
Query: 452 HRDIKCANILVDANGSVKLADFGLAK 477
+RD+K N+++D +G +K+ DFGL K
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
G +LG G FGSV EG DDG V V + I + E A + F+H N
Sbjct: 4 GKILGEGEFGSVMEGQLSQDDGSQLKVA-VKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 392 IVQYYG---TDKDESKL---YIFLELVTKGSLLN--LYQR-----YHLRDSQVSAYTRQI 438
+++ G K+ + L + G L + LY R L + + I
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
LG++YL +++ +HRD+ N ++ + +V +ADFGL+K
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 50/160 (31%), Positives = 86/160 (53%), Gaps = 16/160 (10%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDG----FFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
T ++K +LG G+FG+VY+G+ +G A+KE L + + K + L+ E +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILD-EAYV 62
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----QIL 439
++ ++ ++ + G S + + +L+ G LL+ Y R H +D+ S Y QI
Sbjct: 63 MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLD-YVREH-KDNIGSQYLLNWCVQIA 119
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
G+ YL ++ +VHRD+ N+LV VK+ DFGLAK+
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 26/168 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
G LG G FG V G+ + K + + ++ +S L E+ ++ +
Sbjct: 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVS---- 432
H+NI+ G + LY+ +E +KG+L Y + + Q+S
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 433 ---AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
AY Q+ G++YL + +HRD+ N+LV + +K+ADFGLA+
Sbjct: 143 VSCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 7/146 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
+G G++GSV D V L + Q+ + +E+ LL +HEN++
Sbjct: 23 VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 397 GTDKDESKLYIFLE--LVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ + F E LVT L N+ + L D V Q+L GLKY+H ++
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGII 140
Query: 452 HRDIKCANILVDANGSVKLADFGLAK 477
HRD+K +N+ V+ + +++ DFGLA+
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 32/174 (18%)
Query: 337 LGRGSFGSVY----EGI-----------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
LG G FG V+ EG+ AVK + + K + + +EI
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML----RADVTKTARNDFLKEI 68
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-------- 433
++SR ++ NI++ G + L + E + G L + + + A
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 434 -----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
QI G+KYL + VHRD+ N LV + ++K+ADFG+++ S
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 43/162 (26%), Positives = 85/162 (52%), Gaps = 20/162 (12%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
++ +Q +G G+ G V Y+ + D A+K++S + Q + + +E+ L
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 69
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
+ H+NI+ + ++ +Y+ +EL+ NL Q + L ++S
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 125
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
Q+L G+K+LH ++HRD+K +NI+V ++ ++K+ DFGLA+
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 334 GDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G LG G FGSV EG ++ D V V + + + E + F+H N+
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVA-VKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 393 VQYYGT--DKDESKLY----IFLELVTKGSLLN--LYQRY-----HLRDSQVSAYTRQIL 439
++ G ES+ Y + L + G L + LY R +L + + I
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
G++YL + +HRD+ N +++ N +V +ADFGL+K
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 44/172 (25%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 330 YWQKGDLLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
YW +LG G+ G+V DG FAVK ++D ++ ++ + E+ L +
Sbjct: 34 YWIS-RVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCD 89
Query: 389 HENIVQ-----YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR------- 436
+IV+ ++ + + ++ + +L Q R +
Sbjct: 90 FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149
Query: 437 -QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDL 487
Q+LL + ++H + ++HRDIK ANIL+ +NG VKL DFG +K++ +++ D+
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
|
Length = 496 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 44/184 (23%), Positives = 76/184 (41%), Gaps = 49/184 (26%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVK--------EVSLLDQGSQAKQSISQLEQEIAL 383
G LG G FG V + F +K V +L + + + + + L E L
Sbjct: 3 VLGKTLGEGEFGKVVKA-----TAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNL 56
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------------- 430
L + H ++++ YG + L + +E GSL R LR+S+
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL-----RSFLRESRKVGPSYLGSDGNR 111
Query: 431 -----------------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
+ ++ QI G++YL + +VHRD+ N+LV +K++DF
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDF 171
Query: 474 GLAK 477
GL++
Sbjct: 172 GLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 53/177 (29%), Positives = 78/177 (44%), Gaps = 44/177 (24%)
Query: 334 GDLLGRGSFGSVYE----GIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
G LG G FG V GI D AVK L D + + ++ L E+ L+
Sbjct: 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK--MLKDNATD--KDLADLISEMELMK 72
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR----------------- 427
+H+NI+ G E LY+ +E KG+L R LR
Sbjct: 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL-----REFLRARRPPGPDYTFDITKVP 127
Query: 428 DSQVS-------AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ Q+S AY Q+ G++YL + +HRD+ N+LV + +K+ADFGLA+
Sbjct: 128 EEQLSFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 26/168 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
G LG G FG V GI D V + + + +S L E+ ++ +
Sbjct: 17 GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-------------------QRYHLRDS 429
H+NI+ G + LY+ +E +KG+L ++ +D
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
AY Q+ G++YL Q +HRD+ N+LV + +K+ADFGLA+
Sbjct: 137 VSCAY--QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 46/171 (26%), Positives = 70/171 (40%), Gaps = 31/171 (18%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G+FG VY+G ++ +V +L + Q + QE L+S +H NI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFRQEAELMSDLQHPNI 70
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR---------------- 436
V G E + E + G L + +R+S S
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDL----HEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 437 -----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
QI G++YL VHRD+ N LV +VK++DFGL++ S+
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 33/164 (20%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
LG+GSFG VYEGI+ VK+ + +++ + ++ I L E +++ F
Sbjct: 14 LGQGSFGMVYEGIAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 68
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSA 433
++V+ G + +EL+T+G L + +LR ++
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+I G+ YL+ VHRD+ N +V + +VK+ DFG+ +
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 38/147 (25%), Positives = 76/147 (51%), Gaps = 12/147 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEV----SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G+FG V +G+ + K++ +L ++ K ++ +E ++ + ++ I
Sbjct: 3 LGSGNFGCVKKGV----YKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYI 57
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
V+ G + E+ L + +E+ + G L ++ + S V Q+ +G+KYL ++
Sbjct: 58 VRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 451 VHRDIKCANILVDANGSVKLADFGLAK 477
VHRD+ N+L+ K++DFGL+K
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 22/152 (14%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G+ G VY+ G AVK++ + K+ + L+ + L S + IV+
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD--VVLKS-HDCPYIVK 78
Query: 395 YYGTDKDESKLYIFLELVTK--GSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYL 445
YG +S ++I +EL++ LL Q + + V A L YL
Sbjct: 79 CYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA--------LHYL 130
Query: 446 HD-QDVVHRDIKCANILVDANGSVKLADFGLA 476
+ V+HRD+K +NIL+DA+G+VKL DFG++
Sbjct: 131 KEKHGVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 34/107 (31%), Positives = 59/107 (55%), Gaps = 12/107 (11%)
Query: 379 QEIALLSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQ 430
+E+ L+ H+NI+ + L YI +EL+ NL Q + L +
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELDHER 127
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+S Q+L G+K+LH ++HRD+K +NI+V ++ ++K+ DFGLA+
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 40/147 (27%), Positives = 75/147 (51%), Gaps = 10/147 (6%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LG+G FG V + G +A K++ + +S++ E++I L + +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNSRFVVS 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS-----QVSAYTRQILLGLKYLHDQD 449
+ + L + L L+ G L + YH+ ++ + Y +I GL+ LH +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA 476
+V+RD+K NIL+D +G ++++D GLA
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 21/117 (17%)
Query: 380 EIALLSRFEHENIVQYYGT-----------DKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
E LL H ++++ T S LY +L TK S + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYL---TKRS-----RPLPIDQ 158
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
+ + +QIL GL+YLH Q ++HRD+K NI ++ V + D G A+ + + F
Sbjct: 159 ALI--IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213
|
Length = 357 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 44/157 (28%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
++K LG G+ G V++ G A K + L + K +I +Q+ +E+ +L
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL-----EIKPAIRNQIIRELQVLHECN 61
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
IV +YG + ++ I +E + GSL + ++ Q+ + ++ GL YL +
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 448 Q-DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
+ ++HRD+K +NILV++ G +KL DFG++ + S+
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 39/145 (26%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LG+G FG V + G +A K + + +S++ E++I L + + +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNSQFVVN 64
Query: 395 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVV 451
+ + L + L ++ G L ++Y + + + Y +IL GL+ LH ++ V
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 452 HRDIKCANILVDANGSVKLADFGLA 476
+RD+K NIL+D G ++++D GLA
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 33/111 (29%), Positives = 63/111 (56%), Gaps = 2/111 (1%)
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
+Q+ +E+ +L IV +YG + ++ I +E + GSL L + + + +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 107
Query: 434 YTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
+ +L GL YL ++ ++HRD+K +NILV++ G +KL DFG++ + S+
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 41/145 (28%), Positives = 72/145 (49%), Gaps = 5/145 (3%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
LLG+G+FG V G ++A+K L + AK ++ E +L H +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
+ + +L +E G L +L + + + Y +I+ L YLH +++VV+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 453 RDIKCANILVDANGSVKLADFGLAK 477
RD+K N+++D +G +K+ DFGL K
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 29/162 (17%)
Query: 337 LGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG+GSFG VYEG + D AVK V ++ + ++ I L E +++ F
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTV---NESASLRERIEFL-NEASVMKGFTCH 69
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---------------QVSAYT 435
++V+ G + +EL+ G L + Y R ++ Q++A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKS-YLRSLRPEAENNPGRPPPTLQEMIQMAA-- 126
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+I G+ YL+ + VHRD+ N +V + +VK+ DFG+ +
Sbjct: 127 -EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 21/160 (13%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEV---SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
DLL G+FG ++ GI D +EV ++ D S+ + ++ L QE LL H+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ--VTLLLQESCLLYGLSHQ 68
Query: 391 NI-----VQYYGTDKDE--------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
NI V + L +FL + L L Q+ Q
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
I G+ YLH + V+H+DI N ++D VK+ D L++
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 40/146 (27%), Positives = 75/146 (51%), Gaps = 7/146 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI---V 393
+G G++G+V + D A + L + Q++ + +E+ LL +HEN+ +
Sbjct: 23 VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 394 QYYGTDKDESKLYIF-LELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ D + + F L + G+ L L + L + ++ Q+L GLKY+H ++
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140
Query: 452 HRDIKCANILVDANGSVKLADFGLAK 477
HRD+K N+ V+ + +K+ DFGLA+
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 35/175 (20%)
Query: 337 LGRGSFGSVY-------EGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIA 382
LG G FG V+ + + F F V++ V +L + K + + +E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLKEVK 71
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------------ 430
+LSR + NI++ G DE L + E + G L +HL D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 431 --VSAYTR------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+Y+ QI G+KYL + VHRD+ N LV N ++K+ADFG+++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 25/58 (43%), Positives = 36/58 (62%)
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDLL 488
+ RQ+L GL+ LH +VHRDIK N+LV +G VK+ DFG A + ++F+ L
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPL 368
|
Length = 507 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 43/151 (28%), Positives = 64/151 (42%), Gaps = 13/151 (8%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFA---VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
D +G G FG V G + G A VKE+ + S QE+ H N
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKEL----RASATPDEQLLFLQEVQPYRELNHPN 56
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLR-DSQVSAYTR---QILLGLKYL 445
++Q G + + LE G L N + R + +Q R ++ GL +L
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA 476
H D +H D+ N + A+ SVK+ D+GLA
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 38/147 (25%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LG+G FG V + G +A K++ + ++++ E++I L + +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVS 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-----RDSQVSAYTRQILLGLKYLHDQD 449
+ + L + L L+ G L + Y++ + + Y +I GL+ LH +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLK--FHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA 476
+V+RD+K NIL+D G ++++D GLA
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIALLSR 386
T +K +LG G+FG+VY+GI DG + + +L + + K + L+ E +++
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAG 65
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
+ + G S + + +L+ G LL+ Y R + + + + QI G+
Sbjct: 66 VGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLD-YVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFD 486
YL + +VHRD+ N+LV + VK+ DFGLA++ LD D
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL----LDID 162
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 45/169 (26%), Positives = 71/169 (42%), Gaps = 27/169 (15%)
Query: 337 LGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
LG +FG +Y+G D A+K +L D + Q + +QE +L++ H N
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIK--TLKDINN--PQQWGEFQQEASLMAELHHPN 68
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA----------------- 433
IV G E + + E + +G L L R D S+
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
QI G++YL VH+D+ NIL+ VK++D GL++ S+
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 37/145 (25%), Positives = 64/145 (44%), Gaps = 10/145 (6%)
Query: 336 LLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+LG G FG + G S A+ L G KQ L E L +F+H N
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIH---TLRAGCSDKQRRGFL-AEALTLGQFDHSN 67
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
IV+ G + + I E ++ G+L + +++ L Q+ + G+KYL +
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 450 VVHRDIKCANILVDANGSVKLADFG 474
VH+ + +LV+++ K++ F
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 22/51 (43%), Positives = 33/51 (64%)
Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
L +QV+A RQ+L + Y+H + ++HRDIK N+LV+ + L DFG A
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 35/173 (20%)
Query: 337 LGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G FG V+ FF K +S +G + ++ SQL E+ ++ +H+NIV+Y
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISY--RGLKEREK-SQLVIEVNVMRELKHKNIVRY 77
Query: 396 YGT--DKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHD- 447
+K KLYI +E G L Q+ + + + + TRQ+L L Y H+
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137
Query: 448 ------QDVVHRDIKCANILV---------------DANGS--VKLADFGLAK 477
+ V+HRD+K NI + + NG K+ DFGL+K
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
|
Length = 1021 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 29/97 (29%), Positives = 45/97 (46%)
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
E +L H +I+Q GT + L L + ++ + A R +L
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
++YLH+ ++HRDIK NI ++ G V L DFG A
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 16/165 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFF---AVKEVSLLDQGSQAKQSI---SQLEQE-IAL 383
W+ L+G G FG VYE AV ++ L+ + +++ + + + IAL
Sbjct: 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73
Query: 384 LSRF---EHENIVQYYGTDK-DESKLY---IFLELVTKGSLLNLYQRYHLRDSQ-VSAYT 435
+H I +YYG ++Y I LE + + + +++R ++ + +
Sbjct: 74 WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIM 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480
+ +L L+Y+H+ + H DIK NI+VD N + D+G+A F+
Sbjct: 133 KDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177
|
Length = 294 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFA---VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G G FG V G + G+ A VKE+ + S + Q + +E +H N++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKEL----RVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--------QVSAYTRQILLGLKYL 445
Q G + + + +E G L + + Q A +I LGL +L
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHL 116
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA 476
H + +H D+ N L+ A+ +VK+ D+GL+
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 5/115 (4%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
V + D + ++ + L+ E+ L F H NI+ + S L++ + GS +L
Sbjct: 30 VRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSL 89
Query: 421 YQRYHLRDSQVSAYTRQILLG----LKYLHDQDVVHRDIKCANILVDANGSVKLA 471
+ Y + A IL G L YLH +HR+IK ++IL+ +G V L+
Sbjct: 90 LKTYF-PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 37/150 (24%), Positives = 72/150 (48%), Gaps = 16/150 (10%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LG+G FG V + G +A K++ + ++++ E+ I L + +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNSRFVVS 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-------DSQVSA-YTRQILLGLKYLH 446
+ + L + L ++ G L ++H+ D Q + Y ++ GL+ L
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDL-----KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLA 476
+ +V+RD+K NIL+D G ++++D GLA
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 31/106 (29%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDE-SKLYIFLELVTKGSLLNLYQRYH-LRDSQVS 432
++ +E AL +R H NIV + + L+ E V +L + L +
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETG 82
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGL 475
Q+L L H+Q +VHRD+K NI+V G K+ DFG+
Sbjct: 83 RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 23/163 (14%)
Query: 337 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHEN 391
LG+G+F ++Y+G+ SD +EVS++ + + S E A L+S+ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 392 IVQYYG-TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
+V+ YG +DE+ + E V G L +++ H + VS + +Q+ L YL
Sbjct: 63 LVKLYGVCVRDENI--MVEEYVKFGPL-DVF--LHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 446 HDQDVVHRDIKCANILV---DANGS----VKLADFGLAKVFLS 481
D+ +VH ++ NILV N +KL+D G+ LS
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 7/107 (6%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 436
L+ E+ + F H NIV Y T +++L++ + GS +L H D
Sbjct: 46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMSELAIA 104
Query: 437 QILLG----LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
IL G L Y+H VHR +K ++IL+ +G V L+ GL
Sbjct: 105 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNL 149
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 18/41 (43%), Positives = 26/41 (63%)
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
R++L L YLH + ++HRD+K NI +D + L DFG A
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 18/44 (40%), Positives = 29/44 (65%)
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
Y+ Q+ G+++L + +HRD+ NIL+ N VK+ DFGLA+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 18/74 (24%), Positives = 39/74 (52%), Gaps = 1/74 (1%)
Query: 402 ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460
E +++ L+ G L + ++ ++ + V + ++++ L LH + +V RD+ NI
Sbjct: 57 EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 461 LVDANGSVKLADFG 474
L+D G ++L F
Sbjct: 117 LLDDRGHIQLTYFS 130
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 18/44 (40%), Positives = 29/44 (65%)
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
Y+ Q+ G+++L + +HRD+ NIL+ N VK+ DFGLA+
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 23/66 (34%), Positives = 38/66 (57%), Gaps = 2/66 (3%)
Query: 415 GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLAD 472
G L +L ++ L +++V RQ++ L LH +++H DIK N+L D A + L D
Sbjct: 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCD 153
Query: 473 FGLAKV 478
+GL K+
Sbjct: 154 YGLCKI 159
|
Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 18/45 (40%), Positives = 30/45 (66%)
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+Y+ Q+ G+++L + +HRD+ NIL+ N VK+ DFGLA+
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 37/167 (22%)
Query: 337 LGRGSFGSVYEGISDDGFFFA------VKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEH 389
LG FG VY+G F + V++ +A+ + + + E + SR +H
Sbjct: 13 LGEDRFGKVYKG-----HLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLR-----------DSQVSA---- 433
NIV G K++ IF + S +L++ +R D V +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIF----SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123
Query: 434 -----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
QI G+++L VVH+D+ N+LV +VK++D GL
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 20/42 (47%), Positives = 25/42 (59%), Gaps = 1/42 (2%)
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLA 476
RQIL L LH +VHRD+K NI+ +GS K+ D G A
Sbjct: 262 RQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 17/45 (37%), Positives = 30/45 (66%)
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
++T Q+ G+++L ++ VHRD+ N+L+ VK+ DFGLA+
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 35/143 (24%), Positives = 59/143 (41%), Gaps = 25/143 (17%)
Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHL 426
K I E EI L R + NI++ YG D +L + LE T+G L
Sbjct: 59 KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE----VLD 114
Query: 427 RDSQVSAYTR-QILL----GLKYLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKV-- 478
++ +S T+ + + GL L+ ++++ + LV N +K+ GL K+
Sbjct: 115 KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174
Query: 479 --------FLSSLDFDLLL-IFS 492
F+ + +L IFS
Sbjct: 175 SPPFKNVNFMVYFSYKMLNDIFS 197
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 16/44 (36%), Positives = 29/44 (65%)
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
++ Q+ G+++L ++ VHRD+ N+L+ VK+ DFGLA+
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 514 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.98 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.92 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.91 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.63 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.61 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.35 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.2 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.02 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.93 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.82 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.79 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.43 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.39 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.34 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.31 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.19 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.0 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.98 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.87 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.67 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.59 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.45 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.42 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.37 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.37 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.31 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 97.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.24 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.09 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.92 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.65 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.5 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.45 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.44 | |
| PLN02236 | 344 | choline kinase | 96.33 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.31 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.25 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.21 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.12 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.03 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.59 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.37 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.19 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.04 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.83 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.76 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.4 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.37 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.04 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 92.48 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=330.92 Aligned_cols=186 Identities=25% Similarity=0.448 Sum_probs=166.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...+.|.+.+.||.|+||+||+|++ .++..||||.+..... .++..+.+..||.+|+.++|||||.+++++.+.++
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 4467899999999999999999998 6789999999875332 34556778899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC------CcEEEEeccCce
Q 010231 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN------GSVKLADFGLAK 477 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~------g~vKI~DFGlAk 477 (514)
+|||||||.||+|..|++.. .+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999876 79999999999999999999999999999999999999865 358999999999
Q ss_pred ecccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 478 VFLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 478 ~~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.+... ....|..+.|+||+|++||+|++|.+||...|
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 88754 23567779999999999999999999999653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=326.00 Aligned_cols=185 Identities=28% Similarity=0.422 Sum_probs=166.5
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|+++++||+|+||+||.++. .+++.||+|+++..... ......+...|..||..++||+||+++..|++..++|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv--~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIV--EKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhh--hhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 57899999999999999999987 78999999998754432 3345678899999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
||+||+.||.|+..|++ ..+++..++.|+.+|+.||.|||++|||||||||+|||+|.+|+|+|+|||||+......
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence 99999999999999985 569999999999999999999999999999999999999999999999999999654331
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...+...+|+||||+++|+|++|.+||.+.|
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 2456668999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=334.33 Aligned_cols=188 Identities=30% Similarity=0.501 Sum_probs=165.0
Q ss_pred cccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCC
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE 402 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~ 402 (514)
++...+|..++.||.|+|++||+|+. .++..||||++.... ...+...+.+..|-.+|.+| .||+|++||.+|++.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~--Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY--IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH--HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 34467899999999999999999998 789999999876422 22333445677888889998 899999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 403 SKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~~-lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
..+|+|+||+++|+|.++|++.+ |++...+.|+.||+.||+|||++|||||||||+|||+|.+|++||+|||.|+.+..
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999999998864 89999999999999999999999999999999999999999999999999998753
Q ss_pred C--------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 482 S--------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 482 ~--------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
. .+...+..+|+|+|||+||.|+.|.+||.+.|
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 3 12344457899999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=334.36 Aligned_cols=183 Identities=32% Similarity=0.544 Sum_probs=164.9
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|..+++||+|+|+.||++++ .+|+.||+|+|..... ......+++.+||.|.+.|+|||||++|++|++.+++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l--~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL--KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh--cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 4699999999999999999999 8999999999975322 233445778999999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
|+|+|..++|..++++ +.+++.+++.|++||+.||.|||+++|||||||..|||++.+.+|||+|||||..+..+.
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 9999999999999975 569999999999999999999999999999999999999999999999999999887441
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+.+.+||||+||+||.|++|++||...
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 234456889999999999999999999764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.28 Aligned_cols=188 Identities=28% Similarity=0.378 Sum_probs=160.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchh--HHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA--KQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~--~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.+.++|.+.+.||+|+||.|-+|.. ++|+.||||+++........ ......+.+|+.+|++|.|||||+++++|...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3567899999999999999999988 79999999999865443322 12233467999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC---CcEEEEeccCcee
Q 010231 403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKV 478 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~---g~vKI~DFGlAk~ 478 (514)
+..||||||+.||+|++.+-. ..+.+...+.|++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 999999999999999987754 458888889999999999999999999999999999999876 6899999999998
Q ss_pred cccCC---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSL---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..... ...+..+.|+||+||+||-+++|.+||...
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence 75331 122224679999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=304.71 Aligned_cols=185 Identities=28% Similarity=0.453 Sum_probs=167.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
+++|++++.||.|+||+|.+++. .+|..||+|++...+. ...+..++..+|..+|+.+.||+++++++.|.+.+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v--VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV--VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH--HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 57899999999999999999998 6789999999875433 33455688899999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|||||++||.|+.++++ .++++..++.|+.||+.||+|||.++|++|||||+|||+|.+|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~T 200 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWT 200 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEEE
Confidence 99999999999999987 57999999999999999999999999999999999999999999999999999986543
Q ss_pred -------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....+....|+|+||+++|||+.|.+||-..|
T Consensus 201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 23566779999999999999999999998764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.86 Aligned_cols=189 Identities=30% Similarity=0.507 Sum_probs=166.0
Q ss_pred ccccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec
Q 010231 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (514)
Q Consensus 322 ~~~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~ 400 (514)
+.+.+..+.|+.+++||+|+||.||+|++ .+|+.||+|+|...... .....-..+||.||++|.||||++|.+...
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~---~~~~~t~~REI~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK---EGFPITAIREIKILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC---CcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence 55667778899999999999999999998 79999999999864322 233455679999999999999999999776
Q ss_pred CC--CeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCc
Q 010231 401 DE--SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (514)
Q Consensus 401 ~~--~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlA 476 (514)
+. ..+|||+|||+. +|.-++... +|++.+++.|+.||+.||+|||.+||+|||||.+|||||.+|.+||+|||||
T Consensus 187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence 55 689999999987 777777654 6999999999999999999999999999999999999999999999999999
Q ss_pred eecccCC---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 477 KVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 477 k~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
+++.... ...|+..+|+||.||||.||++|++.|.|.+
T Consensus 266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 9876552 3567778999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.08 Aligned_cols=181 Identities=27% Similarity=0.409 Sum_probs=160.4
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|+.+.++|+|+||.||+|++ .+|+.||||++.-... .....+-..+||++|++++|+|+|.++.+|.....+++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed---d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED---DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc---cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 5688899999999999999999 6899999998864332 23344556899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|+|||+..-| +.|++ ++++.+.++.|++|++.|+.|+|+++||||||||+||||+.+|.+||||||+|+.+..+
T Consensus 79 VFE~~dhTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 79 VFEYCDHTVL-HELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred EeeecchHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 9999998544 44444 57999999999999999999999999999999999999999999999999999988743
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+.+|+...|||++||++.||++|+++|+|.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~ 205 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR 205 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc
Confidence 3477888999999999999999999999985
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.35 Aligned_cols=186 Identities=24% Similarity=0.425 Sum_probs=164.5
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
-.++|+++++||+|+||.||+|+. .+|..||+|+++.... .....+.+++.|-.+|....+++||+||..|++..++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M--~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM--LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH--HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 467999999999999999999987 7899999999875433 3345578889999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
||||||++||++..+|.+. .+++..++.|+.+++.|++.||+.|+|||||||+|+|||..|++||+||||++-+...
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 9999999999999988764 5999999999999999999999999999999999999999999999999999743210
Q ss_pred ----------------------------------------------------------------CCcCcceeehhhhHHH
Q 010231 483 ----------------------------------------------------------------LDFDLLLIFSIFLNGC 498 (514)
Q Consensus 483 ----------------------------------------------------------------~~~~~~~~~DVwSlG~ 498 (514)
....++..+|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0124455789999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 010231 499 KFFLIFLHVLIFRPPN 514 (514)
Q Consensus 499 lLyeLltG~~PF~g~n 514 (514)
|+|||+.|-+||.+.+
T Consensus 377 ImyEmLvGyPPF~s~t 392 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSET 392 (550)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999998754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=304.91 Aligned_cols=182 Identities=27% Similarity=0.489 Sum_probs=163.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-eE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-KL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~-~l 405 (514)
..+.+.++.||+|..|+||++++ .+++.+|+|.+.. .......+++.+|+.+++.++|||||.+|++|..+. .+
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 45677789999999999999999 6899999999954 233455688999999999999999999999999988 49
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCceecccC-
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~- 482 (514)
+|+||||.+|+|..+++. ..+++..+..++.+|++||.|||+ ++||||||||+||||+..|.|||||||.++.+.++
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~ 233 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI 233 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhh
Confidence 999999999999999876 569999999999999999999996 99999999999999999999999999999877554
Q ss_pred ----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....|+..+||||||..++|+.+|++||..+
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 2356777899999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.65 Aligned_cols=185 Identities=32% Similarity=0.480 Sum_probs=163.4
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEE-EecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG-TDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~-~~~~~~~ 404 (514)
....|++.++||+|+||+||++.. .+|..+|.|.+... ....+..+.+..|+.+|++|+|||||++|+ .|..++.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~---~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG---MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh---hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 356899999999999999999988 79999999988732 233455678889999999999999999998 5666666
Q ss_pred -EEEEEeccccCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCCEEEcCCCcEEEEecc
Q 010231 405 -LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHD--QD--VVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 405 -l~LVmEy~~gGsL~~lL~~~-----~lse~~v~~i~~QIl~gL~yLHs--~g--IIHRDLKP~NILId~~g~vKI~DFG 474 (514)
++||||||..|+|..+++.. .+++..+++|+.|++.||.++|. .+ |+||||||.||+|+.+|.|||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 99999999999999998653 49999999999999999999998 44 9999999999999999999999999
Q ss_pred CceecccC-------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 475 LAKVFLSS-------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 475 lAk~~~~~-------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
|++.+.+. .+..+..++||||+||++||||.-++||-|.|
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 99987654 34677789999999999999999999999865
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=301.34 Aligned_cols=188 Identities=27% Similarity=0.378 Sum_probs=163.3
Q ss_pred ccccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec
Q 010231 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (514)
Q Consensus 322 ~~~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~ 400 (514)
..-.+-++.|+.++.|++|+||.||+|++ ++++.||+|.++..+...- . -....+||.+|.+++|||||.+..+..
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G--F-PItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG--F-PITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC--C-cchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 33445678999999999999999999999 7899999999987553321 1 123469999999999999999987654
Q ss_pred --CCCeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCc
Q 010231 401 --DESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (514)
Q Consensus 401 --~~~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlA 476 (514)
+-+.+|||||||+. +|..++... .|...+++.++.|++.||+|||.++|+|||||++|+|++..|.+||+|||||
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchh
Confidence 45679999999987 899888764 5899999999999999999999999999999999999999999999999999
Q ss_pred eecccC--------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 477 KVFLSS--------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 477 k~~~~~--------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.+.++ ....|+..+|+||+|||+.||+++.+.|+|.
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 998876 2356777899999999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.36 Aligned_cols=189 Identities=28% Similarity=0.434 Sum_probs=162.7
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 403 (514)
...+.|.+++.||+|+||+|++|.+ .++..||+|++.............+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3467899999999999999999987 68899999976643221111233456778999999999 999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC-CcEEEEeccCceecc-
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKVFL- 480 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~-g~vKI~DFGlAk~~~- 480 (514)
++||||||+.||+|++++.. ..+.+..++.||+||+.||+|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 99999999999999999877 679999999999999999999999999999999999999999 999999999999772
Q ss_pred cC-------------------CCc-CcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SS-------------------LDF-DLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~-------------------~~~-~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.. ... ..+...||||+|++||.|++|+.||...|
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 21 112 23478999999999999999999998654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.38 Aligned_cols=188 Identities=23% Similarity=0.398 Sum_probs=166.0
Q ss_pred cccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCC
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE 402 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~ 402 (514)
+.-+++|.+.++||+|+||+|+++.. .+++.||||.+++... .....++.+..|.+|+... +||++++++.+|++.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I--l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI--LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce--eccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 34467999999999999999999988 6788999999986443 3344567788888888877 599999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+++|+||||+.||++..+.+...+++..++.|+.+|+.||+|||++||||||||.+|||+|.+|++||+||||++.....
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99999999999999666656678999999999999999999999999999999999999999999999999999975411
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.+..|+...|+|+|||+||+|++|+.||+|.|
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 34678889999999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=289.28 Aligned_cols=182 Identities=28% Similarity=0.454 Sum_probs=161.3
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.+|...++||+|+||.||+|++ .+|+.||||+++....... ......+||++|+.++|+||+.++++|.....+.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG---i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG---INRTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC---ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 4678889999999999999998 7999999999987533211 12345799999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|+||++. +|...++.. -++...++.|+.|++.||+|||+++|+||||||.|+||+.+|.+||+|||+|+.+....
T Consensus 79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9999986 899988764 48999999999999999999999999999999999999999999999999999987542
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...|+...|+||.||++.||+.|.+.|+|.+
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s 206 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS 206 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc
Confidence 2456668899999999999999999999975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.08 Aligned_cols=186 Identities=28% Similarity=0.454 Sum_probs=165.2
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..+-|++++.||.|+-|.|-+|++ .+|+..|||+|....... ......+++||.+|+.+.||||+++|++|.++.++
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s--~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS--SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccc--cccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 356799999999999999999998 899999999998654322 23346789999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 406 YIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~-~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
|+|+||+++|.|+++|- +..+.+.++.+||+||+.|+.|+|..+|+||||||+|+|+|.+++|||+|||+|..-..+
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999999999775 567999999999999999999999999999999999999999999999999999864322
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.....+...||||+|+|||.|+||.+||+..|
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 12344568999999999999999999999877
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=310.42 Aligned_cols=184 Identities=27% Similarity=0.392 Sum_probs=160.9
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 403 (514)
.+.++|.++++||.|+||.||+|+. .++..||||.++..-. .+ +..- -.||++.|++|. ||||++|.+++.+.+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~--ee~~-nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SW--EECM-NLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cH--HHHH-HHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3567899999999999999999998 6889999998874222 11 1122 248999999998 999999999999888
Q ss_pred -eEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 404 -KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 404 -~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
.+|+|||||+. +|+++++.. .|++..++.|++||++||+|+|.+|+.||||||+||||..+..|||+|||||+...
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999999976 899999754 59999999999999999999999999999999999999999999999999999876
Q ss_pred cC-------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SS-------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~-------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
+. ....|+..+|+|++||++||+.+-+++|+|.|
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 44 23567778999999999999999999999975
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=297.01 Aligned_cols=183 Identities=23% Similarity=0.431 Sum_probs=158.5
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++++.||+|+||+||+|.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++.+.+...+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 3689999999999999999987 5789999999874221 123344677889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
||||+++|+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999998865 56899999999999999999999999999999999999999999999999998754210
Q ss_pred --------------------------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 --------------------------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 --------------------------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....+...+|||||||++|+|++|..||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 012345678999999999999999999986
Q ss_pred C
Q 010231 513 P 513 (514)
Q Consensus 513 ~ 513 (514)
.
T Consensus 239 ~ 239 (363)
T cd05628 239 E 239 (363)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=294.15 Aligned_cols=183 Identities=25% Similarity=0.439 Sum_probs=158.7
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|+++++||+|+||+||+|++ .+++.||||++..... ........+.+|+.++..++|+||+++++++.+.+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM--LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 3689999999999999999998 5789999999874321 122344667889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999998865 46899999999999999999999999999999999999999999999999998754211
Q ss_pred -----------------------------------------------------CCcCcceeehhhhHHHHHHHHHhCCCC
Q 010231 483 -----------------------------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLI 509 (514)
Q Consensus 483 -----------------------------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~P 509 (514)
....+...+|||||||++|+|++|.+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 112345679999999999999999999
Q ss_pred CCCC
Q 010231 510 FRPP 513 (514)
Q Consensus 510 F~g~ 513 (514)
|.+.
T Consensus 239 f~~~ 242 (364)
T cd05599 239 FCSD 242 (364)
T ss_pred CCCC
Confidence 9764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=306.92 Aligned_cols=180 Identities=26% Similarity=0.475 Sum_probs=162.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|.+.+.||+|+||.||+|+. .+.+.||||.+.+.. ..++.++.+.+|++|++.++||||+.++++|++..++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g---r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG---RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC---CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 5788999999999999999988 678999999987543 334567889999999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
|+||+.| +|+.++.. ..++++.+..++.|++.||.|||+++|+|||+||.|||+..+|.+|+||||+|+.+...
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9999988 99999976 57999999999999999999999999999999999999999999999999999976532
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....|...+|+|||||++|||+.|++||-.
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 345677789999999999999999999953
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=295.95 Aligned_cols=183 Identities=24% Similarity=0.402 Sum_probs=157.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|.+++.||+|+||+||++.+ .+++.||||++..... ........+.+|+.+++.++|+||+++++++.+.+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 3689999999999999999987 6889999999864221 123345678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
||||+++|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999998865 45889999999999999999999999999999999999999999999999999632110
Q ss_pred --------------------------------------------------------------CCcCcceeehhhhHHHHH
Q 010231 483 --------------------------------------------------------------LDFDLLLIFSIFLNGCKF 500 (514)
Q Consensus 483 --------------------------------------------------------------~~~~~~~~~DVwSlG~lL 500 (514)
....++..+|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 012345679999999999
Q ss_pred HHHHhCCCCCCCC
Q 010231 501 FLIFLHVLIFRPP 513 (514)
Q Consensus 501 yeLltG~~PF~g~ 513 (514)
|+|++|.+||.+.
T Consensus 239 ~elltG~~Pf~~~ 251 (377)
T cd05629 239 FECLIGWPPFCSE 251 (377)
T ss_pred hhhhcCCCCCCCC
Confidence 9999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=296.74 Aligned_cols=183 Identities=32% Similarity=0.453 Sum_probs=160.5
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-eEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-KLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~-~l~L 407 (514)
....+.+.||.|+||+||+|.+.....||||++......... ...+.+|+.+|..++|||||+++|++.... .++|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 345566779999999999999987777999998754433322 678999999999999999999999999887 7999
Q ss_pred EEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCCEEEcCCC-cEEEEeccCceecccC
Q 010231 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANG-SVKLADFGLAKVFLSS 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~g-IIHRDLKP~NILId~~g-~vKI~DFGlAk~~~~~ 482 (514)
||||+++|+|..++.. ..++...+..|+.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999999965 57999999999999999999999999 99999999999999998 9999999999865531
Q ss_pred -------------------C--CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -------------------L--DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -------------------~--~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
. ...++.++||||||++||||+||+.||...+
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 1 2347789999999999999999999998753
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.12 Aligned_cols=182 Identities=24% Similarity=0.423 Sum_probs=157.2
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.|.++++||+|+||+||+|++ .+++.||+|++..... ........+.+|+.+++.+.|+||+++++.+.+.+.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV--LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 588999999999999999998 6788999998874221 2234456788999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc------
Q 010231 409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS------ 481 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~------ 481 (514)
|||+++|+|.+++.+. .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+..
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999999999988664 588899999999999999999999999999999999999999999999999753210
Q ss_pred ---------------------------------------------------------C---CCcCcceeehhhhHHHHHH
Q 010231 482 ---------------------------------------------------------S---LDFDLLLIFSIFLNGCKFF 501 (514)
Q Consensus 482 ---------------------------------------------------------~---~~~~~~~~~DVwSlG~lLy 501 (514)
+ ....+...+|||||||+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 0 1123456789999999999
Q ss_pred HHHhCCCCCCCC
Q 010231 502 LIFLHVLIFRPP 513 (514)
Q Consensus 502 eLltG~~PF~g~ 513 (514)
+|++|++||.+.
T Consensus 240 elltG~~Pf~~~ 251 (382)
T cd05625 240 EMLVGQPPFLAQ 251 (382)
T ss_pred HHHhCCCCCCCC
Confidence 999999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.09 Aligned_cols=184 Identities=26% Similarity=0.437 Sum_probs=160.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|++.+.||+|+||.||+|++ .+++.||+|++..... ........+.+|+.+++.++||||+++++.+...+.+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI--LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 57899999999999999999998 5789999999874221 12233467889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
+||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 174 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT 174 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence 99999999999998865 468899999999999999999999999999999999999999999999999998754321
Q ss_pred --------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 --------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 --------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|||||||++|+|++|..||.+.
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 123456799999999999999999999764
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.01 Aligned_cols=182 Identities=26% Similarity=0.448 Sum_probs=157.2
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.|++++.||+|+||+||+|++ .++..||+|++..... ........+.+|+.+++.++|+||+++++.+.+.+.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV--LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 588999999999999999988 6788999999874221 1233456788999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc------
Q 010231 409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS------ 481 (514)
Q Consensus 409 mEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~------ 481 (514)
|||+++|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++++||+|||+++.+..
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 999999999998865 4588899999999999999999999999999999999999999999999999753210
Q ss_pred ---------------------------------------------------C---------CCcCcceeehhhhHHHHHH
Q 010231 482 ---------------------------------------------------S---------LDFDLLLIFSIFLNGCKFF 501 (514)
Q Consensus 482 ---------------------------------------------------~---------~~~~~~~~~DVwSlG~lLy 501 (514)
. ....++..+|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0 1123456799999999999
Q ss_pred HHHhCCCCCCCC
Q 010231 502 LIFLHVLIFRPP 513 (514)
Q Consensus 502 eLltG~~PF~g~ 513 (514)
+|++|.+||.+.
T Consensus 240 elltG~~Pf~~~ 251 (381)
T cd05626 240 EMLVGQPPFLAP 251 (381)
T ss_pred HHHhCCCCCcCC
Confidence 999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=284.57 Aligned_cols=183 Identities=24% Similarity=0.389 Sum_probs=158.9
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV--IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 3689999999999999999998 5789999999874221 112334668899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence 99999999999988654 58899999999999999999999999999999999999999999999999998654321
Q ss_pred -------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|||||||++|+|++|..||.+.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123456789999999999999999999865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.40 Aligned_cols=186 Identities=25% Similarity=0.440 Sum_probs=166.1
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...-+|++.+.||+|+||+|-+|.. ..|+.||||.++..+ ...++..-++.+||.||+.|+||||+.+|.+|+..++
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk--IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK--IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh--cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 3445899999999999999999987 789999999887533 4556777889999999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+.|||||..+|.|++|+.+ ..+++.+++.||+||+.|+.|+|.++++|||||.+|||+|.|+++||+||||+..|....
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999999999976 569999999999999999999999999999999999999999999999999998775431
Q ss_pred ------------------CcC-cceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------DFD-LLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~-~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... .+...|-||||++||.|+.|.+||+|-
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 122 224688999999999999999999984
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=292.34 Aligned_cols=176 Identities=28% Similarity=0.447 Sum_probs=151.7
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC-----
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----- 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~----- 402 (514)
-.|.-.+++|.|+||.||+|.. .+++.||||++...... -.+|+.+|+.+.|||||+|..+|...
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---------KNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---------CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 3688899999999999999987 56799999998753332 23799999999999999998776422
Q ss_pred CeEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC-CcEEEEeccCc
Q 010231 403 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLA 476 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~-g~vKI~DFGlA 476 (514)
-++.+||||++. +|..+++. ..++.-.++.|++||+.||.|||+.||+||||||.|||||.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 256789999988 88888874 468888899999999999999999999999999999999976 99999999999
Q ss_pred eecccC-------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 477 KVFLSS-------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 477 k~~~~~-------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
+.+... ....|+..+||||.||++.||+.|++.|+|.+
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 987644 23677789999999999999999999999853
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.58 Aligned_cols=184 Identities=24% Similarity=0.357 Sum_probs=160.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|++.+.||+|+||.||++.+ .+++.+|+|++..... ........+.+|+.+++.++||||+++++++.+...+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 46899999999999999999998 5788999999864221 11223355778999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
+||||+++|+|.+++....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 120 lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998653210
Q ss_pred ---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|+|||||+||+|++|++||.+.
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 012456899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=288.54 Aligned_cols=183 Identities=32% Similarity=0.538 Sum_probs=158.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc-eeEEEEEecCCC--
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES-- 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~-- 403 (514)
...|+.+++||+|+||+||+|+. .+|+.||+|++....... -......+|+.+|+.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E---G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE---GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc---CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 45678889999999999999998 688999999998754321 12234579999999999999 999999998877
Q ss_pred ----eEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEecc
Q 010231 404 ----KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 404 ----~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFG 474 (514)
.++||+||+.. +|..++.. .+++...++.|++||+.||.|||+++|+||||||.||||+.+|.+||+|||
T Consensus 87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence 89999999977 89988875 357778899999999999999999999999999999999999999999999
Q ss_pred CceecccCC--------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 475 LAKVFLSSL--------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 475 lAk~~~~~~--------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
+|+.+.-+. ...|....||||+||+++||++++++|+|.+
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 999765331 2356678999999999999999999999863
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=294.57 Aligned_cols=183 Identities=23% Similarity=0.419 Sum_probs=156.7
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|++++.||+|+||.||++++ .+++.||+|++..... ........+.+|+.+++.+.|+||+++++.+.+.+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV--LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH--HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 3689999999999999999998 5789999998864221 122334667899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc-----
Q 010231 408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS----- 481 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~----- 481 (514)
||||+++|+|.+++... .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|..+..
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 99999999999998764 578888999999999999999999999999999999999999999999999853210
Q ss_pred ------------------------------------------------C---------CCcCcceeehhhhHHHHHHHHH
Q 010231 482 ------------------------------------------------S---------LDFDLLLIFSIFLNGCKFFLIF 504 (514)
Q Consensus 482 ------------------------------------------------~---------~~~~~~~~~DVwSlG~lLyeLl 504 (514)
. ....++..+|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0 1123445789999999999999
Q ss_pred hCCCCCCCC
Q 010231 505 LHVLIFRPP 513 (514)
Q Consensus 505 tG~~PF~g~ 513 (514)
+|..||.+.
T Consensus 239 ~G~~Pf~~~ 247 (376)
T cd05598 239 VGQPPFLAD 247 (376)
T ss_pred hCCCCCCCC
Confidence 999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=286.65 Aligned_cols=183 Identities=23% Similarity=0.367 Sum_probs=159.4
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++++.||+|+||.||+|++ .+++.||+|++..... ........+.+|+.++..++|+||+++++++...+.+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 3689999999999999999998 4689999999874321 122334667889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~ 158 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence 9999999999999875 45899999999999999999999999999999999999999999999999999864321
Q ss_pred ------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|||||||++|+|++|..||.+.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 1134556899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=302.03 Aligned_cols=182 Identities=27% Similarity=0.388 Sum_probs=161.0
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
....+.+++.||+|.||.||+|.+.....||+|.++... ...+.+.+|+++|++|+|+|||+|+++|..+..+|
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~------m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS------MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc------cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 345677889999999999999999988899999988532 22356779999999999999999999999988999
Q ss_pred EEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-
Q 010231 407 IFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~- 482 (514)
|||||+..|+|.++|+. ..+...+.+.|+.||+.||+||+++++|||||-++||||+.++.|||+|||||+...++
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999999999999986 45888999999999999999999999999999999999999999999999999954433
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHH-hCCCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIF-LHVLIFRPPN 514 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLl-tG~~PF~g~n 514 (514)
....+..++||||||++||||+ .|+.||++++
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms 409 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS 409 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence 1245567899999999999999 5899988864
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=291.13 Aligned_cols=185 Identities=23% Similarity=0.345 Sum_probs=160.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|++.+.||+|+||.||++.+ .+++.+|+|++..... ........+.+|+.+++.++||||+++++++.+...+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 47899999999999999999998 5788999999864221 11223345778999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
+||||+++|+|..++....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus 120 lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998653210
Q ss_pred ---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 ---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 ---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...++..+|||||||++|+|++|.+||.+.+
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 0124568999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=286.92 Aligned_cols=187 Identities=27% Similarity=0.366 Sum_probs=160.2
Q ss_pred ccccceEeeeeecccCceeEEEEEcc--CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~--~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
...+.|++.+.||+|+||.||+|.+. .+..||+|.+..... ........+.+|+.+++.++||||+++++++.+.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 34678999999999999999999863 336899998864221 12234566789999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+|+||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999998865 46889999999999999999999999999999999999999999999999999875432
Q ss_pred C----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 L----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ~----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
. ...++..+|+|||||++|+|++|.+||.+.+
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 1 1234567999999999999999999998753
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.84 Aligned_cols=184 Identities=27% Similarity=0.450 Sum_probs=161.5
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC----
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---- 401 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~---- 401 (514)
+..+|...+.||+|+||.|+.+.+ .+|..||||++.. ........++..+|+++|+.++|+||+.+++++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~---~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN---PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh---hhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 345677789999999999999998 7899999998762 13445566778899999999999999999998765
Q ss_pred -CCeEEEEEeccccCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 402 -ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 402 -~~~l~LVmEy~~gGsL~~lL~~~~-lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
-+.+|+|+|+|+ .+|..+++..+ +++..+..+++||+.||+|+|+.||+||||||.|+|++.+..+||||||||+.+
T Consensus 97 ~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 97 KFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 356999999994 48999999877 999999999999999999999999999999999999999999999999999988
Q ss_pred cc----C------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 480 LS----S------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 480 ~~----~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.. . ....++..+||||.||||.||++|++.|+|.+
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 42 1 23567778999999999999999999999964
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=289.54 Aligned_cols=183 Identities=24% Similarity=0.439 Sum_probs=158.5
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|++++.||+|+||+||++.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++.+.+.+.+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3689999999999999999988 5789999999874221 223345678889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
||||+++|+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+...
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999998865 46899999999999999999999999999999999999999999999999998744211
Q ss_pred --------------------------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 --------------------------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 --------------------------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....++..+|||||||++|+|++|.+||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 112345678999999999999999999976
Q ss_pred C
Q 010231 513 P 513 (514)
Q Consensus 513 ~ 513 (514)
.
T Consensus 239 ~ 239 (360)
T cd05627 239 E 239 (360)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=284.58 Aligned_cols=177 Identities=27% Similarity=0.372 Sum_probs=152.7
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~ 413 (514)
++||+|+||.||++.+ .+|+.||+|+++.... ........+.+|+.+++.++||||+++++.+...+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 4699999999999987 6789999999874221 123344567789999999999999999999999999999999999
Q ss_pred cCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----------
Q 010231 414 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---------- 482 (514)
Q Consensus 414 gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---------- 482 (514)
+|+|..++.. ..+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 9999988865 45899999999999999999999999999999999999999999999999998753211
Q ss_pred ---------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|..||...
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 1234556899999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=289.92 Aligned_cols=184 Identities=24% Similarity=0.349 Sum_probs=160.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|++.++||+|+||.||++.+ .++..||+|++..... ........+.+|+.+++.++|+||+++++++.+.+.+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM--IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 56899999999999999999998 5788999999864221 11223345678999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
+||||+++|+|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999997653210
Q ss_pred ---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|+|||||++|+|++|.+||.+.
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 112456799999999999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=287.37 Aligned_cols=183 Identities=29% Similarity=0.455 Sum_probs=160.0
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++++.||+|+||+||+|++ .+++.||||++..... ........+.+|+.++..++|+||+++++++.+.+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 3689999999999999999998 5789999999874221 112344667889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999999999998764 68999999999999999999999999999999999999999999999999998654322
Q ss_pred ---------------------------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ---------------------------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ---------------------------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|||||||+||+|++|+.||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 123456899999999999999999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=274.58 Aligned_cols=182 Identities=20% Similarity=0.307 Sum_probs=155.6
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.|++.+.||+|+||.||++.+ .+++.||+|.+...... .......+.+|+.++..+.|+||+++++++.+.+.+|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 378899999999999999988 68999999988643221 122234567899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|||+.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 999999999887743 25888999999999999999999999999999999999999999999999999865321
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++...|||||||++|+|++|+.||.+.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 1134456789999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=290.11 Aligned_cols=180 Identities=47% Similarity=0.700 Sum_probs=154.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC--e
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--K 404 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~--~ 404 (514)
...|..++.||+|+||.||++.+ ++|..+|||.+..... .. .+.+.+|+.+|++++|||||+++|...... .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~----~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS----PT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc----hh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 45688899999999999999998 4599999999876411 11 677899999999999999999999744433 6
Q ss_pred EEEEEeccccCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-CCcEEEEeccCceeccc
Q 010231 405 LYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKVFLS 481 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~~--lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-~g~vKI~DFGlAk~~~~ 481 (514)
++|+|||+++|+|.+++.+.+ +++..++.|.+||+.||+|||++|||||||||+||||+. ++.+||+|||+++....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999999999998865 899999999999999999999999999999999999999 79999999999986652
Q ss_pred --C--------------------C-CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 482 --S--------------------L-DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 482 --~--------------------~-~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
. . .......+|||||||++.||+||.+||..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 1 0 01112389999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=288.79 Aligned_cols=188 Identities=28% Similarity=0.467 Sum_probs=157.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc---------hhHHHHHHHHHHHHHHhhcCCCceeEE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS---------QAKQSISQLEQEIALLSRFEHENIVQY 395 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~---------~~~~~~~~l~~Ei~iL~~L~HpnIv~l 395 (514)
..+++|++++.||+|.||.|-+|++ .+++.||||++....... .....++++.+||.+|+++.|+|||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4578999999999999999999998 689999999986432211 111234578899999999999999999
Q ss_pred EEEecC--CCeEEEEEeccccCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEe
Q 010231 396 YGTDKD--ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (514)
Q Consensus 396 ~~~~~~--~~~l~LVmEy~~gGsL~~lL~~~~-lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~D 472 (514)
+.+..+ .+++|||+|||..|.+.+.-.... +.+.+++.|++.++.||+|||.+|||||||||+|+||+.+|+|||+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 998754 468999999999998865544344 88999999999999999999999999999999999999999999999
Q ss_pred ccCceecccC-------------------------C---CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 473 FGLAKVFLSS-------------------------L---DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 473 FGlAk~~~~~-------------------------~---~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
||.+..+... . ....+...|||++|+.||-|++|++||.+.
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9999876221 0 122335789999999999999999999874
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=276.14 Aligned_cols=181 Identities=27% Similarity=0.420 Sum_probs=154.7
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
+++|++.++||.|+||.||+|.+ .++..||+|.++..... .....+.+|+.+++.++|+||+++++++.+.+.+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE----GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC----CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 46799999999999999999988 57899999998643221 11245678999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
+||||+.+ +|.+++... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 99999986 888887653 4788899999999999999999999999999999999999999999999999754321
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|+|||||++|+|+||.+||.+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1123456799999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=281.99 Aligned_cols=183 Identities=23% Similarity=0.344 Sum_probs=157.7
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++++.||+|+||.||++.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++++.+.+++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM--LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 4689999999999999999997 5789999999874221 122334567889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC-
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD- 484 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~- 484 (514)
||||+.+|+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999999875 4689999999999999999999999999999999999999999999999999876532210
Q ss_pred ------------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 485 ------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 485 ------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..++..+|||||||++|+|++|+.||.+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 12345789999999999999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=281.19 Aligned_cols=182 Identities=25% Similarity=0.393 Sum_probs=154.4
Q ss_pred eEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHH---hhcCCCceeEEEEEecCCCeEE
Q 010231 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL---SRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL---~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
|++.+.||+|+||.||+|.+ .+++.||||+++.... ......+.+.+|+.++ +.++||||+++++++...+.+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 67899999999999999987 5789999999874321 1122345566666554 5668999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
+||||+.+++|..++....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998753211
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....+...+|+|||||++|+|++|..||.+.+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 11234567899999999999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=281.87 Aligned_cols=183 Identities=22% Similarity=0.310 Sum_probs=157.5
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||++++ .+++.||+|.+..... ........+.+|+.++..+.|+||+++++++.+.+.+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM--LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4799999999999999999998 5788999999864221 222334557789999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC-
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD- 484 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~- 484 (514)
||||+.+|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999999975 4688999999999999999999999999999999999999999999999999976532100
Q ss_pred ------------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 485 ------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 485 ------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..+...+|+|||||+||+|++|+.||.+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 12445789999999999999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=280.93 Aligned_cols=182 Identities=25% Similarity=0.382 Sum_probs=151.3
Q ss_pred ccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEec
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~ 400 (514)
.++|+++++||+|+||.||+|.+ .++..||+|.++... .......+.+|+.++..+ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 46899999999999999999974 345789999876321 122345688999999999 8999999999876
Q ss_pred CC-CeEEEEEeccccCCHHHHHhhc-------------------------------------------------------
Q 010231 401 DE-SKLYIFLELVTKGSLLNLYQRY------------------------------------------------------- 424 (514)
Q Consensus 401 ~~-~~l~LVmEy~~gGsL~~lL~~~------------------------------------------------------- 424 (514)
.. ..+|+||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 4689999999999999988642
Q ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--------------
Q 010231 425 --------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-------------- 482 (514)
Q Consensus 425 --------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-------------- 482 (514)
.++...+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 2667788899999999999999999999999999999999999999999999754211
Q ss_pred -------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 -------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 -------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
....++.++|||||||+||+|++ |..||.+.
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 12334567899999999999996 99999763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=298.16 Aligned_cols=179 Identities=27% Similarity=0.401 Sum_probs=158.7
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-C-----CceeEEEEEecC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-H-----ENIVQYYGTDKD 401 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-H-----pnIv~l~~~~~~ 401 (514)
.+|.+.++||+|+||.|.+|.+ .+++.||||+++. .+....+-..|+.+|..|+ | -|||+++++|..
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 3799999999999999999998 7899999999984 3455666778999999996 4 479999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC--cEEEEeccCc
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG--SVKLADFGLA 476 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g--~vKI~DFGlA 476 (514)
.+++|||+|++.. +|+++++.+ +++...++.++.||+.||.+||+.+|||+||||+|||+..-+ .|||+|||.+
T Consensus 260 r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 260 RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999999966 899999875 588899999999999999999999999999999999997544 7999999999
Q ss_pred eecccC----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 477 KVFLSS----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 477 k~~~~~----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...... ....|...+||||||||++||++|.++|+|.|
T Consensus 339 c~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 339 CFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 865433 34677789999999999999999999999976
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=280.37 Aligned_cols=177 Identities=27% Similarity=0.383 Sum_probs=152.2
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~ 413 (514)
+.||+|+||.||++.+ .+|..||+|++..... ........+.+|+.+++.++||||+++++.+...+.+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 4699999999999997 5789999999874221 123345667789999999999999999999999999999999999
Q ss_pred cCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----------
Q 010231 414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---------- 482 (514)
Q Consensus 414 gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---------- 482 (514)
+|+|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 99999888654 5899999999999999999999999999999999999999999999999998753211
Q ss_pred ---------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|+|||||++|+|++|..||...
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 1233456789999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=275.97 Aligned_cols=181 Identities=29% Similarity=0.438 Sum_probs=153.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... .....+.+|+.+++.++|+||+++++++.+...+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE----GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc----ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 46799999999999999999998 47889999998743221 11234668999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
+||||+. ++|.+++.. ..+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 9999996 477777654 35889999999999999999999999999999999999999999999999998753211
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|||||||++|+|++|..||.+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 0123445789999999999999999999763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=281.82 Aligned_cols=183 Identities=27% Similarity=0.378 Sum_probs=159.1
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||+||++.+ .+++.||+|+++.... ........+.+|+.+++.++|+||+++++.+.+.+.+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL--LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 3689999999999999999998 5789999999875321 123345668889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999999764 68999999999999999999999999999999999999999999999999998654221
Q ss_pred ------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|||||||++|+|++|..||...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 122346789999999999999999999764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=278.55 Aligned_cols=178 Identities=27% Similarity=0.431 Sum_probs=151.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
..+|+++++||+|+||.||+|++ .+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 46788899999999999999997 578999999886422 2234467889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC--
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD-- 484 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~-- 484 (514)
+||||+.+++|... ....+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 149 lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 149 VLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 99999999988643 2356777889999999999999999999999999999999999999999999986532210
Q ss_pred ----------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 485 ----------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 485 ----------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
......+|||||||++|+|++|+.||..
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 0112368999999999999999999963
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=277.10 Aligned_cols=175 Identities=26% Similarity=0.405 Sum_probs=151.0
Q ss_pred ecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccC
Q 010231 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (514)
Q Consensus 337 LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gG 415 (514)
||+|+||.||+|++ .++..||+|++..... ........+.+|+.++..++||||+++++.+...+.+|+||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI--VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 79999999999998 5688999999874221 12334566788999999999999999999999999999999999999
Q ss_pred CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC------------
Q 010231 416 SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS------------ 482 (514)
Q Consensus 416 sL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~------------ 482 (514)
+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence 99998865 46899999999999999999999999999999999999999999999999999853221
Q ss_pred -------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|.+||.+.
T Consensus 159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 1123456799999999999999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=280.04 Aligned_cols=177 Identities=25% Similarity=0.377 Sum_probs=152.5
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~ 413 (514)
+.||+|+||.||++.+ .++..||+|++..... ........+.+|+.+++.+.||||+++++++...+.+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 3699999999999997 5789999999874221 123345677889999999999999999999999999999999999
Q ss_pred cCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----------
Q 010231 414 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---------- 482 (514)
Q Consensus 414 gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---------- 482 (514)
+|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 9999988765 45899999999999999999999999999999999999999999999999998753211
Q ss_pred ---------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|+.||.+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 1233456799999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=277.82 Aligned_cols=182 Identities=27% Similarity=0.391 Sum_probs=154.9
Q ss_pred ceEeeeeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCe
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 404 (514)
+|++++.||+|+||.||+++. .++..||+|++..... .......+.+.+|+.++..+ .|+||+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 488999999999999999976 3688999999874221 11223345677899999999 59999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+|+||||+.+|+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 9999999999999988865 568999999999999999999999999999999999999999999999999998642210
Q ss_pred ---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...++..+|||||||++|+|++|..||..
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 12345679999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=270.38 Aligned_cols=182 Identities=24% Similarity=0.361 Sum_probs=155.7
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||++++ .+++.||+|++...... ......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN---EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 3689999999999999999998 57889999998753221 2234567789999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
||||+.++.+..+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9999999877655543 468999999999999999999999999999999999999999999999999998653210
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+|||||++|+|++|++||.+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=275.73 Aligned_cols=182 Identities=22% Similarity=0.307 Sum_probs=153.5
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC-CceeEEEEEecCCCeEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIv~l~~~~~~~~~l~L 407 (514)
+|++++.||+|+||.||+|.+ .+++.||+|++..... ........+..|+.++..+.| ++|+.+++++...+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 488999999999999999988 5678999999874221 112334567788999998876 468889999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
||||+++|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 9999999999988865 45899999999999999999999999999999999999999999999999998753211
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|+|||||++|+|+||+.||.+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 1123456789999999999999999999764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=277.57 Aligned_cols=179 Identities=28% Similarity=0.407 Sum_probs=151.4
Q ss_pred eeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEe
Q 010231 335 DLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE 410 (514)
++||+|+||.||++++ .+++.||+|.++..... ........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 6799999999999986 46789999998743211 112334567789999999999999999999999999999999
Q ss_pred ccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC------
Q 010231 411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL------ 483 (514)
Q Consensus 411 y~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~------ 483 (514)
|+.+++|..++... .+.+..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999988654 47888899999999999999999999999999999999999999999999987532111
Q ss_pred -------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 -------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 -------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...+...+|||||||++|+|++|..||.+.+
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 1223457999999999999999999998753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=277.29 Aligned_cols=183 Identities=23% Similarity=0.333 Sum_probs=156.7
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.++||+|+||.||++++ .++..+|+|++..... ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 3689999999999999999987 5678899999864221 122234457789999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
||||+.+|+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999999976 458899999999999999999999999999999999999999999999999987542110
Q ss_pred -----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|||||||++|+|++|+.||.+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 123456799999999999999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=274.67 Aligned_cols=182 Identities=21% Similarity=0.311 Sum_probs=153.5
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~L 407 (514)
+|.+.+.||+|+||.||+|.+ .++..||+|++..... ........+..|..++..+ .|++|+++++++.+.+.+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 488899999999999999988 5678999999874221 1122334566777777776 58999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
||||+++|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 9999999999988865 46899999999999999999999999999999999999999999999999999853211
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|+|||||++|+|+||+.||.+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 1133456789999999999999999999865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=278.07 Aligned_cols=177 Identities=25% Similarity=0.372 Sum_probs=152.0
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~ 413 (514)
+.||+|+||.||++.+ .++..||+|++..... ........+.+|+.++..++|+||+++++++...+.+||||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 4699999999999987 6789999999874221 122344567789999999999999999999999999999999999
Q ss_pred cCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 414 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 414 gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
+|+|..++.. ..+++..+..|+.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++.....
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 9999988865 468999999999999999999997 79999999999999999999999999998753211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|||||||++|+|++|..||.+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 1234556899999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=274.21 Aligned_cols=180 Identities=27% Similarity=0.434 Sum_probs=150.7
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC-----C
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-----S 403 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-----~ 403 (514)
+|++.++||+|+||.||+|++ .++..||||.+...... ......+.+|+.+++.++||||+++++++... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc---chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 589999999999999999997 57899999988632211 12235678999999999999999999887533 3
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 5899999996 588888765 46899999999999999999999999999999999999999999999999999854211
Q ss_pred C------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 L------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ...++..+|||||||++|+|++|++||.+.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 0 023445789999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-33 Score=278.62 Aligned_cols=187 Identities=24% Similarity=0.353 Sum_probs=166.5
Q ss_pred cccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
+..+++|..+++||+|+||+|.+++. .+++.||||+++. .....+..+.+-..|-++|+..+||++..|...|++++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkK--eviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKK--EVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhh--hheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34578999999999999999999987 7899999998874 23344555667788999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+|+||||..||.|+..|.+ ..+++...+.|..+|+.||.|||+++||+||||.+|+|+|.+|++||+||||++.-...
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 99999999999999887765 56999999999999999999999999999999999999999999999999999864322
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+++|+...|+|.+|++||||+||++||-.+
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 4678899999999999999999999999654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=273.79 Aligned_cols=182 Identities=25% Similarity=0.389 Sum_probs=158.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++++.||+|+||.||++.+ .++..+|+|.+.... .......+.+|+.+++.++|+||+++++++...+.+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 46899999999999999999998 578899999887421 1234567889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
+||||+++++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 159 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence 99999999999999876 4588999999999999999999986 5999999999999999999999999999765322
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|+.||...
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 1123456799999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-33 Score=290.39 Aligned_cols=184 Identities=30% Similarity=0.511 Sum_probs=165.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe-E
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-L 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~-l 405 (514)
.+.|..++++|+|+||.++++++ .++..|++|.+.........+ ...++|+.++++++|||||.|++.|..++. +
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r---~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER---RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh---HHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence 46899999999999999999987 567899999998765543333 367799999999999999999999998888 9
Q ss_pred EEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+|||+||+||+|.+.+.+. .+.++.+..|+.||+.||.|||+++|+|||||+.||+++.++.|||+|||+|+.+...
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999999988653 4899999999999999999999999999999999999999999999999999998765
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.+..|..+.|||+|||++|||++-+++|.+.|
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 35678889999999999999999999999875
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=286.11 Aligned_cols=186 Identities=28% Similarity=0.391 Sum_probs=164.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
++.+-|.+.+.||+|.|..|-+|++ -+|..||||++...+... ....++.+|++.|+.++|||||+||.+..+..+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~---~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT---LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch---hhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 5567899999999999999999998 799999999997655443 344678999999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-CCcEEEEeccCceeccc
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKVFLS 481 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-~g~vKI~DFGlAk~~~~ 481 (514)
+|||+|+-.+|+|++|+.+ .++.+...++||+||+.|+.|+|+.++|||||||+||++.+ -|-|||+|||++..+..
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999999998865 57999999999999999999999999999999999999874 58999999999988765
Q ss_pred CCC-------------------cCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 482 SLD-------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 482 ~~~-------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... ..-....||||||+|||.|+||++||..+|
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 421 122247889999999999999999998876
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=273.62 Aligned_cols=177 Identities=24% Similarity=0.404 Sum_probs=147.6
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhh-cCCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
++||+|+||.||+|.+ .+++.||+|+++..... .......+..|..++.. ..|+||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL--EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 3699999999999997 57889999998742211 12223344556666654 48999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
++|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 99999988865 46899999999999999999999999999999999999999999999999999864321
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|..||.+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 1123456799999999999999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=274.22 Aligned_cols=178 Identities=27% Similarity=0.409 Sum_probs=148.1
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHH-HHhhcCCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
++||+|+||.||+|++ .++..||+|++..... ........+.+|+. +++.++|+||+++++.+.+.+.+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI--LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4699999999999998 5788999999874221 11222344455554 678899999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
++++|..++.. ..+.+..+..|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 99999887765 46889999999999999999999999999999999999999999999999998753211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....+...+|||||||++|+|++|.+||.+.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 11234567999999999999999999997653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=285.86 Aligned_cols=171 Identities=25% Similarity=0.279 Sum_probs=146.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
...|.+.+.||+|+||.||+|.+ .+++.||||.... ..+.+|+.+|+.++|+||+++++++......|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 34799999999999999999998 5688899995431 23458999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
||||++. ++|..++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus 237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9999996 588887754 358999999999999999999999999999999999999999999999999998653211
Q ss_pred --------------------CcCcceeehhhhHHHHHHHHHhCCCCC
Q 010231 484 --------------------DFDLLLIFSIFLNGCKFFLIFLHVLIF 510 (514)
Q Consensus 484 --------------------~~~~~~~~DVwSlG~lLyeLltG~~PF 510 (514)
...++.++|||||||+||+|++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 123445789999999999999987544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=265.64 Aligned_cols=181 Identities=30% Similarity=0.499 Sum_probs=147.0
Q ss_pred cceEeeeeecccCceeEEEEEc--cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc---CCCceeEEEEEec---
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDK--- 400 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~--~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIv~l~~~~~--- 400 (514)
++|++.+.||+|+||.||+|.+ .++..||+|.+........ ....+.+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC---chHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 3689999999999999999987 3578899998875332211 112344566666554 7999999999874
Q ss_pred --CCCeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccC
Q 010231 401 --DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (514)
Q Consensus 401 --~~~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGl 475 (514)
....+++||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 3456999999997 588888864 3488999999999999999999999999999999999999999999999999
Q ss_pred ceecccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 476 AKVFLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 476 Ak~~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
++.+... ....+...+|||||||++|+|++|.+||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 9865322 1233456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=274.36 Aligned_cols=177 Identities=27% Similarity=0.389 Sum_probs=146.6
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHH-HHHhhcCCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI-ALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei-~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
+.||+|+||+||+|++ .+++.||+|++...... .......+..|. .+++.++|+||+++++++...+.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH--hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 4699999999999998 56788999998742211 111223344444 4568889999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
.+|+|..++.. ..+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 99999998865 45888899999999999999999999999999999999999999999999999754211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|||||||++|+|++|.+||.+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 1123456799999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=265.91 Aligned_cols=182 Identities=22% Similarity=0.316 Sum_probs=155.3
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.|++.++||+|+||+||++.+ .++..||+|++...... .......+.+|+.+++.++|+||+++++.+...+.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh--hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 378899999999999999997 57899999988642211 122234567899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|||+.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 999999999987743 358899999999999999999999999999999999999999999999999998653221
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++...|||||||++|+|++|+.||.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 123445789999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=274.33 Aligned_cols=177 Identities=28% Similarity=0.412 Sum_probs=147.8
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHH-HHhhcCCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
++||+|+||+||+|.+ .+|+.||+|++..... ........+..|.. +++.++||||+++++.+...+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI--LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 4699999999999998 5789999999874221 11222334445544 567899999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
.+|+|..++.. ..+.+..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 99999988865 45889999999999999999999999999999999999999999999999998753211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|..||.+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 1133456799999999999999999999765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=273.31 Aligned_cols=178 Identities=25% Similarity=0.366 Sum_probs=149.9
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
++||+|+||.||+|++ .+++.||+|++..... ........+..|+.++..+ +|+||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 3699999999999988 5688999999874211 1123345566788888765 7999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
++++|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 99999988765 46889999999999999999999999999999999999999999999999998754211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||++|+|++|+.||.+.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 11244567999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=265.52 Aligned_cols=174 Identities=23% Similarity=0.366 Sum_probs=149.1
Q ss_pred ecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccC
Q 010231 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (514)
Q Consensus 337 LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gG 415 (514)
||+|+||+||++.+ .+++.||+|.+..... ........+..|+.+++.++|+||+++++++.....+|+||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH--hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 79999999999988 5789999998864221 12233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-------
Q 010231 416 SLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL------- 483 (514)
Q Consensus 416 sL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~------- 483 (514)
+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 99887632 358899999999999999999999999999999999999999999999999997653321
Q ss_pred ------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...++..+|+|||||++|+|++|+.||..
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 12344679999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-33 Score=268.51 Aligned_cols=186 Identities=27% Similarity=0.432 Sum_probs=164.4
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
..+++|++++.||+|.||.||+|+. .++..||+|++.... ........++.+|+.|.+.|+||||+++|++|.+...
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 3468999999999999999999987 678899999986533 3334455778999999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
+|+++||...|+|+..|+. .++++.....|+.|++.||.|+|.++||||||||+|+|++..|.+||+|||.+..-..
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999999999983 3589999999999999999999999999999999999999999999999999876542
Q ss_pred C-----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 482 S-----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 482 ~-----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. .+..+....|+|++|++.||++.|.+||-.+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 2 3355667899999999999999999999765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=291.30 Aligned_cols=179 Identities=27% Similarity=0.406 Sum_probs=163.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
..+|....+||+|..|.||.|+. .+++.||||.+.+.++.. .+-+.+|+.+|+..+|+|||.+++.|.-.+.+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 45788889999999999999987 788999999998755433 345789999999999999999999998889999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
+||||++||+|.+++.+..+++.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||||..+....
T Consensus 347 VVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred EEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876542
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
...|+.+.||||||++++||+.|++||-
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 2567789999999999999999999995
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=272.89 Aligned_cols=178 Identities=26% Similarity=0.394 Sum_probs=150.0
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
++||+|+||+||+|.+ .+++.||+|++..... ........+..|+.++..+ .|+||+++++++...+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 3699999999999998 5788999999874211 1122345566788888766 6999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
++|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 99999988865 46899999999999999999999999999999999999999999999999998753211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....+...+|+|||||++|+|++|..||.+.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 11334567899999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=272.25 Aligned_cols=182 Identities=22% Similarity=0.321 Sum_probs=153.5
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCeEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~L 407 (514)
.|+..+.||+|+||.||+|.+ .+++.||+|++..... ........+..|+.++..+. |++|+++++++.+.+.+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 377889999999999999987 5789999999874221 11233455677888888775 5778889999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
||||+++|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 9999999999998876 46899999999999999999999999999999999999999999999999998753211
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|+|||||++|+|++|.+||.+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 1123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=274.69 Aligned_cols=187 Identities=26% Similarity=0.425 Sum_probs=164.9
Q ss_pred ccccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec
Q 010231 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (514)
Q Consensus 322 ~~~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~ 400 (514)
..|....+.|++.++||.|..++||+|+. ..+..||||++.+. +.......+.+|+..|+.++||||+.++..|.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE----kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE----KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh----hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 34445567999999999999999999998 67899999999863 23344678999999999999999999999999
Q ss_pred CCCeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCce
Q 010231 401 DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk 477 (514)
.+..+|+||.||.+|++.++++. .++.+..+..|+++++.||.|||++|.||||||+.||||+.+|.|||+|||..-
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence 99999999999999999999975 479999999999999999999999999999999999999999999999998866
Q ss_pred ecccC-------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 478 VFLSS-------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 478 ~~~~~-------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.+... .-..|..+.||||||+...||.+|..||.-
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 54322 123556689999999999999999999974
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=285.62 Aligned_cols=182 Identities=26% Similarity=0.403 Sum_probs=159.9
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
..+++.++..||+|.||+||+|.|.. .||||++++.... ....+.|++|+.++++-+|.||+-+.|+|..... .
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt---~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPT---PEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred CHHHhhccceeccccccceeeccccc--ceEEEEEecCCCC---HHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 34567789999999999999999954 6999999875543 2367889999999999999999999999988776 9
Q ss_pred EEEeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc----
Q 010231 407 IFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL---- 480 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~---- 480 (514)
||+.+|+|.+|+.++. +.+|...+...|++||++||.|||.++|||||||..||++.+++.|||+|||||..-.
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 9999999999999885 4567788899999999999999999999999999999999999999999999997521
Q ss_pred --------------------cCCCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 --------------------SSLDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 --------------------~~~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...++.|...+|||+|||++|||+||+.||..+|
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~ 597 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN 597 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC
Confidence 1145788899999999999999999999998664
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=273.64 Aligned_cols=175 Identities=25% Similarity=0.396 Sum_probs=150.2
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
++||+|+||.||++.+ .++..||+|+++.... ........+.+|+.++..+ +||||+++++++.+.+.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV--NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 4699999999999988 5788999999874221 1223445678899999888 7999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
++|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 99999988754 56999999999999999999999999999999999999999999999999998753211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
....++..+|+|||||++|+|++|+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 11234567999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=268.71 Aligned_cols=181 Identities=28% Similarity=0.439 Sum_probs=153.8
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|.+.+.||+|+||.||+|++ .++..+|+|.+....... ....+.+|+.+++.++|+||+++++++...+.+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 46799999999999999999998 578889999987533221 1234668999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
+||||+.+ +|..++... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 99999986 787777543 4788899999999999999999999999999999999999999999999999754221
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|||||||++|+|+||++||.+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 0123456799999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=273.08 Aligned_cols=177 Identities=28% Similarity=0.376 Sum_probs=147.8
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHH-HHhhcCCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
++||+|+||+||+|.+ .+|+.||+|++...... .......+.+|.. +++.++||||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL--NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 4699999999999998 67899999998742211 1222344455554 567789999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 99999988765 46899999999999999999999999999999999999999999999999998753211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|||||||++|+|++|..||.+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 1123456799999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=257.00 Aligned_cols=185 Identities=38% Similarity=0.602 Sum_probs=159.5
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|++.+.||+|+||.||.+.+ .++..+++|.+...............+.+|+.+++.++|+||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999997 578999999987544333334456778899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
||||+++++|.+++.. ..+++..+..|+.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++.+....
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999998865 457888999999999999999999999999999999999999999999999997543210
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+......+|+|||||++|+|++|..||...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 112335789999999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=265.37 Aligned_cols=181 Identities=25% Similarity=0.352 Sum_probs=151.0
Q ss_pred ccceEeeeeecccCceeEEEEEcc-----------------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~-----------------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp 390 (514)
.++|.+.++||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++..++|+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCC
Confidence 357899999999999999999752 23479999876422 123356788999999999999
Q ss_pred ceeEEEEEecCCCeEEEEEeccccCCHHHHHhhc--------------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 010231 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--------------------HLRDSQVSAYTRQILLGLKYLHDQDV 450 (514)
Q Consensus 391 nIv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~--------------------~lse~~v~~i~~QIl~gL~yLHs~gI 450 (514)
||+++++++.+.+.+|+||||+.+|+|.+++... .++...+..++.||+.||.|||++||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999999999999999999999999988643 24567788999999999999999999
Q ss_pred cccCCCCCCEEEcCCCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh--CC
Q 010231 451 VHRDIKCANILVDANGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL--HV 507 (514)
Q Consensus 451 IHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt--G~ 507 (514)
+||||||+|||++.++.+||+|||+++.+... ....++..+|||||||++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999999854221 11234567899999999999986 56
Q ss_pred CCCCC
Q 010231 508 LIFRP 512 (514)
Q Consensus 508 ~PF~g 512 (514)
.||.+
T Consensus 240 ~p~~~ 244 (304)
T cd05096 240 QPYGE 244 (304)
T ss_pred CCCCc
Confidence 77764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=272.29 Aligned_cols=183 Identities=26% Similarity=0.411 Sum_probs=152.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-- 402 (514)
.+.++|++.+.||+|+||.||++.+ .+|..||+|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ---NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc---chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence 3467899999999999999999998 5789999998864321 123345677899999999999999999987644
Q ss_pred ----CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 403 ----~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
..+|+||||+.+ +|..++. ..++...+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 95 LEEFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ccccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 357999999976 4655553 3588899999999999999999999999999999999999999999999999975
Q ss_pred cccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ....+...+|||||||++|+|++|++||.+.
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 4221 1134456799999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=278.57 Aligned_cols=188 Identities=30% Similarity=0.455 Sum_probs=164.9
Q ss_pred cccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCC
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE 402 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~ 402 (514)
..+...|++++.||+|.||.||+++. .+|..+|+|.+....... ......+.+|+.+|+++. ||||+.++++|++.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~--~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG--KEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc--cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 34567899999999999999999998 569999999997544322 224567899999999998 99999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC----CcEEEEeccCcee
Q 010231 403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLADFGLAKV 478 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~----g~vKI~DFGlAk~ 478 (514)
+.+|+|||+|.||.|++.+.+.++++..+..+++||+.++.|||+.||+||||||+|||+... +.+|++|||+|..
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999998866569999999999999999999999999999999999999643 4799999999998
Q ss_pred cccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 479 FLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 479 ~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
+... ....++..+|+||+|+++|.|++|.+||-+.+
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 7652 12567778999999999999999999998753
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=273.13 Aligned_cols=176 Identities=27% Similarity=0.414 Sum_probs=151.5
Q ss_pred eeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEe
Q 010231 335 DLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE 410 (514)
+.||+|+||.||++.+ .+|+.||+|++...... ......+.+|+.++++++|+||+++++++.+.+.+|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 5799999999999875 46889999998753211 1223456789999999999999999999999999999999
Q ss_pred ccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC------
Q 010231 411 LVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL------ 483 (514)
Q Consensus 411 y~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~------ 483 (514)
|+.+|+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 9999999998865 458999999999999999999999999999999999999999999999999997643221
Q ss_pred -------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|||||||++|+|++|+.||.+.
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 123456899999999999999999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=272.59 Aligned_cols=175 Identities=26% Similarity=0.400 Sum_probs=149.3
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
+.||+|+||.||++.+ .+++.||+|+++..... .......+.+|+.++..+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc--chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 4699999999999998 57889999998753221 223345677888888776 7999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
++|+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 99999988765 46999999999999999999999999999999999999999999999999999753211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
....++..+|+|||||++|+|++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 11234567999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=270.17 Aligned_cols=176 Identities=24% Similarity=0.381 Sum_probs=150.7
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
++||+|+||.||++.+ .+++.||+|++..... ........+.+|+.++..+ +|+||+.+++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV--HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 4699999999999988 5778999999874221 2233456678899998888 6999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
++|+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 99999988765 46999999999999999999999999999999999999999999999999999753211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....++..+|+|||||++|+|++|..||..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 123445689999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=275.51 Aligned_cols=149 Identities=27% Similarity=0.429 Sum_probs=134.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|++++.||.|.-|+||++.. .++..+|+|++..... ...+.+.+.+.|..||+.+.||+++.||..|++...+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l--~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL--ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH--hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 45789999999999999999998 4568999999875332 22455677888999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
++||||+||+|..+.++. .+++..++.|+.+|+.||+|||-.|||+|||||+||||.++|+|.|+||.|+..
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 999999999999998764 499999999999999999999999999999999999999999999999988764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=270.93 Aligned_cols=182 Identities=25% Similarity=0.413 Sum_probs=157.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++.+.||+|+||.||++.+ .++..+|+|.+.... .......+.+|+.+++.++|+||+++++++.+.+.+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 36899999999999999999998 478889999876521 1233466889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
+||||+.+++|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 159 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc
Confidence 999999999999998764 588888999999999999999985 79999999999999999999999999997653221
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+|||||++|+|++|+.||...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123445789999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=268.52 Aligned_cols=177 Identities=27% Similarity=0.429 Sum_probs=148.5
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhh-cCCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
+.||+|+||+||+|.+ .++..||+|.++..... ..........|..++.. +.||||+++++++.+.+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 4699999999999998 56789999998752211 11223445567777765 48999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
++|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 99999998876 46889999999999999999999999999999999999999999999999998753211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|+|||||++|+|++|..||.+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 1234556899999999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=268.88 Aligned_cols=177 Identities=24% Similarity=0.406 Sum_probs=148.3
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhh-cCCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
++||+|+||.||+|.+ .++..||+|.++..... .......+..|..++.. +.|+||+++++++.+.+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 4699999999999998 57889999998752211 11223455667777765 48999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 99999988865 46899999999999999999999999999999999999999999999999998743110
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|..||.+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 1134556799999999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=272.01 Aligned_cols=183 Identities=25% Similarity=0.376 Sum_probs=155.3
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC---
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--- 402 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--- 402 (514)
+.+.|++++.||+|+||+||+|.+ .++..||+|.+.... ........+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 456899999999999999999997 678899999886421 1223345677899999999999999999877532
Q ss_pred ---CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 403 ---~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..+|++|+++ +++|..+++...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 678998888788999999999999999999999999999999999999999999999999999875
Q ss_pred ccCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ...++..+|||||||++|+|++|..||.+.
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 4321 123456799999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=275.83 Aligned_cols=181 Identities=29% Similarity=0.450 Sum_probs=152.7
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-----
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----- 403 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 403 (514)
+|++++.||+|+||.||++.+ .+++.||+|.+..... .....+.+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ---NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc---chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 478899999999999999997 6889999998753211 2233467889999999999999999999988776
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+|+||||+.+ +|..++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 78 EIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 79999999975 67776644 56899999999999999999999999999999999999999999999999999864321
Q ss_pred C---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 L---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ~---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
. ...+...+|||||||++|+|++|++||.+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 0 1224567899999999999999999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=282.80 Aligned_cols=180 Identities=24% Similarity=0.360 Sum_probs=154.3
Q ss_pred cceEeeeeecccCceeEEEEEc-cC-CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~-g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
..|.+.+.||+|+||.||+|.. .+ +..||+|.+.... ......+.+|+.+++.++||||+++++.+...+.+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-----ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 3599999999999999999987 34 6788888765321 223356678999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
|||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999999987753 2488889999999999999999999999999999999999999999999999987543
Q ss_pred CC---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 482 SL---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 482 ~~---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ...++..+|||||||++|+|++|..||.+.
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 21 123445789999999999999999999864
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=267.83 Aligned_cols=177 Identities=24% Similarity=0.377 Sum_probs=150.5
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
+.||+|+||+||++.+ .++..||+|+++.... ........+.+|+.++..+ +|+||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4699999999999988 5688999999874221 1123345567888888877 6999999999999999999999999
Q ss_pred ccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
.+|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 999999888765 6999999999999999999999999999999999999999999999999998753211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|+|||||++|+|++|..||.+.
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 1134456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=258.29 Aligned_cols=181 Identities=18% Similarity=0.263 Sum_probs=153.7
Q ss_pred cceEeeeeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
..|++.+.||+|+||.||+|.+ ..+..||+|.++.... ......+.+|+.++.+++||||+++++++...+.
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS----DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4799999999999999999975 3467899998864221 2234568899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+||||||+++|+|.+++... .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999988753 5899999999999999999999999999999999999999999999999987643211
Q ss_pred --------------------CCcCcceeehhhhHHHHHHHHH-hCCCCCCCC
Q 010231 483 --------------------LDFDLLLIFSIFLNGCKFFLIF-LHVLIFRPP 513 (514)
Q Consensus 483 --------------------~~~~~~~~~DVwSlG~lLyeLl-tG~~PF~g~ 513 (514)
....++...|||||||++|+|+ +|..||...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 1123445789999999999977 499999754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=274.20 Aligned_cols=185 Identities=25% Similarity=0.408 Sum_probs=154.8
Q ss_pred ccccccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEE
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~ 396 (514)
+....++|++++.||+|+||.||+|++ .++..||+|.++.... ......+.+|+.+++.+ +|+||++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH----TDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC----HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 334456899999999999999999985 2345799998864221 22345688999999999 899999999
Q ss_pred EEecCCCeEEEEEeccccCCHHHHHhhc----------------------------------------------------
Q 010231 397 GTDKDESKLYIFLELVTKGSLLNLYQRY---------------------------------------------------- 424 (514)
Q Consensus 397 ~~~~~~~~l~LVmEy~~gGsL~~lL~~~---------------------------------------------------- 424 (514)
+++.....+|+||||+.+|+|.+++...
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 9999999999999999999999987532
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 425 -------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 425 -------------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
.+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 25677889999999999999999999999999999999999999999999998643211
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
...++...|||||||++|+|++ |..||..
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~ 317 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 1234567899999999999997 9999965
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=280.15 Aligned_cols=176 Identities=27% Similarity=0.412 Sum_probs=145.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----- 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----- 401 (514)
...|+++++||+|+||.||+|.+ .+++.||||++.... ....+|+.+++.++|+||+++++++..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 35799999999999999999998 578899999875321 123479999999999999999886532
Q ss_pred ---CCeEEEEEeccccCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-cEEEEe
Q 010231 402 ---ESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLAD 472 (514)
Q Consensus 402 ---~~~l~LVmEy~~gGsL~~lL~-----~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-~vKI~D 472 (514)
...+++||||+++ +|..++. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 2357899999986 6666553 24588999999999999999999999999999999999999665 799999
Q ss_pred ccCceecccC-------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 473 FGLAKVFLSS-------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 473 FGlAk~~~~~-------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
||+|+.+... ....++..+|||||||+||+|++|.+||.+.
T Consensus 215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred cccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999865321 0123556799999999999999999999875
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=276.40 Aligned_cols=172 Identities=21% Similarity=0.243 Sum_probs=148.8
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
...|++++.||+|+||.||+|.+ .+++.||+|.... ..+.+|+.+++.++||||+++++++......+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 35799999999999999999998 6789999996431 34578999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
+|||++. ++|..++.. ..++...++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 9999996 578777654 56899999999999999999999999999999999999999999999999999753211
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
....++..+|||||||++|+|++|..||.
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 11234567899999999999999998764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.16 Aligned_cols=183 Identities=25% Similarity=0.365 Sum_probs=153.8
Q ss_pred cccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD 399 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~ 399 (514)
..++|+++++||+|+||.||+|++ .++..||+|+++.... ....+.+.+|+.++..+ +||||+++++++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC----cHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 345899999999999999999974 3566899998864221 22345678999999999 899999999999
Q ss_pred cCCCeEEEEEeccccCCHHHHHhhc-------------------------------------------------------
Q 010231 400 KDESKLYIFLELVTKGSLLNLYQRY------------------------------------------------------- 424 (514)
Q Consensus 400 ~~~~~l~LVmEy~~gGsL~~lL~~~------------------------------------------------------- 424 (514)
......|+||||+++|+|.+++...
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 9999999999999999999888542
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 425 ---------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 425 ---------------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 25667788999999999999999999999999999999999999999999997653211
Q ss_pred ---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 ---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 ---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...++..+|||||||++|+|++ |..||...
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 1234457899999999999997 99999753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=258.21 Aligned_cols=174 Identities=25% Similarity=0.358 Sum_probs=147.3
Q ss_pred ecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccC
Q 010231 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (514)
Q Consensus 337 LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gG 415 (514)
||+|+||.||++.+ .+|+.||+|.+....... ......+..|+.+++.++||||+++++.+.....+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 79999999999987 578999999886422111 112234557999999999999999999999999999999999999
Q ss_pred CHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---------
Q 010231 416 SLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--------- 483 (514)
Q Consensus 416 sL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--------- 483 (514)
+|..++.. ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence 99887754 247888889999999999999999999999999999999999999999999998654321
Q ss_pred ---------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ---------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ---------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...+...+|+|||||++|+|++|..||..
T Consensus 159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 12345678999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=269.23 Aligned_cols=183 Identities=26% Similarity=0.369 Sum_probs=152.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-- 402 (514)
.+.++|++.+.||+|+||.||++.+ .+++.||||++..... .......+.+|+.+++.++|+||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc---CchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence 3467899999999999999999997 5788999998864321 123345677899999999999999999887543
Q ss_pred ----CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 403 ----~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
..+|+||||+.+ +|..++.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 98 LEEFQDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred ccccCeEEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 358999999976 67666643 588889999999999999999999999999999999999999999999999986
Q ss_pred cccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ....+...+|||||||++|+|++|+.||.+.
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 5432 1123456799999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=254.30 Aligned_cols=179 Identities=25% Similarity=0.388 Sum_probs=154.8
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
++|++.+.||+|+||.||++.+..+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.....+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC------ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 4688999999999999999998888889999875321 1134678899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
|||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999999998864 347889999999999999999999999999999999999999999999999987543210
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...+...+|+||||+++|+|++ |++||...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 1233457999999999999999 99999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=268.95 Aligned_cols=183 Identities=26% Similarity=0.387 Sum_probs=153.0
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-- 402 (514)
.+.++|++.+.||+|+||.||++.+ .+++.+|+|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc---ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence 3567899999999999999999988 5788999998864322 223345677899999999999999999987543
Q ss_pred ----CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 403 ----~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
..+|+||||+.+ +|...+.. .++...+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999976 56666543 588889999999999999999999999999999999999999999999999986
Q ss_pred cccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ....+...+|+|||||++|+|++|+.||.+.
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 5432 1123456799999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=256.85 Aligned_cols=179 Identities=31% Similarity=0.453 Sum_probs=152.4
Q ss_pred ceEeeeeecccCceeEEEEEc-----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC--C
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--E 402 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~--~ 402 (514)
+|++.+.||+|+||+||++.. .++..||+|.+..... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG----QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 458999999999999988653 4678899998864221 2234567789999999999999999998764 3
Q ss_pred CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
..+|+||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 46899999999999999998888999999999999999999999999999999999999999999999999999865321
Q ss_pred C----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 L----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ~----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
. ....+.++|||||||++|+|++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 1 13345678999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=271.81 Aligned_cols=175 Identities=23% Similarity=0.262 Sum_probs=150.0
Q ss_pred ccceEeeeeecccCceeEEEEEc---cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~---~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
..+|.+++.||+|+||.||++.. ..+..|++|.+... ....+|+.+++.++|+||+++++++.....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 45899999999999999999975 34678899977531 124579999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+|+|||++. ++|..++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999996 478777754 468999999999999999999999999999999999999999999999999997654321
Q ss_pred C---------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 D---------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ~---------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ..+...+|||||||++|+|++|+.||.+.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 1 23445789999999999999999999764
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=257.59 Aligned_cols=181 Identities=23% Similarity=0.343 Sum_probs=154.1
Q ss_pred eEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEE
Q 010231 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm 409 (514)
|+..++||+|+||+||++.+ .+++.+|+|.+..... ........+.+|+.+++.++|+||+.+++.+...+.+|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 67789999999999999988 6789999998864221 11223345678999999999999999999999999999999
Q ss_pred eccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 410 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 410 Ey~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
||+.+++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 99999999887753 258999999999999999999999999999999999999999999999999997643211
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+|||||++|+|++|..||.+.
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 123445789999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=257.21 Aligned_cols=180 Identities=32% Similarity=0.521 Sum_probs=146.0
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhh---cCCCceeEEEEEecC----
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENIVQYYGTDKD---- 401 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~---L~HpnIv~l~~~~~~---- 401 (514)
+|++.+.||+|+||+||+|.+ .+++.||+|.+......... ...+.+|+.+++. +.|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL---PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC---chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 488999999999999999998 57899999988753221111 1233456665554 479999999998754
Q ss_pred -CCeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCce
Q 010231 402 -ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (514)
Q Consensus 402 -~~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk 477 (514)
...+++||||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 78 RETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred CCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 3468999999985 78888765 248999999999999999999999999999999999999999999999999998
Q ss_pred ecccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 478 VFLSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 478 ~~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+.... ...+...+|||||||++|+|++|.+||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 654221 133456789999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=287.91 Aligned_cols=181 Identities=23% Similarity=0.390 Sum_probs=156.0
Q ss_pred ccceEeeeeecccCceeEEEEEccCC-ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEE-ec---C
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGT-DK---D 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g-~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~-~~---~ 401 (514)
..++++.++|.+|||+.||+|.+..+ ..||+|++... .+...+.+.+||.+|++|. |+|||.|++. .. .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 34788999999999999999999655 99999988753 4566788999999999996 9999999993 21 1
Q ss_pred ---CCeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEcCCCcEEEEec
Q 010231 402 ---ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADF 473 (514)
Q Consensus 402 ---~~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId~~g~vKI~DF 473 (514)
...++|+||||.||.|.++|+. .+|++.++++||+|+++||.+||... |||||||-+||||+.+|+.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1358899999999999999874 46999999999999999999999988 999999999999999999999999
Q ss_pred cCceecccC-------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 474 GLAKVFLSS-------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 474 GlAk~~~~~-------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|-|...... .+..++.+.|||+|||+||-||+...||...
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 999753221 2356667899999999999999999999864
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=253.31 Aligned_cols=180 Identities=33% Similarity=0.470 Sum_probs=156.5
Q ss_pred eEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEE
Q 010231 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm 409 (514)
|++++.||+|+||+||++.+ .+++.||+|.+...... ........+|+.+++.++|+||+++++++.....+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE---EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH---HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc---ccccchhhhhhhccccccccccccccccccccccccccc
Confidence 88999999999999999998 56778999999864322 222233456999999999999999999999999999999
Q ss_pred eccccCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC------
Q 010231 410 ELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS------ 482 (514)
Q Consensus 410 Ey~~gGsL~~lL~-~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~------ 482 (514)
||+.+++|.+++. ...++...+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999997 677999999999999999999999999999999999999999999999999999753110
Q ss_pred -------------C-CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -------------L-DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -------------~-~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ....+..+|+||||+++|+|++|..||...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1 245667899999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=270.47 Aligned_cols=175 Identities=29% Similarity=0.409 Sum_probs=146.0
Q ss_pred ecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc---CCCceeEEEEEecCCCeEEEEEecc
Q 010231 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 337 LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
||+|+||+||+|++ .+++.||+|++..... ...........|..++..+ .||||+++++.+...+.+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 79999999999998 5789999999864221 1122334445566666555 6999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
.+|+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence 99999988765 46899999999999999999999999999999999999999999999999998753211
Q ss_pred -----------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|||||||++|+|++|..||.+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 0123456799999999999999999999764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=253.07 Aligned_cols=184 Identities=39% Similarity=0.585 Sum_probs=156.2
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC--CCeE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKL 405 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~--~~~l 405 (514)
.+|.++++||+|+||.||++.+ .++..|++|.+...............+.+|+.+++.+.|+||+++++.+.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4789999999999999999998 578999999886533333333456788899999999999999999998866 3578
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
|+||||+++++|.+++.. ..+++..+..++.||+.+|.|||+++|+|+||||+|||++.++.++|+|||+++.+...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999998866 45788889999999999999999999999999999999999999999999998753210
Q ss_pred --------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 --------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 --------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.+......+|+|||||++|+|++|..||..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 012334578999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=257.97 Aligned_cols=180 Identities=22% Similarity=0.344 Sum_probs=154.0
Q ss_pred eEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEE
Q 010231 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm 409 (514)
|++.++||+|+||.||++.+ .+++.||+|.+...... .......+.+|+.+++.++|+||+.+++.+.+.+.+|+||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc--chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 67889999999999999988 57899999988643221 1223345678999999999999999999999999999999
Q ss_pred eccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 410 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 410 Ey~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
||+.+++|..++.. ..+++..+..|+.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 99999999988754 358889999999999999999999999999999999999999999999999997643221
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...+....|+|||||++|+|++|..||..
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 12344578999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=253.73 Aligned_cols=180 Identities=28% Similarity=0.388 Sum_probs=156.6
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.+.|++.+.||+|+||.||+|.+.++..||+|.++.... ..+.+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 357999999999999999999987788899998864221 13457789999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
||||+.+++|.+++... .++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999999998653 48899999999999999999999999999999999999999999999999998654220
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...++..+|+|||||++|+|++ |+.||.+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 1223447899999999999999 99999764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=252.96 Aligned_cols=180 Identities=26% Similarity=0.406 Sum_probs=156.0
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|+++++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 46899999999999999999998888889999876321 124678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
+|||+.+++|.+++.. ..++...+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999999998864 347888899999999999999999999999999999999999999999999998654321
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...+....|+|||||++|+|++ |..||.+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 0122346899999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=260.22 Aligned_cols=181 Identities=29% Similarity=0.455 Sum_probs=154.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|.+.+.||.|+||.||+|.+ .++..||+|.+....... ....+.+|+.+++.++|+||+++++++...+.+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 46799999999999999999988 578899999987533221 1234668999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
+||||+.+ +|..++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99999975 88887764 358889999999999999999999999999999999999999999999999987543210
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|||||||++|+|++|.+||.+.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 122445789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=262.80 Aligned_cols=180 Identities=23% Similarity=0.387 Sum_probs=150.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCc----eEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~----~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
..|++.+.||+|+||.||+|.+ .++. .||+|.++.. ......+.+.+|+.+++.+.|+||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 5799999999999999999986 3343 3888887532 1123346688899999999999999999998764
Q ss_pred eEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
..++|++|+.+|+|.+++... .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 578999999999999988764 478888999999999999999999999999999999999999999999999986542
Q ss_pred CC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.. ...++..+|||||||++|+|++ |..||.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 21 1233456899999999999997 99999763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=247.93 Aligned_cols=181 Identities=28% Similarity=0.452 Sum_probs=157.4
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|.+.+.||+|+||.||++.+ .++..|++|.+...... ......+.+|+.+++.++|+||+++++.+...+.+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN---RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC---HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 478889999999999999998 57899999988643222 33456788999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|||+++++|.+++... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.+....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999988653 58888999999999999999999999999999999999999999999999998754321
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+|||||++|+|++|..||...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 122345799999999999999999999765
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=256.16 Aligned_cols=183 Identities=27% Similarity=0.422 Sum_probs=158.6
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||++.+ .+++.+|+|.+..... ........+.+|+.+++.+.|+||+++++.+...+.+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI--VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 3689999999999999999998 5789999998864221 122345678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|.||||+.++.+||+|||+++.+....
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 158 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL 158 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence 9999999999999865 458999999999999999999999999999999999999999999999999998754321
Q ss_pred -------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.......+|+||||+++|+|++|..||...
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 123345789999999999999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=259.67 Aligned_cols=181 Identities=25% Similarity=0.417 Sum_probs=156.1
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||++.+ .++..+|+|.+.... ......++.+|+.+++.++|+||+++++.+...+.+|+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 3689999999999999999987 578889999876421 12334567899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
||||+++++|.+++.+ ..+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++..+....
T Consensus 77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence 9999999999999876 458899999999999999999997 589999999999999999999999999987653211
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++...|+|||||++|+|++|..||.+.
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 123445799999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=249.14 Aligned_cols=183 Identities=55% Similarity=0.864 Sum_probs=160.2
Q ss_pred ceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|+..+.||+|+||.||+|.+. ++..|++|.+.........+...+.+.+|+.+++.++|+||+++++.+.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3777899999999999999985 889999999876544444455667889999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC----
Q 010231 409 LELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL---- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~~-lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~---- 483 (514)
|||+++++|.+++.... +++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 99999999999987654 8899999999999999999999999999999999999999999999999988643221
Q ss_pred --------------CcC-cceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 --------------DFD-LLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 --------------~~~-~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
... +...+|+|+|||++|+|++|..||..
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~ 204 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 112 45679999999999999999999965
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=272.85 Aligned_cols=182 Identities=28% Similarity=0.397 Sum_probs=156.7
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-e
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-K 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~-~ 404 (514)
...+.|....+||+|+||.||+|...+|..||||.+....... ..+|.+|+.++.+++|+|+|+|+|+|.+.+ .
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-----EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-----hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence 4456888889999999999999999988999999766422211 345999999999999999999999999988 5
Q ss_pred EEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 405 LYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQD---VVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~g---IIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.+||+||+++|+|.++|... .++|....+|+.+++.||+|||... |||||||++|||+|.+.+.||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 99999999999999988653 6799999999999999999999854 99999999999999999999999999987
Q ss_pred ccc---------CCC-----------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 479 FLS---------SLD-----------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 479 ~~~---------~~~-----------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
... ... ...+.++||||||++|.||+||+.+.+.
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred CCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 654 111 1233589999999999999999988764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=279.26 Aligned_cols=184 Identities=25% Similarity=0.354 Sum_probs=155.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC---
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--- 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~--- 403 (514)
.++|++.+.||+|+||+||+|.+ .+++.||||.+..... .......+.+|+.++..+.|+||++++..+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 46899999999999999999987 6789999999875332 2334566789999999999999999987664322
Q ss_pred -----eEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEec
Q 010231 404 -----KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (514)
Q Consensus 404 -----~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DF 473 (514)
.+++||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 47899999999999998864 24888999999999999999999999999999999999999999999999
Q ss_pred cCceecccC---------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 474 GLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 474 GlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
|+++.+... ....+..++|||||||++|+|++|..||.+.+
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999865321 11234567999999999999999999998653
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=252.88 Aligned_cols=182 Identities=23% Similarity=0.376 Sum_probs=156.0
Q ss_pred cceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+.+|+.+++.++|+||+++++.+.....+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 46899999999999999999984 6899999988643211 1122456789999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
||||++++.|..++.. ..+++..+..++.||+.+|.|||++||+|+||||+||+++.++.+||+|||++..+....
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9999999888877654 468999999999999999999999999999999999999999999999999998654321
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|+|||||++|+|++|.+||.+.
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 122345789999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=252.63 Aligned_cols=179 Identities=25% Similarity=0.406 Sum_probs=154.8
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+.|.+++.||+|+||+||++.+.++..+|+|.+..... ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 47899999999999999999887777799998763211 124578899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
|||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999998753 58899999999999999999999999999999999999999999999999988553221
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...+...+|+|||||++|+|++ |..||...
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 1223457999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=255.05 Aligned_cols=176 Identities=26% Similarity=0.399 Sum_probs=152.3
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.++||+|+||.||+|.+ .+++.||+|.+.... .......+.+|+.++.++.|+||+++++.+...+..++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 678899999999999999987 678899999886421 122345688999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-----
Q 010231 409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL----- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~----- 483 (514)
|||+++++|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus 78 ~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 78 TEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred EecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 999999998654 357888899999999999999999999999999999999999999999999998653321
Q ss_pred ------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...+...+|+|||||++|+|++|..||..
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 12345678999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=258.08 Aligned_cols=182 Identities=26% Similarity=0.395 Sum_probs=159.3
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
....|.+++.||+|+||.||++.+ .+++.||+|.+..... .....+.+|+.+++.++|+||+++++.+...+.+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 346899999999999999999997 6789999998874322 1235578899999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|+||||+++++|.+++.+..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred EEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 999999999999999988889999999999999999999999999999999999999999999999999987643221
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|+|+|||++|+|++|..||.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 122345789999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=257.62 Aligned_cols=183 Identities=28% Similarity=0.464 Sum_probs=156.5
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.+.||+|+||.||+|.+ .++..|++|.+...............+.+|+.+++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478899999999999999997 5789999999875433212223345567899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 409 LELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~~--lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
|||+ +++|.+++.... +++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.+....
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 889999997654 8999999999999999999999999999999999999999999999999998764321
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+|||||++|+|++|.++|.+.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 112345689999999999999998888653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=252.41 Aligned_cols=180 Identities=32% Similarity=0.469 Sum_probs=155.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++++.||+|+||.||+|++ .++..+|+|++..... .....+.+|+.+++.++|+||+++++.+.....+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 45799999999999999999997 6788999998864321 22345778999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+....
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 99999999999998864 468999999999999999999999999999999999999999999999999987653210
Q ss_pred --------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 --------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 --------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...+...+|+|||||++|+|++|..||..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 11133568999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=257.76 Aligned_cols=182 Identities=25% Similarity=0.392 Sum_probs=158.4
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
....|++.+.||+|+||.||++.+ .++..+++|.+...... ....+.+|+.+++.+.|+||+++++.+.....+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 346899999999999999999997 67889999988753321 235677899999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|+||||+++++|..++....++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred EEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999999999999998777899999999999999999999999999999999999999999999999998753211
Q ss_pred ----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
........+|+|+|||++|+|++|..||...
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 0123346799999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=271.79 Aligned_cols=188 Identities=26% Similarity=0.386 Sum_probs=155.9
Q ss_pred ccccccccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeE
Q 010231 322 GRFKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQ 394 (514)
Q Consensus 322 ~~~~~~~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~ 394 (514)
+++....+.|.++++||+|+||.||+|++. .+..||||++.... .....+.+.+|+.++..+. ||||++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~~l~~l~~HpnIv~ 105 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA----RSSEKQALMSELKIMTHLGPHLNIVN 105 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCCCeee
Confidence 455555678999999999999999999862 24579999886422 1233467889999999996 999999
Q ss_pred EEEEecCCCeEEEEEeccccCCHHHHHhhc--------------------------------------------------
Q 010231 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-------------------------------------------------- 424 (514)
Q Consensus 395 l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~-------------------------------------------------- 424 (514)
+++++.....+|||||||++|+|.+++...
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 999999999999999999999999887532
Q ss_pred -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 010231 425 -----------------------------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (514)
Q Consensus 425 -----------------------------------------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP 457 (514)
.+++..+..++.||+.||.|||+++|+||||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp 265 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA 265 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 256677888999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 458 ANILVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 458 ~NILId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+|||++.++.+||+|||+++.+.... ...++..+|||||||++|+|++ |..||...
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999999998653210 1234557899999999999996 99999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=254.64 Aligned_cols=182 Identities=24% Similarity=0.375 Sum_probs=153.8
Q ss_pred ccceEeeeeecccCceeEEEEEc-----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
...|++.+.||+|+||+||+|.+ ..+..+++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN----NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 35789999999999999999985 356789999886422 123346788999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhh------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC
Q 010231 403 SKLYIFLELVTKGSLLNLYQR------------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA 464 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~------------------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~ 464 (514)
+..|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 999999999999999998842 23677788899999999999999999999999999999999
Q ss_pred CCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 465 NGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 465 ~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
++.+||+|||+++..... ....++..+|+|||||++|+|++ |.+||.+.
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999764321 01234567999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=253.64 Aligned_cols=180 Identities=31% Similarity=0.462 Sum_probs=152.6
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|.+.+.||+|+||.||+|++ .++..||+|.+...... ......+.+|+.+++.+.|+||+++++.+...+.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 488999999999999999998 57899999988653221 12235577899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 409 LELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~~----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
|||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 99997 578887754 35889999999999999999999999999999999999999999999999998754211
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|+|||||++|+|+||++||.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 0112345789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=251.08 Aligned_cols=184 Identities=36% Similarity=0.596 Sum_probs=158.4
Q ss_pred ceEeeeeecccCceeEEEEEccCCceEEEEEEeccccc-chhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~-~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++++.||+|+||.||+|...++..+|+|.+...... .........+.+|+.+++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47889999999999999999888999999988753221 22334456788999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-----
Q 010231 409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS----- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~----- 482 (514)
|||+++++|.+++.+ ..+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 999999999999876 46889999999999999999999999999999999999999999999999998754210
Q ss_pred --------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 --------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 --------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|+|+|||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 0122345799999999999999999999753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=261.05 Aligned_cols=172 Identities=31% Similarity=0.465 Sum_probs=141.2
Q ss_pred eeeecccCceeEEEEEcc---CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC--CCeEEEE
Q 010231 334 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLYIF 408 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~---~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~--~~~l~LV 408 (514)
+++||+|+||+||+|++. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 568999999999999863 568899998864221 1345689999999999999999998753 5678999
Q ss_pred EeccccCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE----cCCCcEEEEecc
Q 010231 409 LELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFG 474 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~----------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI----d~~g~vKI~DFG 474 (514)
|||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 999965 787776421 47888899999999999999999999999999999999 456789999999
Q ss_pred CceecccC-----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 475 LAKVFLSS-----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 475 lAk~~~~~-----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+|+.+... ....++..+|+|||||++|+|++|.+||.+.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99765321 0123456789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=248.27 Aligned_cols=180 Identities=31% Similarity=0.463 Sum_probs=157.1
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||.|+||.||+|.+ .++..+++|.+..... ...+.+.+|+.+++.++|+||+++++.+.....+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-----hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence 5799999999999999999998 5678899999875322 245678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
+|||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..+....
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 9999999999998865 468999999999999999999999999999999999999999999999999987543210
Q ss_pred -----------------Cc---CcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DF---DLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~---~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. .+...+|+|||||++|+|++|.+||.+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 01 3445689999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=249.28 Aligned_cols=182 Identities=28% Similarity=0.437 Sum_probs=156.1
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||+|++ .++..||||.+...... .......+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM--DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC--CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 5799999999999999999998 57899999988653322 23344667889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
||||+++++|..++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999999988742 34788899999999999999999999999999999999999999999999998865321
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
........+|+||||+++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 112334568999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=248.48 Aligned_cols=180 Identities=27% Similarity=0.450 Sum_probs=156.1
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.+.||+|+||.||++.+ .++..+++|.+..... ....+.+.+|+.+++.++|+||+++++.+.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS----SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 488999999999999999998 5789999998864322 22346677899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|||+++++|.+++.. ..+++..+..|+.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+....
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999999988754 247889999999999999999999999999999999999999999999999998664321
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+..+|+||||+++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence 123445789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=252.37 Aligned_cols=181 Identities=25% Similarity=0.405 Sum_probs=157.4
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..+|+++++||.|+||.||+|.+.++..+++|.+.... ......+.+|+.+++.++|+||+++++++.....+|+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 45789999999999999999999889999999876422 2234567889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
||||+++++|.+++.. ..++...+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999999875 347888999999999999999999999999999999999999999999999997653221
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...+....|+|+|||++|+|++ |.+||.+.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 1234457899999999999998 89999764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=253.56 Aligned_cols=181 Identities=31% Similarity=0.478 Sum_probs=157.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|++.+.||.|+||.||++.+ .++..+|+|.+... .......+.+|+.+++.++|+||+++++.+.....+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 35689999999999999999998 57889999988742 2234467888999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
+||||+++++|..++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999999998865 358999999999999999999999999999999999999999999999999886543210
Q ss_pred -----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+|||||++|+|++|.+||...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 122345799999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=250.98 Aligned_cols=180 Identities=26% Similarity=0.399 Sum_probs=155.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
...|.+.+.||+|+||.||+|.+ .++..+++|.+... ......+.+|+.+++.+.|+||+++++.+.....++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 35689999999999999999998 56889999987632 122456788999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
++|||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999988653 47888899999999999999999999999999999999999999999999998654321
Q ss_pred --------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 --------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 --------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...++..+|||||||++|+|++ |..||.+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1223346899999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=248.71 Aligned_cols=181 Identities=28% Similarity=0.384 Sum_probs=157.5
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
..++|.+.++||+|+||.||+|.+.++..+++|.+..... ....+.+|+.+++.+.|+||+++++.+.....++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 3568999999999999999999988788899998764221 2356788999999999999999999999889999
Q ss_pred EEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-
Q 010231 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~- 482 (514)
+||||+.+++|.+++... .++...+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.+...
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999999998653 5889999999999999999999999999999999999999999999999998865421
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.....+...|+|||||++|+|++ |+.||.+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 01234457899999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=251.04 Aligned_cols=178 Identities=24% Similarity=0.353 Sum_probs=153.3
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.+|++.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 36888999999999999999988778899998753211 123567899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
|||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999988653 57889999999999999999999999999999999999999999999999998643210
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
...++.++|+|||||++|+|++ |.+||..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 1233447999999999999999 8999965
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=256.32 Aligned_cols=180 Identities=29% Similarity=0.492 Sum_probs=155.4
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++++.||+|+||.||++.+ .++..||+|.+.... .......+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 3688999999999999999998 488999999886421 12234678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 408 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~----~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
||||+++++|..++... .+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++..+...
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999999988764 68999999999999999999997 59999999999999999999999999998754221
Q ss_pred C-----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 L-----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ~-----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
. ...++..+|+|||||++|+|++|..||..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 0 01235678999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=254.76 Aligned_cols=181 Identities=27% Similarity=0.427 Sum_probs=155.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|+++++||+|+||.||+|.+ .++..+++|.+... .....+.+.+|+.+++.++|+||+++++.+..+..+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 35789999999999999999998 56889999988642 2334567888999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
+||||+++++|..++.+ ..+++..+..++.||+.+|.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999999999887754 46899999999999999999999999999999999999999999999999998753221
Q ss_pred ----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+..+...+|+|||||++|+|++|.+||...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 0122345689999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=271.20 Aligned_cols=179 Identities=20% Similarity=0.321 Sum_probs=142.5
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC------CCceeEEEEEec
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE------HENIVQYYGTDK 400 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~------HpnIv~l~~~~~ 400 (514)
.++|+++++||+|+||+||+|.+ .+++.||||+++.... .......|+.++..++ |.+|+++++++.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK------YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh------hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 46899999999999999999998 5788999999864211 1223445666665554 456888888876
Q ss_pred CC-CeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCC-----------
Q 010231 401 DE-SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANG----------- 466 (514)
Q Consensus 401 ~~-~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g----------- 466 (514)
.. .++||||+++ +++|.+++.+ ..+++..++.|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 54 5789999998 5677777654 468999999999999999999998 5999999999999998765
Q ss_pred -----cEEEEeccCceecccC----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 467 -----SVKLADFGLAKVFLSS----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 467 -----~vKI~DFGlAk~~~~~----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+||+|||++...... ....+...+|||||||++|+|++|++||.+.
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred CCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4999999987643211 1234566789999999999999999999864
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=249.51 Aligned_cols=184 Identities=40% Similarity=0.660 Sum_probs=157.4
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc----hhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS----QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~----~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.|.++..||+|+||.||+|.+ .++..+|+|.+....... ......+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 377889999999999999988 568899999886533221 223445678899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
.++||||+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999876 457888899999999999999999999999999999999999999999999988665210
Q ss_pred -------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+....|+|+|||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 112345689999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=245.83 Aligned_cols=181 Identities=28% Similarity=0.449 Sum_probs=157.2
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|+.+++||.|+||.||.+.. .++..+++|.+...... ......+.+|+.++++++|+||+++++++.+.+.++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc---hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 488999999999999999987 67889999988653322 23345678999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|||+++++|.+++... .+++..+..++.|++.+|.|||++|++|+||||+||+++.++.+||+|||++..+....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 9999999999988654 48889999999999999999999999999999999999999999999999998754322
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+|||||++|+|++|..||.+.
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 123445789999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=256.26 Aligned_cols=176 Identities=23% Similarity=0.283 Sum_probs=150.3
Q ss_pred eeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC----CCeEEEEEe
Q 010231 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKLYIFLE 410 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----~~~l~LVmE 410 (514)
..||+|++|.||+|.. +|+.||||.+..... ......+.+.+|+.+|++++||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK--GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEecccccc--ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5699999999999988 688999998875322 223345678899999999999999999998866 457899999
Q ss_pred ccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEEEeccCceecccC------
Q 010231 411 LVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKVFLSS------ 482 (514)
Q Consensus 411 y~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~------ 482 (514)
|+++|+|.+++.. ..+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.+...
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 182 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccC
Confidence 9999999999865 4588888999999999999999984 9999999999999999999999999998853221
Q ss_pred ------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++.++|||||||++|+|++|..||.+.
T Consensus 183 ~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred cccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 0134567899999999999999999999865
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=251.49 Aligned_cols=183 Identities=22% Similarity=0.334 Sum_probs=152.5
Q ss_pred cccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~ 400 (514)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3568999999999999999998752 35679999875321 1223456789999999999999999999999
Q ss_pred CCCeEEEEEeccccCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEE
Q 010231 401 DESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~~-----------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vK 469 (514)
.....++||||+++++|.+++... .++...+..++.|++.||.|||++|++|+||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999999988642 145677888999999999999999999999999999999999999
Q ss_pred EEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 470 LADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 470 I~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
|+|||+++.+.... ...++...|+|||||++|+|++ |..||.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999987542210 1234557899999999999998 79999764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=258.31 Aligned_cols=186 Identities=24% Similarity=0.415 Sum_probs=162.1
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccc---cchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEec
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ---GSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~---~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~ 400 (514)
.+...|.-.+.||.|..+.|-+++. .+|..+|+|++..... ........+.-.+|+.||+++ .||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 4456788889999999999998887 6888999998865332 233455556667899999998 7999999999999
Q ss_pred CCCeEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 401 DESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
++..+++|+|+|+.|.|+++|... .++++..+.|++|++.|++|||.++||||||||+|||++.+.++||+|||+|+.+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 999999999999999999999764 6999999999999999999999999999999999999999999999999999987
Q ss_pred ccC------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 480 LSS------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 480 ~~~------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
... ....|....|+|++|++||.|+.|++||=
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 543 22455668899999999999999999993
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=300.30 Aligned_cols=183 Identities=26% Similarity=0.337 Sum_probs=162.5
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|+++++||+|+||.|..++. .+++.||+|+++...... ......|..|-.+|.....+=|++++.+|++++++|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK--r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK--RAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh--chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 45899999999999999999998 789999999987533221 223355778889999888999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~-lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|||||++||+|..++.++. +++..++.|+..|+.||.-||+.|+|||||||+|||||..|+|||+|||.|-.+..+
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 9999999999999998876 999999999999999999999999999999999999999999999999999877632
Q ss_pred ---------------------CC-cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 ---------------------LD-FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ---------------------~~-~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.+ ..|+..+|+||+|+++|||++|..||-.
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 12 5677899999999999999999999954
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=249.47 Aligned_cols=180 Identities=26% Similarity=0.382 Sum_probs=150.0
Q ss_pred eEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe--
Q 010231 331 WQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-- 404 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~-- 404 (514)
|++++.||+|+||.||+|... .+..+|+|.++.... .......+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH---TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 578899999999999999863 347899998874221 23345678899999999999999999998765443
Q ss_pred ----EEEEEeccccCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEec
Q 010231 405 ----LYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (514)
Q Consensus 405 ----l~LVmEy~~gGsL~~lL~~-------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DF 473 (514)
.+++|||+++++|..++.. ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+||
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence 7999999999999988743 24788889999999999999999999999999999999999999999999
Q ss_pred cCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 474 GLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 474 GlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
|+++.+.... ...++..+|||||||++|+|++ |.+||.+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9998653221 1234457999999999999999 99999753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=257.55 Aligned_cols=182 Identities=24% Similarity=0.382 Sum_probs=151.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCc--eEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~--~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 403 (514)
.++|++.+.||+|+||.||+|.+ .++. .+++|.++.. ........+.+|+.++..+ +|+||+++++++...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc----CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 35899999999999999999987 3454 3466655421 1233446778899999999 8999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC
Q 010231 404 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g 466 (514)
.+|+||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 999999999999999988643 367888999999999999999999999999999999999999
Q ss_pred cEEEEeccCceecccC------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 467 SVKLADFGLAKVFLSS------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 467 ~vKI~DFGlAk~~~~~------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.+||+|||++...... ....++...|||||||++|+|+| |.+||.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 9999999998632110 11234567999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=277.17 Aligned_cols=186 Identities=25% Similarity=0.415 Sum_probs=164.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.-...|.+.+.||+|.|++|.++++ .++..||||.+...... ....+.+.+|+++|+.+.|||||+++.+..+...
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln---~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN---PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC---hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 3356899999999999999999998 68999999988754332 3344568899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+|+||||+.+|.+++++.+. .+.+..+..+|.|++.+++|||+++|||||||.+|||++.+.++||+|||++..+....
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 99999999999999999775 57788899999999999999999999999999999999999999999999999876331
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....+..+|+|++|++||.|+.|.+||.|+|
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 1234458999999999999999999999986
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=248.09 Aligned_cols=174 Identities=24% Similarity=0.401 Sum_probs=148.4
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~ 413 (514)
+.||+|+||.||+|++ .++..+|+|.+... ........+.+|+.+++.+.|+||+++++++.....+|+||||+.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 3699999999999998 57889999987532 123344668899999999999999999999999999999999999
Q ss_pred cCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 414 KGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 414 gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99999998653 4788999999999999999999999999999999999999999999999998753321
Q ss_pred ------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 483 ------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 483 ------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
....++..+|+|||||++|+|++ |.+||..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 01223446899999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=253.74 Aligned_cols=181 Identities=29% Similarity=0.444 Sum_probs=153.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|++.+.||+|+||.||+|.+ .+++.||+|.+....... ....+.+|+.+++.++|+||+++++++.+.+..|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence 46899999999999999999998 478899999987532211 1123568999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
+||||+.+ +|.+++... .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 99999985 898887653 5788999999999999999999999999999999999999999999999998753211
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|+.||.+.
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 0122445789999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=251.52 Aligned_cols=180 Identities=31% Similarity=0.486 Sum_probs=155.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++.+.||+|+||.||+|.+ .++..||+|.++... ......+.+|+.+++.++|+||+++++.+...+.+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 35788999999999999999987 578899999887432 122345778999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 99999999999998865 468999999999999999999999999999999999999999999999999987543210
Q ss_pred --------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 --------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 --------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...+...+|+|||||++|+|++|..||..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 12244578999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=248.89 Aligned_cols=183 Identities=39% Similarity=0.603 Sum_probs=156.1
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC--CCeEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLY 406 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~--~~~l~ 406 (514)
.|+.++.||+|+||.||++.+ .++..|++|.+...............+.+|+.+++.++|+||+++++.+.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 688899999999999999988 578899999887544333334456678899999999999999999998765 46789
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
++|||+++++|.+++.. ..++...++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||+++.+...
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 99999999999998865 45888899999999999999999999999999999999999999999999998754321
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....++..+|+|||||++|+|++|+.||..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 012234578999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=251.55 Aligned_cols=181 Identities=31% Similarity=0.498 Sum_probs=158.4
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|+..+.||.|+||.||+|.+ .++..+|+|.+.... .......+.+|+.+++.+.|+||+++++.+.+.+.+|+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 4577889999999999999998 568899999887422 12345678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC----
Q 010231 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL---- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~---- 483 (514)
||||+.+++|.+++....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+....
T Consensus 80 v~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 80 IMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999997653211
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...|+|||||++|+|++|.+||...
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123345789999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=247.95 Aligned_cols=185 Identities=37% Similarity=0.573 Sum_probs=156.5
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--CeE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKL 405 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--~~l 405 (514)
..|++.+.||+|+||.||+|.+ .++..+++|.+...............+.+|+.+++.++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3689999999999999999998 5789999998764332223344567888999999999999999999987653 568
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
++||||+++++|.+++.. ..+.+..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.+....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999998865 458889999999999999999999999999999999999999999999999997643210
Q ss_pred ---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.......+|+|||||++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 112345689999999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=252.31 Aligned_cols=180 Identities=24% Similarity=0.385 Sum_probs=148.9
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCce----EEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~----vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
++|++++.||+|+||+||+|.+ .++.. +++|.+.. .........+..|+.++..+.|+||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD----RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc----ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 5789999999999999999987 34553 56665532 2223445677888889999999999999998764 5
Q ss_pred eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
..+++|||+++|+|.+++.. ..+++..+..|+.||+.||.|||+++++||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 67899999999999999865 3588999999999999999999999999999999999999999999999999986432
Q ss_pred CC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.. ...++...|||||||++|+|++ |..||.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 10 1223456899999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=253.27 Aligned_cols=180 Identities=27% Similarity=0.413 Sum_probs=153.5
Q ss_pred cceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.+|.+.+.||+|+||+||++.. .++..+|+|.+... .......+.+|+.+++.+.|+||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4789999999999999999974 24566888877532 223456788999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcE
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY--------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV 468 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~--------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~v 468 (514)
+.+|+||||+++++|.+++... .+++..+..++.||+.+|.|||++||+||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 9999999999999999988643 27889999999999999999999999999999999999999999
Q ss_pred EEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 469 KLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 469 KI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
||+|||+++..... ....+...+|+|||||++|+|++ |.+||.+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999754211 11234457999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=252.13 Aligned_cols=182 Identities=27% Similarity=0.375 Sum_probs=153.3
Q ss_pred ccceEeeeeecccCceeEEEEEccC------CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~------g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
...|++.+.||+|+||.||+|.... ...+++|.+.... .......+.+|+.++..++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA----EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC----CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 3578999999999999999998632 2578899876322 22334568899999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA 464 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~-----------------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~ 464 (514)
....|++|||+.+++|.+++.. ..++...+..++.||+.||.|||++||+|+||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 8999999999999999998864 24677888999999999999999999999999999999999
Q ss_pred CCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 465 NGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 465 ~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
++.+||+|||+++..... .+..++..+|||||||++|+|++ |..||.+.
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999754221 11234457899999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=251.00 Aligned_cols=181 Identities=33% Similarity=0.516 Sum_probs=158.7
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||.|+||.||+|.+ .++..+++|.+.... .......+.+|+.+++.++|+||+++++.+.+...+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 3688899999999999999998 578899999886432 12234567899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC----
Q 010231 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL---- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~---- 483 (514)
|+||+.+++|.+++....+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||+++.+....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 9999999999999988789999999999999999999999999999999999999999999999999998764321
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|+|+|||++|+|++|..||...
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 122445799999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=245.57 Aligned_cols=182 Identities=27% Similarity=0.464 Sum_probs=156.6
Q ss_pred cceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|++.+.||+|+||.||+|.+. +++.||+|.++..... .......+.+|+.+++.++|+||+++++.+...+..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM--DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 57999999999999999999985 8999999988743321 12334678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
||||+++++|..++.. ..++...+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999998853 24788999999999999999999999999999999999999999999999998754321
Q ss_pred C-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 L-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
. ...+...+|+|||||++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 1 12234468999999999999999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=254.53 Aligned_cols=181 Identities=25% Similarity=0.404 Sum_probs=158.5
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
...|++.+.||.|+||.||++.+ .+++.|++|.+..... .....+.+|+.+++.++|+||+++++.+...+.+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-----PKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 35799999999999999999987 6789999998864322 22356788999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
+||||+.+++|..++....+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..+....
T Consensus 93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 93 VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred EEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987543210
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+|||||++|+|++|..||.+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122345789999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=248.50 Aligned_cols=179 Identities=23% Similarity=0.361 Sum_probs=153.7
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.+.|+++++||+|+||.||+|...++..||+|.+..... ....+.+|+.+++.++|+||+++++.+. .+.+|+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 468999999999999999999998889999998764222 2346788999999999999999998864 467899
Q ss_pred EEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
+|||+.+++|.+++.. ..++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..+....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999999998864 347888899999999999999999999999999999999999999999999998655210
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...++...|+||||+++|+|++ |.+||.+.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1223457899999999999999 99999764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=277.65 Aligned_cols=185 Identities=26% Similarity=0.428 Sum_probs=159.3
Q ss_pred ccceEeeeeecccCceeEEEEEcc--CC--ce-EEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD--DG--FF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~--~g--~~-vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.++..+.++||+|.||.||+|... ++ .. ||+|..+.. ....+..+..+.+|.++|++++|+|||++||++...
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~--~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS--SELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc--ccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 445667799999999999999873 22 23 899987641 223456678899999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~~--lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
..+|||||+|.||+|.++|++++ ++..+...|+.+.+.||+|||++++|||||-.+|+|++.++.+||+||||++...
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999999999999865 9999999999999999999999999999999999999999999999999988642
Q ss_pred c----------------C---CCcCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 481 S----------------S---LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 481 ~----------------~---~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
. + ....++..+|||+|||++||+++ |..||.+.+
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 0 0 22456679999999999999998 788998863
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=252.02 Aligned_cols=179 Identities=26% Similarity=0.444 Sum_probs=153.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|++.+.||+|+||.||++.+ .++..+++|.+.... ......+.+|+.+++.++|+||+++++.+...+..|+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 3578889999999999999998 467888998875321 2335667889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
||||+.+++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 9999999999887754 45899999999999999999999999999999999999999999999999998654221
Q ss_pred ---------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 ---------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ---------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....+...+|+|||||++|+|++|.+||..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 112234579999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=249.43 Aligned_cols=182 Identities=25% Similarity=0.396 Sum_probs=159.3
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.|++.+.||.|+||.||++.+ .++..||+|.+..... ........+.+|+.++++++||||+++++.+.....+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC--VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh--cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 489999999999999999998 4789999999874322 1123456788999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-----
Q 010231 409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS----- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~----- 482 (514)
|||+.+++|..++... .+.+..+..|+.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 9999999999998766 7999999999999999999999999999999999999999999999999999865432
Q ss_pred -------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.......++|+|+|||++|+|++|..||...
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 202 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH 202 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCC
Confidence 1122456899999999999999999999864
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=250.45 Aligned_cols=174 Identities=24% Similarity=0.312 Sum_probs=142.2
Q ss_pred eecccCceeEEEEEccC---CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEecc
Q 010231 336 LLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~~~---g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
.||+|+||.||+|.... ...+++|.+... ........+.+|+.+++.++|+||+++++.+.....+|+||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc----CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence 58999999999997533 345677765421 12233456788999999999999999999999999999999999
Q ss_pred ccCCHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 413 TKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 413 ~gGsL~~lL~~~~------lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
.+|+|.+++.... ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999999986532 356678899999999999999999999999999999999999999999998642110
Q ss_pred ------------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 ------------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 ------------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
....+...+|||||||++|+|++ |..||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 01233457999999999999999 88898653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=251.87 Aligned_cols=181 Identities=28% Similarity=0.381 Sum_probs=153.8
Q ss_pred cceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
+.|.+.+.||+|+||.||+|.+. ++..||+|.++.... ......+.+|+.+++.+.|+||+++++.+...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS----NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC----HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 46888999999999999999863 357899998764221 22346788999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhc---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY---------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~---------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~ 467 (514)
..+|+||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 9999999999999999998643 2677888999999999999999999999999999999999999
Q ss_pred EEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 468 VKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 468 vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+||+|||+++.+.... ...++..+|||||||++|+|++ |..||...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999997542210 1233456899999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=254.74 Aligned_cols=181 Identities=24% Similarity=0.395 Sum_probs=150.5
Q ss_pred cceEeeeeecccCceeEEEEEcc-CCc--eEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCe
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD-DGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~-~g~--~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 404 (514)
++|++.++||+|+||.||+|... ++. .+++|.++... .....+.+.+|+.++.++ +||||+++++++.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA----SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC----CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 47899999999999999999873 333 46787765321 122345678899999999 79999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc
Q 010231 405 LYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~ 467 (514)
+|+||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence 99999999999999998653 3677889999999999999999999999999999999999999
Q ss_pred EEEEeccCceecccC------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 468 VKLADFGLAKVFLSS------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 468 vKI~DFGlAk~~~~~------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+||+|||++...... ....++.++|||||||++|+|++ |..||.+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999998632210 01234567999999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=249.64 Aligned_cols=179 Identities=28% Similarity=0.378 Sum_probs=152.1
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|++.++||+|+||.||+|.+.+...||+|.+..... ....+.+|+.+++.++|+||+++++.+.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 357999999999999999999987667799998864221 12467889999999999999999998754 56899
Q ss_pred EEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+||+|||+++.+....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999999999875 347888999999999999999999999999999999999999999999999998653221
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...++..+|+|||||++|+|++ |..||.+.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 1223457999999999999999 89999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=250.21 Aligned_cols=183 Identities=30% Similarity=0.482 Sum_probs=156.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||++.+ .++..++||.+..... ........+.+|+.+++.+.|+||+++++.+...+.+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh--hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 4688899999999999999997 6889999998765332 223344678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+|||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999998863 34788999999999999999999999999999999999999999999999998765321
Q ss_pred C-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 L-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ....+..+|+||||+++|+|++|..||.+.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1 123345689999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=253.33 Aligned_cols=180 Identities=24% Similarity=0.363 Sum_probs=150.7
Q ss_pred ceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 330 YWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
+|++.+.||+|+||.||+|.+. ....+++|.+.... .......+.+|+.+++.+.||||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4788899999999999999862 23567888775321 1233467889999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhhc-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010231 404 KLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~-------------------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~ 458 (514)
..|++|||+.+++|.+++... .++...+..++.||+.||.|||+++|+||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 999999999999999987542 3677888999999999999999999999999999
Q ss_pred CEEEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 459 NILVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 459 NILId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
|||++.++.+||+|||+++.+.... ...++..+|||||||++|+|++ |..||.+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999997542210 1223456899999999999998 99999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=254.51 Aligned_cols=186 Identities=24% Similarity=0.361 Sum_probs=154.5
Q ss_pred ccccccceEeeeeecccCceeEEEEEcc--------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeE
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~~--------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~ 394 (514)
+....+.|.+++.||+|+||.||++.+. +...+|+|.+.... .......+.+|+.+++.+ +|+||++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 3334578999999999999999999752 23568999876421 123345678899999999 7999999
Q ss_pred EEEEecCCCeEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 010231 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (514)
Q Consensus 395 l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP 457 (514)
+++++...+.+|+||||+.+|+|.+++... .++...+..++.||+.||+|||++||+||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 999999999999999999999999998652 367788999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 458 ANILVDANGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 458 ~NILId~~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+|||++.++.+||+|||+++.+... ....++..+|+|||||++|+|++ |..||.+.
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 9999999999999999999754321 01223457899999999999998 89998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=249.83 Aligned_cols=180 Identities=24% Similarity=0.384 Sum_probs=150.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCc----eEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~----~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
..+|++.++||+|+||+||+|.+ .++. .||+|.+.... .......+.+|+.++..+.|+||+++++.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT----SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC----CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 45899999999999999999986 3444 47888876422 22334568899999999999999999998875
Q ss_pred CeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
...+++|+|+++|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 4578999999999999998653 58999999999999999999999999999999999999999999999999998653
Q ss_pred cC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 481 SS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 481 ~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
.. ....++..+|||||||++|+|++ |..||..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 21 11223456799999999999998 9999975
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=254.33 Aligned_cols=183 Identities=25% Similarity=0.380 Sum_probs=157.6
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||+|.+ .++..||+|.+..... ........+.+|+.+++.+.|+||+++++.+......|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM--IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc--chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 3689999999999999999998 4689999999875322 212345678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
||||+.+++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||||+||+|+.++.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999999999875 358889999999999999999999999999999999999999999999999987542210
Q ss_pred -----------------------------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------------------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------------------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|||||||++|+|++|..||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 122344789999999999999999999765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=248.47 Aligned_cols=179 Identities=26% Similarity=0.374 Sum_probs=153.3
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|++.++||+|+||.||+|.+.++..+|+|.+..... ....+.+|+.+++.++|+||+++++.+. ....|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM------SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC------CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 467899999999999999999988888899998874222 1245789999999999999999999875 456899
Q ss_pred EEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
+|||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999998652 48889999999999999999999999999999999999999999999999998653221
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
....+..+|+|||||++|+|++ |.+||.+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 0123347999999999999999 99999764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=243.44 Aligned_cols=182 Identities=29% Similarity=0.471 Sum_probs=158.4
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|...++||+|+||+||+|++ .+++.||+|.+...+...-. .....+||-+|+.++|.|||+++++...++++-+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv---pssalreicllkelkhknivrl~dvlhsdkkltl 78 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV---PSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC---cHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence 3577788999999999999998 67899999999875544322 2446799999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|+|||.. +|..++.. ..+..+.++.++.|++.||.|+|++++.||||||.|+||+.+|.+|++|||+|+.+.-+.
T Consensus 79 vfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 79 VFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred eHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 9999976 78877764 458889999999999999999999999999999999999999999999999999876441
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHH-hCCCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIF-LHVLIFRPPN 514 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLl-tG~~PF~g~n 514 (514)
..-+...+|+||-||++.|+. .|+++|+|.+
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 234556889999999999998 8999999864
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=247.30 Aligned_cols=183 Identities=30% Similarity=0.570 Sum_probs=156.5
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc-hhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.|+.++.||+|+||.||++.+ .+++.+|+|.+....... ........+.+|+.+++.++|+||+++++.+.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999987 678999999987433222 222345788899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-cEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-~vKI~DFGlAk~~~~~~-- 483 (514)
||||+.+++|.+++.+ ..+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999998875 4588899999999999999999999999999999999998776 59999999987654320
Q ss_pred ---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...+..+.|+|+|||++|+|++|..||..
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 12334578999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=281.68 Aligned_cols=180 Identities=26% Similarity=0.466 Sum_probs=154.2
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC-----
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----- 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~----- 402 (514)
.-|..-+.||+|+||.||++++ .+|+.||||.++... .....+...+|+.+|++++|+|||+++++-.+.
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 3567788999999999999997 789999999887533 233446677999999999999999999875443
Q ss_pred -CeEEEEEeccccCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC--C--cEEEEec
Q 010231 403 -SKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--G--SVKLADF 473 (514)
Q Consensus 403 -~~l~LVmEy~~gGsL~~lL~~----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~--g--~vKI~DF 473 (514)
....+|||||.+|+|+.+|+. +++++..+..++..+..||.|||++|||||||||.||++... | ..||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 346899999999999999964 579999999999999999999999999999999999998643 4 4799999
Q ss_pred cCceecccCC-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 474 GLAKVFLSSL-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 474 GlAk~~~~~~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
|.|+.+.... ...++..+|.|||||++|+.+||..||-+
T Consensus 169 G~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 169 GAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9999876441 35677899999999999999999999964
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=286.97 Aligned_cols=182 Identities=20% Similarity=0.269 Sum_probs=154.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|+++++||+|+||.||+|.+ .+++.||+|++..... .......++.+|+.+++.++||||+++++++.+.+..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 6799999999999999999998 5789999998864221 223344678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccC
Q 010231 408 FLELVTKGSLLNLYQRY------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGl 475 (514)
||||++|++|.+++... .++...+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999999988531 244566788999999999999999999999999999999999999999999
Q ss_pred ceecccC-------------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 476 AKVFLSS-------------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 476 Ak~~~~~-------------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
++..... ....++.++|||||||++|+|+||..||.+
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9866110 012334578999999999999999999975
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-29 Score=252.10 Aligned_cols=183 Identities=25% Similarity=0.369 Sum_probs=156.0
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||++.+ .+++.|++|.+..... ........+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL--ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 3689999999999999999998 5678999998864321 122344677899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc------
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL------ 480 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~------ 480 (514)
||||+.+++|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999999866 457888999999999999999999999999999999999999999999999986311
Q ss_pred -------------------------cC---CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 -------------------------SS---LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 -------------------------~~---~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+ ....+...+|+|||||++|+|++|..||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 00 0123445799999999999999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=257.87 Aligned_cols=177 Identities=20% Similarity=0.305 Sum_probs=149.7
Q ss_pred eeeeeccc--CceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEE
Q 010231 333 KGDLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 333 i~~~LG~G--sfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm 409 (514)
++++||+| +|++||++.+ .+|+.||+|.+...... ......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT---NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc---HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 46789999 6899999988 68899999988643221 223456778999999999999999999999999999999
Q ss_pred eccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc-----
Q 010231 410 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS----- 481 (514)
Q Consensus 410 Ey~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~----- 481 (514)
||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999998864 3488999999999999999999999999999999999999999999999976432210
Q ss_pred ------------------CC----C-cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 482 ------------------SL----D-FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 482 ------------------~~----~-~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+. + ..++..+|||||||++|+|++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 00 0 2355679999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=248.11 Aligned_cols=182 Identities=21% Similarity=0.308 Sum_probs=153.1
Q ss_pred ccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.++|++.+.||+|+||.||++.+. ++..||+|.+.... .......+.+|+.+++.+.|+||+++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 468999999999999999999863 34689999875321 12234567789999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEE
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~-----------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI 470 (514)
....|+||||+++++|.+++... .+.+..+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999988642 2567788999999999999999999999999999999999999999
Q ss_pred EeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 471 ADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 471 ~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+|||+++.+... ....++.++|+|||||++|+|++ |..||.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 999998754321 11234457899999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=245.93 Aligned_cols=180 Identities=24% Similarity=0.360 Sum_probs=154.2
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
..+.|++.+.||+|+||.||++.+..+..+++|.+... ......+.+|+.+++.++|+||+++++.+.. ...|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 35689999999999999999999877788999987632 2234568889999999999999999999887 7789
Q ss_pred EEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
++|||+++++|.+++... .++...+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999998653 36778889999999999999999999999999999999999999999999997654221
Q ss_pred C--------------------cCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 D--------------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 ~--------------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
. ..++..+|+|||||++|+|++ |.+||.+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 0 123447899999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=254.58 Aligned_cols=173 Identities=32% Similarity=0.487 Sum_probs=140.9
Q ss_pred eeeeecccCceeEEEEEcc---CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec--CCCeEEE
Q 010231 333 KGDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLYI 407 (514)
Q Consensus 333 i~~~LG~GsfG~Vyka~~~---~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~--~~~~l~L 407 (514)
.+.+||+|+||+||+|... ++..||+|.+..... ...+.+|+.+++.++|+||+++++++. ....+|+
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 3568999999999999863 567899998763211 234678999999999999999999874 4567899
Q ss_pred EEeccccCCHHHHHhh----------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE----cCCCcEEEEec
Q 010231 408 FLELVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADF 473 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~----------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI----d~~g~vKI~DF 473 (514)
||||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9999976 67776642 137788899999999999999999999999999999999 46679999999
Q ss_pred cCceecccCC-----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 474 GLAKVFLSSL-----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 474 GlAk~~~~~~-----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|+++.+.... ...++..+|||||||++|+|+||.+||.+.
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9998653210 122455789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=248.77 Aligned_cols=180 Identities=32% Similarity=0.538 Sum_probs=156.7
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC---CCceeEEEEEecCCCeE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKL 405 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l 405 (514)
.|++.+.||+|+||.||+|.+ .++..+++|.+..... ......+.+|+.+++.+. |+||+++++.+.....+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 578889999999999999997 6789999998864221 223456778999999886 99999999999999999
Q ss_pred EEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|+||||+.+++|.++++...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 999999999999999988889999999999999999999999999999999999999999999999999998654321
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|+|+|||++|+|++|..||.+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 122356799999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=246.49 Aligned_cols=180 Identities=24% Similarity=0.372 Sum_probs=153.8
Q ss_pred cceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
++|.+.+.||+|+||.||+|.+. +...||+|.+.... .......+.+|+.+++.++|+||+++++.+.....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 47899999999999999999873 24578999876422 22334567889999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||+++.+...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999999865 35889999999999999999999999999999999999999999999999999876411
Q ss_pred ---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 483 ---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 483 ---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
....++...|+|+|||++|+|++ |..||..
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 01233457899999999999997 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=250.09 Aligned_cols=180 Identities=30% Similarity=0.424 Sum_probs=150.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|.+.+.||+|+||.||+|.+ .++..|++|.+...... .....+.+|+.+++.++|+||+++++++......|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE----GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC----CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 36899999999999999999987 57889999998643211 11234568999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
+||||+. ++|..++.. ..+.+..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++......
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9999996 566665543 347788899999999999999999999999999999999999999999999987532110
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...+...+|+|||||++|+|++|..||.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11234567999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=248.13 Aligned_cols=180 Identities=27% Similarity=0.423 Sum_probs=156.0
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++++.||+|+||.||+|.+ .++..|++|++...... ......+.+|+.+++.++|+||+++++++.....+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 488999999999999999998 57899999998753321 22345688999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
|||+ +++|.+++.. ..+++..+..++.||+.+|.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9999 9999998865 358999999999999999999999999999999999999999999999999988654321
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|||+|||++|+|++|.++|.+.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 112356799999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=249.06 Aligned_cols=182 Identities=29% Similarity=0.428 Sum_probs=152.8
Q ss_pred ccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.+.|++.+.||+|+||.||+|.+. .+..|++|.+.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 357999999999999999999874 46788888775321 12223567889999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC---cEEE
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKL 470 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~--------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g---~vKI 470 (514)
....|+||||+.+++|.+++... .+++..+..++.||+.||.|||+++++||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 89999999999999999998654 378888999999999999999999999999999999998765 6999
Q ss_pred EeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 471 ADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 471 ~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+|||+++.+... ....++.++|||||||++|+|++ |..||.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999865211 11235567999999999999996 99999764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=249.93 Aligned_cols=184 Identities=24% Similarity=0.382 Sum_probs=154.3
Q ss_pred ccccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT 398 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~ 398 (514)
...++|++.+.||+|+||.||++.+. ....+|+|.+.... .......+.+|+.++..+ +|+||++++++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34568999999999999999999863 33678999876421 123345688999999999 89999999999
Q ss_pred ecCCCeEEEEEeccccCCHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEE
Q 010231 399 DKDESKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461 (514)
Q Consensus 399 ~~~~~~l~LVmEy~~gGsL~~lL~~-----------------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NIL 461 (514)
+.....+|++|||+.+|+|..++.. ..+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 9999999999999999999999853 24778889999999999999999999999999999999
Q ss_pred EcCCCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 462 VDANGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 462 Id~~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
++.++.+||+|||+++.+... ....+...+|||||||++|+|++ |..||.+.
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999999999999999754321 11233456899999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-31 Score=261.76 Aligned_cols=183 Identities=28% Similarity=0.446 Sum_probs=154.8
Q ss_pred cccceEeeeeecccCceeEEEEEcc---C--CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISD---D--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~---~--g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
...+|+++..||+|+||.||+|... + ...+|||.++..+... -.-...-+|+.+++.++|+||+.|..+|..
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t---GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT---GISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC---CcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 3568999999999999999999652 2 3478999887543321 111234589999999999999999998887
Q ss_pred -CCeEEEEEeccccCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC----CcEEE
Q 010231 402 -ESKLYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKL 470 (514)
Q Consensus 402 -~~~l~LVmEy~~gGsL~~lL~~------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~----g~vKI 470 (514)
+..+||++||.+. +|.++++. ..++...++.|++||++|+.|||+++|+||||||.||||..+ |+|||
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 7789999999987 78888753 248888999999999999999999999999999999999887 89999
Q ss_pred EeccCceecccC-----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 471 ADFGLAKVFLSS-----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 471 ~DFGlAk~~~~~-----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+|||||+.+.++ ....|+..+|+|+.|||+.||+|-++.|.|.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999998765 2256777899999999999999999999873
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=243.85 Aligned_cols=179 Identities=25% Similarity=0.375 Sum_probs=155.3
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|++.+.||.|+||.||+|... ++.||+|.+..... ..+++.+|+.+++.+.|+||+++++.+...+..|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 457899999999999999999875 78899998864221 35678899999999999999999999998999999
Q ss_pred EEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
||||+++++|.+++... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 99999999999998754 48999999999999999999999999999999999999999999999999988653221
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...+...+|+|||||++|+|++ |..||...
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 1233346899999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=247.11 Aligned_cols=180 Identities=23% Similarity=0.349 Sum_probs=146.3
Q ss_pred eEeeeeecccCceeEEEEEccC-Cc--eEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC------
Q 010231 331 WQKGDLLGRGSFGSVYEGISDD-GF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD------ 401 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~~~-g~--~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~------ 401 (514)
|.++++||+|+||.||+|.+.. +. .+|+|.++... ........+.+|+.+++.++|+||+++++.+..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 3467899999999999998743 33 58899876422 123345678899999999999999999987632
Q ss_pred CCeEEEEEeccccCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEecc
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~-------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFG 474 (514)
....+++|||+.+|+|..++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence 2357899999999999887632 237888899999999999999999999999999999999999999999999
Q ss_pred CceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 475 LAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 475 lAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+++.+.... ...++...|+|||||++|+|++ |+.||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 998653211 1223457999999999999999 89999753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=249.56 Aligned_cols=182 Identities=22% Similarity=0.299 Sum_probs=150.4
Q ss_pred ccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.++|++.++||+|+||.||+|... .+..||+|.+..... ......+.+|+.+++.++|+||+++++.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS----LRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 468999999999999999998652 345789998753221 1223457789999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEE
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~~-----------lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI 470 (514)
.+..|+||||+.+|+|.+++.... +....+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999999986421 345678889999999999999999999999999999999999999
Q ss_pred EeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 471 ADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 471 ~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+|||+++.+... ....++...|+|||||++|+|++ |.+||.+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998754221 11233457899999999999998 89999753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=245.65 Aligned_cols=178 Identities=26% Similarity=0.373 Sum_probs=150.9
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+.|.+...||+|+||.||++.+..+..+|+|.+..... ....+.+|+.+++.+.|+||+++++++. .+..|+|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM------MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc------cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 57899999999999999999987777899998753221 2245778999999999999999998875 4568999
Q ss_pred EeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|||+.+++|.+++... .++...+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++.+....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999999998653 37888899999999999999999999999999999999999999999999998653221
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
....+..+|+|||||++|+|++ |.+||.+.
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0123346899999999999999 99999764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=247.80 Aligned_cols=178 Identities=29% Similarity=0.446 Sum_probs=150.3
Q ss_pred cceEeeeeecccCceeEEEEEc-----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec--C
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--D 401 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~--~ 401 (514)
..|++.+.||+|+||.||++.. .++..||+|.+... .....+.+.+|+.+++.++|+||+++++++. +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 4688999999999999999973 46889999987642 2334567889999999999999999998764 3
Q ss_pred CCeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
...+|+||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 45689999999999999998653 4888999999999999999999999999999999999999999999999999865
Q ss_pred ccCC----------------------CcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 480 LSSL----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 480 ~~~~----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
.... ...+...+|+|||||++|+|++|..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 3221 1234457899999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=251.79 Aligned_cols=180 Identities=33% Similarity=0.523 Sum_probs=156.6
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|+..+.||+|+||.||+|.+ .++..||+|.+.... .......+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 3577788999999999999987 567889999876422 12334678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC----
Q 010231 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL---- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~---- 483 (514)
||||+++++|.+++....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 80 IMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 9999999999999988889999999999999999999999999999999999999999999999999997643221
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...+...+|+|||||++|+|++|..||..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 12334578999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=247.15 Aligned_cols=180 Identities=24% Similarity=0.367 Sum_probs=152.5
Q ss_pred cceEeeeeecccCceeEEEEEcc-C---CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD-D---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~-~---g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+|++++.||+|+||.||+|.+. + +..+|+|.++... .......+.+|+.+++.++||||+++++.+...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 47899999999999999999873 2 3368888775321 12335678899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+|+||||+++++|.+++... .++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999998754 4788899999999999999999999999999999999999999999999998764322
Q ss_pred C----------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 483 L----------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 483 ~----------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
. ...++...|+|+|||++|++++ |..||..
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 1 1233456899999999999886 9999965
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=252.58 Aligned_cols=184 Identities=26% Similarity=0.382 Sum_probs=153.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc--------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~--------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~ 396 (514)
...++|.+++.||+|+||.||++.. .....+|+|.++... .......+.+|+.+++.+ .|+||++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 3346899999999999999999974 234578999876321 123356688899999999 699999999
Q ss_pred EEecCCCeEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 010231 397 GTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN 459 (514)
Q Consensus 397 ~~~~~~~~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N 459 (514)
+++.....+|+||||+.+|+|.+++... .++...+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999999999999999999999998642 36778889999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 460 ILVDANGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 460 ILId~~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
||++.++.+||+|||+++..... ....++..+|||||||++|+|++ |..||.+.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999754321 01234457899999999999999 89999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=246.08 Aligned_cols=182 Identities=23% Similarity=0.396 Sum_probs=153.6
Q ss_pred ccceEeeeeecccCceeEEEEEcc-CC---ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD-DG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~-~g---~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
...|++.+.||+|+||.||+|.+. ++ ..||+|.+.... .......+..|+.+++.+.||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence 356899999999999999999873 33 369999876421 2334567889999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+++||||+.+++|.+++.. ..++...+..++.|++.||.|||++|++|+||||+|||++.++.+||+|||++..+..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999999998865 3478899999999999999999999999999999999999999999999999875432
Q ss_pred CC------------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SL------------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~------------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.. ...++...|||||||++|+|++ |..||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 11 1122346899999999999886 99999653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=251.59 Aligned_cols=185 Identities=25% Similarity=0.386 Sum_probs=154.1
Q ss_pred cccccceEeeeeecccCceeEEEEEc--------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEE
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY 395 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~--------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l 395 (514)
.....+|.+++.||+|+||.||+|+. .++..+|+|.+... ........+.+|+.+++.+ +|+||+++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCchhe
Confidence 34467899999999999999999974 23457899977531 1223456788999999999 89999999
Q ss_pred EEEecCCCeEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010231 396 YGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458 (514)
Q Consensus 396 ~~~~~~~~~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~ 458 (514)
++.+.....+|+||||+.+|+|.+++... .++...+..++.||+.||.|||++||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999988642 3566778899999999999999999999999999
Q ss_pred CEEEcCCCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 459 NILVDANGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 459 NILId~~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
|||++.++.+||+|||+++.+... ....++..+|||||||++|+|++ |..||.+.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999865321 01224457999999999999998 88898764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=247.56 Aligned_cols=181 Identities=33% Similarity=0.523 Sum_probs=156.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+-|++.+.||.|+||.||+|.+ .++..+|+|.+.... .......+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 3577889999999999999987 578899999875322 12334678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-----
Q 010231 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS----- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~----- 482 (514)
||||+.+++|..++....+++..+..++.|++.+|.|||++||+|+||||+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 80 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 999999999999998888999999999999999999999999999999999999999999999999998754321
Q ss_pred --------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 --------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 --------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
........+|+|||||++|+|++|..||...
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 0122334689999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=242.99 Aligned_cols=175 Identities=26% Similarity=0.426 Sum_probs=149.6
Q ss_pred eeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEecccc
Q 010231 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK 414 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~g 414 (514)
++||+|+||.||+|...++..+|+|.+.... .......+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 3699999999999998888899999876422 122334678899999999999999999999999999999999999
Q ss_pred CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----------
Q 010231 415 GSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---------- 482 (514)
Q Consensus 415 GsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---------- 482 (514)
++|.+++... .+.+..+..++.|++.+|.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9999988643 4788899999999999999999999999999999999999999999999998753221
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
....++...|+||||+++|+|++ |..||.+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 01223457899999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=243.93 Aligned_cols=178 Identities=24% Similarity=0.381 Sum_probs=151.0
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEe-cCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~-~~~~~l~ 406 (514)
...|++.+.||+|+||.||++... +..+++|.++.. ...+.+.+|+.+++.++|+||+++++.+ ...+.+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 357899999999999999999764 678899987531 1235678999999999999999999865 4566799
Q ss_pred EEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+||||+++++|.+++.+. .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999999998754 27788899999999999999999999999999999999999999999999998654321
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...+...+|+|||||++|+|++ |.+||...
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1234457999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=242.60 Aligned_cols=181 Identities=27% Similarity=0.454 Sum_probs=156.3
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++++.||.|+||+||+|.. .++..+++|++..... ......+.+|+.+++.++|+||+++++.+...+..|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc----chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 4689999999999999999987 5778899998764221 1145678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 408 FLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999999999865 247889999999999999999999999999999999999999999999999987554321
Q ss_pred C------------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 D------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ~------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ..++..+|+|+|||++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 1 13445789999999999999999999753
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=249.64 Aligned_cols=180 Identities=28% Similarity=0.382 Sum_probs=152.0
Q ss_pred cceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.+|.+.+.||+|+||.||++.+ .++..+++|.+... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4689999999999999999975 24566888876531 123345688999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~ 465 (514)
+..++||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 9999999999999999998653 26788899999999999999999999999999999999999
Q ss_pred CcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 466 GSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 466 g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+.++|+|||+++...... ...+...+|||||||++|+|+| |..||...
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999997543210 1223346999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=286.54 Aligned_cols=185 Identities=26% Similarity=0.393 Sum_probs=153.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC--C
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--E 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~--~ 402 (514)
...+.|++++.||+|+||+||+|.+ .++..+|+|.+...... ......+.+|+.++..|.||||++++++|.. .
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~---e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK---EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC---HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 4467899999999999999999998 56788999988753222 2334678899999999999999999998743 4
Q ss_pred CeEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCCEEEcC------
Q 010231 403 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-------DVVHRDIKCANILVDA------ 464 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~-------gIIHRDLKP~NILId~------ 464 (514)
..+||||||+.+|+|..+|.. ..+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 679999999999999998864 3589999999999999999999984 4999999999999964
Q ss_pred -----------CCcEEEEeccCceecccC--------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 465 -----------NGSVKLADFGLAKVFLSS--------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 465 -----------~g~vKI~DFGlAk~~~~~--------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+.+||+|||+++.+... ....++..+|||||||+||+|+||..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 235899999999865311 0122456789999999999999999999754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-31 Score=258.24 Aligned_cols=184 Identities=28% Similarity=0.444 Sum_probs=161.3
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.+.|++.++||+|.|+.||++.+ .+|+.+|+|++...+-. ....+++.+|++|.+.|+||||++|.+...+...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~---~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc---cccHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 3467899999999999999999988 78999999988754332 2256789999999999999999999999999999
Q ss_pred EEEEEeccccCCHHH-HHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC---CcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~-lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~---g~vKI~DFGlAk~~~ 480 (514)
.|||+|++.|++|.. +.++.-+++..+..|++||+.+|.|+|.+||||||+||+|+|+-.. --+||+|||+|..+.
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999999875 5566778999999999999999999999999999999999999643 359999999999877
Q ss_pred cC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 481 SS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 481 ~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.. ....+....|||+.|++||-|+.|++||-+
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 33 125666789999999999999999999987
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=241.74 Aligned_cols=175 Identities=27% Similarity=0.416 Sum_probs=151.9
Q ss_pred eeecccCceeEEEEEccC----CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEe
Q 010231 335 DLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~----g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE 410 (514)
+.||+|+||.||+|.+.. +..+++|.+...... .....+.+|+.++..++|+||+++++++.....+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE----EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch----hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 469999999999999843 788999988753221 145678899999999999999999999999999999999
Q ss_pred ccccCCHHHHHhh----------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 411 LVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 411 y~~gGsL~~lL~~----------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
|+++++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+.
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999999875 458999999999999999999999999999999999999999999999999998765
Q ss_pred cCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 481 SSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 481 ~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
... ...++..+|+|||||++|+|++ |..||...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 421 1234457899999999999999 69999763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=240.88 Aligned_cols=181 Identities=26% Similarity=0.446 Sum_probs=153.2
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-CCeEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLYI 407 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~-~~~l~L 407 (514)
.|++.+.||+|+||.||++.+ .+++.+++|.+...... ......+.+|+.+++.++|+|++++++.+.. ...+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS---RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC---HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 488999999999999999997 56788999998643221 2334567889999999999999999988764 456899
Q ss_pred EEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
+|||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+....
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999999998865 248899999999999999999999999999999999999999999999999998654221
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+|||||++|+|++|..||.+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 122335689999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=271.29 Aligned_cols=185 Identities=26% Similarity=0.435 Sum_probs=158.5
Q ss_pred ccccccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEec
Q 010231 322 GRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (514)
Q Consensus 322 ~~~~~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~ 400 (514)
..++.....|+++++||.|+.+.||++...+.+.||+|.+..... ..+.+..+.+||.+|.+| .|.+|++||++-.
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~---D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA---DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc---CHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 345555668999999999999999999998888999998765332 245677899999999999 5999999999999
Q ss_pred CCCeEEEEEeccccCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 401 DESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~~~--lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.+.++||||||-+. +|..+|+++. +....++.|+.|||.+++++|++||||.||||.|+|+ -.|.+||+|||+|..
T Consensus 431 ~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 431 TDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANA 508 (677)
T ss_pred cCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcc
Confidence 99999999998754 8999998765 3434889999999999999999999999999999999 789999999999998
Q ss_pred cccCCC--------------------------------cCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 479 FLSSLD--------------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 479 ~~~~~~--------------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
+..+.. ......+||||||||||+|+.|+.||.
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 764410 114468999999999999999999996
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=242.38 Aligned_cols=180 Identities=36% Similarity=0.631 Sum_probs=157.7
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.+.||+|+||.||++.+ .++..|++|.++..... ......+.+|+.+++.++|+||+++++.+...+.+++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 488999999999999999987 57889999998754322 34567889999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC---
Q 010231 409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD--- 484 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~--- 484 (514)
+||+.+++|.+++... .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++..+.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999999998764 478888999999999999999999999999999999999999999999999886532211
Q ss_pred -----------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 485 -----------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 485 -----------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
......+|+|+|||++|+|++|+.||.+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 1145678999999999999999999965
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=271.37 Aligned_cols=183 Identities=23% Similarity=0.424 Sum_probs=157.3
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|..++.||-|+||+|.+++. .+...||+|.+...+. ..+....+++.|..||.....+-||+||..|++.+.+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV--l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV--LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH--HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 4688999999999999999976 5677899998764332 334456778899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc---cC-
Q 010231 408 FLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL---SS- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~-lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~---~~- 482 (514)
||+|++||++..+|.+.+ |.+..++.|+.++..|++++|..|+|||||||+|||||.+|+|||+|||||+=+. ++
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999999999999887765 6666778899999999999999999999999999999999999999999997431 10
Q ss_pred ---------------------------------------------------------CCcCcceeehhhhHHHHHHHHHh
Q 010231 483 ---------------------------------------------------------LDFDLLLIFSIFLNGCKFFLIFL 505 (514)
Q Consensus 483 ---------------------------------------------------------~~~~~~~~~DVwSlG~lLyeLlt 505 (514)
....++..||+|+.|+|||+|+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 01344557999999999999999
Q ss_pred CCCCCCCC
Q 010231 506 HVLIFRPP 513 (514)
Q Consensus 506 G~~PF~g~ 513 (514)
|++||...
T Consensus 867 g~~pf~~~ 874 (1034)
T KOG0608|consen 867 GQPPFLAD 874 (1034)
T ss_pred CCCCccCC
Confidence 99999765
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=246.97 Aligned_cols=179 Identities=28% Similarity=0.495 Sum_probs=150.8
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecC----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD---- 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~---- 401 (514)
.+.|.+.+.||+|+||.||+|.+ .+++.+|+|.+..... ....+.+|+.++..+ +|+||+++++.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 34678889999999999999987 5788999998864321 124567899999888 69999999998764
Q ss_pred --CCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCc
Q 010231 402 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (514)
Q Consensus 402 --~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlA 476 (514)
...+|+||||+.+++|.+++... .+++..+..++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 34689999999999999988752 4788999999999999999999999999999999999999999999999999
Q ss_pred eecccCC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 477 KVFLSSL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 477 k~~~~~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....... ...+...+|+|||||++|+|++|..||..
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7542110 12344579999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=250.06 Aligned_cols=181 Identities=22% Similarity=0.290 Sum_probs=151.9
Q ss_pred cceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
..|++.+.||+|+||.||+|.+. .+..||+|++.... .......+.+|+.++..++|+||+++++.+...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 46788999999999999999863 35789999886422 123346678899999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC
Q 010231 403 SKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~-----------------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~ 465 (514)
..+++++||+.+++|.+++.. ..++...+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 999999999999999998742 236777889999999999999999999999999999999999
Q ss_pred CcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 466 GSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 466 g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+.+||+|||+++...... ...++..+|||||||++|+|++ |..||.+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999987543211 1234457899999999999998 88898763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=248.25 Aligned_cols=181 Identities=26% Similarity=0.358 Sum_probs=153.2
Q ss_pred ccceEeeeeecccCceeEEEEEcc-----------------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~-----------------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp 390 (514)
.++|++++.||+|+||.||++.+. .+..||+|.+..... ......+.+|+.+++.++|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS----DNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC----HHHHHHHHHHHHHHHhcCCC
Confidence 357899999999999999999763 224578898764221 23456788999999999999
Q ss_pred ceeEEEEEecCCCeEEEEEeccccCCHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010231 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458 (514)
Q Consensus 391 nIv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~ 458 (514)
||+++++++.....++++|||+.+++|..++... .+++..+..++.||+.||.|||++||+||||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 9999999999999999999999999999988654 3788899999999999999999999999999999
Q ss_pred CEEEcCCCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh--CCCCCCC
Q 010231 459 NILVDANGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL--HVLIFRP 512 (514)
Q Consensus 459 NILId~~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt--G~~PF~g 512 (514)
||+++.++.++|+|||+++.+... ....++..+|||||||++|+|++ +..||..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999999999999998854221 01234567999999999999998 7788865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=250.15 Aligned_cols=180 Identities=24% Similarity=0.344 Sum_probs=150.4
Q ss_pred cceEeeeeecccCceeEEEEEcc-----------------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~-----------------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn 391 (514)
++|++.+.||+|+||.||++.+. ++..+|+|.+.... .......+.+|+.+++.++|+|
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA----NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCC
Confidence 46899999999999999998542 24468888876421 1233467889999999999999
Q ss_pred eeEEEEEecCCCeEEEEEeccccCCHHHHHhhcC------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 010231 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN 459 (514)
Q Consensus 392 Iv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~------------lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N 459 (514)
|+++++++...+.+|+||||+.+++|.+++.... ++...+..++.||+.||.|||++||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999886532 5567899999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh--CCCCCCC
Q 010231 460 ILVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL--HVLIFRP 512 (514)
Q Consensus 460 ILId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt--G~~PF~g 512 (514)
||++.++.++|+|||+++.+.... ...++...|+|||||++|+|++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999998643211 1223457899999999999998 7788864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=247.97 Aligned_cols=182 Identities=25% Similarity=0.395 Sum_probs=154.3
Q ss_pred ceEeeeeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCe
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 404 (514)
.|++.+.||+|+||.||++.+ .+|..||+|.+..... .......+.+.+|+.++..+ +|+||+++++.+..+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 478899999999999999987 3788999999864221 11223345677899999999 59999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 9999999999999998865 458899999999999999999999999999999999999999999999999998654321
Q ss_pred ----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
........|+|+|||++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 01234578999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=258.74 Aligned_cols=181 Identities=25% Similarity=0.373 Sum_probs=150.3
Q ss_pred ccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEec
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~ 400 (514)
.++|+++++||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|+.++..+ .|+||+++++++.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----TASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 35799999999999999999964 245789999876321 123345677899999999 7999999999875
Q ss_pred C-CCeEEEEEeccccCCHHHHHhh--------------------------------------------------------
Q 010231 401 D-ESKLYIFLELVTKGSLLNLYQR-------------------------------------------------------- 423 (514)
Q Consensus 401 ~-~~~l~LVmEy~~gGsL~~lL~~-------------------------------------------------------- 423 (514)
. ...++++|||+++++|.+++..
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 4678999999999999988753
Q ss_pred ------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------------
Q 010231 424 ------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------------- 482 (514)
Q Consensus 424 ------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------------- 482 (514)
..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 14678889999999999999999999999999999999999999999999999865211
Q ss_pred ------CCcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 483 ------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 483 ------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
....++.+.|||||||+||+|++ |..||.+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 11234457899999999999997 9999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=250.82 Aligned_cols=180 Identities=23% Similarity=0.347 Sum_probs=150.5
Q ss_pred cceEeeeeecccCceeEEEEEccC---------------CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCcee
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDD---------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~---------------g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv 393 (514)
++|++.+.||+|+||.||++++.. ...||+|.+.... .......+.+|+.+++.++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 578999999999999999997632 2358899876321 123345688999999999999999
Q ss_pred EEEEEecCCCeEEEEEeccccCCHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCE
Q 010231 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRY-------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460 (514)
Q Consensus 394 ~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~-------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI 460 (514)
++++++...+.+|+||||+.+++|.+++... .+.+..+..++.||+.||.|||++|++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 9999999999999999999999999988543 256778889999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh--CCCCCCC
Q 010231 461 LVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL--HVLIFRP 512 (514)
Q Consensus 461 LId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt--G~~PF~g 512 (514)
|++.++.+||+|||++..+.... ...++..+|+|||||++|+|++ +..||..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999997542210 1234568999999999999988 6778864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=241.61 Aligned_cols=178 Identities=29% Similarity=0.494 Sum_probs=156.5
Q ss_pred cceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|++.+.||+|+||.||++.+. ++..+++|.+.... ..+.+.+|+.+++.++|+||+++++.+.....+|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 57889999999999999999985 47899999886421 15678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
+|||+.+++|.+++.. ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++..+....
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999999999999864 458899999999999999999999999999999999999999999999999988654321
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++.++|+|+|||++|+|++|..||...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 122335689999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=257.14 Aligned_cols=182 Identities=29% Similarity=0.496 Sum_probs=153.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC---
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--- 402 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--- 402 (514)
+.++|++.++||+|+||.||+|++ .+|+.||+|.+..... ......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH----QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 356899999999999999999987 6789999998864221 22345677899999999999999999876543
Q ss_pred --CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 --SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 --~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
..+|+||||+.+ +|..++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 79 SFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred ccceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 458999999975 88888888889999999999999999999999999999999999999999999999999987643
Q ss_pred cC-----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SS-----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~-----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ....++..+|||||||++|+|++|++||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 0123445789999999999999999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=254.07 Aligned_cols=182 Identities=26% Similarity=0.377 Sum_probs=152.0
Q ss_pred ccceEeeeeecccCceeEEEEEcc--------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT 398 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~--------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~ 398 (514)
..+|++++.||+|+||.||+|.+. .+..+|+|.+... ........+.+|+.+++++ +|+||++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 457999999999999999999752 2246899977632 1223456788999999999 79999999999
Q ss_pred ecCCCeEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEE
Q 010231 399 DKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461 (514)
Q Consensus 399 ~~~~~~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NIL 461 (514)
+.....+|++|||+++|+|.+++... .++...+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 99999999999999999999998642 2566778889999999999999999999999999999
Q ss_pred EcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 462 VDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 462 Id~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
++.++.+||+|||+++.+.... ...+...+|||||||++|+|++ |..||.+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999998643210 1223347899999999999998 89999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=247.04 Aligned_cols=180 Identities=30% Similarity=0.423 Sum_probs=154.7
Q ss_pred cceEeeeeecccCceeEEEEEc-----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC--
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-- 401 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~-- 401 (514)
.+|++.+.||+|+||.||++.+ .++..+|+|.+...... .....+.+|+.+++.+.|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 4678889999999999999985 34789999988743221 345678999999999999999999998876
Q ss_pred CCeEEEEEeccccCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~~--lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
....++||||+++++|.+++.... ++...+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 567999999999999999997654 899999999999999999999999999999999999999999999999999876
Q ss_pred ccCC----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 480 LSSL----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 480 ~~~~----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.... ...+....|+|||||++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 5210 12344578999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=245.36 Aligned_cols=174 Identities=22% Similarity=0.316 Sum_probs=143.4
Q ss_pred eeecccCceeEEEEEcc---CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEec
Q 010231 335 DLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~---~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy 411 (514)
+.||+|+||.||+|... ++..+++|.+..... ......+.+|+.+++.++|+||+++++.+.+...+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS----VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 35899999999999763 446788887764321 22234678899999999999999999999999999999999
Q ss_pred cccCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 412 VTKGSLLNLYQRY------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 412 ~~gGsL~~lL~~~------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
+++|+|.+++... ......+..++.|++.||.|||+++|+|+||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999999988642 24556778899999999999999999999999999999999999999999986432110
Q ss_pred --------------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 484 --------------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 484 --------------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
...++.++|+|||||++|+|++ |..||..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 0123567899999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=251.24 Aligned_cols=186 Identities=25% Similarity=0.387 Sum_probs=155.8
Q ss_pred ccccccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEE
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~ 396 (514)
+.-..++|.+.+.||+|+||.||++.+ .++..+|+|.++.... ....+.+.+|+.+++++ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~ 105 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----SSEREALMSELKIMSHLGNHENIVNLL 105 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC----hHHHHHHHHHHHHHHhccCCCCcceEE
Confidence 333456899999999999999999974 2455789998764221 22346788999999999 799999999
Q ss_pred EEecCCCeEEEEEeccccCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEec
Q 010231 397 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (514)
Q Consensus 397 ~~~~~~~~l~LVmEy~~gGsL~~lL~~~~---lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DF 473 (514)
+.+...+.+|+||||+.+|+|.+++.... +++..+..|+.||+.||.|||+++|+|+||||+|||++.++.+||+||
T Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999999987532 789999999999999999999999999999999999999999999999
Q ss_pred cCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 474 GLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 474 GlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
|+++.+.... ...++..+|||||||++|+|++ |..||...
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 9998653221 1122346899999999999998 99998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=243.71 Aligned_cols=183 Identities=36% Similarity=0.577 Sum_probs=155.7
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEeccccc-----chhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG-----SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~-----~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
+|.+.+.||.|+||.||+|.+ .+++.+|+|.+...... .......+.+.+|+.+++.++|+||+++++.+...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999987 57889999988642111 112233467888999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+++||||+.+++|.+++.. ..++...+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999998876 45888899999999999999999999999999999999999999999999999754321
Q ss_pred C----------------------C-cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 L----------------------D-FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ~----------------------~-~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
. . ..+...+|+||||+++|+|++|..||..
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 0 0 1245678999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=243.29 Aligned_cols=181 Identities=25% Similarity=0.386 Sum_probs=152.8
Q ss_pred cceEeeeeecccCceeEEEEEcc-CC---ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD-DG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~-~g---~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
++|+..+.||+|+||.||+|... ++ ..+++|.+.... .....+.+.+|+.+++.++|+||+++++.+...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 47888999999999999999873 33 368888776421 12234568899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.|+||||+++++|..++... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999998653 5888999999999999999999999999999999999999999999999999865321
Q ss_pred C----------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 L----------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 ~----------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
. ...++...|+|||||++|+|++ |..||...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 1 1223346899999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=245.72 Aligned_cols=179 Identities=24% Similarity=0.422 Sum_probs=147.3
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHH-HhhcCCCceeEEEEEecCCCeEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
++|++.+.||+|+||.||++.+ .+|..||+|.++..... .....+..|+.+ ++.+.|+||+++++.+...+.+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS----QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc----HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 3689999999999999999998 57999999988753221 112334455554 66778999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
++|||++ |+|..++.. ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+.
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999997 578777653 2588999999999999999999997 99999999999999999999999999988643
Q ss_pred cCC----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 481 SSL----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 481 ~~~----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
... ...++..+|+|+|||++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 210 02234678999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=253.91 Aligned_cols=181 Identities=25% Similarity=0.403 Sum_probs=156.8
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|.....||+|+||.||++.+ .++..||||.+... .......+.+|+.+++.++|+||+++++.+...+..|
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 45666678899999999999987 57889999987642 1233456889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
+||||+++++|.+++....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+....
T Consensus 96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 99999999999999887789999999999999999999999999999999999999999999999999987543211
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++...|+||||+++|+|++|..||...
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 221 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123456799999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=241.89 Aligned_cols=178 Identities=21% Similarity=0.348 Sum_probs=153.4
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.+|++.+.||+|+||.||++.+..+..+|+|.+..... ....+.+|+.+++.+.|+||+++++.+......|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 47889999999999999999887788899998763221 124577899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
|||+.+++|.+++... .+++..+..++.|++.+|.|||+++|+|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999988653 47889999999999999999999999999999999999999999999999987543210
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
...+...+|+|||||++|+|++ |..||..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 1233446899999999999998 9999974
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=249.20 Aligned_cols=178 Identities=29% Similarity=0.468 Sum_probs=150.3
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.+.||+|+||.||+|++ .+|..+++|.+...... ......+.+|+.+++.++|+||+++++++.+...+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc---ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 488899999999999999998 57899999988753221 11224567899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
|||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.+....
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 999975 77777654 458999999999999999999999999999999999999999999999999998653210
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
...+...+|||||||++|+|++|..||.
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 1123557899999999999999988853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=270.16 Aligned_cols=180 Identities=34% Similarity=0.544 Sum_probs=162.6
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.|...++||+|+||.||+|.+ .+++.||||++.+ ...+..++.+++|+.+|.+++++||.++|+.+..+..+|++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~L----e~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDL----EEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEech----hhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 566779999999999999998 7899999999986 34455678899999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhcCC-CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-----
Q 010231 409 LELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS----- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~~l-se~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~----- 482 (514)
||||.||++.++++..++ .+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+-.+...
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 999999999999998776 88888999999999999999999999999999999999999999999999876544
Q ss_pred --------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 --------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 --------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....|..+.||||||++.|||.+|.+||...
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 1235667899999999999999999999753
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=242.90 Aligned_cols=177 Identities=27% Similarity=0.465 Sum_probs=150.8
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.+.|++.+.||+|+||.||++.. ++..+|+|.+.... ....+.+|+.+++.++|+||+++++.+... ..|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 46799999999999999999874 67789999876321 235678899999999999999999988654 5799
Q ss_pred EEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
||||+.+++|.+++... .++...+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence 99999999999998653 4788889999999999999999999999999999999999999999999999864322
Q ss_pred --------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 --------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 --------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
....++...|+|||||++|+|++ |++||.+.
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 11344457899999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=249.08 Aligned_cols=181 Identities=25% Similarity=0.363 Sum_probs=156.3
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|++.+.||+|+||+||++.+ .++..||+|++.... .......+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC----cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 5788999999999999999998 578899999876422 12334678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
||||+++++|..++.+. .+++..+..++.|++.+|.|||+ ++|+|+||||+||+++.++.++|+|||++..+...
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence 99999999999988764 58899999999999999999997 68999999999999999999999999998754211
Q ss_pred --------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 --------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 --------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|+|||||++|+|++|+.||...
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 1224456899999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=245.20 Aligned_cols=184 Identities=26% Similarity=0.440 Sum_probs=153.0
Q ss_pred ccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEe--
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD-- 399 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~-- 399 (514)
+....++|++.+.||+|+||.||++.+ .++..+|+|++.... .....+.+|+.+++.+ +|+||+++++++
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344567899999999999999999988 568899999875321 1124567899999998 699999999987
Q ss_pred ---cCCCeEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEE
Q 010231 400 ---KDESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA 471 (514)
Q Consensus 400 ---~~~~~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~ 471 (514)
...+.+|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 345679999999999999987642 347888899999999999999999999999999999999999999999
Q ss_pred eccCceecccCC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 472 DFGLAKVFLSSL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 472 DFGlAk~~~~~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|||+++.+.... ...++..+|+|||||++|+|++|..||...
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 999997643210 112456789999999999999999998653
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=242.66 Aligned_cols=174 Identities=28% Similarity=0.446 Sum_probs=148.1
Q ss_pred eeecccCceeEEEEEccC--C--ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEe
Q 010231 335 DLLGRGSFGSVYEGISDD--G--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~--g--~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE 410 (514)
++||+|+||.||+|.+.. + ..+|+|.+...... ...+.+.+|+.++++++|+||+++++.+.. ..+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 468999999999998732 3 36899987642221 456788899999999999999999999888 89999999
Q ss_pred ccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC----
Q 010231 411 LVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL---- 483 (514)
Q Consensus 411 y~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~---- 483 (514)
|+++++|.+++... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++.+....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999999998764 47889999999999999999999999999999999999999999999999998764310
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...++..+|||||||++|+|++ |..||...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1233456899999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=249.55 Aligned_cols=181 Identities=27% Similarity=0.412 Sum_probs=157.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|.+.+.||+|+||.||++.+ .++..|++|.+..... .....+.+|+.+++.++||||+++++.+...+..|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 46889999999999999999987 5788899998764221 22356788999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
+||||+++++|.+++.+..++...+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..+....
T Consensus 93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred EEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999886543211
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|+|+|||++|+|++|..||...
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123445799999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=242.77 Aligned_cols=174 Identities=23% Similarity=0.403 Sum_probs=146.8
Q ss_pred eecccCceeEEEEEc---cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEecc
Q 010231 336 LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~---~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
.||+|+||.||+|.+ .++..+|+|+++... ......+.+.+|+.+++.+.|+||+++++.+. ....++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence 589999999999975 467889999876432 22334567889999999999999999999875 45678999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC-------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD------- 484 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~------- 484 (514)
++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||+++.+.....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999998865 4689999999999999999999999999999999999999999999999999976532210
Q ss_pred ---------------cCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 485 ---------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 485 ---------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
..+....|+|||||++|+|++ |..||...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 123347999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=245.60 Aligned_cols=182 Identities=23% Similarity=0.311 Sum_probs=154.0
Q ss_pred ccceEeeeeecccCceeEEEEEccC-----CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDD-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD- 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~-----g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~- 401 (514)
.++|++.+.||+|+||.||+|.+.. +..|++|.+... ........+.+|+.+++.+.|+||+++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 4579999999999999999999854 688899987532 223345678899999999999999999997655
Q ss_pred CCeEEEEEeccccCCHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEe
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~---------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~D 472 (514)
....+++++|+.+++|..++.. ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5678999999999999998865 3478889999999999999999999999999999999999999999999
Q ss_pred ccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 473 FGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 473 FGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
||+++.+... ....++..+|||||||++|+|++ |.+||...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 9999865321 01234467999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=241.30 Aligned_cols=174 Identities=24% Similarity=0.402 Sum_probs=146.3
Q ss_pred eeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEe
Q 010231 335 DLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE 410 (514)
++||+|+||.||+|.+. .+..+|+|.+...... .....+.+|+.+++.+.|+||+++++++. .+.+++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 46999999999999762 2368999987643221 34467889999999999999999999876 456899999
Q ss_pred ccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC-----
Q 010231 411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD----- 484 (514)
Q Consensus 411 y~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~----- 484 (514)
|+.+++|.+++... .+++..+..++.||+.+|.|||.++|+|+||||+|||++.++.+||+|||+++.+.....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999999999765 489999999999999999999999999999999999999999999999999986532211
Q ss_pred -----------------cCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 485 -----------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 485 -----------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
..++..+|+|||||++|+|++ |.+||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 223347899999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=246.01 Aligned_cols=178 Identities=28% Similarity=0.427 Sum_probs=149.9
Q ss_pred EeeeeecccCceeEEEEEcc-----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 332 QKGDLLGRGSFGSVYEGISD-----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 332 ~i~~~LG~GsfG~Vyka~~~-----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.+.||.|.||.||+|.+. .+..|+||.++.. ........+.+|+.++++++|+||+++++++.....++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS----SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT----SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc----cccccceeeeeccccccccccccccccccccccccccc
Confidence 46789999999999999875 4678999988531 22334678889999999999999999999999888899
Q ss_pred EEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-
Q 010231 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~- 482 (514)
+||||+++|+|.+++... .+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999775 6899999999999999999999999999999999999999999999999999877211
Q ss_pred --------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 --------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 --------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 01234568899999999999999 78998753
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=243.49 Aligned_cols=173 Identities=23% Similarity=0.366 Sum_probs=144.9
Q ss_pred eecccCceeEEEEEcc---CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEecc
Q 010231 336 LLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~~---~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
.||+|+||.||+|.+. ++..||+|.+... ......+.+.+|+.+++.++|+||+++++++.. ...++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeC
Confidence 3899999999999763 4567999987642 123344678899999999999999999998864 5789999999
Q ss_pred ccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-------
Q 010231 413 TKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL------- 483 (514)
Q Consensus 413 ~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~------- 483 (514)
++++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+....
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999998864 468999999999999999999999999999999999999999999999999997543210
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...+...+|+|||||++|+|++ |..||...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 1223447899999999999996 99999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=245.51 Aligned_cols=179 Identities=30% Similarity=0.487 Sum_probs=152.4
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.++||.|+||.||+|++ .++..||||++...... .....+.+|+.+++.++|+||+++++.+...+.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc----cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 488999999999999999998 57899999998753221 1224566899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 409 LELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~----~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
|||+.+ +|.+++... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 999986 788877543 4889999999999999999999999999999999999999999999999999754221
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|+|+|||++|+|++|..||.+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 0112345789999999999999999999764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=249.71 Aligned_cols=183 Identities=27% Similarity=0.454 Sum_probs=153.4
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--C
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--S 403 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--~ 403 (514)
..++|++.+.||+|+||.||+|.+ .+|..||+|.+....... .....+.+|+.++++++|+||+++++++... +
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 356899999999999999999998 578999999987532211 1122356799999999999999999988654 5
Q ss_pred eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+|+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+..
T Consensus 82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 68999999975 78887764 4588999999999999999999999999999999999999999999999999986542
Q ss_pred C--------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 482 S--------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 482 ~--------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ....+...+|+|||||++|+|++|++||.+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 0123456789999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=247.49 Aligned_cols=178 Identities=28% Similarity=0.433 Sum_probs=150.5
Q ss_pred cceEeeeeecccCceeEEEEEc-----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC-
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE- 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~- 402 (514)
..|++++.||+|+||.||++.. .++..||+|.++... .......+.+|+.+++.+.|+||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 3578899999999999999973 467889999876432 123346788999999999999999999988765
Q ss_pred -CeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 403 -SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 403 -~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..+++||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 5789999999999999998653 4788999999999999999999999999999999999999999999999999765
Q ss_pred ccCC----------------------CcCcceeehhhhHHHHHHHHHhCCCCC
Q 010231 480 LSSL----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIF 510 (514)
Q Consensus 480 ~~~~----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF 510 (514)
.... ...++..+|+|||||++|+|++++.|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 3211 123445799999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=248.40 Aligned_cols=182 Identities=26% Similarity=0.446 Sum_probs=154.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--Ce
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK 404 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--~~ 404 (514)
.+.|++.+.||.|+||.||+|.+ .++..+++|.++..... ......+.+|+.+++.++|+||+++++++... +.
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 46799999999999999999998 46889999998754322 22234566899999999999999999988776 88
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999999985 888887653 4899999999999999999999999999999999999999999999999999866443
Q ss_pred C--------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 L--------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ~--------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. .......+|+|||||++|+|++|.+||.+.
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 011345689999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=241.88 Aligned_cols=179 Identities=27% Similarity=0.490 Sum_probs=152.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCC---
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE--- 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~--- 402 (514)
.++|++.+.||+|+||.||+|.+ .+++.+++|.+..... ....+.+|+.+++.+ .|+||+++++.+...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch------hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 47899999999999999999998 5678999998864221 235678999999998 799999999998654
Q ss_pred ---CeEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEecc
Q 010231 403 ---SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 403 ---~~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFG 474 (514)
..+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.+||+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 458999999999999988754 358899999999999999999999999999999999999999999999999
Q ss_pred CceecccCC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 475 LAKVFLSSL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 475 lAk~~~~~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
++....... +..+...+|||+|||+||+|++|.+||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 987543210 12344578999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=245.76 Aligned_cols=182 Identities=25% Similarity=0.400 Sum_probs=155.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||+|.+ .+++.|++|.++.... .......+.+|+.+++.+.|+||+++++.+...+.+|+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 3699999999999999999998 4688999998764221 12334678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC--
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD-- 484 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~-- 484 (514)
||||++++.+..+..+ ..++...+..++.||+.||.|||+++|+|+||+|+||+++.++.+||+|||++..+.....
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9999998777666654 4589999999999999999999999999999999999999999999999999886543321
Q ss_pred ------------------c-CcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 485 ------------------F-DLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 485 ------------------~-~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. .++...|+||||+++|+|++|.+||.+.
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 4456789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=257.56 Aligned_cols=170 Identities=22% Similarity=0.238 Sum_probs=143.2
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|.+++.||+|+||.||+|++ .++..||+|.... .....|+.+++.++|+||+++++++......|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 4699999999999999999998 4678899996432 112468999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
||||+.+ +|..++.. ..+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 135 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 135 VLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred EEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence 9999964 78777754 45889999999999999999999999999999999999999999999999999743211
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIF 510 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF 510 (514)
....+...+|||||||++|+|+++..++
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1124456789999999999999754443
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=247.14 Aligned_cols=186 Identities=27% Similarity=0.454 Sum_probs=153.2
Q ss_pred ccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
+....+.|++.+.||+|+||.||+|.+ .+++.||||.+....... .....+.+|+.+++.++|+||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC---CchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 345567899999999999999999998 578999999886432211 1223456799999999999999999987654
Q ss_pred C--------eEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEe
Q 010231 403 S--------KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (514)
Q Consensus 403 ~--------~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~D 472 (514)
. ..|+||||+.+ +|..++... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence 3 46999999975 787777654 589999999999999999999999999999999999999999999999
Q ss_pred ccCceecccCC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 473 FGLAKVFLSSL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 473 FGlAk~~~~~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
||++..+.... ...+...+|+||||+++|+|++|++||.+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99997553211 011345789999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=246.98 Aligned_cols=181 Identities=30% Similarity=0.466 Sum_probs=154.3
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|++.++||+|+||.||+|.+ .+++.||+|.+...... ....+.+.+|+.+++.++|+||+++++++.....+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 3689999999999999999998 46899999987542221 1234567789999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
||||+.++.|..+... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+....
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 9999999988887654 358999999999999999999999999999999999999999999999999987643210
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...++..+|||||||++|+|++|.+||.+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 11234568999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=265.68 Aligned_cols=183 Identities=23% Similarity=0.336 Sum_probs=160.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|..-++||+|+||.||-+.. .+|+.||+|++.. +....+......++|-.+|..+..++||.+-.+|++.+.++
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~K--KRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDK--KRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHH--HHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 45688889999999999999987 7899999997643 22333444455678999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-c--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-
Q 010231 407 IFLELVTKGSLLNLYQR-Y--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~- 482 (514)
+||..|+||+|...|-+ . ++++..+..|+.+|+.||++||+.+||+|||||+|||+|..|+|.|+|+|||..+...
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999999999865533 3 6999999999999999999999999999999999999999999999999999987643
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.+..|....|+|+|||+||+|+.|+.||..
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 334577899999999999999999999974
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=275.02 Aligned_cols=188 Identities=30% Similarity=0.587 Sum_probs=161.3
Q ss_pred CCCCccccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEE
Q 010231 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396 (514)
Q Consensus 318 ~s~~~~~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~ 396 (514)
..|.++|.++ ..+||+|+|-+||+|.+ .+|..||.-.++..+. .+.....+++..|+.+|+.|+|+||+++|
T Consensus 35 ~~p~gRy~k~------~evLGrGafKtVYka~De~~giEVAWnqvk~~d~-~q~~~~leR~~~Ev~lLKsL~H~NIirfy 107 (632)
T KOG0584|consen 35 KDPTGRYLKF------DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV-TQSPEELERLYSEVHLLKSLKHPNIIRFY 107 (632)
T ss_pred cCCCCceeeh------hhhcccccceeeeeccccccchhhHHHHHhHHHh-hcChHHHHHHHHHHHHHccCCCCceeeee
Confidence 4556665544 57899999999999999 6788888877764333 34455678899999999999999999999
Q ss_pred EEecCCCe--EEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEcC-CCcEEE
Q 010231 397 GTDKDESK--LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKL 470 (514)
Q Consensus 397 ~~~~~~~~--l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId~-~g~vKI 470 (514)
+.|.+... +.+|+|++..|+|..|+++. .++...++.|++||+.||.|||++. |||||||++||+|+. .|.|||
T Consensus 108 ~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKI 187 (632)
T KOG0584|consen 108 DSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKI 187 (632)
T ss_pred eheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceee
Confidence 99887655 88999999999999999875 5899999999999999999999986 999999999999985 589999
Q ss_pred EeccCceecccC----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 471 ADFGLAKVFLSS----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 471 ~DFGlAk~~~~~----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+|+|||+....+ ....|....||||||+.|.||+|+.+||..
T Consensus 188 GDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 188 GDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred cchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 999999977544 235667789999999999999999999963
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=255.93 Aligned_cols=181 Identities=26% Similarity=0.381 Sum_probs=149.1
Q ss_pred ccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEec
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~ 400 (514)
.++|+++++||+|+||.||+|.+ .+++.||||.++... .......+.+|+.++..+ +|+||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 45799999999999999999974 457899999886422 122345678899999999 6899999999775
Q ss_pred C-CCeEEEEEeccccCCHHHHHhhc-------------------------------------------------------
Q 010231 401 D-ESKLYIFLELVTKGSLLNLYQRY------------------------------------------------------- 424 (514)
Q Consensus 401 ~-~~~l~LVmEy~~gGsL~~lL~~~------------------------------------------------------- 424 (514)
. ...+++||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 45689999999999999988542
Q ss_pred -------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 425 -------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 425 -------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
.++...+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 2466677889999999999999999999999999999999999999999999764211
Q ss_pred ------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 483 ------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 483 ------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
....++...|+|+|||++|+|++ |..||.+
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 01234457899999999999996 9999965
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=238.79 Aligned_cols=181 Identities=33% Similarity=0.523 Sum_probs=158.5
Q ss_pred cceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|+||.||+|.+. +++.|++|++...... .....+.+|+.++..++|+||+++++.+.....+|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 36889999999999999999984 6999999988753221 345678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC-
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD- 484 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~- 484 (514)
||||+++++|.+++.. ..+++..+..++.||+.+|.|||+ ++++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999999875 568999999999999999999999 9999999999999999999999999999987643211
Q ss_pred ------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 485 ------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 485 ------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..++...|+|+||+++|+|++|..||...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 12344789999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=244.77 Aligned_cols=175 Identities=25% Similarity=0.414 Sum_probs=144.5
Q ss_pred eeecccCceeEEEEEcc-CCc--eEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeEEEEEe
Q 010231 335 DLLGRGSFGSVYEGISD-DGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~-~g~--~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmE 410 (514)
++||+|+||.||+|.+. ++. .+++|.++.. ........+.+|+.++..+ .|+||+++++++...+.+|+|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 36899999999999873 443 4677776531 1123345678899999999 79999999999999999999999
Q ss_pred ccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEec
Q 010231 411 LVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (514)
Q Consensus 411 y~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DF 473 (514)
|+++|+|.+++... .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 99999999998653 3678889999999999999999999999999999999999999999999
Q ss_pred cCceecccC------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 474 GLAKVFLSS------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 474 GlAk~~~~~------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
|++...... ....++...|+|||||++|+|++ |..||.+.
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 998522110 11234457899999999999996 99999754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=246.19 Aligned_cols=179 Identities=27% Similarity=0.392 Sum_probs=151.7
Q ss_pred cceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.+|.+.++||+|+||.||++.. .++..+++|.+... .......+.+|+.+++.+.|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4688899999999999999964 24567888876532 233456788999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g 466 (514)
...|++|||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 9999999999999999988653 377888999999999999999999999999999999999999
Q ss_pred cEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 467 SVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 467 ~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
.+||+|||+++..... ....++..+|+|||||++|+|++ |.+||..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999754211 11233456899999999999998 9999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=243.03 Aligned_cols=180 Identities=26% Similarity=0.383 Sum_probs=152.2
Q ss_pred cceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
+.|++...||+|+||.||+|+.. +...+++|.+.... .......+.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK----DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc----chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 57889999999999999999863 34678888765322 122456688999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEe
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~----------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~D 472 (514)
...|+||||+++++|.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999998653 388999999999999999999999999999999999999999999999
Q ss_pred ccCceecccC--------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 473 FGLAKVFLSS--------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 473 FGlAk~~~~~--------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
||+++..... .........|||||||++|+|++ |..||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9998743211 11223456899999999999998 8889864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=237.85 Aligned_cols=180 Identities=30% Similarity=0.502 Sum_probs=155.6
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.+.||+|+||.||++.. .+++.|++|.+...... ......+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 488999999999999999987 57889999998753221 22345778999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|||+.+++|.+++... .+++..+..|+.||+.||.|||+++++|+||+|+|||++.++.++|+|||++..+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999999988653 47888999999999999999999999999999999999999999999999998654321
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....+...|+|||||++|+|++|..||..
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 12334578999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=242.29 Aligned_cols=180 Identities=27% Similarity=0.417 Sum_probs=150.7
Q ss_pred cceEeeeeecccCceeEEEEEccC----CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~----g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
..|.+.++||+|+||.||+|.+.+ ...++||.+..... ....+.+.+|+.+++.+.|+||+++++++.+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS----PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC----HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 468899999999999999998632 34688887754221 2344678899999999999999999998875 55
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.|+||||+++++|.+++... .++...+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 78999999999999999753 4789999999999999999999999999999999999999999999999998764321
Q ss_pred C--------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 L--------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 ~--------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
. ...++..+|+|||||++|+|++ |..||.+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 0 1233457899999999999985 99999764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=249.10 Aligned_cols=181 Identities=31% Similarity=0.477 Sum_probs=150.5
Q ss_pred ceEeeeeecccCceeEEEEEcc---CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--Ce
Q 010231 330 YWQKGDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK 404 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~---~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--~~ 404 (514)
.|++.+.||+|+||.||+|.+. ++..||+|.+..... ........+.+|+.++..++||||+++++.+... ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 4788999999999999999983 589999999875321 1122235567899999999999999999999888 88
Q ss_pred EEEEEeccccCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC----CCcEEEEecc
Q 010231 405 LYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA----NGSVKLADFG 474 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~----~g~vKI~DFG 474 (514)
+|+||||+.+ +|..++.. ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999986 56665532 14788899999999999999999999999999999999999 8999999999
Q ss_pred CceecccCCC-----------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 475 LAKVFLSSLD-----------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 475 lAk~~~~~~~-----------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+++.+..... ..+...+|+|||||++|+|++|++||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9886532211 12345689999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=244.31 Aligned_cols=175 Identities=24% Similarity=0.371 Sum_probs=148.5
Q ss_pred ecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccC
Q 010231 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (514)
Q Consensus 337 LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gG 415 (514)
||+|+||+||++.+ .+|..||+|.+..... ........+.+|+.+++.++|+||+++++.+...+.+|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 69999999999987 5788999998864221 11223445678999999999999999999999999999999999999
Q ss_pred CHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----------
Q 010231 416 SLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---------- 482 (514)
Q Consensus 416 sL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---------- 482 (514)
+|.+++... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..+...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence 999888653 5889999999999999999999999999999999999999999999999998754311
Q ss_pred --------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 --------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 --------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|+|+|||++|+|++|..||...
T Consensus 159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 0122445789999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=253.98 Aligned_cols=182 Identities=25% Similarity=0.383 Sum_probs=152.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC---
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--- 402 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--- 402 (514)
+.+.|++.+.||+|+||.||+|.+ .++..||+|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc---ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 467899999999999999999998 5889999998753211 122335567899999999999999999987643
Q ss_pred ---CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 403 ---~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..+|+||||+.+ +|.+++... ++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 357999999965 788777654 899999999999999999999999999999999999999999999999999865
Q ss_pred ccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ...+..++|||||||++|+|++|..||.+.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 4321 123445789999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=243.92 Aligned_cols=181 Identities=24% Similarity=0.377 Sum_probs=153.1
Q ss_pred ccceEeeeeecccCceeEEEEEcc-CCc----eEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD-DGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~-~g~----~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
..+|++++.||+|+||.||+|.+. +|. .+|+|.+.... .......+.+|+.++..+.|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 357899999999999999999863 333 57888765322 13445678899999999999999999999887
Q ss_pred CeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
...++||||+.+|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7899999999999999988753 58899999999999999999999999999999999999999999999999998653
Q ss_pred cCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 481 SSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 481 ~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
... ...+....|+|||||++|+|++ |..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 221 1233457999999999999998 99999763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=237.77 Aligned_cols=181 Identities=27% Similarity=0.430 Sum_probs=155.3
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.+.||+|+||.||++.+ .+++.+++|.+..... .......+.+|+.+++.++|+||+++++.+...+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 488999999999999999988 5788999999875322 223356788999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-cEEEEeccCceecccCC-
Q 010231 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-~vKI~DFGlAk~~~~~~- 483 (514)
|||+++++|.+++... .+++..+..++.|++.+|.|||++||+|+||||+||+++.++ .+||+|||++..+....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999998753 378899999999999999999999999999999999998654 68999999998654321
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+..+|+||||+++|+|++|..||.+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 122345799999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=251.94 Aligned_cols=179 Identities=26% Similarity=0.396 Sum_probs=154.4
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|.....||+|+||.||++.+ .++..||+|.+..... .....+.+|+.++..+.|+||+++++.+...+.+|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 3455566899999999999988 5789999998864221 223557889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC----
Q 010231 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL---- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~---- 483 (514)
||||+++++|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 96 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 96 LMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred EEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 9999999999998888789999999999999999999999999999999999999999999999999987543211
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...++..+|+|||||++|+|++|..||..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12344578999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=234.28 Aligned_cols=181 Identities=45% Similarity=0.716 Sum_probs=159.1
Q ss_pred ceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--CeEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKLY 406 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--~~l~ 406 (514)
+|++.+.||+|+||.||+|.+. ++..+++|.+...... ......+.+|+.+++.+.|+||+++++.+... ..++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 4788899999999999999985 7899999988754322 34457788999999999999999999999888 8999
Q ss_pred EEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC-
Q 010231 407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD- 484 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~- 484 (514)
+||||+.+++|.+++... .+++..+..++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 999999999999998765 789999999999999999999999999999999999999999999999999987654321
Q ss_pred --------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 485 --------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 485 --------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
......+|+|+||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12456799999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=243.68 Aligned_cols=180 Identities=27% Similarity=0.475 Sum_probs=151.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEec-----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK----- 400 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~----- 400 (514)
.+.|++.+.||.|+||.||+|.+ .+++.+|+|.+.... .....+..|+.++..+ .|+||+++++.+.
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE------DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 35788899999999999999998 678899999876421 2235577889998888 6999999999875
Q ss_pred -CCCeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCc
Q 010231 401 -DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (514)
Q Consensus 401 -~~~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlA 476 (514)
..+.+|++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 35679999999999999998865 24788888999999999999999999999999999999999999999999998
Q ss_pred eecccCC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 477 KVFLSSL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 477 k~~~~~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....... ...+...+|+|||||++|+|++|..||...
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 7532110 123445789999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=245.14 Aligned_cols=180 Identities=30% Similarity=0.481 Sum_probs=152.0
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++++.||.|+||.||+|++ .++..||||.+...... ......+.+|+.+++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc---cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 488999999999999999988 57889999988643221 12234677899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|||+. ++|..++.. ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++..+....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 99996 578887754 458899999999999999999999999999999999999999999999999987543210
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
........|+|||||++|+|+||..||.+.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 011245689999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=243.70 Aligned_cols=178 Identities=28% Similarity=0.383 Sum_probs=143.5
Q ss_pred eecccCceeEEEEEc-cCCceEEEEEEecccccchh-HHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccc
Q 010231 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~-~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~ 413 (514)
+||+|+||.||++.+ .+++.||+|.+......... ..........+.+++...|+||+.+++.+...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999988 57889999988643221111 1111111223345555689999999999999999999999999
Q ss_pred cCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---------
Q 010231 414 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--------- 483 (514)
Q Consensus 414 gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--------- 483 (514)
+++|..++.. ..+++..++.|+.|++.||.|||+++|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 160 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence 9999988865 358999999999999999999999999999999999999999999999999987543210
Q ss_pred ---------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ---------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ---------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++...|+|||||++|+|++|..||...
T Consensus 161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 123456789999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=260.06 Aligned_cols=185 Identities=24% Similarity=0.384 Sum_probs=152.7
Q ss_pred ccccccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEE
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYY 396 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~ 396 (514)
+....++|.+++.||+|+||.||+|++. .+..||+|+++.... ....+.+.+|+.+|..+. |+||++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR----SSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC----hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 3334567899999999999999999852 456899999874221 222346789999999997 99999999
Q ss_pred EEecCCCeEEEEEeccccCCHHHHHhhc----------------------------------------------------
Q 010231 397 GTDKDESKLYIFLELVTKGSLLNLYQRY---------------------------------------------------- 424 (514)
Q Consensus 397 ~~~~~~~~l~LVmEy~~gGsL~~lL~~~---------------------------------------------------- 424 (514)
+++.....+||||||+.+|+|.+++.+.
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 9999999999999999999999988542
Q ss_pred -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 010231 425 -----------------------------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (514)
Q Consensus 425 -----------------------------------------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP 457 (514)
.++...+..|+.||+.||.|||+++|+||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 145556788999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 458 ANILVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 458 ~NILId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
+|||++.++.+||+|||+++.+.... ...+....|+|||||++|+|++ |..||..
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999998653211 1223456899999999999998 8999965
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=245.44 Aligned_cols=181 Identities=24% Similarity=0.372 Sum_probs=152.3
Q ss_pred cceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
++|++.+.||+|+||.||++.+. ++..+|+|.+.... .......+.+|+.+++.+.|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 57899999999999999999863 56789999876321 123345688899999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhc-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY-----------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN 459 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~-----------------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N 459 (514)
..+|+||||+++++|.+++... .+++..+..++.||+.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 9999999999999999998642 25677889999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 460 ILVDANGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 460 ILId~~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
||++.++.+||+|||++..+... ....++..+|||||||++|+|++ |..||.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998754211 01233456899999999999997 88888653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=268.91 Aligned_cols=184 Identities=25% Similarity=0.329 Sum_probs=142.0
Q ss_pred ccccceEeeeeecccCceeEEEEEcc--CCceEEEEEEec------------ccccchhHHHHHHHHHHHHHHhhcCCCc
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSL------------LDQGSQAKQSISQLEQEIALLSRFEHEN 391 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~--~g~~vAIK~v~~------------~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn 391 (514)
.+.++|+++++||+|+||+||+|..+ ++...++|.+.. .+...........+.+|+.+|+.++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34678999999999999999998752 233333331110 0001112234456789999999999999
Q ss_pred eeEEEEEecCCCeEEEEEeccccCCHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC
Q 010231 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465 (514)
Q Consensus 392 Iv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~------lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~ 465 (514)
|+++++++...+..|+||+++.+ +|..++.... .....++.|+.||+.||.|||++|||||||||+||||+.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999999999999999999965 6666654322 3356678899999999999999999999999999999999
Q ss_pred CcEEEEeccCceecccCC--------------------CcCcceeehhhhHHHHHHHHHhCCCCC
Q 010231 466 GSVKLADFGLAKVFLSSL--------------------DFDLLLIFSIFLNGCKFFLIFLHVLIF 510 (514)
Q Consensus 466 g~vKI~DFGlAk~~~~~~--------------------~~~~~~~~DVwSlG~lLyeLltG~~PF 510 (514)
+.+||+|||+++.+.... ...+...+|||||||+||+|++|.+++
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999998654321 123445789999999999999988644
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=243.13 Aligned_cols=175 Identities=29% Similarity=0.390 Sum_probs=142.2
Q ss_pred eecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHH---HHHhhcCCCceeEEEEEecCCCeEEEEEec
Q 010231 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei---~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy 411 (514)
+||+|+||.||++.+ .++..+|+|.+.......... .....+|. .++....|+||+.+++.+...+.+|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH--HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 489999999999998 578899999886433221111 12223333 334445799999999999999999999999
Q ss_pred cccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--------
Q 010231 412 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-------- 482 (514)
Q Consensus 412 ~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-------- 482 (514)
+.+++|..++.. ..+++..+..|+.||+.||.|||+++|+||||||+|||++.++.++|+|||++..+...
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence 999999988865 45899999999999999999999999999999999999999999999999998654211
Q ss_pred ----------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 ----------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ----------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....+...+|+|||||++|+|++|..||.+
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 012345678999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=237.41 Aligned_cols=181 Identities=31% Similarity=0.471 Sum_probs=153.8
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec--CCCeEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLY 406 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~--~~~~l~ 406 (514)
+|++.+.||.|+||.||++.+ .++..+|+|.+..... .....+.+.+|+.+++.++|+||+++++.+. ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 488899999999999999987 6788999998864322 2333467889999999999999999998765 445789
Q ss_pred EEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCCEEEcCCCcEEEEeccCc
Q 010231 407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLH-----DQDVVHRDIKCANILVDANGSVKLADFGLA 476 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLH-----s~gIIHRDLKP~NILId~~g~vKI~DFGlA 476 (514)
++|||+++++|.+++.. ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 99999999999998864 35888999999999999999999 899999999999999999999999999999
Q ss_pred eecccCCC-------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 477 KVFLSSLD-------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 477 k~~~~~~~-------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..+..... ...+...|+|+||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 87643221 12335689999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=252.56 Aligned_cols=183 Identities=23% Similarity=0.409 Sum_probs=155.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC--
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-- 403 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~-- 403 (514)
+.++|++++.||+|+||.||++.+ .++..||+|.+.... ........+.+|+.+++.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 456899999999999999999987 678999999885322 12233456789999999999999999999887553
Q ss_pred ----eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 404 ----~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
.+|+||||+ +++|..++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 679999888778999999999999999999999999999999999999999999999999999865
Q ss_pred ccCCC-----------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSSLD-----------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~~~-----------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..... ...+...|+|+|||++|+|++|.+||.+.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43211 22456789999999999999999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=244.37 Aligned_cols=181 Identities=27% Similarity=0.420 Sum_probs=149.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCe--
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK-- 404 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~-- 404 (514)
++|++.+.||+|+||.||+|.+ .++..||+|.+...... ......+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE---EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc---cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 3689999999999999999998 57899999987643211 112345778999999995 6999999998876655
Q ss_pred ---EEEEEeccccCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-CCcEEEEecc
Q 010231 405 ---LYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFG 474 (514)
Q Consensus 405 ---l~LVmEy~~gGsL~~lL~~------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-~g~vKI~DFG 474 (514)
+|+||||+.+ +|..++.. ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78877643 24788999999999999999999999999999999999998 8999999999
Q ss_pred CceecccC--------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 475 LAKVFLSS--------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 475 lAk~~~~~--------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+++.+... ....+...+|+|+|||++|+|++|..||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 98864321 0123456799999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=242.39 Aligned_cols=179 Identities=30% Similarity=0.538 Sum_probs=153.4
Q ss_pred eEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--CeEEE
Q 010231 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKLYI 407 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--~~l~L 407 (514)
|++.+.||.|+||.||+|.+. +++.+|+|.+.... ........+.+|+.+++.++|+||+++++++... ..+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 678899999999999999984 68899999987532 1122335677899999999999999999999887 89999
Q ss_pred EEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
||||+.+ +|..++... .+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+....
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 78 VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred Eeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9999985 888887654 68999999999999999999999999999999999999999999999999998764331
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|||+|||++|+|++|..||...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 112345789999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=242.65 Aligned_cols=181 Identities=28% Similarity=0.441 Sum_probs=153.0
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC--CCeE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKL 405 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~--~~~l 405 (514)
+.|...+.||.|+||.||++.+ .+++.+|+|.+..... ......+.+|+.+++.++|+||+++++.+.. .+.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN----PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc----hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 3688999999999999999998 5788999998874321 2334668899999999999999999998754 4479
Q ss_pred EEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 406 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999999887653 347888999999999999999999999999999999999999999999999987533
Q ss_pred cCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... ...++..+|+|+|||++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 123445789999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=242.89 Aligned_cols=182 Identities=28% Similarity=0.455 Sum_probs=152.4
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCC-
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~- 402 (514)
...++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++..+ +|+||+++++.+...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3467899999999999999999998 678899999886321 1234567889999888 899999999987643
Q ss_pred ----CeEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEec
Q 010231 403 ----SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (514)
Q Consensus 403 ----~~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DF 473 (514)
..+|+||||+++++|.++++. ..+++..++.++.|++.||.|||+++|+|+||||+||+++.++.+||+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 468999999999999988752 45889999999999999999999999999999999999999999999999
Q ss_pred cCceecccCC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 474 GLAKVFLSSL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 474 GlAk~~~~~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|++..+.... +..++.++|+|||||++|+|++|++||...
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 9987543210 011356799999999999999999999753
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=237.08 Aligned_cols=175 Identities=25% Similarity=0.403 Sum_probs=150.2
Q ss_pred eeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEecccc
Q 010231 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK 414 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~g 414 (514)
++||+|+||.||++.+..++.|++|.+...... .....+.+|+.+++++.|+||+++++++......|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 469999999999999866999999987643221 3446788999999999999999999999999999999999999
Q ss_pred CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----------
Q 010231 415 GSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---------- 482 (514)
Q Consensus 415 GsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---------- 482 (514)
++|.+++.. ..++...+..++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999999865 34788889999999999999999999999999999999999999999999999754310
Q ss_pred -----------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 -----------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 -----------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
....++...|+|||||++|+|++ |..||...
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 01234457899999999999998 89998753
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=237.27 Aligned_cols=179 Identities=28% Similarity=0.461 Sum_probs=153.0
Q ss_pred eEeeeeecccCceeEEEEEccC-----CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 331 WQKGDLLGRGSFGSVYEGISDD-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~~~-----g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
+++.+.||.|+||.||++.+.. +..+|+|.+..... ......+.+|+.++..+.|+||+++++.+.+.+..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD----EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC----hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 3567889999999999998843 48899998864221 12456788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 406 YIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~---lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
|++|||+++++|.+++.... +++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||+++.....
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999999987533 899999999999999999999999999999999999999999999999999865432
Q ss_pred --------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 --------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 --------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
........+|+|+|||++|+|++ |.+||...
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01234457899999999999998 89998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=232.15 Aligned_cols=179 Identities=31% Similarity=0.513 Sum_probs=157.7
Q ss_pred ceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|.+.+.||+|+||.||++.+. ++..+++|++..... .....+.+|+.+++.+.|+||+++++.+......+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4788899999999999999984 788999998875322 3456788999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
|||+++++|.+++... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence 9999999999998765 68999999999999999999999999999999999999999999999999998765432
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...|+|+||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 122345799999999999999999999753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=238.91 Aligned_cols=175 Identities=27% Similarity=0.387 Sum_probs=151.6
Q ss_pred ecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccC
Q 010231 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (514)
Q Consensus 337 LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gG 415 (514)
||.|+||.||++++ .+++.+++|++..... ......+.+.+|+.+++.++|+||+++++.+.+.+.+|+||||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc--hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 79999999999998 4688999999864321 22234467889999999999999999999999999999999999999
Q ss_pred CHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-----------
Q 010231 416 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL----------- 483 (514)
Q Consensus 416 sL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~----------- 483 (514)
+|.+++.+. .++...+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||+++......
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCc
Confidence 999998764 57899999999999999999999999999999999999999999999999998765421
Q ss_pred -------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+....|+|+|||++|+|++|..||...
T Consensus 159 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 195 (262)
T cd05572 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195 (262)
T ss_pred cChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence 122345689999999999999999999764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=233.36 Aligned_cols=180 Identities=39% Similarity=0.641 Sum_probs=157.7
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.+.||+|+||.||++.+ .+++.|++|.+...... ......+.+|+.+++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC---HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 478899999999999999987 46789999998754322 24457789999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC---
Q 010231 409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD--- 484 (514)
Q Consensus 409 mEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~--- 484 (514)
|||+++++|.+++.. ..+++..+..++.|++.+|.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999999998876 4689999999999999999999999999999999999999999999999999987654321
Q ss_pred ----------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 485 ----------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 485 ----------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.......|+|+||+++|+|++|..||..
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1234579999999999999999999964
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=244.06 Aligned_cols=179 Identities=26% Similarity=0.378 Sum_probs=155.5
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---- 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~---- 402 (514)
.++|.+.+.||+|+|+-||++.. .++..||+|++.... .+.++..++|+...++++||||++++++....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 46899999999999999999997 789999999988532 45567788999999999999999998865433
Q ss_pred -CeEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEcCCCcEEEEecc
Q 010231 403 -SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 403 -~~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId~~g~vKI~DFG 474 (514)
...||+++|...|+|.+.++. ..+++.++..|+.+|+.||++||+.. +.||||||.|||+...+.++|+|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 349999999999999998754 25899999999999999999999998 9999999999999999999999999
Q ss_pred CceecccC-------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 475 LAKVFLSS-------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 475 lAk~~~~~-------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
.++...-. ..-..+.++|||||||+||+|++|..||.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 98864210 22345568999999999999999999996
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=244.95 Aligned_cols=182 Identities=25% Similarity=0.387 Sum_probs=154.1
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|++.+.||+|+||.||+|.+ .+++.||+|++..... ......+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc--CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 4688899999999999999988 5789999998864322 223344668899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
||||+.+ +|.+++. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++......
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~ 171 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF 171 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCCc
Confidence 9999975 6666654 346899999999999999999999999999999999999999999999999998754311
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|||+||+++|+|++|..||.+.
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 1123456799999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=274.35 Aligned_cols=173 Identities=36% Similarity=0.555 Sum_probs=151.2
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~ 413 (514)
-+||+|+||+||.|++ .+...+|||.+... .....+-+..||.+.+.|+|.|||+|+|.+..+.++-|+||-++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek-----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK-----DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc-----cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence 3699999999999999 56778999998742 23345678999999999999999999999999999999999999
Q ss_pred cCCHHHHHhh--cCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc-CCCcEEEEeccCceecc--cC----
Q 010231 414 KGSLLNLYQR--YHL--RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKVFL--SS---- 482 (514)
Q Consensus 414 gGsL~~lL~~--~~l--se~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId-~~g~vKI~DFGlAk~~~--~~---- 482 (514)
||+|..+++. ..+ ++.++..|.+||++||+|||++.|||||||-+|+||+ -.|.+||.|||.++.+- ++
T Consensus 656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9999999975 345 7888999999999999999999999999999999997 47899999999998753 12
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....|+...|||||||.+-||.||++||-.
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 224556688999999999999999999964
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=247.29 Aligned_cols=181 Identities=23% Similarity=0.395 Sum_probs=148.8
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCc----eEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~----~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.++|+..+.||+|+||.||+|.+ .++. .+|+|.+.... .......+.+|+.+++.+.|+||+++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT----GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 35788999999999999999987 4454 46777665321 122334678899999999999999999988754
Q ss_pred CeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
..++++||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 467999999999999988754 47888999999999999999999999999999999999999999999999998653
Q ss_pred cCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 481 SSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 481 ~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
... ...++..+|||||||++|+|++ |..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 211 1223346899999999999997 99999763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=244.41 Aligned_cols=184 Identities=30% Similarity=0.561 Sum_probs=153.2
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~- 403 (514)
...++|++.+.||+|+||.||+|.+ .+++.||+|.+...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc---cCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 4467899999999999999999998 46889999998753221 112245678999999999999999999887654
Q ss_pred ---------eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEe
Q 010231 404 ---------KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (514)
Q Consensus 404 ---------~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~D 472 (514)
.+|+||||+++ +|..++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 79999999987 66666654 3589999999999999999999999999999999999999999999999
Q ss_pred ccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 473 FGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 473 FGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
||++..+.... ...++..+|||+|||++|+|++|++||...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99998653211 112345789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=242.00 Aligned_cols=183 Identities=29% Similarity=0.495 Sum_probs=158.1
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCeEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLY 406 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~ 406 (514)
++|++.+.||+|+||.||++.+ .++..|++|++..... ........+.+|+.+++.+. |+||+++++++...+.++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL--IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc--cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 3689999999999999999998 5789999998864222 12233466788999999998 999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
+||||+.+++|.+++... .++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 999999999999998775 68999999999999999999999999999999999999999999999999988654321
Q ss_pred -------------------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -------------------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -------------------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+..+|+|+|||++|+|++|..||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 112345799999999999999999999864
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=250.67 Aligned_cols=184 Identities=27% Similarity=0.430 Sum_probs=154.2
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-- 402 (514)
.+.++|++.+.||+|+||.||++.+ .+++.||+|++.... ........+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 3457899999999999999999987 678999999886421 1122345677899999999999999999887532
Q ss_pred ----CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 403 ----~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
..+|++++++ +++|.++++...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 4578888887 67999888877899999999999999999999999999999999999999999999999999876
Q ss_pred cccCCC-----------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSLD-----------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~~-----------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...... ..+..++|+|||||++|+|++|++||...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 170 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred ccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 432210 23445799999999999999999999754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=240.79 Aligned_cols=178 Identities=29% Similarity=0.421 Sum_probs=147.2
Q ss_pred eEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCC--CeEE
Q 010231 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE--SKLY 406 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~--~~l~ 406 (514)
|++.+.||+|+||.||++.+ .++..||+|.++...... . .....+|+.++..+. |+||+++++++.+. +.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 67889999999999999997 578899999876432111 1 123346888888885 99999999999877 8899
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++. +.+||+|||+++.+....
T Consensus 77 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 77 LVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 99999975 77777654 35899999999999999999999999999999999999999 999999999998653221
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....+..+|+|||||++|+|++|.+||.+.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 1223467999999999999999999998653
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=237.48 Aligned_cols=177 Identities=28% Similarity=0.469 Sum_probs=145.8
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHH-HhhcCCCceeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
+.||+|+||.||+|.+ .+++.||+|.+...... .......+..|..+ .....|+||+++++.+...+.+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI--AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh--HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 5699999999999988 56889999988642211 11222333444443 45568999999999999999999999999
Q ss_pred ccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---------
Q 010231 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--------- 482 (514)
Q Consensus 413 ~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--------- 482 (514)
.+++|..+++. ..+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y 159 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDY 159 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcCc
Confidence 99999999876 46899999999999999999999999999999999999999999999999998764321
Q ss_pred ------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|+|+||+++|+|++|..||.+.
T Consensus 160 ~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred cChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 0122456799999999999999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=241.65 Aligned_cols=180 Identities=29% Similarity=0.447 Sum_probs=149.4
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++.+.||+|.||+||+|.+ .+++.||+|.+...... ......+.+|+.+++.++|+||+++++++.....+|+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 5799999999999999999998 47889999987643221 1223457789999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-CCcEEEEeccCceecccC-
Q 010231 408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-~g~vKI~DFGlAk~~~~~- 482 (514)
||||+.+ +|..++... .+++..+..++.||+.||.|||+++|+|+||||+||+++. ++.+||+|||++..+...
T Consensus 79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9999965 777766542 2577888899999999999999999999999999999985 567999999999754211
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....+...+|+|||||++|+|++|++||..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 012344578999999999999999999964
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=265.26 Aligned_cols=165 Identities=25% Similarity=0.419 Sum_probs=147.2
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccc
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~ 413 (514)
++-||.|+-|.||+|+.. ++.||||+|+. .-+.+|+-|++|+|+||+.+.|+|.....+|||||||.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 456999999999999875 56899997762 22367888999999999999999999999999999999
Q ss_pred cCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----------
Q 010231 414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---------- 482 (514)
Q Consensus 414 gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---------- 482 (514)
.|-|.++|+.. .+....+..|..+|+.||.|||.+.|||||||.-||||..+..|||+|||.++.+..-
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTV 275 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTV 275 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhH
Confidence 99999999864 5899999999999999999999999999999999999999999999999999876432
Q ss_pred --------CCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 483 --------LDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 483 --------~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
.+.....+.|||||||+||||+||+.||.
T Consensus 276 aWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk 312 (904)
T KOG4721|consen 276 AWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK 312 (904)
T ss_pred hhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence 24455678999999999999999999985
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=238.05 Aligned_cols=174 Identities=23% Similarity=0.398 Sum_probs=141.7
Q ss_pred eeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec-CCCeEEEEE
Q 010231 335 DLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-DESKLYIFL 409 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~-~~~~l~LVm 409 (514)
+.||+|+||.||+|.+. ....+|+|.+.... .......+.+|+.+++.++|+||+++++++. .++..|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC----CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 36899999999999862 34578999765321 1233567788999999999999999999765 456689999
Q ss_pred eccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-----
Q 010231 410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS----- 482 (514)
Q Consensus 410 Ey~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~----- 482 (514)
||+.+++|.+++... .+....+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999999998753 3567778889999999999999999999999999999999999999999999754211
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
....+...+|||||||++|+|++ |.+||..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 01233457899999999999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=240.98 Aligned_cols=173 Identities=17% Similarity=0.234 Sum_probs=138.8
Q ss_pred eecccCceeEEEEEccCCc---eEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEecc
Q 010231 336 LLGRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~~~g~---~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
.||+|+||.||++...++. .+++|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA----SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC----ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 5999999999999764433 34455444321 1233467889999999999999999999999999999999999
Q ss_pred ccCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc------
Q 010231 413 TKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS------ 481 (514)
Q Consensus 413 ~gGsL~~lL~~~-----~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~------ 481 (514)
++|+|.+++.+. .+....+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999988653 245567788999999999999999999999999999999999999999999863211
Q ss_pred ------------CC----------CcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 482 ------------SL----------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 482 ------------~~----------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
+. ....+...|||||||++|+|++ +..||..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 00 0122457899999999999996 5778864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=238.34 Aligned_cols=171 Identities=23% Similarity=0.308 Sum_probs=141.8
Q ss_pred eeecccCceeEEEEEccCCc-----------eEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 335 DLLGRGSFGSVYEGISDDGF-----------FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~-----------~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
+.||+|+||.||+|.+.... .+++|.+.... .....+.+|+.+++.++|+||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH------RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch------hhHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence 46999999999999984322 46667654321 114677889999999999999999999887 7
Q ss_pred eEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-------cEEEEecc
Q 010231 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------SVKLADFG 474 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-------~vKI~DFG 474 (514)
..++||||+.+|+|.+++... .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 789999999999999998754 488889999999999999999999999999999999999888 79999999
Q ss_pred CceecccC---------------CC--cCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 475 LAKVFLSS---------------LD--FDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 475 lAk~~~~~---------------~~--~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
++...... .. ..+...+|+|||||++|+|++ |..||..
T Consensus 154 ~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~ 209 (259)
T cd05037 154 IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209 (259)
T ss_pred cccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence 99874321 00 145567999999999999999 6888754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=242.04 Aligned_cols=178 Identities=26% Similarity=0.408 Sum_probs=154.2
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.|...+.||+|+||.||++.+ .++..+++|.+.... ....+.+.+|+.+++.+.|+||+++++.+...+..|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 345567899999999999987 578899999876422 22235578999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-----
Q 010231 409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL----- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~----- 483 (514)
+||+.+++|.+++....++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 95 MEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred EeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 999999999999988789999999999999999999999999999999999999999999999999887543221
Q ss_pred --------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 --------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 --------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...++.++|+|||||++|+|++|..||..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 12345679999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=240.75 Aligned_cols=179 Identities=26% Similarity=0.420 Sum_probs=156.0
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.+.||.|+||.||++.+ .+++.+++|.+..... ......+.+|+.+++.+.|+||+++++.+...+.+|++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 578889999999999999998 4789999998865321 23456788999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|||+.+++|.+++.. ..+++..+..++.||+.+|.|||+ .|++|+||||+||+++.++.++|+|||++..+...
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 999999999999875 468889999999999999999999 99999999999999999999999999998755321
Q ss_pred --------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 --------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 --------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....+...+|+|||||++|+|++|..||..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 201 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 112445679999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=237.75 Aligned_cols=175 Identities=29% Similarity=0.504 Sum_probs=150.9
Q ss_pred ecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccC
Q 010231 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (514)
Q Consensus 337 LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gG 415 (514)
||.|+||.||++++. +++.+++|.+..... ..+.....+.+|+.+++.++|+||+++++.+.....+|++|||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh--hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999984 699999998864322 22345677889999999999999999999999999999999999999
Q ss_pred CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-----------
Q 010231 416 SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL----------- 483 (514)
Q Consensus 416 sL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~----------- 483 (514)
+|.+++.. ..+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 99999876 468999999999999999999999999999999999999999999999999987543221
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
........|+|+|||++|+|++|..||...
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 112345789999999999999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-28 Score=232.20 Aligned_cols=181 Identities=30% Similarity=0.528 Sum_probs=158.0
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.+.||.|+||.||++.+ .++..+++|++...... ......+.+|+.+++.++|+|++++++.+.....+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS---EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC---hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 488999999999999999998 47889999988753322 33456678999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
|||+++++|..++.. ..++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999998865 458899999999999999999999999999999999999999999999999998754331
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
........|+|+||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 123456799999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=236.84 Aligned_cols=175 Identities=37% Similarity=0.557 Sum_probs=148.5
Q ss_pred eeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEec
Q 010231 333 KGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (514)
Q Consensus 333 i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy 411 (514)
....||+|+||.||+|.+ .++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++...+.+++||||
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 345799999999999997 567889999876421 22346788999999999999999999999999999999999
Q ss_pred cccCCHHHHHhhc--CC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-CCcEEEEeccCceecccC----
Q 010231 412 VTKGSLLNLYQRY--HL--RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 412 ~~gGsL~~lL~~~--~l--se~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-~g~vKI~DFGlAk~~~~~---- 482 (514)
+.+++|..++... .+ ....+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++..+...
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 9999999988753 34 77888899999999999999999999999999999986 679999999998754311
Q ss_pred ------------C-----CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 ------------L-----DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ------------~-----~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
. ...++..+|+||||+++|+|++|..||..
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 0 01245678999999999999999999964
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=238.63 Aligned_cols=180 Identities=24% Similarity=0.362 Sum_probs=147.3
Q ss_pred eEeeeeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC---
Q 010231 331 WQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--- 403 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~--- 403 (514)
|.+.+.||+|+||.||+|.+ .++..+|||.+..... .....+++.+|+.+++.+.||||+++++.+....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF---SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC---ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 56788999999999999985 3578999998864221 2233566889999999999999999999875432
Q ss_pred ---eEEEEEeccccCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEec
Q 010231 404 ---KLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (514)
Q Consensus 404 ---~l~LVmEy~~gGsL~~lL~~-------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DF 473 (514)
..+++++|+.+|+|..++.. ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence 34789999999999887642 13678889999999999999999999999999999999999999999999
Q ss_pred cCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 474 GLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 474 GlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
|+++.+.... ...++..+|||||||++|+|++ |.+||.+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 9998653221 1223456899999999999999 89998754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=239.16 Aligned_cols=174 Identities=23% Similarity=0.319 Sum_probs=142.3
Q ss_pred eeecccCceeEEEEEccC-------------CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 335 DLLGRGSFGSVYEGISDD-------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~-------------g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
+.||+|+||.||+|+..+ ...+++|.+... .......+.+|+.++..++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----HRDISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 368999999999998522 224677765431 22334567788999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc-------EEEEe
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-------VKLAD 472 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~-------vKI~D 472 (514)
....++||||+++++|..++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++. +|++|
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 8999999999999999888764 35889999999999999999999999999999999999987664 89999
Q ss_pred ccCceecccCC----------------CcCcceeehhhhHHHHHHHHH-hCCCCCCCC
Q 010231 473 FGLAKVFLSSL----------------DFDLLLIFSIFLNGCKFFLIF-LHVLIFRPP 513 (514)
Q Consensus 473 FGlAk~~~~~~----------------~~~~~~~~DVwSlG~lLyeLl-tG~~PF~g~ 513 (514)
||++..+.... ...++..+|||||||++|+|+ .|..||...
T Consensus 156 ~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 156 PGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred CCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 99987543210 233456789999999999998 689988653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=249.61 Aligned_cols=184 Identities=27% Similarity=0.414 Sum_probs=153.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCC-
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~- 402 (514)
.+.++|++.+.||+|+||.||+|.+ .++..+|+|.+..... .......+.+|+.+++++ +|+||+++++++...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR---NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC---cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 4567899999999999999999998 4688999998753211 112234567899999999 999999999987643
Q ss_pred -CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 403 -SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 403 -~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
..+|+||||+.+ +|..++....+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 81 DKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred CceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 468999999975 899988777788888999999999999999999999999999999999999999999999985532
Q ss_pred CC-------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 482 SL-------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 482 ~~-------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ...+...+|+|||||++|+|++|++||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 21 112345789999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=270.40 Aligned_cols=185 Identities=23% Similarity=0.325 Sum_probs=162.1
Q ss_pred ccceEeeeeecccCceeEEEEEccCC-ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g-~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
+.+++++..||-|+||.|-++..... ..+|+|+++.... ......+++..|-++|..++.++||++|.+|.+..++|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI--VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI--VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc--cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 45677788899999999998876433 3589998875433 33445678889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|+||-|-||.|+.+|+. ..+.+...+.|+.+++.|++|||++|||+|||||+|+|++.+|.+||.|||+|+++...
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 99999999999999976 45899999999999999999999999999999999999999999999999999988755
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.+..+....|.|+||+++|||++|.+||.+.|
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 23455568899999999999999999999875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=249.98 Aligned_cols=180 Identities=29% Similarity=0.478 Sum_probs=151.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---- 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~---- 402 (514)
..+|.+.+.||.|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.+++.++|+||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 46899999999999999999998 5789999998875332 2345678899999999999999998765443
Q ss_pred ----------CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-CCcEEEE
Q 010231 403 ----------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLA 471 (514)
Q Consensus 403 ----------~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-~g~vKI~ 471 (514)
..+|+||||+.+ +|..++....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 468999999974 8988888778999999999999999999999999999999999999984 5678999
Q ss_pred eccCceecccC-----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 472 DFGLAKVFLSS-----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 472 DFGlAk~~~~~-----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|||+++.+... ....+..++|+|||||++|+|++|+.||.+.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999754211 0122345789999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=239.86 Aligned_cols=180 Identities=30% Similarity=0.469 Sum_probs=157.8
Q ss_pred ccceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|+..+.||+|+||.||++.+. ++..+++|.+..... ....+.+|+.+++.++|+||+++++.+...+..|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 456888899999999999999984 788999999875322 3466788999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
+||||+.+++|.+++... .++...+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999999876 6899999999999999999999999999999999999999999999999987654321
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|+|+|||++|+|++|..||...
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 1123456799999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=241.17 Aligned_cols=172 Identities=20% Similarity=0.234 Sum_probs=140.4
Q ss_pred eecccCceeEEEEEcc-------------------------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCC
Q 010231 336 LLGRGSFGSVYEGISD-------------------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~~-------------------------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp 390 (514)
.||+|+||.||+|... ....|++|.+.. ........+.+|+.+++.++|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP-----SHRDIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh-----HHHHHHHHHHHHHHHHhcCCCC
Confidence 5999999999999741 113477777643 1223345677889999999999
Q ss_pred ceeEEEEEecCCCeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC--
Q 010231 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-- 466 (514)
Q Consensus 391 nIv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-- 466 (514)
||+++++++......||||||+++|+|..++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++..+
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999999988864 4588899999999999999999999999999999999997654
Q ss_pred -----cEEEEeccCceecccC----------------CCcCcceeehhhhHHHHHHHHH-hCCCCCCC
Q 010231 467 -----SVKLADFGLAKVFLSS----------------LDFDLLLIFSIFLNGCKFFLIF-LHVLIFRP 512 (514)
Q Consensus 467 -----~vKI~DFGlAk~~~~~----------------~~~~~~~~~DVwSlG~lLyeLl-tG~~PF~g 512 (514)
.+||+|||++...... ....+...+|+|||||++|+|+ +|..||..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred cCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 4899999988643211 0123456799999999999995 79999965
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=233.58 Aligned_cols=181 Identities=31% Similarity=0.464 Sum_probs=156.2
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.+.||+|+||.||++.+ .+++.+++|.+...... ......+.+|+.+++.++|+||+++++.+.+....|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS---QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc---HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 488899999999999999987 57889999988743221 23345677899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
|||+++++|..++.+ ..+++..+..++.||+.||.|||++|++|+||+|.||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999998865 458888999999999999999999999999999999999999999999999998654321
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+|+||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122345799999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=234.70 Aligned_cols=181 Identities=29% Similarity=0.506 Sum_probs=154.0
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|++.+.||+|+||.||++.+ .++..+|+|.+...... ......+.+|+.+++.++|+||+++++.+.....+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP---VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc---chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 488999999999999999998 56888999988753221 12235677899999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-cEEEEeccCceecccCC-
Q 010231 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-~vKI~DFGlAk~~~~~~- 483 (514)
|||+++++|.+++... .+++..+..|+.||+.||.|||+++|+|+||||+||+++.++ .+||+|||++..+....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999988653 378899999999999999999999999999999999999886 46999999987654321
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+....|+|||||++|+|++|..||.+.
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 122335789999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-28 Score=241.89 Aligned_cols=185 Identities=21% Similarity=0.271 Sum_probs=137.9
Q ss_pred ccceEeeeeecccCceeEEEEEccC----CceEEEEEEecccccchhHHH------HHHHHHHHHHHhhcCCCceeEEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQS------ISQLEQEIALLSRFEHENIVQYYG 397 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~----g~~vAIK~v~~~~~~~~~~~~------~~~l~~Ei~iL~~L~HpnIv~l~~ 397 (514)
.+.|++.++||+|+||+||+|.+.. +..+++|...........+.. ......++..+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3589999999999999999998743 455666654332211111100 011223445566778999999998
Q ss_pred EecCCC----eEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEe
Q 010231 398 TDKDES----KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (514)
Q Consensus 398 ~~~~~~----~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~D 472 (514)
++.... ..+++|+++.. ++.+++... ..++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 765433 45788888754 566666553 367888899999999999999999999999999999999999999999
Q ss_pred ccCceecccC--------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 473 FGLAKVFLSS--------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 473 FGlAk~~~~~--------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
||+|+.+... ....++..+|||||||++|+|++|.+||.+.
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999865311 1123455789999999999999999999754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=245.71 Aligned_cols=184 Identities=28% Similarity=0.382 Sum_probs=155.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-CC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~-~~ 403 (514)
.+.++|++.+.||.|+||.||++.+ .++..||+|++..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS---TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3567899999999999999999987 5889999998753211 12234567789999999999999999998865 56
Q ss_pred eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
.+|++|||+. ++|..+++...+....+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++.......
T Consensus 84 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 84 DIYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred cEEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 7899999994 589999887788899999999999999999999999999999999999999999999999987543210
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+....|+|+|||++|+|++|..||.+.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 023456789999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=241.05 Aligned_cols=173 Identities=21% Similarity=0.310 Sum_probs=141.8
Q ss_pred eeecccCceeEEEEEcc-CC-------ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 335 DLLGRGSFGSVYEGISD-DG-------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~-~g-------~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
+.||+|+||.||+|.+. .+ ..+++|.+.. ......+.+.+|+.+++.+.|+||+++++++......+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 36999999999999873 22 2367776542 22344567788999999999999999999999989999
Q ss_pred EEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc--------EEEEeccCc
Q 010231 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--------VKLADFGLA 476 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~--------vKI~DFGlA 476 (514)
+||||+.+|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++
T Consensus 76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999999998754 4788889999999999999999999999999999999987764 699999998
Q ss_pred eecccCC----------------CcCcceeehhhhHHHHHHHHHhC-CCCCCC
Q 010231 477 KVFLSSL----------------DFDLLLIFSIFLNGCKFFLIFLH-VLIFRP 512 (514)
Q Consensus 477 k~~~~~~----------------~~~~~~~~DVwSlG~lLyeLltG-~~PF~g 512 (514)
....... ...++..+|+|||||++|+|++| .+||..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 156 ITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 7543211 12245678999999999999998 566653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=239.20 Aligned_cols=179 Identities=31% Similarity=0.498 Sum_probs=151.6
Q ss_pred eEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEE
Q 010231 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm 409 (514)
|++.+.||.|++|.||+|.+ .+|..||+|++...... ......+.+|+.+++.++|+||+++++.+.+.+..|++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc---ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 67789999999999999987 57899999988753221 112245678999999999999999999999999999999
Q ss_pred eccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 410 ELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 410 Ey~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
||+. ++|.+++... .+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++..+...
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 9995 5899888654 4899999999999999999999999999999999999999999999999998754211
Q ss_pred ------------C----CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ------------L----DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ------------~----~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ...+...+|+|||||++|+|++|.+||.+.
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 0 012345689999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-27 Score=242.34 Aligned_cols=182 Identities=26% Similarity=0.384 Sum_probs=154.2
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|...+.||+|+||.||++.+ .++..+|+|.+...... .......+.+|+.+++.++|+|++++++++...+..|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC--chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 4588899999999999999997 57889999988643222 23345678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+++|+||||+|+||+++.++.+||+|||++......
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF 181 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccc
Confidence 9999975 77776643 45888999999999999999999999999999999999999999999999998754321
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|+|||||++|+|++|..||...
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 1123556789999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=237.89 Aligned_cols=176 Identities=20% Similarity=0.315 Sum_probs=144.7
Q ss_pred ccceEeeeee--cccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLL--GRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~L--G~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 403 (514)
.+.|.+.+.+ |+|+||.||++.. .++..+|+|.+...... . .|+.+...+ +|+||+++++.+...+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------~--~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--------A--IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--------h--hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 4566666665 9999999999987 57888999988642111 0 122222222 6999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-cEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-~vKI~DFGlAk~~~~ 481 (514)
.+|+||||+++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||+++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 999999999999999998765 789999999999999999999999999999999999999998 999999999886543
Q ss_pred CC---------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 482 SL---------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 482 ~~---------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ...+...+|+|||||++|+|++|..||...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 163 PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 21 123445789999999999999999999743
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=249.05 Aligned_cols=182 Identities=24% Similarity=0.445 Sum_probs=152.7
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec----CC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----DE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~----~~ 402 (514)
.++|++.+.||+|+||.||+|.+ .++..||+|.+..... .......+.+|+.+++.++|+||+++++++. ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc---cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 46899999999999999999997 5789999998864221 1223456778999999999999999988765 34
Q ss_pred CeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
..+|+||||+. ++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 57899999996 578888754 4589999999999999999999999999999999999999999999999999976532
Q ss_pred CC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 482 SL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 482 ~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ...+...+|+|+|||++|+|++|++||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 11 023456799999999999999999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=237.72 Aligned_cols=175 Identities=30% Similarity=0.448 Sum_probs=145.4
Q ss_pred eeecccCceeEEEEEccC-------CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 335 DLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~-------g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.||+|+||.||+|++.+ +..+++|.+.... .......+.+|+.+++.++|+||+++++++......|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc----chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 368999999999998632 3578999775321 12234567889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-----cEEEEecc
Q 010231 408 FLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-----SVKLADFG 474 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~--------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-----~vKI~DFG 474 (514)
||||+++++|.+++... .++...+..++.||+.||.|||+++++|+||||+|||++.++ .+||+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999988642 367788999999999999999999999999999999999887 89999999
Q ss_pred CceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 475 LAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 475 lAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+++.+... .....+...|||||||++|+|++ |..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 98754221 11234457899999999999998 99999754
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-29 Score=248.95 Aligned_cols=182 Identities=25% Similarity=0.390 Sum_probs=155.7
Q ss_pred cccceEe-eeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCC
Q 010231 327 IITYWQK-GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (514)
Q Consensus 327 ~~~~Y~i-~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 403 (514)
+.+.|++ .+.||+|+|+.|-.+.. .+|..||||++... ......++.+|+.++.+. .|+||++|+++|+++.
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 3445654 46899999999999987 89999999998753 344567788999999988 5999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc---EEEEeccCceec
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKVF 479 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~---vKI~DFGlAk~~ 479 (514)
.+|||||-+.||.|...+++ ..+++.++..+...|+.||.|||.+||.||||||+|||...... ||||||.|+.-+
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 99999999999998887754 57999999999999999999999999999999999999976554 899999887643
Q ss_pred c--cC-----------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 L--SS-----------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~--~~-----------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. .+ ....|...+|.||||++||-|+.|-+||.|.
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 2 11 1245566899999999999999999999874
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=238.10 Aligned_cols=179 Identities=30% Similarity=0.514 Sum_probs=153.3
Q ss_pred eEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEE
Q 010231 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm 409 (514)
|++.+.||+|++|.||++.+ .+++.+++|.+...... ......+.+|+.+++.++|+||+++++.+...+.+|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 56778999999999999998 57889999988643221 123456778999999999999999999999999999999
Q ss_pred eccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC----
Q 010231 410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL---- 483 (514)
Q Consensus 410 Ey~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~---- 483 (514)
||+.+ +|.+++... .+++..+..++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++..+....
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 99976 788777653 68899999999999999999999999999999999999999999999999987664321
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...|+|+|||++|+|++|+.||.+.
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 113456789999999999999999999764
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=276.44 Aligned_cols=182 Identities=31% Similarity=0.481 Sum_probs=157.7
Q ss_pred cceEeeeeecccCceeEEEEEc--cCC----ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS--DDG----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~--~~g----~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
...++++.||+|.||.||.|.. ..+ ..||||.++.. ...+....|.+|..+|+.+.|||||+++|++.+.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 3567889999999999999986 333 34788877642 2345567899999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~--------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFG 474 (514)
...+|++|||.+|+|..+|++. .++...+..++.||+.|++||+++++|||||.++|+|++....|||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999999865 37888999999999999999999999999999999999999999999999
Q ss_pred Cceeccc-C--------------------CCcCcceeehhhhHHHHHHHHH-hCCCCCCCCC
Q 010231 475 LAKVFLS-S--------------------LDFDLLLIFSIFLNGCKFFLIF-LHVLIFRPPN 514 (514)
Q Consensus 475 lAk~~~~-~--------------------~~~~~~~~~DVwSlG~lLyeLl-tG~~PF~g~n 514 (514)
||+.+.. + .+..++.++||||||++|||++ .|..||+..+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 9994322 1 3467778999999999999999 6999998753
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=241.98 Aligned_cols=183 Identities=29% Similarity=0.510 Sum_probs=150.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----- 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----- 401 (514)
+++|++.++||+|+||.||+|.+ .+++.+++|.+........ ....+.+|+.+++.++|+||+++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 57899999999999999999998 5788999998864322111 12345689999999999999999987643
Q ss_pred ---CCeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCc
Q 010231 402 ---ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (514)
Q Consensus 402 ---~~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlA 476 (514)
...+|+||||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 3357999999976 56666553 36899999999999999999999999999999999999999999999999999
Q ss_pred eecccCC-------------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 477 KVFLSSL-------------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 477 k~~~~~~-------------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
..+.... ...+...+|||||||++|+|++|.+||.+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 7543210 1123456899999999999999999997653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=246.02 Aligned_cols=181 Identities=27% Similarity=0.432 Sum_probs=150.3
Q ss_pred EeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHH---------HHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ---------SISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 332 ~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~---------~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.+.+.||.|+||+||+|.+ .+++.||+|.+........... ....+.+|+.+++.++|+||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 4567899999999999997 5789999999864322211000 01246789999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
.+.+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYG 170 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecc
Confidence 999999999997 588888765 468999999999999999999999999999999999999999999999999998654
Q ss_pred cC----------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SS----------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~----------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ....+...+|+|||||++|+|++|.+||.+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred cccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 00 0112356789999999999999999999754
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=243.06 Aligned_cols=179 Identities=26% Similarity=0.402 Sum_probs=154.3
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.|....+||+|+||.||++.. .++..+|+|.+.... ......+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 344457899999999999988 678999999875322 22345688999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-----
Q 010231 409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL----- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~----- 483 (514)
|||+++++|.+++....+++..+..++.||+.+|.|||++||+|+||||+||+++.++.++|+|||++..+....
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 96 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 999999999999887788999999999999999999999999999999999999999999999999987553221
Q ss_pred --------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 --------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 --------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+||||+++|+|++|..||.+.
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122345789999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-29 Score=254.39 Aligned_cols=185 Identities=22% Similarity=0.305 Sum_probs=155.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l 405 (514)
..+|..+.+||+|+||+|.++.. -+.+.||||+++..-... ....+.-..|-++|... +-|++++++.+|++-+.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ--dDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ--DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeee--cCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 46899999999999999999987 466789999886421111 11223345677777766 578999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
|+||||+.||+|.-.+++ .++.+..+..|+.+|+-||-|||++|||+||||.+|||++.+|+|||+|||+++.-.-+
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 999999999999888877 46899999999999999999999999999999999999999999999999999853221
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....|+...|+|+||++||||+.|++||.|-+
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 22466678999999999999999999999853
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=234.38 Aligned_cols=179 Identities=31% Similarity=0.507 Sum_probs=147.6
Q ss_pred eEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc---CCCceeEEEEEecCCCe--
Q 010231 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESK-- 404 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIv~l~~~~~~~~~-- 404 (514)
|++.+.||+|+||.||+|++. ++..||+|.+....... .....+.+|+.+++.+ .|+||+++++.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE---GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc---hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 678999999999999999985 58999999987533211 1123455677666555 69999999999887776
Q ss_pred ---EEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 405 ---LYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 405 ---l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
++++|||+.+ +|.+++... .+++..+..++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++..
T Consensus 78 ~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 78 ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred CceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999975 788877652 489999999999999999999999999999999999999999999999999987
Q ss_pred cccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.... ...+...+|+|||||++|+|++|++||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 64321 123345789999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=247.27 Aligned_cols=182 Identities=26% Similarity=0.418 Sum_probs=152.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---- 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~---- 402 (514)
.+.|.+.+.||+|+||+||++.+ .++..||||.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 45799999999999999999998 6789999998764221 122234567899999999999999999877543
Q ss_pred -CeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 -SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 -~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
..+||||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 35899999996 578887765 468999999999999999999999999999999999999999999999999998653
Q ss_pred cCC--------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SSL--------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~~--------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... ...+....|+|||||++|+|++|++||.+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 320 123456799999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=238.24 Aligned_cols=181 Identities=27% Similarity=0.390 Sum_probs=153.1
Q ss_pred ceEeeeeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCe
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 404 (514)
.|++.+.||+|+||.||++.+ .++..||+|.++.... .........+.+|+.++..+ .|+||+++++.+.....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 478899999999999999975 3678899998874221 12223445678899999999 59999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+|+||||+.+++|..++.. ..+++..++.++.|++.+|.|||+++++|+||||.||+++.++.++|+|||+++.+....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 9999999999999988865 458899999999999999999999999999999999999999999999999987643221
Q ss_pred C----------------------cCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 484 D----------------------FDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 484 ~----------------------~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
. ......+|+|+||+++|+|++|..||.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 0 013457899999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=234.62 Aligned_cols=184 Identities=26% Similarity=0.465 Sum_probs=152.7
Q ss_pred ceEeeeeecccCceeEEEEEcc--CCceEEEEEEeccccc-----chhHHHHHHHHHHHHHHhh-cCCCceeEEEEEecC
Q 010231 330 YWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQG-----SQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKD 401 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~--~g~~vAIK~v~~~~~~-----~~~~~~~~~l~~Ei~iL~~-L~HpnIv~l~~~~~~ 401 (514)
.|++.+.||+|+||.||++.+. ++..+|+|.+...... .........+.+|+.++.. ++|+||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3788899999999999999984 4788999988643211 1223445667788888765 799999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccC
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGL 475 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGl 475 (514)
.+.+|+||||+.+++|.+++.. ..+++..++.++.|++.+|.|||+ .+|+|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999987742 358889999999999999999996 7899999999999999999999999999
Q ss_pred ceecccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 476 AKVFLSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 476 Ak~~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+....... ...+...+|+||||+++|+|++|.+||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 98654321 122345789999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=244.84 Aligned_cols=180 Identities=31% Similarity=0.474 Sum_probs=154.2
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-----
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----- 403 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 403 (514)
+|++.+.||.|+||.||+|++ .++..|++|.+..... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 488999999999999999998 4689999998864321 1233466889999999999999999999887765
Q ss_pred eEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+|+||+|+.+ +|..++... .+++..+..++.||+.||.|||++||+|+||||.|||++.++.++|+|||++......
T Consensus 78 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 78 DVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred ceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 79999999985 788887654 6899999999999999999999999999999999999999999999999999976543
Q ss_pred CC----------------------c-CcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 LD----------------------F-DLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ~~----------------------~-~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. . .....+|+|||||++|+|++|.+||.+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 20 1 4455799999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=247.63 Aligned_cols=184 Identities=26% Similarity=0.411 Sum_probs=155.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|++.+.||+|+||.||+|.+ .++..||+|.+.... ........+.+|+.+++.+.|+||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 3466899999999999999999998 568899999876421 112234567789999999999999999887765543
Q ss_pred ------EEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 405 ------LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 405 ------l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
+|+|+||+ +++|.+++....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 56999999888899999999999999999999999999999999999999999999999999986
Q ss_pred cccCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.... ....+...|||||||++|+|++|+.||.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 53220 123446799999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=287.94 Aligned_cols=185 Identities=35% Similarity=0.618 Sum_probs=162.4
Q ss_pred cccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
..+.-+|+.+..||.|.||.||.|.+ .+|...|+|.++..... ......+.+|..++..++|||+|+|||+-....
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHH
Confidence 34455789999999999999999998 78999999999865443 555677889999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhhcCCCHH-HHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQRYHLRDS-QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~~lse~-~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+||+||||.+|+|.++++..++-++ ....|..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|..+...
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999999999998765444 45678899999999999999999999999999999999999999999987654
Q ss_pred C--------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 L--------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ~--------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
. ....+...|||||||+..||+||+.||..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence 2 13445678999999999999999999865
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=243.30 Aligned_cols=176 Identities=23% Similarity=0.344 Sum_probs=147.6
Q ss_pred eeeccc--CceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEec
Q 010231 335 DLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (514)
Q Consensus 335 ~~LG~G--sfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy 411 (514)
..||+| +||+||++.+ .+|+.||+|++...... ....+.+.+|+.+++.++|+||++++++|...+.+|+||||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT---EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 456666 9999999998 58999999988753222 23357788999999999999999999999999999999999
Q ss_pred cccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc-------
Q 010231 412 VTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS------- 481 (514)
Q Consensus 412 ~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~------- 481 (514)
+.+++|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.+.....
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999999988753 488889999999999999999999999999999999999999999999975422110
Q ss_pred ----------------C-----CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 482 ----------------S-----LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 482 ----------------~-----~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+ ....++..+|||||||++|+|++|.+||.+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0 0022456789999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=238.01 Aligned_cols=179 Identities=24% Similarity=0.417 Sum_probs=147.9
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCeEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLY 406 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~ 406 (514)
++|+..+.||+|+||.||++.+ .++..+|+|.+...... .....+.+|+.++.++. |+||+++++++......+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE----KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh----HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 3566778999999999999998 57899999988643221 33456788999999986 999999999999889999
Q ss_pred EEEeccccCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 407 IFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~------~~~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
++|||+.. +|..+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99999875 4444321 24588999999999999999999974 9999999999999999999999999998754
Q ss_pred ccCC------------------C---cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 480 LSSL------------------D---FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 480 ~~~~------------------~---~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.... . ..++..+|||||||++|+|++|.+||..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 3220 0 1355679999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=239.89 Aligned_cols=178 Identities=21% Similarity=0.270 Sum_probs=147.8
Q ss_pred eEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEe
Q 010231 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE 410 (514)
|.+++.+|.|+++.||++.. ++..||+|++.... ........+.+|+.+++.++|+||+++++++...+.+|++||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 79 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDS---CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP 79 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccc---cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence 44555566666666665554 78999999987532 123345778999999999999999999999999999999999
Q ss_pred ccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC----
Q 010231 411 LVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL---- 483 (514)
Q Consensus 411 y~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~---- 483 (514)
|+++++|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+..+....
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999999999875 358889999999999999999999999999999999999999999999999886442110
Q ss_pred ------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...++..+|+|||||++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 01245679999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=235.77 Aligned_cols=179 Identities=31% Similarity=0.505 Sum_probs=153.7
Q ss_pred eEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEE
Q 010231 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm 409 (514)
|++.+.||+|.||.||+|+. .+++.+++|.+..... .......+.+|+.+++.+.|+||+++++.+.+...+|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 56788999999999999998 4689999999875331 1222355678999999999999999999999999999999
Q ss_pred eccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC----
Q 010231 410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL---- 483 (514)
Q Consensus 410 Ey~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~---- 483 (514)
||+.+ +|.+++... .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||+++......
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 99985 899998765 68999999999999999999999999999999999999999999999999987653321
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
........|+|+|||++|+|++|.+||.+.
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 113445789999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=251.18 Aligned_cols=178 Identities=30% Similarity=0.520 Sum_probs=159.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
..-|.++.+||+|+||.||+|++ ..|+.+|||.+.+ ....+.+..||.+++++..+++|+||+.+-.+..+|
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW 104 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW 104 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence 34578899999999999999998 6899999999876 334577889999999999999999999998899999
Q ss_pred EEEeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 407 IFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
||||||.-|++.++++ +..+++.++..+++..+.||+|||...-||||||..|||++.+|+.||+|||.|-.+....
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999999999999886 4569999999999999999999999999999999999999999999999999998775441
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...|....||||||+...||..|++||..
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 23445678999999999999999999964
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=235.72 Aligned_cols=178 Identities=28% Similarity=0.420 Sum_probs=150.2
Q ss_pred eEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCeEEEE
Q 010231 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LV 408 (514)
|++.+.||+|+||+||+|.. .+++.|+||.+...... .......+|+..++.+. |+||+++++.+...+..|+|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 67889999999999999998 46789999987642221 11223456889999998 99999999999999999999
Q ss_pred EeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|||+ +++|.+++... .+++..+..++.||+.+|.|||++||+|+||||+||+++.++.++|+|||+++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 9999 77898887653 57999999999999999999999999999999999999999999999999998664321
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.......+|+||||+++|+|++|.+||...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 112345789999999999999999999754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-29 Score=262.66 Aligned_cols=182 Identities=27% Similarity=0.405 Sum_probs=160.1
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.|.-++.||.|+||.||.|++ .+.+.||||++....+ +.....+.+..|+..|++++|||++.|.++|..+...|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK--Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccccc--ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 466678899999999999998 7889999998875443 4455568899999999999999999999999999999999
Q ss_pred EeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 409 LELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
||||-| +..+++. +.++.+..+..|+.+.+.||.|||+++.||||||..|||+...|.|||+|||.|......
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFv 183 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFV 183 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhccc
Confidence 999976 6666664 567999999999999999999999999999999999999999999999999998864322
Q ss_pred --------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 --------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 --------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....|..+.||||||+...+|...++|+.-+|
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN 229 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 229 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch
Confidence 34677789999999999999999999987765
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=268.14 Aligned_cols=181 Identities=28% Similarity=0.401 Sum_probs=156.8
Q ss_pred cceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.+....+.||+|.||+||+|+. .+...||||.++-. ...+..++|++|+.++..++|||||+|+|+|..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~----a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK----AENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 4567788999999999999975 35678999987632 2234568899999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhc-----------C----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY-----------H----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~-----------~----lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~ 467 (514)
+.+|||+|||..|+|.++|+.. . ++..+.+.|+.||+.||.||-++.+|||||-.+|+||..+..
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 9999999999999999998531 1 677889999999999999999999999999999999999999
Q ss_pred EEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHH-hCCCCCCCC
Q 010231 468 VKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIF-LHVLIFRPP 513 (514)
Q Consensus 468 vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLl-tG~~PF~g~ 513 (514)
|||+||||++..-.. ....++..+|||||||+|||++ +|..|+-|.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl 709 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL 709 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc
Confidence 999999999864332 2356778999999999999999 688888664
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=242.64 Aligned_cols=182 Identities=24% Similarity=0.406 Sum_probs=150.7
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC---
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--- 402 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--- 402 (514)
+.++|.+.+.||+|+||.||+|++ .++..||+|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 346899999999999999999997 5789999998864221 122234577899999999999999999987654
Q ss_pred ---CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 403 ---~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..+|+||||+.. +|..++. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 90 DEFQDFYLVMPYMQT-DLQKIMG-HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred CCCceEEEEeccccc-CHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 357999999975 6766653 46899999999999999999999999999999999999999999999999999754
Q ss_pred ccCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ...+...+|+|||||++|+|++|+.||.+.
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2210 123455789999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=255.98 Aligned_cols=175 Identities=27% Similarity=0.446 Sum_probs=152.1
Q ss_pred eeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEecc
Q 010231 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
.++||.|.||+||-|++ ++|+.||||++.+..-. .+...++.+|+.||.++.||.||.+.-.|++.+.+|+|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp---~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP---TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCC---CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 46899999999999998 79999999998754322 222378899999999999999999999999999999999999
Q ss_pred ccCCHHHH-Hh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC---CcEEEEeccCceecccC----
Q 010231 413 TKGSLLNL-YQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 413 ~gGsL~~l-L~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~---g~vKI~DFGlAk~~~~~---- 482 (514)
.| ++.++ |. +.++++...+.++.||+.||.|||-+||+|+||||+|||+... -++||||||+|+.+...
T Consensus 646 ~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 646 HG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred cc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 76 55554 43 4579999999999999999999999999999999999999754 37999999999988654
Q ss_pred --------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 --------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 --------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.+..|....|+||.|+|+|--+.|.+||+.
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 346777899999999999999999999985
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=232.69 Aligned_cols=183 Identities=26% Similarity=0.401 Sum_probs=149.2
Q ss_pred ceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+|.+.+.||+|+||.||++.+. .+..+++|.++.............++.+|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4889999999999999999883 455566666554332222222334566789999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
|||+++++|..++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||+++.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988753 35889999999999999999999999999999999999964 679999999998654321
Q ss_pred C-------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 D-------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ~-------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ..+....|+|+||+++|+|++|..||.+.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1 12234689999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=249.46 Aligned_cols=181 Identities=25% Similarity=0.362 Sum_probs=156.4
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
+...++++||+|.||.|.+|....+..||+|.++.... ......|.+||++|.+|+||||+.++++|..++.++||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~----~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT----KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccc----hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 45678899999999999999988889999998875322 33357899999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 409 LELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~~---lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|||+++|+|.+++.++. +.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+-..
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999999997763 234556679999999999999999999999999999999999999999999955433
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHH--hCCCCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIF--LHVLIFRPP 513 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLl--tG~~PF~g~ 513 (514)
....++.++|+|+||+.|||++ |.+.||...
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l 744 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL 744 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence 2256677999999999999987 677777643
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-27 Score=236.37 Aligned_cols=182 Identities=26% Similarity=0.373 Sum_probs=152.4
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|...+.||+|+||+||+|++ .++..|++|.+...... .......+.+|+.+++.++|+|++++++++.+.+..|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ--TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3467778899999999999987 57889999988643222 23345678889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
||||+.+ +|..++.. ..+++..+..++.||+.+|.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 99 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~ 177 (313)
T cd06633 99 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF 177 (313)
T ss_pred EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCc
Confidence 9999965 67776644 35888999999999999999999999999999999999999999999999998753211
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|+|||||++|+|++|..||...
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 0123445789999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=236.34 Aligned_cols=181 Identities=26% Similarity=0.411 Sum_probs=152.1
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|...+.||+|+||.||+|++ .++..+++|.+...... .......+.+|+.+++.++|+|++++++++......|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3577788999999999999998 56788999988642221 22334567889999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
||||+. |+|.+++.. ..+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++..+....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcccc
Confidence 999997 577776643 358889999999999999999999999999999999999999999999999988654321
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.......+|||||||++|+|++|..||..
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 12345578999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-27 Score=225.95 Aligned_cols=175 Identities=31% Similarity=0.459 Sum_probs=151.1
Q ss_pred ecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccC
Q 010231 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (514)
Q Consensus 337 LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gG 415 (514)
||+|+||.||++.+ .+++.+++|.+..... ........+..|+.+++.++|+||+++++.+...+.+|+||||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh--cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 69999999999998 4688999998875322 22234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC------------
Q 010231 416 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS------------ 482 (514)
Q Consensus 416 sL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~------------ 482 (514)
+|.+++... .+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence 999998765 6899999999999999999999999999999999999999999999999999865432
Q ss_pred -------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.........|+|+|||++|+|++|..||...
T Consensus 159 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred ccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 0122345799999999999999999999754
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-27 Score=238.57 Aligned_cols=180 Identities=28% Similarity=0.463 Sum_probs=147.1
Q ss_pred ceEeeeeecccCceeEEEEEcc-C--CceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEec----C
Q 010231 330 YWQKGDLLGRGSFGSVYEGISD-D--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK----D 401 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~-~--g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~----~ 401 (514)
+|++.+.||+|+||.||++.+. . +..||+|.+..... .....+.+.+|+.+++.+ .|+||+++++.+. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 4888999999999999999983 4 78899998763211 122345677899999998 5999999998643 2
Q ss_pred CCeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
...+|++|+|+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 356889999986 578887754 568999999999999999999999999999999999999999999999999997543
Q ss_pred cCC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SSL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... ...++..+|+|||||++|+|++|.+||.+.
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 210 123345789999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=234.64 Aligned_cols=187 Identities=23% Similarity=0.360 Sum_probs=155.6
Q ss_pred ccccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEe
Q 010231 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD 399 (514)
Q Consensus 322 ~~~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~ 399 (514)
.++..-+++.+.+..||.|+.|.||+++. .+|..+|||.+..... +...++++..+.++... .+|+||+.+|+|
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N----kee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC----HHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 34445567778889999999999999988 6789999999876433 34456677777776555 489999999999
Q ss_pred cCCCeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCc
Q 010231 400 KDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLA 476 (514)
Q Consensus 400 ~~~~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlA 476 (514)
..+..++|.||.|.. .+..+++. ..+++..+-++...++.||.||.+ ++|||||+||+|||+|..|+|||||||++
T Consensus 161 i~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 161 ITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred eeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccc
Confidence 999999999999964 56666654 457887788899999999999986 57999999999999999999999999999
Q ss_pred eecccC---------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 477 KVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 477 k~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
-.+..+ ....|..++||||||+.|+||.||++||.+-
T Consensus 240 GrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 240 GRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred ceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence 876543 2345667899999999999999999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=242.89 Aligned_cols=182 Identities=24% Similarity=0.371 Sum_probs=158.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l 405 (514)
.++|.++++||+|+|.+|.+++. ++.+.||+|+++.... +..+.+.-++.|..+..+. +||++|.++.+|+++..+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~--nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc--CCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 57899999999999999999988 7889999999875322 2223344456677777666 799999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
++|.||++||+|...+++ .+++++.++.|..+|+.||.|||++|||+||||.+|+|+|..|++||+|+|+++.-..+
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 999999999999877764 57999999999999999999999999999999999999999999999999999975433
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
....|++..|+|+||++||||+.|+.||+
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 23567788999999999999999999997
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=262.25 Aligned_cols=182 Identities=26% Similarity=0.416 Sum_probs=158.9
Q ss_pred ccceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|.|+..||.|+||+||+|.++ ++-..|.|.|.. .....++.+.-||.||..+.||+||+|+++|...+++|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 356889999999999999999985 455556677653 44566788899999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
|++|||.||-+..++-. ..+++.++..+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+......
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 99999999988877654 56999999999999999999999999999999999999999999999999997653321
Q ss_pred ----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.+..|.++.||||||+.|.+|..+.+|....|
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 45678889999999999999999999987544
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=233.10 Aligned_cols=181 Identities=25% Similarity=0.402 Sum_probs=148.6
Q ss_pred cccceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 404 (514)
..+.|++.+.||+|+||.||+|.+. +++.||+|.++.... ......+.+|+.++... .|+||+++++++.+...
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4578999999999999999999985 589999999874321 12234455677666555 59999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
+|++|||+.+ +|..++.. ..+++..+..++.||+.||.|||+ +||+||||+|+||+++.++.+||+|||++..+..
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9999999865 77776654 358888899999999999999997 6999999999999999999999999999875432
Q ss_pred CC----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 482 SL----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 482 ~~----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.. ...++...|+|||||++|+|++|..||..
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 11 01244578999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=270.69 Aligned_cols=179 Identities=34% Similarity=0.555 Sum_probs=150.7
Q ss_pred ccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD- 401 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~- 401 (514)
+.|...+|+.+.+||+|+||.||++++ -+|+.||||+|.... ......++.+|+.+|.+|+|||||+||..|.+
T Consensus 474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 456788999999999999999999999 599999999987632 34456778899999999999999999831000
Q ss_pred --------------------------------------------------------------------------------
Q 010231 402 -------------------------------------------------------------------------------- 401 (514)
Q Consensus 402 -------------------------------------------------------------------------------- 401 (514)
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence
Q ss_pred ------------------------------C--------CeEEEEEeccccCCHHHHHhhcCCC--HHHHHHHHHHHHHH
Q 010231 402 ------------------------------E--------SKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLG 441 (514)
Q Consensus 402 ------------------------------~--------~~l~LVmEy~~gGsL~~lL~~~~ls--e~~v~~i~~QIl~g 441 (514)
+ ..+||-||||+..+|.+++..+.+. ....+++|+||+.|
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHH
Confidence 0 2479999999998888898887775 67889999999999
Q ss_pred HHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc---cC------------------------------------
Q 010231 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL---SS------------------------------------ 482 (514)
Q Consensus 442 L~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~---~~------------------------------------ 482 (514)
|.|+|++|||||||||.||+++.++.|||+|||+|+... ..
T Consensus 710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999999999999999999999999999999999999721 00
Q ss_pred -CCcCcceeehhhhHHHHHHHHHhC
Q 010231 483 -LDFDLLLIFSIFLNGCKFFLIFLH 506 (514)
Q Consensus 483 -~~~~~~~~~DVwSlG~lLyeLltG 506 (514)
....|..++|+||||++||||+.-
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~yP 814 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLYP 814 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhcc
Confidence 002467789999999999999953
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=253.47 Aligned_cols=180 Identities=26% Similarity=0.402 Sum_probs=156.8
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
..+.....+||-|.||.||.|.| +-...||||.++- ..-.+.+|+.|..+|+.++|||+|+|+++|..+..+|
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE------DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhh------cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 34566778999999999999999 4567899998762 2345678999999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 407 IFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~---lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
||+|||..|+|.+||++.+ ++.-.++.++.||..||+||..+++|||||-..|+||.++..|||+||||++++..+.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999999999999998743 5556677889999999999999999999999999999999999999999999886552
Q ss_pred --------------------CcCcceeehhhhHHHHHHHHH-hCCCCCCCC
Q 010231 484 --------------------DFDLLLIFSIFLNGCKFFLIF-LHVLIFRPP 513 (514)
Q Consensus 484 --------------------~~~~~~~~DVwSlG~lLyeLl-tG~~PF~g~ 513 (514)
.+.+..++|||+||++|||+. +|..||+|-
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 245556899999999999998 588888873
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-28 Score=231.92 Aligned_cols=174 Identities=23% Similarity=0.417 Sum_probs=150.8
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCC--C
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE--S 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~--~ 403 (514)
.++|++.+++|+|.|+.||.|++ .+++.++||+++. ...+++.+|+.||..|. |+||++++++..+. .
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 56899999999999999999998 6778899999874 23467889999999996 99999999987654 3
Q ss_pred eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC-CcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~-g~vKI~DFGlAk~~~~~ 482 (514)
...+|+||+.+.+...++. .++.-.++.|+.|++.||.|+|+.||+|||+||.|++||.. ..++|+|+|||.++...
T Consensus 109 tpaLiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred CchhHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 5789999999988887765 47788899999999999999999999999999999999965 57999999999998765
Q ss_pred CC-------------------cCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 483 LD-------------------FDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 483 ~~-------------------~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
.+ ..+.+..|+|||||+|..|++.+-||-
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 33 345568899999999999999888874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=223.12 Aligned_cols=178 Identities=24% Similarity=0.417 Sum_probs=148.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhh-cCCCceeEEEEEecCCCeEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIv~l~~~~~~~~~l~ 406 (514)
+....+..||+|+||.|-+.++ .+|...|+|.+...-. .+..+++.+|+.+... ..+|++|.+||....+..+|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 3445567899999999988887 7899999999875332 2334567788887644 47999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
|.||.|.. +|..+.++ ..+++.-+-+|+..++.||.|||++ .|||||+||+||||+.+|+|||||||++-.+.
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99999965 67665532 3588888889999999999999986 79999999999999999999999999988765
Q ss_pred cC----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 481 SS----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 481 ~~----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
++ .+..|..++||||||+.++||.++++||.
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 43 23467789999999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-26 Score=213.77 Aligned_cols=178 Identities=33% Similarity=0.535 Sum_probs=155.4
Q ss_pred eEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEE
Q 010231 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm 409 (514)
|.+++.||.|+||.||++... ++..+++|.+...... .....+.+|+..++.++|+|++++++.+......++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 567899999999999999985 4889999998753221 24567889999999999999999999999889999999
Q ss_pred eccccCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC----
Q 010231 410 ELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL---- 483 (514)
Q Consensus 410 Ey~~gGsL~~lL~~~~--lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~---- 483 (514)
||+.+++|.+++.... +++..+..++.|++.+|.|||+++++|+||+|.||+++.++.++|+|||++..+....
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999999987654 8899999999999999999999999999999999999999999999999998775431
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...+....|+|+||+++|+|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12223478999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=223.11 Aligned_cols=163 Identities=17% Similarity=0.213 Sum_probs=137.3
Q ss_pred cCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccCCHH
Q 010231 340 GSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL 418 (514)
Q Consensus 340 GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gGsL~ 418 (514)
|.||.||++.+ .+++.||+|.+.... ...+|...+....||||+++++.+...+.+|+||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 89999999998 688999999886421 1223445555567999999999999999999999999999999
Q ss_pred HHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--------------
Q 010231 419 NLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-------------- 483 (514)
Q Consensus 419 ~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-------------- 483 (514)
+++.+ ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~ 153 (237)
T cd05576 74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEV 153 (237)
T ss_pred HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcc
Confidence 98755 468999999999999999999999999999999999999999999999999876443210
Q ss_pred --CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 --DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 --~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....+...|+||+||++|+|++|..||..
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 12344578999999999999999988753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=245.21 Aligned_cols=187 Identities=23% Similarity=0.342 Sum_probs=156.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEeccccc--chhHHHHHHHHHHHHHHhhcCCCceeEEEEEec-C
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG--SQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-D 401 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~--~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~-~ 401 (514)
.+.++|.++.+||+|+|+.||+|.+ ...++||||+-.+.+.. .......+...+|..|.+.|.||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 4457899999999999999999998 67789999976543322 222334456779999999999999999999885 5
Q ss_pred CCeEEEEEeccccCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEcC---CCcEEEEeccC
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA---NGSVKLADFGL 475 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~~-lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId~---~g~vKI~DFGl 475 (514)
.+.+|-|+|||+|.+|..||+..+ +++.+++.|+.||+.||.||.+.. |||=||||.|||+-. .|.+||+||||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 667999999999999999998754 899999999999999999999864 999999999999953 47899999999
Q ss_pred ceecccCCC------------------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 476 AKVFLSSLD------------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 476 Ak~~~~~~~------------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
++.+..+.+ ..++.+.||||+|+|+|..++|+-||..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 998765422 1223478899999999999999999975
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=234.91 Aligned_cols=175 Identities=23% Similarity=0.312 Sum_probs=144.6
Q ss_pred ccceEee-eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEec----
Q 010231 328 ITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK---- 400 (514)
Q Consensus 328 ~~~Y~i~-~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~---- 400 (514)
.++|.+. ++||-|-.|+|..+.. .+++.+|+|++.- ..+..+|+.+.-.. .|+|||.++++|.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 4455543 5799999999999987 7899999997641 13345777775444 7999999999765
Q ss_pred CCCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC---CcEEEEecc
Q 010231 401 DESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFG 474 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~---g~vKI~DFG 474 (514)
....+.||||+++||.|+..++.. .+++.++..|++||..|+.|||+.+|.||||||+|+|...+ -.+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 345789999999999999998764 39999999999999999999999999999999999999754 469999999
Q ss_pred CceecccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 475 LAKVFLSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 475 lAk~~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+|+...... ...+...+|+||+|+++|-|+||-+||=.
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 999866331 13355689999999999999999999954
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=235.84 Aligned_cols=181 Identities=30% Similarity=0.475 Sum_probs=151.3
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-----
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----- 403 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 403 (514)
+.+-.+.||.|.||.||.+++ ++|+.||+|++... ...-...+++.+|+++|..++|.|++..++..+..+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv---fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV---FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH---HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 344567899999999999999 89999999977532 233445577889999999999999999888765443
Q ss_pred eEEEEEeccccCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~-~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+|+++|++.. +|..++- ...++...++-+++||+.||+|||+.||+||||||.|+|++.|..+||||||+|+.....
T Consensus 131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 36788888866 6766654 356899999999999999999999999999999999999999999999999999986543
Q ss_pred C---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 L---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ~---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
. ...|+...||||.||++.||+-++++|..+|
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 1 2345568999999999999999999998765
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=245.67 Aligned_cols=178 Identities=30% Similarity=0.464 Sum_probs=152.1
Q ss_pred ceEeeeeecccCceeEEEEEcc---CC--ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 330 YWQKGDLLGRGSFGSVYEGISD---DG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~---~g--~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...+.++||.|.||.||+|... .| -.||||..+.... ....+.|.+|..+|++++||||++++|+|.+ ..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t----~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT----PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC----hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 4456788999999999999862 23 4678887765332 2335788999999999999999999999875 57
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.|||||+++.|.|..||+.+ .++...+..|++||+.+|.|||++++|||||-.+||||.....|||+||||++.+..+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999999999865 4888889999999999999999999999999999999999999999999999976544
Q ss_pred C--------------------CcCcceeehhhhHHHHHHHHH-hCCCCCCC
Q 010231 483 L--------------------DFDLLLIFSIFLNGCKFFLIF-LHVLIFRP 512 (514)
Q Consensus 483 ~--------------------~~~~~~~~DVwSlG~lLyeLl-tG~~PF~g 512 (514)
. ...++..+|||-||+.+||++ .|.-||.|
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 1 234556899999999999988 89999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=247.66 Aligned_cols=177 Identities=26% Similarity=0.341 Sum_probs=150.8
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 404 (514)
+...|.+...||.|+|+.|-.+.+ .+++.+++|++..... ...+|+.++... .|+||+++++++.+..+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---------DNQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc---------ccccccchhhhhcCCCcceeecceecCCce
Confidence 466788888999999999999987 6888999999875311 123566555444 79999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-cCCCcEEEEeccCceecccC-
Q 010231 405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV-DANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI-d~~g~vKI~DFGlAk~~~~~- 482 (514)
+|+|||++.|+.|.+-+........++..|++||+.++.|||++|||||||||+|||+ +..|+++|+|||.++.....
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~ 470 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC 470 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhh
Confidence 9999999999988887766555457778899999999999999999999999999999 68999999999999977654
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....++..+||||||++||+|++|+.||..
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~ 515 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAA 515 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcccc
Confidence 224667799999999999999999999974
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-28 Score=235.94 Aligned_cols=183 Identities=27% Similarity=0.469 Sum_probs=151.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC----
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---- 401 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~---- 401 (514)
..+.|+...+||+|.||.||+|+. ++|+.||+|++-..... .-.-....+|+++|..++|+|++.++..|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK---eGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc---cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 345788889999999999999998 67888898865431111 1112344689999999999999999876643
Q ss_pred ----CCeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccC
Q 010231 402 ----ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (514)
Q Consensus 402 ----~~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGl 475 (514)
...+||||.+|+. +|.-++.. -+++..++++++.++++||.|+|+..|+|||+|++|+||+.+|.+||+|||+
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 2349999999987 77777754 3689999999999999999999999999999999999999999999999999
Q ss_pred ceecccC------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 476 AKVFLSS------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 476 Ak~~~~~------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|+.+..+ .+.+++...|+|.-||+|.+|.|+.+.|.|.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 9877544 2356677899999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=243.92 Aligned_cols=182 Identities=26% Similarity=0.370 Sum_probs=151.2
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhH---HHHHHHHHHHHHHhhcC---CCceeEEEEEecC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK---QSISQLEQEIALLSRFE---HENIVQYYGTDKD 401 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~---~~~~~l~~Ei~iL~~L~---HpnIv~l~~~~~~ 401 (514)
..|..++.||.|+||.|++|++ .+...|+||.+.+........ ...-.+--||+||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4699999999999999999998 456788889876422111000 01112346999999997 9999999999999
Q ss_pred CCeEEEEEeccc-cCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 402 ESKLYIFLELVT-KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 402 ~~~l~LVmEy~~-gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
++++||+||-.. +.+|++++.. ..+.+..++.||+||+-|+++||++||||||||-+|++++.+|.+||+|||.|...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 999999999765 4489999875 46999999999999999999999999999999999999999999999999999876
Q ss_pred ccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCC
Q 010231 480 LSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIF 510 (514)
Q Consensus 480 ~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF 510 (514)
.+.. +...+...|||++|++||.+++.+-||
T Consensus 721 ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 721 KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 6542 233345788999999999999999887
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=246.41 Aligned_cols=181 Identities=25% Similarity=0.375 Sum_probs=155.6
Q ss_pred ccceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.+...+.++||+|.||.|++|.|. +...||||+++..... .....|.+|+.+|.+|+|+|+++|||+..+ .
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~----~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN----AIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc----hhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 456677889999999999999983 3357899998754332 256789999999999999999999999887 7
Q ss_pred eEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 404 KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
.+.||||+++.|+|.+.|.+ ..|-...+..|+.||+.||.||..+++|||||-..|||+-....|||+||||.+.+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78999999999999999876 246778889999999999999999999999999999999999999999999999876
Q ss_pred cCCC----------------------cCcceeehhhhHHHHHHHHH-hCCCCCCCC
Q 010231 481 SSLD----------------------FDLLLIFSIFLNGCKFFLIF-LHVLIFRPP 513 (514)
Q Consensus 481 ~~~~----------------------~~~~~~~DVwSlG~lLyeLl-tG~~PF~g~ 513 (514)
...+ ..+...+|||+||+.+|||+ +|+.||.|-
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 5532 34445889999999999999 688888774
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-27 Score=233.38 Aligned_cols=179 Identities=27% Similarity=0.420 Sum_probs=149.2
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHh-hcCCCceeEEEEEecCCCeEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS-RFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~-~L~HpnIv~l~~~~~~~~~l~ 406 (514)
++.+-+..||.|.||+|++..+ ..|+.+|||.+..... ....++++.|..... .-+.||||++||+.-.+...|
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 4556677899999999999987 6799999999985322 344567777777654 447999999999998889999
Q ss_pred EEEeccccCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 407 IFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~------~~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
|-||+|.- +|..+++ +..+++.-+-.|...++.||.||.. ..||||||||+|||++..|.|||||||++-.+
T Consensus 140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 99999965 6665543 4568998888999999999999975 57999999999999999999999999998765
Q ss_pred ccC--------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 480 LSS--------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 480 ~~~--------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
..+ .+..+..++|+||||+.|||+.||.+|+++
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 433 334577899999999999999999999975
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=250.70 Aligned_cols=180 Identities=24% Similarity=0.393 Sum_probs=157.5
Q ss_pred cceEeeeeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+..+.++||.|.||.||+|+. +....||||.++.. ...+....|+.|..||-++.||||++|.|+......
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC----ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 3567889999999999999987 34568999998853 334456789999999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+.||+|||++|+|..+|+++ .|+..++.-+++.|+.||+||-+.|+|||||...||||+.+-.+|++||||++.+.++
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999999999764 5888899999999999999999999999999999999999999999999999988655
Q ss_pred CC----------------------cCcceeehhhhHHHHHHHHH-hCCCCCCC
Q 010231 483 LD----------------------FDLLLIFSIFLNGCKFFLIF-LHVLIFRP 512 (514)
Q Consensus 483 ~~----------------------~~~~~~~DVwSlG~lLyeLl-tG~~PF~g 512 (514)
.+ ..++..+||||||++|||.+ +|+.||=.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 32 23344789999999999988 89888743
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-24 Score=227.36 Aligned_cols=127 Identities=28% Similarity=0.421 Sum_probs=110.6
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-----C---CceeEEEEEe
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----H---ENIVQYYGTD 399 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-----H---pnIv~l~~~~ 399 (514)
.+|.+.++||.|.|++||+|.+ .+.++||+|+++ ..+...+....||++|++++ | ..||+|++.|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK------SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK------SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe------hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 6899999999999999999998 788999999997 34566677789999999984 2 3599999987
Q ss_pred c----CCCeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEE
Q 010231 400 K----DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILV 462 (514)
Q Consensus 400 ~----~~~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILI 462 (514)
. ...++|||+|++. .+|..+|+. .+++...++.|++|||.||.|||. .||||.||||+|||+
T Consensus 152 khsGpNG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred eecCCCCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 5 4568999999994 477777765 469999999999999999999997 599999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=242.49 Aligned_cols=179 Identities=23% Similarity=0.386 Sum_probs=154.4
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC------CCceeEEEEEecC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE------HENIVQYYGTDKD 401 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~------HpnIv~l~~~~~~ 401 (514)
+.|.+....|+|-|++|..|.+ ..|+.||||+|.. .+...+.=+.|+.||++|. --|+++|+..|..
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn------NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN------NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeec------chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 5788999999999999999998 5678999999973 2334455568999999995 3479999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC-CcEEEEeccCc
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLA 476 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~----~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~-g~vKI~DFGlA 476 (514)
.+++|||+|-+.. +|.++|+++ +|....+..|+.|++.||.+|...||+|.||||+||||+.. ..+||||||.|
T Consensus 506 knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 9999999999865 899999876 47788999999999999999999999999999999999975 46899999999
Q ss_pred eecccC-----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 477 KVFLSS-----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 477 k~~~~~-----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...... ....|.+.+|+||.||.||||+||.++|+|.+
T Consensus 585 ~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 876533 34566678999999999999999999999863
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=233.39 Aligned_cols=179 Identities=22% Similarity=0.328 Sum_probs=150.6
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-C-C----ceeEEEEEe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-H-E----NIVQYYGTD 399 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-H-p----nIv~l~~~~ 399 (514)
+..+|.++..||+|+||.|.++.+ ..+..||+|+++.. ....+..+-|+.+|.++. + | -++++.++|
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 356899999999999999999998 45799999998732 333445567899999883 2 2 278888999
Q ss_pred cCCCeEEEEEeccccCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC------------
Q 010231 400 KDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA------------ 464 (514)
Q Consensus 400 ~~~~~l~LVmEy~~gGsL~~lL~~~~---lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~------------ 464 (514)
.-.+++|||+|.+. -+++++|+.++ ++...++.|.+||+.+++|||+.+++|.||||+|||+..
T Consensus 161 dyrghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 99999999999994 48999998753 788999999999999999999999999999999999832
Q ss_pred --------CCcEEEEeccCceecccC----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 465 --------NGSVKLADFGLAKVFLSS----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 465 --------~g~vKI~DFGlAk~~~~~----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+-.|||+|||-|+.-... ....+.+.+||||+||||+|++||..+|.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 235899999999976544 235777899999999999999999999976
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=242.21 Aligned_cols=175 Identities=24% Similarity=0.361 Sum_probs=125.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cC----CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEE----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT---- 398 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~----g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~---- 398 (514)
.++|.+.++||+|+||.||+|++ .+ +..||+|.+..... . +....+ .+....+.++..++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--V-----EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--h-----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 56899999999999999999998 45 78999998753211 0 001111 1111112222221111
Q ss_pred --ecCCCeEEEEEeccccCCHHHHHhhcCC---------------------CHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 010231 399 --DKDESKLYIFLELVTKGSLLNLYQRYHL---------------------RDSQVSAYTRQILLGLKYLHDQDVVHRDI 455 (514)
Q Consensus 399 --~~~~~~l~LVmEy~~gGsL~~lL~~~~l---------------------se~~v~~i~~QIl~gL~yLHs~gIIHRDL 455 (514)
......++|||||+.+++|.+++....+ ....+..|+.||+.||.|||+++|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456789999999999999998865331 12345679999999999999999999999
Q ss_pred CCCCEEEcC-CCcEEEEeccCceecccCCC------------------------------------------cCcceeeh
Q 010231 456 KCANILVDA-NGSVKLADFGLAKVFLSSLD------------------------------------------FDLLLIFS 492 (514)
Q Consensus 456 KP~NILId~-~g~vKI~DFGlAk~~~~~~~------------------------------------------~~~~~~~D 492 (514)
||+|||++. ++.+||+|||+|+.+....+ ..+..++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 68999999999985432110 01223459
Q ss_pred hhhHHHHHHHHHhCCCCCC
Q 010231 493 IFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 493 VwSlG~lLyeLltG~~PF~ 511 (514)
||||||+||+|+++..++.
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999877654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=228.62 Aligned_cols=174 Identities=30% Similarity=0.422 Sum_probs=145.5
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC----
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---- 402 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~---- 402 (514)
+.++..+.+.||+|.||.||+|.++ |+.||||++...++..+.+ +.||..-..|+|+||+.+++....+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfr------EtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFR------ETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccchhhhhh------HHHHHHHHHhccchhhhhhhccccCCCce
Confidence 4567899999999999999999986 7799999998766555433 2444445567999999999876543
Q ss_pred CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCCEEEcCCCcEEEEecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~--------gIIHRDLKP~NILId~~g~vKI~DFG 474 (514)
.++|||++|.+.|+|++||+.+.++.+...+++..++.||+|||-. .|.|||||..||||.++|.+.|+|||
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 3699999999999999999999999999999999999999999952 39999999999999999999999999
Q ss_pred CceecccCCC-----------------------------cCcceeehhhhHHHHHHHHHhCC
Q 010231 475 LAKVFLSSLD-----------------------------FDLLLIFSIFLNGCKFFLIFLHV 507 (514)
Q Consensus 475 lAk~~~~~~~-----------------------------~~~~~~~DVwSlG~lLyeLltG~ 507 (514)
||-...+..+ .+.-...||||||.++||++.++
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc 423 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC 423 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence 9988765521 01112578999999999998754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=245.94 Aligned_cols=179 Identities=26% Similarity=0.424 Sum_probs=152.9
Q ss_pred ceEeeeeecccCceeEEEEEc-cCC----ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDG----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g----~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.....++||+|+||+||+|.+ ..| ..||||++.. ....+....+.+|..+|..++|||+++|++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~----~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE----FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeec----cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 456678999999999999998 333 4677776653 233344567889999999999999999999998765
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+.||++|++.|+|.++++. .++.....+.|+.||++||.|||.++++||||-.+||||..-.++||+|||+|+.+..+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 8899999999999999975 46888999999999999999999999999999999999999999999999999987654
Q ss_pred C---------------------CcCcceeehhhhHHHHHHHHH-hCCCCCCCC
Q 010231 483 L---------------------DFDLLLIFSIFLNGCKFFLIF-LHVLIFRPP 513 (514)
Q Consensus 483 ~---------------------~~~~~~~~DVwSlG~lLyeLl-tG~~PF~g~ 513 (514)
. ...++..+|||+||+.+||++ +|.-|+.+.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi 904 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI 904 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC
Confidence 2 235556899999999999998 688888764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=253.36 Aligned_cols=173 Identities=21% Similarity=0.333 Sum_probs=144.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
...|...++||+|+||.||+|++ .++..||+|.+..... ....|+.++++++||||+++++++.+....|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 34566778999999999999997 6889999998763221 1124578899999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCCEEEcCCCcEEEEeccCceecc---
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH---DQDVVHRDIKCANILVDANGSVKLADFGLAKVFL--- 480 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLH---s~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~--- 480 (514)
+||||+++|+|.++++ .+++..+..|+.||+.||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 760 lv~Ey~~~g~L~~~l~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~ 836 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT 836 (968)
T ss_pred EEEeCCCCCcHHHHHh--cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC
Confidence 9999999999999986 4788889999999999999999 6699999999999999998887775 55543221
Q ss_pred ---------cC---CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 481 ---------SS---LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 481 ---------~~---~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.+ ....++.++|||||||++|||+||+.||..
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 11 123456789999999999999999999853
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=238.97 Aligned_cols=180 Identities=26% Similarity=0.448 Sum_probs=156.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEec-----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK----- 400 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~----- 400 (514)
.+-|++.++||.|.||.||+++. .+++..|+|+....... -+.++.|+.+|+.+ .|||++.+|++|.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~------deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE------EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc------cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 45689999999999999999998 78899999987653322 24466788888888 6999999999874
Q ss_pred CCCeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCce
Q 010231 401 DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk 477 (514)
.++++|||||||.+|+..++++. ..+.++.+..|++.++.||.+||++.+||||||-.|||++.+|.|||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 35789999999999999999876 358899999999999999999999999999999999999999999999999988
Q ss_pred ecccC------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 478 VFLSS------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 478 ~~~~~------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+... .+..|...+|+||||++..||--|.+||-.+
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 76432 4567778999999999999999999998655
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=233.52 Aligned_cols=185 Identities=24% Similarity=0.379 Sum_probs=135.8
Q ss_pred ccceEeeeeecccCceeEEEEEc-----------------cCCceEEEEEEecccccchhH---------HHHHHHHHHH
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-----------------DDGFFFAVKEVSLLDQGSQAK---------QSISQLEQEI 381 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-----------------~~g~~vAIK~v~~~~~~~~~~---------~~~~~l~~Ei 381 (514)
.++|.+.++||+|+||+||+|.. ..++.||||.+.......... ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 245679999986532211100 0111233466
Q ss_pred HHHhhcCCCce-----eEEEEEecC--------CCeEEEEEeccccCCHHHHHhhc------------------------
Q 010231 382 ALLSRFEHENI-----VQYYGTDKD--------ESKLYIFLELVTKGSLLNLYQRY------------------------ 424 (514)
Q Consensus 382 ~iL~~L~HpnI-----v~l~~~~~~--------~~~l~LVmEy~~gGsL~~lL~~~------------------------ 424 (514)
.++.+++|.++ ++++++|.. ....||||||+.+++|.+++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777766554 556665532 35689999999999999887531
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC-------------------
Q 010231 425 -HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD------------------- 484 (514)
Q Consensus 425 -~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~------------------- 484 (514)
.+....++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 124456788999999999999999999999999999999999999999999975422110
Q ss_pred -----------------------cCcceeehhhhHHHHHHHHHhCCC-CCCC
Q 010231 485 -----------------------FDLLLIFSIFLNGCKFFLIFLHVL-IFRP 512 (514)
Q Consensus 485 -----------------------~~~~~~~DVwSlG~lLyeLltG~~-PF~g 512 (514)
+.....+|+||+||++|+|+++.. ||..
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 000123699999999999999986 7653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=229.19 Aligned_cols=174 Identities=28% Similarity=0.413 Sum_probs=147.2
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhh--cCCCceeEEEEEecCCC---
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDES--- 403 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIv~l~~~~~~~~--- 403 (514)
...++.++||+|.||.||+|...+ +.||||++.. +..+.+.+|..|.+. ++|+||+++++.-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 345677899999999999998754 8999999874 233556677777655 58999999998765544
Q ss_pred -eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCCEEEcCCCcEEEEec
Q 010231 404 -KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------DVVHRDIKCANILVDANGSVKLADF 473 (514)
Q Consensus 404 -~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~---------gIIHRDLKP~NILId~~g~vKI~DF 473 (514)
.++||++|.+.|+|.+||+.+.+++....+++..|++||+|||+- .|+|||||..||||..++.+.|+||
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 799999999999999999999999999999999999999999962 4999999999999999999999999
Q ss_pred cCceecccC---------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 474 GLAKVFLSS---------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 474 GlAk~~~~~---------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
|||..+... .+.....++||||+|.+||||+.++.-+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 999987532 11223357899999999999999887664
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=240.22 Aligned_cols=151 Identities=30% Similarity=0.507 Sum_probs=135.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
++.|.++++||+|+||+||+|.+ .++..||||+++.... ........+.+|+.++..++|+||+++++++...+++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM--INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc--cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence 46899999999999999999998 4789999999874322 22334567889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
|||||+.+++|..++.. ..+.+..++.|+.||+.||.|||.++||||||||+||||+.++.+||+|||+++...
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 99999999999999875 357888999999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=200.66 Aligned_cols=168 Identities=33% Similarity=0.533 Sum_probs=146.3
Q ss_pred CceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccCCHHH
Q 010231 341 SFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 419 (514)
Q Consensus 341 sfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gGsL~~ 419 (514)
+||.||+|.+. +++.+++|++........ ...+.+|+.+++.++|+||+++++.+......+++|||+.+++|..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 58999999985 589999998875322111 5678899999999999999999999998899999999999999999
Q ss_pred HHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---------------
Q 010231 420 LYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--------------- 483 (514)
Q Consensus 420 lL~~~~-lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--------------- 483 (514)
++.... ++...+..++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||++.......
T Consensus 77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 987654 8899999999999999999999999999999999999999999999999998765420
Q ss_pred ---CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 ---DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ---~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....+...|+|+||+++|+|++|..||..
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12344579999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=220.00 Aligned_cols=180 Identities=20% Similarity=0.317 Sum_probs=150.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEE-EecCCC
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG-TDKDES 403 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~-~~~~~~ 403 (514)
+.+.|.+.+.||+|.||.+.++.+ .....+++|.+.. .......|.+|...--.| .|.||+.-|+ .|++.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 457899999999999999999998 5677889998863 233456788888765555 5889998776 588888
Q ss_pred eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC--CCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~--~g~vKI~DFGlAk~~~~ 481 (514)
.++++|||++.|+|..-+...++.+...++++.|+++||.|||++++||||||.+||||.. ..+|||||||+.+....
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999999999888899999999999999999999999999999999999999963 34899999999886543
Q ss_pred C---------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 482 S---------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 482 ~---------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
. .........|+|.||+++|..+||++|+..
T Consensus 176 tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 176 TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 2 112223468899999999999999999863
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=236.10 Aligned_cols=185 Identities=26% Similarity=0.423 Sum_probs=156.1
Q ss_pred ccccccceEeeeeecccCceeEEEEEc----c----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeE
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS----D----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~----~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~ 394 (514)
+....++..+.+.||.|.||.|++|.. . ....||||..+.... ....+.+..|+.+|+.+ .|+||+.
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~----~~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS----SSEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC----cHHHHHHHHHHHHHHHhcCCcchhh
Confidence 333344556777999999999999974 1 256789997764222 24457788999999999 5999999
Q ss_pred EEEEecCCCeEEEEEeccccCCHHHHHhhcC-----------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 010231 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (514)
Q Consensus 395 l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~-----------------lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP 457 (514)
+++++.....+++|+||+..|+|..++++.+ +....+..+++||+.|++||+++.+|||||-.
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa 446 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA 446 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence 9999999999999999999999999998777 88889999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeccCceecccC----------------------CCcCcceeehhhhHHHHHHHHH-hCCCCCCC
Q 010231 458 ANILVDANGSVKLADFGLAKVFLSS----------------------LDFDLLLIFSIFLNGCKFFLIF-LHVLIFRP 512 (514)
Q Consensus 458 ~NILId~~g~vKI~DFGlAk~~~~~----------------------~~~~~~~~~DVwSlG~lLyeLl-tG~~PF~g 512 (514)
+||||..+..+||+|||+|+..... .+..++.++||||||++||||+ .|..||++
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999953322 1245667899999999999999 68888876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=186.58 Aligned_cols=163 Identities=38% Similarity=0.603 Sum_probs=142.0
Q ss_pred ecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccC
Q 010231 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (514)
Q Consensus 337 LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gG 415 (514)
||+|.+|.||++... +++.+++|.+....... ....+.+|+.+++.+.|++|+++++++......+++|||+.++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 689999999999985 48999999887532211 3467889999999999999999999999989999999999999
Q ss_pred CHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-CCcEEEEeccCceecccCC---------
Q 010231 416 SLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKVFLSSL--------- 483 (514)
Q Consensus 416 sL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-~g~vKI~DFGlAk~~~~~~--------- 483 (514)
+|..++... .++...+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence 999999875 6899999999999999999999999999999999999999 8999999999998665431
Q ss_pred ----------Cc-CcceeehhhhHHHHHHHH
Q 010231 484 ----------DF-DLLLIFSIFLNGCKFFLI 503 (514)
Q Consensus 484 ----------~~-~~~~~~DVwSlG~lLyeL 503 (514)
.. ......|+|+||+++|+|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 01 444678999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=215.44 Aligned_cols=180 Identities=24% Similarity=0.367 Sum_probs=151.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC---
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--- 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~--- 403 (514)
..+|.-+..+|.|.- .|..+.+ -.++.||+|.+... .......++..+|+.++..+.|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p---f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP---FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc---cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 457888889999987 6777766 57889999987643 222444566779999999999999999999886543
Q ss_pred ---eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 404 ---KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 404 ---~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
.+|+||||+.. +|...+. ..+..++++.++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+.-.
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 58999999976 7877766 567888999999999999999999999999999999999999999999999998755
Q ss_pred cC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ....+....||||+||++.||++|...|+|.
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 44 2234566899999999999999999999985
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=215.38 Aligned_cols=149 Identities=21% Similarity=0.187 Sum_probs=117.9
Q ss_pred ccccccceEeeeeecccCceeEEEEEcc--CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeE-EEEEec
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ-YYGTDK 400 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~~--~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~-l~~~~~ 400 (514)
...+.+.|.+.++||+|+||+||+|.+. +++.+|||++...............+.+|+.+|+.++|+||+. +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3455678999999999999999999873 6778899976522110011233456889999999999999985 5442
Q ss_pred CCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCCEEEcCCCcEEEEeccCceec
Q 010231 401 DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI-KCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDL-KP~NILId~~g~vKI~DFGlAk~~ 479 (514)
...||||||+.|++|.. +.. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.+
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 35799999999999963 221 11 2568899999999999999999999 999999999999999999999977
Q ss_pred ccC
Q 010231 480 LSS 482 (514)
Q Consensus 480 ~~~ 482 (514)
...
T Consensus 163 ~~~ 165 (365)
T PRK09188 163 RRR 165 (365)
T ss_pred ccC
Confidence 543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=192.21 Aligned_cols=146 Identities=17% Similarity=0.146 Sum_probs=112.2
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchh---------------------HHHHHHHHHHHHHHhhcCCCce
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA---------------------KQSISQLEQEIALLSRFEHENI 392 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~---------------------~~~~~~l~~Ei~iL~~L~HpnI 392 (514)
...||+|+||.||+|.+.+|+.||+|+++........ +.......+|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999998753221111 0011233569999999987766
Q ss_pred eEEEEEecCCCeEEEEEeccccCCHHHH-HhhcCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCCEEEcCCCcEEE
Q 010231 393 VQYYGTDKDESKLYIFLELVTKGSLLNL-YQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 393 v~l~~~~~~~~~l~LVmEy~~gGsL~~l-L~~~~lse~~v~~i~~QIl~gL~yL-Hs~gIIHRDLKP~NILId~~g~vKI 470 (514)
...+..... ..+|||||++++++... +....++...+..++.||+.+|.|| |+.||+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 433222222 23899999999877554 4556789999999999999999999 799999999999999998 588999
Q ss_pred EeccCceecccC
Q 010231 471 ADFGLAKVFLSS 482 (514)
Q Consensus 471 ~DFGlAk~~~~~ 482 (514)
+|||+|.....+
T Consensus 159 iDFG~a~~~~~~ 170 (190)
T cd05147 159 IDVSQSVEHDHP 170 (190)
T ss_pred EEccccccCCCc
Confidence 999999875444
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-22 Score=188.42 Aligned_cols=146 Identities=18% Similarity=0.167 Sum_probs=115.0
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccc---------------------hhHHHHHHHHHHHHHHhhcCCCce
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---------------------QAKQSISQLEQEIALLSRFEHENI 392 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~---------------------~~~~~~~~l~~Ei~iL~~L~HpnI 392 (514)
...||+|+||.||+|.+.+|+.||||++....... ........+.+|+..+..+.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998889999999987542110 011112334678999999999887
Q ss_pred eEEEEEecCCCeEEEEEeccccCCHH-HHHhhcCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEE
Q 010231 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 393 v~l~~~~~~~~~l~LVmEy~~gGsL~-~lL~~~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI 470 (514)
.....+.... .||||||++++++. ..+....++...+..++.|++.+|.+||. +||+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence 4433332222 48999999988543 34566678888999999999999999999 9999999999999998 899999
Q ss_pred EeccCceecccC
Q 010231 471 ADFGLAKVFLSS 482 (514)
Q Consensus 471 ~DFGlAk~~~~~ 482 (514)
+|||+|+.+...
T Consensus 159 iDFG~a~~~~~~ 170 (190)
T cd05145 159 IDVSQAVELDHP 170 (190)
T ss_pred EEcccceecCCC
Confidence 999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=201.88 Aligned_cols=178 Identities=22% Similarity=0.323 Sum_probs=151.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l 405 (514)
.-.|.++++||+|+||.+++|.+ -+++.||||.-.... ...++..|.+..+.| ..++|...|.+.+...+-
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-------~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-------EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC-------CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 34799999999999999999998 789999999765432 235677888888888 479999999999999999
Q ss_pred EEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-----cEEEEeccCcee
Q 010231 406 YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-----SVKLADFGLAKV 478 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-----~vKI~DFGlAk~ 478 (514)
.||||++ |-+|.+++.. ..|+.+++..++.|++.-++|+|++++|+|||||+|+||..-+ .|.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999 5589888865 5699999999999999999999999999999999999997543 589999999999
Q ss_pred cccCCCc--------------------------CcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSLDF--------------------------DLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~~~--------------------------~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+..+... .-..+-|+=+||.++++.+.|.+||.|.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 8765221 1123566999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-22 Score=222.60 Aligned_cols=172 Identities=34% Similarity=0.530 Sum_probs=139.5
Q ss_pred eEeeeeecccCcee-EEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeEEEE
Q 010231 331 WQKGDLLGRGSFGS-VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 331 Y~i~~~LG~GsfG~-Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LV 408 (514)
|.--+++|.|+.|+ ||+|.. +|+.||||.+- .....-..+|+.+|+.- .||||+++|+.-.+...+||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 44456799999987 699976 46799999764 33345567999999888 699999999999999999999
Q ss_pred EeccccCCHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC---CC--cEEEEeccCcee
Q 010231 409 LELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NG--SVKLADFGLAKV 478 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~~-----lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~---~g--~vKI~DFGlAk~ 478 (514)
+|+|.. +|.+++.... .........+.|++.||+|||+.+||||||||.||||.. ++ +++|+|||++++
T Consensus 582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 999976 8999997631 111345678999999999999999999999999999986 33 689999999998
Q ss_pred cccCC----------------------CcCcceeehhhhHHHHHHHHHhC-CCCCCC
Q 010231 479 FLSSL----------------------DFDLLLIFSIFLNGCKFFLIFLH-VLIFRP 512 (514)
Q Consensus 479 ~~~~~----------------------~~~~~~~~DVwSlG~lLyeLltG-~~PF~g 512 (514)
+.... ....+...|||+|||++|+.++| ..||.-
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 76431 12233478999999999999988 999964
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-23 Score=222.62 Aligned_cols=178 Identities=34% Similarity=0.480 Sum_probs=157.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|+++.++|.|+||.||++++ .+++..|+|+|++.. ...+.-+++||-+++..+|+||+.|++.+...+.+|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-----~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC-----CccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 46899999999999999999999 789999999998632 233456789999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|.||||.+|+|.+++.- ..+++.++...++..+.||+|||++|-+|||||-.|||++..|.+|+.|||.+-.+...
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 99999999999998765 46899999999999999999999999999999999999999999999999998766533
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIF 510 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF 510 (514)
....|...+|||++|+...|+-.-++|-
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 2245556899999999999998777764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-20 Score=179.15 Aligned_cols=179 Identities=33% Similarity=0.489 Sum_probs=152.1
Q ss_pred eEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCC-ceeEEEEEecCCCeEEEEE
Q 010231 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~l~LVm 409 (514)
|.+...||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +|+++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 778899999999999999887 7788888865332221 2456788999999999988 7999999998777889999
Q ss_pred eccccCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-cEEEEeccCceecccCC-
Q 010231 410 ELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 410 Ey~~gGsL~~lL~~~----~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-~vKI~DFGlAk~~~~~~- 483 (514)
+|+.+++|..++... .+....+..++.|++.++.|+|+.+++||||||+||+++..+ .++++|||+++.+....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999999777765 688999999999999999999999999999999999999988 79999999987443211
Q ss_pred ------------------------C---cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------------D---FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------------~---~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. .......|+|++|+++|++++|..||...
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 24556888999999999999999998754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-22 Score=205.30 Aligned_cols=145 Identities=29% Similarity=0.461 Sum_probs=128.0
Q ss_pred ccccccceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEE
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT 398 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~ 398 (514)
++.+.+.|.++++||.|+|++||++++. ....||+|.+..... ..++.+|+.+|..+ .+.||+++.++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-------p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-------PSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-------chHHHHHHHHHHHhccchhhhcchhh
Confidence 3455678999999999999999999873 578999998875332 35578999999988 59999999999
Q ss_pred ecCCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-CCcEEEEeccCce
Q 010231 399 DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAK 477 (514)
Q Consensus 399 ~~~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-~g~vKI~DFGlAk 477 (514)
+..++++.+||||++.....+++.. ++...++.|++.++.||.++|.+|||||||||.|||.+. .+...|+|||||.
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999999999988865 556778999999999999999999999999999999985 5789999999998
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=188.11 Aligned_cols=167 Identities=13% Similarity=0.081 Sum_probs=130.4
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHH------HHHHHHHHhhcCCCceeEEEEEec
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQ------LEQEIALLSRFEHENIVQYYGTDK 400 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~------l~~Ei~iL~~L~HpnIv~l~~~~~ 400 (514)
+.++|++.++||.|+||.||++.. ++..+|+|++....... +..... +++|+..+..+.|++|..+.+.+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~--~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT--ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch--HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 346899999999999999999655 57789999886432222 222233 679999999999999999887754
Q ss_pred CC--------CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEe
Q 010231 401 DE--------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (514)
Q Consensus 401 ~~--------~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~D 472 (514)
.. ...+|||||++|.+|.++.. +++ ....+|+.+|..||++|++||||||.||+++.+| ++|+|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 32 35899999999999987732 332 2466999999999999999999999999999989 99999
Q ss_pred ccCceecccCC-------CcCcceeehhhhHHHHHHHHH
Q 010231 473 FGLAKVFLSSL-------DFDLLLIFSIFLNGCKFFLIF 504 (514)
Q Consensus 473 FGlAk~~~~~~-------~~~~~~~~DVwSlG~lLyeLl 504 (514)
||..+.+.... ...+....|+|+||+.+..+.
T Consensus 178 fg~~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhHHHHHHHhHhcccccccceeEeehHHH
Confidence 99998765431 123335899999999876554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=188.10 Aligned_cols=179 Identities=23% Similarity=0.269 Sum_probs=147.4
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC-CceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIv~l~~~~~~~~~ 404 (514)
..+.|.++++||.|+||.+|+|.. ..|..||||.-...-. -.++..|.++.+.|++ ..|..+..++.+..+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-------hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-------HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-------CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 357899999999999999999998 7899999997653221 2356678888888864 677888888888889
Q ss_pred EEEEEeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC---CcEEEEeccCceec
Q 010231 405 LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKVF 479 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~---g~vKI~DFGlAk~~ 479 (514)
-.|||+++ |-+|.++++ ...++-.+++.++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.|+|||||+.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999999 558988875 4578999999999999999999999999999999999999754 46899999999987
Q ss_pred ccCCC---------c-----------------CcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSSLD---------F-----------------DLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~~~---------~-----------------~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..... . .....-|+-|+|-+|.++-.|..||.|.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 64311 1 1112456899999999999999999874
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=178.74 Aligned_cols=171 Identities=18% Similarity=0.113 Sum_probs=127.4
Q ss_pred EeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCeEEEEEe
Q 010231 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 332 ~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVmE 410 (514)
.+...|++|+||+||.+.. .+..++.+.+.....-. .......+.+|+.+|++|. |++|++++++ +..|++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~-~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWL-RGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhh-hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3567899999999997765 67777766655322110 1111235789999999995 5789999886 34699999
Q ss_pred ccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCCEEEcCCCcEEEEeccCceecccCCCc----
Q 010231 411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI-KCANILVDANGSVKLADFGLAKVFLSSLDF---- 485 (514)
Q Consensus 411 y~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDL-KP~NILId~~g~vKI~DFGlAk~~~~~~~~---- 485 (514)
|+.|.+|...+... ...++.|++.+|.+||++||+|||| ||.|||++.+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 79 YLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 99999987543221 2457899999999999999999999 799999999999999999999854422110
Q ss_pred ------------------------------CcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 486 ------------------------------DLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 486 ------------------------------~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
......++++.|+.+|.++|+..++-+.|
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00012236789999999999999986654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=180.13 Aligned_cols=136 Identities=21% Similarity=0.336 Sum_probs=105.9
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-----CCCceeEEEEEecCCC---eE
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-----EHENIVQYYGTDKDES---KL 405 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-----~HpnIv~l~~~~~~~~---~l 405 (514)
..+||+|+||.||. +......+||++..... .....+.+|+.+++.+ .||||+++|+++.++. .+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 46799999999996 43223346888764221 1235688999999999 5799999999998874 43
Q ss_pred E-EEEec--cccCCHHHHHhhcCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCCEEEcCC----CcEEEEe-ccCc
Q 010231 406 Y-IFLEL--VTKGSLLNLYQRYHLRDSQVSAYTRQILLGL-KYLHDQDVVHRDIKCANILVDAN----GSVKLAD-FGLA 476 (514)
Q Consensus 406 ~-LVmEy--~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL-~yLHs~gIIHRDLKP~NILId~~----g~vKI~D-FGlA 476 (514)
+ +|||| +.+++|.+++++..+.+. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+| ||..
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 4 78999 558999999987666655 46788888888 99999999999999999999743 3799999 5544
Q ss_pred ee
Q 010231 477 KV 478 (514)
Q Consensus 477 k~ 478 (514)
..
T Consensus 158 ~~ 159 (210)
T PRK10345 158 TF 159 (210)
T ss_pred ce
Confidence 44
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.4e-20 Score=188.34 Aligned_cols=178 Identities=24% Similarity=0.274 Sum_probs=141.7
Q ss_pred ceEeeeeecccCceeEEEEEccC--CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC----CCceeEEEEEe-cCC
Q 010231 330 YWQKGDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE----HENIVQYYGTD-KDE 402 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~~--g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~----HpnIv~l~~~~-~~~ 402 (514)
.|.+.++||+|+||.||++.+.. ...+|+|.......... ..+..|+.++..+. ..++..+++.+ ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 89999999999999999999854 35789998764322111 13556777777775 36899999998 578
Q ss_pred CeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC-----CcEEEEecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GSVKLADFG 474 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~-----g~vKI~DFG 474 (514)
...||||+++ |.+|.++... ..++..++..++.|++.+|++||+.|+|||||||.|+++... ..+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 8899999999 5589988754 359999999999999999999999999999999999999865 369999999
Q ss_pred Cce--ecccCC---------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 475 LAK--VFLSSL---------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 475 lAk--~~~~~~---------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+|+ .+.... ....+..-|+||++-++.+++.|..|+.+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 999 432111 112223567999999999999999998653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.1e-19 Score=168.38 Aligned_cols=141 Identities=21% Similarity=0.251 Sum_probs=114.5
Q ss_pred eeecccCceeEEEEEccCCceEEEEEEeccccc---chhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEec
Q 010231 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~---~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy 411 (514)
+.||+|++|.||+|.+ .|..+++|........ .........+.+|+.++..+.|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6678889875432111 11222335678899999999999887666666666778999999
Q ss_pred cccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 412 VTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 412 ~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
++|++|.+++..... ....++.+|+.+|.+||++|++|+|++|.|||++ ++.++|+|||++....
T Consensus 81 ~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 999999998865332 7788999999999999999999999999999998 8899999999998643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=177.24 Aligned_cols=149 Identities=19% Similarity=0.172 Sum_probs=115.8
Q ss_pred ceEeeeeecccCceeEEEEE--ccCCceEEEEEEecccccc-------------------hhHHHHHHHHHHHHHHhhcC
Q 010231 330 YWQKGDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGS-------------------QAKQSISQLEQEIALLSRFE 388 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~--~~~g~~vAIK~v~~~~~~~-------------------~~~~~~~~l~~Ei~iL~~L~ 388 (514)
-|.+.+.||+|+||.||+|. ..+|+.||+|++....... ........+.+|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 4789999999987532110 01112234678999999997
Q ss_pred CCc--eeEEEEEecCCCeEEEEEeccccCCHHHHH-hhcCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCCEEEcC
Q 010231 389 HEN--IVQYYGTDKDESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDA 464 (514)
Q Consensus 389 Hpn--Iv~l~~~~~~~~~l~LVmEy~~gGsL~~lL-~~~~lse~~v~~i~~QIl~gL~yLHs~g-IIHRDLKP~NILId~ 464 (514)
+.+ +.+++.. ...||||||+.+++|..++ ....+....+..++.||+.+|.+||++| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 4455543 2348999999998886654 3445666677899999999999999999 99999999999999
Q ss_pred CCcEEEEeccCceecccCC
Q 010231 465 NGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 465 ~g~vKI~DFGlAk~~~~~~ 483 (514)
++.++|+|||+|.......
T Consensus 184 ~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 184 DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred CCCEEEEEChhhhccCCcc
Confidence 8899999999999765543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=166.24 Aligned_cols=144 Identities=19% Similarity=0.166 Sum_probs=112.3
Q ss_pred ceEeeeeecccCceeEEEEEccCCceEEEEEEecccccch-----------------hHHHHHHHHHHHHHHhhcCCC--
Q 010231 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ-----------------AKQSISQLEQEIALLSRFEHE-- 390 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~-----------------~~~~~~~l~~Ei~iL~~L~Hp-- 390 (514)
.|.+.+.||+|+||.||++...+|+.+|||++........ .........+|+.++..+.|.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4778899999999999999988899999998764221100 001122356788899888777
Q ss_pred ceeEEEEEecCCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEE
Q 010231 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 391 nIv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI 470 (514)
.++.+++. ...++||||+.+++|..+... .....++.+|+.++.++|+.||+||||||+||+++.++.++|
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 44455542 345899999999998765431 345678999999999999999999999999999999999999
Q ss_pred EeccCceecccC
Q 010231 471 ADFGLAKVFLSS 482 (514)
Q Consensus 471 ~DFGlAk~~~~~ 482 (514)
+|||++......
T Consensus 167 iDfg~~~~~~~~ 178 (198)
T cd05144 167 IDWPQMVSTDHP 178 (198)
T ss_pred EECCccccCCCc
Confidence 999999765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=164.32 Aligned_cols=137 Identities=24% Similarity=0.262 Sum_probs=108.2
Q ss_pred eecccCceeEEEEEccCCceEEEEEEeccccc---chhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEecc
Q 010231 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~---~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
.||+|+||.||++.+ ++..+++|........ ........++.+|+.++..+.|+++......+...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 5678999975432111 112333466789999999998876544444444556679999999
Q ss_pred ccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 413 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 413 ~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
+|++|.+++..... .++.|++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++....
T Consensus 80 ~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 99999988754321 7899999999999999999999999999999 8999999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-19 Score=205.48 Aligned_cols=122 Identities=16% Similarity=0.150 Sum_probs=95.0
Q ss_pred CceeEEEEEe-------cCCCeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCE
Q 010231 390 ENIVQYYGTD-------KDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460 (514)
Q Consensus 390 pnIv~l~~~~-------~~~~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI 460 (514)
.||.+++++| .....++++|||+ +++|.+++.. ..+++..++.|++||+.||.|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4666666665 2334678888987 5599999965 3489999999999999999999999999999999999
Q ss_pred EEcC-------------------CCcEEEEeccCceecc--------------------------------cC---CCcC
Q 010231 461 LVDA-------------------NGSVKLADFGLAKVFL--------------------------------SS---LDFD 486 (514)
Q Consensus 461 LId~-------------------~g~vKI~DFGlAk~~~--------------------------------~~---~~~~ 486 (514)
||+. ++.+||+|||+++... .+ ....
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9954 4556777777775321 11 1233
Q ss_pred cceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 487 LLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 487 ~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+...+|||||||+||||++|.+||..
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhh
Confidence 55688999999999999999998864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=187.17 Aligned_cols=142 Identities=21% Similarity=0.223 Sum_probs=112.6
Q ss_pred ceEeeeeecccCceeEEEEEccCCceEEEEE-Eecccc--cchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKE-VSLLDQ--GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~-v~~~~~--~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.|...+.||+|+||+||++.+.... +++|. +..... ..........+.+|+.++..++|++|+..+.++......+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 3456788999999999999875443 33443 221111 1112233466889999999999999988777766667789
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
+||||+++++|.+++. ....++.||+.+|.|||++||+||||||+|||+ .++.++|+|||+++...
T Consensus 413 lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 9999999999998875 356789999999999999999999999999999 68899999999998754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-18 Score=178.49 Aligned_cols=179 Identities=22% Similarity=0.323 Sum_probs=144.7
Q ss_pred cceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD- 401 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~- 401 (514)
.++++..++-+|+||.||.|++. +.+.+-+|.++. .-.+.....+.+|--++..+.|+|+..+.+++.+
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 35778888999999999999763 345556665553 2234445667889889999999999999998754
Q ss_pred CCeEEEEEeccccCCHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEe
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~---------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~D 472 (514)
....+.++.++.-|+|..++.. ..++..++..++.|+..|++|||++||||.||-.+|.+|+..-+|||+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence 4567888899999999998872 1266677888999999999999999999999999999999999999999
Q ss_pred ccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCC
Q 010231 473 FGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFR 511 (514)
Q Consensus 473 FGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~ 511 (514)
=.|++.+... .+..+...+|+||||++|||||| |..|+.
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 9999865432 23556678999999999999994 777764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.4e-18 Score=191.51 Aligned_cols=185 Identities=19% Similarity=0.220 Sum_probs=140.4
Q ss_pred CCCccccccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 010231 319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT 398 (514)
Q Consensus 319 s~~~~~~~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~ 398 (514)
.+...+......|.|-+.||+|+||+||.|...+|+.||+|+-+.... |.--...+++..++ ++. -+-|..+..+
T Consensus 688 ~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--WEfYI~~q~~~RLk-~~~--~~~~~~~~~a 762 (974)
T KOG1166|consen 688 NPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--WEFYICLQVMERLK-PQM--LPSIMHISSA 762 (974)
T ss_pred CccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--eeeeehHHHHHhhc-hhh--hcchHHHHHH
Confidence 334444445568999999999999999999998899999998653211 11111122222222 111 2345556566
Q ss_pred ecCCCeEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-------CCcEEE
Q 010231 399 DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-------NGSVKL 470 (514)
Q Consensus 399 ~~~~~~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-------~g~vKI 470 (514)
....+.-+||+||.+.|+|.++++.. .+++..+..+..||+..|++||..+|||+||||+|+||.. .--++|
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred HccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence 66677789999999999999999864 4888889999999999999999999999999999999953 235999
Q ss_pred EeccCceecc---cC------------------CCcCcceeehhhhHHHHHHHHHhCCC
Q 010231 471 ADFGLAKVFL---SS------------------LDFDLLLIFSIFLNGCKFFLIFLHVL 508 (514)
Q Consensus 471 ~DFGlAk~~~---~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~ 508 (514)
+|||-+.-+. .. .+..|++.+|.|.|..++|-|++|++
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999987432 11 45688889999999999999999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-17 Score=153.47 Aligned_cols=143 Identities=22% Similarity=0.236 Sum_probs=101.9
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchhHHH-------------------HHHHHHHHHHHhhcCCCc--e
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-------------------ISQLEQEIALLSRFEHEN--I 392 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~-------------------~~~l~~Ei~iL~~L~Hpn--I 392 (514)
++.||+|+||+||+|.+.+++.||||++............ ......|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5679999999999999888999999988643221111100 011135566666654432 4
Q ss_pred eEEEEEecCCCeEEEEEeccccCCHH-HHHhhcCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEE
Q 010231 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 393 v~l~~~~~~~~~l~LVmEy~~gGsL~-~lL~~~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI 470 (514)
.+++++ ...++||||++++.+. ..+...... ..+..++.|++.++.++|. +||+|+||||+||+++ ++.++|
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~l 155 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYI 155 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEE
Confidence 445543 2358999999995432 122221111 5678899999999999999 9999999999999999 999999
Q ss_pred EeccCceecccC
Q 010231 471 ADFGLAKVFLSS 482 (514)
Q Consensus 471 ~DFGlAk~~~~~ 482 (514)
+|||.+.....+
T Consensus 156 iDfg~a~~~~~~ 167 (187)
T cd05119 156 IDVPQAVEIDHP 167 (187)
T ss_pred EECcccccccCc
Confidence 999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.8e-18 Score=186.82 Aligned_cols=174 Identities=25% Similarity=0.373 Sum_probs=145.9
Q ss_pred eecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCeEEEEEe
Q 010231 336 LLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVmE 410 (514)
++|+|.||.|+++.. ..+..+|+|+.+........+. ....|..++..++ ||+++++...+++..++|++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 479999999998764 4678889998765443332222 4556778888886 9999999999999999999999
Q ss_pred ccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC-----
Q 010231 411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD----- 484 (514)
Q Consensus 411 y~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~----- 484 (514)
|..+|.|...+.+. .+.+..++.|...++.+++++|+.+|+|||+|++||+++.+|++|+.|||+.+.......
T Consensus 78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~ 157 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTY 157 (612)
T ss_pred hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccch
Confidence 99999998877654 477778899999999999999999999999999999999999999999999987643321
Q ss_pred --------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 485 --------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 485 --------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
..+....|.|+||+++|+|+||..||.+
T Consensus 158 eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 158 EYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch
Confidence 1355678999999999999999999976
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=161.69 Aligned_cols=181 Identities=22% Similarity=0.265 Sum_probs=121.2
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC----------CceeEEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH----------ENIVQYYGT 398 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H----------pnIv~l~~~ 398 (514)
.+..++.||.|+|+.||.+++ .+++.+|+|+..... ......++++++|......+.+ -.++-.++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 567889999999999999999 679999999987655 3444556777777655555322 112211111
Q ss_pred ---------e---cCCC-----eEEEEEeccccCCHHHHHhh---c-CC----CHHHHHHHHHHHHHHHHHHHHCCcccc
Q 010231 399 ---------D---KDES-----KLYIFLELVTKGSLLNLYQR---Y-HL----RDSQVSAYTRQILLGLKYLHDQDVVHR 453 (514)
Q Consensus 399 ---------~---~~~~-----~l~LVmEy~~gGsL~~lL~~---~-~l----se~~v~~i~~QIl~gL~yLHs~gIIHR 453 (514)
+ .... +.+++|+-+.+ +|..++.. . .. .......+..|++..+++||.+||+|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 1 1111 24677887744 77776532 1 12 122234566899999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEEeccCceecccC------------------------CCcCcceeehhhhHHHHHHHHHhCCCC
Q 010231 454 DIKCANILVDANGSVKLADFGLAKVFLSS------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLI 509 (514)
Q Consensus 454 DLKP~NILId~~g~vKI~DFGlAk~~~~~------------------------~~~~~~~~~DVwSlG~lLyeLltG~~P 509 (514)
||||+|++++.+|.++|+||+........ .+..++...|.|.||+++|.|.|++.|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 99999999999999999999887754322 112355678999999999999999999
Q ss_pred CCCC
Q 010231 510 FRPP 513 (514)
Q Consensus 510 F~g~ 513 (514)
|...
T Consensus 250 f~~~ 253 (288)
T PF14531_consen 250 FGLS 253 (288)
T ss_dssp TCCC
T ss_pred CCCC
Confidence 9854
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=3e-16 Score=155.74 Aligned_cols=142 Identities=18% Similarity=0.210 Sum_probs=106.7
Q ss_pred eeeec-ccCceeEEEEEccCCceEEEEEEecccc--------cchhHHHHHHHHHHHHHHhhcCCCce--eEEEEEecCC
Q 010231 334 GDLLG-RGSFGSVYEGISDDGFFFAVKEVSLLDQ--------GSQAKQSISQLEQEIALLSRFEHENI--VQYYGTDKDE 402 (514)
Q Consensus 334 ~~~LG-~GsfG~Vyka~~~~g~~vAIK~v~~~~~--------~~~~~~~~~~l~~Ei~iL~~L~HpnI--v~l~~~~~~~ 402 (514)
+..|| .|+.|+||.+... +..+++|.+..... ..........+.+|+.++..+.|++| +..++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34576 7778888887664 66788888753110 00111234567889999999998875 5666553322
Q ss_pred -C---eEEEEEecccc-CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCce
Q 010231 403 -S---KLYIFLELVTK-GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (514)
Q Consensus 403 -~---~l~LVmEy~~g-GsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk 477 (514)
. ..+|||||++| .+|.+++....+++. .+.||+.+|.+||++||+||||||.|||++.++.++|+|||.+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 2 23599999997 689988877666554 36789999999999999999999999999999999999999999
Q ss_pred ecc
Q 010231 478 VFL 480 (514)
Q Consensus 478 ~~~ 480 (514)
...
T Consensus 191 ~~~ 193 (239)
T PRK01723 191 LRT 193 (239)
T ss_pred cCC
Confidence 865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.6e-18 Score=186.65 Aligned_cols=181 Identities=25% Similarity=0.375 Sum_probs=141.3
Q ss_pred EeeeeecccCceeEEEEEc-cCCceEEEEEEeccc-ccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEE
Q 010231 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 332 ~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~-~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm 409 (514)
....++|.|.||.|+.+.. .....++.|.+.... ...........+..|+-+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998877765 334444555433110 22233333344777888888899999987777666666666669
Q ss_pred eccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC----
Q 010231 410 ELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD---- 484 (514)
Q Consensus 410 Ey~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~---- 484 (514)
|||++ +|+.++... .+....+..++.||+.||+|||..||.|||||++|+|+..+|.+||+|||.+..+..+.+
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99999 999988876 799999999999999999999999999999999999999999999999999998764422
Q ss_pred --------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 485 --------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 485 --------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.......||||.|++++.|++|+.||..+
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a 528 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVA 528 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccc
Confidence 11124677999999999999999999754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.1e-16 Score=137.81 Aligned_cols=132 Identities=20% Similarity=0.243 Sum_probs=110.5
Q ss_pred eeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC--CceeEEEEEecCCCeEEEEEe
Q 010231 333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 333 i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pnIv~l~~~~~~~~~l~LVmE 410 (514)
+++.||.|.++.||++...+ ..+++|.+..... ...+.+|+.++..+.| .++++++..+...+..|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence 35789999999999999855 6789998753221 3467789999999976 588899988888788999999
Q ss_pred ccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---DVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 411 y~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~---gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
|+.++.+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+.++++|||++..
T Consensus 74 ~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9998877644 4456677899999999999985 699999999999999989999999999975
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.8e-16 Score=159.43 Aligned_cols=186 Identities=22% Similarity=0.284 Sum_probs=138.3
Q ss_pred ccccceEeeeeecccCceeEEEEEccC------------------------------------CceEEEEEEecccccch
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDD------------------------------------GFFFAVKEVSLLDQGSQ 369 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~------------------------------------g~~vAIK~v~~~~~~~~ 369 (514)
..+++|++++.||+|....||.+...+ ..+.|||.+...+....
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 346899999999999999999886311 12456676655555555
Q ss_pred hHHHHHHHHHHHH------H--------Hhh--------cCCCceeEEEEEecC--------------------------
Q 010231 370 AKQSISQLEQEIA------L--------LSR--------FEHENIVQYYGTDKD-------------------------- 401 (514)
Q Consensus 370 ~~~~~~~l~~Ei~------i--------L~~--------L~HpnIv~l~~~~~~-------------------------- 401 (514)
.....+.+-+|+. . .+. -+|||||++.++|.+
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 5555555444431 0 011 369999999876543
Q ss_pred -CCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc--CCC--cEEEEeccCc
Q 010231 402 -ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG--SVKLADFGLA 476 (514)
Q Consensus 402 -~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId--~~g--~vKI~DFGlA 476 (514)
...+|+||.-+.. +|..|+.....+......++.|+++|+.|||++||.|||+|.+||||. .++ .+.|+|||+|
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 2368999998876 899999888889999999999999999999999999999999999984 444 4789999998
Q ss_pred eecccC--------CC-----------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 477 KVFLSS--------LD-----------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 477 k~~~~~--------~~-----------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
-.-... .+ ...-.+.|.|+.|.+.||++...-||=+
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 643321 00 0111367899999999999999999954
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.4e-15 Score=139.28 Aligned_cols=91 Identities=23% Similarity=0.212 Sum_probs=78.4
Q ss_pred CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----------
Q 010231 415 GSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---------- 482 (514)
Q Consensus 415 GsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---------- 482 (514)
|+|.+++.. ..+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~y~a 72 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPYFMA 72 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccccCCCcccccC
Confidence 689998875 35999999999999999999999998 999999999999999 9999865432
Q ss_pred ----CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+..++|||||||++|+|+||+.||...
T Consensus 73 PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1234556899999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.3e-16 Score=174.23 Aligned_cols=178 Identities=23% Similarity=0.239 Sum_probs=140.2
Q ss_pred ceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm 409 (514)
+|...+.||.+.|=+|.+|++.+|. |+||++...+........ .+...|++ ...+++||++++.-+-.++...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPF-KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHH-HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 7888899999999999999999887 889988765543333333 33445566 66778999999988877778889999
Q ss_pred eccccCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec--ccCC---
Q 010231 410 ELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF--LSSL--- 483 (514)
Q Consensus 410 Ey~~gGsL~~lL~~~~-lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~--~~~~--- 483 (514)
+|+.. +|++.+.... +..-+.+-|+.||+.||.-+|..||+|+|||.+||||+.-+=+.|+||---+.. ..+.
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99976 7888776544 556667788999999999999999999999999999999998999999655421 1110
Q ss_pred -------------------------------CcC-cceeehhhhHHHHHHHHHhC-CCCCC
Q 010231 484 -------------------------------DFD-LLLIFSIFLNGCKFFLIFLH-VLIFR 511 (514)
Q Consensus 484 -------------------------------~~~-~~~~~DVwSlG~lLyeLltG-~~PF~ 511 (514)
+.. .+..+||||+||+++||++. ++||.
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 111 33578899999999999965 99985
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.8e-14 Score=149.26 Aligned_cols=144 Identities=20% Similarity=0.138 Sum_probs=97.9
Q ss_pred eeecccCceeEEEEEccCCceEEEEEEecccccch-----------------------------hHHHHH------HHHH
Q 010231 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ-----------------------------AKQSIS------QLEQ 379 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~-----------------------------~~~~~~------~l~~ 379 (514)
+.||.|++|.||+|+..+|+.||||+.+..-.... ...... .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999753211000 000111 1334
Q ss_pred HHHHHhhc----CCCceeEEEEE-ecCCCeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHH-HHHHHHHCCcc
Q 010231 380 EIALLSRF----EHENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILL-GLKYLHDQDVV 451 (514)
Q Consensus 380 Ei~iL~~L----~HpnIv~l~~~-~~~~~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~-gL~yLHs~gII 451 (514)
|...+..+ +|.+-+.+-.+ +......+|||||++|++|.++.... ++. ...++.+++. .+..+|..|++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCce
Confidence 55444444 22222222222 22234569999999999998776432 232 2345556655 46788999999
Q ss_pred ccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 452 HRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 452 HRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
|+|+||.||+++.+|.++|+|||++..+..
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999988754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.7e-13 Score=127.90 Aligned_cols=146 Identities=16% Similarity=0.124 Sum_probs=106.2
Q ss_pred eeeecccCceeEEEEEccC-------CceEEEEEEeccccc---------------------chhHHHHHHHHHHHHHHh
Q 010231 334 GDLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQG---------------------SQAKQSISQLEQEIALLS 385 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~-------g~~vAIK~v~~~~~~---------------------~~~~~~~~~l~~Ei~iL~ 385 (514)
..+||.|.-+.||.|...+ +..+|||+.+..... ...+....-.++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998753 579999987532110 011111112348999998
Q ss_pred hcCC--CceeEEEEEecCCCeEEEEEeccccCCHH-HHHhhcCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCCEE
Q 010231 386 RFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANIL 461 (514)
Q Consensus 386 ~L~H--pnIv~l~~~~~~~~~l~LVmEy~~gGsL~-~lL~~~~lse~~v~~i~~QIl~gL~yL-Hs~gIIHRDLKP~NIL 461 (514)
++.. -++..++++ ..-+|||||+.++.+. ..++...++...+..++.|++.+|..| |+.||||+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8854 345566654 3458999999875442 234444566667778899999999998 8999999999999999
Q ss_pred EcCCCcEEEEeccCceecccCCC
Q 010231 462 VDANGSVKLADFGLAKVFLSSLD 484 (514)
Q Consensus 462 Id~~g~vKI~DFGlAk~~~~~~~ 484 (514)
++ ++.++|+|||.|.....+..
T Consensus 158 ~~-~~~v~iIDF~qav~~~hp~a 179 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPTHPHG 179 (197)
T ss_pred EE-CCcEEEEECCCceeCCCCCH
Confidence 96 57899999999998765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.6e-14 Score=152.24 Aligned_cols=146 Identities=16% Similarity=0.117 Sum_probs=96.3
Q ss_pred ccceEeeeeecccCceeEEEEEccC-CceEEEEEEeccccc-----------------------------chhHHHHHHH
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQG-----------------------------SQAKQSISQL 377 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~-g~~vAIK~v~~~~~~-----------------------------~~~~~~~~~l 377 (514)
...|+. +.||.|++|.||+|+..+ |+.||||++...-.. ....+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445666 789999999999999876 999999998642100 0011122223
Q ss_pred HH------HHHHHhhc----CCCceeEEEEEec-CCCeEEEEEeccccCCHHHH--HhhcCC-----CHHHHHHHHHHHH
Q 010231 378 EQ------EIALLSRF----EHENIVQYYGTDK-DESKLYIFLELVTKGSLLNL--YQRYHL-----RDSQVSAYTRQIL 439 (514)
Q Consensus 378 ~~------Ei~iL~~L----~HpnIv~l~~~~~-~~~~l~LVmEy~~gGsL~~l--L~~~~l-----se~~v~~i~~QIl 439 (514)
.+ |...+.++ .+.+.+.+-.++. -....+|||||+.|+.+.++ +...+. .+..+..|+.||+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 33 33333333 2333333222222 23456899999999999764 344443 3334445556654
Q ss_pred HHHHHHHHCCccccCCCCCCEEEcCCC----cEEEEeccCceeccc
Q 010231 440 LGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKVFLS 481 (514)
Q Consensus 440 ~gL~yLHs~gIIHRDLKP~NILId~~g----~vKI~DFGlAk~~~~ 481 (514)
..|++|+|+||.||+|+.+| .++++|||++..+..
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999888 999999999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.9e-14 Score=158.31 Aligned_cols=145 Identities=26% Similarity=0.354 Sum_probs=107.0
Q ss_pred cccceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
....|..+++|..|+||.||.++++ +.+.+|+|+-+. .. +.+- ++.....|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---~l--------ilRn--ilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---NL--------ILRN--ILTFAGNPFVV------------ 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccccc---ch--------hhhc--cccccCCccee------------
Confidence 3567899999999999999999984 677888853221 00 0110 33444445544
Q ss_pred EEEEeccccCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 406 YIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~-lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
|+-..+++..+ ++. +++.+++|||+.||+|||+||+|+||+.-|++|++|||+.+......
T Consensus 136 ---------gDc~tllk~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---------chhhhhcccCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 44444454422 222 33889999999999999999999999999999999999998754321
Q ss_pred ---------------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ---------------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ---------------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
-..|+..+|+|++|+|+|+.+.|+.||.|.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 134556789999999999999999999985
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.2e-13 Score=121.65 Aligned_cols=128 Identities=20% Similarity=0.170 Sum_probs=95.3
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCce-eEEEEEecCCCeEEEEEecc
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~LVmEy~ 412 (514)
++.|+.|.++.||++... +..|++|....... ....+.+|+.++..+.+.++ .+++..+.+ ..++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEec
Confidence 467899999999999865 67899997653211 11234678888888765444 445555432 347999999
Q ss_pred ccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 413 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV-----VHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 413 ~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gI-----IHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
+|.++... . .....++.+++.+|..||..++ +|+|++|.|||++ ++.++|+|||.|..
T Consensus 74 ~G~~l~~~----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99877543 1 1123467899999999999885 9999999999998 77899999999985
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.2e-13 Score=133.37 Aligned_cols=180 Identities=15% Similarity=0.224 Sum_probs=137.6
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
....+..+|.+...|..|+|+++.+ .++.|++++.. .....-..|..|.-.|+-+.||||+.+++.|....++.++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~---~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVRE---VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCc-chhhhhhhhhh---cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 3456677889999999999999754 44556655422 2223335677888889999999999999999999999999
Q ss_pred EeccccCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEcCCCcEEE--EeccCce----
Q 010231 409 LELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKL--ADFGLAK---- 477 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~~---lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId~~g~vKI--~DFGlAk---- 477 (514)
..|++.|+|+.++.+.. +...++.+++..|+.|+.|||+.. |.---|....++||++-..+| +|--++-
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~g 345 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVG 345 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeeccc
Confidence 99999999999997643 667788999999999999999875 444468889999998876554 3422211
Q ss_pred -ecc----------cCCCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 478 -VFL----------SSLDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 478 -~~~----------~~~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.|. ..........+|+|||.+++|||.|++.||..
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad 391 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD 391 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence 111 11223344689999999999999999999964
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.8e-13 Score=152.32 Aligned_cols=182 Identities=26% Similarity=0.361 Sum_probs=147.8
Q ss_pred cceEeeeeecccCceeEEEEEc--cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCeE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKL 405 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~--~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l 405 (514)
..|.+.+.||+|+|+.|-.... .....+|+|.+.... .......+...|..+-..+. |.|++.+++........
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 4577788899999999988876 344566667665432 23334455666787777776 99999999999999999
Q ss_pred EEEEeccccCCHHHHH-hhc--CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCCEEEcCCC-cEEEEeccCceecc
Q 010231 406 YIFLELVTKGSLLNLY-QRY--HLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANG-SVKLADFGLAKVFL 480 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL-~~~--~lse~~v~~i~~QIl~gL~yLH-s~gIIHRDLKP~NILId~~g-~vKI~DFGlAk~~~ 480 (514)
+++++|..+++++..+ ... .+.......++.|+..++.|+| ..++.|+||||+|.+++..+ .+|+.|||+|..+.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999998877 432 5777888999999999999999 99999999999999999999 99999999999876
Q ss_pred c-C---------CC--------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 S-S---------LD--------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~-~---------~~--------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. . .. .......|+||.|+++..|++|..|...+
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 5 1 01 11123678999999999999999998654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-10 Score=110.87 Aligned_cols=139 Identities=19% Similarity=0.203 Sum_probs=100.5
Q ss_pred eeecccCceeEEEEEccCCceEEEEEEecc---cccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEec
Q 010231 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLL---DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~---~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy 411 (514)
.++++|+-+.+|.+.+.+ ..+.+|.-... ......+-...+..+|.+++..++--.|...+-++.+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 458899999999996643 33555643211 11123334445667899999988755554444444566777899999
Q ss_pred cccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 412 VTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 412 ~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
++|..|.+++... ...+++.+=.-+.-||..||||+||.++||++..++ +.++||||+..-..
T Consensus 81 I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 81 IEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred eCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 9999999888765 144667777778889999999999999999996554 99999999996443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.1e-11 Score=113.20 Aligned_cols=140 Identities=19% Similarity=0.205 Sum_probs=102.2
Q ss_pred eeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCC--ceeEEEEEecCC---CeEEEEE
Q 010231 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDE---SKLYIFL 409 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIv~l~~~~~~~---~~l~LVm 409 (514)
+.|+.|.++.||++...+|..+++|........ .....+.+|+.++..+.+. ++.+++.+.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 578999999999998876788999986532211 1234677899999998653 456677766553 3678999
Q ss_pred eccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 010231 410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD------------------------------------------ 447 (514)
Q Consensus 410 Ey~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs------------------------------------------ 447 (514)
||++|.++...+....++......++.+++..|.+||+
T Consensus 80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99999877654422345555556666666666666663
Q ss_pred --------------CCccccCCCCCCEEEcC--CCcEEEEeccCcee
Q 010231 448 --------------QDVVHRDIKCANILVDA--NGSVKLADFGLAKV 478 (514)
Q Consensus 448 --------------~gIIHRDLKP~NILId~--~g~vKI~DFGlAk~ 478 (514)
..++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998885
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.3e-11 Score=130.17 Aligned_cols=129 Identities=27% Similarity=0.458 Sum_probs=110.7
Q ss_pred HhhcCCCceeEEEEEecCCCeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCc-cccCCCCCCE
Q 010231 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDV-VHRDIKCANI 460 (514)
Q Consensus 384 L~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gI-IHRDLKP~NI 460 (514)
|+.+.|.|+.+++|.+.+...+++|.+||..|+|.+.+... ++...-...+++.|+.||.|||.--| .|+.|+..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45788999999999999999999999999999999998764 45666667889999999999998765 9999999999
Q ss_pred EEcCCCcEEEEeccCceecccC-------------------------CCc---CcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 461 LVDANGSVKLADFGLAKVFLSS-------------------------LDF---DLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 461 LId~~g~vKI~DFGlAk~~~~~-------------------------~~~---~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+++....+||+|||+....... ... ..+...|+||||+++||+++..-||+-
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998876310 011 135678999999999999999999975
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-10 Score=109.28 Aligned_cols=134 Identities=26% Similarity=0.257 Sum_probs=91.0
Q ss_pred eEEEEEccCCceEEEEEEeccc---------------------ccchhHHHHHHHHHHHHHHhhcCCC--ceeEEEEEec
Q 010231 344 SVYEGISDDGFFFAVKEVSLLD---------------------QGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDK 400 (514)
Q Consensus 344 ~Vyka~~~~g~~vAIK~v~~~~---------------------~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIv~l~~~~~ 400 (514)
.||.|...+|..+|+|+.+... ...+.........+|...|..+..- ++.+++.+..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 4899999889999999875321 1123334445577899999999765 4566665532
Q ss_pred CCCeEEEEEeccc--cCCHHHHHhhcCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCCEEEcCCCcEEEEeccCce
Q 010231 401 DESKLYIFLELVT--KGSLLNLYQRYHLRDSQVSAYTRQILLGLKY-LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (514)
Q Consensus 401 ~~~~l~LVmEy~~--gGsL~~lL~~~~lse~~v~~i~~QIl~gL~y-LHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk 477 (514)
-+|||||++ |..+..+ ....++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.|.
T Consensus 81 ----~~ivME~I~~~G~~~~~l-~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav 154 (188)
T PF01163_consen 81 ----NVIVMEYIGEDGVPLPRL-KDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAV 154 (188)
T ss_dssp ----TEEEEE--EETTEEGGCH-HHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred ----CEEEEEecCCCccchhhH-HhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcce
Confidence 379999999 6555443 33333355677788899986555 579999999999999999877 99999999999
Q ss_pred ecccCC
Q 010231 478 VFLSSL 483 (514)
Q Consensus 478 ~~~~~~ 483 (514)
....+.
T Consensus 155 ~~~~p~ 160 (188)
T PF01163_consen 155 DSSHPN 160 (188)
T ss_dssp ETTSTT
T ss_pred ecCCcc
Confidence 876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.8e-10 Score=123.85 Aligned_cols=148 Identities=22% Similarity=0.264 Sum_probs=117.4
Q ss_pred ccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccCCHHHHHhhcCCCHH
Q 010231 350 SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS 429 (514)
Q Consensus 350 ~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~lse~ 429 (514)
..++.++.|..++.... .......+-++-|+.++||||++|+..+.....+|||+|-+.- |..++++. ...
T Consensus 34 k~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l--~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL--GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh--HHH
Confidence 36778888887775322 2344567788899999999999999999999999999998853 66666553 366
Q ss_pred HHHHHHHHHHHHHHHHH-HCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC------------C-----cCcceee
Q 010231 430 QVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL------------D-----FDLLLIF 491 (514)
Q Consensus 430 ~v~~i~~QIl~gL~yLH-s~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~------------~-----~~~~~~~ 491 (514)
.+..-++||+.||.||| +.+++|++|.-..|+|+..|..||++|-++....... . .......
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~s~ 184 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEWSI 184 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccccch
Confidence 77788999999999998 5689999999999999999999999998875433221 0 0111346
Q ss_pred hhhhHHHHHHHHHhC
Q 010231 492 SIFLNGCKFFLIFLH 506 (514)
Q Consensus 492 DVwSlG~lLyeLltG 506 (514)
|.|-|||++++++-|
T Consensus 185 D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhHHHHHHHHhCc
Confidence 999999999999988
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.9e-09 Score=102.84 Aligned_cols=152 Identities=24% Similarity=0.252 Sum_probs=109.7
Q ss_pred eeeeecccCceeEEEEEccCCceEEEEEEec---ccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEE
Q 010231 333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSL---LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 333 i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~---~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm 409 (514)
...+|-+|+-+.|+++.+. |+.+.||.-.. .......+....+..+|+++|.++.--.|.-..-++.+.+.-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678899999999999875 56666665321 1112233445567789999998886555544333455666678999
Q ss_pred eccccC-CHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC---cEEEEeccCceecccC
Q 010231 410 ELVTKG-SLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKVFLSS 482 (514)
Q Consensus 410 Ey~~gG-sL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g---~vKI~DFGlAk~~~~~ 482 (514)
||++|. ++.+++... ...++....++++|-..|.-||.++|||+||-.+||++..+| .+.|+|||+...-..+
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~~~ 169 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSRLP 169 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcccCc
Confidence 999874 666666542 233444478899999999999999999999999999998766 3589999999876555
Q ss_pred CCc
Q 010231 483 LDF 485 (514)
Q Consensus 483 ~~~ 485 (514)
.+.
T Consensus 170 EDK 172 (229)
T KOG3087|consen 170 EDK 172 (229)
T ss_pred ccc
Confidence 443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.7e-09 Score=108.68 Aligned_cols=145 Identities=24% Similarity=0.253 Sum_probs=111.2
Q ss_pred ceEeeeeecccCceeEEEEEccCCceEEEEEEec-----------------ccccchhHHHHHHHHHHHHHHhhcCCC--
Q 010231 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL-----------------LDQGSQAKQSISQLEQEIALLSRFEHE-- 390 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~-----------------~~~~~~~~~~~~~l~~Ei~iL~~L~Hp-- 390 (514)
-+.++..||.|.-+.||.|.+..|..+|||.=+. .....+.-......++|..+|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3567899999999999999999999999996321 112223344455567899999998654
Q ss_pred ceeEEEEEecCCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEE
Q 010231 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 391 nIv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI 470 (514)
.|.+.+++ +...+||||+.|..|... .+..+....++..|+.-+..+-..||||+|+.+-||||+.+|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 56666654 566899999999766543 2245566677888888877777899999999999999999999999
Q ss_pred EeccCceecccC
Q 010231 471 ADFGLAKVFLSS 482 (514)
Q Consensus 471 ~DFGlAk~~~~~ 482 (514)
+||=.+.....+
T Consensus 244 IDwPQ~v~~~hp 255 (304)
T COG0478 244 IDWPQAVPISHP 255 (304)
T ss_pred EeCcccccCCCC
Confidence 999877765443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.7e-10 Score=123.57 Aligned_cols=100 Identities=24% Similarity=0.338 Sum_probs=86.5
Q ss_pred CeEEEEEeccccCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 403 SKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~~----lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.++||.|++|...+|.++|.+.. .+....+.++.|+..|++| ++.+|+|+||.||+...+..+||.||||...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999999999997543 4556678899999999999 9999999999999999999999999999886
Q ss_pred cccCC-------------------------CcCcceeehhhhHHHHHHHHHh
Q 010231 479 FLSSL-------------------------DFDLLLIFSIFLNGCKFFLIFL 505 (514)
Q Consensus 479 ~~~~~-------------------------~~~~~~~~DVwSlG~lLyeLlt 505 (514)
..... ..++..+.|||+||.+|||++.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 54332 2566778999999999999997
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.7e-08 Score=102.26 Aligned_cols=142 Identities=12% Similarity=0.083 Sum_probs=93.7
Q ss_pred eecccCceeEEEEEccCCceEEEEEEecccccchhH------HHHHHHHHHHHHHhhcCCCce--eEEEEEecC-----C
Q 010231 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAK------QSISQLEQEIALLSRFEHENI--VQYYGTDKD-----E 402 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~------~~~~~l~~Ei~iL~~L~HpnI--v~l~~~~~~-----~ 402 (514)
.+-......|++... +|+.|.||...........+ .......+|...+..+..-+| +.++.++.. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333344555543 56678888653211100000 011136688888777743333 223333221 3
Q ss_pred CeEEEEEeccccC-CHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-------CCcEEEE
Q 010231 403 SKLYIFLELVTKG-SLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-------NGSVKLA 471 (514)
Q Consensus 403 ~~l~LVmEy~~gG-sL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-------~g~vKI~ 471 (514)
..-+||||++++. +|.+++.. ..........++.+|...+.-||++||+|+|+++.||||+. ++.+.|+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 4578999999986 79888753 33555667789999999999999999999999999999985 4679999
Q ss_pred eccCcee
Q 010231 472 DFGLAKV 478 (514)
Q Consensus 472 DFGlAk~ 478 (514)
||+.+..
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.6e-08 Score=107.06 Aligned_cols=160 Identities=14% Similarity=0.204 Sum_probs=126.5
Q ss_pred eeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC----CCeEEEEEeccccC-C
Q 010231 343 GSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKLYIFLELVTKG-S 416 (514)
Q Consensus 343 G~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----~~~l~LVmEy~~gG-s 416 (514)
.+.|++.. .+|..|++|++........ .....-+..++++.|.|||++..+|.+ +..+++|++|.++. +
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST-----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc-----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 56799986 7899999999843222111 112244778999999999999988763 34689999999864 7
Q ss_pred HHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 417 LLNLYQR----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 417 L~~lL~~----------------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
|.++.-. .+.++..++.|+.||..||.++|+.|+..+-|.+.+||++.+.+++|.-.|+...+.
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7776521 136678899999999999999999999999999999999999999999999988776
Q ss_pred cCC--CcCcceeehhhhHHHHHHHHHhCC
Q 010231 481 SSL--DFDLLLIFSIFLNGCKFFLIFLHV 507 (514)
Q Consensus 481 ~~~--~~~~~~~~DVwSlG~lLyeLltG~ 507 (514)
.+. .......-|.-.||.+++.|.||+
T Consensus 445 ~d~~~~le~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 445 EDPTEPLESQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CCCCcchhHHhhhhHHHHHHHHHHHhhcc
Confidence 654 233336778889999999999995
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.7e-09 Score=115.86 Aligned_cols=181 Identities=24% Similarity=0.176 Sum_probs=137.0
Q ss_pred cccccceEeeeeecccCceeEEEEEc--cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecC
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD 401 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~--~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~ 401 (514)
.....+|..+..||.|.|+.|+.... .++..|++|.+......... .+. -..|+.+...+ .|.+++.++..|..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~--di~-sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS--DIF-SLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh--hhc-chhhhhHhhHhhcccccCCCCCCccc
Confidence 34567899999999999999998754 57788999977643222211 111 23455555444 58999999988888
Q ss_pred CCeEEEEEeccccCCHHHHH-hhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC-CcEEEEeccCceec
Q 010231 402 ESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKVF 479 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL-~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~-g~vKI~DFGlAk~~ 479 (514)
..+.||-.|||.++++..-+ -...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+++.+
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 88899999999998776433 22346777888999999999999999999999999999999876 78899999998632
Q ss_pred c---c---------------CCCcCcceeehhhhHHHHHHHHHhCCC
Q 010231 480 L---S---------------SLDFDLLLIFSIFLNGCKFFLIFLHVL 508 (514)
Q Consensus 480 ~---~---------------~~~~~~~~~~DVwSlG~lLyeLltG~~ 508 (514)
. . ..+..+....|+++||.-+++..++.+
T Consensus 418 ~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 418 AFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ceecccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 1 0 123444457889999999888888764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.8e-09 Score=114.68 Aligned_cols=179 Identities=26% Similarity=0.260 Sum_probs=139.5
Q ss_pred cceEeeeeecc--cCceeEEEEEc---cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCC
Q 010231 329 TYWQKGDLLGR--GSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE 402 (514)
Q Consensus 329 ~~Y~i~~~LG~--GsfG~Vyka~~---~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~ 402 (514)
..|.+...+|. |.+|.||.+.. ..+..+|+|.-+..-... .....-.+|+...+.+ .|+|.++.+..+...
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p---~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP---LDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc---cccccccchhhcccccCccccccccCcccccC
Confidence 34666788999 99999999876 578889998743221111 1112223566666666 499999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCCEEEcCC-CcEEEEeccC
Q 010231 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILL----GLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGL 475 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~----gL~yLHs~gIIHRDLKP~NILId~~-g~vKI~DFGl 475 (514)
+.+|+-+|+|. .+|..+... ..+++..++.++.+... ||.++|..+|+|-|+||+||++..+ ..++++|||+
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 99999999997 467666543 23788889999999999 9999999999999999999999999 8899999999
Q ss_pred ceecccCC-----------------------CcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 476 AKVFLSSL-----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 476 Ak~~~~~~-----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
...+.... +..++...|++++|-+..+..++..++.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc
Confidence 98876542 2233446779999999999999887764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=9.2e-08 Score=92.77 Aligned_cols=106 Identities=25% Similarity=0.299 Sum_probs=81.1
Q ss_pred HHHHHHHHHHhhcCCCce--eEEEEEecC----CCeEEEEEeccccC-CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHH
Q 010231 375 SQLEQEIALLSRFEHENI--VQYYGTDKD----ESKLYIFLELVTKG-SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLH 446 (514)
Q Consensus 375 ~~l~~Ei~iL~~L~HpnI--v~l~~~~~~----~~~l~LVmEy~~gG-sL~~lL~~-~~lse~~v~~i~~QIl~gL~yLH 446 (514)
.+..+|...+..|..-+| ...+.+... ....+||||++++. +|.+++.. ...+......++.++...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 356677777766643332 333333322 13568999999985 78888876 33666677889999999999999
Q ss_pred HCCccccCCCCCCEEEcCCC---cEEEEeccCceecc
Q 010231 447 DQDVVHRDIKCANILVDANG---SVKLADFGLAKVFL 480 (514)
Q Consensus 447 s~gIIHRDLKP~NILId~~g---~vKI~DFGlAk~~~ 480 (514)
++||+|+|+++.||||+.++ .+.|+||+-++...
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999999999999887 89999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=94.26 Aligned_cols=146 Identities=17% Similarity=0.152 Sum_probs=101.1
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchh-------------------HHHHHHHHHHHHHHhhcC--CCce
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-------------------KQSISQLEQEIALLSRFE--HENI 392 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~-------------------~~~~~~l~~Ei~iL~~L~--HpnI 392 (514)
...|..|..+.||+|...++..+|+|+++........ +....=...|+.-|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3478899999999999988999999998753222111 000011234666665553 2233
Q ss_pred eEEEEEecCCCeEEEEEeccccCC-HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEE
Q 010231 393 VQYYGTDKDESKLYIFLELVTKGS-LLNLYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 393 v~l~~~~~~~~~l~LVmEy~~gGs-L~~lL~~~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI 470 (514)
.+.+.+. +..|||||+.... -.-.|+.-.+..+....+..++++.+.-|-. .++||+||+.-|||+. ++.+.|
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 3444432 2379999997641 1123344445555678889999999999876 8999999999999998 999999
Q ss_pred EeccCceecccCCC
Q 010231 471 ADFGLAKVFLSSLD 484 (514)
Q Consensus 471 ~DFGlAk~~~~~~~ 484 (514)
+|||.|.....+..
T Consensus 208 ID~~QaV~~~hp~a 221 (268)
T COG1718 208 IDVSQAVTIDHPNA 221 (268)
T ss_pred EECccccccCCCch
Confidence 99999998775543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=9.9e-09 Score=117.21 Aligned_cols=188 Identities=16% Similarity=0.138 Sum_probs=139.2
Q ss_pred ccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
+.--.+.+.+.+.+-.|.|+.++.+.- ..|...++|........ .+..++....+-.++...++|.++.....+...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i--~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI--RTNDYESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhh--ccccccccCCccCccccCCCCceecccCCCCCC
Confidence 334456788889999999999998876 34555666654432111 111223334444455555678888777777777
Q ss_pred CeEEEEEeccccCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 403 SKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~~-lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
...+++|+|+.+++|...++.-+ .+.+-.+.+...+..+++|||...++|+|++|.|+|+..+|+.++.|||+......
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 88999999999999999988755 66667778889999999999999999999999999999999999999985443210
Q ss_pred C--------------------------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 482 S--------------------------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 482 ~--------------------------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
- .....+...|+|++|+.+|+.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00112235669999999999999999998
Q ss_pred CC
Q 010231 512 PP 513 (514)
Q Consensus 512 g~ 513 (514)
..
T Consensus 1037 a~ 1038 (1205)
T KOG0606|consen 1037 AE 1038 (1205)
T ss_pred Cc
Confidence 64
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.4e-07 Score=103.42 Aligned_cols=146 Identities=17% Similarity=0.190 Sum_probs=94.5
Q ss_pred eeecccCceeEEEEEccCCceEEEEEEecccc----------------------c---c----hhHHHHHH------HHH
Q 010231 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ----------------------G---S----QAKQSISQ------LEQ 379 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~----------------------~---~----~~~~~~~~------l~~ 379 (514)
+.|+.++-|.||+|+..+|+.||||+....-. . . ...+..+. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999998542100 0 0 11111122 223
Q ss_pred HHHHHhhcC-----CCceeEEEEEecCCCeEEEEEeccccCCHHHH--HhhcCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 010231 380 EIALLSRFE-----HENIVQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452 (514)
Q Consensus 380 Ei~iL~~L~-----HpnIv~l~~~~~~~~~l~LVmEy~~gGsL~~l--L~~~~lse~~v~~i~~QIl~gL~yLHs~gIIH 452 (514)
|..-+.+++ .++|.-..-++.-...-.|+|||+.|..+.++ ++..+++...+...+.+++- ..+-..|++|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~--~q~~~dgffH 288 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL--RQLLRDGFFH 288 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--HHHHhcCccc
Confidence 444444332 33332222222334456899999999988776 55666775544433333222 2222379999
Q ss_pred cCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 453 RDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 453 RDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.|.+|.||+|+.+|++.+.|||+...+...
T Consensus 289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 289 ADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999887643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.8e-07 Score=88.01 Aligned_cols=143 Identities=17% Similarity=0.164 Sum_probs=98.3
Q ss_pred ecccCceeEEEEEccCCceEEEEEEecccccchh-HHHHHHHHHHHHHHhhcCCCc--eeEEEEEe--c--CCCeEEEEE
Q 010231 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFEHEN--IVQYYGTD--K--DESKLYIFL 409 (514)
Q Consensus 337 LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~-~~~~~~l~~Ei~iL~~L~Hpn--Iv~l~~~~--~--~~~~l~LVm 409 (514)
-|+|+.+-|+.....+. .+-+|.-...-..... ......+.+|+..|..|..-+ +.++.... . ....-+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 35678888888654333 5666754311111111 223456788999888885433 33333211 1 123578999
Q ss_pred ecccc-CCHHHHHhhcCC---CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc--EEEEeccCceecc
Q 010231 410 ELVTK-GSLLNLYQRYHL---RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKVFL 480 (514)
Q Consensus 410 Ey~~g-GsL~~lL~~~~l---se~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~--vKI~DFGlAk~~~ 480 (514)
|-+.+ .+|.+++....+ +......++.+|...|.-||+.|+.|+|+.+.|||++.+|. |+++||--++...
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~l 181 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRRL 181 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchhh
Confidence 97764 388888876444 56666789999999999999999999999999999987777 9999998877543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.6e-07 Score=96.23 Aligned_cols=130 Identities=21% Similarity=0.323 Sum_probs=98.1
Q ss_pred HHHHHHhhcCCCceeEEEEEecCC-----CeEEEEEeccccCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC
Q 010231 379 QEIALLSRFEHENIVQYYGTDKDE-----SKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ 448 (514)
Q Consensus 379 ~Ei~iL~~L~HpnIv~l~~~~~~~-----~~l~LVmEy~~gGsL~~lL~~~-----~lse~~v~~i~~QIl~gL~yLHs~ 448 (514)
.-..-|-++-|.|||+++.+|.+. ....+++||+..|+|..+|++. .+.....++|+.||+.||.|||+.
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 334455666799999998776543 3588999999999999999763 377788899999999999999987
Q ss_pred C--ccccCCCCCCEEEcCCCcEEEEeccCcee---------ccc--------------CCCcCcceeehhhhHHHHHHHH
Q 010231 449 D--VVHRDIKCANILVDANGSVKLADFGLAKV---------FLS--------------SLDFDLLLIFSIFLNGCKFFLI 503 (514)
Q Consensus 449 g--IIHRDLKP~NILId~~g~vKI~DFGlAk~---------~~~--------------~~~~~~~~~~DVwSlG~lLyeL 503 (514)
. |+|+++.++-|++..+|.|||.---.... ... ....+....+|||+||....+|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 5 99999999999999999998852111000 000 0123444678999999988888
Q ss_pred HhCCC
Q 010231 504 FLHVL 508 (514)
Q Consensus 504 ltG~~ 508 (514)
..+..
T Consensus 276 ailEi 280 (458)
T KOG1266|consen 276 AILEI 280 (458)
T ss_pred HHhee
Confidence 87654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.1e-06 Score=96.65 Aligned_cols=144 Identities=17% Similarity=0.155 Sum_probs=95.1
Q ss_pred eeecccCceeEEEEEccCCceEEEEEEecccccc--------------------------hhHHHHHHHH------HHHH
Q 010231 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS--------------------------QAKQSISQLE------QEIA 382 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~--------------------------~~~~~~~~l~------~Ei~ 382 (514)
+.||.-+.|.||+|+.++|+.||||+-+..-... ...+..+.+. +|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5699999999999999999999999854211100 0001111122 2222
Q ss_pred ----HHhhcCCCc------eeEEEEEecCCCeEEEEEeccccCCHHH--HHhhcCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 010231 383 ----LLSRFEHEN------IVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450 (514)
Q Consensus 383 ----iL~~L~Hpn------Iv~l~~~~~~~~~l~LVmEy~~gGsL~~--lL~~~~lse~~v~~i~~QIl~gL~yLHs~gI 450 (514)
+.+.+.|-+ |.++|..+ ...-.|+||||.|..+.+ .+.+.+++...+...+.+...-+-+ ..|+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf--~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF--KTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH--hcCC
Confidence 223334544 34444332 234589999999986654 5677888888766555554433333 3689
Q ss_pred cccCCCCCCEEEcC----CCcEEEEeccCceecccC
Q 010231 451 VHRDIKCANILVDA----NGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 451 IHRDLKP~NILId~----~g~vKI~DFGlAk~~~~~ 482 (514)
+|+|-+|.||+|.. ++.+.+-|||+...+...
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 99999999999984 568999999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.7e-06 Score=79.52 Aligned_cols=139 Identities=21% Similarity=0.241 Sum_probs=82.1
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCC--ceeEEEEEe---cCCCeEEEE
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTD---KDESKLYIF 408 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIv~l~~~~---~~~~~l~LV 408 (514)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 4679999999999998877 58889976531 2345667888888777433 245555533 233457999
Q ss_pred EeccccCCHHH----------------HHh---hc--C---CCHHH---H---HH---H------------HHHHHH-HH
Q 010231 409 LELVTKGSLLN----------------LYQ---RY--H---LRDSQ---V---SA---Y------------TRQILL-GL 442 (514)
Q Consensus 409 mEy~~gGsL~~----------------lL~---~~--~---lse~~---v---~~---i------------~~QIl~-gL 442 (514)
|++++|..+.. .+. .. . +.... . .. . ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999987766 111 11 0 00000 0 00 0 111222 23
Q ss_pred HHHHH-------CCccccCCCCCCEEEc-CCCcEEEEeccCceecc
Q 010231 443 KYLHD-------QDVVHRDIKCANILVD-ANGSVKLADFGLAKVFL 480 (514)
Q Consensus 443 ~yLHs-------~gIIHRDLKP~NILId-~~g~vKI~DFGlAk~~~ 480 (514)
..+++ ..++|+|+.+.|||++ .++.+.|+||+.+....
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~~ 199 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWGD 199 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEEE
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceECC
Confidence 33332 3599999999999999 66777899999987643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.9e-06 Score=81.49 Aligned_cols=139 Identities=16% Similarity=0.185 Sum_probs=83.1
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHH------HHHHHHHHhhc---CCCceeEEEE--
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQ------LEQEIALLSRF---EHENIVQYYG-- 397 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~------l~~Ei~iL~~L---~HpnIv~l~~-- 397 (514)
++|...+++-.....-|.+-. -+|..+.+|.-..... ..+..... ..+.+..+..+ ..-.+..++-
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe-i~~~kyIlK~pr~~~~--r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE-IDGKKYILKEPREENR--RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred CCceEEEeecCCCccEEEEEE-ECCcEEEEeccchhhh--hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456666666665555554443 3567788886543211 11111111 12333333333 2222223222
Q ss_pred ---EecCCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEecc
Q 010231 398 ---TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 398 ---~~~~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFG 474 (514)
.+.-....+|+|||++|..|.++.. +.+ .+...|..+|.-||+.|+.|+|++|.|++++.++ ++++||+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 2223345679999999988766532 222 2445677889999999999999999999998554 9999998
Q ss_pred Ccee
Q 010231 475 LAKV 478 (514)
Q Consensus 475 lAk~ 478 (514)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 7764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.5e-06 Score=82.41 Aligned_cols=135 Identities=13% Similarity=0.143 Sum_probs=83.1
Q ss_pred eeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc--eeEEEEEecCCCeEEEEEecc
Q 010231 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~l~LVmEy~ 412 (514)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +.+.+.+....+...+|||++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 56899999999984 24456778664311 1234578999988876433 356677777777789999999
Q ss_pred ccCC-HHHH--------------H----hh-cCC-----CHHH-HHHHHHHH----------HH-HHHHHHH----CCcc
Q 010231 413 TKGS-LLNL--------------Y----QR-YHL-----RDSQ-VSAYTRQI----------LL-GLKYLHD----QDVV 451 (514)
Q Consensus 413 ~gGs-L~~l--------------L----~~-~~l-----se~~-v~~i~~QI----------l~-gL~yLHs----~gII 451 (514)
.|.. +... + .+ +.+ .... ...+..++ .. ...+|.. ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9963 1111 1 00 011 1110 11111111 11 1222221 2478
Q ss_pred ccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 452 HRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 452 HRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
|+|+.|.||+++.++ +.|+||+.+..-.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~Gd 184 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGYGN 184 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCcCC
Confidence 999999999999888 9999999987543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.3e-05 Score=77.94 Aligned_cols=139 Identities=21% Similarity=0.309 Sum_probs=97.3
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEeccccc-----------chhHHHHHHHHHHHHHHhhcC------CCceeEEE
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-----------SQAKQSISQLEQEIALLSRFE------HENIVQYY 396 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~-----------~~~~~~~~~l~~Ei~iL~~L~------HpnIv~l~ 396 (514)
...||+|+.-.||.- ......+||+....... ........+..+|+.....+. +.+|.++|
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 357999999999964 44556788887653300 000112344455665555544 78899999
Q ss_pred EEecCCCeEEEEEecccc------CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC----
Q 010231 397 GTDKDESKLYIFLELVTK------GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---- 466 (514)
Q Consensus 397 ~~~~~~~~l~LVmEy~~g------GsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g---- 466 (514)
|+.+++-.+-+|+|.+.. -+|.+++++..++. . +...+-.-..||-+++|+.+||+|.||++....
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence 999999999999998753 26888888777776 3 333444456788899999999999999997432
Q ss_pred cEEEEe-ccCcee
Q 010231 467 SVKLAD-FGLAKV 478 (514)
Q Consensus 467 ~vKI~D-FGlAk~ 478 (514)
.+.|+| ||-...
T Consensus 160 ~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 160 RLVLIDGLGEKEL 172 (199)
T ss_pred EEEEEeCCCCccc
Confidence 588888 666554
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.5e-05 Score=78.43 Aligned_cols=135 Identities=19% Similarity=0.139 Sum_probs=81.6
Q ss_pred eecccCc-eeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCeEEEEEeccc
Q 010231 336 LLGRGSF-GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVT 413 (514)
Q Consensus 336 ~LG~Gsf-G~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVmEy~~ 413 (514)
.|-.|.+ ..||+.... +..+.+|...... ...+.+|+.+++.+. +--+.+++.++...+..++||++++
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence 3455555 778998764 3677778654321 234567888887773 3345567777766667899999999
Q ss_pred cCCHHHHH----------------hh-cCCCHH------HHHHHHHH-----------------------HHHHHHHHH-
Q 010231 414 KGSLLNLY----------------QR-YHLRDS------QVSAYTRQ-----------------------ILLGLKYLH- 446 (514)
Q Consensus 414 gGsL~~lL----------------~~-~~lse~------~v~~i~~Q-----------------------Il~gL~yLH- 446 (514)
|..|.... .+ ..++.. .......+ +...+..|-
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 87765331 00 011100 00000000 111122221
Q ss_pred ------HCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 447 ------DQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 447 ------s~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
...++|+|+.|.|||++.++.+.|+||+.|...
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 124899999999999999888899999988753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.4e-06 Score=88.12 Aligned_cols=142 Identities=17% Similarity=0.193 Sum_probs=102.3
Q ss_pred ceEeeeeecccCceeEEEEEccCCceEEEEEEe-----------------cccccchhHHHHHHHHHHHHHHhhcC-CCc
Q 010231 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS-----------------LLDQGSQAKQSISQLEQEIALLSRFE-HEN 391 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~-----------------~~~~~~~~~~~~~~l~~Ei~iL~~L~-Hpn 391 (514)
-+.+++.||-|.-+.||.+-+.+|+.+++|.=. ......|.....-...+|...|+.|. |-+
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 356789999999999999999999999999621 11223344444444567888888874 332
Q ss_pred -eeEEEEEecCCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEE
Q 010231 392 -IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 392 -Iv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI 470 (514)
+.+.+ +.+..++|||++.+-.|...-+ + ..+..++..++.-+.-|..+|+||+|..--||+|+.++.+++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~---v--~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH---V--EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeee---c--CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 23333 3456789999999877654321 1 123445666777777889999999999999999999999999
Q ss_pred EeccCceecc
Q 010231 471 ADFGLAKVFL 480 (514)
Q Consensus 471 ~DFGlAk~~~ 480 (514)
+||=......
T Consensus 244 IDFPQmvS~s 253 (465)
T KOG2268|consen 244 IDFPQMVSTS 253 (465)
T ss_pred eechHhhccC
Confidence 9996655433
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.6e-05 Score=76.49 Aligned_cols=98 Identities=26% Similarity=0.208 Sum_probs=80.4
Q ss_pred HHHHHHHhhcCC-CceeEEEEEecCCCeEEEEEeccccCCHHH----HHhhcCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 010231 378 EQEIALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLN----LYQRYHLRDSQVSAYTRQILLGLKYLHD---QD 449 (514)
Q Consensus 378 ~~Ei~iL~~L~H-pnIv~l~~~~~~~~~l~LVmEy~~gGsL~~----lL~~~~lse~~v~~i~~QIl~gL~yLHs---~g 449 (514)
.+|.-+++.+.+ +++.+++|+|.. ++|+||...+++.. +.+-...++....+|+.+++..+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888865 699999999865 78999999876642 2222456888899999999999999987 34
Q ss_pred ccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 450 VVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 450 IIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
+.-.|++++||-|+.+|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.5e-05 Score=73.60 Aligned_cols=133 Identities=20% Similarity=0.171 Sum_probs=92.2
Q ss_pred EeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCcee-EEEEEecCCCeEEEEEe
Q 010231 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV-QYYGTDKDESKLYIFLE 410 (514)
Q Consensus 332 ~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv-~l~~~~~~~~~l~LVmE 410 (514)
+..+.|++|++|.||++.+..+ .+|+|+-... .....++.|.++|..+.-.++. ++|.+..+ ++.||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d-------s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRD-------SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecCC-------cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 4456799999999999998655 7888865532 2235677899999888766654 45554332 56699
Q ss_pred ccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-CCCEEEcCCCcEEEEeccCceecccC
Q 010231 411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK-CANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 411 y~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLK-P~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
|+.|-.|..+.... . ++-...++..---|-..||-|..|. |..++|..++.+.|+||.-|+.-..+
T Consensus 93 ~i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 93 YIDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP 159 (201)
T ss_pred hhcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence 99998887664321 1 2223445555445667899999997 55555556669999999999954444
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.5e-05 Score=88.69 Aligned_cols=143 Identities=16% Similarity=0.285 Sum_probs=88.1
Q ss_pred eeeecccCceeEEEEEccCC---ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCce--eEEEEEecCC---Ce
Q 010231 334 GDLLGRGSFGSVYEGISDDG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENI--VQYYGTDKDE---SK 404 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g---~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnI--v~l~~~~~~~---~~ 404 (514)
++.|+.|.++.+|+....++ ..+++|+...... ......+.+|+.+|+.+. |.+| .+++.++.+. ..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~----~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL----LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc----CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 56789999999999876543 3566665432111 011245779999999985 6665 6777776654 45
Q ss_pred EEEEEeccccCCHHH--------------------HHhh-cCCC----------------HHHHHHHHHH----------
Q 010231 405 LYIFLELVTKGSLLN--------------------LYQR-YHLR----------------DSQVSAYTRQ---------- 437 (514)
Q Consensus 405 l~LVmEy~~gGsL~~--------------------lL~~-~~ls----------------e~~v~~i~~Q---------- 437 (514)
.|+||||++|..+.+ .+.. +.++ ..++..|..|
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 789999998764211 1110 0110 1123222222
Q ss_pred -----HHHHHHHHHH-----------CCccccCCCCCCEEEcCC-Cc-EEEEeccCceecc
Q 010231 438 -----ILLGLKYLHD-----------QDVVHRDIKCANILVDAN-GS-VKLADFGLAKVFL 480 (514)
Q Consensus 438 -----Il~gL~yLHs-----------~gIIHRDLKP~NILId~~-g~-vKI~DFGlAk~~~ 480 (514)
+...+.+|.. ..+||+|+++.|||++.+ +. +-|.||+++..-.
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2223556642 249999999999999853 34 5799999988643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.87 E-value=6.1e-05 Score=74.06 Aligned_cols=31 Identities=29% Similarity=0.306 Sum_probs=26.6
Q ss_pred CccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 449 DVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 449 gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
+++|+|+.+.|||++.++..-|+||+.|..-
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 4899999999999987665679999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.87 E-value=5.5e-05 Score=79.43 Aligned_cols=153 Identities=17% Similarity=0.184 Sum_probs=103.7
Q ss_pred EeeeeecccCceeEEEEEccCCceEEEEEEecccccc--------------------hhHHHHHH-HHHHHHHHhhcCCC
Q 010231 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS--------------------QAKQSISQ-LEQEIALLSRFEHE 390 (514)
Q Consensus 332 ~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~--------------------~~~~~~~~-l~~Ei~iL~~L~Hp 390 (514)
.+-.+|..|.-+.||-|...+|..+|||+++..-... +....++. .+.|++-|.++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4556789999999999999999999999976321100 11111111 24566666666544
Q ss_pred ceeEEEEEecCCCeEEEEEeccccCC-HHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCCEEEcCCCcE
Q 010231 391 NIVQYYGTDKDESKLYIFLELVTKGS-LLNLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANGSV 468 (514)
Q Consensus 391 nIv~l~~~~~~~~~l~LVmEy~~gGs-L~~lL~~~~lse~~v~~i~~QIl~gL~yLH-s~gIIHRDLKP~NILId~~g~v 468 (514)
.|...--... ....|||+|+.... ..-.|+...++...+..+..|++.-|.-|- ..++||.||.--|+|+ .+|.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 4321110101 12478999997432 223556667888888888899988888884 5789999999999999 67899
Q ss_pred EEEeccCceecccCCCcCc
Q 010231 469 KLADFGLAKVFLSSLDFDL 487 (514)
Q Consensus 469 KI~DFGlAk~~~~~~~~~~ 487 (514)
.|+|.+.+.....+....+
T Consensus 304 yiIDVSQSVE~DHP~aldF 322 (520)
T KOG2270|consen 304 YIIDVSQSVEHDHPHALDF 322 (520)
T ss_pred EEEEccccccCCChhHHHH
Confidence 9999998876655544333
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00053 Score=66.97 Aligned_cols=131 Identities=26% Similarity=0.282 Sum_probs=89.0
Q ss_pred ccceEeeeeecccCc-eeEEEEEccCCceEEEEEEeccccc----------chh------HHHHHHHHHHHHHHhhc---
Q 010231 328 ITYWQKGDLLGRGSF-GSVYEGISDDGFFFAVKEVSLLDQG----------SQA------KQSISQLEQEIALLSRF--- 387 (514)
Q Consensus 328 ~~~Y~i~~~LG~Gsf-G~Vyka~~~~g~~vAIK~v~~~~~~----------~~~------~~~~~~l~~Ei~iL~~L--- 387 (514)
...++.++.||.|.- |.||++.. +|+.||+|..+..... ... .....-+..|.+...+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 368999999999999 99999976 4669999993321100 000 02233456676665555
Q ss_pred CCCce--eEEEEEec-C-----------------CCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH
Q 010231 388 EHENI--VQYYGTDK-D-----------------ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447 (514)
Q Consensus 388 ~HpnI--v~l~~~~~-~-----------------~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs 447 (514)
.+.++ |+.+|+.. + .....||.||++... .++. .-+.+|+.-|..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccch----hHHHHHHHHHHHHHH
Confidence 45566 88888642 1 112457778776643 1222 235678888999999
Q ss_pred CCccccCCCCCCEEEcCCCcEEEEeccCc
Q 010231 448 QDVVHRDIKCANILVDANGSVKLADFGLA 476 (514)
Q Consensus 448 ~gIIHRDLKP~NILId~~g~vKI~DFGlA 476 (514)
.||+-+|+|+.|.. .-||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999986 3589999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00045 Score=73.57 Aligned_cols=171 Identities=16% Similarity=0.130 Sum_probs=107.1
Q ss_pred EeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEE------ecCCC-
Q 010231 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT------DKDES- 403 (514)
Q Consensus 332 ~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~------~~~~~- 403 (514)
..++.||+|+.+.+|..-.-. ..+.|++..-....+. +-+..|... .||-+-.-+.| .....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~--d~VAKIYh~Pppa~~a--------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR--DQVAKIYHAPPPAAQA--------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CCCccccCCccceeeecchhh--chhheeecCCCchHHH--------HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 346789999999999653321 1234655432221111 112223332 45543221111 12222
Q ss_pred eEEEEEeccccC-CHHHHHhh----c---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccC
Q 010231 404 KLYIFLELVTKG-SLLNLYQR----Y---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (514)
Q Consensus 404 ~l~LVmEy~~gG-sL~~lL~~----~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGl 475 (514)
.+-++|..+.+. -...++.. . ...+.-+.+..+.|+.+..-||+.|.+-+|+.++|+||..++.|.|+|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 377888888765 23334321 1 256677888999999999999999999999999999999999888886322
Q ss_pred ceecccC-----------------------CCcCcceeehhhhHHHHHHHHHhC-CCCCCC
Q 010231 476 AKVFLSS-----------------------LDFDLLLIFSIFLNGCKFFLIFLH-VLIFRP 512 (514)
Q Consensus 476 Ak~~~~~-----------------------~~~~~~~~~DVwSlG~lLyeLltG-~~PF~g 512 (514)
-..-.+. .....+...|.|.||+++|+++.| +.||.|
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 1111111 112333467899999999999988 999987
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00047 Score=67.25 Aligned_cols=135 Identities=14% Similarity=0.145 Sum_probs=79.2
Q ss_pred eeeecccCceeEEEEEccC--CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc-eeEEEEEecCCCeEEEEEe
Q 010231 334 GDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~--g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~l~LVmE 410 (514)
++.|..|-...+|++...+ +..|++|....... ......+|+.++..+...+ ..+++..+.. .+|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEE
Confidence 4568888889999997764 66788886543111 1112346888888774333 3455554432 47999
Q ss_pred ccccCCHHH--------------HHhh---c--CCC-----------HHHHHHHHHH----------------------H
Q 010231 411 LVTKGSLLN--------------LYQR---Y--HLR-----------DSQVSAYTRQ----------------------I 438 (514)
Q Consensus 411 y~~gGsL~~--------------lL~~---~--~ls-----------e~~v~~i~~Q----------------------I 438 (514)
|++|.++.. .+.+ . ... ...+..|... +
T Consensus 73 ~i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 152 (235)
T cd05157 73 FIPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQL 152 (235)
T ss_pred eeCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHH
Confidence 998865421 1111 0 010 1122222211 1
Q ss_pred HHHHHHH----HH----CCccccCCCCCCEEEcC-CCcEEEEeccCcee
Q 010231 439 LLGLKYL----HD----QDVVHRDIKCANILVDA-NGSVKLADFGLAKV 478 (514)
Q Consensus 439 l~gL~yL----Hs----~gIIHRDLKP~NILId~-~g~vKI~DFGlAk~ 478 (514)
...+..| -. ..++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 153 ~~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 153 RDEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1111122 11 25999999999999997 57899999988874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0014 Score=67.11 Aligned_cols=138 Identities=17% Similarity=0.151 Sum_probs=78.8
Q ss_pred eeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc--eeEEEEEe------cCCCe
Q 010231 333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTD------KDESK 404 (514)
Q Consensus 333 i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--Iv~l~~~~------~~~~~ 404 (514)
..+.|+.|....+|+....++ .+++|+...... ...+..|+.++..|...+ +.+++... ...+.
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~-------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK-------AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eccccCCccccceEEEEeCCC-cEEEEEecCCCC-------HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 356677887789999876555 566786643110 123345556665553222 34444321 12456
Q ss_pred EEEEEeccccCCHH-----------HHH---hh--cCCC--------HHH-----HH----------HHHHHHHHHHHHH
Q 010231 405 LYIFLELVTKGSLL-----------NLY---QR--YHLR--------DSQ-----VS----------AYTRQILLGLKYL 445 (514)
Q Consensus 405 l~LVmEy~~gGsL~-----------~lL---~~--~~ls--------e~~-----v~----------~i~~QIl~gL~yL 445 (514)
.+++|+|++|..+. ..+ .. ..+. ... .. .....+...+++|
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999885421 111 10 0110 000 00 0011223345555
Q ss_pred HH-------CCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 446 HD-------QDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 446 Hs-------~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.. .++||+|+++.||+++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 42 5799999999999999888778999999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0018 Score=66.48 Aligned_cols=77 Identities=13% Similarity=0.118 Sum_probs=53.0
Q ss_pred eeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC---CceeEEEEEecC---CCeEE
Q 010231 333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---ENIVQYYGTDKD---ESKLY 406 (514)
Q Consensus 333 i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H---pnIv~l~~~~~~---~~~l~ 406 (514)
-.+.||.|..+.||.....+++ +.+|..+.. .....+..|...|+.+.- -.+.++++++.. .+..+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~-------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSF-------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEeccc-------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 3567999999999999776664 555654320 011356788888887743 356777776643 35689
Q ss_pred EEEeccccCCH
Q 010231 407 IFLELVTKGSL 417 (514)
Q Consensus 407 LVmEy~~gGsL 417 (514)
||||++.++++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00058 Score=67.92 Aligned_cols=133 Identities=18% Similarity=0.199 Sum_probs=75.2
Q ss_pred eecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCce-eEEEEEecCCCeEEEEEecccc
Q 010231 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELVTK 414 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~LVmEy~~g 414 (514)
.+..|-.+.+|+.. .++..+++|......... .....+|..+++.+....+ .+++..+. -++||||++|
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~-----~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKAL-----GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccc-----cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccC
Confidence 35567778889886 445667777543211110 0123578888887754333 34444432 2789999998
Q ss_pred CCHHH--------------HHhh-c--C-----CCH-HHHHHHHHHH---------HHHHHHHHH--------CCccccC
Q 010231 415 GSLLN--------------LYQR-Y--H-----LRD-SQVSAYTRQI---------LLGLKYLHD--------QDVVHRD 454 (514)
Q Consensus 415 GsL~~--------------lL~~-~--~-----lse-~~v~~i~~QI---------l~gL~yLHs--------~gIIHRD 454 (514)
..+.. .+.+ + . +.. ..+..+..++ ...+..+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 65421 1111 1 1 111 1222333222 111222221 2489999
Q ss_pred CCCCCEEEcCCCcEEEEeccCceec
Q 010231 455 IKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 455 LKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
+.|.|||++.++ +.|+||..|..-
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCcC
Confidence 999999999877 789999888753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0032 Score=67.49 Aligned_cols=81 Identities=15% Similarity=0.167 Sum_probs=52.4
Q ss_pred eeeecccCceeEEEEEccCC-ceEEEEEEecccc--cchhHHHHHHHHHHHHHHhhcC---CCceeEEEEEecCCCeEEE
Q 010231 334 GDLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g-~~vAIK~v~~~~~--~~~~~~~~~~l~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l~L 407 (514)
.+.||.|.+..||++...+| +.+.||....... ...-.....+...|...|..+. ..++.+++.+.. ...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 35799999999999998776 5899997431111 0000122345566777776652 345777777643 55789
Q ss_pred EEeccccCC
Q 010231 408 FLELVTKGS 416 (514)
Q Consensus 408 VmEy~~gGs 416 (514)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0011 Score=67.00 Aligned_cols=136 Identities=16% Similarity=0.136 Sum_probs=80.0
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc--eeEEEEE------ecCCCeE
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGT------DKDESKL 405 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--Iv~l~~~------~~~~~~l 405 (514)
.+.|..|....+|+....+ ..+++|.... . ....+..|+.++..+.+.+ +.+++.. ....+..
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---V-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---C-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 5567788888999886544 4677787642 1 1234556777776664322 4444432 1223467
Q ss_pred EEEEeccccCCHHH-----------HHhh-----cCCCH--------HHHH------------HHHHHHHHHHHHHHH--
Q 010231 406 YIFLELVTKGSLLN-----------LYQR-----YHLRD--------SQVS------------AYTRQILLGLKYLHD-- 447 (514)
Q Consensus 406 ~LVmEy~~gGsL~~-----------lL~~-----~~lse--------~~v~------------~i~~QIl~gL~yLHs-- 447 (514)
++|++|++|..+.. .+.+ ..+.. .... .....+...+.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999998865311 1100 01100 0000 011112334444443
Q ss_pred -----CCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 448 -----QDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 448 -----~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.++||+|+.|.|||++.++.+.|+||+.|..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999887789999988775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00023 Score=80.96 Aligned_cols=63 Identities=10% Similarity=-0.003 Sum_probs=46.8
Q ss_pred cccCCCCC-CEEEcCCCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHhCCC
Q 010231 451 VHRDIKCA-NILVDANGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFLHVL 508 (514)
Q Consensus 451 IHRDLKP~-NILId~~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLltG~~ 508 (514)
.|++.+|. |++++..+.+++.|||.++..... ....+...+|||||||+||+|++|++
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~ 578 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIP 578 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 44566666 677777777888899987754211 12335567999999999999999999
Q ss_pred CCCCC
Q 010231 509 IFRPP 513 (514)
Q Consensus 509 PF~g~ 513 (514)
||.+.
T Consensus 579 pf~~~ 583 (669)
T cd05610 579 PFNDE 583 (669)
T ss_pred CCCCC
Confidence 99864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=3.4e-05 Score=85.90 Aligned_cols=77 Identities=27% Similarity=0.351 Sum_probs=62.1
Q ss_pred HHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEEEeccCceecccCCC----------------------------cCc
Q 010231 437 QILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD----------------------------FDL 487 (514)
Q Consensus 437 QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~----------------------------~~~ 487 (514)
++..||.|+|+. ++||++|.|++|.++.+|..||+.|+++.......+ ...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 444999999975 799999999999999999999999999876554211 222
Q ss_pred ceeehhhhHHHHHHHHH-hCCCCCCCC
Q 010231 488 LLIFSIFLNGCKFFLIF-LHVLIFRPP 513 (514)
Q Consensus 488 ~~~~DVwSlG~lLyeLl-tG~~PF~g~ 513 (514)
+...|+||+||++|.+. .|...|.+.
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhcc
Confidence 34688999999999999 777777654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0013 Score=66.83 Aligned_cols=74 Identities=16% Similarity=0.160 Sum_probs=45.8
Q ss_pred eeeecccCceeEEEEEccC-------CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc-eeEEEEEecCCCeE
Q 010231 334 GDLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESKL 405 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~-------g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~l 405 (514)
++.|..|-...+|+....+ +..+++|+...... ......+|..++..+...+ ..++++.+..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~------~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~---- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE------LLIDRERELVVFARLSERNLGPKLYGIFPN---- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc------ceechHHHHHHHHHHHhCCCCCceEEEeCC----
Confidence 3556677777899887654 57888887653211 1223457777777774333 3455555542
Q ss_pred EEEEeccccCCH
Q 010231 406 YIFLELVTKGSL 417 (514)
Q Consensus 406 ~LVmEy~~gGsL 417 (514)
.+|++|++|..+
T Consensus 73 ~~v~e~i~G~~l 84 (302)
T cd05156 73 GRIEEFIPSRTL 84 (302)
T ss_pred CchhheeCCCcC
Confidence 358999887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.011 Score=60.54 Aligned_cols=31 Identities=26% Similarity=0.374 Sum_probs=26.7
Q ss_pred CCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 448 QDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 448 ~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.++||+|+++.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999998665568999999864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0052 Score=62.52 Aligned_cols=33 Identities=33% Similarity=0.395 Sum_probs=27.4
Q ss_pred CccccCCCCCCEEEcCCCc-EEEEeccCceeccc
Q 010231 449 DVVHRDIKCANILVDANGS-VKLADFGLAKVFLS 481 (514)
Q Consensus 449 gIIHRDLKP~NILId~~g~-vKI~DFGlAk~~~~ 481 (514)
.++|+|+++.|||++.++. .-|+||+.|..-..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDP 219 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDP 219 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCH
Confidence 4899999999999997565 46999999987543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.011 Score=62.51 Aligned_cols=78 Identities=15% Similarity=0.157 Sum_probs=46.9
Q ss_pred eecccCceeEEEEEccCC-ceEEEEEEecccc--cchhHHHHHHHHHHHHHHhhcC--CC-ceeEEEEEecCCCeEEEEE
Q 010231 336 LLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFE--HE-NIVQYYGTDKDESKLYIFL 409 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~~~g-~~vAIK~v~~~~~--~~~~~~~~~~l~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~l~LVm 409 (514)
.||.|....||++...+| ..++||.-...-. +..-.....+..-|...|+... .| .+.++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998654 5799997431111 1111222334445666665542 23 45566654 344557999
Q ss_pred eccccC
Q 010231 410 ELVTKG 415 (514)
Q Consensus 410 Ey~~gG 415 (514)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.02 Score=67.76 Aligned_cols=171 Identities=19% Similarity=0.204 Sum_probs=114.0
Q ss_pred ecccCceeEEEEEcc-----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe----EEE
Q 010231 337 LGRGSFGSVYEGISD-----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK----LYI 407 (514)
Q Consensus 337 LG~GsfG~Vyka~~~-----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~----l~L 407 (514)
|..-++|+++...+. .-+.+.++.-. ......+..+...+-|+..+..+.|+|++.++.+...... +.+
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~--~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v 263 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDY--ESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDV 263 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcc--cCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHH
Confidence 555667777777651 11122222100 1112344556667778888999999999999887544322 334
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC---CEEEcCCCcEEEE--eccCceeccc
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA---NILVDANGSVKLA--DFGLAKVFLS 481 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~---NILId~~g~vKI~--DFGlAk~~~~ 481 (514)
..++|.+.++..+++. ..++...++.|..+++.||.|+|+....|.-|... +..++..+.+.+. ||+..+.+..
T Consensus 264 ~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d 343 (1351)
T KOG1035|consen 264 LQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD 343 (1351)
T ss_pred HHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCC
Confidence 4578888888888776 45788889999999999999999997666655555 5555666777777 8888776543
Q ss_pred C--------------------CCcCcceeehhhhHHHHHHHHHhCCCC
Q 010231 482 S--------------------LDFDLLLIFSIFLNGCKFFLIFLHVLI 509 (514)
Q Consensus 482 ~--------------------~~~~~~~~~DVwSlG~lLyeLltG~~P 509 (514)
. .........|+|.+|.++..+..|..+
T Consensus 344 ~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 344 NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcc
Confidence 2 112222356899999999888877543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.029 Score=57.56 Aligned_cols=32 Identities=19% Similarity=0.213 Sum_probs=29.1
Q ss_pred CccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 449 gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
++||+|+.+.|||++.++.+.|+||..+..-.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d~ 228 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFAS 228 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccCC
Confidence 69999999999999999999999999888644
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.055 Score=54.85 Aligned_cols=30 Identities=27% Similarity=0.486 Sum_probs=26.3
Q ss_pred CCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 448 QDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 448 ~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.++||+|+++.|||++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.037 Score=58.07 Aligned_cols=135 Identities=13% Similarity=0.121 Sum_probs=77.0
Q ss_pred eeeecccCceeEEEEEcc-----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCce-eEEEEEecCCCeEEE
Q 010231 334 GDLLGRGSFGSVYEGISD-----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYI 407 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~-----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~L 407 (514)
+..|-.|-...+|++... .+..|.+|+...... ..+ ...+|+.+++.+..-++ .++++.+... .
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-----~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~ 110 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-----LFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----R 110 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-----eee-chHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence 445655777889998642 235788886643211 111 22578888877754333 3556665432 5
Q ss_pred EEeccccCCHHH--------------HHhh---cCC-------CHHHHHHHHHHH-----------------HHHHHHH-
Q 010231 408 FLELVTKGSLLN--------------LYQR---YHL-------RDSQVSAYTRQI-----------------LLGLKYL- 445 (514)
Q Consensus 408 VmEy~~gGsL~~--------------lL~~---~~l-------se~~v~~i~~QI-----------------l~gL~yL- 445 (514)
|++|+++.+|.. .+.+ ..+ -..++..|..++ ...+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 788887655421 1111 011 012333333222 1112222
Q ss_pred ---H----HCCccccCCCCCCEEEcC-CCcEEEEeccCcee
Q 010231 446 ---H----DQDVVHRDIKCANILVDA-NGSVKLADFGLAKV 478 (514)
Q Consensus 446 ---H----s~gIIHRDLKP~NILId~-~g~vKI~DFGlAk~ 478 (514)
. ...++|+|+++.|||++. ++.+.|+||..|..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225899999999999986 47899999988874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.00064 Score=75.55 Aligned_cols=169 Identities=19% Similarity=0.109 Sum_probs=119.0
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc-eeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~l 405 (514)
..+.|....-+++|+++++|+.+....+.+..+.+... ....-++.+|.+++||| .+.+++-+..++..
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 34566777789999999999998855555556766531 22345788999999999 77888888888999
Q ss_pred EEEEeccccC-CHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 406 YIFLELVTKG-SLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 406 ~LVmEy~~gG-sL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+++|+++.++ +....+. ...+.+-+...+++.-..++++||+.--+|+| ||+. .++..|..||+.+..+...
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG-SEEEVKLLDFAVPPQLTRT 384 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc-cccccccccccCCcccCcc
Confidence 9999999987 2221111 11233344455677777899999988778998 7777 4478899999988765432
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHhCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIF 510 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF 510 (514)
....+....+.|++|.-..+|.-|-+|-
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 1123334566899987777776666664
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.027 Score=58.75 Aligned_cols=134 Identities=10% Similarity=0.175 Sum_probs=74.4
Q ss_pred eeecccCceeEEEEEccC----CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCce-eEEEEEecCCCeEEEEE
Q 010231 335 DLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFL 409 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~----g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~LVm 409 (514)
+.|..|=...+|+....+ +..|++|+....... .-.-.+|..+++.+..-++ .++++.+... +|.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~------~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~ 89 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY------VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQ 89 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe------EechHHHHHHHHHHHhcCCCCceeEEeCCc----Eee
Confidence 445556677788886432 236778866432211 1223477888887755444 3556555322 588
Q ss_pred eccccCCHHH--------------HHhh---cCCC-------HHHHHHHHHHH----------------------HHHHH
Q 010231 410 ELVTKGSLLN--------------LYQR---YHLR-------DSQVSAYTRQI----------------------LLGLK 443 (514)
Q Consensus 410 Ey~~gGsL~~--------------lL~~---~~ls-------e~~v~~i~~QI----------------------l~gL~ 443 (514)
+|+++..|.. .+++ ..++ ...+..|+.++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 8887654411 1111 1111 12233333222 11122
Q ss_pred HHH----HCC----ccccCCCCCCEEEcC-CCcEEEEeccCcee
Q 010231 444 YLH----DQD----VVHRDIKCANILVDA-NGSVKLADFGLAKV 478 (514)
Q Consensus 444 yLH----s~g----IIHRDLKP~NILId~-~g~vKI~DFGlAk~ 478 (514)
.+. ..+ ++|.|+.+.|||++. ++.++++||..|-.
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 222 112 799999999999975 57899999988764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.015 Score=61.46 Aligned_cols=73 Identities=23% Similarity=0.374 Sum_probs=54.3
Q ss_pred CCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 401 DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
+..+.|++|++-. +.|. .+ .....+++..|+++.+..+.-+..+ ..-|||+.-.||||+ +|+|.|+||-+++.
T Consensus 297 e~~y~yl~~kdhg-t~is-~i--k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDHG-TPIS-II--KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecCC-ceee-ee--ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3456788888763 3332 11 2345567788888877766666543 588999999999999 99999999999994
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.024 Score=60.87 Aligned_cols=80 Identities=16% Similarity=0.142 Sum_probs=49.6
Q ss_pred eeeecccCceeEEEEEccC-CceEEEEEEeccc-ccchhHHHHHHHHHHHHHHhhcC--CC-ceeEEEEEecCCCeEEEE
Q 010231 334 GDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFE--HE-NIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~-g~~vAIK~v~~~~-~~~~~~~~~~~l~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~l~LV 408 (514)
.+.||.|.-.-||++.+.+ +.-|+||.-...- .+..-.-...+..-|...|+.+. .| ++.++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999743 5678898643111 11111233445556667776652 23 46667665 34456789
Q ss_pred EeccccC
Q 010231 409 LELVTKG 415 (514)
Q Consensus 409 mEy~~gG 415 (514)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9998653
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.0032 Score=75.81 Aligned_cols=156 Identities=17% Similarity=0.074 Sum_probs=105.2
Q ss_pred EEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec--CCCeEEEEEeccccCCHHHHHhhc-----CCCH
Q 010231 356 FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLYIFLELVTKGSLLNLYQRY-----HLRD 428 (514)
Q Consensus 356 vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~--~~~~l~LVmEy~~gGsL~~lL~~~-----~lse 428 (514)
+.+|+.+-.+-....+...+-+..|...++.+.|+++...+.-.. +....|++++|+.+|.+++.+-+. .+..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 445554433333333333344455666667778999888766443 234579999999999999987542 1223
Q ss_pred HHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCCEEEcCCCcEEEEeccCceecccC-------------------CC
Q 010231 429 SQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADFGLAKVFLSS-------------------LD 484 (514)
Q Consensus 429 ~~v~~i~~QIl~gL~yLHs~g-----IIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-------------------~~ 484 (514)
.-+.....+.+....-+|... .+|++||+.|.+|..+.++|+.++|+.+..... ..
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ 1414 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE 1414 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH
Confidence 333333444366666666531 789999999999999999999999999943322 11
Q ss_pred cCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 485 FDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 485 ~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
..++.+.|+|..|+.+|++..|..+|.
T Consensus 1415 ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1415 IKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 233345899999999999999887763
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.092 Score=56.64 Aligned_cols=78 Identities=15% Similarity=0.134 Sum_probs=47.7
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchh--HHHHHHHHHHHHHHhhcC---CCceeEEEEEecCCCeEEEE
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA--KQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~--~~~~~~l~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l~LV 408 (514)
.+.||.|....||+..+. +..++||.-......... .....+...|...|+.+. ..++.++|.++.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 567899999999998874 456888864311110000 011233334555555543 3477888888763 45788
Q ss_pred Eecccc
Q 010231 409 LELVTK 414 (514)
Q Consensus 409 mEy~~g 414 (514)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.054 Score=55.70 Aligned_cols=75 Identities=17% Similarity=0.183 Sum_probs=43.4
Q ss_pred EeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc---CCCceeEEEEEecCCCeEEEE
Q 010231 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 332 ~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIv~l~~~~~~~~~l~LV 408 (514)
+..+.|+.|....+|+.. .+++.+-+|.-... ....+..|..-|+.| ..-.+.+++.+....+.-|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~--------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES--------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG--------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChh--------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 345678889999999987 56667888866521 112355666666666 345577888887766677999
Q ss_pred EeccccC
Q 010231 409 LELVTKG 415 (514)
Q Consensus 409 mEy~~gG 415 (514)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.13 Score=53.68 Aligned_cols=110 Identities=15% Similarity=0.229 Sum_probs=67.3
Q ss_pred HHHHHHHHHHHHhhcCCCc--eeEEEEEecCCC--eEEEEEeccccCCH---------H---------HHHhh-c-----
Q 010231 373 SISQLEQEIALLSRFEHEN--IVQYYGTDKDES--KLYIFLELVTKGSL---------L---------NLYQR-Y----- 424 (514)
Q Consensus 373 ~~~~l~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~--~l~LVmEy~~gGsL---------~---------~lL~~-~----- 424 (514)
......+|+.+++.+.--- +...++.|.+.. ..|+||+|++|..+ . +.|.. +
T Consensus 64 ~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~ 143 (321)
T COG3173 64 SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAA 143 (321)
T ss_pred hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCc
Confidence 3455668888888774322 234455666555 67999999988322 1 11110 0
Q ss_pred ---------CCCHHHHHHHHHHH--------------HHHHHHHHHC--------CccccCCCCCCEEEcCCCcEEEEec
Q 010231 425 ---------HLRDSQVSAYTRQI--------------LLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLADF 473 (514)
Q Consensus 425 ---------~lse~~v~~i~~QI--------------l~gL~yLHs~--------gIIHRDLKP~NILId~~g~vKI~DF 473 (514)
.+...++..+..+. ..-..||+.+ .++|+|+++.||||+.++-+=|+||
T Consensus 144 ~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDw 223 (321)
T COG3173 144 GLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDW 223 (321)
T ss_pred CCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEec
Confidence 01111222222222 2235566543 4899999999999999999999999
Q ss_pred cCceecccC
Q 010231 474 GLAKVFLSS 482 (514)
Q Consensus 474 GlAk~~~~~ 482 (514)
+++..-...
T Consensus 224 e~~~lGDP~ 232 (321)
T COG3173 224 ELATLGDPL 232 (321)
T ss_pred cccccCCcH
Confidence 999875544
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.071 Score=53.92 Aligned_cols=35 Identities=37% Similarity=0.506 Sum_probs=28.3
Q ss_pred ccccCCCCCCEEEcCC--C---cEEEEeccCceecccCCC
Q 010231 450 VVHRDIKCANILVDAN--G---SVKLADFGLAKVFLSSLD 484 (514)
Q Consensus 450 IIHRDLKP~NILId~~--g---~vKI~DFGlAk~~~~~~~ 484 (514)
|+|+|++..|||+..+ | .++++||.+++......+
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g~p~~D 256 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYGSPAID 256 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccCCCcHhH
Confidence 8999999999999765 3 699999999886554433
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.24 Score=59.40 Aligned_cols=31 Identities=45% Similarity=0.609 Sum_probs=26.9
Q ss_pred CCccccCCCCCCEEEcCCC--cEE-EEeccCcee
Q 010231 448 QDVVHRDIKCANILVDANG--SVK-LADFGLAKV 478 (514)
Q Consensus 448 ~gIIHRDLKP~NILId~~g--~vK-I~DFGlAk~ 478 (514)
+++||.|+.+.|||++.++ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 565 999999874
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.62 Score=48.41 Aligned_cols=29 Identities=24% Similarity=0.263 Sum_probs=25.0
Q ss_pred CCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 448 QDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 448 ~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3689999999999995 4 578999999875
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.25 Score=52.88 Aligned_cols=79 Identities=15% Similarity=0.226 Sum_probs=44.2
Q ss_pred eeeecccCceeEEEEEccCC--ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCce-eEEEEEecCCCeEEEEEe
Q 010231 334 GDLLGRGSFGSVYEGISDDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g--~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~LVmE 410 (514)
++.|..|-...+|++...++ ..+.+|.+-....+.. ....-.-.+|+.+++.+...++ .++++.+.. ++|.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 45566687889999875332 2332232211111111 1111223578888888865544 556666653 69999
Q ss_pred ccccCCH
Q 010231 411 LVTKGSL 417 (514)
Q Consensus 411 y~~gGsL 417 (514)
|++|..|
T Consensus 130 fIeGr~l 136 (383)
T PTZ00384 130 WVEGNTM 136 (383)
T ss_pred EeccccC
Confidence 9988664
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.40 E-value=0.3 Score=48.89 Aligned_cols=84 Identities=23% Similarity=0.252 Sum_probs=57.9
Q ss_pred HHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH--CCccccC
Q 010231 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD--QDVVHRD 454 (514)
Q Consensus 377 l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs--~gIIHRD 454 (514)
+.++.+++.++ ..|+++..- ....+-+++|+|-.-... ...++.-=+..|.-.|+ .+.+|+|
T Consensus 105 y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i~------------~~N~i~agi~~L~~fH~~~~~~lHGD 168 (308)
T PF07387_consen 105 YFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKIN------------FSNFITAGIKDLMDFHSENQHCLHGD 168 (308)
T ss_pred hhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCcccc------------hhHHHHHhHHHHHHhhccCCCeecCC
Confidence 45667777765 367887732 445678999999553111 01122222556777784 4699999
Q ss_pred CCCCCEEEcCCCcEEEEeccCc
Q 010231 455 IKCANILVDANGSVKLADFGLA 476 (514)
Q Consensus 455 LKP~NILId~~g~vKI~DFGlA 476 (514)
..|+|||-|..|.+||.|=+..
T Consensus 169 ~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 169 CNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred CChhheeecCCCCEEecChhhh
Confidence 9999999999999999997653
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.37 E-value=0.63 Score=46.82 Aligned_cols=73 Identities=16% Similarity=0.206 Sum_probs=46.2
Q ss_pred eecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC---CCceeEEEEEecCCCeEEEEEecc
Q 010231 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 336 ~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
.+.-|-.-..|...+ ....+-+|+-. +.....+..|+.-|..|. .-.+.+++.+..+.++.|+||||+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~--------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQ--------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecc--------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 344443344444433 33455566422 334456677777766663 355778899999999999999999
Q ss_pred ccCCH
Q 010231 413 TKGSL 417 (514)
Q Consensus 413 ~gGsL 417 (514)
+.+.+
T Consensus 94 ~~~~~ 98 (286)
T COG3001 94 PTGPL 98 (286)
T ss_pred cCCCC
Confidence 87654
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.04 E-value=0.26 Score=53.19 Aligned_cols=60 Identities=18% Similarity=0.173 Sum_probs=44.8
Q ss_pred eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCCEEEc
Q 010231 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY-LHDQDVVHRDIKCANILVD 463 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~y-LHs~gIIHRDLKP~NILId 463 (514)
...||=+|..|-.+..+++....++.-+++++.-..+++-- |--.+++|.|++|.||+|.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 34566678888888888887777776666666666666443 3456899999999999995
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.48 E-value=0.3 Score=54.07 Aligned_cols=104 Identities=16% Similarity=0.294 Sum_probs=67.6
Q ss_pred HHHHHHHHHhhcCCCceeEEEEEecC-CCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 010231 376 QLEQEIALLSRFEHENIVQYYGTDKD-ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454 (514)
Q Consensus 376 ~l~~Ei~iL~~L~HpnIv~l~~~~~~-~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRD 454 (514)
++.-...+++.+.|+|...++++... .....+|||++.. +|.+++....+...... .+++.|-
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~l~~~s~~--------------~~~~~~~- 91 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGNLKDESLL--------------AHGVLHL- 91 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcccchhhhc--------------cccccee-
Confidence 44556788899999999999987654 3458899999965 89888876543222211 2233322
Q ss_pred CCCCCEEEcCCCcEEEEeccCceecccCCCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 455 IKCANILVDANGSVKLADFGLAKVFLSSLDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 455 LKP~NILId~~g~vKI~DFGlAk~~~~~~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
+.++++| -++..+ ......++|||++|.++.+++.|...|.
T Consensus 92 -----------~~~~~td-~~~t~~----~~~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 92 -----------NIIYITD-HFLTKY----PSPIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----------hhhhccc-cccccC----CCCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 2233344 222222 3333369999999999999999986653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 514 | ||||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-15 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-05 |
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 1e-76
Identities = 61/176 (34%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
S +TE S + +LG+G++G VY G + A+KE+ D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH- 425
+ L +EIAL +H+NIVQY G+ + + IF+E V GSL L +
Sbjct: 61 -----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115
Query: 426 ---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAK 477
+ + YT+QIL GLKYLHD +VHRDIK N+L++ +G +K++DFG +K
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-66
Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 18/186 (9%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKE 360
+ D +S +GR + + +GRGSF +VY+G+ ++ A E
Sbjct: 5 NQQQDDIEELETKAVGMSNDGR------FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCE 58
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG----TDKDESKLYIFLELVTKGS 416
+ K + ++E +L +H NIV++Y T K + + + EL+T G+
Sbjct: 59 LQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 115
Query: 417 LLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLAD 472
L +R+ ++ + ++ RQIL GL++LH + ++HRD+KC NI + GSVK+ D
Sbjct: 116 LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175
Query: 473 FGLAKV 478
GLA +
Sbjct: 176 LGLATL 181
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 4e-63
Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 301 TEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK 359
E ED+ TE + + + ++ + + +GRGSFG V+ GF AVK
Sbjct: 32 PETEDNEGVLLTEKLKPV--DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89
Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
+V L +E+ + IV YG ++ + IF+EL+ GSL
Sbjct: 90 KVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 420 LYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-VKLADFGLAK 477
L ++ L + + Y Q L GL+YLH + ++H D+K N+L+ ++GS L DFG A
Sbjct: 140 LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-55
Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 9/187 (4%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKE 360
++S T P + P+ +Q+ LG GS+G V++ S +DG +AVK
Sbjct: 32 SFRGEASETLQSPGYD--PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR 89
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
+G + + L + + +H V+ ++ LY+ EL SL
Sbjct: 90 SMSPFRGPKDRARK--LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQH 146
Query: 421 YQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ + L ++QV Y R LL L +LH Q +VH D+K ANI + G KL DFGL
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 479 FLSSLDF 485
L +
Sbjct: 207 -LGTAGA 212
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-54
Identities = 40/177 (22%), Positives = 74/177 (41%), Gaps = 27/177 (15%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
R T + + + +G G FGSV++ + DG +A+K GS +Q+ L + A
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNA--LREVYAHA 65
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQIL 439
+H ++V+Y+ ++ + I E GSL + + +++++ Q+
Sbjct: 66 VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGS-------------------VKLADFGLAK 477
GL+Y+H +VH DIK +NI + K+ D G
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-53
Identities = 52/185 (28%), Positives = 90/185 (48%), Gaps = 9/185 (4%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD 365
+P + P+ + + + + +GRG F VY DG A+K+V + D
Sbjct: 11 PPVPQFQPQKALRPDMGYNTLANF-RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD 69
Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY- 424
++ + +EI LL + H N+++YY + ++++L I LEL G L + + +
Sbjct: 70 LMDA--KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 127
Query: 425 ----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480
+ + V Y Q+ L+++H + V+HRDIK AN+ + A G VKL D GL + F
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187
Query: 481 SSLDF 485
S
Sbjct: 188 SKTTA 192
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-53
Identities = 38/181 (20%), Positives = 81/181 (44%), Gaps = 8/181 (4%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 361
+ T + ++ S N + +G G V++ +++ +A+K V
Sbjct: 29 HMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 88
Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
+L Q++ EIA L++ + + I++ Y + + +Y+ +E L +
Sbjct: 89 NL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 144
Query: 420 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
L ++ + + +Y + +L + +H +VH D+K AN L+ +G +KL DFG+A
Sbjct: 145 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203
Query: 479 F 479
Sbjct: 204 M 204
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 40/181 (22%), Positives = 80/181 (44%), Gaps = 9/181 (4%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 361
H SS N+ + Y +G G V++ +++ +A+K V
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60
Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
+L Q++ EIA L++ + + I++ Y + + +Y+ +E L +
Sbjct: 61 NL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 116
Query: 420 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
L ++ + + +Y + +L + +H +VH D+K AN L+ +G +KL DFG+A
Sbjct: 117 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175
Query: 479 F 479
Sbjct: 176 M 176
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 6e-49
Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
IS GR + +G G V++ +++ +A+K V+L Q++
Sbjct: 4 ISVKGR------IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSY 54
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAY 434
EIA L++ + + I++ Y + + +Y+ +E L + L ++ + + +Y
Sbjct: 55 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY 113
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ +L + +H +VH D+K AN L+ +G +KL DFG+A
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-48
Identities = 53/178 (29%), Positives = 99/178 (55%), Gaps = 8/178 (4%)
Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA 370
+ + + N F+ + Y + +G GSFG S +DG + +KE+++ S+
Sbjct: 8 SSGVDLGTENLYFQSMEKY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLR 427
++ +E+A+L+ +H NIVQY + ++ LYI ++ G L +N + +
Sbjct: 67 REES---RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
+ Q+ + QI L LK++HD+ ++HRDIK NI + +G+V+L DFG+A+V S+++
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-45
Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 22/190 (11%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
R + +++ +LG+G+FG V + + D ++A+K++ ++ +S + E+ LL
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLL 56
Query: 385 SRFEHENIVQYYGTDKDE-------------SKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
+ H+ +V+YY + S L+I +E G+L +L +L +
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 432 SA--YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDLLL 489
RQIL L Y+H Q ++HRD+K NI +D + +VK+ DFGLAK SLD L
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 490 IFSIFLNGCK 499
++ +
Sbjct: 177 SQNLPGSSDN 186
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-44
Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 30/195 (15%)
Query: 293 LSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD 352
+ S S + D+ +S G+ + D+LG G+ G++ D
Sbjct: 1 MGSSPSLEQDDGDEETSVVIV--------GKIS-----FCPKDVLGHGAEGTIVYRGMFD 47
Query: 353 GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLEL 411
AVK + + S ++E+ LL EH N+++Y+ T+KD YI +EL
Sbjct: 48 NRDVAVKRIL--------PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99
Query: 412 VTKGSLLNLYQRYHLRDSQVSAYT--RQILLGLKYLHDQDVVHRDIKCANILVDANGS-- 467
+L ++ + T +Q GL +LH ++VHRD+K NIL+ +
Sbjct: 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHG 158
Query: 468 ---VKLADFGLAKVF 479
++DFGL K
Sbjct: 159 KIKAMISDFGLCKKL 173
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-42
Identities = 42/174 (24%), Positives = 75/174 (43%), Gaps = 29/174 (16%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
++ +L+G G FG V++ DG + +K V ++ + E+E+ L++ +H
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHV 64
Query: 391 NIVQYYG----------------TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQV 431
NIV Y G + L+I +E KG+L ++ L
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
QI G+ Y+H + +++RD+K +NI + VK+ DFGL +
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 16/167 (9%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ +G GS+G + DG KE+ KQ L E+ LL +H
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ---MLVSEVNLLRELKHP 65
Query: 391 NIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLK 443
NIV+YY D+ + LYI +E G L ++ + +L + V Q+ L LK
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 444 YLHDQ-----DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
H + V+HRD+K AN+ +D +VKL DFGLA++ F
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-42
Identities = 60/176 (34%), Positives = 97/176 (55%), Gaps = 12/176 (6%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKE 360
H S P F ++ + +G+GSFG V++GI A+K
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKL-------EKIGKGSFGEVFKGIDNRTQKVVAIKI 54
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
+ L +A+ I ++QEI +LS+ + + +YYG+ ++KL+I +E + GS L+L
Sbjct: 55 IDL----EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 110
Query: 421 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
+ L ++Q++ R+IL GL YLH + +HRDIK AN+L+ +G VKLADFG+A
Sbjct: 111 LEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-42
Identities = 42/171 (24%), Positives = 76/171 (44%), Gaps = 21/171 (12%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ LGRG FG V+E + D +A+K + L + + ++ +E+ L++ EH
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHP 63
Query: 391 NIVQYYGTDKDESK------------LYIFLELVTKGSLLNLYQR----YHLRDSQVSAY 434
IV+Y+ +++ LYI ++L K +L + S
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
QI +++LH + ++HRD+K +NI + VK+ DFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-41
Identities = 42/160 (26%), Positives = 83/160 (51%), Gaps = 9/160 (5%)
Query: 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLE 378
I ++ G+LLG+GSF VY S G A+K + + + ++ ++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR----VQ 59
Query: 379 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTR 436
E+ + + +H +I++ Y +D + +Y+ LE+ G + + +++ +
Sbjct: 60 NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
QI+ G+ YLH ++HRD+ +N+L+ N ++K+ADFGLA
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 8/149 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+ LG G+FG VY+ + + G A K + ++++ + EI +L+ +H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYIVEIEILATCDH 75
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
IV+ G + KL+I +E G++ + L + Q+ RQ+L L +LH
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLA 476
+ ++HRD+K N+L+ G ++LADFG++
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SL 363
+ P I R + +G LG+G F +E D FA K V SL
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78
Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQ 422
L + Q ++ + EI++ H+++V ++G +D +++ LEL + SLL +
Sbjct: 79 LLKPHQREK----MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR 134
Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
R L + + Y RQI+LG +YLH V+HRD+K N+ ++ + VK+ DFGLA
Sbjct: 135 RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-40
Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 9/156 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEI 381
+ Y +G LG+G F +E D FA K V SLL + Q ++ + EI
Sbjct: 12 RSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEI 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
++ H+++V ++G +D +++ LEL + SLL +R L + + Y RQI+L
Sbjct: 67 SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 126
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
G +YLH V+HRD+K N+ ++ + VK+ DFGLA
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA 370
E P F + +G GSFG+VY + A+K++S + Q+
Sbjct: 44 AELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QS 94
Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRD 428
+ + +E+ L + H N +QY G E ++ +E GS +L + + L++
Sbjct: 95 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 153
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
+++A T L GL YLH +++HRD+K NIL+ G VKL DFG A
Sbjct: 154 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-39
Identities = 48/172 (27%), Positives = 92/172 (53%), Gaps = 14/172 (8%)
Query: 315 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 373
MS S + ++ +++G G+ V A+K ++L + + S
Sbjct: 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTS 56
Query: 374 ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------- 425
+ +L +EI +S+ H NIV YY + + +L++ ++L++ GS+L++ +
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116
Query: 426 -LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
L +S ++ R++L GL+YLH +HRD+K NIL+ +GSV++ADFG++
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 12/169 (7%)
Query: 315 MSNISPNGRFKRIIT------YWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG 367
+++ + ++ +G GS G V G AVK + L Q
Sbjct: 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ- 83
Query: 368 SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR 427
Q L E+ ++ ++H N+V+ Y + +L++ +E + G+L ++ + L
Sbjct: 84 ----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN 139
Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
+ Q++ +L L YLH Q V+HRDIK +IL+ +G VKL+DFG
Sbjct: 140 EEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-39
Identities = 44/149 (29%), Positives = 80/149 (53%), Gaps = 6/149 (4%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
+ + + +G+G+ G+VY + G A+++++L Q + EI ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMREN 74
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
++ NIV Y + +L++ +E + GSL ++ + + Q++A R+ L L++LH
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLA 476
V+HRDIK NIL+ +GSVKL DFG
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 315 MSNISPNGRFKRII--------TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLD 365
M++ SP I ++ +L+G G++G VY+G G A+K + +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-- 59
Query: 366 QGSQAKQSISQLEQEIALLSRF-EHENIVQYYG------TDKDESKLYIFLELVTKGSLL 418
+++QEI +L ++ H NI YYG + +L++ +E GS+
Sbjct: 60 ----TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
Query: 419 NLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
+L + L++ ++ R+IL GL +LH V+HRDIK N+L+ N VKL DFG+
Sbjct: 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 476 A 476
+
Sbjct: 176 S 176
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 47/151 (31%), Positives = 86/151 (56%), Gaps = 10/151 (6%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
+ + LG GS+GSVY+ I + G A+K+V + + ++ +EI+++ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQC 81
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYL 445
+ ++V+YYG+ + L+I +E GS+ ++ + + L + +++ + L GL+YL
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA 476
H +HRDIK NIL++ G KLADFG+A
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 37/180 (20%), Positives = 79/180 (43%), Gaps = 15/180 (8%)
Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRG--SFGSVYEGI-SDDGFFFAVK 359
H + + MS+ P G ++ ++G+G +V G + V+
Sbjct: 5 HHHHMENLYFQGMSSFLPEG------GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
++L + + + ++ L+ E+ + F H NIV Y T +++L++ + GS +
Sbjct: 59 RINL---EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD 115
Query: 420 LYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
L + + + ++ + +L L Y+H VHR +K ++IL+ +G V L+
Sbjct: 116 LICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 47/146 (32%), Positives = 76/146 (52%), Gaps = 4/146 (2%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G LG+G FG+VY F A+K V Q +A QL +E+ + S H NI
Sbjct: 14 GRPLGKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGV-EHQLRREVEIQSHLRHPNI 71
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVV 451
++ YG D +++Y+ LE G++ Q+ + + + Y ++ L Y H + V+
Sbjct: 72 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 452 HRDIKCANILVDANGSVKLADFGLAK 477
HRDIK N+L+ + G +K+ADFG +
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSV 157
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 15/161 (9%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
W D+LG+G+ +V+ G G FA+K + + + +E +L +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLN 65
Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLN-LYQR---YHLRDSQVSAYTRQILLGL 442
H+NIV+ + + + +E GSL L + Y L +S+ R ++ G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKVF 479
+L + +VHR+IK NI+ D KL DFG A+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 39/202 (19%), Positives = 82/202 (40%), Gaps = 24/202 (11%)
Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS- 362
+D S+ + N + + I ++ L +G F + D F+A+K+
Sbjct: 7 KDILSNYSNLIYLNKYVKEK-DKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEK 64
Query: 363 -----------LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411
+ K + E+ +++ ++E + G + ++YI E
Sbjct: 65 SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY 124
Query: 412 VTKGSL---------LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANIL 461
+ S+ L+ + + + +L Y+H++ ++ HRD+K +NIL
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184
Query: 462 VDANGSVKLADFGLAKVFLSSL 483
+D NG VKL+DFG ++ +
Sbjct: 185 MDKNGRVKLSDFGESEYMVDKK 206
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 15/157 (9%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G F V DG F+A+K + + +Q + ++E + F H
Sbjct: 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-----QQDREEAQREADMHRLFNHP 86
Query: 391 NIVQYYG----TDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLG 441
NI++ + + ++ L +G+L N +R L + Q+ I G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
L+ +H + HRD+K NIL+ G L D G
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-36
Identities = 46/148 (31%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
G LG+G FG+VY + F A+K + S L++ Q L +EI + S H
Sbjct: 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----LRREIEIQSHLRHP 74
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
NI++ Y D ++Y+ LE +G L Q++ + + + + ++ L Y H++
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK 477
V+HRDIK N+L+ G +K+ADFG +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSV 162
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 15/161 (9%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
W D+LG+G+ +V+ G G FA+K + + + +E +L +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLN 65
Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLN-LYQR---YHLRDSQVSAYTRQILLGL 442
H+NIV+ + + + +E GSL L + Y L +S+ R ++ G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKVF 479
+L + +VHR+IK NI+ D KL DFG A+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 27/195 (13%)
Query: 319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--------------- 362
S + + + D +G+GS+G V + +D ++A+K +S
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 363 ------LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTK 414
Q + I Q+ QEIA+L + +H N+V+ D +E LY+ ELV +
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 415 GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474
G ++ + L + Q Y + ++ G++YLH Q ++HRDIK +N+LV +G +K+ADFG
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 475 LAKVFLSSLDFDLLL 489
++ F S D LL
Sbjct: 183 VSNEFKGS---DALL 194
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 32/187 (17%)
Query: 316 SNISPNGRFKRIIT-YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI 374
S I+ F++ + +LG GS G+V S G AVK +
Sbjct: 1 SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--------IDFC 52
Query: 375 SQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
EI LL+ +H N+++YY ++ + LYI LEL +L +L + ++ D +
Sbjct: 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKL 111
Query: 434 YT--------RQILLGLKYLHDQDVVHRDIKCANILVD-------------ANGSVKLAD 472
RQI G+ +LH ++HRD+K NILV N + ++D
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 473 FGLAKVF 479
FGL K
Sbjct: 172 FGLCKKL 178
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 41/156 (26%), Positives = 80/156 (51%), Gaps = 7/156 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K LG G+ G V++ G A K + L +Q+ +E+ +L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNS 90
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQ 448
IV +YG + ++ I +E + GSL + ++ + + + + ++ GL YL ++
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
++HRD+K +NILV++ G +KL DFG++ + S+
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 40/154 (25%), Positives = 72/154 (46%), Gaps = 9/154 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSRFEH 389
LG G+ G V A++ +S ++ +E EI +L + H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
I++ D YI LEL+ G L + + L+++ Y Q+LL ++YLH+
Sbjct: 200 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258
Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
++HRD+K N+L+ + + +K+ DFG +K+
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 309 STTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG 367
S + ISP + + +GRG++GSV + + G AVK +
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS---- 57
Query: 368 SQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH- 425
+ ++ QL ++ ++ + IVQ+YG E +I +EL++ S Y+ +
Sbjct: 58 TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYS 116
Query: 426 -----LRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ + + T + L +L + ++HRDIK +NIL+D +G++KL DFG++
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 480 LSSL 483
+ S+
Sbjct: 177 VDSI 180
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFE 388
+ LGRG++G V + G AVK + + Q +L ++ + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA----TVNSQEQKRLLMDLDISMRTVD 64
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-----SQVSAYTRQILLGLK 443
V +YG E ++I +EL+ SL Y++ + + I+ L+
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 444 YLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
+LH + V+HRD+K +N+L++A G VK+ DFG++ + +
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 9/154 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSRFEH 389
LG G+ G V A+K +S ++ +E EI +L + H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
I++ D YI LEL+ G L + + L+++ Y Q+LL ++YLH+
Sbjct: 75 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133
Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
++HRD+K N+L+ + + +K+ DFG +K+
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 52/154 (33%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+K LG G FG V G AVK L + + S +QEI +L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKADAGPQH-RSGWKQEIDILRT 89
Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
HE+I++Y G D + L + +E V GSL + R+ + +Q+ + +QI G+ Y
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAY 149
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
LH Q +HRD+ N+L+D + VK+ DFGLAK
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 40/148 (27%), Positives = 76/148 (51%), Gaps = 8/148 (5%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G++LG+G FG + + G +KE L+ + ++ +E+ ++ EH N+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQR---TFLKEVKVMRCLEHPNV 69
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDV 450
+++ G + +L E + G+L + + SQ ++ + I G+ YLH ++
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKV 478
+HRD+ N LV N +V +ADFGLA++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARL 157
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 51/250 (20%), Positives = 95/250 (38%), Gaps = 28/250 (11%)
Query: 258 MNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSN 317
M+ SS D KE A R I + + + + S+
Sbjct: 1 MHHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK 60
Query: 318 ISP----------------------NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGF 354
++ K + D++GRG V + G
Sbjct: 61 LNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120
Query: 355 FFAVKEVS---LLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLE 410
FAVK + Q ++ +E +L + H +I+ + + S +++ +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180
Query: 411 LVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469
L+ KG L + L ++ L + + + R +L + +LH ++VHRD+K NIL+D N ++
Sbjct: 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR 240
Query: 470 LADFGLAKVF 479
L+DFG +
Sbjct: 241 LSDFGFSCHL 250
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 7/153 (4%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS----LLDQGSQAKQSISQLEQEIALLSR-F 387
++LGRG V I +AVK + + ++ +E+ +L +
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
H NI+Q T + + ++ +L+ KG L + L ++ L + + R +L + LH
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
++VHRD+K NIL+D + ++KL DFG +
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 16/178 (8%)
Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
+ N+ G + LG G+FG V+ G +K ++ +
Sbjct: 7 HSSGRENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINK----DR 59
Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL-----NLYQRY 424
++ + Q+E EI +L +H NI++ + +D +YI +E G LL +
Sbjct: 60 SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119
Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
L + V+ +Q++ L Y H Q VVH+D+K NIL + +K+ DFGLA++F
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 50/221 (22%), Positives = 82/221 (37%), Gaps = 46/221 (20%)
Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV 361
H S+ E + G + + +G+GS+G V I A+K +
Sbjct: 2 HHHHHHSSGRENL--YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIM 59
Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--- 418
+ + + +++ E+ L+ + H NI + Y +DE + + +EL G LL
Sbjct: 60 NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119
Query: 419 --------------------------------------NLYQRYHLRDSQVSAYTRQILL 440
+ R+ +S RQI
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179
Query: 441 GLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKVF 479
L YLH+Q + HRDIK N L + + +KL DFGL+K F
Sbjct: 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF 220
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 6/165 (3%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
+ W LG G++G V + AVK V + +A +++EI +
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 59
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
HEN+V++YG ++ + Y+FLE + G L + + + + + Q++ G+
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDLL 488
YLH + HRDIK N+L+D ++K++DFGLA VF + LL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G +G GSFG+VY+G D AVK +L+ + Q + + E+ +L + H NI
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ + G +L I + SL + ++ RQ G+ YLH + +
Sbjct: 83 LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKV 478
+HRD+K NI + + +VK+ DFGLA
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATE 169
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 46/160 (28%), Positives = 83/160 (51%), Gaps = 8/160 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
+ +LG+GSFG V + +AVK ++++ S + S + +E+ L
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVEL 74
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
L + +H NI++ + +D S YI EL T G L + + +R + + +Q+ G+
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
Y+H ++VHRD+K NIL+ + + +K+ DFGL+ F
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-32
Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 10/151 (6%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+ +G GSFG+V+ G AVK +L + + +++ +E+A++ R H NIV
Sbjct: 42 KEKIGAGSFGTVHRAEWH-GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+ G L I E +++GSL L R L + + + + G+ YLH+++
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 450 --VVHRDIKCANILVDANGSVKLADFGLAKV 478
+VHR++K N+LVD +VK+ DFGL+++
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-32
Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 10/151 (6%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
++LG G+F V+ G FA+K + S LE EIA+L + +HENI
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIK-----KSPAFRDSSLENEIAVLKKIKHENI 68
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
V + + Y+ ++LV+ G L + + +R + S +Q+L +KYLH+ +V
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKVF 479
HRD+K N+L + N + + DFGL+K+
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKME 159
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 46/151 (30%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+ LG+G+F V + G FA K +++ + + +LE+E + + +H NI
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
V+ + + ++ES Y+ +LVT G L + R ++ S +QIL + Y H +V
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKVF 479
HR++K N+L+ +VKLADFGLA
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEV 158
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+++G+G F V I+ + G FAVK V + S S L++E ++ +H +I
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDS----QVSAYTRQILLGLKYLHD 447
V+ T + LY+ E + L + +R S Y RQIL L+Y HD
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 448 QDVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
+++HRD+K +L+ + + VKL FG+A
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-32
Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+++G G FG VY G AVK + D Q+I + QE L + +H NI+
Sbjct: 12 EEIIGIGGFGKVYRAFWI-GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---DV 450
G E L + +E G L + + + + QI G+ YLHD+ +
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 451 VHRDIKCANILVD--------ANGSVKLADFGLAKV 478
+HRD+K +NIL+ +N +K+ DFGLA+
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G+L+G+G FG VY G + A++ L+D + + ++E+ + HEN+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIR---LIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
V + G L I L +L ++ + L ++ ++I+ G+ YLH + +
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKV 478
+H+D+K N+ D NG V + DFGL +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSI 178
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 41/152 (26%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQ 394
+G G+ G V++ G AVK++ S K+ ++ ++ +L + IVQ
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRR----SGNKEENKRILMDLDVVLKSHDCPYIVQ 88
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQ-DVV 451
+GT + ++I +EL+ L +R + + + T I+ L YL ++ V+
Sbjct: 89 CFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 452 HRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
HRD+K +NIL+D G +KL DFG++ +
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 33/198 (16%)
Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL 363
E SS + + + K+I Q +G+G +G V+ G G AVK
Sbjct: 16 EQSQSSGSGSGLPLLVQRTIAKQI----QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT 70
Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT----KGSLLN 419
++ S + E EI HENI+ + D + + L L+T GSL
Sbjct: 71 TEEASWFR------ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL-- 122
Query: 420 LYQRYHLRDSQVSAYTR-----QILLGLKYLHDQD--------VVHRDIKCANILVDANG 466
+L+ + + A + + GL +LH + + HRD+K NILV NG
Sbjct: 123 ---YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 467 SVKLADFGLAKVFLSSLD 484
+ +AD GLA F+S +
Sbjct: 180 TCCIADLGLAVKFISDTN 197
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
+ F + K LG GSF + + FAVK +S K+ + ++
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--------KRMEANTQK 54
Query: 380 EIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQ 437
EI L H NIV+ + D+ ++ +EL+ G L + ++ H +++ S R+
Sbjct: 55 EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK 114
Query: 438 ILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
++ + ++HD VVHRD+K N+L + N +K+ DFG A++
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 6/165 (3%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
+ W LG G++G V + AVK V + +A +++EI +
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 59
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
HEN+V++YG ++ + Y+FLE + G L + + + + + Q++ G+
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDLL 488
YLH + HRDIK N+L+D ++K++DFGLA VF + LL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE---QEIALLSRFEH 389
+ +GRGS+G V + A K++ K + ++ QEI ++ +H
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIP--------KYFVEDVDRFKQEIEIMKSLDH 65
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
NI++ Y T +D + +Y+ +EL T G L + + R+S + + +L + Y H
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
+V HRD+K N L + +KL DFGLA F
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 16/189 (8%)
Query: 307 SSSTTTEPMSNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVK 359
+ + + + R + + LG+G+FGSV + G AVK
Sbjct: 17 TENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76
Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSL 417
+ L ++ E+EI +L +H+NIV+Y G L + +E + GSL
Sbjct: 77 K---LQHSTEEHLR--DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131
Query: 418 LNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
+ Q++ + ++ YT QI G++YL + +HRD+ NILV+ VK+ DFGL
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191
Query: 476 AKVFLSSLD 484
KV +
Sbjct: 192 TKVLPQDKE 200
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ LG+G+FGSV + G AVK+ L ++ E+EI +L
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLR--DFEREIEILKS 67
Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGL 442
+H+NIV+Y G L + +E + GSL + Q++ + ++ YT QI G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
+YL + +HRD+ NILV+ VK+ DFGL KV +
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 50/170 (29%), Positives = 88/170 (51%), Gaps = 10/170 (5%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG--SQAKQSISQLEQEIA 382
++I + GDLLG GS+G V E + S+ AVK +L + + + +++EI
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQ 58
Query: 383 LLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGS--LLNLYQRYHLRDSQVSAYTRQI 438
LL R H+N++Q ++++ K+Y+ +E G +L+ Q Y Q+
Sbjct: 59 LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDLL 488
+ GL+YLH Q +VH+DIK N+L+ G++K++ G+A+ D
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 46/151 (30%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+ LG+G+F V + G FA K +++ + + +LE+E + + +H NI
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
V+ + + ++ES Y+ +LVT G L + R ++ S +QIL + Y H +V
Sbjct: 91 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 150
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKVF 479
HR++K N+L+ +VKLADFGLA
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 7/153 (4%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHEN 391
G+ LG G F V + G +A K + S+ S ++E+E+ +L H N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
I+ + ++++ + + LELV+ G L + L ++ L + + + + +QIL G+ YLH + +
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRI 129
Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKVF 479
H D+K NI++ N +KL DFG+A
Sbjct: 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 35/252 (13%), Positives = 74/252 (29%), Gaps = 37/252 (14%)
Query: 261 RALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISP 320
SS ++ + G+ + V + S + + S++
Sbjct: 5 HHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRV 64
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
+G +LG+ + E + G F V ++ +I Q+++
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKE 122
Query: 380 EIALLSRF-------------------------EHENIVQYYGTDKDESKLYIFLEL-VT 413
E+ L + + +++ ++D L F
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182
Query: 414 KGSLLNLY--------QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465
+ +L L T Q++ L LH +VH ++ +I++D
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 242
Query: 466 GSVKLADFGLAK 477
G V L F
Sbjct: 243 GGVFLTGFEHLV 254
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 16/179 (8%)
Query: 309 STTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSL 363
+ +P + + P F++ + ++ LG G FG V + G AVK
Sbjct: 4 VSEKKPATEVDPT-HFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--- 57
Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY 421
L S I+ L++EI +L HENIV+Y G T+ + + + +E + GSL
Sbjct: 58 LKPESGGNH-IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL 116
Query: 422 Q--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ + Q Y QI G+ YL + VHRD+ N+LV++ VK+ DFGL K
Sbjct: 117 PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-31
Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 7/160 (4%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
++ +LG+GSFG V G AVK +S + + K L +E+ L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK--RQVKQKTDKESLLREVQL 79
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
L + +H NI++ Y +D+ Y+ E+ T G L + + R + + RQ+L G+
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
Y+H +VHRD+K N+L+ + ++++ DFGL+ F
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LGRG+ VY +A+K + + EI +L R H NI
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNI 110
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
++ + +++ + LELVT G L + + ++ + + + +QIL + YLH+ +V
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKVF 479
HRD+K N+L + +K+ADFGL+K+
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIV 201
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 23/208 (11%)
Query: 289 DDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEG 348
D +SE + D ++S + + + + I + +G+G FG V+ G
Sbjct: 6 DRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTI----VLQESIGKGRFGEVWRG 61
Query: 349 ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408
G AVK S S+ ++S + E EI HENI+ + D ++ +
Sbjct: 62 KWR-GEEVAVKIFS-----SREERSWFR-EAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114
Query: 409 LELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIK 456
L LV+ GSL + RY + + GL +LH + + HRD+K
Sbjct: 115 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174
Query: 457 CANILVDANGSVKLADFGLAKVFLSSLD 484
NILV NG+ +AD GLA S+ D
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATD 202
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 50/174 (28%), Positives = 86/174 (49%), Gaps = 11/174 (6%)
Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
+ N+ G F Y +LG+GSFG V + +AVK ++ S
Sbjct: 7 HSSGRENLYFQGTFAER--Y-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA---SA 60
Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRD 428
+ S + +E+ LL + +H NI++ + +D S YI EL T G L + + +R +
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
+ +Q+ G+ Y+H ++VHRD+K NIL+ + + +K+ DFGL+ F
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 46/165 (27%), Positives = 70/165 (42%), Gaps = 19/165 (11%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+ +G+G +G V+ G G AVK S S+ ++S + E E+ HEN
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ-GENVAVKIFS-----SRDEKSWFR-ETELYNTVMLRHEN 63
Query: 392 IVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
I+ + +D +L++ GSL + Q L I GL +LH
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 448 QD--------VVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
+ + HRD+K NILV NG +AD GLA + S +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 44/153 (28%), Positives = 81/153 (52%), Gaps = 7/153 (4%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHEN 391
G+ LG G F V + G +A K + + S+ S ++E+E+++L + H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
++ + ++ + + + LELV+ G L + L Q+ L + + +++ +QIL G+ YLH + +
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKVF 479
H D+K NI++ +KL DFGLA
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G++G V A+K + S + S S+L +E+A+L +H NI
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKT---SVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
++ Y +D+ Y+ +E G L + + R + + +Q+L G+ YLH ++V
Sbjct: 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKVF 479
HRD+K N+L+ + + +K+ DFGL+ VF
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVF 189
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--------LLDQGSQAKQS 373
+ +I + K LG G++G V + A+K + D ++
Sbjct: 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 374 ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVS 432
++ EI+LL +H NI++ + +D+ Y+ E G L + R+ + +
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
+QIL G+ YLH ++VHRDIK NIL+ ++ ++K+ DFGL+ F
Sbjct: 150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 33/160 (20%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
K + + + LGRG FG V+ + + K V + +++EI++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISI 54
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLG 441
L+ H NI+ + + + +L + E ++ + + L + ++ +Y Q+
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 442 LKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKVF 479
L++LH ++ H DI+ NI+ + ++K+ +FG A+
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 57/204 (27%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 361
H S Q ++ RG FG V++ + AVK
Sbjct: 5 HHHHSSGVDLGTENLYFQSMPL--------QLLEVKARGRFGCVWKAQLL-NEYVAVKIF 55
Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT----KGSL 417
Q KQS Q E E+ L +HENI+Q+ G +K + + + L L+T KGSL
Sbjct: 56 P-----IQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL 109
Query: 418 LNLYQRYHLRDSQVSAYTR-QILL----GLKYLHDQD----------VVHRDIKCANILV 462
L+ + VS I GL YLH+ + HRDIK N+L+
Sbjct: 110 -----SDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164
Query: 463 DANGSVKLADFGLAKVFLSSLDFD 486
N + +ADFGLA F +
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAG 188
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 35/197 (17%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQ---------KGDLLGRGSFGSVYEGISDDGFFFA 357
++++ + +S+ + L+G G FG VY+G+ DG A
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67
Query: 358 VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKL-YIFLELVTK 414
+K S Q I + E EI LS H ++V G +++E L Y + +
Sbjct: 68 LK---RRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY---KYMEN 119
Query: 415 GSLLNLYQRYHLRDSQVSAY-----TR-QILL----GLKYLHDQDVVHRDIKCANILVDA 464
G+L + HL S + R +I + GL YLH + ++HRD+K NIL+D
Sbjct: 120 GNL-----KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE 174
Query: 465 NGSVKLADFGLAKVFLS 481
N K+ DFG++K
Sbjct: 175 NFVPKITDFGISKKGTE 191
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ LG+G+FGSV + G AVK L G ++ ++EI +L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRD---FQREIQILKA 80
Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLG 441
+ IV+Y G L + +E + G L + + R L S++ Y+ QI G
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKG 139
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
++YL + VHRD+ NILV++ VK+ADFGLAK+ D
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 3e-30
Identities = 41/169 (24%), Positives = 69/169 (40%), Gaps = 18/169 (10%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
+ W+ + LG G FG V I D G A+K+ + ++ + EI +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ----ELSPKNRERWCLEIQI 65
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSL---LNLYQRYH-LRDSQVSA 433
+ + H N+V KL + +E G L LN ++ L++ +
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKVF 479
I L+YLH+ ++HRD+K NI++ K+ D G AK
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+L+GRG +G+VY+G D AVK S +Q+ E+ I + EH+NI
Sbjct: 18 LELIGRGRYGAVYKGSLD-ERPVAVKVFS-----FANRQNFIN-EKNIYRVPLMEHDNIA 70
Query: 394 QYYGTDK-----DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
++ D+ + + +E GSL + + GL YLH +
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 449 D---------VVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
+ HRD+ N+LV +G+ ++DFGL+ +
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+ LG+G+F V + G +A + + + + +LE+E + +H NI
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMII---NTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
V+ + + +E Y+ +LVT G L + R + ++ S +QIL + + H VV
Sbjct: 73 VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 132
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKVF 479
HR++K N+L+ +VKLADFGLA
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEV 163
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 43/166 (25%), Positives = 88/166 (53%), Gaps = 5/166 (3%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI 374
++I+ + I ++ +G+G+F V G A+K ++D+ S+
Sbjct: 2 NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSL 58
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
+L +E+ ++ H NIV+ + + E LY+ +E + G + + L +++ + +
Sbjct: 59 QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 118
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
RQI+ ++Y H + +VHRD+K N+L+DA+ ++K+ADFG + F
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 44/153 (28%), Positives = 80/153 (52%), Gaps = 7/153 (4%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHEN 391
G+ LG G F V + G +A K + + S+ ++E+E+++L + H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
I+ + ++ + + + LELV+ G L + L Q+ L + + +++ +QIL G+ YLH + +
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKVF 479
H D+K NI++ +KL DFGLA
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 8/146 (5%)
Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G+FG+V +G AVK L + +L E ++ + ++ IV
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKI---LKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ G + ES + +E+ G L L Q H++D + Q+ +G+KYL + + VH
Sbjct: 82 RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 453 RDIKCANILVDANGSVKLADFGLAKV 478
RD+ N+L+ K++DFGL+K
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKA 166
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-30
Identities = 42/219 (19%), Positives = 87/219 (39%), Gaps = 10/219 (4%)
Query: 266 SSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFK 325
G+E R + ++ + + + D+ + +
Sbjct: 94 CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
++ ++ + LG G+FG V+ G FA K V + + + +EI +
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVRKEIQTM 208
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGL 442
S H +V + +D++++ + E ++ G L + + + + Y RQ+ GL
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 268
Query: 443 KYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKVF 479
++H+ + VH D+K NI+ + +KL DFGL
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 18/186 (9%)
Query: 301 TEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK 359
T E + + + + + ++ G +LG GSF +V +A+K
Sbjct: 4 TAAEPRPGAGSLQHAQPPPQPRKKR--PEDFKFGKILGEGSFSTVVLARELATSREYAIK 61
Query: 360 EVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
+ K+ I + + E ++SR +H V+ Y T +D+ KLY L
Sbjct: 62 ILE--------KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113
Query: 414 KGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472
G LL ++ D + YT +I+ L+YLH + ++HRD+K NIL++ + +++ D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 473 FGLAKV 478
FG AKV
Sbjct: 174 FGTAKV 179
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 42/153 (27%), Positives = 78/153 (50%), Gaps = 7/153 (4%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHEN 391
G+ LG G F V + G +A K + + S+ S +E+E+++L +H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
++ + ++++ + + LELV G L + L ++ L + + + + +QIL G+ YLH +
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKVF 479
H D+K NI++ +K+ DFGLA
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 23/213 (10%), Positives = 56/213 (26%), Gaps = 38/213 (17%)
Query: 300 TTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAV 358
+ ++T + + + + + + L G V+ + FA+
Sbjct: 33 PAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL 92
Query: 359 KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT-------------------- 398
K ++ + +L + +R E+ +
Sbjct: 93 K--VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQ 150
Query: 399 ------DKDESKLYIFLELVTKGSLLNLY--------QRYHLRDSQVSAYTRQILLGLKY 444
D + + + L L+ R + T Q++
Sbjct: 151 LSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
L + +VH N+ + +G + L D
Sbjct: 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 6/161 (3%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS---LLDQGSQAKQSISQLEQE 380
+ LG G+FG V+ + + VK + +L+ + ++ E
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQI 438
IA+LSR EH NI++ +++ + +E G L + + L + S RQ+
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ + YL +D++HRDIK NI++ + ++KL DFG A
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 44/200 (22%), Positives = 85/200 (42%), Gaps = 10/200 (5%)
Query: 285 KEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGS 344
V + D + + + Y+ + LG G+FG
Sbjct: 7 HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66
Query: 345 VYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403
V+ + G F K ++ + ++ EI+++++ H ++ + +D+
Sbjct: 67 VHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121
Query: 404 KLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
++ + LE ++ G L + + Y + +++V Y RQ GLK++H+ +VH DIK NI+
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181
Query: 462 V--DANGSVKLADFGLAKVF 479
SVK+ DFGLA
Sbjct: 182 CETKKASSVKIIDFGLATKL 201
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 44/151 (29%), Positives = 71/151 (47%), Gaps = 8/151 (5%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G FG V G + AVK ++ +GS ++ + QE + + H +V
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVK---MIKEGSMSED---EFFQEAQTMMKLSHPKLV 66
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
++YG E +YI E ++ G LLN + L SQ+ + G+ +L +
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 452 HRDIKCANILVDANGSVKLADFGLAKVFLSS 482
HRD+ N LVD + VK++DFG+ + L
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 45/232 (19%), Positives = 100/232 (43%), Gaps = 21/232 (9%)
Query: 264 SSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGR 323
+++ + D+ + + + T S T+ + +P
Sbjct: 13 DLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAP 72
Query: 324 FKRIITYWQKGDL-----------LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
F I ++G + LG G FG V++ G A K + ++
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGM 127
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDS 429
+ +++ EI+++++ +H N++Q Y + ++ + + +E V G L + + + Y+L +
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL 187
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKVF 479
+ +QI G++++H ++H D+K NIL +K+ DFGLA+ +
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 44/171 (25%), Positives = 72/171 (42%), Gaps = 11/171 (6%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQ 369
+ P +I + + LG GSFG V G S AVK L
Sbjct: 3 AGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK--CLKPDVLS 60
Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLR 427
+++ +E+ + +H N+++ YG + + EL GSLL+ + H
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL 119
Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+S Y Q+ G+ YL + +HRD+ N+L+ VK+ DFGL +
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 45/173 (26%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQL 377
S +GRF+ + Y + D+LG G+ V I+ +AVK + Q S++
Sbjct: 5 SFSGRFEDV--YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK-----QPGHIRSRV 57
Query: 378 EQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
+E+ +L + + H N+++ ++E + Y+ E + GS+L+ +++R H + + S
Sbjct: 58 FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV 117
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVFLSSLDF 485
+ + L +LH++ + HRD+K NIL + VK+ DF L + D
Sbjct: 118 QDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 24/153 (15%), Positives = 55/153 (35%), Gaps = 11/153 (7%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
L G +++G G VK +L + + +E L F H N++
Sbjct: 15 LTKLNENHSGELWKGR-WQGNDIVVK---VLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 394 QYYG--TDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ 448
G + + GSL N+ + + SQ + + G+ +LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 449 D--VVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ + + ++++D + + +++ + F
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 40/160 (25%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+G+G FG V++G D A+K + + ++ + + ++E+ ++S H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR-----QILLGLKYL 445
NIV+ YG + + +E V G LY R + + + I LG++Y+
Sbjct: 84 NIVKLYGLMHN--PPRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 446 HDQD--VVHRDIKCANILVDANG-----SVKLADFGLAKV 478
+Q+ +VHRD++ NI + + K+ADFGL++
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 37/189 (19%), Positives = 66/189 (34%), Gaps = 28/189 (14%)
Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLD 365
+ I P F+ LLG G+F VYE D F +K
Sbjct: 48 QCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--- 104
Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH 425
Q + L +++Y ++ + EL + G+LLN Y
Sbjct: 105 --PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK 162
Query: 426 LRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILV-----------DANGSV 468
+ V ++ ++L ++ +HD +++H DIK N ++ D + +
Sbjct: 163 NTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222
Query: 469 KLADFGLAK 477
L D G +
Sbjct: 223 ALIDLGQSI 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 55/171 (32%), Positives = 91/171 (53%), Gaps = 12/171 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAK 371
S+ N F+ ++ +QK + +G G++G VY+ G A+K + L D+G
Sbjct: 6 HHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI--- 62
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRD 428
+ + +EI+LL H NIV E L + F+E K L + L+D
Sbjct: 63 -PSTAI-REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQD 118
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
SQ+ Y Q+L G+ + H ++HRD+K N+L++++G++KLADFGLA+ F
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF 169
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 35/151 (23%), Positives = 69/151 (45%), Gaps = 8/151 (5%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G G FG V+ G + A+K + +G+ +++ +E ++ + H +V
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIK---TIREGAMSEE---DFIEEAEVMMKLSHPKLV 66
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
Q YG +++ + + E + G L + + R + + G+ YL + V+
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 452 HRDIKCANILVDANGSVKLADFGLAKVFLSS 482
HRD+ N LV N +K++DFG+ + L
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 8/160 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIA 382
K ++K D LG G F +VY+ + A+K++ L S+AK I +EI
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIK 64
Query: 383 LLSRFEHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
LL H NI+ +S + + F+E + + + L S + AY L
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTL 122
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
GL+YLH ++HRD+K N+L+D NG +KLADFGLAK F
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 6/163 (3%)
Query: 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS-ISQL 377
+ I ++ GD LG G+FG V G G AVK +L++ + ++
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKI 58
Query: 378 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTR 436
++EI L F H +I++ Y + ++ +E V+ G L + + + + + + +
Sbjct: 59 KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
QIL + Y H VVHRD+K N+L+DA+ + K+ADFGL+ +
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G FG V G + A+K ++ +GS ++ + +E ++ HE +V
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 82
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
Q YG + ++I E + G LLN + R+ + Q+ + + ++YL + +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 452 HRDIKCANILVDANGSVKLADFGLAKVFLSS 482
HRD+ N LV+ G VK++DFGL++ L
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 47/168 (27%), Positives = 85/168 (50%), Gaps = 14/168 (8%)
Query: 320 PNGRFKRIITYWQ--KGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAKQ 372
PN RI+ + K +LG G+FG+VY+G+ +G A+KE L + + K
Sbjct: 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKA 60
Query: 373 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQ 430
+ L E +++ ++ ++ + G + + + +L+ G LL+ + ++
Sbjct: 61 NKEIL-DEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ + QI G+ YL D+ +VHRD+ N+LV VK+ DFGLAK+
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 20/170 (11%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEH 389
+ +L G F VYE G +A+K + + ++ + QE+ + + H
Sbjct: 31 RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-----EEKNRAIIQEVCFMKKLSGH 85
Query: 390 ENIVQYYG-------TDKDESKLYIFLELVTKGSLLNLYQRYHLRD----SQVSAYTRQI 438
NIVQ+ ++ L + KG L+ ++ R V Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 439 LLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFD 486
++++H Q ++HRD+K N+L+ G++KL DFG A D+
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 17/187 (9%)
Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV 361
H S F Y LGRG F V + IS G +A K
Sbjct: 5 HHHSSGVDLGTENLYFQSMENFNNF--YILTSKELGRGKFAVVRQCISKSTGQEYAAK-- 60
Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
L + + + +++ EIA+L + ++ + ++ S++ + LE G + +
Sbjct: 61 -FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119
Query: 420 ----LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLAD 472
L + D V +QIL G+ YLH ++VH D+K NIL+ G +K+ D
Sbjct: 120 CLPELAEMVSEND--VIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 473 FGLAKVF 479
FG+++
Sbjct: 178 FGMSRKI 184
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 10/154 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRF 387
+QK + +G G++G VY+ + G A+K++ L +G + + +EI+LL
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV----PSTAI-REISLLKEL 59
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
H NIV+ E+KLY+ E + + ++ + + +Y Q+L GL +
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
H V+HRD+K N+L++ G++KLADFGLA+ F
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 153
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 32/193 (16%)
Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL 363
+D + + +R I Y ++G GSFG V++ + A+K+V L
Sbjct: 19 DDPNKVIKVLASDGKTG---EQREIAY-TNCKVIGNGSFGVVFQAKLVESDEVAIKKV-L 73
Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGSL 417
D+ + + E+ ++ +H N+V G KDE L + LE V +
Sbjct: 74 QDKRFKNR--------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE--- 122
Query: 418 LNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSV 468
+Y+ R++ + Q + Y Q+L L Y+H + HRDIK N+L+D G +
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVL 181
Query: 469 KLADFGLAKVFLS 481
KL DFG AK+ ++
Sbjct: 182 KLIDFGSAKILIA 194
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 9/149 (6%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G+ +GRG+FG V+ G D AVK + L QE +L ++ H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVK---SCRETLPPDLKAKFL-QEARILKQYSHPNI 174
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
V+ G + +YI +ELV G L + + LR + G++YL +
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKV 478
+HRD+ N LV +K++DFG+++
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSRE 262
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 30/195 (15%)
Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS 362
D S T ++ + ++Y ++G GSFG VY+ D G A+K+V
Sbjct: 30 RDKDGSKVTTVVATPGQGPDRPQEVSY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV- 87
Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGS 416
L D+ + + E+ ++ + +H NIV+ G KDE L + L+ V +
Sbjct: 88 LQDKRFKNR--------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-- 137
Query: 417 LLNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GS 467
+Y+ R++ R Q V Y Q+ L Y+H + HRDIK N+L+D +
Sbjct: 138 --TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195
Query: 468 VKLADFGLAKVFLSS 482
+KL DFG AK +
Sbjct: 196 LKLCDFGSAKQLVRG 210
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 12/158 (7%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++G G G V G A+K L G +Q L E +++ +F+H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK---ALKAGYTERQRRDFL-SEASIMGQFDH 109
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
NI++ G I E + GSL + R H Q+ R + G++YL
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
D VHRD+ N+LVD+N K++DFGL++V D
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 11/179 (6%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS--- 362
+ + ++P + + + +Q G LLG G FGSVY GI D A+K V
Sbjct: 21 MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80
Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDESKLYIFLELVT-KGSLLN 419
+ D G + ++ E+ LL + +++ + + LE L +
Sbjct: 81 ISDWGELPNGT--RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 138
Query: 420 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLA 476
+ +R L++ ++ Q+L +++ H+ V+HRDIK NIL+D N G +KL DFG
Sbjct: 139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 7/177 (3%)
Query: 306 DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLL 364
++ + + + ++ L+G GS+G V + + D G A+K+
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES 61
Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY 424
D K + +EI LL + HEN+V K + + Y+ E V ++L+ + +
Sbjct: 62 DDDKMVK--KIAM-REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF 117
Query: 425 --HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
L V Y QI+ G+ + H +++HRDIK NILV +G VKL DFG A+
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHEN 391
+ +G GS+ I FAVK + +S +EI +L R+ +H N
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIID---------KSKRDPTEEIEILLRYGQHPN 77
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
I+ D +Y+ EL+ G LL+ + ++ + + SA I ++YLH Q V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKVF 479
VHRD+K +NIL S+++ DFG AK
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 42/147 (28%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G+FGSV +G+ A+K L QG++ + ++ +E ++ + ++ IV
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADT-EEMMREAQIMHQLDNPYIV 73
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ G + E+ L + +E+ G L R + S V+ Q+ +G+KYL +++ V
Sbjct: 74 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 452 HRDIKCANILVDANGSVKLADFGLAKV 478
HRD+ N+L+ K++DFGL+K
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKA 159
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 12/154 (7%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFE 388
+ + +G G++G VY+ ++ G FA+K++ L D+G + + +EI++L +
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTI-REISILKELK 58
Query: 389 HENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
H NIV+ Y + +L + L+ K L L ++ Q+L G+ Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYC 116
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
HD+ V+HRD+K N+L++ G +K+ADFGLA+ F
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 41/152 (26%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K +G GS+G V++ + D G A+K+ + K L +EI +L + +H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK--KIAL-REIRMLKQLKH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHD 447
N+V + + +L++ E ++L+ RY + + V + T Q L + + H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ +HRD+K NIL+ + +KL DFG A++
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLL 152
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 54/167 (32%), Positives = 83/167 (49%), Gaps = 13/167 (7%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIA 382
+ ++ +G G++G+VY+ G F A+K V + G IS + +E+A
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV-REVA 63
Query: 383 LL---SRFEHENIVQ-----YYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVS 432
LL FEH N+V+ E K+ + E V + + L+ L +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
RQ L GL +LH +VHRD+K NILV + G+VKLADFGLA+++
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY 170
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 334 GDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
++G G FG VY+G+ A+K L G KQ + L E ++ +F
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFL-GEAGIMGQFS 104
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYL 445
H NI++ G + I E + G+L + R Q+ R I G+KYL
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ + VHRD+ NILV++N K++DFGL++V
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 46/152 (30%), Positives = 70/152 (46%), Gaps = 13/152 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+LG G FG VYEG+ + AVK + + E ++ +H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKT---CKKDCTLDNKEKFM-SEAVIMKNLDH 72
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLGLKYLH 446
+IV+ G ++E +I +EL G L + Y + L+ + Y+ QI + YL
Sbjct: 73 PHIVKLIGIIEEEP-TWIIMELYPYGELGH-YLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ VHRDI NILV + VKL DFGL++
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 15/153 (9%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
G +G G FG V++GI S + A+K + L QE + +F+H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFL-QEALTMRQFDH 75
Query: 390 ENIVQYYG--TDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYL 445
+IV+ G T E+ ++I +EL T G L + ++Y L + + Y Q+ L YL
Sbjct: 76 PHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ VHRDI N+LV +N VKL DFGL++
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 10/150 (6%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G +G VYEG+ AVK L + + + + +E A++ +H N+
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNL 71
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
VQ G E YI E +T G+LL+ R + + QI ++YL ++
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVF 479
+HRD+ N LV N VK+ADFGL+++
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM 161
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 7/169 (4%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQ 372
PM+ + I ++ GD LG G+FG V G G AVK +L++
Sbjct: 2 PMAE-KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSL 57
Query: 373 S-ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQ 430
+ ++ +EI L F H +I++ Y S +++ +E V+ G L + + + L + +
Sbjct: 58 DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE 117
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+QIL G+ Y H VVHRD+K N+L+DA+ + K+ADFGL+ +
Sbjct: 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 42/218 (19%), Positives = 73/218 (33%), Gaps = 58/218 (26%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK----------------EVSLLDQ-- 366
R +T ++ +GRG FG V+E + D +A+K EV L +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 367 -----------------------------------GSQAKQSISQLEQEIALLSRFEHEN 391
+ + +I + F +N
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----SQVSAYTRQILLGLKYLHD 447
V + LYI ++L K +L + R + QI +++LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
+ ++HRD+K +NI + VK+ DFGL +
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 18/153 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+++GRG+FG V + A+K++ +++ E+ LSR H NIV
Sbjct: 13 EEVVGRGAFGVVCKAK-WRAKDVAIKQI-------ESESERKAFIVELRQLSRVNHPNIV 64
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+ YG + + + +E GSL N+ + + ++ Q G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 450 ---VVHRDIKCANILVDANGSV-KLADFGLAKV 478
++HRD+K N+L+ A G+V K+ DFG A
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 22/162 (13%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
G +LG+G FGSV E +DG F AVK +L A I + +E A + F+H
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVK---MLKADIIASSDIEEFLREAACMKEFDH 84
Query: 390 ENIVQYYG--TDKD----ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--- 440
++ + G + L + G L + Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA-FLLASRIGENPFNLPLQTLVRFM 143
Query: 441 -----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
G++YL ++ +HRD+ N ++ + +V +ADFGL++
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSL--LDQG--SQAKQSISQLE 378
R ++ +G G++G V++ + G F A+K V + ++G + ++ L
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 379 QEIALLSRFEHENIVQ-----YYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQV 431
L FEH N+V+ E+KL + E V + + L+ + +
Sbjct: 67 H----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
Q+L GL +LH VVHRD+K NILV ++G +KLADFGLA+++
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++G G FG V G S A+K L G KQ L E +++ +F+H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIK---TLKVGYTEKQRRDFL-GEASIMGQFDH 105
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
NI++ G + I E + GSL + + R H Q+ R I G+KYL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
D VHRD+ NIL+++N K++DFGL +V
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 49/155 (31%), Positives = 85/155 (54%), Gaps = 13/155 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRF 387
++K + +G G++G+V++ + + A+K V L D+G S L +EI LL
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSAL-REICLLKEL 58
Query: 388 EHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
+H+NIV+ + + KL + F + K + L V ++ Q+L GL +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGF 116
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
H ++V+HRD+K N+L++ NG +KLA+FGLA+ F
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 30/191 (15%)
Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
S + + + K + + Q + G+G+FG+V G G A+K+V +
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQD 59
Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYY-------GTDKDESKLYIFLELVTKGSLLN 419
+ + Q + L+ H NIVQ D+ + L + +E V
Sbjct: 60 PRFRNREL----QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD----T 111
Query: 420 LYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQ--DVVHRDIKCANILVD-ANGSV 468
L++ R + R + + Q++ + LH +V HRDIK N+LV+ A+G++
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171
Query: 469 KLADFGLAKVF 479
KL DFG AK
Sbjct: 172 KLCDFGSAKKL 182
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 45/194 (23%), Positives = 83/194 (42%), Gaps = 16/194 (8%)
Query: 292 VLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI-ITYWQKGDLLGRGSFGSVYE-GI 349
L F ++ + + R R+ ++ ++GRG+FG V
Sbjct: 31 ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90
Query: 350 SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTDKDES 403
+A+K +S K + + E +++ +VQ + +D+
Sbjct: 91 KSTRKVYAMKLLS--------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142
Query: 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD 463
LY+ +E + G L+NL Y + + YT +++L L +H +HRD+K N+L+D
Sbjct: 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202
Query: 464 ANGSVKLADFGLAK 477
+G +KLADFG
Sbjct: 203 KSGHLKLADFGTCM 216
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 51/164 (31%), Positives = 88/164 (53%), Gaps = 24/164 (14%)
Query: 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
G+ +G G FG VY+G ++ AVK+++ ++D + ++ Q +QEI ++++
Sbjct: 31 PISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITT--EELKQQFDQEIKVMAKC 87
Query: 388 EHENIVQYYG--TDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVSA----YTR-QIL 439
+HEN+V+ G +D D+ L Y + GSLL+ L + + R +I
Sbjct: 88 QHENLVELLGFSSDGDDLCLVY---VYMPNGSLLD-----RLSCLDGTPPLSWHMRCKIA 139
Query: 440 L----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
G+ +LH+ +HRDIK ANIL+D + K++DFGLA+
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 16/151 (10%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+ LG G FG V+ G + AVK L QGS + E L+ + +H+ +V
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVK---SLKQGSMSPD---AFLAEANLMKQLQHQRLV 71
Query: 394 QYYG--TDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHD 447
+ Y T + +YI E + GSL++ + L +++ QI G+ ++ +
Sbjct: 72 RLYAVVT---QEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKV 478
++ +HRD++ ANILV S K+ADFGLA++
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 40/192 (20%), Positives = 82/192 (42%), Gaps = 17/192 (8%)
Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFF 356
H + T P S I +++ LG G++G VY+ I
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62
Query: 357 AVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK 414
A+K + L ++G + + +E++LL +H NI++ +L++ E
Sbjct: 63 AIKRIRLEHEEEGV----PGTAI-REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 415 --GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GS 467
++ + + + ++ Q++ G+ + H + +HRD+K N+L+ +
Sbjct: 118 DLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175
Query: 468 VKLADFGLAKVF 479
+K+ DFGLA+ F
Sbjct: 176 LKIGDFGLARAF 187
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 14/168 (8%)
Query: 320 PNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAKQ 372
RI T +K +LG G FG+V++G+ +G +K ++ S Q
Sbjct: 2 AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV---IEDKSGR-Q 57
Query: 373 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQ 430
S + + + +H +IV+ G S L + + + GSLL+ R L
Sbjct: 58 SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQL 116
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ + QI G+ YL + +VHR++ N+L+ + V++ADFG+A +
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 50/157 (31%), Positives = 89/157 (56%), Gaps = 13/157 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
+++ + LG G++ +VY+G++ G + A+KEV L ++G+ + + +EI+L+ +
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAI-REISLMKELK 61
Query: 389 HENIVQYYGTDKDESKLYI---FLELVTKG---SLLNLYQRYHLRDSQVSAYTRQILLGL 442
HENIV+ Y E+KL + F++ K S L + V + Q+L GL
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ H+ ++HRD+K N+L++ G +KL DFGLA+ F
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 11/151 (7%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+++GRG FG VY G +DG AVK L++ + + +SQ E ++ F H
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 85
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
N++ G + E + L + G L N + ++ + + Q+ G+KYL
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ VHRD+ N ++D +VK+ADFGLA+
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 7/158 (4%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIA 382
KR I + + LG GSFG V A+K + + K ++E+EI+
Sbjct: 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREIS 61
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLG 441
L H +I++ Y + + + +E G L + + ++ + + + + +QI+
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
++Y H +VHRD+K N+L+D N +VK+ADFGL+ +
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 46/169 (27%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 319 SPNGRFKRIITYWQ--KGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAK 371
+PN RI+ + K +LG G+FG+VY+G+ +G A+KE L + + K
Sbjct: 3 APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPK 59
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDS 429
++ E +++ ++ ++ + G + + + +L+ G LL+ + ++
Sbjct: 60 A-NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ + QI G+ YL D+ +VHRD+ N+LV VK+ DFGLAK+
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 21/180 (11%)
Query: 315 MSNISPNGRFK--RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
M+ + ++ ++K +G+G+FG V++ G A+K+V + K
Sbjct: 1 MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM----ENEK 56
Query: 372 QSI-SQLEQEIALLSRFEHENIVQ--------YYGTDKDESKLYI---FLELVTKGSLLN 419
+ +EI +L +HEN+V ++ + +Y+ F E G L N
Sbjct: 57 EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
S++ + +L GL Y+H ++HRD+K AN+L+ +G +KLADFGLA+ F
Sbjct: 117 --VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 50/153 (32%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ K D LG G++ +VY+G S A+KE+ L + +I +E++LL +H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLKH 59
Query: 390 ENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
NIV + E L + +L+ K L + + V + Q+L GL Y H
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
Q V+HRD+K N+L++ G +KLADFGLA+
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAK 150
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 51/148 (34%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG+G FG V+ G + A+K L G+ + + QE ++ + HE +V
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE---AFLQEAQVMKKLRHEKLV 242
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
Q Y +E +YI E ++KGSLL+ +LR Q+ QI G+ Y+ +
Sbjct: 243 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKV 478
VHRD++ ANILV N K+ADFGLA++
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARL 329
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 26/157 (16%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
+G+GSFG V D +A+K ++ KQ + + E+ ++ E
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMN--------KQKCVERNEVRNVFKELQIMQGLE 73
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR------DSQVSAYTRQILLGL 442
H +V + + +DE +++ ++L+ G L RYHL+ + V + ++++ L
Sbjct: 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDL-----RYHLQQNVHFKEETVKLFICELVMAL 128
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
YL +Q ++HRD+K NIL+D +G V + DF +A +
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 48/217 (22%), Positives = 98/217 (45%), Gaps = 15/217 (6%)
Query: 279 ADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLG 338
+ A ++ + E + +++P +++ +I ++ L+G
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 339 RGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
GS+G V E + A+K++ + K+ + +EIA+L+R H+++V+
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILNRLNHDHVVKVL 118
Query: 397 GTDKDES-----KLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+ +LY+ LE+ S +L + + +L+G+KY+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFD 486
++HRD+K AN LV+ + SVK+ DFGLA+ + +
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 45/190 (23%), Positives = 78/190 (41%), Gaps = 14/190 (7%)
Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFF 356
S T+ + P R + ++ G LLG+G FG+V+ G D
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDR-EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV 59
Query: 357 AVKEVS---LLDQGSQAKQSISQLEQEIALLSR----FEHENIVQYYGTDKDESKLYIFL 409
A+K + +L + E+ALL + H +++ + + + L
Sbjct: 60 AIKVIPRNRVLGWSPLSDSV--TCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117
Query: 410 ELVTKGS-LLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NG 466
E L + + ++ L + + Q++ +++ H + VVHRDIK NIL+D G
Sbjct: 118 ERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG 177
Query: 467 SVKLADFGLA 476
KL DFG
Sbjct: 178 CAKLIDFGSG 187
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 41/147 (27%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G+FGSV +G+ A+K L QG++ + + +E ++ + ++ IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMM-REAQIMHQLDNPYIV 399
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ G + E+ L + +E+ G L + +R + S V+ Q+ +G+KYL +++ V
Sbjct: 400 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 452 HRDIKCANILVDANGSVKLADFGLAKV 478
HR++ N+L+ K++DFGL+K
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKA 485
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 39/163 (23%), Positives = 64/163 (39%), Gaps = 22/163 (13%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF- 387
Y +LG G G V + + FA+K + + +E+ L R
Sbjct: 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----------DCPKARREVELHWRAS 68
Query: 388 EHENIVQYYG----TDKDESKLYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILL 440
+ +IV+ L I +E + G L + + R + + S + I
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 441 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVFL 480
++YLH ++ HRD+K N+L N +KL DFG AK
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G+G FG V G G AVK + + A+ E +++++ H N+V
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVK---CIKNDATAQA----FLAEASVMTQLRHSNLV 77
Query: 394 QYYGT-DKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQD 449
Q G +++ LYI E + KGSL++ + R L + ++ + ++YL +
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK 477
VHRD+ N+LV + K++DFGL K
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
G +LG G FGSV EG +DG AVK + + +++ I + E A + F H
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVK---TMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 390 ENIVQYYG--TDKD---ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------R 436
N+++ G + K + L + G L Y Y ++
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT-YLLYSRLETGPKHIPLQTLLKFMV 154
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
I LG++YL +++ +HRD+ N ++ + +V +ADFGL+K
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 273 EKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI----I 328
+KEGE A +I K ++ S + + DD + E + P+ R I I
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392
Query: 329 TYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
G +G G FG V++GI + A+K + L QE +
Sbjct: 393 E---LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVREKFL-QEALTM 445
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLG 441
+F+H +IV+ G + ++I +EL T G L + + + L + + Y Q+
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTA 503
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
L YL + VHRDI N+LV +N VKL DFGL++
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 11/154 (7%)
Query: 332 QKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
++G+G FG VY G + + A+K +S Q + +E L+
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS----RITEMQQVEAFLREGLLMRGL 79
Query: 388 EHENIVQYYGT-DKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKY 444
H N++ G E ++ L + G LL + + + ++ Q+ G++Y
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478
L +Q VHRD+ N ++D + +VK+ADFGLA+
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 12/150 (8%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G +G VYEG+ AVK L + + + +E A++ +H N+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEE---FLKEAAVMKEIKHPNL 278
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHDQ 448
VQ G E YI E +T G+LL+ Y R + + QI ++YL +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKV 478
+ +HR++ N LV N VK+ADFGL+++
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRL 367
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 51/148 (34%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG+G FG V+ G + A+K L G+ + + QE ++ + HE +V
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE---AFLQEAQVMKKLRHEKLV 325
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
Q Y +E +YI E ++KGSLL+ +LR Q+ QI G+ Y+ +
Sbjct: 326 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKV 478
VHRD++ ANILV N K+ADFGLA++
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARL 412
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 26/155 (16%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
LG GSFG V + G +A+K + KQ + +L+Q E +L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILD--------KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV----SA--YTRQILLGL 442
+V+ + KD S LY+ +E V G + HLR A Y QI+L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-----SHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+YLH D+++RD+K N+L+D G +++ DFG AK
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 12/149 (8%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G FG V+ + AVK + GS + + E ++ +H+ +V
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVK---TMKPGSMSVE---AFLAEANVMKTLQHDKLV 246
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----YTRQILLGLKYLHDQD 449
+ + E +YI E + KGSLL+ + + Q ++ QI G+ ++ ++
Sbjct: 247 KLHAVVTKEP-IYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKV 478
+HRD++ ANILV A+ K+ADFGLA+V
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 48/150 (32%), Positives = 86/150 (57%), Gaps = 16/150 (10%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
LG GSFG V+ S +G ++A+K + K+ + +L+Q E +LS
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIVT 64
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHD 447
H I++ +GT +D ++++ ++ + G L +L ++ + V+ Y ++ L L+YLH
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477
+D+++RD+K NIL+D NG +K+ DFG AK
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAK 154
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 11/156 (7%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+++GRG FG VY G +DG AVK L++ + + +SQ E ++ F H
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 149
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
N++ G + E + L + G L N + ++ + + Q+ G+K+L
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
+ VHRD+ N ++D +VK+ADFGLA+
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 35/156 (22%), Positives = 61/156 (39%), Gaps = 20/156 (12%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+LG G G V E G A+K + ++ E + +IV
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDH-HWQASGGPHIV 85
Query: 394 QYYGT----DKDESKLYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILLGLKYLH 446
+ L I +E + G L + + +R + + + R I +++LH
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 447 DQDVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
++ HRD+K N+L + + +KL DFG AK
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 54/160 (33%), Positives = 77/160 (48%), Gaps = 28/160 (17%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+LGRG FG VY+G DG AVK L ++ +Q + Q + E+ ++S H N+++
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLRL 92
Query: 396 YG--TDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TR-QILLG----L 442
G E L Y + GS+ LR+ S R +I LG L
Sbjct: 93 RGFCMTPTERLLVY---PYMANGSV-----ASCLRERPESQPPLDWPKRQRIALGSARGL 144
Query: 443 KYLHDQ---DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
YLHD ++HRD+K ANIL+D + DFGLAK+
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 32/164 (19%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 334 GDLLGRGSFGSVYEGI---SDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFE 388
+ LG+G+F +++G+ D EV L LD+ + + +++S+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE--SFFEAASMMSKLS 70
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
H+++V YG + + E V GSL + + + +Q+ + +L
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 447 DQDVVHRDIKCANILVDA--------NGSVKLADFGLAKVFLSS 482
+ ++H ++ NIL+ +KL+D G++ L
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 20/152 (13%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLE--QEIALLSRFEHEN 391
+G+G FG V G G AVK + K + E +++++ H N
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI---------KNDATAQAFLAEASVMTQLRHSN 247
Query: 392 IVQYYG--TDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYL 445
+VQ G +++ LYI E + KGSL++ Y R L + ++ + ++YL
Sbjct: 248 LVQLLGVIV-EEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ VHRD+ N+LV + K++DFGL K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 40/178 (22%), Positives = 70/178 (39%), Gaps = 15/178 (8%)
Query: 306 DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLL 364
D + TT P+ + +G G+FG AVK +
Sbjct: 2 DRAPVTTGPLDM-----PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YI 53
Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQR 423
++G +++EI H NIV++ + L I +E + G L +
Sbjct: 54 ERG---AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA 110
Query: 424 YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKVF 479
+ + + +Q+L G+ Y H + HRD+K N L+D + +K+ DFG +K
Sbjct: 111 GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 42/201 (20%), Positives = 74/201 (36%), Gaps = 25/201 (12%)
Query: 294 SESCSFTTEHEDDSSSTTTEPMSNISPNGRFKR---IITYWQKGDLLGRGSFGSVYEGIS 350
+ P ++ + K+ I Y +LG G G V + +
Sbjct: 24 PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83
Query: 351 -DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD----ESK 404
FA+K + + +E+ L R + +IV+ ++
Sbjct: 84 KRTQEKFALKMLQ----------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 405 LYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
L I +E + G L + + R + + S + I ++YLH ++ HRD+K N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 462 V---DANGSVKLADFGLAKVF 479
N +KL DFG AK
Sbjct: 194 YTSKRPNAILKLTDFGFAKET 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 25/168 (14%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ +G +GRG++G VY+ D +A+K++ A + EIALL
Sbjct: 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EIALLRE 74
Query: 387 FEHENIVQYYG--TDKDESKLYI---FLE------LVTKGSLLNLYQRYHLRDSQVSAYT 435
+H N++ + K+++ + E + + + L V +
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDA----NGSVKLADFGLAKVF 479
QIL G+ YLH V+HRD+K ANILV G VK+AD G A++F
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 23/162 (14%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
LG+GSFG VYEG++ A+K +++ + ++ + E +++ F
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRE-RIEFLNEASVMKEF 85
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------------LRDSQVSAYT 435
++V+ G + +EL+T+G L + Y R S++
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS-YLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+I G+ YL+ VHRD+ N +V + +VK+ DFG+ +
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 47/217 (21%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 273 EKEGEEADRAIVKEEEDD--MVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI-IT 329
+ + + E D + L + C+ + + + E + + R+
Sbjct: 15 DGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHRE 74
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIA 382
++ ++GRG+FG V + FA+K ++ K + + + E
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--------KWEMLKRAETACFREERD 126
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILL 440
+L + + I + +D++ LY+ ++ G LL L ++ R + A Y ++++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ +H VHRDIK NIL+D NG ++LADFG
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 33/180 (18%), Positives = 62/180 (34%), Gaps = 37/180 (20%)
Query: 333 KGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
+G +LG+ + E + G F V ++ +I Q+++E+ L
Sbjct: 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIK 139
Query: 388 ---------------------EHENIVQYYGTDKDESKLYIFL-------ELVTKGSLLN 419
+ + +++ ++D L F L T G +L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 420 LYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ H L T Q++ L LH +VH ++ +I++D G V L F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 23/162 (14%)
Query: 334 GDLLGRGSFGSVYEG----ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
LG G+FG VYEG + +D AVK L + + E ++S+F
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQD-ELDFLMEALIISKF 90
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------LRDSQVSAYTRQI 438
H+NIV+ G +I +EL+ G L + + R L + R I
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKS-FLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK 477
G +YL + +HRDI N L+ G K+ DFG+A+
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 50/164 (30%), Positives = 73/164 (44%), Gaps = 30/164 (18%)
Query: 337 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG V+ + D AVK +L D A++ ++E LL+ +HE
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARK---DFQREAELLTNLQHE 77
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------------- 435
+IV++YG D L + E + G L + R H D+ +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNK-FLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 436 ---RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
QI G+ YL Q VHRD+ N LV AN VK+ DFG++
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 39/167 (23%), Positives = 61/167 (36%), Gaps = 29/167 (17%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
+ LG FG VY+G A+K L ++ + E L +R
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPL-REEFRHEAMLRARL 69
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT------------ 435
+H N+V G + L + + G L + S V +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE-FLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 436 ------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
QI G++YL VVH+D+ N+LV +VK++D GL
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 29/163 (17%)
Query: 337 LGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG V+ + AVK L + S + + ++E LL+ +H+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVK---ALKEAS--ESARQDFQREAELLTMLQHQ 103
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------------- 435
+IV+++G + L + E + G L + R H D+++ A
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNR-FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 436 --RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
Q+ G+ YL VHRD+ N LV VK+ DFG++
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 46/159 (28%), Positives = 66/159 (41%), Gaps = 23/159 (14%)
Query: 337 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG VYEG AVK L + + E ++S+F H+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQD-ELDFLMEALIISKFNHQ 134
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------LRDSQVSAYTRQILLG 441
NIV+ G +I LEL+ G L + + R L + R I G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKS-FLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 442 LKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK 477
+YL + +HRDI N L+ G K+ DFG+A+
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 26/200 (13%)
Query: 292 VLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGD-----LLGRGSFGSVY 346
+ + + +D + + I + R+ Q+ D ++GRG+F V
Sbjct: 23 GVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRL----QRDDFEILKVIGRGAFSEVA 78
Query: 347 EGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTD 399
G +A+K ++ K + + + E +L + I Q +
Sbjct: 79 VVKMKQTGQVYAMKIMN--------KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130
Query: 400 KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILLGLKYLHDQDVVHRDIKC 457
+DE+ LY+ +E G LL L ++ R A Y +I++ + +H VHRDIK
Sbjct: 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190
Query: 458 ANILVDANGSVKLADFGLAK 477
NIL+D G ++LADFG
Sbjct: 191 DNILLDRCGHIRLADFGSCL 210
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 51/174 (29%), Positives = 88/174 (50%), Gaps = 17/174 (9%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQA 370
M N R+ +I+ D LG G +VY D A+K ++ +
Sbjct: 3 HMIGKIINERY-KIV------DKLGGGGMSTVYLAE--DTILNIKVAIK--AIFIPPREK 51
Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRD 428
++++ + E+E+ S+ H+NIV D+++ Y+ +E + +G L+ + L
Sbjct: 52 EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI-EGPTLSEYIESHGPLSV 110
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
+T QIL G+K+ HD +VHRDIK NIL+D+N ++K+ DFG+AK +
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 20/162 (12%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLE------QEIALLSRFEHE 390
+ GS+G+V G+ +G A+K V + +S +EI LL+ F H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 391 NIVQYYGTDKDESK-----LYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILL 440
NI+ + LY+ EL+ +L Q R + + + ILL
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
GL LH+ VVHRD+ NIL+ N + + DF LA+ +
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 32/171 (18%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
G LG G+FG V + AVK L D ++ + +S L E+ ++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 95
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
+H+NI+ G + LY+ +E +KG+L Y R +Y
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLRARRPPGMEYSYDINRVPEEQM 154
Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
Q+ G++YL Q +HRD+ N+LV N +K+ADFGLA+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENI 392
L+GRGS+G VY + A+K+V+ + + K+ + +EI +L+R + + I
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL----REITILNRLKSDYI 87
Query: 393 VQYYGTDKDESK-----LYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYL 445
++ Y + LYI LE+ S L L + + +LLG ++
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
H+ ++HRD+K AN L++ + SVK+ DFGLA+ S D
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 37/176 (21%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LG G FG V + + AVK +L + + + + L E +L +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSE-LRDLLSEFNVLKQV 83
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------------- 425
H ++++ YG + L + +E GSL + R
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG-FLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 426 ----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
L + ++ QI G++YL + +VHRD+ NILV +K++DFGL++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-------LL 384
+LG+G +G V+ ++ G FA+K + K I + ++ A +L
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--------KAMIVRNAKDTAHTKAERNIL 75
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
+H IV + KLY+ LE ++ G L L + + Y +I + L
Sbjct: 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481
+LH + +++RD+K NI+++ G VKL DFGL K +
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 42/166 (25%), Positives = 69/166 (41%), Gaps = 27/166 (16%)
Query: 334 GDLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EH 389
D++G G+FG V + I DG A+K + + + E+ +L + H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDD-HRDFAGELEVLCKLGHH 85
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-------------- 435
NI+ G + LY+ +E G+LL+ + R A+
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 436 ----RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ G+ YL + +HRD+ NILV N K+ADFGL++
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 45/171 (26%), Positives = 67/171 (39%), Gaps = 33/171 (19%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LGRG+FG V E + AVK L + + L E+ +L
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATH--SEHRALMSELKILIHI 87
Query: 388 -EHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYH------------------L 426
H N+V G T L + +E G+L Y R L
Sbjct: 88 GHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLST-YLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ Y+ Q+ G+++L + +HRD+ NIL+ VK+ DFGLA+
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 37/176 (21%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
+G G+FG V++ + + AVK +L + + A + ++E AL++ F
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADM-QADFQREAALMAEF 107
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT------------ 435
++ NIV+ G + + E + G L + R + S
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE-FLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 436 --------------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
RQ+ G+ YL ++ VHRD+ N LV N VK+ADFGL++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 18/156 (11%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSR 386
+LG+GSFG V+ SD +A+K + K ++ ++ E +L
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLK--------KATLKVRDRVRTKMERDILVE 82
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
H IV+ + + E KLY+ L+ + G L L + + V Y ++ L L +L
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481
H +++RD+K NIL+D G +KL DFGL+K +
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 32/171 (18%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
G LG G FG V + AVK L D ++ + +S L E+ ++
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 141
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
+H+NI+ G + LY+ +E +KG+L Y R +Y
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLRARRPPGMEYSYDINRVPEEQM 200
Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
Q+ G++YL Q +HRD+ N+LV N +K+ADFGLA+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 32/171 (18%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
G LG G+FG V + AVK L ++ + +S L E+ ++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATE--KDLSDLISEMEMMK 129
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
+H+NI+ G + LY+ +E +KG+L Y + +Y
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLQARRPPGLEYSYNPSHNPEEQL 188
Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
Q+ G++YL + +HRD+ N+LV + +K+ADFGLA+
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 29/221 (13%)
Query: 274 KEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQK 333
EE + T + ++ T + F+ +
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE-NFELL------ 59
Query: 334 GDLLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA------- 382
+LG G++G V+ D G +A+K + K +I Q +
Sbjct: 60 -KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK--------KATIVQKAKTTEHTRTERQ 110
Query: 383 -LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
L + +V + + E+KL++ L+ + G L L QR + +V Y +I+L
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481
L++LH +++RDIK NIL+D+NG V L DFGL+K F++
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 11/156 (7%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G++G V G A+K++ D+ A +++ +EI +L F+HENI+
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENIITI 74
Query: 396 YGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ + +S +YI EL+ L + L D + + Q L +K LH +V
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNV 133
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFD 486
+HRD+K +N+L+++N +K+ DFGLA++ S +
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 8e-22
Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 34/243 (13%)
Query: 261 RALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCS--FTTEHEDDSSSTTTEPMSNI 318
R + + ++ ++ ++ + +V + F E+ + +
Sbjct: 106 REIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKF 165
Query: 319 SPNGRFKRIITY-WQKGD------------LLGRGSFGSVYEGIS-DDGFFFAVKEVSLL 364
+ +F R + + + ++GRG FG VY D G +A+K +
Sbjct: 166 IESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD-- 223
Query: 365 DQGSQAKQSISQLEQE---------IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415
K+ I + E ++L+S + IV KL L+L+ G
Sbjct: 224 ------KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 416 SLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474
L L Q ++ + Y +I+LGL+++H++ VV+RD+K ANIL+D +G V+++D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 475 LAK 477
LA
Sbjct: 338 LAC 340
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 45/170 (26%), Positives = 63/170 (37%), Gaps = 32/170 (18%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LG G+FG V E SD AVK +L + + L E+ +LS
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTE-REALMSELKVLSYL 83
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT----------- 435
H NIV G + E G LLN + R S +
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN-FLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
Q+ G+ +L ++ +HRD+ NIL+ K+ DFGLA
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 43/159 (27%), Positives = 65/159 (40%), Gaps = 30/159 (18%)
Query: 334 GDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
L+GRG G VYE +D A+K L+ L + +R + E
Sbjct: 39 RRLVGRGGMGDVYEA--EDTVRERIVALK---LMS---------ETLSSDPVFRTRMQRE 84
Query: 391 ----------NIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQI 438
++V + + + +LY+ + L+ G L L ++ L + A RQI
Sbjct: 85 ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI-NGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
L H HRD+K NILV A+ L DFG+A
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS 182
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 49/216 (22%), Positives = 92/216 (42%), Gaps = 18/216 (8%)
Query: 271 DNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITY 330
+ +E EE AI + D + + S ++ E M + + +
Sbjct: 91 ETPEEREEWTTAI-QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIAL 383
++ LLG+G+FG V G ++A+K + K+ I ++ E +
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--------KEVIVAKDEVAHTLTENRV 201
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
L H + + + +L +E G L L + + + Y +I+ L
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 261
Query: 443 KYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
YLH +++VV+RD+K N+++D +G +K+ DFGL K
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 43/166 (25%), Positives = 66/166 (39%), Gaps = 28/166 (16%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LG G+FG V E + AVK +L + A + L E+ ++S
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADE-KEALMSELKIMSHL 106
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT----------- 435
+HENIV G + + E G LLN + R R +
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLN-FLRRKSRVLETDPAFAIANSTASTRD 165
Query: 436 -----RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
Q+ G+ +L ++ +HRD+ N+L+ K+ DFGLA
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 44/204 (21%), Positives = 76/204 (37%), Gaps = 61/204 (29%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
+ + G LG GSFG V E + G FA+K+V + +E+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKN----RELD 52
Query: 383 LLSRFEHENIVQ----YYGTD----------------------------------KDESK 404
++ +H NI++ +Y T
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 405 LYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIK 456
L + +E V L++ + +R + +S Y Q+ + ++H + HRDIK
Sbjct: 113 LNVIMEYVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK 168
Query: 457 CANILVDAN-GSVKLADFGLAKVF 479
N+LV++ ++KL DFG AK
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKL 192
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 5e-21
Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 287 EEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKR---------IITYWQKGDLL 337
E V C + D S MS + +F ++ +Q +
Sbjct: 11 EPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPI 70
Query: 338 GRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
G G+ G V + A+K++S + AK++ +E+ L+ H+NI+
Sbjct: 71 GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISL 126
Query: 396 Y------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
T ++ +Y+ +EL+ + L + L ++S Q+L G+K+LH
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 184
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
++HRD+K +NI+V ++ ++K+ DFGLA+ +S
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G++G V + + A+K++S + + ++++ +EI +L RF HENI+
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ + +YI +L+ L L + HL + + + QIL GLKY+H +V
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDLLL 489
+HRD+K +N+L++ +K+ DFGLA+V D L
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
LLG+G+FG V G ++A+K + K+ I ++ E +L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILR--------KEVIIAKDEVAHTVTESRVLQNTR 63
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHD 447
H + + +L +E G L L + + + Y +I+ L+YLH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477
+DVV+RDIK N+++D +G +K+ DFGL K
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCK 153
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G++GSV I G A+K++S AK++ +E+ LL +HEN++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENVIG 87
Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
+ ++ Y+ + + +L + + ++ Q+L GLKY+H
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLKYIH 143
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
VVHRD+K N+ V+ + +K+ DFGLA+ + +
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 2e-20
Identities = 64/331 (19%), Positives = 117/331 (35%), Gaps = 38/331 (11%)
Query: 167 TQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPP 226
+ A+ G +D ++ P S + + SS + + R L +
Sbjct: 178 VRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDK 237
Query: 227 GMRQPVIDNACSTWDILR--DFAPKDGITPSSVMNDRALSSSSDDEDNEKE----GEEAD 280
R V WD+ DF S + E E +
Sbjct: 238 DRRLSV---EIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPE 294
Query: 281 RAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFK----RIITYWQKGDL 336
+ EE T+ ++ ++ T N R K + +
Sbjct: 295 GSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM------V 348
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSRF 387
LG+GSFG V +AVK + K + Q +E+ + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRV-LALPG 399
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
+ + Q + + +LY +E V G L ++ Q ++ Y +I +GL +L
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ +++RD+K N+++D+ G +K+ADFG+ K
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 34/168 (20%)
Query: 334 GDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-- 388
G++LG G V+ D AVK +L + L ++ + RF
Sbjct: 17 GEILGFGGMSEVHLAR--DLRDHRDVAVK---VLR---------ADLARDPSFYLRFRRE 62
Query: 389 --------HENIVQYY--GTDKDESKL--YIFLELVTKGSLLN--LYQRYHLRDSQVSAY 434
H IV Y G + + YI +E V G L ++ + +
Sbjct: 63 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEV 121
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
L + H ++HRD+K ANI++ A +VK+ DFG+A+ S
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 3e-20
Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 15/152 (9%)
Query: 334 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ G G +Y + D +G +K L+ G Q+++ E++ + H
Sbjct: 85 KGCIAHGGLGWIYLAL-DRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFL--AEVVHP 139
Query: 391 NIVQYY--GTDKD---ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
+IVQ + D + YI +E V G L + L ++ AY +IL L YL
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVG-GQSLKRSKGQKLPVAEAIAYLLEILPALSYL 198
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
H +V+ D+K NI++ +KL D G
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 15/145 (10%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394
LGRG + V+E I + VK + + K+ +EI +L NI+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIK----REIKILENLRGGPNIIT 95
Query: 395 YYGTDKDES--KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
KD + E V LYQ L D + Y +IL L Y H ++H
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMH 153
Query: 453 RDIKCANILVD-ANGSVKLADFGLA 476
RD+K N+++D + ++L D+GLA
Sbjct: 154 RDVKPHNVMIDHEHRKLRLIDWGLA 178
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 39/152 (25%), Positives = 75/152 (49%), Gaps = 19/152 (12%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
++GRGS+ V + +A+K V K+ ++ E+ +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVK--------KELVNDDEDIDWVQTEKHV-FEQA 66
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
H +V + + ES+L+ +E V G L+ + ++ L + Y+ +I L L YL
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
H++ +++RD+K N+L+D+ G +KL D+G+ K
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 48/175 (27%), Positives = 72/175 (41%), Gaps = 37/175 (21%)
Query: 334 GDLLGRGSFGSVYEG----ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G +LG G+FG V IS G AVK L ++ +++ L E+ ++++
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSERE--ALMSELKMMTQL 105
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--------------------- 425
HENIV G +Y+ E G LLN Y R
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN-YLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 426 ----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
L + + Q+ G+++L + VHRD+ N+LV VK+ DFGLA
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 6e-20
Identities = 40/159 (25%), Positives = 80/159 (50%), Gaps = 30/159 (18%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
+LGRG FG V+ + G +A K+++ K+ + + + E +L++
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--------KKRLKKRKGYQGAMVEKKILAKVH 243
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----------YTRQI 438
IV + ++ L + + ++ G + RYH+ + YT QI
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ GL++LH +++++RD+K N+L+D +G+V+++D GLA
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 18/152 (11%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
+LG+G FG V + G +A K++ K+ I + + E +L +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--------KKRIKKRKGEAMALNEKQILEKVN 242
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYL 445
+V + + L + L L+ G L + + +++ Y +I GL+ L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
H + +V+RD+K NIL+D +G ++++D GLA
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLAV 334
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 13/155 (8%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G++G+V + G A+K++ AK++ +E+ LL HEN++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHENVIG 88
Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
T D + Y+ + + L L + L + ++ Q+L GL+Y+H
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
++HRD+K N+ V+ + +K+ DFGLA+ S +
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 38/152 (25%), Positives = 75/152 (49%), Gaps = 19/152 (12%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
++GRGS+ V + +A++ V K+ ++ E+ +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVK--------KELVNDDEDIDWVQTEKHV-FEQA 109
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
H +V + + ES+L+ +E V G L+ + ++ L + Y+ +I L L YL
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
H++ +++RD+K N+L+D+ G +KL D+G+ K
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 43/156 (27%), Positives = 79/156 (50%), Gaps = 18/156 (11%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G+ G V + A+K++S + AK++ +E+ L+ H+NI+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIG 88
Query: 395 YYGTDKDESK------LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
+ +YI +EL+ NL Q + L ++S Q+L G+K+LH
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
++HRD+K +NI+V ++ ++K+ DFGLA+ +S
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
+LG+GSFG V + G +AVK + K I Q E+ I L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLK--------KDVILQDDDVECTMTEKRI-LSLA 80
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
H + Q + + +L+ +E V G L+ + + +++ Y +I+ L +L
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
HD+ +++RD+K N+L+D G KLADFG+ K
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 31/158 (19%)
Query: 336 LLGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLS 385
++G+GSFG V + F+AVK + K++I + E+ + LL
Sbjct: 45 VIGKGSFGKVLLARHK-AEEVFYAVKVLQ--------KKAILKKKEEKHIMSERNV-LLK 94
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQIL 439
+H +V + + + KLY L+ + G L YHL+ + Y +I
Sbjct: 95 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIA 149
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
L YLH ++V+RD+K NIL+D+ G + L DFGL K
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK 187
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 46/150 (30%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G++GSV + G AVK++S AK++ +E+ LL +HEN++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 92
Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+ ++ + +Y+ L+ L N+ + L D V QIL GLKY+H
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKV 478
D++HRD+K +N+ V+ + +K+ DFGLA+
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARH 181
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 44/152 (28%), Positives = 79/152 (51%), Gaps = 19/152 (12%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
+LG+GSFG V+ FFA+K + K + +E+ + L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALK--------KDVVLMDDDVECTMVEKRV-LSLA 74
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
+EH + + T + + L+ +E + G L+ + + S+ + Y +I+LGL++L
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
H + +V+RD+K NIL+D +G +K+ADFG+ K
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCK 166
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 24/160 (15%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF-EHEN 391
LG+G++G V++ I G AVK++ + A+++ +EI +L+ HEN
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHEN 70
Query: 392 IVQYYGTDKDESK--LYIFLEL-------VTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
IV + ++ +Y+ + V + ++L Q++ +
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE--------PVHKQYVVYQLIKVI 122
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
KYLH ++HRD+K +NIL++A VK+ADFGL++ F++
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 46/169 (27%), Positives = 83/169 (49%), Gaps = 22/169 (13%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV-- 393
LG G G V+ + +D A+K++ L D K ++ +EI ++ R +H+NIV
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHAL----REIKIIRRLDHDNIVKV 73
Query: 394 ------------QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 441
G+ + + +YI E + + L N+ ++ L + + Q+L G
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 442 LKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKVFLSSLDFDLLL 489
LKY+H +V+HRD+K AN+ ++ + +K+ DFGLA++ L
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 39/152 (25%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
+LG+GSFG V +AVK + K + Q +E+ + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRV-LALP 77
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
+ + Q + + +LY +E V G L+ + Q ++ Y +I +GL +L
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ +++RD+K N+++D+ G +K+ADFG+ K
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 19/145 (13%), Positives = 38/145 (26%), Gaps = 6/145 (4%)
Query: 334 GDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
G ++ + D A+ + QG + + LSR +
Sbjct: 36 LIFHGGVPPLQFWQAL-DTALDRQVALTF--VDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ + + + E + GSL + + + H V
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADAAHRAGVA 151
Query: 452 HRDIKCANILVDANGSVKLADFGLA 476
+ + V +G V LA
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 4e-15
Identities = 34/215 (15%), Positives = 63/215 (29%), Gaps = 51/215 (23%)
Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ- 366
S P S+ P + +R +K +G G FG V++ I+D A+K +++
Sbjct: 6 SQKGPVPFSHCLPTEKLQRC----EK---IGEGVFGEVFQTIADHTPV-AIKIIAIEGPD 57
Query: 367 --GSQAKQSISQLEQEIALLSRFE---------HENIVQYYG------------------ 397
+++ ++ EI + E +
Sbjct: 58 LVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDH 117
Query: 398 ------------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
+ +L+I LE G L + + + Q+ L
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177
Query: 446 HDQ-DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
HRD+ N+L+ KL K
Sbjct: 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 38/172 (22%), Positives = 64/172 (37%), Gaps = 27/172 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
W+ G +G+G FG +Y + ++ L E+ R
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE---PSDNGPLFTELKFYQRAAKP 93
Query: 391 NIVQ-----------------YYGTDKDESKLYIFL--ELVTKGSLLNLYQRYHLRDSQ- 430
+Q G K Y F+ + L +Y+ R S+
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRK 152
Query: 431 -VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKVF 479
V + +IL L+Y+H+ + VH DIK +N+L++ V L D+GLA +
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 40/169 (23%), Positives = 73/169 (43%), Gaps = 25/169 (14%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
R+ ++ G +G GSFG +Y G G A+K K QL E +
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-------VKTKHPQLHIESKIY 58
Query: 385 SRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-----R 436
+ I +++ G + D + + +EL+ +L ++ + S T
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYN--VMVMELLGP----SLEDLFNFCSRKFSLKTVLLLAD 112
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKVFLSS 482
Q++ ++Y+H ++ +HRD+K N L+ V + DFGLAK + +
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 40/179 (22%), Positives = 76/179 (42%), Gaps = 26/179 (14%)
Query: 315 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 373
MS + + +++ G +G GSFG ++EG + + A+K +
Sbjct: 1 MSGQN-----NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-------RRSD 48
Query: 374 ISQLEQEIALLSRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
QL E I V Y+G + + + ++L+ SL +L + S
Sbjct: 49 APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN--VLVIDLLGP-SLEDLLDLCGRKFSV 105
Query: 431 --VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAKVFLSS 482
V+ +Q+L ++ +H++ +V+RDIK N L+ S + + DFG+ K +
Sbjct: 106 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 36/173 (20%), Positives = 63/173 (36%), Gaps = 32/173 (18%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W G +G G FG +Y + A V + Q L E+ R
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV------EYQENGPLFSELKFYQRVAK 92
Query: 390 ENIVQ-----------------YYGTDKDESKLYIFL--ELVTK--GSLLNLYQRYHLRD 428
++ ++ G + + + Y F+ E + + +
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKVF 479
V ++L L+Y+H+ + VH DIK AN+L+ V LAD+GL+ +
Sbjct: 153 --VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
R+ ++ G +G GSFG +Y G + A+K + K QL E +
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-------VKTKHPQLLYESKI 55
Query: 384 LSRFE-HENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--VSAYTRQI 438
+ I V+++G + D + + ++L+ SL +L+ + S V Q+
Sbjct: 56 YRILQGGTGIPNVRWFGVEGDYN--VLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQM 112
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKVFLSS 482
+ ++++H + +HRDIK N L+ V + DFGLAK + +
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 34/168 (20%), Positives = 61/168 (36%), Gaps = 19/168 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF---------FAVK---EVSLLDQGSQAKQSISQLE 378
W+ R + G +YE F++K + L Q ++
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 379 Q--EIALLSRFEHENIVQYYGTDKDESKLYIF-LELVTK--GSLLNLYQRYHLRDSQVSA 433
Q + L I G + K L + + S L++ ++ L + V
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ 163
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKVF 479
++L L++LH+ + VH ++ NI VD V LA +G A +
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 39/169 (23%), Positives = 73/169 (43%), Gaps = 23/169 (13%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIAL 383
+ ++ G +G G+FG + G + + A+K E K QL E
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE--------PMKSRAPQLHLEYRF 57
Query: 384 LSRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--VSAYTRQI 438
+ + I V Y+G + + LEL+ SL +L+ S V Q+
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYN--AMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQL 114
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAKVFLSS 482
+ ++Y+H +++++RD+K N L+ G+ + + DF LAK ++
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 21/155 (13%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHE-- 390
++G+GSFG V + A+K V + QA + I LE L + + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILE----HLRKQDKDNT 158
Query: 391 -NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-----RYH-LRDSQVSAYTRQILLGLK 443
N++ + + + EL++ +NLY+ ++ V + IL L
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLS----MNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 444 YLHDQDVVHRDIKCANILVDANGS--VKLADFGLA 476
LH ++H D+K NIL+ G +K+ DFG +
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 36/180 (20%), Positives = 66/180 (36%), Gaps = 44/180 (24%)
Query: 335 DLLGRGSFGSVYEGI--SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLE 378
D LG G+FG V E I G AVK E+ +L + ++ +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVL-------EHLNTTD 72
Query: 379 QE-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
+ +L FEH IV + Y F++ N + + L
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIV----FELLGLSTYDFIKE-------NGFLPFRL--DH 119
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDLLLI 490
+ QI + +LH + H D+K NIL + + + + + + ++ D+ ++
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 38/188 (20%), Positives = 70/188 (37%), Gaps = 52/188 (27%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLD 365
+ R+ ++ LG G F +V+ + A+K E+ LL
Sbjct: 18 DARYI-LV------RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 366 QGSQAKQSISQLEQE---IALLSRFEHEN-------IVQYYGTDKDESKLYIFLELVTKG 415
+ + A + + LL F H+ +V + L ++
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMV----FEVLGENLLALIKK---- 122
Query: 416 SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVD------ANGSV 468
++ L V ++Q+LLGL Y+H + ++H DIK N+L++ +
Sbjct: 123 ---YEHRGIPL--IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 469 KLADFGLA 476
K+AD G A
Sbjct: 178 KIADLGNA 185
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 35/183 (19%), Positives = 61/183 (33%), Gaps = 59/183 (32%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLEQ 379
+G G+FG V D+ ++AVK E +L + + + +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNI-- 98
Query: 380 EIALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 436
+ +F + + ++ + LY + N Y +H+ + Y
Sbjct: 99 -VKYHGKFMYYDHMCLI----FEPLGPSLYEIITR-------NNYNGFHI--EDIKLYCI 144
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANG-------------------------SVKLA 471
+IL L YL + H D+K NIL+D +KL
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 472 DFG 474
DFG
Sbjct: 205 DFG 207
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 34/180 (18%), Positives = 63/180 (35%), Gaps = 44/180 (24%)
Query: 335 DLLGRGSFGSVYEGI--SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLE 378
LG G+FG V E + + A+K E+++L + I + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVL-------KKIKEKD 77
Query: 379 QE-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
+E + + F I + + FL+ N +Q Y L
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIA----FELLGKNTFEFLKE-------NNFQPYPL--PH 124
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDLLLI 490
V Q+ L++LH+ + H D+K NIL + L + + S + + +
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 35/169 (20%), Positives = 65/169 (38%), Gaps = 47/169 (27%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLEQ 379
L+G+GSFG V + + + A+K EV LL+ +++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLEL-------MNKHDT 112
Query: 380 E-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
E + L F N +V + LY L ++ L +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLV----FEMLSYNLYDLLRN-------TNFRGVSL--NLT 159
Query: 432 SAYTRQILLGLKYLHDQD--VVHRDIKCANILV--DANGSVKLADFGLA 476
+ +Q+ L +L + ++H D+K NIL+ ++K+ DFG +
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 18/55 (32%), Positives = 31/55 (56%)
Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
+ L + Y+ Q+ G+++L + +HRD+ NIL+ VK+ DFGLA+
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 27/120 (22%), Positives = 39/120 (32%), Gaps = 8/120 (6%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
G LGRG+FG V E GI V L + + L E+ +L
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGH 84
Query: 389 HENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
H N+V G K L + +E G+L + + G Y+
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 6e-06
Identities = 53/468 (11%), Positives = 126/468 (26%), Gaps = 134/468 (28%)
Query: 95 EDF---AIPAAAWEARKNRSASDLL-PRSRLKQLDTLKETVER-QSDAAGAVVGELCDRV 149
++F + ++ + + L T+ Q + V E+
Sbjct: 31 DNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN 90
Query: 150 SDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSN 209
+ +TE + + + R +N A + L P
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP-------------- 136
Query: 210 YVKGIKGVRPPL--LKPPP-----GM----RQPVIDNACSTWDILRDFAPKDGI------ 252
+R L L+P G+ + V + C ++ + I
Sbjct: 137 ----YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD--FKIFWLNLK 190
Query: 253 ---TPSSVMN---------DRALSSSSDDEDNEK----EGEEADRAIVKEEE-------- 288
+P +V+ D +S SD N K + R ++K +
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL 250
Query: 289 DDMVLSESC--SFTTEHEDDSSST--TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGS 344
+ V + +F + S TT RFK++ D L +
Sbjct: 251 LN-VQNAKAWNAF-----NLSCKILLTT----------RFKQVT------DFLSAATTTH 288
Query: 345 VYEGISDDGF-------FFA-VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV--- 393
+ + D + + +++++ + +
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT-TNPRR--LSIIAESIRDGLATWD 345
Query: 394 --QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL--RDSQVSAYTRQIL-LGLKYLHDQ 448
++ DK + + L ++ ++ R + + + ++ +
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-------VFLSSLDFDLLL 489
VV+ KL + L + + + S+ +L +
Sbjct: 406 VVVN----------------KLHKYSLVEKQPKESTISIPSIYLELKV 437
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 18/54 (33%), Positives = 27/54 (50%), Gaps = 4/54 (7%)
Query: 416 SLLNLYQRYHLR---DSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDAN 465
LL + + + V +Q+L GL YLH + ++H DIK NIL+ N
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 514 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.98 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.98 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.98 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.98 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.76 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.57 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.16 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.14 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.13 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.77 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.51 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.33 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.19 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.03 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.97 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.89 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.66 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.28 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.55 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.3 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 90.74 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=365.86 Aligned_cols=185 Identities=26% Similarity=0.436 Sum_probs=164.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|+++++||+|+||+||+|++ .+|+.||||++..... ......+.+.+|+.+|+.++|||||+++++|.+.+++|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 46899999999999999999998 6899999999974321 12233567899999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
||||||.||+|.+++++ ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999976 479999999999999999999999999999999999999999999999999999764221
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...++..+|||||||+||+|+||++||.+.|
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1345668999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=370.46 Aligned_cols=181 Identities=26% Similarity=0.388 Sum_probs=163.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|++++.||+|+||+||+|++ .+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 5799999999999999999998 689999999997543322 2457799999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-----
Q 010231 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS----- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~----- 482 (514)
|||||+||+|.+++.+..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 149 vmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp EECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred EEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999976433
Q ss_pred --------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 --------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 --------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||+||+|++|++||.+.|
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 12456678999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=368.04 Aligned_cols=185 Identities=28% Similarity=0.480 Sum_probs=159.0
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
.+++|++++.||+|+||+||+|++ .+|+.||||++...... ....+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---SKEREESRREVAVLANMKHPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC---HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 357899999999999999999998 68999999999754332 23457789999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
|||||||+||+|.+++... .+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999999999643 3688899999999999999999999999999999999999999999999999976432
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++.++|||||||+||+|+||++||.+.|
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 23456779999999999999999999998764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=370.80 Aligned_cols=182 Identities=26% Similarity=0.381 Sum_probs=164.5
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++++.||+|+||+||+|++ .+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence 35799999999999999999998 689999999997643322 245789999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
||||||.||+|.++++...+++..++.|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+...
T Consensus 225 iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp EEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred EEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999976433
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||+||+|++|++||.+.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 12456678999999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=347.51 Aligned_cols=184 Identities=24% Similarity=0.397 Sum_probs=151.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
+++|++++.||+|+||+||+|++ .+|+.||||++...... .......+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA--KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 47899999999999999999998 68999999998753221 2233467889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|||||| +|+|.+++.+ ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 999999 5688888765 57999999999999999999999999999999999999999999999999999865432
Q ss_pred ---------------CCcC-cceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ---------------LDFD-LLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ---------------~~~~-~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.... .+..+|||||||+||+|+||++||.+.|
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 1122 3467999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=355.69 Aligned_cols=179 Identities=27% Similarity=0.407 Sum_probs=158.1
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...++|++.++||+|+||+||+|++ .+|+.||||+++.... ..+|+.+|+.++|||||++++++.+.+.
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPW 124 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3456899999999999999999998 6799999999975221 1369999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-cEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-~vKI~DFGlAk~~~~~ 482 (514)
+|||||||+||+|.+++++ ..+++..++.|+.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+.+...
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999999999976 4699999999999999999999999999999999999999988 6999999999875321
Q ss_pred ------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++.++|||||||+||+|+||++||.+.+
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 12445668999999999999999999998753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=354.49 Aligned_cols=184 Identities=26% Similarity=0.377 Sum_probs=154.6
Q ss_pred ccceEeeeeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.++|++++.||+|+||+||+|++ .+++.||||++......... ...+.+|+.+|+.++|||||++++++.+.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE---CC------CCCCCCCCTTEECEEEEEEETT
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH---HHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 36899999999999999999986 35789999998753322111 235678999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+|||||||+||+|.+++.+ ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999999876 46999999999999999999999999999999999999999999999999999865322
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||+||+|+||++||.+.|
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 12455678999999999999999999998864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=348.46 Aligned_cols=181 Identities=27% Similarity=0.412 Sum_probs=157.1
Q ss_pred cceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
++|.+.+.||+|+||+||+|++ .++..||||.++.. .....+.+.+|+.+|++++|||||+++++|.+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 5799999999999999999986 35789999998642 233456789999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcE
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY--------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV 468 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~--------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~v 468 (514)
+.+|||||||++|+|.++++.. .+++..+..|+.||+.||.|||+++||||||||+||||+.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 9999999999999999999653 48999999999999999999999999999999999999999999
Q ss_pred EEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 469 KLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 469 KI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
||+|||+|+..... ....++.++|||||||+||||+| |+.||.+.+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999864322 12355678999999999999998 899998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=342.96 Aligned_cols=181 Identities=27% Similarity=0.462 Sum_probs=156.1
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC----CCe
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESK 404 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----~~~ 404 (514)
+|++.++||+|+||+||+|++ .++..||+|.+...... ....+.+.+|+.+|+.++|||||+++++|.+ ...
T Consensus 27 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred eEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 457788999999999999998 67899999998753322 3345778999999999999999999998864 456
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEcC-CCcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId~-~g~vKI~DFGlAk~~~ 480 (514)
+|||||||++|+|.+++.+ ..+++..++.|+.||+.||.|||++| ||||||||+||||+. +|.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 8999999999999999976 46999999999999999999999999 999999999999984 7999999999998543
Q ss_pred cC----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SS----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ....++.++|||||||+||+|+||++||.+.
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 22 1134567899999999999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=346.40 Aligned_cols=182 Identities=25% Similarity=0.365 Sum_probs=154.5
Q ss_pred ccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.++|.+.++||+|+||+||+|++. ++..||||+++.. .....+.+.+|+.+|++++|||||+++++|.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 357899999999999999999853 5789999998642 23345779999999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~ 465 (514)
.+.+|||||||++|+|.++++.. .+++..+..|+.||+.||.|||+++||||||||+||||+.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 99999999999999999998653 38889999999999999999999999999999999999999
Q ss_pred CcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 466 GSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 466 g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
+.+||+|||+|+.+... ....++.++|||||||+||||+| |+.||.+.+
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 99999999999865322 12345678999999999999998 899998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=342.80 Aligned_cols=181 Identities=26% Similarity=0.391 Sum_probs=155.2
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|+++++||+|+||+||+|++.. .||||+++.... .....+.+.+|+.+|++++|||||++++++.. +.+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP---TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 4678899999999999999998754 589998875332 23446789999999999999999999998764 56899
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|||||++|+|.+++.. ..+++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999999964 46999999999999999999999999999999999999999999999999999864321
Q ss_pred ---------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ---------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ---------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.+..++.++|||||||+||||+||+.||.+.+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 01235668999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=341.78 Aligned_cols=183 Identities=22% Similarity=0.335 Sum_probs=157.2
Q ss_pred ccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
...+++++.||+|+||+||+|.+ .+++.||||.++.... ....+.+.+|+.++++++|||||+++++|.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~----~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE----GPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC----hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 35788999999999999999986 3578999998864322 2234678999999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA 464 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~-----------------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~ 464 (514)
...+|||||||++|+|.++|.. ..+++..+..|+.||+.||.|||+++||||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 9999999999999999999953 24888999999999999999999999999999999999999
Q ss_pred CCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 465 NGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 465 ~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
++.+||+|||+|+.+... ....++.++|||||||+||||+| |+.||.+.+
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999865322 11345568999999999999998 899998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.29 Aligned_cols=180 Identities=27% Similarity=0.428 Sum_probs=148.4
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~- 403 (514)
+++++|++++.||+|+||+||+|++ .+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 3467899999999999999999998 689999999987532 2334567889999999999999999999886543
Q ss_pred -----------eEEEEEeccccCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcE
Q 010231 404 -----------KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV 468 (514)
Q Consensus 404 -----------~l~LVmEy~~gGsL~~lL~~~~----lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~v 468 (514)
++|||||||.+|+|.+++.... .....++.|+.||+.||+|||++|||||||||+||||+.+|.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence 4799999999999999997643 3445688999999999999999999999999999999999999
Q ss_pred EEEeccCceecccC-------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 469 KLADFGLAKVFLSS-------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 469 KI~DFGlAk~~~~~-------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
||+|||+|+.+... ....++.++|||||||+||+|++ ||.+
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999999875421 12356678999999999999996 7764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=347.41 Aligned_cols=183 Identities=25% Similarity=0.416 Sum_probs=157.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----- 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----- 401 (514)
.++|++++.||+|+||+||+|++ .+|+.||||+++.... .....+.+.+|+.+|+.++|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD---VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc---chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 46799999999999999999998 6899999999864322 22334678899999999999999999998653
Q ss_pred -CCeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 402 -ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 402 -~~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
.+.+|||||||. |+|.+++.. ..+++..++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 467999999996 578888865 56999999999999999999999999999999999999999999999999999865
Q ss_pred ccC------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 480 LSS------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 480 ~~~------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... ....++..+||||+||++|+|++|++||.+.|
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 321 11234668999999999999999999998864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=330.15 Aligned_cols=178 Identities=29% Similarity=0.384 Sum_probs=150.7
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES---- 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~---- 403 (514)
.++|.+.++||+|+||+||+|++ +|+.||||++.... ......+.|+..+..++|||||++++++...+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 35789999999999999999987 58899999986421 11122346777778899999999999987543
Q ss_pred eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCCEEEcCCCcEEEEeccC
Q 010231 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLADFGL 475 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~--------gIIHRDLKP~NILId~~g~vKI~DFGl 475 (514)
.+|||||||++|+|.++++...+++..+..|+.|++.||.|||++ +||||||||+||||+.++.+||+|||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 689999999999999999999999999999999999999999987 999999999999999999999999999
Q ss_pred ceecccCCC-----------------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 476 AKVFLSSLD-----------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 476 Ak~~~~~~~-----------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
|+....... ..++.++|||||||+||||+||.+||..
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 987543211 0234478999999999999999887753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=360.65 Aligned_cols=186 Identities=27% Similarity=0.370 Sum_probs=159.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc-hhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
+++|+++++||+|+||+||+|++ .+|+.||||++....... ..........+++.+++.++|||||+++++|.+.+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 67899999999999999999998 689999999997432111 1112222333456777888999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
|||||||.||+|..++.+ ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|+|||+|||+|+.+...
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~ 347 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCCC
Confidence 999999999999999976 46999999999999999999999999999999999999999999999999999876533
Q ss_pred ----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||+||+|++|.+||.+.
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1235677899999999999999999999763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=336.02 Aligned_cols=179 Identities=21% Similarity=0.298 Sum_probs=155.3
Q ss_pred cccccceEeeeeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEe
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD 399 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~ 399 (514)
..+.+.|+++++||+|+||+||+|++ .+++.||+|.+.... ...++.+|+.+|+.+ .||||++++++|
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-------HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-------CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-------CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 35567899999999999999999986 357899999886422 124577899999988 699999999999
Q ss_pred cCCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC-CcEEEEeccCcee
Q 010231 400 KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKV 478 (514)
Q Consensus 400 ~~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~-g~vKI~DFGlAk~ 478 (514)
.+.+++|||||||++|+|.++++ .+++..++.|++||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+.
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EECCEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999999999985 58999999999999999999999999999999999999876 8999999999975
Q ss_pred cccC------------------------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCC
Q 010231 479 FLSS------------------------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIF 510 (514)
Q Consensus 479 ~~~~------------------------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF 510 (514)
+... ....++..+||||+||++|+|+||++||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 4211 1123566889999999999999999999
Q ss_pred CC
Q 010231 511 RP 512 (514)
Q Consensus 511 ~g 512 (514)
.+
T Consensus 248 ~~ 249 (361)
T 4f9c_A 248 YK 249 (361)
T ss_dssp SC
T ss_pred CC
Confidence 54
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.29 Aligned_cols=183 Identities=25% Similarity=0.344 Sum_probs=156.0
Q ss_pred cccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC-CceeEEEEEe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTD 399 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIv~l~~~~ 399 (514)
..++|++++.||+|+||+||+|.+. +++.||||.+.... .....+.+.+|+.+|.++.| ||||+++++|
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~----~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 3578999999999999999999863 34679999886422 12335678999999999965 8999999998
Q ss_pred cC-CCeEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEE
Q 010231 400 KD-ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461 (514)
Q Consensus 400 ~~-~~~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NIL 461 (514)
.. .+.+|||||||++|+|.++|+.. .+++..+..|+.||+.||.|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 65 46799999999999999999642 3788999999999999999999999999999999999
Q ss_pred EcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 462 VDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 462 Id~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
++.++.+||+|||+|+.+.... +..++.++|||||||+||||+| |+.||.+.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999998764321 2345668999999999999998 99999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.91 Aligned_cols=184 Identities=22% Similarity=0.358 Sum_probs=163.0
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.++++|++++.||+|+||+||+|++ .+|+.||+|++.... ....+.+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3567999999999999999999998 689999999987532 2234668899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC--CcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~--g~vKI~DFGlAk~~~ 480 (514)
+|||||||.||+|.+++.. ..+++..++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999999998853 469999999999999999999999999999999999999854 899999999999865
Q ss_pred cC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.. ....++..+|||||||+||+|++|.+||.+.|
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 33 12446678999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=299.22 Aligned_cols=182 Identities=25% Similarity=0.391 Sum_probs=162.5
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|++++.||+|+||+||+|.+ .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+.+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 356899999999999999999997 78899999998754322 235578999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|+||||+.+|+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 999999999999999998899999999999999999999999999999999999999999999999999998764321
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|||||||++|+|++|..||.+.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 133456889999999999999999999765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.22 Aligned_cols=185 Identities=24% Similarity=0.392 Sum_probs=162.8
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|++++.||+|+||.||+|.+ .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 467899999999999999999998 7899999999875332 233456788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~ 484 (514)
|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 999999999999998865 5799999999999999999999999999999999999999999999999999986543211
Q ss_pred ------------------cC-cceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 485 ------------------FD-LLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 485 ------------------~~-~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.. .+..+|||||||++|+|++|+.||.+.+
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 11 2357899999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.59 Aligned_cols=186 Identities=25% Similarity=0.373 Sum_probs=159.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 404 (514)
..++|+++++||+|+||+||+|++ .+++.||||+++.... ........+.+|+.++..+ .||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh--cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 357899999999999999999998 5789999999874211 1233456678899999988 79999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+||||||+.+|+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+......
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 9999999999999998865 569999999999999999999999999999999999999999999999999998643221
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...++..+|||||||++|+|++|++||.+.+
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 1224568899999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.76 Aligned_cols=186 Identities=23% Similarity=0.325 Sum_probs=161.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|+++++||+|+||+||+|++ .+++.||+|++..... ........+.+|+.++..++||||+++++++.+...+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 357899999999999999999998 5789999999874211 1111123467899999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC-
Q 010231 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD- 484 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~- 484 (514)
||||||+++|+|.++++...+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+.....
T Consensus 145 ~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred EEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999987543210
Q ss_pred -----------------------cCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 485 -----------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 485 -----------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
..++..+|||||||++|+|++|.+||.+.+
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 115568999999999999999999998753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.61 Aligned_cols=185 Identities=26% Similarity=0.369 Sum_probs=161.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++++.||+|+||+||+|++ .+|+.||+|++..... ........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 57899999999999999999998 5799999999874211 12233466789999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|||||+++|+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 99999999999998865 46899999999999999999999999999999999999999999999999999864221
Q ss_pred ----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|+|||||++|+|++|..||.+.+
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 12345668999999999999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=293.76 Aligned_cols=187 Identities=26% Similarity=0.382 Sum_probs=162.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|++++.||+|+||.||+|.+ .++..||+|.+..... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR--EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc--ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 3457899999999999999999997 6789999999865332 223456788999999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999998764 58999999999999999999999999999999999999999999999999997653221
Q ss_pred --------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 --------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 --------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...+...+|||||||++|+|++|+.||.+.+
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1234457899999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.77 Aligned_cols=185 Identities=26% Similarity=0.422 Sum_probs=162.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++++.||+|+||+||+|++ .+|+.||+|++..... ........+.+|+.+++.++||||+++++++.+...+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 57899999999999999999998 5799999999874221 11223466788999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
+||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++......
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~ 162 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCcccc
Confidence 99999999999999876 468999999999999999999999999999999999999999999999999998754321
Q ss_pred --------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 --------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 --------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...++..+|+|||||++|+|++|..||.+.+
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 2345568999999999999999999998653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=302.53 Aligned_cols=187 Identities=26% Similarity=0.405 Sum_probs=160.4
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 403 (514)
...++|+++++||+|+||+||+|++ .+++.||||+++.... ........+..|..++..+ +||||+++++++.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh--hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3467899999999999999999998 5789999999874221 1122345677888888876 8999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+||||||+.+|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999999876 57999999999999999999999999999999999999999999999999999864221
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|+|||||++|+|++|..||.+.+
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 12345668899999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=301.66 Aligned_cols=185 Identities=24% Similarity=0.364 Sum_probs=162.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++++.||+|+||.||+|++ .+|+.||+|++..... ........+.+|+.+++.++||||+++++++.+...+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 57899999999999999999998 5799999999874221 11233467889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
|||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~ 197 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCccc
Confidence 99999999999999876 569999999999999999999999999999999999999999999999999998764321
Q ss_pred --------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 --------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 --------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...++..+|||||||++|+|++|..||.+.+
T Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 2345668999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=296.73 Aligned_cols=183 Identities=19% Similarity=0.326 Sum_probs=160.9
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|++++.||+|+||.||+|.+ .++..||+|.+.... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 75 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc------ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence 3567899999999999999999998 578999999886421 223567899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC--CCcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~--~g~vKI~DFGlAk~~~ 480 (514)
+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999999999999764 5899999999999999999999999999999999999987 7899999999998764
Q ss_pred cCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... ...++..+|||||||++|+|++|..||.+.+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 321 1224568999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.90 Aligned_cols=185 Identities=22% Similarity=0.320 Sum_probs=160.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|+++++||+|+||+||+|++ .+++.||+|++..... ........+.+|+.++..++|+||++++++|.+.+.+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh--hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 56899999999999999999998 5688999999874211 11112234778999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
|||||+.+|+|.+++.+ ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999999999999976 569999999999999999999999999999999999999999999999999998654321
Q ss_pred ------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 ------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 ------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...++..+|||||||++|+|++|++||.+.+
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 1234567999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=293.54 Aligned_cols=185 Identities=30% Similarity=0.469 Sum_probs=159.2
Q ss_pred cccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
..+.++|++++.||+|+||+||+|.+.+++.||+|++..... .......+.+|+.+++.++||||+++++++.+...
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc---cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 456789999999999999999999998899999999864322 22234667899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999986 777777653 4899999999999999999999999999999999999999999999999999875422
Q ss_pred --------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 --------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 --------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|+.||.+.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 1134566889999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=298.72 Aligned_cols=183 Identities=25% Similarity=0.376 Sum_probs=160.7
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l 405 (514)
.++|++++.||+|+||.||+|++ .+++.||+|++...... .......+.+|+.++..+ +||||+++++++.+...+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC--SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc--chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 56899999999999999999998 57899999999753322 234456788999999887 899999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
||||||+.+|+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 999999999999998875 56999999999999999999999999999999999999999999999999999864221
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....++..+|+|||||++|+|++|..||..
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 113456689999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=306.64 Aligned_cols=184 Identities=21% Similarity=0.402 Sum_probs=161.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++++.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.+++.++||||+++++++.+...+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc--ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57899999999999999999998 6788999999874221 12233467889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
+||||+.+|+|..++... .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 171 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence 999999999999998764 69999999999999999999999999999999999999999999999999998753221
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|||||||++|+|++|..||.+.
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 123566889999999999999999999753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=310.18 Aligned_cols=185 Identities=24% Similarity=0.308 Sum_probs=161.5
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|+++++||+|+||+||+|++ .+++.||+|++..... ........+.+|+.++..++|+||+++++++.+.+.+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM--LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 57899999999999999999998 5899999999874221 11223345788999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
|||||+.+|+|.+++.+ ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 99999999999999976 369999999999999999999999999999999999999999999999999998764321
Q ss_pred --------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 --------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 --------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...++..+|||||||++|+|++|+.||.+.+
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 1235667899999999999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.75 Aligned_cols=187 Identities=26% Similarity=0.387 Sum_probs=159.2
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
+.+.|++++.||+|+||+||+|++ .+++.||||++...............+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456899999999999999999998 6789999999874321111111346788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc---EEEEeccCce
Q 010231 406 YIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK 477 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~-----~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~---vKI~DFGlAk 477 (514)
||||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999998877532 3899999999999999999999999999999999999987654 9999999998
Q ss_pred ecccCC-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 478 VFLSSL-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 478 ~~~~~~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+.... ...++..+|||||||++|+|++|..||.+.
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 765321 123556899999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=307.06 Aligned_cols=183 Identities=25% Similarity=0.375 Sum_probs=158.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l 405 (514)
.++|+++++||+|+||+||+|++ .+++.||+|+++..... .......+.+|+.++.++ +||||+++++++.+.+.+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~--~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc--CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 57899999999999999999998 57889999999753322 223345577899998877 899999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
||||||+.+|+|..++.+ ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 999999999999998875 56999999999999999999999999999999999999999999999999999863221
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....++..+|||||||++|+|++|++||.+
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 123456689999999999999999999964
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=300.99 Aligned_cols=189 Identities=24% Similarity=0.417 Sum_probs=163.4
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc-hhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.+.+.|++++.||+|+||+||+|++ .+|+.||+|++....... ........+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 4567899999999999999999998 578999999997543221 11123457889999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC----cEEEEeccCcee
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKV 478 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g----~vKI~DFGlAk~ 478 (514)
.+||||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999999875 4699999999999999999999999999999999999998877 799999999987
Q ss_pred cccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 479 FLSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 479 ~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
+.... ...++..+|||||||++|+|++|.+||.+.+
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 64331 1245568999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=301.54 Aligned_cols=186 Identities=22% Similarity=0.303 Sum_probs=160.8
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 404 (514)
..++|+++++||+|+||+||+|++ .+++.||+|+++.... ........+.+|..++..+ +||||+++++++.+.+.
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 357899999999999999999998 4688999999875221 1122345678899999887 79999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~- 482 (514)
+||||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 9999999999999999876 57999999999999999999999999999999999999999999999999999864211
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||++|+|++|+.||.+.+
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 12345668899999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=303.98 Aligned_cols=187 Identities=25% Similarity=0.359 Sum_probs=152.9
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHH-HhhcCCCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpnIv~l~~~~~~~~ 403 (514)
...++|+++++||+|+||+||+|++ .++..||+|++...... .......+.+|..+ ++.++||||+++++++.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 3467899999999999999999998 57889999999753322 12233456667766 57789999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+||||||+.+|+|..++.+ ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999998876 46899999999999999999999999999999999999999999999999999863221
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|+|||||++|+|++|..||.+.+
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 12345568999999999999999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=294.88 Aligned_cols=186 Identities=24% Similarity=0.360 Sum_probs=152.2
Q ss_pred ccceEeeeeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.++|++++.||+|+||.||++++ .+++.||+|+++..... ........+.+|+.+++.++||||+++++++...+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 56899999999999999999987 57899999998753221 11233456778999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+||||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 99999999999999998875 46899999999999999999999999999999999999999999999999999854321
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....+...+|||||||++|+|++|..||.+.+
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 12334568899999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.53 Aligned_cols=183 Identities=26% Similarity=0.383 Sum_probs=158.9
Q ss_pred cccceEeeeeecccCceeEEEEEc--------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG 397 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~--------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~ 397 (514)
..++|++++.||+|+||.||+|.+ .++..||+|+++... .......+.+|+.+++.+ +||||+++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC----BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc----CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 357899999999999999999975 245679999886421 234456789999999999 8999999999
Q ss_pred EecCCCeEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCE
Q 010231 398 TDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460 (514)
Q Consensus 398 ~~~~~~~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI 460 (514)
++...+.+||||||+.+|+|.+++... .++...+..|+.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 999999999999999999999999753 378889999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 461 LVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 461 LId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
||+.++.+||+|||+++.+.... ...++..+|||||||++|+|++ |..||.+.
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999998654321 1234567899999999999999 99999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.70 Aligned_cols=185 Identities=26% Similarity=0.411 Sum_probs=152.7
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 403 (514)
.+.++|++++.||+|+||.||+|.+ .+++.||||++.... ........+.+|+.+++.+. |+||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 4567999999999999999999998 688999999886322 22344567789999999997 999999999987544
Q ss_pred --eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 --KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 --~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+||||||+.+ +|..++....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+..
T Consensus 83 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 83 DRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp SSCEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred CCEEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 79999999985 899999888899999999999999999999999999999999999999999999999999986532
Q ss_pred C-----------------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 482 S-----------------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 482 ~-----------------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
. ....++..+|||||||++|+|++|++||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0 11345678999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=288.20 Aligned_cols=181 Identities=28% Similarity=0.471 Sum_probs=158.0
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
++|++++.||+|+||+||+|.+.+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 579999999999999999999988999999998753321 12235677999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
|||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 999987 89888865 46899999999999999999999999999999999999999999999999999764321
Q ss_pred ----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|..||.+.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1123567899999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=291.29 Aligned_cols=186 Identities=30% Similarity=0.507 Sum_probs=154.7
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccch---------------------hHHHHHHHHHHHHHHh
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ---------------------AKQSISQLEQEIALLS 385 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~---------------------~~~~~~~l~~Ei~iL~ 385 (514)
.++|++.+.||+|+||.||+|++ .+++.||||++........ .....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 57899999999999999999997 6789999999875322110 1122456889999999
Q ss_pred hcCCCceeEEEEEecC--CCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc
Q 010231 386 RFEHENIVQYYGTDKD--ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD 463 (514)
Q Consensus 386 ~L~HpnIv~l~~~~~~--~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId 463 (514)
.++||||+++++++.+ ...+||||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 9999999999999876 57899999999999998887777899999999999999999999999999999999999999
Q ss_pred CCCcEEEEeccCceecccCCC-------------------cC---cceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 464 ANGSVKLADFGLAKVFLSSLD-------------------FD---LLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 464 ~~g~vKI~DFGlAk~~~~~~~-------------------~~---~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.++.+||+|||+++.+..... .. ....+|||||||++|+|++|+.||.+.
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999987643210 01 234679999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=290.30 Aligned_cols=184 Identities=26% Similarity=0.382 Sum_probs=156.4
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
...++|++.+.||+|+||+||+|.+ ++..||+|++..... .......+.+|+.++++++||||+++++++.....+
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF---HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3457899999999999999999987 578899999864332 234456788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 406 YIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~----lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
|+||||+.+|+|.+++.... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999997654 899999999999999999999999 999999999999999999999999999754
Q ss_pred ccC-------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSS-------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~-------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... ....++.++|||||||++|+|++|+.||.+.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 322 1233456789999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=297.01 Aligned_cols=183 Identities=26% Similarity=0.475 Sum_probs=157.7
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
+.++|++++.||+|+||+||+|++ .+++.||+|++..... ....+.+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc----cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 467999999999999999999998 5889999999864322 22235678999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
|+||||+.+++|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 9999999999999988754 69999999999999999999999999999999999999999999999999998653211
Q ss_pred --------------------CcC-cceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 --------------------DFD-LLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 --------------------~~~-~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... .+..+|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 111 245789999999999999999999764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=291.00 Aligned_cols=182 Identities=25% Similarity=0.451 Sum_probs=157.2
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC--
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-- 403 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~-- 403 (514)
..++|+++++||+|+||+||+|.+ .+++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 356899999999999999999998 5689999999874322 122456679999999999999999999887654
Q ss_pred eEEEEEeccccCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE----cCCCcEEEEeccC
Q 010231 404 KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGL 475 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~~----lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI----d~~g~vKI~DFGl 475 (514)
.+||||||+.+++|.+++.... +++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 7899999999999999997532 8999999999999999999999999999999999999 7788899999999
Q ss_pred ceecccCC--------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 476 AKVFLSSL--------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 476 Ak~~~~~~--------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
++.+.... ...++..+|||||||++|+|++|..||.+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 98764321 23455689999999999999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=297.07 Aligned_cols=185 Identities=19% Similarity=0.283 Sum_probs=162.6
Q ss_pred ccccceEeeeeeccc--CceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 326 RIITYWQKGDLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~G--sfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
...++|+++++||+| +||.||+|++ .+++.||||++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC---SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc---ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 346789999999999 9999999998 5799999999975332 234557788999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
+.+||||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999999999875 46899999999999999999999999999999999999999999999999998653
Q ss_pred ccC--------------------------CC--cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSS--------------------------LD--FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~--------------------------~~--~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... .. ..++..+|||||||++|+|++|+.||.+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 211 01 34667889999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=295.76 Aligned_cols=192 Identities=27% Similarity=0.438 Sum_probs=161.5
Q ss_pred ccccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec
Q 010231 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (514)
Q Consensus 322 ~~~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~ 400 (514)
+....+.++|++++.||+|+||.||+|.+ .++..||+|++...............+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 44556778999999999999999999998 67889999998753322222344577899999999999999999999999
Q ss_pred CCCeEEEEEeccccCCHHHHHhh-----------------------------------------cCCCHHHHHHHHHHHH
Q 010231 401 DESKLYIFLELVTKGSLLNLYQR-----------------------------------------YHLRDSQVSAYTRQIL 439 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~-----------------------------------------~~lse~~v~~i~~QIl 439 (514)
+.+.+|+||||+.+|+|.+++.. ..+++..++.++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 99999999999999999998852 1135667888999999
Q ss_pred HHHHHHHHCCccccCCCCCCEEEcCCC--cEEEEeccCceecccC-------------------------CCcCcceeeh
Q 010231 440 LGLKYLHDQDVVHRDIKCANILVDANG--SVKLADFGLAKVFLSS-------------------------LDFDLLLIFS 492 (514)
Q Consensus 440 ~gL~yLHs~gIIHRDLKP~NILId~~g--~vKI~DFGlAk~~~~~-------------------------~~~~~~~~~D 492 (514)
.||.|||++||+||||||+||||+.++ .+||+|||+++.+... ....++..+|
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999999998776 8999999999865321 1134556899
Q ss_pred hhhHHHHHHHHHhCCCCCCCC
Q 010231 493 IFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 493 VwSlG~lLyeLltG~~PF~g~ 513 (514)
||||||++|+|++|..||.+.
T Consensus 259 iwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=286.32 Aligned_cols=180 Identities=24% Similarity=0.404 Sum_probs=159.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|.++++||+|+||+||+|.+ .++..||+|.+... .......+.+|+.+++.++||||+++++++.+...+|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 46899999999999999999998 57899999988532 2344577889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
+||||+.+++|.++++. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999976 468999999999999999999999999999999999999999999999999998653221
Q ss_pred --------------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 --------------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 --------------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
...++.++|||||||++|+|++|..||..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 12345689999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=296.67 Aligned_cols=185 Identities=26% Similarity=0.412 Sum_probs=161.3
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|++++.||+|+||.||+|.+ .++..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 4467899999999999999999998 57899999999753322 2345678899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC---cEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g---~vKI~DFGlAk~~~ 480 (514)
+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999999988865 4589999999999999999999999999999999999998654 59999999998765
Q ss_pred cCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... ...++..+|||||||++|+|++|.+||.+.
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 321 124566899999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=291.50 Aligned_cols=188 Identities=24% Similarity=0.398 Sum_probs=162.4
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccch-hHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.+.++|.+++.||+|+||.||+|.+ .++..||+|++........ .......+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3457899999999999999999998 5789999999875432211 1123467889999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC----cEEEEeccCcee
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKV 478 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g----~vKI~DFGlAk~ 478 (514)
.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 99999999999999999865 4689999999999999999999999999999999999999887 899999999987
Q ss_pred cccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.... ...++..+|||||||++|+|++|..||.+.
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 168 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp CCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 64221 134556799999999999999999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.38 Aligned_cols=182 Identities=30% Similarity=0.521 Sum_probs=144.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++++.||+|+||.||+|.+ .+++.||+|++...... .....+.+|+.+++.++||||+++++++...+.+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE----GTPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT----CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 45799999999999999999998 57899999998754321 12245778999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 407 IFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~-------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
|||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9999998 5899888642 4889999999999999999999999999999999999999999999999999875
Q ss_pred ccCC--------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 480 LSSL--------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 480 ~~~~--------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.... ...++..+|||||||++|+|++|+.||.+.+
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4221 1245678999999999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=282.58 Aligned_cols=184 Identities=19% Similarity=0.292 Sum_probs=160.8
Q ss_pred ccccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
+....++|++++.||+|+||.||+|.+.++..||+|++...... .+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC------HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 33345789999999999999999999988889999998743221 245789999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999999999654 489999999999999999999999999999999999999999999999999986532
Q ss_pred CC--------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SL--------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~--------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.. ...++..+|||||||++|+|++ |.+||.+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 20 1334567899999999999999 99999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=283.64 Aligned_cols=184 Identities=23% Similarity=0.369 Sum_probs=158.7
Q ss_pred ccccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
+....++|++++.||+|+||.||++.+.++..||+|++...... ...+.+|+.+++.++|+||+++++++.+.+
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC------HHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 34446799999999999999999999998889999998743221 245789999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999999975 5699999999999999999999999999999999999999999999999999986532
Q ss_pred C--------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 S--------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~--------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
. ....++...|||||||++|+|++ |+.||.+.
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 1 01234567899999999999998 99999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.02 Aligned_cols=186 Identities=24% Similarity=0.356 Sum_probs=153.1
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|+++++||+|+||.||+|.+ .+++.||||++..... ........+.+|+.+++.++||||+++++++...+.+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--C-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh--hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 457899999999999999999997 6789999999874211 1223345677899999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCceecccC-
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~- 482 (514)
||||||+.+|+|..++.. ..+++..++.|+.||+.||.|||+ +||+||||||+||||+.++.+||+|||+|+.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 999999999999998865 568999999999999999999998 99999999999999999999999999999864322
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||+||+|++|+.||.+.+
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 12345668999999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=304.89 Aligned_cols=185 Identities=25% Similarity=0.333 Sum_probs=160.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|++++.||+|+||+||+|.+ .+|+.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC---HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 4567999999999999999999987 6899999999875332 23345678899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc---CCCcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId---~~g~vKI~DFGlAk~~~ 480 (514)
+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999999988765 5699999999999999999999999999999999999998 46789999999998664
Q ss_pred cCC-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SSL-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... ...++..+|||||||++|+|++|.+||.+.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 331 124567899999999999999999999764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=294.39 Aligned_cols=184 Identities=18% Similarity=0.254 Sum_probs=155.0
Q ss_pred CccccccccceEeeeeecccCceeEEEEE------ccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC---CCc
Q 010231 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HEN 391 (514)
Q Consensus 321 ~~~~~~~~~~Y~i~~~LG~GsfG~Vyka~------~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~---Hpn 391 (514)
...+....+.|.+.++||+|+||+||+|+ ..+++.||+|++.... ...+.+|+.++..+. |+|
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~l~~~~~~~ 128 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--------PWEFYIGTQLMERLKPSMQHM 128 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--------HHHHHHHHHHHHHSCGGGGGG
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--------hhHHHHHHHHHHHhhhhhhhh
Confidence 33444456789999999999999999994 3678999999986421 234566777777775 999
Q ss_pred eeEEEEEecCCCeEEEEEeccccCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-
Q 010231 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA- 464 (514)
Q Consensus 392 Iv~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~- 464 (514)
|+++++++...+..||||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 129 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208 (365)
T ss_dssp BCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGG
T ss_pred hhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccc
Confidence 99999999999999999999999999999963 45999999999999999999999999999999999999998
Q ss_pred ----------CCcEEEEeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 465 ----------NGSVKLADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 465 ----------~g~vKI~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
++.+||+|||+|+.+... ....++..+|||||||++|+|+||+.||..
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999764311 123456789999999999999999999954
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=291.53 Aligned_cols=186 Identities=22% Similarity=0.310 Sum_probs=157.4
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~- 403 (514)
.+.++|++++.||+|+||.||+|++ .+++.||+|++..... ........+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT--TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc--CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 4567899999999999999999997 7889999999875322 22445567889999999999999999999876543
Q ss_pred ---eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 404 ---KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 404 ---~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 35999999999999999875 46999999999999999999999999999999999999999999999999999865
Q ss_pred ccCC----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSSL----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~~----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ...+...+|||||||++|+|++|+.||.+.
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 3221 123456789999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=287.48 Aligned_cols=181 Identities=26% Similarity=0.416 Sum_probs=153.7
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~- 403 (514)
++.++|++++.||+|+||.||+|++ .+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----ELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST----TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 4578999999999999999999998 4899999999975332 233467889999999999999999999875432
Q ss_pred --------------------------------------------------------eEEEEEeccccCCHHHHHhhcC--
Q 010231 404 --------------------------------------------------------KLYIFLELVTKGSLLNLYQRYH-- 425 (514)
Q Consensus 404 --------------------------------------------------------~l~LVmEy~~gGsL~~lL~~~~-- 425 (514)
.+|+||||+.+++|.+++....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 4899999999999999997643
Q ss_pred --CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--------------------
Q 010231 426 --LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-------------------- 483 (514)
Q Consensus 426 --lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-------------------- 483 (514)
..+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 4555688999999999999999999999999999999999999999999998765431
Q ss_pred -----------CcCcceeehhhhHHHHHHHHHhCCCCC
Q 010231 484 -----------DFDLLLIFSIFLNGCKFFLIFLHVLIF 510 (514)
Q Consensus 484 -----------~~~~~~~~DVwSlG~lLyeLltG~~PF 510 (514)
...++..+|||||||++|+|++|..|+
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 124456889999999999999998775
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=283.23 Aligned_cols=178 Identities=28% Similarity=0.454 Sum_probs=153.5
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++++.||+|+||+||+|.+ .+++.||+|++...... ......+.+|+.+++.++|+||+++++++.+.+.+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc---CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 5799999999999999999998 57899999999754332 2334567899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
||||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 79 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 9999987 55554443 569999999999999999999999999999999999999999999999999998754221
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIF 510 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF 510 (514)
...++..+|||||||++|+|++|..||
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 122567899999999999999888775
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.45 Aligned_cols=181 Identities=28% Similarity=0.395 Sum_probs=155.5
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-- 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~-- 403 (514)
...++|+++++||+|+||+||+|++. ++.||||++.... .......+|+.+++.++||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD------KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc------hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 33578999999999999999999876 7899999986421 22344567999999999999999999987643
Q ss_pred --eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCCEEEcCCCcEEEE
Q 010231 404 --KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ----------DVVHRDIKCANILVDANGSVKLA 471 (514)
Q Consensus 404 --~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~----------gIIHRDLKP~NILId~~g~vKI~ 471 (514)
.+|+||||+.+|+|.++++...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred CceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 489999999999999999988899999999999999999999999 99999999999999999999999
Q ss_pred eccCceecccCCC--------------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 472 DFGLAKVFLSSLD--------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 472 DFGlAk~~~~~~~--------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|||+++.+..... ..++.++|||||||++|+|++|+.||.+.
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 9999986543211 12223569999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=290.63 Aligned_cols=182 Identities=23% Similarity=0.321 Sum_probs=157.5
Q ss_pred ccceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.++|++.++||+|+||.||+|.+. .+..||||.++... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 568999999999999999999983 34569999987422 2334567889999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+||||||+.+++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999999965 3699999999999999999999999999999999999999999999999999987643
Q ss_pred CCC----------------------cCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SLD----------------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~~----------------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
... ..++..+|||||||++|+|++ |..||.+.
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 311 233447899999999999999 99999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=289.70 Aligned_cols=181 Identities=26% Similarity=0.403 Sum_probs=157.9
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-----CCceeEEEEEe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----HENIVQYYGTD 399 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-----HpnIv~l~~~~ 399 (514)
.+.++|+++++||+|+||+||+|++ .+++.||||++... ......+..|+.+++.+. |+||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc------hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 4467899999999999999999998 67899999998631 233455678999999886 99999999999
Q ss_pred cCCCeEEEEEeccccCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC------------
Q 010231 400 KDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA------------ 464 (514)
Q Consensus 400 ~~~~~l~LVmEy~~gGsL~~lL~~~~---lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~------------ 464 (514)
...+.+||||||+ +++|.+++.... +++..++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence 9999999999999 889999987653 899999999999999999999999999999999999975
Q ss_pred -------------CCcEEEEeccCceecccC----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 465 -------------NGSVKLADFGLAKVFLSS----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 465 -------------~g~vKI~DFGlAk~~~~~----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
++.+||+|||+|+..... ....++..+|||||||++|+|++|+.||.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 789999999999865432 1234567899999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=296.32 Aligned_cols=185 Identities=22% Similarity=0.406 Sum_probs=155.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-- 402 (514)
.+.+.|++++.||+|+||.||+|.+ .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 4467899999999999999999998 689999999885422 2234456788999999999999999999998765
Q ss_pred ----CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 403 ----~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
..+|+||||+ +++|.++++...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 3569999999 77999999888899999999999999999999999999999999999999999999999999987
Q ss_pred cccCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 479 FLSSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 479 ~~~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
..... ...++..+|||||||++|+|++|++||.+.+
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 178 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 54321 1345678999999999999999999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=295.21 Aligned_cols=185 Identities=24% Similarity=0.383 Sum_probs=158.3
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
+.++.|.+++.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc--cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 4567999999999999999999998 7889999999874211 111223568899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~-~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+||||||+ +|+|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999999 568887764 4679999999999999999999999999999999999999999999999999998654321
Q ss_pred ------------------CcC-cceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------DFD-LLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~-~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... .+..+|||||||++|+|++|+.||.+.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 111 245789999999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=286.80 Aligned_cols=177 Identities=11% Similarity=0.017 Sum_probs=156.6
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
+.++|++.+.||+|+||.||+|++ .+++.||||++...... .......+.+|+.++..++|+||+++++++...+.+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL--PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc--CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence 346899999999999999999998 56899999988753322 234557788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCCc
Q 010231 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~~ 485 (514)
||||||+.+++|.++++.. .....+..|+.||+.||.|||++||+||||||+||||+.+|.+||+++|...
T Consensus 107 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~~-------- 177 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMP-------- 177 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCCT--------
T ss_pred EEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccccC--------
Confidence 9999999999999999654 5666788999999999999999999999999999999999999999877653
Q ss_pred CcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 486 DLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 486 ~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.++..+|||||||++|+|+||+.||.+.+
T Consensus 178 ~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 178 DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 46788999999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=283.47 Aligned_cols=183 Identities=23% Similarity=0.388 Sum_probs=160.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++++.||+|+||+||+|.+ .+++.||+|++.... ........+.+|+.+++.++|+||+++++++...+.+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC---C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence 57899999999999999999998 568999999886432 22334566789999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
+||||+.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999999988865 469999999999999999999999999999999999999999999999999998754221
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|||||||++|+|++|.+||.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 234567899999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=278.60 Aligned_cols=181 Identities=25% Similarity=0.366 Sum_probs=159.7
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
..++|++++.||+|+||.||+|.+.++..||+|.+...... ...+.+|+.+++.++||||+++++++.....+|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS------EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 35789999999999999999999988889999998743221 245789999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC
Q 010231 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~ 484 (514)
+||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999999998753 489999999999999999999999999999999999999999999999999986543311
Q ss_pred --------------------cCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 485 --------------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 485 --------------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
..++..+|||||||++|+|++ |..||...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 133457899999999999999 99999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=291.11 Aligned_cols=179 Identities=21% Similarity=0.304 Sum_probs=156.8
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 404 (514)
+.++|++++.||+|+||.||+|.+ .+++.||||++...... ..+.+|+.+++.+ +|+||+++++++...+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 456899999999999999999997 78999999998753221 3467899999999 99999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc-----EEEEeccCce
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK 477 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~-----vKI~DFGlAk 477 (514)
+||||||+ +++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++. +||+|||+++
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 8999999974 57999999999999999999999999999999999999998887 9999999999
Q ss_pred ecccCC--------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 478 VFLSSL--------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 478 ~~~~~~--------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+.... ...++..+|||||||++|+|++|..||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 764321 123455789999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=284.69 Aligned_cols=184 Identities=23% Similarity=0.344 Sum_probs=159.2
Q ss_pred ccccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD 399 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~ 399 (514)
...++|.+++.||+|+||.||+|.+ .++..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3467899999999999999999986 345889999886422 234457788999999999999999999999
Q ss_pred cCCCeEEEEEeccccCCHHHHHhhc-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 010231 400 KDESKLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454 (514)
Q Consensus 400 ~~~~~l~LVmEy~~gGsL~~lL~~~-------------------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRD 454 (514)
...+.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 9999999999999999999998753 278889999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 455 IKCANILVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 455 LKP~NILId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
|||+||||+.++.+||+|||+++.+.... ...++..+|||||||++|+|++ |..||.+
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998664321 1123457899999999999999 9999986
Q ss_pred C
Q 010231 513 P 513 (514)
Q Consensus 513 ~ 513 (514)
.
T Consensus 256 ~ 256 (314)
T 2ivs_A 256 I 256 (314)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=296.51 Aligned_cols=184 Identities=23% Similarity=0.398 Sum_probs=160.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 3467899999999999999999998 578999999987432 2223568899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC--CCcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~--~g~vKI~DFGlAk~~~ 480 (514)
+||||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+.
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999999999988653 5899999999999999999999999999999999999974 4789999999998764
Q ss_pred cCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... ...++..+|||||||++|+|++|..||.+.+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 321 1345568999999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=282.01 Aligned_cols=184 Identities=28% Similarity=0.458 Sum_probs=158.1
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.+.|.+.+.||+|+||.||+|.+ .++..+|+|.+..... ......+.+|+.+++.++||||+++++++.+...
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS----QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc----chhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 4567899999999999999999998 6788999999875332 2234678899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE---cCCCcEEEEeccCc
Q 010231 405 LYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLA 476 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI---d~~g~vKI~DFGlA 476 (514)
+|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999988743 469999999999999999999999999999999999999 45688999999999
Q ss_pred eecccCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 477 KVFLSSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 477 k~~~~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.+.... ...+...+|||||||++|+|++|+.||.+.
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp CC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 8654321 123456889999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=287.49 Aligned_cols=179 Identities=26% Similarity=0.383 Sum_probs=159.6
Q ss_pred ceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
.|...+.||+|+||.||+|++. +|+.||||++..... .....+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 5788889999999999999984 799999999875332 2235678999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-----
Q 010231 409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL----- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~----- 483 (514)
|||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999998764321
Q ss_pred --------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 --------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 --------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|||||||++|+|++|+.||.+.
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123456799999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=304.63 Aligned_cols=184 Identities=26% Similarity=0.388 Sum_probs=154.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-- 402 (514)
.+.++|++++.||+|+||+||+|.+ .+++.||||++.... ......+++.+|+.+++.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG---GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc---cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 3467899999999999999999998 678999999987432 2334456788999999999999999999998654
Q ss_pred ----CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 403 ----~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
..+||||||+.++ |..++.. .+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 136 ~~~~~~~~lv~E~~~~~-l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDAN-LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp TTTCCEEEEEEECCSEE-HHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred cccCCeEEEEEeCCCCC-HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 4689999999875 6666543 599999999999999999999999999999999999999999999999999987
Q ss_pred cccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 479 FLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 479 ~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.... ....++..+|||||||++|+|++|++||.+.+
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 5432 12345568999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=290.41 Aligned_cols=186 Identities=25% Similarity=0.352 Sum_probs=161.9
Q ss_pred cccccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 323 RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 323 ~~~~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.+....++|++.+.||+|+||.||+|.+.++..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-----SQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3445678999999999999999999999889999999876432 12346788999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCce
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~-----~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk 477 (514)
+.+|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999999999999988653 38889999999999999999999999999999999999999999999999998
Q ss_pred ecccCC---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 478 VFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 478 ~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...... ...++..+|||||||++|+|++|+.||.+.
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 643211 123456789999999999999999999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=286.22 Aligned_cols=186 Identities=30% Similarity=0.490 Sum_probs=152.0
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc---CCCceeEEEEEecCC
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDE 402 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIv~l~~~~~~~ 402 (514)
+.++|+++++||+|+||+||+|++ .+++.||+|++...............+.+|+.+++.+ .||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356899999999999999999998 6889999999875432221111123445666666665 599999999998765
Q ss_pred C-----eEEEEEeccccCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEecc
Q 010231 403 S-----KLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 403 ~-----~l~LVmEy~~gGsL~~lL~~~~---lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFG 474 (514)
. .+++||||+. ++|.+++.... +++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4 5899999997 49999987643 8999999999999999999999999999999999999999999999999
Q ss_pred CceecccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 475 LAKVFLSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 475 lAk~~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+++.+.... ...++..+|||||||++|+|++|.+||.+.
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 998654221 234566899999999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=293.78 Aligned_cols=181 Identities=22% Similarity=0.309 Sum_probs=152.6
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|++++.||+|+||+||++++ .+++.||+|++...... ...+.+|+.+++.++||||+++++++.+...+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI------DENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS------CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc------cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 356899999999999999999998 58899999998743221 24577999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc--EEEEeccCceecccC
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKVFLSS 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~--vKI~DFGlAk~~~~~ 482 (514)
|+||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+|||+++.....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999999998865 56999999999999999999999999999999999999987765 999999999843221
Q ss_pred C------------------CcCc-ceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 L------------------DFDL-LLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ~------------------~~~~-~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ...+ ...+|||||||++|+|++|++||.+.
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 0 1122 23489999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=302.67 Aligned_cols=184 Identities=27% Similarity=0.454 Sum_probs=147.2
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec----
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK---- 400 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~---- 400 (514)
.+.++|+++++||+|+||+||+|++ .+++.||||++.... ......+.+.+|+.+|+.++|+||+++++++.
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 3457899999999999999999998 588999999886422 22344567889999999999999999999984
Q ss_pred -CCCeEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 401 -DESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 401 -~~~~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
....+||||||+. ++|..++... .+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.
T Consensus 127 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 127 EKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 3367999999985 5898888764 599999999999999999999999999999999999999999999999999986
Q ss_pred cccC-----------------------------------------------CCcCcceeehhhhHHHHHHHHHh------
Q 010231 479 FLSS-----------------------------------------------LDFDLLLIFSIFLNGCKFFLIFL------ 505 (514)
Q Consensus 479 ~~~~-----------------------------------------------~~~~~~~~~DVwSlG~lLyeLlt------ 505 (514)
+... ....++..+|||||||+||+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 5311 12345668899999999999999
Q ss_pred -----CCCCCCCC
Q 010231 506 -----HVLIFRPP 513 (514)
Q Consensus 506 -----G~~PF~g~ 513 (514)
|.++|.|.
T Consensus 286 ~~~~~~~p~f~g~ 298 (458)
T 3rp9_A 286 AYHADRGPLFPGS 298 (458)
T ss_dssp SSGGGCCCSCC--
T ss_pred cccccccccCCCC
Confidence 88888764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=276.82 Aligned_cols=183 Identities=26% Similarity=0.441 Sum_probs=160.0
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|++.+.||+|+||.||+|.+ .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD 80 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence 3467899999999999999999998 5678999999875322 224568899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE---cCCCcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI---d~~g~vKI~DFGlAk~~~ 480 (514)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999999988765 468999999999999999999999999999999999999 788999999999998764
Q ss_pred cCCC-----------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SSLD-----------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~~~-----------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ..++..+|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 3311 22456889999999999999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=290.87 Aligned_cols=185 Identities=24% Similarity=0.348 Sum_probs=157.9
Q ss_pred cccccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEE
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG 397 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~ 397 (514)
....++|++++.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|+.++..+ +||||+++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC----CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 34467899999999999999999973 467899999986422 233356788999999999 7899999999
Q ss_pred EecCCC-eEEEEEeccccCCHHHHHhhcC---------------------------------------------------
Q 010231 398 TDKDES-KLYIFLELVTKGSLLNLYQRYH--------------------------------------------------- 425 (514)
Q Consensus 398 ~~~~~~-~l~LVmEy~~gGsL~~lL~~~~--------------------------------------------------- 425 (514)
++...+ .+|+||||+.+|+|.+++....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 987755 4999999999999999987532
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC------
Q 010231 426 ----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL------ 483 (514)
Q Consensus 426 ----------------lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~------ 483 (514)
+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 8888999999999999999999999999999999999999999999999998653221
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...++..+|||||||++|+|++ |..||.+.
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 299 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence 1334568899999999999998 99999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=280.85 Aligned_cols=187 Identities=24% Similarity=0.355 Sum_probs=161.5
Q ss_pred cccccccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEE
Q 010231 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY 395 (514)
Q Consensus 323 ~~~~~~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l 395 (514)
.+....++|++++.||+|+||.||+|.+ .++..||+|.+..... ....+.+.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh----HHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 3444467999999999999999999974 4678999999874321 23346788999999999 99999999
Q ss_pred EEEecCCCeEEEEEeccccCCHHHHHhhcC-------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 010231 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456 (514)
Q Consensus 396 ~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~-------------------lse~~v~~i~~QIl~gL~yLHs~gIIHRDLK 456 (514)
++++...+.+|+||||+.+|+|.+++.... +++..+..++.||+.||.|||++||+|||||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 172 (313)
T 1t46_A 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (313)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 999999999999999999999999987542 8899999999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEEeccCceecccCCC---------------------cCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 457 CANILVDANGSVKLADFGLAKVFLSSLD---------------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 457 P~NILId~~g~vKI~DFGlAk~~~~~~~---------------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
|+|||++.++.+||+|||+++.+..... ..++..+|||||||++|+|++ |..||.+.
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999999987643321 234457899999999999998 99999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=277.03 Aligned_cols=186 Identities=25% Similarity=0.486 Sum_probs=158.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...++|++++.||+|+||.||+|++ .+++.||+|.+..... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 3457899999999999999999998 6889999999864211 112234678899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999999999876 35899999999999999999999999999999999999999999999999999875422
Q ss_pred C-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 L-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ...+...+|||||||++|+|++|..||...
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 1 123445889999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.16 Aligned_cols=182 Identities=24% Similarity=0.367 Sum_probs=149.0
Q ss_pred cccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
..+.+.|++.+.||+|+||.||+|++ .+++.||||++.... ..+.+.+|+.+++.++|+||+++++++....
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT 121 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence 34567899999999999999999998 468899999987421 2345778999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC---CCcEEEEeccCceec
Q 010231 404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKVF 479 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~---~g~vKI~DFGlAk~~ 479 (514)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++..
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999999999988754 5899999999999999999999999999999999999975 889999999999865
Q ss_pred ccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... ....++..+|||||||++|+|++|..||.+.
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 432 1124567899999999999999999999754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=287.15 Aligned_cols=183 Identities=24% Similarity=0.337 Sum_probs=159.3
Q ss_pred cccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~ 400 (514)
..++|++++.||+|+||.||+|++. ++..||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3578999999999999999999874 35889999886422 2334567889999999999999999999999
Q ss_pred CCCeEEEEEeccccCCHHHHHhh-------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 010231 401 DESKLYIFLELVTKGSLLNLYQR-------------------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~-------------------------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDL 455 (514)
..+.+|+||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999999976 45888999999999999999999999999999
Q ss_pred CCCCEEEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 456 KCANILVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 456 KP~NILId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
||+||||+.++.+||+|||+++.+.... ...++..+|||||||++|+|++ |..||.+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 9999999999999999999997643211 1234568999999999999999 99999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=274.64 Aligned_cols=185 Identities=26% Similarity=0.410 Sum_probs=160.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|++.+.||+|+||.||+|.+ .++..||+|++..... .......+.+|+.+++.++|+||+++++++...+.
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence 3467899999999999999999998 5789999999875432 23345678899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc---EEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~---vKI~DFGlAk~~~ 480 (514)
.|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999999887754 56899999999999999999999999999999999999987655 9999999998765
Q ss_pred cCCC------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SSLD------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~~~------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ..++..+|||||||++|+|++|..||.+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 3321 23456899999999999999999999764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.96 Aligned_cols=186 Identities=25% Similarity=0.371 Sum_probs=160.4
Q ss_pred ccccccceEeeeeecccCceeEEEEEc--------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeE
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~--------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~ 394 (514)
+....++|.++++||+|+||.||+|.+ ..+..||+|+++.. ........+.+|+.+++.+ +||||++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 344457999999999999999999986 23467999988643 2234456788999999999 9999999
Q ss_pred EEEEecCCCeEEEEEeccccCCHHHHHhhcC-----------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 010231 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (514)
Q Consensus 395 l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~-----------------lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP 457 (514)
+++++...+.+|+||||+.+|+|.+++.... +++..++.|+.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999997643 89999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 458 ANILVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 458 ~NILId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+||||+.++.+||+|||+|+.+.... ...++.++|||||||++|+|++ |..||.+.
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998654321 1234457899999999999999 99999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=278.01 Aligned_cols=186 Identities=26% Similarity=0.425 Sum_probs=159.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...++|++++.||+|+||.||+|.+ .++..||+|++..... ........+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc--chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 3467899999999999999999987 5678999999864221 122234568899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999998865 568999999999999999999999999999999999999999999999999986543221
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|||||||++|+|++|..||.+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 123456789999999999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=295.91 Aligned_cols=184 Identities=24% Similarity=0.364 Sum_probs=159.7
Q ss_pred ccccceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...++|.+++.||+|+||.||+|.+. ++..||||.++... .......+.+|+.+++.++||||+++++++.....
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL----PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS----CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 34578999999999999999999984 78999999876321 12334567899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+||||||+++|+|.+++... .++...+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999999998753 4899999999999999999999999999999999999999999999999999864322
Q ss_pred C---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 L---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 ~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
. ...++.++|||||||++|+|++ |..||.+.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 0223457899999999999998 99999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.04 Aligned_cols=184 Identities=22% Similarity=0.368 Sum_probs=161.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|.+.++||+|+||.||+|++ .+|+.||+|++..... ........+.+|+.+++.++||||+++++++.+...+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL--KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh--hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 56899999999999999999998 5799999999874221 11233467889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 407 IFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~-----~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
|||||+.||+|..++... .+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.+..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999988653 489999999999999999999999999999999999999999999999999987543
Q ss_pred CC-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 482 SL-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 482 ~~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ...++..+|||||||++|+|++|.+||.+.
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 21 124556789999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=287.36 Aligned_cols=178 Identities=24% Similarity=0.374 Sum_probs=151.9
Q ss_pred ccceEee---eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCC
Q 010231 328 ITYWQKG---DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~---~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~ 402 (514)
.++|++. ++||+|+||.||+|.+ .+++.||||++... ....+.+|+.+++.+. ||||+++++++.+.
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 4567764 7899999999999998 57899999998631 2345678999999997 99999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC---cEEEEeccCcee
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKV 478 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g---~vKI~DFGlAk~ 478 (514)
..+||||||+.+|+|.+++... .+++..+..|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999999999999999988764 599999999999999999999999999999999999998766 899999999986
Q ss_pred cccCC-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSL-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..... ...++..+|||||||++|+|++|..||.+.
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 54321 123456789999999999999999999763
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.91 Aligned_cols=184 Identities=21% Similarity=0.332 Sum_probs=160.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|+++++||+|+||.||+|++ .+|+.||+|++..... ........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh--hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 56899999999999999999998 5899999999874221 11223456789999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
|||||+.+|+|..++... .+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 999999999999988753 38999999999999999999999999999999999999999999999999998764321
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|||||||++|+|++|..||.+.
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 123556789999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.60 Aligned_cols=188 Identities=24% Similarity=0.423 Sum_probs=162.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc-hhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.+.++|++++.||+|+||.||+|++ .++..||+|++....... ........+.+|+.+++.+.||||+++++++.+..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4567899999999999999999998 578999999987543221 11113466889999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC----cEEEEeccCcee
Q 010231 404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKV 478 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g----~vKI~DFGlAk~ 478 (514)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 999999999999999998764 589999999999999999999999999999999999999888 799999999987
Q ss_pred cccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.... ...++..+|||||||++|+|++|..||.+.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 65331 134456889999999999999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=295.44 Aligned_cols=177 Identities=28% Similarity=0.502 Sum_probs=152.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-- 402 (514)
.+.++|+++++||+|+||.||+|++ .+++.||||++.... ......+.+.+|+.+|+.++|+||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 4567999999999999999999998 678999999986432 2234456788999999999999999999998766
Q ss_pred ---CeEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 403 ---SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 403 ---~~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
..+||||||+.+ +|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 100 ~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 100 LKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp TTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 579999999975 999988764 599999999999999999999999999999999999999999999999999987
Q ss_pred cccC------------------------------------------CCcCcceeehhhhHHHHHHHHHhC
Q 010231 479 FLSS------------------------------------------LDFDLLLIFSIFLNGCKFFLIFLH 506 (514)
Q Consensus 479 ~~~~------------------------------------------~~~~~~~~~DVwSlG~lLyeLltG 506 (514)
+... ....++..+|||||||++|+|++|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 5321 123456688999999999999984
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=282.18 Aligned_cols=183 Identities=22% Similarity=0.339 Sum_probs=154.6
Q ss_pred ccccceEee-eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCC
Q 010231 326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE 402 (514)
Q Consensus 326 ~~~~~Y~i~-~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~ 402 (514)
++.+.|++. ++||+|+||+||+|++ .+++.||||++..... .....+.+|+.++.++ +||||+++++++.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 345678885 7899999999999997 5789999999875322 2235678999999885 799999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc---EEEEeccCcee
Q 010231 403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKV 478 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~---vKI~DFGlAk~ 478 (514)
+.+|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999998865 46899999999999999999999999999999999999998776 99999999876
Q ss_pred cccCC-------------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSL-------------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~-------------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.... ...++..+|||||||++|+|++|+.||.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 53110 012445789999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=283.81 Aligned_cols=184 Identities=28% Similarity=0.452 Sum_probs=161.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|.+++.||+|+||.||++.+ .+++.||+|++...... .......+.+|+.+++.++|+||+++++++.+.+.+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 56899999999999999999998 56889999998753221 2334567889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 99999999999998875 569999999999999999999999999999999999999999999999999998764221
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|||||||++|+|++|+.||.+.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 123455789999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=275.58 Aligned_cols=185 Identities=28% Similarity=0.446 Sum_probs=161.8
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|.+++.||+|+||.||++.+ .+++.+|+|++...... .......+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 456899999999999999999998 56889999998753322 233456788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999999999999998875 468999999999999999999999999999999999999999999999999998754221
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|+|||||++|+|++|+.||.+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123456899999999999999999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=279.99 Aligned_cols=180 Identities=28% Similarity=0.458 Sum_probs=154.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD- 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~- 401 (514)
.++|++++.||+|+||+||+|++ .+++.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 56899999999999999999983 57899999988642 23445678899999999999999999998854
Q ss_pred -CCeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 402 -ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 402 -~~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
...+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 45689999999999999999764 499999999999999999999999999999999999999999999999999986
Q ss_pred cccCC----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 479 FLSSL----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 479 ~~~~~----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+.... ...++.++|||||||++|+|++|..||..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 54321 12345688999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=285.43 Aligned_cols=181 Identities=20% Similarity=0.391 Sum_probs=155.1
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC--CceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pnIv~l~~~~~~~~~ 404 (514)
..+.|++++.||+|+||.||++.+.+++.||||++..... .......+.+|+.++..+.| +||+++++++.....
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc---chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 3568999999999999999999998899999999875432 23445678899999999976 999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+|||||+ .+++|.+++... .+++..+..|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9999994 577999988764 689999999999999999999999999999999999996 7889999999998653221
Q ss_pred C--------------------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 484 D--------------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 484 ~--------------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
. ..++..+|||||||++|+|++|+.||.+
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 0 2345578999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.95 Aligned_cols=184 Identities=26% Similarity=0.402 Sum_probs=151.1
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|++.+.||+|+||.||+|.+. +..||+|++...... ......+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDE-DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcc-cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 468999999999999999999975 889999987643221 223335678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCCEEEcC--------CCcEEEEeccCc
Q 010231 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD---VVHRDIKCANILVDA--------NGSVKLADFGLA 476 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~g---IIHRDLKP~NILId~--------~g~vKI~DFGlA 476 (514)
||||+.+++|.+++....+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 999999999999998889999999999999999999999999 999999999999986 778999999999
Q ss_pred eecccCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 477 KVFLSSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 477 k~~~~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.+.... ...++..+|||||||++|+|++|+.||.+.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred cccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 8654321 123456789999999999999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=279.48 Aligned_cols=175 Identities=23% Similarity=0.321 Sum_probs=153.1
Q ss_pred ccccceEee-eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHH-hhcCCCceeEEEEEecC-
Q 010231 326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKD- 401 (514)
Q Consensus 326 ~~~~~Y~i~-~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL-~~L~HpnIv~l~~~~~~- 401 (514)
.+.+.|.+. ++||+|+||.||+|.+ .+++.||+|++... ..+.+|+.++ +.+.||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 445677776 8899999999999998 67899999998631 2355788877 66699999999998876
Q ss_pred ---CCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC---CCcEEEEe
Q 010231 402 ---ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLAD 472 (514)
Q Consensus 402 ---~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~---~g~vKI~D 472 (514)
...+||||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 67899999999999999999764 4899999999999999999999999999999999999998 78999999
Q ss_pred ccCceecccCCCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 473 FGLAKVFLSSLDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 473 FGlAk~~~~~~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
||++..... ..++..+|||||||++|+|++|..||.+.
T Consensus 164 fg~a~~~~~---~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 164 FGFAKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp CTTCEECTT---CGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ccccccccc---ccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 999987653 45778899999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=275.16 Aligned_cols=188 Identities=22% Similarity=0.352 Sum_probs=162.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEeccccc----chhHHHHHHHHHHHHHHhhcC-CCceeEEEEEe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG----SQAKQSISQLEQEIALLSRFE-HENIVQYYGTD 399 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~----~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~ 399 (514)
.+.++|++.+.||+|+||.||+|.+ .+++.||+|++...... .........+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 4567999999999999999999998 57899999999754321 122344567889999999995 99999999999
Q ss_pred cCCCeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 400 KDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 400 ~~~~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.....+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999999999999875 4689999999999999999999999999999999999999999999999999987
Q ss_pred cccCC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.... ...++..+|||||||++|+|++|..||.+.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 54321 123456889999999999999999999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=277.97 Aligned_cols=184 Identities=28% Similarity=0.408 Sum_probs=148.9
Q ss_pred cccccceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~ 400 (514)
....++|++++.||+|+||.||+|.+. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 344678999999999999999999873 3457899977532 12344567889999999999999999999985
Q ss_pred CCCeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 401 DESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.+.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 46789999999999999999754 589999999999999999999999999999999999999999999999999986
Q ss_pred cccCC--------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 479 FLSSL--------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 479 ~~~~~--------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+.... ...++..+|||||||++|+|++ |..||.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 54321 1234457899999999999996 99999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=279.47 Aligned_cols=178 Identities=27% Similarity=0.349 Sum_probs=149.6
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhh--cCCCceeEEEEEec---
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDK--- 400 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIv~l~~~~~--- 400 (514)
.+.++|++++.||+|+||+||+|.+ +++.||||++... ....+.+|..++.. ++||||+++++++.
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 3467899999999999999999987 6889999988642 12334455555555 79999999998754
Q ss_pred -CCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCCEEEcCCCcEEEE
Q 010231 401 -DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--------DQDVVHRDIKCANILVDANGSVKLA 471 (514)
Q Consensus 401 -~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLH--------s~gIIHRDLKP~NILId~~g~vKI~ 471 (514)
....+|+||||+.+|+|.++++...+++..+..++.||+.||.||| ++||+||||||+||||+.++.+||+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 3456999999999999999998889999999999999999999999 9999999999999999999999999
Q ss_pred eccCceecccCCC-----------------------c------CcceeehhhhHHHHHHHHHhC----------CCCCCC
Q 010231 472 DFGLAKVFLSSLD-----------------------F------DLLLIFSIFLNGCKFFLIFLH----------VLIFRP 512 (514)
Q Consensus 472 DFGlAk~~~~~~~-----------------------~------~~~~~~DVwSlG~lLyeLltG----------~~PF~g 512 (514)
|||+|+....... . .++.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999976432211 0 223578999999999999999 888854
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=273.33 Aligned_cols=180 Identities=19% Similarity=0.300 Sum_probs=159.0
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|++.+.||+|+||.||+|.+.++..||+|.+...... .+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence 4689999999999999999999988899999998753221 2467899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC--
Q 010231 408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL-- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~-- 483 (514)
||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999999999764 48999999999999999999999999999999999999999999999999998653210
Q ss_pred ------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 ------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 ------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
...++..+|||||||++|+|++ |.+||.+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 1234557999999999999999 99999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=294.11 Aligned_cols=182 Identities=26% Similarity=0.399 Sum_probs=155.4
Q ss_pred ccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.++|++++.||+|+||+||+|.+ .++..||||.+... ........+.+|+.+++.++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc----cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 46899999999999999999984 35778999988532 123334568899999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC---cEEE
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKL 470 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~--------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g---~vKI 470 (514)
....||||||+.+|+|.+++... .++...++.|+.||+.||.|||++||+||||||+||||+.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999999763 388899999999999999999999999999999999999655 5999
Q ss_pred EeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 471 ADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 471 ~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+|||+|+.+... ....++..+|||||||++|+|++ |..||.+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999754211 02335568899999999999998 99999865
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=289.53 Aligned_cols=186 Identities=29% Similarity=0.438 Sum_probs=151.8
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|++++.||+|+||.||+|++ .+|+.||+|++...............+.+|+.+++.++|+||+++++++.....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 356899999999999999999998 5789999999875332222222234677999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
|+||||+.+ +|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999987 888888764 48899999999999999999999999999999999999999999999999998653221
Q ss_pred --------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 --------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 --------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++..+|||||||++|+|++|.+||.+.
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 123556789999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=289.29 Aligned_cols=182 Identities=22% Similarity=0.407 Sum_probs=151.6
Q ss_pred ccceEe--eeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 328 ITYWQK--GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 328 ~~~Y~i--~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...|.+ .++||+|+||.||+|.+ .+|..||+|++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKND 160 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 344554 67899999999999997 678999999987532 2334678899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE--cCCCcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI--d~~g~vKI~DFGlAk~~~ 480 (514)
+||||||+++++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 9999999999999988764 358999999999999999999999999999999999999 567899999999999764
Q ss_pred cCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... ...++..+|||||||++|+|++|..||.+.+
T Consensus 241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 241 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp TTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 331 1234457899999999999999999998753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=278.47 Aligned_cols=182 Identities=32% Similarity=0.508 Sum_probs=162.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|++++.||+|+||.||+|++ .+++.||+|++...... .....+.+|+.+++.+.|+||+++++++.....+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS----TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 45799999999999999999987 67899999998754322 23467889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
+||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998754321
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|||||||++|+|++|..||...
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 123456789999999999999999999764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=286.51 Aligned_cols=181 Identities=23% Similarity=0.390 Sum_probs=149.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceE----EEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~v----AIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.++|+++++||+|+||+||+|++ .++..+ |+|.+.. .........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 46899999999999999999997 455554 6665542 12233456788999999999999999999999875
Q ss_pred CeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
. .++||+|+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 4 7899999999999999876 358999999999999999999999999999999999999999999999999998654
Q ss_pred cCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 481 SSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 481 ~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
... ...++.++|||||||++|+|++ |..||.+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 321 1234567899999999999999 99999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=278.22 Aligned_cols=183 Identities=27% Similarity=0.466 Sum_probs=152.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec----
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK---- 400 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~---- 400 (514)
.+.++|++++.||+|+||.||+|.+ .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-----hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 4567899999999999999999998 468999999987432 344567889999999999999999998863
Q ss_pred ----------CCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc-CCCcEE
Q 010231 401 ----------DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVK 469 (514)
Q Consensus 401 ----------~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId-~~g~vK 469 (514)
....+|+||||+. |+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 4478999999998 5999999888899999999999999999999999999999999999997 567999
Q ss_pred EEeccCceecccC-----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 470 LADFGLAKVFLSS-----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 470 I~DFGlAk~~~~~-----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
|+|||+++.+... ....++..+|||||||++|+|++|+.||.+.+
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999865321 11345567899999999999999999998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.61 Aligned_cols=177 Identities=24% Similarity=0.312 Sum_probs=150.1
Q ss_pred cccceEee-eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHH-hhcCCCceeEEEEEecC--
Q 010231 327 IITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKD-- 401 (514)
Q Consensus 327 ~~~~Y~i~-~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL-~~L~HpnIv~l~~~~~~-- 401 (514)
+.+.|.+. ++||+|+||+||+|.+ .+++.||||++... ..+.+|+.++ +..+|+||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 45567666 7999999999999998 57899999998631 2355778776 45589999999998764
Q ss_pred --CCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC---CCcEEEEec
Q 010231 402 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADF 473 (514)
Q Consensus 402 --~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~---~g~vKI~DF 473 (514)
...+||||||+.+|+|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 66799999999999999999764 4899999999999999999999999999999999999997 789999999
Q ss_pred cCceecccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 474 GLAKVFLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 474 GlAk~~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|+++..... ....++..+|||||||++|+|++|..||.+.
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 999865422 1234566899999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.15 Aligned_cols=186 Identities=28% Similarity=0.434 Sum_probs=162.1
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|.+++.||+|+||.||+|++ .+|+.||||++..... ........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467899999999999999999998 5899999999874221 1122346788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
||||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 999999999999999875 469999999999999999999999999999999999999999999999999998764321
Q ss_pred -----------------Cc-CcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 -----------------DF-DLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 -----------------~~-~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.. ..+..+|||||||++|+|++|..||.+.+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 01 12457899999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=282.88 Aligned_cols=186 Identities=30% Similarity=0.440 Sum_probs=159.2
Q ss_pred cccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
-...++|++++.||+|+||.||+|++ .+++.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 97 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD---DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK 97 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC---chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence 34568999999999999999999998 5689999999865332 2334456789999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+|+||||+.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999999999887653 56999999999999999999999999999999999999999999999999999765322
Q ss_pred --------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 --------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 --------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|+.||.+.
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1124567889999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=287.99 Aligned_cols=181 Identities=30% Similarity=0.442 Sum_probs=153.3
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|.+++.||+|+||+||+|.+ .+++.||+|++...... .....+.+|+.+++.++|+||+++++++...+.+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE----GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc----ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 5799999999999999999998 58899999998643211 111234579999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 78 VFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred Eeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 9999985 888887653 4899999999999999999999999999999999999999999999999999754321
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||++|+|++|+.||.+.+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11345678999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=272.09 Aligned_cols=184 Identities=23% Similarity=0.346 Sum_probs=157.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 403 (514)
++.++|++++.||+|+||+||+|.+ .+++.||+|.+....... .....+.+|+.++..+ +||||+++++++.+.+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS---VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS---HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc---HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 4567999999999999999999998 489999999987533222 2345677899999998 9999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC-------------
Q 010231 404 KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN------------- 465 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~------------- 465 (514)
.+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999999865 458999999999999999999999999999999999999844
Q ss_pred ------CcEEEEeccCceecccCC----------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 466 ------GSVKLADFGLAKVFLSSL----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 466 ------g~vKI~DFGlAk~~~~~~----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
..+||+|||++....... ...++..+|||||||++|+|++|.++|..
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 479999999998765432 12344689999999999999999988753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=288.77 Aligned_cols=181 Identities=23% Similarity=0.357 Sum_probs=151.6
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCce----EEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~----vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.++|+++++||+|+||+||+|.+ .++.. ||+|.+.... .......+.+|+.+++.++|+||+++++++. .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS----GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT----SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc----cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 46899999999999999999997 45555 6666654221 1122234668999999999999999999886 4
Q ss_pred CeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
..+++||||+.+|+|.+++... .+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 6789999999999999998753 68999999999999999999999999999999999999999999999999998754
Q ss_pred cCCC---------------------cCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 481 SSLD---------------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 481 ~~~~---------------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.... ..++..+|||||||++|+|++ |..||.+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 221 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence 3211 234557899999999999999 99999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=286.58 Aligned_cols=183 Identities=27% Similarity=0.460 Sum_probs=159.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-- 402 (514)
.+.++|++++.||+|+||.||+|.+ .++..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc----CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 4456899999999999999999998 578899999987422 233456788999999999999999999988654
Q ss_pred ---CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 403 ---~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..+|+||||+.+ +|.++++...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 100 ~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 100 EQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp TTCCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 469999999985 8999998889999999999999999999999999999999999999999999999999999865
Q ss_pred ccCC-----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSSL-----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~~-----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ...++..+|||||||++|+|++|++||.+.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 4221 123556789999999999999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=313.12 Aligned_cols=186 Identities=22% Similarity=0.303 Sum_probs=160.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 404 (514)
..++|+++++||+|+||+||+|++ .+++.||||+++.... ........+..|..++..+ +|+||+++++++.+.+.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH--HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 457899999999999999999998 5788999999874211 1122345677899999887 79999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~- 482 (514)
+||||||+.+|+|..++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 9999999999999999876 56999999999999999999999999999999999999999999999999999864321
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||+||+|++|++||.+.+
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 12345668999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=284.31 Aligned_cols=183 Identities=26% Similarity=0.389 Sum_probs=156.6
Q ss_pred cccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD 399 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~ 399 (514)
..++|.+++.||+|+||.||+|.+ .++..||+|++.... .......+.+|+.++..+ .||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 357899999999999999999986 356789999987422 223346788999999999 899999999999
Q ss_pred cCCCeEEEEEeccccCCHHHHHhhcC------------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 010231 400 KDESKLYIFLELVTKGSLLNLYQRYH------------------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455 (514)
Q Consensus 400 ~~~~~l~LVmEy~~gGsL~~lL~~~~------------------------lse~~v~~i~~QIl~gL~yLHs~gIIHRDL 455 (514)
...+.+|+||||+++|+|.+++.... +++..+..++.||+.||.|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 99999999999999999999997532 688899999999999999999999999999
Q ss_pred CCCCEEEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 456 KCANILVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 456 KP~NILId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
||+||||+.++.+||+|||+++.+.... ...++..+|||||||++|+|+| |..||.+.
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999998654321 1234557899999999999998 99999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=274.76 Aligned_cols=185 Identities=26% Similarity=0.455 Sum_probs=160.6
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|++++.||+|+||.||+|.+ .++..||+|++..... ........+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 357899999999999999999998 5788999999874211 1112245688999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 999999999999998865 468999999999999999999999999999999999999999999999999997654321
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...+...+|+|||||++|+|++|..||...
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 123556899999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=282.34 Aligned_cols=183 Identities=29% Similarity=0.503 Sum_probs=158.7
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-- 402 (514)
.+.++|++++.||+|+||.||+|.+ .+|+.||||.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD----KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS----SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc----cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 4567899999999999999999998 578999999986422 233456678999999999999999999987653
Q ss_pred ---CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 403 ---~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..+|+||||+.+ +|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 84 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 84 ENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TTCCCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CccceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 679999999985 8999998888999999999999999999999999999999999999999999999999999865
Q ss_pred ccC------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSS------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... ....++..+|||||||++|+|++|..||.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 1134556789999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=273.32 Aligned_cols=186 Identities=25% Similarity=0.381 Sum_probs=160.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc-hhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
.++|++++.||+|+||.||+|++ .+++.||+|+++...... ........+.+|+.+++.++||||+++++++.....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 46899999999999999999998 478999999987543221 1112346788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC----cEEEEeccCceecc
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKVFL 480 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g----~vKI~DFGlAk~~~ 480 (514)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 999999999999999865 5699999999999999999999999999999999999998877 89999999998754
Q ss_pred cCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... ...++..+|||||||++|+|++|..||.+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 321 134456799999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.56 Aligned_cols=186 Identities=25% Similarity=0.439 Sum_probs=160.1
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|+++++||+|+||+||+|.+ .+++.||||++....... .....+.+|+.+++.++||||+++++++.+...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 4567999999999999999999998 588999999987432211 224567899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc---CCCcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId---~~g~vKI~DFGlAk~~~ 480 (514)
+|+||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.+.
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999999887754 5799999999999999999999999999999999999995 45679999999998654
Q ss_pred cCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... ...+...+|||||||++|+|++|.+||.+.+
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 1234567899999999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=276.37 Aligned_cols=180 Identities=18% Similarity=0.258 Sum_probs=154.7
Q ss_pred ccceEeeeeecccCceeEEEEEcc-CC-------ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEe
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD-DG-------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD 399 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~-~g-------~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~ 399 (514)
.++|++.+.||+|+||+||+|++. ++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-----RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-----GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-----HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 468999999999999999999873 33 469999886422 23346788999999999999999999999
Q ss_pred cCCCeEEEEEeccccCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc--------EE
Q 010231 400 KDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--------VK 469 (514)
Q Consensus 400 ~~~~~l~LVmEy~~gGsL~~lL~~~~--lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~--------vK 469 (514)
...+..|+||||+.+++|.+++.... +++..+..++.||+.||.|||++||+||||||+||||+.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999999997654 999999999999999999999999999999999999998887 99
Q ss_pred EEeccCceecccC----------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 470 LADFGLAKVFLSS----------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 470 I~DFGlAk~~~~~----------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
|+|||++...... ....++..+|||||||++|+|++ +.+||..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 162 LSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp ECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred eccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 9999999765322 11446678999999999999999 5566654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=285.89 Aligned_cols=183 Identities=26% Similarity=0.397 Sum_probs=159.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.+.|.+++.||+|+||+||+|++ .+++.||||++..... ......+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc--cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 35699999999999999999997 6899999999875332 22344567889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
|||||+.+ +|.+++. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 131 lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 209 (348)
T 1u5q_A 131 LVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209 (348)
T ss_dssp EEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred EEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence 99999984 7777774 356899999999999999999999999999999999999999999999999999865432
Q ss_pred ----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|..||.+.
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1234566899999999999999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.62 Aligned_cols=184 Identities=21% Similarity=0.392 Sum_probs=153.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...++|+++++||+|+||+||+|++ .+++.||||++..... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc---ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3467899999999999999999997 6889999998864322 22334567799999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc-----CCCcEEEEeccCcee
Q 010231 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-----ANGSVKLADFGLAKV 478 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId-----~~g~vKI~DFGlAk~ 478 (514)
+||||||+.+ +|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999986 899888764 699999999999999999999999999999999999994 455699999999976
Q ss_pred cccC--------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSS--------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~--------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+... ....++..+|||||||++|+|++|..||.+.
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 5321 0123567899999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=275.50 Aligned_cols=183 Identities=26% Similarity=0.475 Sum_probs=159.6
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
+.++|++++.||+|+||.||+|.+ .+++.||+|++..... ......+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence 467899999999999999999998 5789999999875332 22346788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 9999999999999988653 68999999999999999999999999999999999999999999999999998643110
Q ss_pred --------------------CcC-cceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 --------------------DFD-LLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 --------------------~~~-~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
... ....+|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 112 245789999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=292.03 Aligned_cols=182 Identities=24% Similarity=0.364 Sum_probs=151.0
Q ss_pred ccceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.++|.+.+.||+|+||.||+|++. ++..||||.++... .....+.+.+|+.++++++||||+++++++....
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 458999999999999999999874 67789999886422 2334567889999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+||||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999999999764 589999999999999999999999999999999999999999999999999987543
Q ss_pred CC----------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SL----------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~----------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.. ...++..+|||||||++|+|++ |+.||.+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1234457899999999999997 99999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=295.11 Aligned_cols=182 Identities=25% Similarity=0.449 Sum_probs=155.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC--
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-- 403 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~-- 403 (514)
..++|.++++||+|+||+||+|.+ .+++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 356899999999999999999998 5689999999874322 222456678999999999999999999987654
Q ss_pred eEEEEEeccccCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE----cCCCcEEEEeccC
Q 010231 404 KLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGL 475 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~----~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI----d~~g~vKI~DFGl 475 (514)
.+|+||||+.+|+|.+++... .+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 789999999999999998753 28999999999999999999999999999999999999 7778899999999
Q ss_pred ceecccCCC--------------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 476 AKVFLSSLD--------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 476 Ak~~~~~~~--------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
++.+..... ..++..+|||||||++|+|++|+.||.+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 987643311 2234578999999999999999999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=282.89 Aligned_cols=183 Identities=22% Similarity=0.346 Sum_probs=144.9
Q ss_pred ccceEeeeeecccCceeEEEEEccC-C---ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDD-G---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~-g---~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.++|++++.||+|+||.||+|.+.. + ..||+|++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII---ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc---CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 4689999999999999999999843 3 2799998864221 2233567889999999999999999999988766
Q ss_pred eE------EEEEeccccCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEE
Q 010231 404 KL------YIFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 404 ~l------~LVmEy~~gGsL~~lL~~~-------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI 470 (514)
.. |+||||+.+|+|.+++... .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 55 9999999999999988543 4889999999999999999999999999999999999999999999
Q ss_pred EeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 471 ADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 471 ~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+|||+++.+.... ...++..+|||||||++|+|++ |..||.+.
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 9999998653321 1234568899999999999999 99999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=298.93 Aligned_cols=189 Identities=24% Similarity=0.401 Sum_probs=159.1
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc--------hhHHHHHHHHHHHHHHhhcCCCceeEEE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS--------QAKQSISQLEQEIALLSRFEHENIVQYY 396 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~--------~~~~~~~~l~~Ei~iL~~L~HpnIv~l~ 396 (514)
.+.+.|.++++||+|+||+||+|.+ .++..||+|++....... ........+.+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 4567899999999999999999998 578899999987532111 1113346788999999999999999999
Q ss_pred EEecCCCeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC---cEEEEe
Q 010231 397 GTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLAD 472 (514)
Q Consensus 397 ~~~~~~~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g---~vKI~D 472 (514)
+++.+...+|||||||.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999987754 5799999999999999999999999999999999999999876 699999
Q ss_pred ccCceecccCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 473 FGLAKVFLSSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 473 FGlAk~~~~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
||+++.+.... ...++..+|||||||++|+|++|.+||.+.+
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998765331 1234568899999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=285.88 Aligned_cols=183 Identities=26% Similarity=0.376 Sum_probs=154.0
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC--
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-- 403 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~-- 403 (514)
+.++|++++.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC---ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 467899999999999999999997 5789999999874322 2334567889999999999999999999987654
Q ss_pred ----eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 404 ----~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
.+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ccccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 78999999986 6877775 46899999999999999999999999999999999999999999999999999865
Q ss_pred ccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 480 LSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 480 ~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... ....++..+|||||||++|+|++|..||.+.+
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 12345668999999999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=288.13 Aligned_cols=184 Identities=20% Similarity=0.289 Sum_probs=149.6
Q ss_pred ccceEeeeeecccCceeEEEEEccC------CceEEEEEEecccccchhH------HHHHHHHHHHHHHhhcCCCceeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAK------QSISQLEQEIALLSRFEHENIVQY 395 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~------g~~vAIK~v~~~~~~~~~~------~~~~~l~~Ei~iL~~L~HpnIv~l 395 (514)
.+.|+++++||+|+||.||+|.+.. ++.||||++.......... .....+.+|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999998743 5789999987533211110 011123456677888899999999
Q ss_pred EEEecCC----CeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc--CCCc
Q 010231 396 YGTDKDE----SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANGS 467 (514)
Q Consensus 396 ~~~~~~~----~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId--~~g~ 467 (514)
++++... ..+||||||+ +++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9988654 5689999999 9999999976 4599999999999999999999999999999999999999 8899
Q ss_pred EEEEeccCceecccCC--------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 468 VKLADFGLAKVFLSSL--------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 468 vKI~DFGlAk~~~~~~--------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+||+|||+|+.+.... ...++..+|||||||++|+|+||+.||.+
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999998653221 12345678999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=279.82 Aligned_cols=186 Identities=23% Similarity=0.285 Sum_probs=155.7
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...+.|++.+.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.+++.++||||+++++++...+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS--SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG--GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc--cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 4467899999999999999999998 5789999998864322 223445778899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~- 482 (514)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999999876 46999999999999999999999999999999999999999999999999998765332
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....+...+|||||||++|+|++|..||.+.
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 1123456899999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=275.16 Aligned_cols=184 Identities=26% Similarity=0.387 Sum_probs=160.6
Q ss_pred ccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
+....++|++.+.||+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS------THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 334467899999999999999999998 568899999986421 2346788999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999999999975 34899999999999999999999999999999999999999999999999999865
Q ss_pred ccCC--------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 480 LSSL--------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 480 ~~~~--------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.... ...++..+|||||||++|+|++ |..||.+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4331 1234557899999999999999 99999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=286.03 Aligned_cols=180 Identities=27% Similarity=0.347 Sum_probs=152.1
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC--------CCceeEEEE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--------HENIVQYYG 397 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~--------HpnIv~l~~ 397 (514)
+.++|+++++||+|+||+||+|++ .+++.||||++... ......+.+|+.+++.++ |+||+++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 457899999999999999999987 67899999998632 233466788999999885 788999999
Q ss_pred Eec----CCCeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCC---
Q 010231 398 TDK----DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANG--- 466 (514)
Q Consensus 398 ~~~----~~~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g--- 466 (514)
++. ....+||||||+. ++|.+++.. ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 887 6678999999995 566655543 3599999999999999999999998 999999999999999775
Q ss_pred ----------------------------------------------cEEEEeccCceecccCC----------------C
Q 010231 467 ----------------------------------------------SVKLADFGLAKVFLSSL----------------D 484 (514)
Q Consensus 467 ----------------------------------------------~vKI~DFGlAk~~~~~~----------------~ 484 (514)
.+||+|||+++...... .
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHT
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcC
Confidence 79999999998764331 1
Q ss_pred cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 485 FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 485 ~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..++..+|||||||+||+|++|+.||.+.
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 23566899999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.01 Aligned_cols=182 Identities=24% Similarity=0.353 Sum_probs=159.0
Q ss_pred cccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
....++|++.+.||+|+||.||+|.+.++..||||.++.... ..+.+.+|+.+|+.++||||+++++++. ...
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc------cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 334578999999999999999999998889999999874321 2467889999999999999999999986 567
Q ss_pred EEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 405 LYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
+||||||+.+|+|.++++.. .++...+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 89999999999999999753 688999999999999999999999999999999999999999999999999986532
Q ss_pred CC--------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SL--------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~--------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.. ...++.++|||||||+||+|++ |+.||.+.
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 10 1334567899999999999999 99999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=298.52 Aligned_cols=186 Identities=25% Similarity=0.417 Sum_probs=156.0
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.+.|++++.||+|+||+||+|++ .++..||+|++....... .....+.+|+.+++.++||||+++++++.+...
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 110 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST---SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc---hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 4456899999999999999999998 578999999987533211 123567899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC---CcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~---g~vKI~DFGlAk~~~ 480 (514)
+|+||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.. +.+||+|||+++.+.
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999999887754 579999999999999999999999999999999999999764 459999999998764
Q ss_pred cCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... ...++..+|||||||++|+|++|.+||.+.+
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 1235568999999999999999999998753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.44 Aligned_cols=187 Identities=26% Similarity=0.420 Sum_probs=162.1
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|+++++||+|+||.||+|++ .+++.||||++....... ......+.+|+.+++.++||||+++++++.+...
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB--SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc--chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3457899999999999999999998 589999999987533221 2234678899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE---cCCCcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI---d~~g~vKI~DFGlAk~~~ 480 (514)
+|+||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+.
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999999988765 569999999999999999999999999999999999999 467899999999998654
Q ss_pred cCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... ...+...+|||||||++|+|++|.+||.+.+
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 331 1245668999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=282.27 Aligned_cols=183 Identities=26% Similarity=0.384 Sum_probs=157.1
Q ss_pred cccceEeeeeecccCceeEEEEEc--------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG 397 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~--------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~ 397 (514)
..++|.+++.||+|+||.||+|.+ .++..||+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 357899999999999999999986 356789999886422 234456788999999999 8999999999
Q ss_pred EecCCCeEEEEEeccccCCHHHHHhhcC-----------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCE
Q 010231 398 TDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460 (514)
Q Consensus 398 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~-----------------lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI 460 (514)
++...+.+|+||||+.+|+|.+++.... +++..+..++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999997542 78899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 461 LVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 461 LId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
||+.++.+||+|||+++.+.... ...++..+|||||||++|+|++ |..||.+.
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999998654321 1223457899999999999999 99999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=279.63 Aligned_cols=175 Identities=25% Similarity=0.401 Sum_probs=153.7
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecC--CC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD--ES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~--~~ 403 (514)
.++|++++.||+|+||.||+|++ .+++.||+|++.... ...+.+|+.+++.+. |+||+++++++.. ..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 46899999999999999999987 688999999986321 256789999999997 9999999999987 67
Q ss_pred eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-cEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-~vKI~DFGlAk~~~~~ 482 (514)
..++||||+.+++|..+++ .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+.+...
T Consensus 107 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ceEEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 8999999999999999875 488999999999999999999999999999999999999777 8999999999865432
Q ss_pred C-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 L-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
. ...++..+|||||||++|+|++|..||..
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 1 13456689999999999999999999943
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=286.35 Aligned_cols=182 Identities=25% Similarity=0.402 Sum_probs=160.5
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|++++.||+|+||.||+|.+ .++..||+|++.... .......+.+|+.+++.++|+||+++++++...+.+|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 56899999999999999999998 578999999987532 2344567889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
+||||+.+++|.+++... .+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.+...
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 187 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 187 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc
Confidence 999999999999998764 699999999999999999999996 9999999999999999999999999999754221
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|+.||.+.
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1234567899999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=279.42 Aligned_cols=185 Identities=22% Similarity=0.327 Sum_probs=158.8
Q ss_pred cccccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT 398 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~ 398 (514)
....++|++.+.||+|+||.||+|++. ++..||+|.+.... .......+.+|+.+++.++|+||++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc----CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 344678999999999999999999864 47889999886322 22334568899999999999999999999
Q ss_pred ecCCCeEEEEEeccccCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc
Q 010231 399 DKDESKLYIFLELVTKGSLLNLYQR-----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467 (514)
Q Consensus 399 ~~~~~~l~LVmEy~~gGsL~~lL~~-----------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~ 467 (514)
+.+.+.+|+||||+.+|+|.+++.. ..++...+..++.||+.||.|||++||+||||||+||||+.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 9999999999999999999999864 34688999999999999999999999999999999999999999
Q ss_pred EEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 468 VKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 468 vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+||+|||+++...... ...++..+|||||||++|+|++ |..||.+.
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 9999999998543221 1234567899999999999999 89999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=287.92 Aligned_cols=187 Identities=24% Similarity=0.343 Sum_probs=159.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccch---hHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ---AKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~---~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.+.++|++++.||+|+||.||+|++ .++..||||++........ .......+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 4567899999999999999999997 6889999999875432111 01122345689999999999999999999999
Q ss_pred CCeEEEEEeccccC-CHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 402 ESKLYIFLELVTKG-SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 402 ~~~l~LVmEy~~gG-sL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
.+.+|+||||+.+| +|..++... .+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999777 999998765 6999999999999999999999999999999999999999999999999999876
Q ss_pred ccCC------------------CcCc-ceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 480 LSSL------------------DFDL-LLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 480 ~~~~------------------~~~~-~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.... ...+ +..+|||||||++|+|++|..||..
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 4331 1122 4578999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=286.04 Aligned_cols=178 Identities=27% Similarity=0.390 Sum_probs=152.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 403 (514)
.+.+.|++++.||+|+||.||+|.+ .+++.||+|++..... ...+|+.++..+ +||||+++++++.+..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 4567899999999999999999998 5789999999875322 123677777777 7999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC----CcEEEEeccCcee
Q 010231 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLADFGLAKV 478 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~----g~vKI~DFGlAk~ 478 (514)
.+|+||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++.
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999999998865 458999999999999999999999999999999999998543 3599999999997
Q ss_pred cccCCC-------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 479 FLSSLD-------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 479 ~~~~~~-------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+..... ..++..+|||||||++|+|++|..||.+
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 643311 1134578999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.87 Aligned_cols=185 Identities=27% Similarity=0.417 Sum_probs=145.2
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-- 402 (514)
.+.++|++++.||+|+||.||+|.+ .+|+.||||++.... ........+.+|+.+++.++|+||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 4567999999999999999999997 688999999886422 2233456788999999999999999999998654
Q ss_pred ----CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 403 ----~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
..+|+||||+ +++|.+++....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred cccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 5689999999 67999998888899999999999999999999999999999999999999999999999999986
Q ss_pred cccC-----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 479 FLSS-----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 479 ~~~~-----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.... ....++..+|||||||++|+|++|++||.+.+
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5322 11345678999999999999999999998753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.37 Aligned_cols=185 Identities=25% Similarity=0.389 Sum_probs=156.2
Q ss_pred ccceEeeeeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~ 402 (514)
.++|+++++||+|+||.||+|++ .+++.||||+++...... .......+.+|+.+++.+ .|+||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-hhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 57899999999999999999987 478999999986422110 011123456789999999 699999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
..+||||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 999999999999999998865 5699999999999999999999999999999999999999999999999999986532
Q ss_pred CC----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 482 SL----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 482 ~~----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ...++..+|||||||++|+|++|+.||...
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 11 123456789999999999999999999753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=275.12 Aligned_cols=179 Identities=21% Similarity=0.296 Sum_probs=156.1
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 404 (514)
+.++|++++.||+|+||.||+|.+ .+++.||+|++..... ...+.+|+.++..+ +|+||+++++++.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 456899999999999999999997 7899999998864322 13467899999999 79999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc-----EEEEeccCce
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK 477 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~-----vKI~DFGlAk 477 (514)
.|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+|||+++
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 8999999975 35899999999999999999999999999999999999987776 9999999998
Q ss_pred ecccCCC--------------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 478 VFLSSLD--------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 478 ~~~~~~~--------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+..... ..++..+|||||||++|+|++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 7653311 23456789999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=270.22 Aligned_cols=183 Identities=14% Similarity=0.194 Sum_probs=157.2
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC--Ce
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--~~ 404 (514)
..++|++.+.||+|+||.||+|.+. +..||+|++...... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS---TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCC---HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccC---HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 3568999999999999999999985 888999998753322 23446788999999999999999999999877 78
Q ss_pred EEEEEeccccCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 405 LYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~~---lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
+++||||+++|+|.+++.... +++..+..|+.||+.||.|||++| |+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999999997653 899999999999999999999999 999999999999999999999999887654
Q ss_pred ccCCC-----------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSSLD-----------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~~~-----------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..... ..++.++|||||||++|+|++|+.||.+.
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 164 QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 32211 11222699999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=280.91 Aligned_cols=187 Identities=24% Similarity=0.370 Sum_probs=154.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEeccccc---chhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~---~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.+.++|.+++.||+|+||.||+|.+ .+++.||||++...... .........+.+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 3457899999999999999999998 57899999998643211 1112223457899999999999999999999876
Q ss_pred CCeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc---EEEEeccCce
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK 477 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~---vKI~DFGlAk 477 (514)
.. +|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+|||+++
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 55 8999999999999998865 46899999999999999999999999999999999999987664 9999999998
Q ss_pred ecccC---------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 478 VFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 478 ~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+... ....++..+|||||||++|+|++|..||.+.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 76432 1234556899999999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-33 Score=284.98 Aligned_cols=190 Identities=23% Similarity=0.382 Sum_probs=164.1
Q ss_pred ccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEeccccc---chhHHHHHHHHHHHHHHhhc-CCCceeEEEEE
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRF-EHENIVQYYGT 398 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~---~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~ 398 (514)
+..+.++|++.+.||+|+||.||+|.+ .+|+.||||++...... .........+.+|+.+++.+ .||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 345567899999999999999999998 57999999998754321 12233456788999999999 79999999999
Q ss_pred ecCCCeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCce
Q 010231 399 DKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (514)
Q Consensus 399 ~~~~~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk 477 (514)
+.....+|+||||+.+++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++.
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 9999999999999999999998875 469999999999999999999999999999999999999999999999999998
Q ss_pred ecccCC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 478 VFLSSL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 478 ~~~~~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+.... ...++..+|||||||++|+|++|..||.+.
T Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 754321 113556799999999999999999999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=279.72 Aligned_cols=184 Identities=26% Similarity=0.409 Sum_probs=143.7
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...++|++++.||+|+||.||+|.+ .+++.||+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 3457899999999999999999998 578899999876422 12334567899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccC
Q 010231 405 LYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~---------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGl 475 (514)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999998863 3489999999999999999999999999999999999999999999999999
Q ss_pred ceecccCC-------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 476 AKVFLSSL-------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 476 Ak~~~~~~-------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+..+.... ...++..+|||||||++|+|++|..||.+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 87543210 023556889999999999999999999763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=286.89 Aligned_cols=177 Identities=27% Similarity=0.417 Sum_probs=148.8
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec-----
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----- 400 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~----- 400 (514)
..++|++++.||+|+||+||+|++ .+|+.||||++...... ..+|+.+++.++|+||+++++++.
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 356899999999999999999997 78999999988643221 237999999999999999999873
Q ss_pred ---------------------------------CCCeEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHH
Q 010231 401 ---------------------------------DESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGL 442 (514)
Q Consensus 401 ---------------------------------~~~~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL 442 (514)
....+++||||+++ +|.+++.. ..+++..++.|+.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 34458999999985 77766643 4699999999999999999
Q ss_pred HHHHHCCccccCCCCCCEEEc-CCCcEEEEeccCceecccCC-------------------CcCcceeehhhhHHHHHHH
Q 010231 443 KYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKVFLSSL-------------------DFDLLLIFSIFLNGCKFFL 502 (514)
Q Consensus 443 ~yLHs~gIIHRDLKP~NILId-~~g~vKI~DFGlAk~~~~~~-------------------~~~~~~~~DVwSlG~lLye 502 (514)
.|||++||+||||||+|||++ .++.+||+|||+|+.+.... ...++..+|||||||++|+
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 999999999999999999998 68999999999998753221 1235678999999999999
Q ss_pred HHhCCCCCCCC
Q 010231 503 IFLHVLIFRPP 513 (514)
Q Consensus 503 LltG~~PF~g~ 513 (514)
|++|++||.+.
T Consensus 235 ll~g~~pf~~~ 245 (383)
T 3eb0_A 235 LILGKPLFSGE 245 (383)
T ss_dssp HHHSSCSSCCS
T ss_pred HHhCCCCCCCC
Confidence 99999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=285.63 Aligned_cols=183 Identities=26% Similarity=0.359 Sum_probs=157.6
Q ss_pred cccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
....++|.+.+.||+|+||.||+|.+.++..||+|++...... .....+.+|+.+++.++|+||+++++++.....
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc----hHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 3446789999999999999999999888999999988643211 112257899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCCEEEcCCCcEEEEeccCc
Q 010231 405 LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ---DVVHRDIKCANILVDANGSVKLADFGLA 476 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~-----~lse~~v~~i~~QIl~gL~yLHs~---gIIHRDLKP~NILId~~g~vKI~DFGlA 476 (514)
.++||||+.+|+|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 99999999999999999754 288999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCC--------------------CcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 477 KVFLSSL--------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 477 k~~~~~~--------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
+.+.... ...++..+|||||||++|+|++|+.||.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 8764221 1233457899999999999999999995
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=276.31 Aligned_cols=183 Identities=28% Similarity=0.326 Sum_probs=149.7
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhh-cCCCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIv~l~~~~~~~~ 403 (514)
.+.++|+++++||+|+||+||+|++ .+++.||||++....... . .......|+..+.. ..|+||+++++++.+..
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP--K-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH--H-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh--H-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 3457899999999999999999998 489999999876432221 2 22334455555444 48999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+||||||+ +++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999999999 5688887765 3599999999999999999999999999999999999999999999999999987643
Q ss_pred CC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 482 SL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 482 ~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
.. ...++..+|||||||++|+|++|..||.+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp -----CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 12345678999999999999999776653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=272.84 Aligned_cols=181 Identities=24% Similarity=0.360 Sum_probs=157.0
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
...+.|++++.||+|+||.||+|.+.++..||+|.+..... ....+.+|+.+++.++|+||+++++++.. +.+
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 34578999999999999999999998888999998864321 23567899999999999999999998864 568
Q ss_pred EEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999999998653 6999999999999999999999999999999999999999999999999999876432
Q ss_pred CC--------------------cCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 LD--------------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 ~~--------------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.. ..++..+|||||||++|+|++ |+.||.+.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 10 123346899999999999999 99999764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=282.77 Aligned_cols=183 Identities=26% Similarity=0.453 Sum_probs=154.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC----
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---- 401 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~---- 401 (514)
..++|++++.||+|+||.||+|++ .+++.||+|++....... .....+.+|+.+++.++|+||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc---cchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 357899999999999999999998 688999999886533222 122456789999999999999999998876
Q ss_pred ----CCeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccC
Q 010231 402 ----ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (514)
Q Consensus 402 ----~~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGl 475 (514)
.+.+|+||||+.+ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4578999999986 67666654 4699999999999999999999999999999999999999999999999999
Q ss_pred ceecccC------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 476 AKVFLSS------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 476 Ak~~~~~------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|+.+... ....++..+|||||||++|+|++|.+||.+.
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9865311 0123567899999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-33 Score=288.22 Aligned_cols=180 Identities=21% Similarity=0.397 Sum_probs=154.1
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC--CCceeEEEEEecCCCeE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDESKL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~--HpnIv~l~~~~~~~~~l 405 (514)
...|++++.||+|+||+||+|.+.+++.||||++..... .......+.+|+.+|+.+. |+||+++++++...+.+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc---cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 457999999999999999999998899999999875432 2344577889999999996 59999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~ 484 (514)
||||| +.+++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+.....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999 567799998876 4588889999999999999999999999999999999995 68999999999986532210
Q ss_pred --------------------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 485 --------------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 485 --------------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
..++..+|||||||+||+|++|..||.+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 1355678999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=270.56 Aligned_cols=185 Identities=27% Similarity=0.412 Sum_probs=160.2
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|++++.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.+++.++|+||+++++++.....+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc--cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 357899999999999999999998 4899999999874221 1223346788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 999999999999998865 468999999999999999999999999999999999999999999999999998654321
Q ss_pred -----------------Cc-CcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 -----------------DF-DLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 -----------------~~-~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ..+..+|+|||||++|+|++|..||...
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 01 1246799999999999999999999764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=275.84 Aligned_cols=180 Identities=27% Similarity=0.418 Sum_probs=153.2
Q ss_pred ccceEeeeeecccCceeEEEEE----c-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~----~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.++|++++.||+|+||.||+|+ + .+++.||+|++.... .......+.+|+.+++.++|+||+++++++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 4579999999999999999998 2 578999999987432 122346788999999999999999999998876
Q ss_pred --CeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 403 --SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 403 --~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 679999999999999999854 3589999999999999999999999999999999999999999999999999987
Q ss_pred cccCCC----------------------cCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 479 FLSSLD----------------------FDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 479 ~~~~~~----------------------~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
+..... ..++..+|||||||++|+|++|+.||.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 643311 123346899999999999999998864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=278.81 Aligned_cols=187 Identities=25% Similarity=0.397 Sum_probs=159.2
Q ss_pred cccccccceEeeeeecccCceeEEEEEcc-CC-----ceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEE
Q 010231 323 RFKRIITYWQKGDLLGRGSFGSVYEGISD-DG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY 395 (514)
Q Consensus 323 ~~~~~~~~Y~i~~~LG~GsfG~Vyka~~~-~g-----~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l 395 (514)
.+....++|++++.||+|+||.||+|.+. ++ ..||+|.+.... .......+.+|+.+++.+ +||||+++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~ 115 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEALMSELKIMSHLGQHENIVNL 115 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----ChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 34444678999999999999999999873 23 479999886432 123456788999999999 89999999
Q ss_pred EEEecCCCeEEEEEeccccCCHHHHHhhc---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCE
Q 010231 396 YGTDKDESKLYIFLELVTKGSLLNLYQRY---------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460 (514)
Q Consensus 396 ~~~~~~~~~l~LVmEy~~gGsL~~lL~~~---------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI 460 (514)
++++...+.+|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI 195 (333)
T 2i1m_A 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195 (333)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGC
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceE
Confidence 99999999999999999999999988642 478899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 461 LVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 461 LId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
||+.++.+||+|||+++.+.... ...++..+|||||||++|+|++ |..||.+.
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999998653321 1234567899999999999998 99999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-33 Score=275.47 Aligned_cols=183 Identities=27% Similarity=0.395 Sum_probs=158.0
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.+.|.+++.||+|+||.||+|++ .+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 3457899999999999999999998 5789999999874321 123467899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE---cCCCcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI---d~~g~vKI~DFGlAk~~~ 480 (514)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999999988764 568999999999999999999999999999999999999 778999999999998644
Q ss_pred cC-----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SS-----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~-----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ....++..+|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 32 1233556899999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=292.49 Aligned_cols=183 Identities=17% Similarity=0.210 Sum_probs=148.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHH---HHHhhcCCCceeEEE-------
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYY------- 396 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei---~iL~~L~HpnIv~l~------- 396 (514)
.++|++++.||+|+||+||+|++ .+|+.||||++....... ....+.+.+|+ .+++.++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC--TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc--hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 56899999999999999999998 679999999987432222 22346788999 555666899999988
Q ss_pred EEecCCC-----------------eEEEEEeccccCCHHHHHhhc-CCCH-------HHHHHHHHHHHHHHHHHHHCCcc
Q 010231 397 GTDKDES-----------------KLYIFLELVTKGSLLNLYQRY-HLRD-------SQVSAYTRQILLGLKYLHDQDVV 451 (514)
Q Consensus 397 ~~~~~~~-----------------~l~LVmEy~~gGsL~~lL~~~-~lse-------~~v~~i~~QIl~gL~yLHs~gII 451 (514)
+++.+.+ ..||||||+ +|+|.+++... .+++ ..+..|+.||+.||.|||++||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 5555443 389999999 57999998753 3444 67778999999999999999999
Q ss_pred ccCCCCCCEEEcCCCcEEEEeccCceecccCC---------------Cc-----------CcceeehhhhHHHHHHHHHh
Q 010231 452 HRDIKCANILVDANGSVKLADFGLAKVFLSSL---------------DF-----------DLLLIFSIFLNGCKFFLIFL 505 (514)
Q Consensus 452 HRDLKP~NILId~~g~vKI~DFGlAk~~~~~~---------------~~-----------~~~~~~DVwSlG~lLyeLlt 505 (514)
||||||+||||+.++.+||+|||+|+...... .. .++.++|||||||+||+|++
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence 99999999999999999999999998644211 01 46678999999999999999
Q ss_pred CCCCCCCC
Q 010231 506 HVLIFRPP 513 (514)
Q Consensus 506 G~~PF~g~ 513 (514)
|+.||.+.
T Consensus 309 g~~Pf~~~ 316 (377)
T 3byv_A 309 ADLPITKD 316 (377)
T ss_dssp SSCCC---
T ss_pred CCCCCccc
Confidence 99999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=276.29 Aligned_cols=182 Identities=26% Similarity=0.433 Sum_probs=156.7
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..+.|++++.||+|+||.||+|.+ .++..||+|++.... ......+.+|+.+++.++||||+++++++...+.+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 457899999999999999999998 568999999886432 22346788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-
Q 010231 406 YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~- 482 (514)
|+||||+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999998864 56999999999999999999999999999999999999999999999999987532110
Q ss_pred -----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|..||...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 1234556899999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=278.98 Aligned_cols=180 Identities=31% Similarity=0.460 Sum_probs=156.5
Q ss_pred cceEeeeeecccCceeEEEEEc-----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC--
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-- 401 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~-- 401 (514)
++|++++.||+|+||+||++.+ .+++.||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA----GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc----ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 3569999999999999988864 378999999987432 23445678899999999999999999999876
Q ss_pred CCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
...+|+||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred CceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 46899999999999999999988899999999999999999999999999999999999999999999999999987653
Q ss_pred CCC----------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 482 SLD----------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 482 ~~~----------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
... ..++..+|||||||++|+|++|+.||..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 311 1233467999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=272.62 Aligned_cols=184 Identities=28% Similarity=0.407 Sum_probs=156.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEe--cCCC
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--KDES 403 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~--~~~~ 403 (514)
..++|++++.||+|+||.||++.+ .+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 357899999999999999999998 57899999998753322 23456788999999999999999999977 4567
Q ss_pred eEEEEEeccccCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCCEEEcCCCcEEEEec
Q 010231 404 KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADF 473 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~-----~lse~~v~~i~~QIl~gL~yLHs~g-----IIHRDLKP~NILId~~g~vKI~DF 473 (514)
.+|+||||+++++|.+++... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 899999999999999998653 3899999999999999999999999 999999999999999999999999
Q ss_pred cCceecccCC-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 474 GLAKVFLSSL-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 474 GlAk~~~~~~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|+++.+.... ...++..+|||||||++|+|++|..||.+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 9997654321 123456799999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=283.89 Aligned_cols=181 Identities=23% Similarity=0.386 Sum_probs=148.7
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceE----EEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~v----AIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.++|+++++||+|+||.||+|.+ .+++.+ ++|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC----SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc----cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 46899999999999999999997 456655 55554321 1222346788999999999999999999999875
Q ss_pred CeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
. .++||+|+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4 8899999999999999875 358999999999999999999999999999999999999999999999999998653
Q ss_pred cCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 481 SSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 481 ~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
... ...++..+|||||||++|+|++ |..||.+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 221 1234567899999999999999 99999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-33 Score=275.90 Aligned_cols=181 Identities=27% Similarity=0.492 Sum_probs=153.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
...+.|++++.||+|+||.||+|.+ .+|+.||+|.+.... ....+.+|+.+++.++|+||+++++++...+.
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 4456899999999999999999998 568999999987532 13457889999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+|+||||+.+++|.+++. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999999999986 356999999999999999999999999999999999999999999999999999865432
Q ss_pred C-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 L-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ...++..+|||||||++|+|++|..||...
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1 123456789999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=271.77 Aligned_cols=184 Identities=24% Similarity=0.365 Sum_probs=155.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchh--HHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA--KQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~--~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.++|++.+.||+|+||+||+|++ .+++.||+|.+......... ....+.+.+|+.+++.++|+||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46899999999999999999998 68899999988653322211 112267889999999999999999999998766
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEcCCCc-----EEEEeccC
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGS-----VKLADFGL 475 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId~~g~-----vKI~DFGl 475 (514)
++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++. +||+|||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 799999999999988754 35899999999999999999999999 999999999999988776 99999999
Q ss_pred ceecccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 476 AKVFLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 476 Ak~~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
++..... ....++..+|||||||++|+|++|+.||.+.
T Consensus 176 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp CBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 9754322 1122345789999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=271.20 Aligned_cols=183 Identities=27% Similarity=0.451 Sum_probs=157.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC----C
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----E 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----~ 402 (514)
..+|.+.+.||+|+||.||+|.+ .++..||+|.+...... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC---HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 45789999999999999999998 67889999998753322 3345778899999999999999999998754 4
Q ss_pred CeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEc-CCCcEEEEeccCcee
Q 010231 403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAKV 478 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId-~~g~vKI~DFGlAk~ 478 (514)
..+|+||||+.+++|.+++.. ..+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 669999999999999999976 56899999999999999999999999 99999999999998 789999999999975
Q ss_pred cccCC----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSL----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..... ...++..+|||||||++|+|++|..||.+.
T Consensus 182 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 182 KRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 43221 123456889999999999999999999763
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=281.71 Aligned_cols=187 Identities=26% Similarity=0.414 Sum_probs=155.1
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEeccccc------chhHHHHHHHHHHHHHHhhcCCCceeEEEEEe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG------SQAKQSISQLEQEIALLSRFEHENIVQYYGTD 399 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~------~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~ 399 (514)
.+.+.|.+++.||+|+||.||+|.+.++..||||++...... .......+.+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 456789999999999999999999988999999998643221 12233457789999999999999999999988
Q ss_pred -----cCCCeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEe
Q 010231 400 -----KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (514)
Q Consensus 400 -----~~~~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~D 472 (514)
.....+|+||||+.+ +|.+++... .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 445579999999985 787777654 589999999999999999999999999999999999999999999999
Q ss_pred ccCceecccC-------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 473 FGLAKVFLSS-------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 473 FGlAk~~~~~-------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
||+++..... ....++..+|||||||++|+|++|+.||.+.
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999754322 1134567799999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=293.86 Aligned_cols=179 Identities=25% Similarity=0.374 Sum_probs=155.6
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-eE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-KL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~-~l 405 (514)
..++|++++.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|++++||||+++++++.... .+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 4578999999999999999999875 6799999987422 2356889999999999999999999876654 79
Q ss_pred EEEEeccccCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 406 YIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~---lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
||||||+.+|+|.+++...+ ++...+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999999997643 688999999999999999999999999999999999999999999999999865432
Q ss_pred C----------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 L----------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 ~----------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
. ...++.++|||||||+||+|++ |+.||.+.
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 390 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 2345568999999999999998 99999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=273.27 Aligned_cols=185 Identities=29% Similarity=0.475 Sum_probs=152.6
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|++.+.||+|+||.||+|.+ .++..||+|++...... .......+.+|+.+++.++|+||+++++++...+.+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 356899999999999999999997 67899999998753322 234456788999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 406 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998864 358999999999999999999999999999999999999999999999999997654
Q ss_pred cC-------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SS-------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~-------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ....+...+|||||||++|+|++|..||.+.
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 32 1223456889999999999999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=275.50 Aligned_cols=182 Identities=27% Similarity=0.478 Sum_probs=154.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecC--
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD-- 401 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~-- 401 (514)
...+.|++++.||+|+||.||+|++ .+++.||+|++..... ....+.+|+.+++.+ +|+||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 4467899999999999999999998 6889999999875322 124677899999998 79999999999865
Q ss_pred ----CCeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEecc
Q 010231 402 ----ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 402 ----~~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFG 474 (514)
...+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 5689999999999999999875 468999999999999999999999999999999999999999999999999
Q ss_pred CceecccCC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 475 LAKVFLSSL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 475 lAk~~~~~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
++..+.... ...++..+|||||||++|+|++|..||.+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 998653220 233456789999999999999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=271.86 Aligned_cols=181 Identities=22% Similarity=0.352 Sum_probs=154.4
Q ss_pred ccceEeee-eecccCceeEEEEEc---cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~-~LG~GsfG~Vyka~~---~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.++|.+.+ .||+|+||.||+|.+ .++..||+|++.... .....+.+.+|+.+++.++||||+++++++. .+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc----chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence 35666666 999999999999986 367889999987532 2344577889999999999999999999984 56
Q ss_pred eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 69999999999999999854 4589999999999999999999999999999999999999999999999999987643
Q ss_pred CCC----------------------cCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SLD----------------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~~----------------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
... ..++..+|||||||++|+|++ |+.||.+.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 211 223457899999999999998 99999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=280.32 Aligned_cols=182 Identities=24% Similarity=0.400 Sum_probs=154.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceE--EEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~v--AIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 403 (514)
.++|++.+.||+|+||.||+|++ .++..+ |+|.+.... .......+.+|+.+++.+ +||||+++++++.+.+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc----chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 36899999999999999999998 456644 888876422 223345688999999999 8999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC
Q 010231 404 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g 466 (514)
.+|+||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999999999998754 489999999999999999999999999999999999999999
Q ss_pred cEEEEeccCceecccCC------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 467 SVKLADFGLAKVFLSSL------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 467 ~vKI~DFGlAk~~~~~~------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.+||+|||+++...... ...++..+|||||||++|+|++ |..||.+.
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 99999999997432110 1223567899999999999998 99999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=275.21 Aligned_cols=180 Identities=24% Similarity=0.417 Sum_probs=151.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEe------
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTD------ 399 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~------ 399 (514)
..+|++.++||+|+||.||+|.+ .+++.||+|.+... .......+.+|+.++..+. ||||+++++++
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 45899999999999999999997 58899999988542 2334567889999999996 99999999988
Q ss_pred --cCCCeEEEEEeccccCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEcCCCcEEEE
Q 010231 400 --KDESKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLA 471 (514)
Q Consensus 400 --~~~~~l~LVmEy~~gGsL~~lL~~----~~lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId~~g~vKI~ 471 (514)
.....+|+||||+. |+|.+++.. ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 44556899999997 588887754 45999999999999999999999999 9999999999999999999999
Q ss_pred eccCceecccC----------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 472 DFGLAKVFLSS----------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 472 DFGlAk~~~~~----------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|||+++.+... ....++..+|||||||++|+|++|+.||...
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 99999865321 1223456889999999999999999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=275.64 Aligned_cols=184 Identities=24% Similarity=0.348 Sum_probs=156.9
Q ss_pred ccccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT 398 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~ 398 (514)
...++|++++.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.++..+ +||||++++++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 3457899999999999999999974 467899999987422 223446788999999999 79999999999
Q ss_pred ecCCC-eEEEEEeccccCCHHHHHhhcC-----------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCE
Q 010231 399 DKDES-KLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460 (514)
Q Consensus 399 ~~~~~-~l~LVmEy~~gGsL~~lL~~~~-----------------lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI 460 (514)
+...+ .+|+||||+.+++|.+++.... +++..+..++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87654 5999999999999999997643 78889999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 461 LVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 461 LId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
||+.++.+||+|||+++.+.... ...++..+|||||||++|+|++ |..||.+.
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999998653321 1234567899999999999998 99999764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=275.21 Aligned_cols=179 Identities=22% Similarity=0.315 Sum_probs=153.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec----CC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----DE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~----~~ 402 (514)
.++|++++.||+|+||.||++.+ .+++.||+|++... .......+.+|+.+++.++||||+++++++. ..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 46899999999999999999998 78899999988642 2334567889999999999999999999886 44
Q ss_pred CeEEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCce
Q 010231 403 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk 477 (514)
..+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 579999999999999998865 458999999999999999999999999999999999999999999999999987
Q ss_pred eccc-------------------------CC------CcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 478 VFLS-------------------------SL------DFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 478 ~~~~-------------------------~~------~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
.... +. ...++..+|||||||++|+|++|+.||.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 5421 10 1113568899999999999999999995
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=300.33 Aligned_cols=183 Identities=25% Similarity=0.380 Sum_probs=159.5
Q ss_pred ccccceEeeeeecccCceeEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.....|++.+.||+|+||.||+|.+. ++..||||.++.... ..+.+.+|+.+|+.++||||+++++++.....
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc------chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 34568999999999999999999984 588999998864221 24568899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
+||||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999999999975 3488999999999999999999999999999999999999999999999999987643
Q ss_pred CCC--------------------cCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 482 SLD--------------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 482 ~~~--------------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
... ..++.++|||||||+||+|++ |..||.+.+
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 210 123457899999999999999 999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.35 Aligned_cols=179 Identities=25% Similarity=0.354 Sum_probs=148.9
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-----
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----- 401 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----- 401 (514)
...+|.++++||+|+||+||+|++..+..+|+|++...... ..+|+.+++.++|+||+++++++..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 35689999999999999999999976667999988642211 1369999999999999999998843
Q ss_pred -CCeEEEEEeccccCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc-CCCcEEEEeccC
Q 010231 402 -ESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGL 475 (514)
Q Consensus 402 -~~~l~LVmEy~~gGsL~~lL~----~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId-~~g~vKI~DFGl 475 (514)
...+|+||||+.++.+..+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+
T Consensus 109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 334899999999864443332 34689999999999999999999999999999999999999 799999999999
Q ss_pred ceecccCC-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 476 AKVFLSSL-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 476 Ak~~~~~~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
|+.+.... ...++..+|||||||++|+|++|++||.+.+
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98753221 1246678999999999999999999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.66 Aligned_cols=186 Identities=27% Similarity=0.447 Sum_probs=152.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEe--cCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--KDE 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~--~~~ 402 (514)
++.++|++++.||+|+||.||++.+ .++..||+|++...... ........+.+|+.+++.++|+||+++++++ ...
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH-HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc-ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence 3467899999999999999999998 67889999998742211 1122346788999999999999999999988 455
Q ss_pred CeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..+|+||||+.++ |.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 6899999999987 6666653 46899999999999999999999999999999999999999999999999999875
Q ss_pred ccCC-----------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 480 LSSL-----------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 480 ~~~~-----------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ....+..+|||||||++|+|++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 4210 111245789999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=273.67 Aligned_cols=181 Identities=24% Similarity=0.339 Sum_probs=155.7
Q ss_pred ccccceEeeeeecccCceeEEEEEc--cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc------eeEEEE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN------IVQYYG 397 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~--~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn------Iv~l~~ 397 (514)
.+.++|++++.||+|+||+||+|.+ .+++.||+|++... ......+.+|+.+++.++|++ |+++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 3457899999999999999999987 47889999998632 233466788999998887654 999999
Q ss_pred EecCCCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC----------
Q 010231 398 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---------- 464 (514)
Q Consensus 398 ~~~~~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~---------- 464 (514)
++...+.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 999999999999999 78999988764 4889999999999999999999999999999999999987
Q ss_pred ---------CCcEEEEeccCceecccCC----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 465 ---------NGSVKLADFGLAKVFLSSL----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 465 ---------~g~vKI~DFGlAk~~~~~~----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
++.+||+|||+++...... ...++..+|||||||++|+|++|..||.+.
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 6789999999998754321 234566899999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=288.86 Aligned_cols=177 Identities=28% Similarity=0.433 Sum_probs=147.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----- 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----- 401 (514)
...|+++++||+|+||.||+|++ .+++.||||++..... ...+|+.+|+.++|+||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 45799999999999999999998 5799999998864221 12379999999999999999988732
Q ss_pred -CCeEEEEEeccccCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC-CcEEEEecc
Q 010231 402 -ESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFG 474 (514)
Q Consensus 402 -~~~l~LVmEy~~gGsL~~lL~-----~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~-g~vKI~DFG 474 (514)
..++++||||+.+ +|..++. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 2347899999987 5655543 2468999999999999999999999999999999999999965 578999999
Q ss_pred CceecccCC-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 475 LAKVFLSSL-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 475 lAk~~~~~~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
+|+.+.... ...++..+|||||||+||+|++|++||.+.+
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 998753221 1245678899999999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=272.40 Aligned_cols=180 Identities=24% Similarity=0.388 Sum_probs=148.4
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|+++++||+|+||.||+|.+.. .+|+|+++.... .....+.+.+|+.+++.++|+||+++++++ ....+++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 4689999999999999999998754 499998875432 234457788999999999999999999965 4567899
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9999999999999854 45899999999999999999999999999999999999999999999999999754321
Q ss_pred ---------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|+.||.+.
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 0233455789999999999999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=269.07 Aligned_cols=182 Identities=23% Similarity=0.340 Sum_probs=146.3
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|++++.||+|+||+||+|.+ .+++.||+|++..... .......+.++..+++.++||||+++++++...+.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C---HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC---cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 357899999999999999999998 6899999999864321 222334455566668889999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 406 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999986 78776643 4699999999999999999999998 9999999999999999999999999999764
Q ss_pred ccC----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 480 LSS----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 480 ~~~----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
... ....++..+|||||||++|+|++|..||..
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 322 122345678999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=273.75 Aligned_cols=184 Identities=26% Similarity=0.382 Sum_probs=149.3
Q ss_pred cccceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
..++|.+++.||+|+||.||+|.+. ++..||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS---SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc---chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3568999999999999999999763 456899998864322 233456788999999999999999999998765
Q ss_pred C-----eEEEEEeccccCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEE
Q 010231 403 S-----KLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 403 ~-----~l~LVmEy~~gGsL~~lL~~-------~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI 470 (514)
. ..|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 4 45999999999999998842 35899999999999999999999999999999999999999999999
Q ss_pred EeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 471 ADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 471 ~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+|||+++.+.... ...++..+|||||||++|+|++ |..||.+.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 9999998653221 1234557899999999999999 99999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=271.03 Aligned_cols=180 Identities=22% Similarity=0.312 Sum_probs=148.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEE-EecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG-TDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~-~~~~~~ 403 (514)
.+.++|++++.||+|+||.||+|++ .+++.||+|++...... ..+.+|+.+++.+.|++++..+. ++...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-------CCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-------hHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence 3457899999999999999999997 78899999987643221 24678999999998877666554 456778
Q ss_pred eEEEEEeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE---cCCCcEEEEeccCcee
Q 010231 404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKV 478 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI---d~~g~vKI~DFGlAk~ 478 (514)
..++||||+ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 899999999 889999987 3569999999999999999999999999999999999999 7899999999999987
Q ss_pred cccCCC--------------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSLD--------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~~--------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+..... ..++..+|||||||++|+|++|+.||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence 643211 23445789999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=271.42 Aligned_cols=182 Identities=24% Similarity=0.380 Sum_probs=152.7
Q ss_pred ccceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEe-cCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~-~~~ 402 (514)
...|++.++||+|+||.||+|.+. ....+|+|.+.... .....+.+.+|+.+++.++||||+++++++ ...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC----CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 457999999999999999999863 23367888876422 234456788999999999999999999985 556
Q ss_pred CeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
+..|+||||+.+|+|.+++.. ..++...+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 688999999999999999965 358899999999999999999999999999999999999999999999999998653
Q ss_pred cCC-----------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 481 SSL-----------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 481 ~~~-----------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
... ...++.++|||||||++|+|++ +.+||.+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 221 1234557899999999999999 77777654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=270.20 Aligned_cols=180 Identities=24% Similarity=0.404 Sum_probs=151.2
Q ss_pred cceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
-.|.+.++||+|+||+||+|.+. ++..+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT----EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc----cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 36888999999999999999862 33478999886422 23445778899999999999999999999987665
Q ss_pred E-EEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 405 L-YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 405 l-~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
. ++||||+.+++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 5 999999999999999975 4588999999999999999999999999999999999999999999999999975432
Q ss_pred C-----------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 482 S-----------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 482 ~-----------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
. ....++..+|||||||++|+|++ +.+||..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~ 231 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc
Confidence 1 11234567899999999999999 5555544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=292.41 Aligned_cols=187 Identities=22% Similarity=0.358 Sum_probs=153.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc---hhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~---~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.+.++|.+.+.||+|+||+||+|.+ .+++.||+|++....... ........+.+|+.+|+.++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567899999999999999999988 678999999987533211 112223357899999999999999999999864
Q ss_pred CCeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC---cEEEEeccCce
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAK 477 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g---~vKI~DFGlAk 477 (514)
..+||||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 568999999999999887754 4699999999999999999999999999999999999997654 59999999998
Q ss_pred ecccCC---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 478 VFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 478 ~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+.... ...++..+|||||||++|+|++|.+||.+.
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 654321 123456889999999999999999999763
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=288.61 Aligned_cols=182 Identities=21% Similarity=0.313 Sum_probs=155.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc------CCCceeEEEEE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF------EHENIVQYYGT 398 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L------~HpnIv~l~~~ 398 (514)
.+..+|+++++||+|+||.||+|.+ .+++.||||++... ......+.+|+.+++.+ .|+||++++++
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 3456899999999999999999988 57899999998642 22335566788887776 57799999999
Q ss_pred ecCCCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc--EEEEec
Q 010231 399 DKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADF 473 (514)
Q Consensus 399 ~~~~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~--vKI~DF 473 (514)
+...+.+||||||+. ++|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999999996 5899888764 3899999999999999999999999999999999999999987 999999
Q ss_pred cCceecccCC----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 474 GLAKVFLSSL----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 474 GlAk~~~~~~----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
|+|+...... ...++..+|||||||+||+|++|.+||.+.+
T Consensus 247 G~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 247 GSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9997654331 1245678999999999999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-32 Score=273.93 Aligned_cols=172 Identities=26% Similarity=0.373 Sum_probs=143.8
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhh--cCCCceeEEEEEecCC-
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDE- 402 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIv~l~~~~~~~- 402 (514)
.+.++|++++.||+|+||.||+|.+. +..||||++.... .....+|..++.. ++|+||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 45678999999999999999999876 8899999986321 1223344555544 4899999999998776
Q ss_pred ---CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCCEEEcCCCcEEEE
Q 010231 403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLA 471 (514)
Q Consensus 403 ---~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~--------gIIHRDLKP~NILId~~g~vKI~ 471 (514)
..+|+||||+.+|+|.++++...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999988999999999999999999999999 99999999999999999999999
Q ss_pred eccCceecccCCCc-----------------------Ccce------eehhhhHHHHHHHHHhC
Q 010231 472 DFGLAKVFLSSLDF-----------------------DLLL------IFSIFLNGCKFFLIFLH 506 (514)
Q Consensus 472 DFGlAk~~~~~~~~-----------------------~~~~------~~DVwSlG~lLyeLltG 506 (514)
|||+|+.+...... .... .+|||||||++|+|++|
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 99999765332110 1111 27999999999999999
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=272.78 Aligned_cols=181 Identities=27% Similarity=0.400 Sum_probs=155.0
Q ss_pred eEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEe
Q 010231 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE 410 (514)
|..++.||+|+||.||+|.+ ++..||+|++...... ......+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI-TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTS-CTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE-CCceEEEEEEecccCc-chHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44568999999999999987 5789999988643221 223345678899999999999999999999999999999999
Q ss_pred ccccCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC--
Q 010231 411 LVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD-- 484 (514)
Q Consensus 411 y~~gGsL~~lL~~----~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~-- 484 (514)
|+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999863 3489999999999999999999999999999999999999999999999999986543211
Q ss_pred ------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 485 ------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 485 ------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
..++..+|||||||++|+|++|..||.+.
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 237 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEH 237 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred cccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccC
Confidence 12345789999999999999999999764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=275.99 Aligned_cols=180 Identities=29% Similarity=0.415 Sum_probs=156.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec--
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-- 400 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~-- 400 (514)
.++|++++.||+|+||.||+|++ .++..||+|++... .....+.+.+|+.+++.++|+||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 36899999999999999999983 57899999998642 2334467889999999999999999999875
Q ss_pred CCCeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 401 DESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
....+|+||||+.+++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 56679999999999999999875 3599999999999999999999999999999999999999999999999999987
Q ss_pred cccCCC----------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 479 FLSSLD----------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 479 ~~~~~~----------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+..... ..++..+|||||||++|+|++|+.||..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 643211 1234578999999999999999999854
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-32 Score=272.60 Aligned_cols=184 Identities=30% Similarity=0.496 Sum_probs=152.7
Q ss_pred ccccceEeeeeecccCceeEEEEEc--cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc---CCCceeEEEEEec
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDK 400 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~--~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIv~l~~~~~ 400 (514)
+..++|++++.||+|+||.||+|.+ .+++.||+|++......... ...+.+|+.+++.+ .||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC---CchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 4457899999999999999999997 46889999998753322111 12344666666555 8999999999886
Q ss_pred -----CCCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEe
Q 010231 401 -----DESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (514)
Q Consensus 401 -----~~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~D 472 (514)
....+|+||||+. |+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence 5678999999998 5999988763 389999999999999999999999999999999999999999999999
Q ss_pred ccCceecccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 473 FGLAKVFLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 473 FGlAk~~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
||+++.+... ....+...+|||||||++|+|++|..||.+.
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999865422 1133556799999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.62 Aligned_cols=181 Identities=28% Similarity=0.364 Sum_probs=155.6
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
...+.|++.+.||+|+||.||+|.+..+..||||.++.... ..+.+.+|+.+|+.++||||+++++++.. ..+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 34578999999999999999999998888899998874321 13568899999999999999999999876 678
Q ss_pred EEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 406 YIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
||||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999999964 35899999999999999999999999999999999999999999999999999865422
Q ss_pred C--------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 L--------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 ~--------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
. ...++.++|||||||+||+|++ |+.||.+.
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 1 1234567899999999999999 99999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=282.24 Aligned_cols=183 Identities=25% Similarity=0.416 Sum_probs=154.6
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
+.++|.+++.||+|+||.||+|.+ .+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc---chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 456899999999999999999998 6799999999874322 234456788999999999999999999999877654
Q ss_pred ------EEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 406 ------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 406 ------~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
|+||||+.+ +|..++. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 117 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 117 RNFYDFYLVMPFMQT-DLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp TTCCCCEEEEECCCE-EHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred ccceeEEEEEccccc-cHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 999999985 7887764 35999999999999999999999999999999999999999999999999999865
Q ss_pred ccCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 480 LSSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 480 ~~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.... ...++..+|||||||++|+|++|..||.+.+
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 195 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 1345678999999999999999999998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=289.73 Aligned_cols=180 Identities=30% Similarity=0.463 Sum_probs=143.3
Q ss_pred ccccceEe-eeeecccCceeEEEEEcc---CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEe--
Q 010231 326 RIITYWQK-GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-- 399 (514)
Q Consensus 326 ~~~~~Y~i-~~~LG~GsfG~Vyka~~~---~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~-- 399 (514)
++.+.|.+ +++||+|+||+||+|++. ++..||||++..... ...+.+|+.+|+.++||||+++++++
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLS 89 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-------CHHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-------CHHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence 44567777 668999999999999963 688999998864221 13467899999999999999999998
Q ss_pred cCCCeEEEEEeccccCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE----cCC
Q 010231 400 KDESKLYIFLELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DAN 465 (514)
Q Consensus 400 ~~~~~l~LVmEy~~gGsL~~lL~~~----------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI----d~~ 465 (514)
.....+||||||+.+ +|.+++... .+++..++.|+.||+.||.|||++||+||||||+|||| +.+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 557889999999976 777766421 38999999999999999999999999999999999999 677
Q ss_pred CcEEEEeccCceecccC-----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 466 GSVKLADFGLAKVFLSS-----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 466 g~vKI~DFGlAk~~~~~-----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.+||+|||+|+.+... ....++..+|||||||++|+|++|++||.+.
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 89999999999865421 0123567899999999999999999999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=270.33 Aligned_cols=182 Identities=23% Similarity=0.368 Sum_probs=154.8
Q ss_pred ccceEeee-eecccCceeEEEEEc---cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~-~LG~GsfG~Vyka~~---~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.+.|.+.+ .||+|+||.||+|.+ .++..||+|++..... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 46789888 999999999999964 4578999999874321 223356788999999999999999999998 556
Q ss_pred eEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 789999999999999999764 4899999999999999999999999999999999999999999999999999876433
Q ss_pred CC----------------------cCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 LD----------------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 ~~----------------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.. ..++..+|||||||++|+|++ |..||.+.
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 11 123447899999999999999 99999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=268.64 Aligned_cols=182 Identities=26% Similarity=0.347 Sum_probs=153.4
Q ss_pred ccccceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
...++|.+.+.||+|+||.||+|++. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 34578999999999999999999863 34569999876422 22345678899999999999999999999875
Q ss_pred CCeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
. ..|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4 568999999999999999753 4899999999999999999999999999999999999999999999999999865
Q ss_pred ccCC--------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCC
Q 010231 480 LSSL--------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRP 512 (514)
Q Consensus 480 ~~~~--------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g 512 (514)
.... ...++..+|||||||++|+|++ |..||..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 4321 1234457899999999999998 9999965
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=277.33 Aligned_cols=177 Identities=25% Similarity=0.385 Sum_probs=144.9
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEe-----cCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-----KDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~-----~~~ 402 (514)
.++|++++.||+|+||.||+|++ +++.||||++..... .....+.++..+..++|+||+++++.+ ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 57899999999999999999976 688999999874211 111123444445568999999998743 334
Q ss_pred CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCCEEEcCCCcEEEEec
Q 010231 403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------DVVHRDIKCANILVDANGSVKLADF 473 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~---------gIIHRDLKP~NILId~~g~vKI~DF 473 (514)
..+||||||+++|+|.+++.....++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+||
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 4689999999999999999988889999999999999999999999 9999999999999999999999999
Q ss_pred cCceecccCCC----------------------------------cCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 474 GLAKVFLSSLD----------------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 474 GlAk~~~~~~~----------------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
|+++.+..... ..++.++|||||||++|+|++|..||.
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 99986542100 122246799999999999999976653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-32 Score=276.62 Aligned_cols=182 Identities=23% Similarity=0.362 Sum_probs=152.9
Q ss_pred ccceEeeeeecccCceeEEEEEccC-----CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDD-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~-----g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
...|.+.++||+|+||.||+|.+.. +..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 4589999999999999999998732 3469999886422 223345788999999999999999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
+.+||||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999999999875 358999999999999999999999999999999999999999999999999998654
Q ss_pred cCC----------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 481 SSL----------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 481 ~~~----------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
... ...++..+|||||||++|+|++ |..||.+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 321 1234457899999999999998 99999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=282.81 Aligned_cols=183 Identities=13% Similarity=0.096 Sum_probs=138.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc--CCCceeEEEE-------
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF--EHENIVQYYG------- 397 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L--~HpnIv~l~~------- 397 (514)
...|++++.||+|+||+||+|++ .+++.||||++...... .......+.+|+.++..+ +||||++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN--SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT--HHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc--cccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 34699999999999999999997 58999999999864322 234456677885544444 6999888653
Q ss_pred EecCC-----------------CeEEEEEeccccCCHHHHHhhc--CCCHHHH------HHHHHHHHHHHHHHHHCCccc
Q 010231 398 TDKDE-----------------SKLYIFLELVTKGSLLNLYQRY--HLRDSQV------SAYTRQILLGLKYLHDQDVVH 452 (514)
Q Consensus 398 ~~~~~-----------------~~l~LVmEy~~gGsL~~lL~~~--~lse~~v------~~i~~QIl~gL~yLHs~gIIH 452 (514)
++... ..+||||||+. |+|.+++... .+..... ..++.||+.||.|||++||+|
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 33211 34899999999 7999999753 3444444 567799999999999999999
Q ss_pred cCCCCCCEEEcCCCcEEEEeccCceecccCC----------------C--cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 453 RDIKCANILVDANGSVKLADFGLAKVFLSSL----------------D--FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 453 RDLKP~NILId~~g~vKI~DFGlAk~~~~~~----------------~--~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|||||+||||+.+|.+||+|||+|+...... . ..++..+|||||||+||+|++|+.||.+.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999998764332 1 34567899999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=278.17 Aligned_cols=185 Identities=24% Similarity=0.382 Sum_probs=158.0
Q ss_pred ccccceEee-eeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCC
Q 010231 326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE 402 (514)
Q Consensus 326 ~~~~~Y~i~-~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~ 402 (514)
.+.++|.+. +.||+|+||.||+|.+ .+++.||+|++....... .....+.+|+.++..+. ||||+++++++...
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ---DCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE---ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 455678887 8999999999999998 578999999987543222 22356789999999984 69999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC---CCcEEEEeccCc
Q 010231 403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLA 476 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~---~g~vKI~DFGlA 476 (514)
..+|+||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 999999999999999998754 45899999999999999999999999999999999999987 789999999999
Q ss_pred eecccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 477 KVFLSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 477 k~~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.+.... ...++..+|||||||++|+|++|..||.+.
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 182 RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp EEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 8764331 234556899999999999999999999765
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=270.33 Aligned_cols=179 Identities=34% Similarity=0.515 Sum_probs=152.5
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
..|....+||+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++...+.+++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 3445556899999999999997 678899999987532 2234568899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-CCcEEEEeccCceecccC
Q 010231 408 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~----~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-~g~vKI~DFGlAk~~~~~ 482 (514)
||||+++++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++. ++.+||+|||+++.+...
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999999999998764 3568889999999999999999999999999999999987 899999999999875421
Q ss_pred C---------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 L---------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ~---------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
. ...++..+|||||||++|+|++|..||..
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 1 01245689999999999999999999964
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=268.82 Aligned_cols=177 Identities=25% Similarity=0.400 Sum_probs=153.9
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC---
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--- 401 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~--- 401 (514)
.+.++|++++.||+|+||.||+|.+ .+++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 4567899999999999999999998 489999999987532 235689999999999999999998753
Q ss_pred -------------CCeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC
Q 010231 402 -------------ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465 (514)
Q Consensus 402 -------------~~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~ 465 (514)
...+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 4458999999999999999964 368999999999999999999999999999999999999999
Q ss_pred CcEEEEeccCceecccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 466 GSVKLADFGLAKVFLSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 466 g~vKI~DFGlAk~~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
+.+||+|||+++.+.... ...++..+|||||||++|+|++|..||.
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999999998765331 1234567999999999999999998874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=275.47 Aligned_cols=178 Identities=28% Similarity=0.399 Sum_probs=153.9
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhh--cCCCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIv~l~~~~~~~~ 403 (514)
.+.++|.+.+.||+|+||.||+|.+ +++.||||++... ....+.+|+.++.. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 4457899999999999999999988 5889999998631 12456678888877 78999999999988776
Q ss_pred ----eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCCEEEcCCCcEEEE
Q 010231 404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--------DQDVVHRDIKCANILVDANGSVKLA 471 (514)
Q Consensus 404 ----~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLH--------s~gIIHRDLKP~NILId~~g~vKI~ 471 (514)
.+|+||||+.+|+|.+++....+++..+..++.||+.||.||| ++||+||||||+||||+.++.+||+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 8999999999999999999889999999999999999999999 8999999999999999999999999
Q ss_pred eccCceecccCCCc-----------------------------CcceeehhhhHHHHHHHHHhC----------CCCCCC
Q 010231 472 DFGLAKVFLSSLDF-----------------------------DLLLIFSIFLNGCKFFLIFLH----------VLIFRP 512 (514)
Q Consensus 472 DFGlAk~~~~~~~~-----------------------------~~~~~~DVwSlG~lLyeLltG----------~~PF~g 512 (514)
|||+++.+...... .++.++|||||||++|+|++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 99999865432110 112468999999999999999 788865
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=269.86 Aligned_cols=180 Identities=24% Similarity=0.368 Sum_probs=150.1
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC-Ce
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-SK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~-~~ 404 (514)
...++|++++.||+|+||.||++.+. +..||+|++.... ..+.+.+|+.+++.++|+||+++++++... +.
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 34578999999999999999999874 7899999876321 235688999999999999999999986544 57
Q ss_pred EEEEEeccccCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 405 LYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~~---lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
+|+||||+.+++|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999999999987543 88999999999999999999999999999999999999999999999999986543
Q ss_pred CC----------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SL----------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~----------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.. ...++..+|||||||++|+|++ |+.||...
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1234567999999999999998 99999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.6e-32 Score=266.32 Aligned_cols=186 Identities=25% Similarity=0.440 Sum_probs=160.1
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++...... ......+.+|+.+++.++||||+++++++.....
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS---SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 4567899999999999999999998 47899999998753322 1234568899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC---CcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~---g~vKI~DFGlAk~~~ 480 (514)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++..+.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999999887754 579999999999999999999999999999999999999764 479999999998654
Q ss_pred cCCC-----------------cCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SSLD-----------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~~~-----------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.... ..+...+|||||||++|+|++|..||.+.+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 3211 234567899999999999999999998753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-32 Score=273.43 Aligned_cols=189 Identities=23% Similarity=0.376 Sum_probs=153.8
Q ss_pred CCccccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHH-HHhhcCCCceeEEEE
Q 010231 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYG 397 (514)
Q Consensus 320 ~~~~~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpnIv~l~~ 397 (514)
+...+....++|++++.||+|+||.||+|.+ .+++.||||++..... ......+.+|+. +++.++||||+++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKEQKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----HHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----chHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence 3334444567999999999999999999998 5899999999875321 222334455555 778889999999999
Q ss_pred EecCCCeEEEEEeccccCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEE
Q 010231 398 TDKDESKLYIFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 398 ~~~~~~~l~LVmEy~~gGsL~~lL~------~~~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI 470 (514)
++...+.+|+||||+.+ +|.+++. ...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 99999999999999986 7777765 35689999999999999999999999 9999999999999999999999
Q ss_pred EeccCceecccC----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 471 ADFGLAKVFLSS----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 471 ~DFGlAk~~~~~----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+|||+++.+... ....++..+|||||||++|+|++|+.||.+.
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp CCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred ccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 999999765322 1123456889999999999999999999763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=297.31 Aligned_cols=182 Identities=28% Similarity=0.377 Sum_probs=158.3
Q ss_pred cccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
....+.|++.++||+|+||.||+|.+..+..||||+++.... ..+.+.+|+.+|+.++|+||+++++++.. ..
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 334578999999999999999999998888899999875321 13568899999999999999999999876 67
Q ss_pred EEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
+||||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 8999999999999999964 3589999999999999999999999999999999999999999999999999986532
Q ss_pred C--------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 S--------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~--------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
. ....++.++|||||||+||+|++ |+.||.+.
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 01234567899999999999999 99999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-32 Score=266.85 Aligned_cols=174 Identities=30% Similarity=0.507 Sum_probs=150.5
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC---
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--- 401 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~--- 401 (514)
++.++|++++.||+|+||.||+|++ .+++.||+|.+... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 3567899999999999999999998 58899999998631 2345678899999999999999999998754
Q ss_pred ----------CCeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEE
Q 010231 402 ----------ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469 (514)
Q Consensus 402 ----------~~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vK 469 (514)
...+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence 45789999999999999999754 467788999999999999999999999999999999999999999
Q ss_pred EEeccCceecccC----------------------------------CCcCcceeehhhhHHHHHHHHHh
Q 010231 470 LADFGLAKVFLSS----------------------------------LDFDLLLIFSIFLNGCKFFLIFL 505 (514)
Q Consensus 470 I~DFGlAk~~~~~----------------------------------~~~~~~~~~DVwSlG~lLyeLlt 505 (514)
|+|||+++.+... ....++..+|||||||++|+|++
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999999865321 01245678999999999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.7e-32 Score=265.76 Aligned_cols=180 Identities=22% Similarity=0.312 Sum_probs=152.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEE-EecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG-TDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~-~~~~~~ 403 (514)
.+.++|++++.||+|+||.||+|++ .+++.||+|++...... ..+.+|+.+++.+.|++++..+. ++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence 3567899999999999999999997 78999999988753321 24678999999999887655544 456778
Q ss_pred eEEEEEeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE---cCCCcEEEEeccCcee
Q 010231 404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKV 478 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI---d~~g~vKI~DFGlAk~ 478 (514)
.+|+||||+ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 899999999 889999987 3469999999999999999999999999999999999999 4889999999999987
Q ss_pred cccCCC--------------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSLD--------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~~--------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+..... ..++..+|||||||++|+|++|+.||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 643311 13445789999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=276.13 Aligned_cols=182 Identities=25% Similarity=0.375 Sum_probs=152.2
Q ss_pred ccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.++|++++.||+|+||.||+|++ .++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 46899999999999999999984 467789999886321 23344578899999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC---CCcEEE
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKL 470 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~--------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~---~g~vKI 470 (514)
...+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+. ++.+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999999764 3888999999999999999999999999999999999984 446999
Q ss_pred EeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 471 ADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 471 ~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+|||+++...... ...++..+|||||||++|+|++ |..||.+.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999987432110 1334568999999999999998 99999764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=277.96 Aligned_cols=184 Identities=21% Similarity=0.272 Sum_probs=148.2
Q ss_pred ccceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhH------HHHHHHHHHHHHHhhcCCCceeEEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAK------QSISQLEQEIALLSRFEHENIVQYYG 397 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~------~~~~~l~~Ei~iL~~L~HpnIv~l~~ 397 (514)
.++|++++.||+|+||.||+|.+. ++..+|+|.+.......... .....+.+|+.++..+.|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999984 67899999887533211111 11123567889999999999999999
Q ss_pred EecC----CCeEEEEEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC--cEEE
Q 010231 398 TDKD----ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG--SVKL 470 (514)
Q Consensus 398 ~~~~----~~~l~LVmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g--~vKI 470 (514)
++.. ...+||||||+ +++|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9877 77899999999 89999998754 699999999999999999999999999999999999999887 9999
Q ss_pred EeccCceecccCC--------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 471 ADFGLAKVFLSSL--------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 471 ~DFGlAk~~~~~~--------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+|||+|+.+.... ...++..+|||||||++|+|++|+.||.+
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999998653210 12355689999999999999999999954
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-32 Score=271.58 Aligned_cols=175 Identities=25% Similarity=0.381 Sum_probs=147.4
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|++.+.||+|+||.||++.+. ++.||+|.+.. ....+.+.+|+.+++.++||||+++++++.+ .+|+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES-------ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS-------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC-------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence 468999999999999999999875 67899998753 1234578899999999999999999998874 4799
Q ss_pred EEeccccCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCCEEEcCCCc-EEEEeccCceec
Q 010231 408 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHD---QDVVHRDIKCANILVDANGS-VKLADFGLAKVF 479 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~----~lse~~v~~i~~QIl~gL~yLHs---~gIIHRDLKP~NILId~~g~-vKI~DFGlAk~~ 479 (514)
||||+++++|.+++... .++...+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++..+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999999999754 37888999999999999999999 89999999999999998886 799999999765
Q ss_pred ccC----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 480 LSS----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 480 ~~~----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
... ....++..+|||||||++|+|++|+.||..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 157 QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred ccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 432 123456689999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-32 Score=267.44 Aligned_cols=183 Identities=24% Similarity=0.366 Sum_probs=148.1
Q ss_pred ccceEeeeeecccCceeEEEEEc--cCC--ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS--DDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~--~~g--~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.++|++++.||+|+||+||+|.+ .++ ..||+|+++.... ......+.+.+|+.+++.++|+||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 46899999999999999999986 233 3689998764321 12334577889999999999999999999988765
Q ss_pred eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 8999999999999998875 3589999999999999999999999999999999999999999999999999987643
Q ss_pred CCC----------------------cCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SLD----------------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~~----------------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
... ..++..+|||||||++|+|++ |+.||.+.
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 211 123457899999999999999 99999865
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.2e-32 Score=271.40 Aligned_cols=181 Identities=22% Similarity=0.316 Sum_probs=152.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCC-ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc------eeEEEE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN------IVQYYG 397 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g-~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn------Iv~l~~ 397 (514)
.+.++|++++.||+|+||+||+|.+ .++ ..||+|++... ......+.+|+.+++.+.|++ ++.+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 3457899999999999999999997 344 78999998632 233456778999999887766 899999
Q ss_pred EecCCCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE------------
Q 010231 398 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV------------ 462 (514)
Q Consensus 398 ~~~~~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI------------ 462 (514)
++.....+||||||+ +++|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||
T Consensus 90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 999999999999999 55676666543 48999999999999999999999999999999999999
Q ss_pred -------cCCCcEEEEeccCceecccCC----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 463 -------DANGSVKLADFGLAKVFLSSL----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 463 -------d~~g~vKI~DFGlAk~~~~~~----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+.++.+||+|||+++...... ...++..+|||||||++|+|++|..||.+.
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 667899999999998654321 234566899999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=279.36 Aligned_cols=175 Identities=20% Similarity=0.233 Sum_probs=149.3
Q ss_pred ccceEeeeeecccCceeEEEEEcc---------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeE----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD---------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ---- 394 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~---------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~---- 394 (514)
.++|++++.||+|+||.||+|++. .++.||+|.+... ..+.+|+.+++.++|+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhh
Confidence 468999999999999999999985 3889999998742 24678999999999999887
Q ss_pred -----------EEEEecC-CCeEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 010231 395 -----------YYGTDKD-ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN 459 (514)
Q Consensus 395 -----------l~~~~~~-~~~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N 459 (514)
+++++.. ...+||||||+ +++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 5555554 67899999999 8999999976 469999999999999999999999999999999999
Q ss_pred EEEcCCC--cEEEEeccCceecccCC--------------------------CcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 460 ILVDANG--SVKLADFGLAKVFLSSL--------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 460 ILId~~g--~vKI~DFGlAk~~~~~~--------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
||++.++ .+||+|||+++.+.... ...++..+|||||||++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 99999999997654221 1234568999999999999999999997
Q ss_pred CC
Q 010231 512 PP 513 (514)
Q Consensus 512 g~ 513 (514)
+.
T Consensus 270 ~~ 271 (352)
T 2jii_A 270 NC 271 (352)
T ss_dssp GG
T ss_pred cC
Confidence 63
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=274.54 Aligned_cols=187 Identities=22% Similarity=0.401 Sum_probs=159.3
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccch------------hHHHHHHHHHHHHHHhhcCCCcee
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ------------AKQSISQLEQEIALLSRFEHENIV 393 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~------------~~~~~~~l~~Ei~iL~~L~HpnIv 393 (514)
...++|++++.||+|+||.||+|.+ +++.||+|.+........ .......+.+|+.+++.++||||+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3467999999999999999999999 999999999874321110 001126788999999999999999
Q ss_pred EEEEEecCCCeEEEEEeccccCCHHHH------Hhh---cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEc
Q 010231 394 QYYGTDKDESKLYIFLELVTKGSLLNL------YQR---YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVD 463 (514)
Q Consensus 394 ~l~~~~~~~~~l~LVmEy~~gGsL~~l------L~~---~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId 463 (514)
++++++.+.+.+|+||||+.+++|.++ +.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999987 543 468999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEeccCceecccC-----------------CCc-Ccce-eehhhhHHHHHHHHHhCCCCCCCC
Q 010231 464 ANGSVKLADFGLAKVFLSS-----------------LDF-DLLL-IFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 464 ~~g~vKI~DFGlAk~~~~~-----------------~~~-~~~~-~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.++.+||+|||++..+... ... .+.. .+|||||||++|+|++|..||.+.
T Consensus 187 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999875322 011 2333 799999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=277.39 Aligned_cols=183 Identities=25% Similarity=0.409 Sum_probs=155.0
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe-
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK- 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~- 404 (514)
+.++|.+.+.||+|+||.||+|.+ .+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence 457899999999999999999998 679999999986432 223345678899999999999999999999887654
Q ss_pred -----EEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 405 -----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 405 -----l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
+|+||||+.+ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 99 RNFYDFYLVMPFMQT-DLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp GGCCCCEEEEECCSE-EGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred ccceeEEEEeccccC-CHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 5999999985 78776643 5999999999999999999999999999999999999999999999999999864
Q ss_pred ccCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 480 LSSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 480 ~~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.... ...++..+|||||||++|+|++|..||.+.+
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3221 1345668999999999999999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=271.24 Aligned_cols=180 Identities=28% Similarity=0.458 Sum_probs=154.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.++|++++.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-----EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-----SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 46899999999999999999983 578999999987421 23456788999999999999999999988664
Q ss_pred C--eEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 403 S--KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 403 ~--~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
. .+++||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4 789999999999999999764 489999999999999999999999999999999999999999999999999987
Q ss_pred cccCCC----------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 479 FLSSLD----------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 479 ~~~~~~----------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+..... ..++..+|||||||++|+|++|..||..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 643311 1234578999999999999999998853
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=282.95 Aligned_cols=181 Identities=24% Similarity=0.378 Sum_probs=146.5
Q ss_pred cceEeeeeecccCceeEEEEEcc--C--CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec-CCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISD--D--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-DES 403 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~--~--g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~-~~~ 403 (514)
..|++.++||+|+||+||+|++. + +..||+|.+.... .......+.+|+.+++.++||||+++++++. ..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS----CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 46889999999999999999863 2 2467888775322 2234567889999999999999999999864 456
Q ss_pred eEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
..|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 789999999999999999753 478889999999999999999999999999999999999999999999999985432
Q ss_pred CC-----------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SL-----------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~-----------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.. ...++.++|||||||++|+|+| |.+||.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 10 1234567899999999999999 78888764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=295.89 Aligned_cols=181 Identities=22% Similarity=0.345 Sum_probs=153.2
Q ss_pred cceEeee-eecccCceeEEEEEcc---CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 329 TYWQKGD-LLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 329 ~~Y~i~~-~LG~GsfG~Vyka~~~---~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
+.|.+.+ .||+|+||.||+|.+. ++..||||+++.... ....+.+.+|+.+|+.++||||+++++++.. +.
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS----STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 4555555 8999999999999873 567899998874321 2234678899999999999999999999976 56
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+||||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999999999864 35899999999999999999999999999999999999999999999999999865322
Q ss_pred C----------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 483 L----------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 483 ~----------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
. ...++.++|||||||+||+|++ |+.||.+.+
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 1 1234567899999999999998 999998753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=265.24 Aligned_cols=186 Identities=24% Similarity=0.360 Sum_probs=145.2
Q ss_pred cccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 323 ~~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.+....++|++++.||+|+||.||+|.+ .+++.||||++...... ......+.++..+++.++|+||+++++++..
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK---EENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH---HHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc---hHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 4555678999999999999999999998 57899999998753321 2223344555667888899999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.+.+|+||||+ ++.+..++.. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99999999999 5566666553 5689999999999999999999995 999999999999999999999999999976
Q ss_pred cccC-----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 479 FLSS-----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 479 ~~~~-----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+... ....++..+|||||||++|+|++|+.||..
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 5322 112345578999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=265.22 Aligned_cols=182 Identities=20% Similarity=0.385 Sum_probs=154.9
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC--CCceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~--HpnIv~l~~~~~~~~~ 404 (514)
..+.|++++.||+|+||.||++.+.+++.||+|++..... .......+.+|+.++..+. |+||+++++++.....
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc---cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 3568999999999999999999998899999999875332 2334577889999999997 5999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
+|+||| +.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence 999999 557799998876 4689999999999999999999999999999999999996 5899999999998653211
Q ss_pred --------------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 484 --------------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 484 --------------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
...++.++|||||||++|+|++|..||...
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 024556789999999999999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=275.46 Aligned_cols=184 Identities=28% Similarity=0.363 Sum_probs=140.5
Q ss_pred ccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~ 402 (514)
.....++|++.+.||+|+||.||+|++ .++..||||++...... .....+++..+..++||||+++++++...
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF------RNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC------CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc------cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 345578999999999999999999998 67899999988643221 12345678888889999999999988543
Q ss_pred C-------eEEEEEeccccCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCCEEEcC-CCc
Q 010231 403 S-------KLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLKYLH--DQDVVHRDIKCANILVDA-NGS 467 (514)
Q Consensus 403 ~-------~l~LVmEy~~gGsL~~lL~-----~~~lse~~v~~i~~QIl~gL~yLH--s~gIIHRDLKP~NILId~-~g~ 467 (514)
. .+|+||||+.++ |...+. ...+++..+..++.||+.||.||| ++||+||||||+||||+. ++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred ccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 2 389999999875 443332 245888999999999999999999 999999999999999996 899
Q ss_pred EEEEeccCceecccCC-------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 468 VKLADFGLAKVFLSSL-------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 468 vKI~DFGlAk~~~~~~-------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
+||+|||+++.+.... ...++..+|||||||++|+|++|+.||.+.+
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 9999999998754321 1235678999999999999999999998753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=275.40 Aligned_cols=182 Identities=21% Similarity=0.361 Sum_probs=153.9
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CC-----ceeEEEEE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HE-----NIVQYYGT 398 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-Hp-----nIv~l~~~ 398 (514)
.+.++|+++++||+|+||+||+|++ .+++.||||+++.. ......+.+|+.++..+. |+ +|++++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 4568999999999999999999998 57889999998632 233456677888887774 44 59999999
Q ss_pred ecCCCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCCEEEc--CCCcEEEE
Q 010231 399 DKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLH--DQDVVHRDIKCANILVD--ANGSVKLA 471 (514)
Q Consensus 399 ~~~~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLH--s~gIIHRDLKP~NILId--~~g~vKI~ 471 (514)
+...+.+||||||+.+ +|.+++... .+++..++.++.||+.||.||| ++||+||||||+||||+ .++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999999965 999988764 4899999999999999999999 57999999999999995 47889999
Q ss_pred eccCceecccCC----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 472 DFGLAKVFLSSL----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 472 DFGlAk~~~~~~----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
|||+|+.+.... ...++..+|||||||++|+|++|++||.+.+
T Consensus 204 DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998764321 2345678999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=272.52 Aligned_cols=179 Identities=21% Similarity=0.275 Sum_probs=143.9
Q ss_pred ccccceEeee-eecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC--
Q 010231 326 RIITYWQKGD-LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-- 401 (514)
Q Consensus 326 ~~~~~Y~i~~-~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~-- 401 (514)
.+.++|++.+ +||+|+||+||+|.+ .+++.||||++... .. ...+....++.+.|+||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PK---ARQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HH---HHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 4567899855 699999999999998 57999999998631 11 11223334567799999999998865
Q ss_pred --CCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC---CCcEEEEec
Q 010231 402 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADF 473 (514)
Q Consensus 402 --~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~---~g~vKI~DF 473 (514)
...+||||||+.+|+|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 45689999999999999999764 4899999999999999999999999999999999999986 455999999
Q ss_pred cCceecccCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 474 GLAKVFLSSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 474 GlAk~~~~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
|+++...... ...++..+|||||||++|+|++|..||.+.
T Consensus 176 g~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 176 GFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp TTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 9998654321 122345789999999999999999999653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=285.97 Aligned_cols=180 Identities=22% Similarity=0.289 Sum_probs=153.7
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC-CceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIv~l~~~~~~~~ 403 (514)
.+.++|+++++||+|+||.||+|++ .+++.||||++...... ..+.+|+.+++.+.| ++|..+..++...+
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~ 76 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGD 76 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence 4567899999999999999999997 67899999987753322 236789999999976 55666666777888
Q ss_pred eEEEEEeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE---cCCCcEEEEeccCcee
Q 010231 404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKV 478 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI---d~~g~vKI~DFGlAk~ 478 (514)
..||||||+ +++|.+++. ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 77 ~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999999999 889999997 4579999999999999999999999999999999999999 6889999999999987
Q ss_pred cccCCC--------------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSSLD--------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~~~--------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+..... ..+....|||||||+||+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~ 216 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 654321 13345779999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=270.33 Aligned_cols=187 Identities=23% Similarity=0.345 Sum_probs=147.8
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchh-HHHHHHHHHHHHHHhhc----CCCceeEEEEEe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRF----EHENIVQYYGTD 399 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~-~~~~~~l~~Ei~iL~~L----~HpnIv~l~~~~ 399 (514)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++......... ......+.+|+.++..+ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 4467899999999999999999988 67889999998643221110 11223455788888888 899999999999
Q ss_pred cCCCeEEEEEec-cccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc-CCCcEEEEeccCc
Q 010231 400 KDESKLYIFLEL-VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLA 476 (514)
Q Consensus 400 ~~~~~l~LVmEy-~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId-~~g~vKI~DFGlA 476 (514)
...+..++|||| +.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999999 789999999875 4599999999999999999999999999999999999999 8899999999999
Q ss_pred eecccCCC-----------------cC-cceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 477 KVFLSSLD-----------------FD-LLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 477 k~~~~~~~-----------------~~-~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+.+..... .. ....+|||||||++|+|++|+.||.+
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 87654311 11 12478999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=292.78 Aligned_cols=177 Identities=23% Similarity=0.370 Sum_probs=151.4
Q ss_pred eeeecccCceeEEEEEc---cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEe
Q 010231 334 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~---~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE 410 (514)
.+.||+|+||.||+|.+ .++..||||+++.... .....+.+.+|+.+|+.++|+||+++++++.. ..++||||
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E 449 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME 449 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG---CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEE
Confidence 45899999999999965 4578899999875322 22334678899999999999999999999875 45899999
Q ss_pred ccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC------
Q 010231 411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL------ 483 (514)
Q Consensus 411 y~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~------ 483 (514)
|+.+|+|.+++... .+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+....
T Consensus 450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999999999764 58999999999999999999999999999999999999999999999999998654321
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
...++.++|||||||+||+|++ |+.||.+.+
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 1245568899999999999998 999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=272.75 Aligned_cols=182 Identities=23% Similarity=0.413 Sum_probs=151.1
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
...++|++++.||+|+||.||+|.+.. .+|+|.+....... ...+.+.+|+.+++.++|+||+++++++.....+
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE---DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC---CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH---HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 345789999999999999999998754 49999886532211 1123466899999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-
Q 010231 406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~- 482 (514)
|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999999999765 489999999999999999999999999999999999998 789999999997653210
Q ss_pred --------------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 --------------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 --------------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|||||||++|+|++|+.||.+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 0123456789999999999999999999764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=270.61 Aligned_cols=189 Identities=24% Similarity=0.357 Sum_probs=156.8
Q ss_pred ccccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhH-HHHHHHHHHHHHHhhcC--CCceeEEEEEe
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK-QSISQLEQEIALLSRFE--HENIVQYYGTD 399 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~-~~~~~l~~Ei~iL~~L~--HpnIv~l~~~~ 399 (514)
...+.++|++++.||+|+||.||+|++ .+++.||||++.......... .....+.+|+.+++.+. |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344567899999999999999999987 678999999987543221000 11234567899999996 59999999999
Q ss_pred cCCCeEEEEEecccc-CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc-CCCcEEEEeccCc
Q 010231 400 KDESKLYIFLELVTK-GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLA 476 (514)
Q Consensus 400 ~~~~~l~LVmEy~~g-GsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId-~~g~vKI~DFGlA 476 (514)
...+.+++||||+.+ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999999986 899998865 5689999999999999999999999999999999999999 7899999999999
Q ss_pred eecccCCC------------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 477 KVFLSSLD------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 477 k~~~~~~~------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+.+..... ...+..+|||||||++|+|++|+.||..
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 87654311 1124567999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=273.01 Aligned_cols=179 Identities=25% Similarity=0.341 Sum_probs=149.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-----------CCceeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----------HENIVQY 395 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-----------HpnIv~l 395 (514)
.++|++++.||+|+||+||+|.+ .+++.||||++... ......+.+|+.+++.+. |+||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 46899999999999999999998 68899999998631 223456778898888876 8999999
Q ss_pred EEEecCCC----eEEEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEcC---
Q 010231 396 YGTDKDES----KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDA--- 464 (514)
Q Consensus 396 ~~~~~~~~----~l~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILId~--- 464 (514)
++++.... .+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++ ||+||||||+||||+.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99887543 799999999 7899998875 3489999999999999999999998 9999999999999953
Q ss_pred ---CCcEEEEeccCceecccCC----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 465 ---NGSVKLADFGLAKVFLSSL----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 465 ---~g~vKI~DFGlAk~~~~~~----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+.+||+|||+++.+.... ...++..+|||||||++|+|++|+.||.+.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 3489999999998765331 123566899999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=276.41 Aligned_cols=178 Identities=31% Similarity=0.401 Sum_probs=146.1
Q ss_pred cccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l 405 (514)
+.+.|.+.++||+|+||+||.+...+|+.||||.+... ....+.+|+.++..+ +||||+++++++.+...+
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence 34567888999999999998776678999999988641 123567899999876 899999999999999999
Q ss_pred EEEEeccccCCHHHHHhhcCCC--------HHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC------------
Q 010231 406 YIFLELVTKGSLLNLYQRYHLR--------DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN------------ 465 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~ls--------e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~------------ 465 (514)
||||||+. |+|.+++...... +..+..++.||+.||.|||++||+||||||+||||+.+
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 99999996 5999999765432 22356799999999999999999999999999999754
Q ss_pred -CcEEEEeccCceecccCC------------------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 466 -GSVKLADFGLAKVFLSSL------------------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 466 -g~vKI~DFGlAk~~~~~~------------------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+.+||+|||+++.+.... ...++..+|||||||++|+|++ |..||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 489999999998754321 1335567999999999999999 99999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=289.23 Aligned_cols=183 Identities=28% Similarity=0.407 Sum_probs=155.2
Q ss_pred ccccceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
...++|++++.||+|+||.||+|.+. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST----TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 34578999999999999999999873 3467888876532 12334567889999999999999999999985
Q ss_pred CCeEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
.+.+||||||+.+|+|.++++.. .+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 46689999999999999999754 5889999999999999999999999999999999999999999999999999875
Q ss_pred ccCC--------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 480 LSSL--------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 480 ~~~~--------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.... ...++..+|||||||++|+|++ |..||.+.
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 4321 1234457899999999999997 99999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=278.63 Aligned_cols=183 Identities=18% Similarity=0.247 Sum_probs=147.8
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEeccccc---chhHHHHHHHHHHHHHHhhcC---------CCceeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFE---------HENIVQY 395 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~---~~~~~~~~~l~~Ei~iL~~L~---------HpnIv~l 395 (514)
.++|++++.||+|+||+||+|++ +|+.||||++...... .......+.+.+|+.+++.++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46899999999999999999998 7899999999864321 011223356778888888875 7777776
Q ss_pred EEEe-----------------c-------------CCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHH
Q 010231 396 YGTD-----------------K-------------DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445 (514)
Q Consensus 396 ~~~~-----------------~-------------~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yL 445 (514)
++++ . ....+||||||+.+|++.+.+.+..+++..++.|+.||+.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 6653 2 267899999999999777766667799999999999999999999
Q ss_pred H-HCCccccCCCCCCEEEcCCC--------------------cEEEEeccCceecccCC-------------CcCcceee
Q 010231 446 H-DQDVVHRDIKCANILVDANG--------------------SVKLADFGLAKVFLSSL-------------DFDLLLIF 491 (514)
Q Consensus 446 H-s~gIIHRDLKP~NILId~~g--------------------~vKI~DFGlAk~~~~~~-------------~~~~~~~~ 491 (514)
| ++||+||||||+||||+.++ .+||+|||+|+.+.... .......+
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~~~~~ 257 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQF 257 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCSSHHH
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCCccce
Confidence 9 99999999999999999887 89999999998764320 11225678
Q ss_pred hhhhHHHH-HHHHHhCCCCCC
Q 010231 492 SIFLNGCK-FFLIFLHVLIFR 511 (514)
Q Consensus 492 DVwSlG~l-LyeLltG~~PF~ 511 (514)
|||||+++ .++++.|..||.
T Consensus 258 Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 258 DIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp HHHHHHHHHHTTCTTSCCTHH
T ss_pred ehhhhhCCCCcccccccCCCc
Confidence 99998766 888889999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=292.95 Aligned_cols=181 Identities=22% Similarity=0.261 Sum_probs=152.0
Q ss_pred ccccceEeeeeecccCceeEEEEEcc--CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~--~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.+.++|+++++||+|+||.||+|.+. +++.||||++.... .......+.+|+.++..++||||+++++++...+
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG----DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC----CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 34579999999999999999999984 68999999875321 2334467789999999999999999999987655
Q ss_pred e-----EEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 404 K-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 404 ~-----l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
. +||||||+.+++|.+++.. .+++..+..|+.||+.||.|||++|||||||||+||||+.+ .+||+|||+++.
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 4 7999999999999988765 79999999999999999999999999999999999999875 999999999987
Q ss_pred cccCCC--------------cCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 479 FLSSLD--------------FDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 479 ~~~~~~--------------~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
+..... ...+..+|||||||+||+|++|.+||.+
T Consensus 231 ~~~~~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 231 INSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TTCCSCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred cccCCccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcc
Confidence 654311 1224578999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=278.07 Aligned_cols=176 Identities=28% Similarity=0.372 Sum_probs=143.7
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~L 407 (514)
..|.+.++||+|+||+||.....+++.||||++..... ..+.+|+.+|+.+ +||||+++++++.+...+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 47999999999999997765557889999998864221 1245799999999 79999999999999999999
Q ss_pred EEeccccCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC---C--CcEEEEeccCceecc
Q 010231 408 FLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---N--GSVKLADFGLAKVFL 480 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~--lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~---~--g~vKI~DFGlAk~~~ 480 (514)
||||+.+ +|.+++.... +.+..+..|+.||+.||.|||++||+||||||+||||+. + ..+||+|||+|+.+.
T Consensus 96 v~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 96 AIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 9999975 9999987653 455567899999999999999999999999999999953 2 358899999998654
Q ss_pred cCC-------------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 481 SSL-------------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 481 ~~~-------------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
... ...++..+|||||||++|+|++ |..||...
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 210 1233447899999999999999 99999653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=267.21 Aligned_cols=183 Identities=19% Similarity=0.198 Sum_probs=138.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC-Cce-------------
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENI------------- 392 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnI------------- 392 (514)
...|.++++||+|+||+||+|++ .+|+.||||++...... .....+.+.+|+.+++.+.| .|+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP--PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc--cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34688999999999999999997 68999999988743322 22335678899999999976 211
Q ss_pred --eE------EEEEecC-----CCeEEEEEeccccCCHHHHHh--------hcCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 010231 393 --VQ------YYGTDKD-----ESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451 (514)
Q Consensus 393 --v~------l~~~~~~-----~~~l~LVmEy~~gGsL~~lL~--------~~~lse~~v~~i~~QIl~gL~yLHs~gII 451 (514)
+. ++..+.. ...++++|+++ +++|.++++ ...+++..+..++.||+.||.|||++|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 11 1111111 22467788876 468988885 22366778888999999999999999999
Q ss_pred ccCCCCCCEEEcCCCcEEEEeccCceecccC-------------------------CCcCcceeehhhhHHHHHHHHHhC
Q 010231 452 HRDIKCANILVDANGSVKLADFGLAKVFLSS-------------------------LDFDLLLIFSIFLNGCKFFLIFLH 506 (514)
Q Consensus 452 HRDLKP~NILId~~g~vKI~DFGlAk~~~~~-------------------------~~~~~~~~~DVwSlG~lLyeLltG 506 (514)
||||||+||||+.++.+||+|||+++..... ....++.++|||||||++|+|++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999999999999999865432 112244588999999999999999
Q ss_pred CCCCCCC
Q 010231 507 VLIFRPP 513 (514)
Q Consensus 507 ~~PF~g~ 513 (514)
+.||.+.
T Consensus 314 ~~Pf~~~ 320 (413)
T 3dzo_A 314 DLPNTDD 320 (413)
T ss_dssp SCCCCTT
T ss_pred CCCCCCc
Confidence 9999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=285.16 Aligned_cols=181 Identities=23% Similarity=0.360 Sum_probs=154.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----- 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----- 401 (514)
.++|+++++||+|+||.||+|.+ .+|..||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 47899999999999999999998 67899999987642 123445678899999999999999999998765
Q ss_pred -CCeEEEEEeccccCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCc---EEEEec
Q 010231 402 -ESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADF 473 (514)
Q Consensus 402 -~~~l~LVmEy~~gGsL~~lL~~~----~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~---vKI~DF 473 (514)
.+..|+||||+.+|+|.+++... .+++..++.|+.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 67789999999999999999763 4889999999999999999999999999999999999997765 999999
Q ss_pred cCceecccCC------------------CcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 474 GLAKVFLSSL------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 474 GlAk~~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
|++..+.... ...++..+|||||||++|+|++|..||.+
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9998754321 13455688999999999999999999965
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=256.95 Aligned_cols=169 Identities=14% Similarity=0.058 Sum_probs=123.9
Q ss_pred eeecccCceeEEEEEc-cCCceEEEEEEeccc-----ccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCCeEEE
Q 010231 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD-----QGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~-----~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~L 407 (514)
..++.|.+|.+..++. ..|+.|++|.+.... .....+...+.+.+|+.+|+++ .|+||++++++++++..+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3567777777776654 578999999987432 1223455567799999999999 79999999999999999999
Q ss_pred EEeccccCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCCcC
Q 010231 408 FLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFD 486 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~-lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~~~ 486 (514)
||||++|++|.+++...+ ++. ..|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-- 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-- 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C--
T ss_pred EEecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--
Confidence 999999999999998754 544 35899999999999999999999999999999999999999999997654322
Q ss_pred cceeehhhhHHHHHHHHHhCCCC
Q 010231 487 LLLIFSIFLNGCKFFLIFLHVLI 509 (514)
Q Consensus 487 ~~~~~DVwSlG~lLyeLltG~~P 509 (514)
.....+|+.|.+..|++.|+.+
T Consensus 395 -~~~t~vGTp~YmAPE~l~g~~~ 416 (569)
T 4azs_A 395 -WPTNLVQSFFVFVNELFAENKS 416 (569)
T ss_dssp -CSHHHHHHHHHHHHHHC-----
T ss_pred -cccCceechhhccHHHhCCCCC
Confidence 1223455555555555555543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=229.72 Aligned_cols=170 Identities=17% Similarity=0.146 Sum_probs=126.2
Q ss_pred EeeeeecccCceeEEEEEccCCceEEEEEEeccccc---chhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 332 ~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~---~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
...++||+|+||.||+|.. .+..+++|.+...... .......+++.+|+.++++++||||+++..++...+..|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999944 5678888876542221 12233356689999999999999999444444455667999
Q ss_pred EeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCCC----
Q 010231 409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD---- 484 (514)
Q Consensus 409 mEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~~---- 484 (514)
|||+++++|.+++.. +..|+.||+.||.|||++||+||||||+|||++. .+||+|||+|+.+.....
T Consensus 418 mE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp EECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred EECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 999999999999876 5689999999999999999999999999999998 999999999998754311
Q ss_pred ------------------------cCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 485 ------------------------FDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 485 ------------------------~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
..|...+|+|+...-..+.+..+.+|.
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 122235678888888888877776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=207.39 Aligned_cols=143 Identities=17% Similarity=0.175 Sum_probs=113.3
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEeccccc-------------chhHHHHHHHHHHHHHHhhcCCCceeEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-------------SQAKQSISQLEQEIALLSRFEHENIVQY 395 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~-------------~~~~~~~~~l~~Ei~iL~~L~HpnIv~l 395 (514)
..|.+++.||+|+||.||+|.+.+|+.||+|.++..... .+.......+.+|+.+++.++|.++..+
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~ 169 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 169 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeE
Confidence 356677999999999999999988999999998642211 1111345678899999999985444443
Q ss_pred EEEecCCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccC
Q 010231 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (514)
Q Consensus 396 ~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGl 475 (514)
++ . +..|+||||+++++|.+ +. ......++.||+.||.|||++||+||||||+||||+ +|.+||+|||+
T Consensus 170 ~~---~-~~~~lvmE~~~g~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 170 YA---W-EGNAVLMELIDAKELYR-VR-----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp EE---E-ETTEEEEECCCCEEGGG-CC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred Ee---c-cceEEEEEecCCCcHHH-cc-----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 32 2 45699999999999987 32 233567999999999999999999999999999999 99999999999
Q ss_pred ceecccC
Q 010231 476 AKVFLSS 482 (514)
Q Consensus 476 Ak~~~~~ 482 (514)
|+.....
T Consensus 239 a~~~~~~ 245 (282)
T 1zar_A 239 SVEVGEE 245 (282)
T ss_dssp CEETTST
T ss_pred CeECCCC
Confidence 9976544
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.8e-21 Score=190.56 Aligned_cols=145 Identities=21% Similarity=0.262 Sum_probs=112.0
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCce--EEEEEEecccccch-------------------hHHHHHHHHHHHHHHhhc
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFF--FAVKEVSLLDQGSQ-------------------AKQSISQLEQEIALLSRF 387 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~--vAIK~v~~~~~~~~-------------------~~~~~~~l~~Ei~iL~~L 387 (514)
.|.+.+.||+|+||.||+|.+ .+|+. ||||+++....... .......+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998 78888 99998754211110 112234678899999999
Q ss_pred CCCce--eEEEEEecCCCeEEEEEecccc-C----CHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCC
Q 010231 388 EHENI--VQYYGTDKDESKLYIFLELVTK-G----SLLNLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCAN 459 (514)
Q Consensus 388 ~HpnI--v~l~~~~~~~~~l~LVmEy~~g-G----sL~~lL~~~~lse~~v~~i~~QIl~gL~yLH-s~gIIHRDLKP~N 459 (514)
.|++| ..++.. +..+|||||+.+ | .|.++... .++..+..++.||+.+|.||| ++||+||||||+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 88754 444443 245899999953 3 67766432 234567889999999999999 9999999999999
Q ss_pred EEEcCCCcEEEEeccCceecccC
Q 010231 460 ILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 460 ILId~~g~vKI~DFGlAk~~~~~ 482 (514)
||++. .++|+|||+|.....+
T Consensus 202 ILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp EEESS--SEEECCCTTCEETTST
T ss_pred EEEcC--cEEEEECcccccCCCc
Confidence 99988 9999999999987544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.5e-19 Score=187.14 Aligned_cols=144 Identities=14% Similarity=0.108 Sum_probs=104.2
Q ss_pred ceEeeeeecccCceeEEEEEccCCceEEEEEEecccccc-----------------hhHHHHHHHHHHHHHHhhcCCCce
Q 010231 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS-----------------QAKQSISQLEQEIALLSRFEHENI 392 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~-----------------~~~~~~~~l~~Ei~iL~~L~HpnI 392 (514)
-|.++.+||+|+||.||+|.+.+|+.||||+++...... +.........+|...|..+.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 389999999999999999999999999999875321100 000111112356666666644443
Q ss_pred --eEEEEEecCCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC----
Q 010231 393 --VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---- 466 (514)
Q Consensus 393 --v~l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g---- 466 (514)
...++.. ..+|||||+.|+.|..+. ..+....++.||+.+|.|||++|||||||||.||||+.+|
T Consensus 176 ~vp~p~~~~----~~~LVME~i~G~~L~~l~-----~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 176 PVPEPIAQS----RHTIVMSLVDALPMRQVS-----SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp SCCCEEEEE----TTEEEEECCSCEEGGGCC-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCeeeecc----CceEEEEecCCccHhhhc-----ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 2223321 227999999998876542 2234567899999999999999999999999999998877
Q ss_pred ------cEEEEeccCceecccC
Q 010231 467 ------SVKLADFGLAKVFLSS 482 (514)
Q Consensus 467 ------~vKI~DFGlAk~~~~~ 482 (514)
.+.|+||+.+.....+
T Consensus 247 ~~~~~~~~~iID~~Q~V~~~hp 268 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSMDHP 268 (397)
T ss_dssp TTSEEEEEEECCCTTCEETTST
T ss_pred ccccccceEEEEeCCcccCCCC
Confidence 3899999998875544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.7e-12 Score=126.33 Aligned_cols=144 Identities=13% Similarity=0.117 Sum_probs=112.8
Q ss_pred ccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~ 404 (514)
..+..|.+...++.|+++.||++... +..+++|......... ...+.+|+.+++.+. +..+.++++++.....
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 34567889999999999999999754 6789999876421111 124778999998884 6677889988888889
Q ss_pred EEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 010231 405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD------------------------------------- 447 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs------------------------------------- 447 (514)
.|+||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred eEEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999999876531 222345788999999999998
Q ss_pred ----------------------CCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 448 ----------------------QDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 448 ----------------------~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..++|+|++|.|||++.++.+.|+||+.+...
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 44899999999999987656679999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=2.8e-12 Score=123.05 Aligned_cols=138 Identities=20% Similarity=0.149 Sum_probs=100.9
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc--eeEEEEEecCCCeE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDKDESKL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~l 405 (514)
...|.+..+.+.|..+.||++...+|..+++|..... ....+.+|+.+++.+.+.+ +.+++.++...+..
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 4456655544566679999998777888999986532 1134668888888885444 45688888877889
Q ss_pred EEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 010231 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD------------------------------------ 449 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~g------------------------------------ 449 (514)
|+||||++|.+|. . .... ...++.++...|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~--~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--S--SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEEECCSSEETT--T--SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEEecCCcccC--c--CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 9999999998873 1 1111 2246677777777777643
Q ss_pred ----------------------ccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 450 ----------------------VVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 450 ----------------------IIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
++|+|++|.|||++.++.+.|+|||.|....
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 9999999999999877667799999988643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.2e-10 Score=119.00 Aligned_cols=141 Identities=13% Similarity=0.232 Sum_probs=103.4
Q ss_pred eeeeecccCceeEEEEEccCCceEEEEEEe--cccccchhHHHHHHHHHHHHHHhhcC--CCceeEEEEEecCC---CeE
Q 010231 333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVS--LLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDE---SKL 405 (514)
Q Consensus 333 i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~--~~~~~~~~~~~~~~l~~Ei~iL~~L~--HpnIv~l~~~~~~~---~~l 405 (514)
.++.|+.|.++.||++...+ ..+++|+.. ... .......+.+|+.+++.+. +..+.+++.++.+. ...
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~----~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSK----LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCC----CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 35778999999999998754 567777543 211 0112346778999999886 34577888887766 348
Q ss_pred EEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 010231 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD-------------------------------------- 447 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs-------------------------------------- 447 (514)
|+||||++|..+.+.. ...++......++.++...|..||+
T Consensus 117 ~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999999987764311 1246777888899999999999997
Q ss_pred --------------------CCccccCCCCCCEEEcCCCc--EEEEeccCceec
Q 010231 448 --------------------QDVVHRDIKCANILVDANGS--VKLADFGLAKVF 479 (514)
Q Consensus 448 --------------------~gIIHRDLKP~NILId~~g~--vKI~DFGlAk~~ 479 (514)
..+||+|+++.|||++.++. +.|+||++|...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997753 699999999863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=9.1e-10 Score=109.93 Aligned_cols=165 Identities=18% Similarity=0.130 Sum_probs=115.6
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCc--eeEEEEEecCCC---eEEE
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HEN--IVQYYGTDKDES---KLYI 407 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-Hpn--Iv~l~~~~~~~~---~l~L 407 (514)
++.|+.|.+..||++. ..+++|.... ......+.+|..+|+.+. +.. +.+++....... ..|+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence 3558999999999873 4688886542 133467889999998873 332 345555544333 3489
Q ss_pred EEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 010231 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD---------------------------------------- 447 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs---------------------------------------- 447 (514)
||++++|..|..... ..++......++.|+...|..||+
T Consensus 94 vm~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EEECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EEcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999999988764322 356777777788888888888885
Q ss_pred ------------------CCccccCCCCCCEEEcC--CCcEEEEeccCceecccCCC----------c----------Cc
Q 010231 448 ------------------QDVVHRDIKCANILVDA--NGSVKLADFGLAKVFLSSLD----------F----------DL 487 (514)
Q Consensus 448 ------------------~gIIHRDLKP~NILId~--~g~vKI~DFGlAk~~~~~~~----------~----------~~ 487 (514)
..++|+|+++.|||++. .+.+.|+||+.+.......+ . .|
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 13799999999999998 45688999999875322100 0 00
Q ss_pred c------------eeehhhhHHHHHHHHHhCCCCC
Q 010231 488 L------------LIFSIFLNGCKFFLIFLHVLIF 510 (514)
Q Consensus 488 ~------------~~~DVwSlG~lLyeLltG~~PF 510 (514)
. ...+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 1235899999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=6.8e-07 Score=89.70 Aligned_cols=135 Identities=20% Similarity=0.138 Sum_probs=90.0
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCC---ceeEEEEEec-CCCeEEEEE
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE---NIVQYYGTDK-DESKLYIFL 409 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp---nIv~l~~~~~-~~~~l~LVm 409 (514)
++.++.|....||+. +..+++|+-.. ......+.+|..+|+.+.+. .+.+++.++. .....|+||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence 456888999999988 56788886421 22346788999999998642 2455665553 455678999
Q ss_pred eccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 010231 410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD------------------------------------------ 447 (514)
Q Consensus 410 Ey~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs------------------------------------------ 447 (514)
+|++|..|.... -..++......++.|+...|..||+
T Consensus 93 e~i~G~~l~~~~-~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 93 RKVQGQILGEDG-MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECCCSEECHHHH-HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eccCCeECchhh-hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999998776521 1123333333444444444444442
Q ss_pred ------------------CCccccCCCCCCEEEcC---CCc-EEEEeccCceecc
Q 010231 448 ------------------QDVVHRDIKCANILVDA---NGS-VKLADFGLAKVFL 480 (514)
Q Consensus 448 ------------------~gIIHRDLKP~NILId~---~g~-vKI~DFGlAk~~~ 480 (514)
..++|+|+++.|||++. ++. +.|+||+.+....
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 13699999999999987 455 4899999988643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.7e-06 Score=83.94 Aligned_cols=134 Identities=13% Similarity=0.152 Sum_probs=90.5
Q ss_pred eecccCce-eEEEEEcc-CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCeEEEEEecc
Q 010231 336 LLGRGSFG-SVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 336 ~LG~GsfG-~Vyka~~~-~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVmEy~ 412 (514)
.+..|..| .||+.... ++..+.+|.-.. .....+.+|..+|+.+. +--+.+++.++.+.+..|+|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 34445554 68988764 566788887652 12345778888888774 223567788888888999999999
Q ss_pred ccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------------
Q 010231 413 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-------------------------------------------- 448 (514)
Q Consensus 413 ~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~-------------------------------------------- 448 (514)
+|.++.+..... ......++.++...|.-||..
T Consensus 103 ~G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 103 PGKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp CSEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred CCccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 998876654321 111223344444444444421
Q ss_pred --------------CccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 449 --------------DVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 449 --------------gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
.++|+|+.+.|||++.++.+-|+||+.+....
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 16899999999999887777899999998654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=2.4e-06 Score=86.61 Aligned_cols=84 Identities=4% Similarity=-0.030 Sum_probs=51.8
Q ss_pred Eeeeee-cccCceeEEEEEcc-------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC---CceeEEEEEec
Q 010231 332 QKGDLL-GRGSFGSVYEGISD-------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---ENIVQYYGTDK 400 (514)
Q Consensus 332 ~i~~~L-G~GsfG~Vyka~~~-------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H---pnIv~l~~~~~ 400 (514)
...+.| +.|....+|+.... ++..+++|.......... .....+.+|+.+++.+.. -.+.+++.++.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~--~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV--FPTYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS--SSCCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc--CchhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 345678 88999999988654 256788886542110000 001235677777777742 24667777765
Q ss_pred CC---CeEEEEEeccccCCH
Q 010231 401 DE---SKLYIFLELVTKGSL 417 (514)
Q Consensus 401 ~~---~~l~LVmEy~~gGsL 417 (514)
+. ...|+||||++|..+
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCC
T ss_pred CCCccCCceEEEEecCCCCh
Confidence 54 356899999987543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=1e-05 Score=80.48 Aligned_cols=31 Identities=19% Similarity=0.355 Sum_probs=28.4
Q ss_pred CCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 448 QDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 448 ~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
..+||+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998865
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=7.2e-06 Score=84.64 Aligned_cols=80 Identities=14% Similarity=0.150 Sum_probs=48.0
Q ss_pred eeeecccCceeEEEEEcc-CCceEEEEEEecccc--cchhHHHHHHHHHHHHHHhhcCC--C-ceeEEEEEecCCCeEEE
Q 010231 334 GDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFEH--E-NIVQYYGTDKDESKLYI 407 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~~--~~~~~~~~~~l~~Ei~iL~~L~H--p-nIv~l~~~~~~~~~l~L 407 (514)
.+.||.|.++.||++... ++..+++|....... .........++..|..+++.+.. + .+.+++.+.. ...++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~--~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC--CccEE
Confidence 567999999999999763 567899997642111 00000112345678888777632 3 3445665533 34589
Q ss_pred EEeccccC
Q 010231 408 FLELVTKG 415 (514)
Q Consensus 408 VmEy~~gG 415 (514)
||||+.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.77 E-value=7.9e-05 Score=77.73 Aligned_cols=33 Identities=15% Similarity=0.269 Sum_probs=28.8
Q ss_pred HCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 447 s~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
...++|+|+++.|||++.++ ++|+||+.+....
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 45799999999999998777 9999999988643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00015 Score=72.74 Aligned_cols=33 Identities=33% Similarity=0.332 Sum_probs=28.5
Q ss_pred CCccccCCCCCCEEEcCC----CcEEEEeccCceecc
Q 010231 448 QDVVHRDIKCANILVDAN----GSVKLADFGLAKVFL 480 (514)
Q Consensus 448 ~gIIHRDLKP~NILId~~----g~vKI~DFGlAk~~~ 480 (514)
..++|+|+.+.|||++.+ +.+.|+||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 469999999999999875 689999999988643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00058 Score=69.15 Aligned_cols=75 Identities=17% Similarity=0.159 Sum_probs=56.6
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC---CCceeEEEEEecCCCeEEEEEe
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIFLE 410 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l~LVmE 410 (514)
.+.|+.|.+..+|+... ++..+++|..... ....+..|...|+.|. ...+.+++.++......|+|||
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 46789999999999976 4567778876521 1345678888887773 3557788888877788999999
Q ss_pred ccccCCH
Q 010231 411 LVTKGSL 417 (514)
Q Consensus 411 y~~gGsL 417 (514)
|+++..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00055 Score=67.30 Aligned_cols=78 Identities=17% Similarity=0.021 Sum_probs=53.5
Q ss_pred ceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC---CceeEEEEEecCCCeEE
Q 010231 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---ENIVQYYGTDKDESKLY 406 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H---pnIv~l~~~~~~~~~l~ 406 (514)
...-+..+|.|..+.||+....+|+.|.+|+....... ....+..|...|+.|.. --+.+++.+.. -+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA-----LDGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC-----CTTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc-----hhhHHHHHHHHHHHHHhhCCCCcceEEeccC----ce
Confidence 45567889999999999999999999999965422111 11235678888887742 12445555533 27
Q ss_pred EEEeccccCC
Q 010231 407 IFLELVTKGS 416 (514)
Q Consensus 407 LVmEy~~gGs 416 (514)
+||||+.++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999998654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00032 Score=69.50 Aligned_cols=132 Identities=9% Similarity=0.055 Sum_probs=73.3
Q ss_pred eeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCce-eEEEEEecCCCeEEEEEecc
Q 010231 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~LVmEy~ 412 (514)
++.|+.|....+|++ ..+++|+........ ....+|+.+++.+...++ .+++..+.+ .-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY------INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C------CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce------eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeec
Confidence 677999999999999 467888765311111 112356666666532222 456655443 347899999
Q ss_pred -ccCCHHH---------------HHh---hcC--C----C-HHHHHHHHHH--------------HHHHHHHHH----H-
Q 010231 413 -TKGSLLN---------------LYQ---RYH--L----R-DSQVSAYTRQ--------------ILLGLKYLH----D- 447 (514)
Q Consensus 413 -~gGsL~~---------------lL~---~~~--l----s-e~~v~~i~~Q--------------Il~gL~yLH----s- 447 (514)
++.+|.. .+. ... + . ...+..+..+ +...+..|. .
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 5543321 111 101 1 0 1112222111 111222221 1
Q ss_pred ---CCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 448 ---QDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 448 ---~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..++|+|+.+.||| ..++.+.|+||..|..-
T Consensus 170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 23899999999999 56778899999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00069 Score=67.22 Aligned_cols=138 Identities=12% Similarity=0.067 Sum_probs=76.1
Q ss_pred eeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc--eeEEEEEe------cCCCe
Q 010231 333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTD------KDESK 404 (514)
Q Consensus 333 i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--Iv~l~~~~------~~~~~ 404 (514)
-.+.|+.|....+|+....+| .+++|...... ....+..|+.++..+...+ +.+++... ...+.
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEECC---EEEEEEEESSC-CEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred EeeccCCCcccceEEEEeCCc-cEEEEEeCCCC-------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 356688888899999876555 57788775310 1123445666666553222 23333211 12356
Q ss_pred EEEEEeccccCCHH-----------HHH---h----hcCC------CHHHHHHH---------------HHHHHHHHHHH
Q 010231 405 LYIFLELVTKGSLL-----------NLY---Q----RYHL------RDSQVSAY---------------TRQILLGLKYL 445 (514)
Q Consensus 405 l~LVmEy~~gGsL~-----------~lL---~----~~~l------se~~v~~i---------------~~QIl~gL~yL 445 (514)
.+++|+|++|..+. ..+ . .... ........ ...+...+.+|
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 78999999875421 011 1 1111 10000000 01133445555
Q ss_pred HH-------CCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 446 HD-------QDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 446 Hs-------~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
+. .++||+|+++.|||++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 53 3699999999999998776668999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00092 Score=66.48 Aligned_cols=136 Identities=13% Similarity=0.076 Sum_probs=76.4
Q ss_pred eeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc--eeEEEEE-----ecCCCeEEE
Q 010231 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGT-----DKDESKLYI 407 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--Iv~l~~~-----~~~~~~l~L 407 (514)
..|+ |....||+....+|..+++|....... ....+..|..++..+.... +++++.. ....+..++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~------~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC------CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 4466 777899998777777899998753111 1234556777766663222 3334332 112446688
Q ss_pred EEeccccCCH-----HH------HH---h----hcC------CCHHHH----H------------------HHHHHHHHH
Q 010231 408 FLELVTKGSL-----LN------LY---Q----RYH------LRDSQV----S------------------AYTRQILLG 441 (514)
Q Consensus 408 VmEy~~gGsL-----~~------lL---~----~~~------lse~~v----~------------------~i~~QIl~g 441 (514)
||+|++|..+ .. .+ . ... +..... . ..+.+++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 9999987432 11 11 1 000 111110 0 111112222
Q ss_pred HHHH----HHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 442 LKYL----HDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 442 L~yL----Hs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
+.-+ +...++|+|+++.|||++ + .+.|+||+.+...
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 2211 123589999999999998 4 8999999888754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00086 Score=70.61 Aligned_cols=72 Identities=10% Similarity=0.005 Sum_probs=46.8
Q ss_pred eeeeecccCceeEEEEEccC--------CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc-eeEEEEEecCCC
Q 010231 333 KGDLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES 403 (514)
Q Consensus 333 i~~~LG~GsfG~Vyka~~~~--------g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~ 403 (514)
.++.|+.|....||++...+ +..+++|+.... .. ...+.+|..++..+...+ ..++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--
Confidence 35678888889999997642 467888876321 11 123446888877774333 3567776653
Q ss_pred eEEEEEeccccC
Q 010231 404 KLYIFLELVTKG 415 (514)
Q Consensus 404 ~l~LVmEy~~gG 415 (514)
.+||||++|.
T Consensus 148 --g~v~e~l~G~ 157 (429)
T 1nw1_A 148 --GRLEEYIPSR 157 (429)
T ss_dssp --EEEECCCCEE
T ss_pred --CEEEEEeCCc
Confidence 3899999863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0012 Score=68.57 Aligned_cols=135 Identities=16% Similarity=0.144 Sum_probs=80.0
Q ss_pred eeeecccCceeEEEEEcc--------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCe
Q 010231 334 GDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK 404 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~--------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~ 404 (514)
++.|..|-...+|++... ++..+.+|+.... ......+.+|..+++.+. +.-..++++.+.+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~------~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI------LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc------cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---
Confidence 355777777888998763 2467888864211 112344558888887774 2223567777654
Q ss_pred EEEEEeccccCCHH--------------HHHhh---cC------CC--HHHHHHHHHHHHH-------------------
Q 010231 405 LYIFLELVTKGSLL--------------NLYQR---YH------LR--DSQVSAYTRQILL------------------- 440 (514)
Q Consensus 405 l~LVmEy~~gGsL~--------------~lL~~---~~------ls--e~~v~~i~~QIl~------------------- 440 (514)
.+||||++|..|. ..|.+ .. .. ..++..|+.|+-.
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 3899999875431 11111 11 11 2445556655422
Q ss_pred HHHHHH----HC----CccccCCCCCCEEEcCC----CcEEEEeccCcee
Q 010231 441 GLKYLH----DQ----DVVHRDIKCANILVDAN----GSVKLADFGLAKV 478 (514)
Q Consensus 441 gL~yLH----s~----gIIHRDLKP~NILId~~----g~vKI~DFGlAk~ 478 (514)
.+..|. .. .++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233333 22 49999999999999876 7899999998875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00066 Score=69.21 Aligned_cols=73 Identities=8% Similarity=-0.071 Sum_probs=41.1
Q ss_pred eeeecccCceeEEEEEccC---------CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc-eeEEEEEecCCC
Q 010231 334 GDLLGRGSFGSVYEGISDD---------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES 403 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~---------g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~ 403 (514)
...|+.|....+|++...+ +..+++|+....... ......|..+++.+...+ +.++++.+. +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~------~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE------LYNTISEFEVYKTMSKYKIAPQLLNTFN--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG------TSCHHHHHHHHHHHHHTTSSCCEEEEET--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc------eecHHHHHHHHHHHHhcCCCCceEEecC--C
Confidence 4567888888999987643 257777765421110 112346777777664333 446666552 2
Q ss_pred eEEEEEeccccCC
Q 010231 404 KLYIFLELVTKGS 416 (514)
Q Consensus 404 ~l~LVmEy~~gGs 416 (514)
++||+|++|..
T Consensus 110 --~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 --GRIEEWLYGDP 120 (369)
T ss_dssp --EEEEECCCSEE
T ss_pred --cEEEEEecCCc
Confidence 78999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0037 Score=63.33 Aligned_cols=33 Identities=24% Similarity=0.349 Sum_probs=28.8
Q ss_pred CCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 448 ~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
..++|+|+.+.|||++.++.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 359999999999999988899999998887643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.017 Score=61.39 Aligned_cols=73 Identities=10% Similarity=-0.019 Sum_probs=45.7
Q ss_pred eeeecccCceeEEEEEccC-CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCce-eEEEEEecCCCeEEEEEec
Q 010231 334 GDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLEL 411 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~-g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~LVmEy 411 (514)
++.|+.|-...+|++...+ +..+++|+........ ....+|..++..|...++ .++++.+.. .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~------idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI------INREREKKISCILYNKNIAKKIYVFFTN----GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC------SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh------cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEe
Confidence 4678888889999998754 4678888764211111 112478888888754444 567777642 359999
Q ss_pred cccCC
Q 010231 412 VTKGS 416 (514)
Q Consensus 412 ~~gGs 416 (514)
++|..
T Consensus 183 I~G~~ 187 (458)
T 2qg7_A 183 MDGYA 187 (458)
T ss_dssp CCSEE
T ss_pred eCCcc
Confidence 98743
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.55 E-value=0.028 Score=59.21 Aligned_cols=73 Identities=4% Similarity=-0.123 Sum_probs=44.8
Q ss_pred eeeecccCceeEEEEEccC--------CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCe
Q 010231 334 GDLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK 404 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~--------g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~ 404 (514)
++.|..|-...+|+....+ +..+++++....... .....+|..+++.+. +.-..++++.+..
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~------~idR~~E~~~l~~L~~~gi~P~l~~~~~~--- 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK------FYDSKVELDVFRYLSNINIAPNIIADFPE--- 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C------CCCHHHHHHHHHHHHHTTSSCCEEEEETT---
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch------hcCHHHHHHHHHHHHhcCCCCCEEEEcCC---
Confidence 4567778888899987642 567888865321111 112346777777764 2223456655432
Q ss_pred EEEEEeccccCC
Q 010231 405 LYIFLELVTKGS 416 (514)
Q Consensus 405 l~LVmEy~~gGs 416 (514)
++||+|++|..
T Consensus 146 -~~I~efI~G~~ 156 (424)
T 3mes_A 146 -GRIEEFIDGEP 156 (424)
T ss_dssp -EEEEECCCSEE
T ss_pred -CEEEEEeCCcc
Confidence 78999999855
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.30 E-value=0.16 Score=52.56 Aligned_cols=29 Identities=28% Similarity=0.433 Sum_probs=25.3
Q ss_pred ccccCCCCCCEEE------cCCCcEEEEeccCcee
Q 010231 450 VVHRDIKCANILV------DANGSVKLADFGLAKV 478 (514)
Q Consensus 450 IIHRDLKP~NILI------d~~g~vKI~DFGlAk~ 478 (514)
++|+|+.+.|||+ +.++.++++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3467899999998875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=90.74 E-value=0.6 Score=45.08 Aligned_cols=90 Identities=19% Similarity=0.044 Sum_probs=60.0
Q ss_pred CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCCEEEcCCCcEEEEeccCce----ecccCC--Cc
Q 010231 415 GSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAK----VFLSSL--DF 485 (514)
Q Consensus 415 GsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLH-s~gIIHRDLKP~NILId~~g~vKI~DFGlAk----~~~~~~--~~ 485 (514)
-+|.++|+- ..+++++++.++.|.+.+|.-+- .+.-..+=+.|..|++..+|.|.+.+ +.+. .+..+. ..
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~~~~~~~~~pe~~~~ 111 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADDAGEPPPVAGKLGYS 111 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------CCSSS
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-ccccccccCCCChhhccc
Confidence 378998875 46999999999999999987762 22222333457999999999998874 2221 111111 11
Q ss_pred CcceeehhhhHHHHHHHHHh
Q 010231 486 DLLLIFSIFLNGCKFFLIFL 505 (514)
Q Consensus 486 ~~~~~~DVwSlG~lLyeLlt 505 (514)
..+.+.-|++||+++|.-+-
T Consensus 112 ~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 112 QCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp SSCHHHHHHHHHHHHHHHHT
T ss_pred cchHHHHHHHHHHHHHHHhh
Confidence 22355669999999998774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 514 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-39 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-38 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-35 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-32 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-30 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-30 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-29 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-17 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-43
Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
+W+ LG G+FG VY+ + + A K + +++++ + EI +L+ +
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCD 67
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLH 446
H NIV+ E+ L+I +E G++ + L +SQ+ +Q L L YLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
D ++HRD+K NIL +G +KLADFG++ ++
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 2e-41
Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 11/177 (6%)
Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
E P F + +G GSFG+VY + A+K++S G Q
Sbjct: 4 VAELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQ 54
Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRD 428
+ + + +E+ L + H N +QY G E ++ +E + L + L++
Sbjct: 55 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 114
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
+++A T L GL YLH +++HRD+K NIL+ G VKL DFG A + + F
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 171
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-40
Identities = 46/154 (29%), Positives = 78/154 (50%), Gaps = 4/154 (2%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ G LG+G FG+VY F A+K + + QL +E+ + S H
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
NI++ YG D +++Y+ LE G++ Q+ + + + Y ++ L Y H +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
V+HRDIK N+L+ + G +K+ADFG + SS
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-39
Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 6/151 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W LG G++G V ++ AVK V + +A +++EI + H
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
EN+V++YG ++ + Y+FLE + G L + + + + + Q++ G+ YLH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ HRDIK N+L+D ++K++DFGLA VF
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVF 153
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-38
Identities = 41/156 (26%), Positives = 80/156 (51%), Gaps = 7/156 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K LG G+ G V++ G A K + L +Q+ +E+ +L
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNS 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
IV +YG + ++ I +E + GSL + ++ + + + + ++ GL YL ++
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483
++HRD+K +NILV++ G +KL DFG++ + S+
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-38
Identities = 44/151 (29%), Positives = 71/151 (47%), Gaps = 8/151 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
G +G GSFG+VY+G AVK +L+ + Q + + E+ +L + H
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDV--AVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQ 448
NI+ + G +L I + SL + ++ RQ G+ YLH +
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
++HRD+K NI + + +VK+ DFGLA V
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-38
Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 13/161 (8%)
Query: 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE 378
P ++ R + +G+G+ G+VY + G A+++++L Q +
Sbjct: 18 PKKKYTRF-------EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELII 65
Query: 379 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQI 438
EI ++ ++ NIV Y + +L++ +E + GSL ++ + + Q++A R+
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 125
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
L L++LH V+HRDIK NIL+ +GSVKL DFG
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 8e-38
Identities = 44/151 (29%), Positives = 79/151 (52%), Gaps = 4/151 (2%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ G +LG GSF +V +A+K + + + + + +E ++SR +H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDH 67
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
V+ Y T +D+ KLY L G LL ++ ++ YT +I+ L+YLH +
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
++HRD+K NIL++ + +++ DFG AKV
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 158
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-37
Identities = 52/162 (32%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ +G GS+G + DG KE LD GS + L E+ LL +H
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 390 ENIVQYY--GTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGL 442
NIV+YY D+ + LYI +E G L ++ + +L + V Q+ L L
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 443 KYLHDQD-----VVHRDIKCANILVDANGSVKLADFGLAKVF 479
K H + V+HRD+K AN+ +D +VKL DFGLA++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (345), Expect = 9e-37
Identities = 42/160 (26%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
+ Y+ + LG G+FG V+ + G F K ++ + ++ EI++
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISI 79
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLG 441
+++ H ++ + +D+ ++ + LE ++ G L + Y + +++V Y RQ G
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139
Query: 442 LKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKVF 479
LK++H+ +VH DIK NI+ + SVK+ DFGLA
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 2e-36
Identities = 55/175 (31%), Positives = 93/175 (53%), Gaps = 18/175 (10%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ 376
+S +GRF + +GRGSF +VY+G+ ++ A E L K +
Sbjct: 4 MSNDGRFLKF------DIEIGRGSFKTVYKGLDTETTVEVAWCE---LQDRKLTKSERQR 54
Query: 377 LEQEIALLSRFEHENIVQYYG----TDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQV 431
++E +L +H NIV++Y T K + + + EL+T G+L +R+ ++ +
Sbjct: 55 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 114
Query: 432 SAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLADFGLAKVFLSSL 483
++ RQIL GL++LH + ++HRD+KC NI + GSVK+ D GLA + +S
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 135 bits (341), Expect = 3e-36
Identities = 38/162 (23%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
+ ++ ++ + LG G+FG V+ G FA K V + + +EI
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEI 74
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQIL 439
+S H +V + +D++++ + E ++ G L + + + + Y RQ+
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 440 LGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKVF 479
GL ++H+ + VH D+K NI+ + +KL DFGL
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 132 bits (332), Expect = 1e-35
Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 7/156 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 385
++ ++LGRG V I +AVK + + GS + + + +L + E+ +L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
+ H NI+Q T + + ++ +L+ KG L + L ++ L + + R +L +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
LH ++VHRD+K NIL+D + ++KL DFG +
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-35
Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 8/151 (5%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G FG V G + A+K + + S + +E ++ HE +V
Sbjct: 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
Q YG + ++I E + G LLN R+ + Q+ + + ++YL + +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 452 HRDIKCANILVDANGSVKLADFGLAKVFLSS 482
HRD+ N LV+ G VK++DFGL++ L
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 133 bits (335), Expect = 3e-35
Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 3/155 (1%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFE 388
+ ++GRG FG VY D G +A+K + + ++++ E ++L+S +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
IV KL L+L+ G L +L Q ++ + Y +I+LGL+++H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
+ VV+RD+K ANIL+D +G V+++D GLA F
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-35
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 10/151 (6%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+ + LG G FG V+ G + AVK + Q S E L+ + +H+
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQR 69
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+V+ Y E +YI E + GSL L L +++ QI G+ ++ ++
Sbjct: 70 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ +HRD++ ANILV S K+ADFGLA++
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLI 159
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 7e-35
Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 2/150 (1%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
D LG G F +VY+ + A+K++ L + +EI LL H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+S + + + + + + L S + AY L GL+YLH ++H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 453 RDIKCANILVDANGSVKLADFGLAKVFLSS 482
RD+K N+L+D NG +KLADFGLAK F S
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSP 153
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-34
Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G+FGSV +G+ A+K + K ++ +E ++ + ++ IV
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ G + E L + +E+ G L +R + S V+ Q+ +G+KYL +++ V
Sbjct: 73 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 452 HRDIKCANILVDANGSVKLADFGLAKVF 479
HRD+ N+L+ K++DFGL+K
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKAL 159
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (323), Expect = 3e-34
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++G G FG V G F A+K + ++ E +++ +F+H
Sbjct: 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDH 86
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHD 447
N++ G + + I E + GSL + ++ + + Q+ R I G+KYL D
Sbjct: 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
+ VHRD+ NILV++N K++DFGL++
Sbjct: 147 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-33
Identities = 34/151 (22%), Positives = 65/151 (43%), Gaps = 8/151 (5%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G G FG V+ G + A+K + + S +E ++ + H +V
Sbjct: 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVV 451
Q YG +++ + + E + G L + + + + + G+ YL + V+
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 452 HRDIKCANILVDANGSVKLADFGLAKVFLSS 482
HRD+ N LV N +K++DFG+ + L
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 1e-33
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ D+LG G+F V A+K ++ + +E EIA+L + +H
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK----KALEGKEGSMENEIAVLHKIKH 66
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
NIV + LY+ ++LV+ G L + + ++ + S Q+L +KYLHD
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
+VHRD+K N+L D + + ++DFGL+K+
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-33
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 8/153 (5%)
Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G+FG+V +G AVK +L + +L E ++ + ++ IV
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ G + ES + +E+ G L L Q H++D + Q+ +G+KYL + + VH
Sbjct: 72 RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 453 RDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
RD+ N+L+ K++DFGL+K + ++
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (312), Expect = 7e-33
Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 4/152 (2%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+ +G G++G VY+ ++ G FA+K++ L + +EI++L +H N
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS---TTIREISILKELKHSN 61
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNL-YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
IV+ Y + +L + E + + L L ++ Q+L G+ Y HD+ V
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
+HRD+K N+L++ G +K+ADFGLA+ F
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIP 153
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 7e-33
Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG+G FG V+ G + A+K + S QE ++ + HE +V
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDV 450
Q Y +E +YI E ++KGSLL+ + +LR Q+ QI G+ Y+ +
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
VHRD++ ANILV N K+ADFGLA++ +
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDN 166
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 7e-33
Identities = 33/160 (20%), Positives = 74/160 (46%), Gaps = 11/160 (6%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
K + + + LGRG FG V+ + + + K V + +++EI++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISI 54
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLG 441
L+ H NI+ + + + +L + E ++ + + L + ++ +Y Q+
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 442 LKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKVF 479
L++LH ++ H DI+ NI+ + ++K+ +FG A+
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (314), Expect = 1e-32
Identities = 46/151 (30%), Positives = 84/151 (55%), Gaps = 4/151 (2%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+Q LG GSFG V+ S +G ++A+K + + + + E +LS H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--EIVVRLKQVEHTNDERLMLSIVTH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 448
I++ +GT +D ++++ ++ + G L +L ++ + V+ Y ++ L L+YLH +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
D+++RD+K NIL+D NG +K+ DFG AK
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYV 154
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-32
Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 3/154 (1%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ +LG+GSFG V+ FFA+K + D + ++ L +EH
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+ + T + + L+ +E + G L+ + + S+ + Y +I+LGL++LH +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
+V+RD+K NIL+D +G +K+ADFG+ K +
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-32
Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+ +G+G FG V G G AVK + + E +++++ H N
Sbjct: 10 KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKN-------DATAQAFLAEASVMTQLRHSN 61
Query: 392 IVQYYGTD-KDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHD 447
+VQ G +++ LYI E + KGSL++ + R L + ++ + ++YL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
+ VHRD+ N+LV + K++DFGL K S+ D
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-32
Identities = 47/163 (28%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+ +G+G FG V+ G G AVK S ++ S + E EI HENI+
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHENIL 60
Query: 394 QYYGTDKDE----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--- 446
+ D + ++L++ + GSL + RY + + GL +LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 447 -----DQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
+ HRD+K NILV NG+ +AD GLA S+ D
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (309), Expect = 2e-32
Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 10/150 (6%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G +G VYEG+ AVK + + + + +E A++ +H N+
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQD 449
VQ G E YI E +T G+LL+ + R + + QI ++YL ++
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKVF 479
+HRD+ N LV N VK+ADFGL+++
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLM 165
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-32
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 7/156 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRF- 387
+Q G LLG G FGSVY GI D A+K V + +++ E+ LL +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKY 444
+++ + + LE L + +R L++ ++ Q+L +++
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 445 LHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKVF 479
H+ V+HRDIK NIL+D N G +KL DFG +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 8e-32
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 9/160 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ + LG GSFG V G S AVK + +++ +E+ +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAMHS 67
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
+H N+++ YG + + EL GSLL+ +++ H +S Y Q+ G+ Y
Sbjct: 68 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
L + +HRD+ N+L+ VK+ DFGL + + D
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 35/180 (19%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G +LG G+FG V + AVK + S+ + L E+ ++++
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA----LMSELKMMTQL 97
Query: 388 E-HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--------------------- 425
HENIV G +Y+ E G LLN +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 426 ---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
L + + Q+ G+++L + VHRD+ N+LV VK+ DFGLA+ +S
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
F ++ ++K +G+G+FG V++ G A+K+V + ++ +EI
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI---TALREIK 61
Query: 383 LLSRFEHENIVQYYGT--------DKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSA 433
+L +HEN+V ++ + +Y+ + L S++
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ +L GL Y+H ++HRD+K AN+L+ +G +KLADFGLA+ F
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-31
Identities = 48/158 (30%), Positives = 83/158 (52%), Gaps = 6/158 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+QK + +G G++G VY+ + G A+K++ L ++ + S +EI+LL H
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
NIV+ E+KLY+ E + + + + + +Y Q+L GL + H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
V+HRD+K N+L++ G++KLADFGLA+ F +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-31
Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
G +G G FG V++GI + A+K S ++ QE + +F+H
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK----FLQEALTMRQFDH 67
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
+IV+ G E+ ++I +EL T G L + Q L + + Y Q+ L YL
Sbjct: 68 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ VHRDI N+LV +N VKL DFGL++
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-31
Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ +G G++G V + A+K++S + + ++ +EI +L RF H
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR----TLREIKILLRFRH 65
Query: 390 ENIVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
ENI+ + + K + + L L + HL + + + QIL GLKY+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
H +V+HRD+K +N+L++ +K+ DFGLA+V D
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 4e-31
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 4/151 (2%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ LLG+G+FG V G ++A+K + + AK ++ E +L H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQNTRH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+ + +L +E G L L + + + Y +I+ L+YLH +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
DVV+RDIK N+++D +G +K+ DFGL K
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 45/172 (26%), Positives = 65/172 (37%), Gaps = 30/172 (17%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LG G+FG V E SD AVK + S L E+ +LS
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP----SAHLTEREALMSELKVLSYL 83
Query: 388 E-HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------LR 427
H NIV G + E G LLN +R L
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ +++ Q+ G+ +L ++ +HRD+ NIL+ K+ DFGLA+
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 8/179 (4%)
Query: 310 TTTEPMSNISPNGRFKRI-ITYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLL 364
T + + G +++ I ++ +LG G++G V+ D G +A+K +
Sbjct: 4 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK- 62
Query: 365 DQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQ 422
Q ++ E +L +V + + E+KL++ L+ + G L L Q
Sbjct: 63 ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ 122
Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481
R + +V Y +I+L L++LH +++RDIK NIL+D+NG V L DFGL+K F++
Sbjct: 123 RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-30
Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 7/157 (4%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRF 387
Y+ G+ LG G F V + G +A K + + S+ S +E+E+++L
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
+H N++ + ++++ + + LELV G L + L + + + + +QIL G+ YLH
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 447 DQDVVHRDIKCANILVDANGS----VKLADFGLAKVF 479
+ H D+K NI++ +K+ DFGLA
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-30
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 11/158 (6%)
Query: 332 QKGDLLGRGSFGSVYEGISDDG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ ++G G FG VY+G+ A+K + ++ E ++ +
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGEAGIMGQ 65
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKY 444
F H NI++ G + I E + G+L + Q+ R I G+KY
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
L + + VHRD+ NILV++N K++DFGL++V
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 4e-30
Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 23/187 (12%)
Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
S TT + R + + +Y ++G GSFG VY+ D G A+K+V
Sbjct: 1 SKVTTVVATPGQGPDRPQEV-SY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----- 53
Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGSLLNL 420
Q +E+ ++ + +H NIV+ G KDE L + L+ V +
Sbjct: 54 ----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 421 YQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-VKLADFGL 475
+ L V Y Q+ L Y+H + HRDIK N+L+D + + +KL DFG
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 476 AKVFLSS 482
AK +
Sbjct: 170 AKQLVRG 176
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-30
Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 5/151 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K + +G G++G+V++ + + A+K V L D +EI LL +H
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+NIV+ + + KL + E + L V ++ Q+L GL + H +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+V+HRD+K N+L++ NG +KLA+FGLA+ F
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAF 151
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (295), Expect = 6e-30
Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 11/184 (5%)
Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFF 356
F + ++D P N + +F RI LG GSFG V + G +
Sbjct: 17 EFLAKAKEDFLKKWETPSQNTAQLDQFDRI-------KTLGTGSFGRVMLVKHKESGNHY 69
Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
A+K + Q + I E +L +V+ + KD S LY+ +E V G
Sbjct: 70 AMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 417 LLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
+ + L + + Y QI+L +YLH D+++RD+K N+L+D G +++ DFG
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 476 AKVF 479
AK
Sbjct: 188 AKRV 191
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (290), Expect = 1e-29
Identities = 41/182 (22%), Positives = 73/182 (40%), Gaps = 35/182 (19%)
Query: 332 QKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
+ +G G+FG V++ + + AVK + + + ++E AL++
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMA 71
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------- 425
F++ NIV+ G + + E + G L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 426 -----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480
L ++ RQ+ G+ YL ++ VHRD+ N LV N VK+ADFGL++
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 481 SS 482
S+
Sbjct: 192 SA 193
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-29
Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 331 WQKGDLLGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
++ +G G++G V++ + + G F A+K V + S + + L FE
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 389 HENIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLG 441
H N+V+ + E+KL + E V + L + + + Q+L G
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
L +LH VVHRD+K NILV ++G +KLADFGLA+++
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-29
Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 21/165 (12%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HEN 391
D++G G+FG V + DG + + S K E+ +L + H N
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPN 72
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAY 434
I+ G + LY+ +E G+LL+ ++ L Q+ +
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ G+ YL + +HRD+ NILV N K+ADFGL++
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 177
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (287), Expect = 5e-29
Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 15/154 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
+Q LGRG + V+E I+ + VK + ++++EI +L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88
Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
NI+ D + E V LYQ L D + Y +IL L Y H
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 447 DQDVVHRDIKCANILVDA-NGSVKLADFGLAKVF 479
++HRD+K N+++D + ++L D+GLA+ +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 6e-29
Identities = 41/168 (24%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 324 FKRIITY--WQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQ 376
RI+ ++K +LG G+FG+VY+G+ A+KE+ ++ +
Sbjct: 2 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS----PKANKE 57
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAY 434
+ E +++ ++ ++ + G + + +L+ G LL+ + + + +
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 116
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
QI G+ YL D+ +VHRD+ N+LV VK+ DFGLAK+ +
Sbjct: 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 7e-29
Identities = 41/165 (24%), Positives = 66/165 (40%), Gaps = 22/165 (13%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-F 387
Y +LG G G V + + FA+K + Q + +E+ L R
Sbjct: 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRAS 62
Query: 388 EHENIVQYYGT----DKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILL 440
+ +IV+ L I +E + G L + Q + + S + I
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 441 GLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKVFLSS 482
++YLH ++ HRD+K N+L + N +KL DFG AK S
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 9e-29
Identities = 47/186 (25%), Positives = 81/186 (43%), Gaps = 16/186 (8%)
Query: 306 DSSSTTTEPMSNISPN--GRFKRIITYWQKGDLLGRGSFGSVYEGISDD----GFFFAVK 359
D S+ E + + G I+ + +++GRG FG VY G D AVK
Sbjct: 5 DLSALNPELVQAVQHVVIGPSSLIVHF---NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61
Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDESKLYIFLELVTKGSLL 418
++ + +SQ E ++ F H N++ G + E + L + G L
Sbjct: 62 SLNRITD----IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117
Query: 419 NLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
N + ++ + + Q+ G+K+L + VHRD+ N ++D +VK+ADFGLA
Sbjct: 118 NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 477 KVFLSS 482
+
Sbjct: 178 RDMYDK 183
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 111 bits (279), Expect = 3e-28
Identities = 37/160 (23%), Positives = 67/160 (41%), Gaps = 8/160 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ G++LG G V+ AVK + ++ + +E + H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALNH 66
Query: 390 ENIVQYYGTDKDESK----LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
IV Y T + E+ YI +E V +L ++ + + L +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLD 484
H ++HRD+K ANI++ A +VK+ DFG+A+ S +
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 5e-27
Identities = 38/166 (22%), Positives = 72/166 (43%), Gaps = 21/166 (12%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
LG+GSFG VYEG+ + A+K V+ + + + + E +++ F
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEF 80
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTR 436
++V+ G + +EL+T+G L + + S++
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482
+I G+ YL+ VHRD+ N +V + +VK+ DFG+ + +
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-26
Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 9/154 (5%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
Q +G G++GSV G AVK+ L + Q+ + +E+ LL +HE
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 391 NIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
N++ +E + + L N+ + L D V QIL GLKY+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
H D++HRD+K +N+ V+ + +K+ DFGLA+
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 8e-26
Identities = 37/152 (24%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ +G G++G+V + G A+K+ L + Q++ + +E+ LL HE
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKK---LYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL-----NLYQRYHLRDSQVSAYTRQILLGLKYL 445
N++ + L F + + L + L + ++ Q+L GL+Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
H ++HRD+K N+ V+ + +K+ DFGLA+
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (259), Expect = 2e-25
Identities = 37/160 (23%), Positives = 63/160 (39%), Gaps = 13/160 (8%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
R+ ++ G +G GSFG +Y G G A+K + K QL E +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-------KTKHPQLHIESKIY 56
Query: 385 SRFEHEN-IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGL 442
+ I + + +EL+ L + V Q++ +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKVF 479
+Y+H ++ +HRD+K N L+ V + DFGLAK +
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-25
Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 30/172 (17%)
Query: 334 GDLLGRGSFGSVYEGI--------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
G LG G+FG V + AVK + ++ +S L E+ ++
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMK 73
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLR 427
+H+NI+ G + LY+ +E +KG+L Q L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
+ + Q+ G++YL + +HRD+ N+LV + +K+ADFGLA+
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 8e-25
Identities = 43/179 (24%), Positives = 72/179 (40%), Gaps = 27/179 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
+ G LGRG+FG V E + AVK +L +G+ + + + + L+
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILI 71
Query: 385 SRFEHENIVQYYG-TDKDESKLYIFLELVTKGSLLNLYQRY-----------------HL 426
H N+V G K L + +E G+L + L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDF 485
+ Y+ Q+ G+++L + +HRD+ NIL+ VK+ DFGLA+ D+
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 101 bits (253), Expect = 1e-24
Identities = 32/162 (19%), Positives = 63/162 (38%), Gaps = 15/162 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ G +G GSFG ++EG + + A+K + QL E
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-------RSDAPQLRDEYRTYKLLAG 59
Query: 390 -ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
I Y ++ + ++L+ L V+ +Q+L ++ +H+
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 448 QDVVHRDIKCANILVDA-----NGSVKLADFGLAKVFLSSLD 484
+ +V+RDIK N L+ + + DFG+ K + +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 6e-24
Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
Q +G G+ G V A+K+ L + Q + + +E+ L+ H+
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKK---LSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 391 NIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
NI+ T ++ +Y+ +EL+ + ++S Q+L G+K+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--RMSYLLYQMLCGIKH 134
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479
LH ++HRD+K +NI+V ++ ++K+ DFGLA+
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 8e-22
Identities = 27/168 (16%), Positives = 55/168 (32%), Gaps = 24/168 (14%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSL-------------LDQGSQAKQSISQLEQE 380
G L+G G +V+ S+ VK + + +I E
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL 440
L + + + + Y + + + +EL+ L + IL
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDE------VLDMILE 114
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSLDFDLL 488
+ + + +VH D+ N+LV G + + DF + ++L
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREIL 161
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.7 bits (195), Expect = 8e-17
Identities = 39/184 (21%), Positives = 70/184 (38%), Gaps = 38/184 (20%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
+ R+ LG G F +V+ + A+K V K E
Sbjct: 12 DARY-------ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAED 58
Query: 380 EIALLSRFEHENIVQ-------------YYGTDKDESKLYIFLELVTKG----SLLNLYQ 422
EI LL R + + + K + +++ + G +L+ Y+
Sbjct: 59 EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE 118
Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANG------SVKLADFGL 475
+ V ++Q+LLGL Y+H + ++H DIK N+L++ +K+AD G
Sbjct: 119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 178
Query: 476 AKVF 479
A +
Sbjct: 179 ACWY 182
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 514 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.77 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.14 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.69 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.42 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=347.95 Aligned_cols=181 Identities=26% Similarity=0.410 Sum_probs=163.0
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++++.||+|+||+||+|++ .+|+.||||++...... ..+.+.+|+.+|+.++||||+++++++.+.+.+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence 4689999999999999999998 68999999998754322 23568899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-----
Q 010231 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS----- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~----- 482 (514)
|||||++|+|.+++.+..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 95 vmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999999976432
Q ss_pred --------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 --------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 --------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||++|+|+||++||.+.+
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 12345678999999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=339.83 Aligned_cols=185 Identities=26% Similarity=0.431 Sum_probs=163.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
+++|++++.||+|+||+||+|++ .+++.||+|++..... ........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc--cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 67899999999999999999998 5789999999874221 12233466889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
||||||++|+|.+++.+ ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 99999999999998876 57999999999999999999999999999999999999999999999999999876543
Q ss_pred --------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 --------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 --------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++.++|||||||+||+|++|++||.+.+
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 12345678999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=345.15 Aligned_cols=183 Identities=26% Similarity=0.480 Sum_probs=158.6
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
++++|++++.||+|+||+||+|++ .+|+.||||++..... ....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~ 78 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc----chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence 467899999999999999999998 6799999999875322 22335688999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
|||||||++|+|.+++.. ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999999998865 46999999999999999999999999999999999999999999999999999865321
Q ss_pred -------------------CCcC-cceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -------------------LDFD-LLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -------------------~~~~-~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ++..+|||||||+||+|+||++||.+.
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence 0122 345789999999999999999999765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=348.01 Aligned_cols=183 Identities=25% Similarity=0.403 Sum_probs=162.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
.++|+++++||+|+||+||+|++ .+|+.||+|+++.... .....++.+|+.+|+.++|||||+++++|.+.+++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46899999999999999999998 6899999999875322 223467889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
|||||+.+|+|.+++.+ ..+++..++.|+.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+.+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 160 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 160 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc
Confidence 99999999999998865 579999999999999999999997 59999999999999999999999999999965322
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||++|+|++|+.||.+.+
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 12456678999999999999999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=340.02 Aligned_cols=184 Identities=27% Similarity=0.444 Sum_probs=162.0
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++++.||+|+||+||+|++ .+++.||||++..... ........+.+|+.+|+.++||||+++++++.+.+.+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc--cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 5799999999999999999998 6799999999874221 122334678899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
|||||++|+|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999999998865 57999999999999999999999999999999999999999999999999999876422
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++.++|||||||+||+|+||++||.+.|
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence 12345668999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=340.60 Aligned_cols=181 Identities=27% Similarity=0.435 Sum_probs=159.8
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|++++.||+|+||+||+|++ .++..||||++..... ...+.+.+|+.+|++++||||+++++++.+.+.+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 5799999999999999999998 6789999999875322 223567899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|||||++|+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 9999999999998754 45999999999999999999999999999999999999999999999999999865321
Q ss_pred ---------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ---------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ---------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++.++|||||||+||+|+||++||.+.+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 12335678999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=344.04 Aligned_cols=185 Identities=26% Similarity=0.369 Sum_probs=164.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
+++|++++.||+|+||+||+|++ .+|+.||||++..... .......++.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 57899999999999999999998 6899999999974221 12234567889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
||||||++|+|..++.+ ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 99999999999998876 56899999999999999999999999999999999999999999999999999875432
Q ss_pred ----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||++|+|++|++||.+.|
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 12455678999999999999999999998864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.5e-41 Score=344.07 Aligned_cols=183 Identities=23% Similarity=0.397 Sum_probs=161.7
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
+.++|++++.||+|+||+||+|++ .+|+.||||++.... ......+.+|+.+|+.++||||++++++|.+++.+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 457899999999999999999998 689999999987532 12235678999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc--CCCcEEEEeccCceeccc
Q 010231 406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId--~~g~vKI~DFGlAk~~~~ 481 (514)
|||||||++|+|.+++... .+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.+..
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999999999999877543 589999999999999999999999999999999999998 578999999999998653
Q ss_pred C------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 482 S------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 482 ~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
. ....++.++|||||||+||+|+||++||.+.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 3 12446678999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9e-41 Score=338.78 Aligned_cols=185 Identities=26% Similarity=0.421 Sum_probs=163.3
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
+++|++++.||+|+||+||+|++ .+|+.||||++..... ......+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence 56899999999999999999998 6799999999874221 12233567889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
+|||||.||+|..++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~ 160 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 160 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence 99999999999998876 46888899999999999999999999999999999999999999999999999986533
Q ss_pred -------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++.++|||||||+||+|+||+.||.+.|
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 22446678999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.9e-40 Score=329.17 Aligned_cols=187 Identities=23% Similarity=0.359 Sum_probs=164.1
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc----hhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS----QAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~----~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~ 401 (514)
.++|++++.||+|+||+||+|++ .+|+.||||++....... ..+...+.+.+|+.+++++. ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999998 689999999997644322 22344566889999999997 9999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
++.+||||||+++|+|.++++. ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999999999999965 579999999999999999999999999999999999999999999999999999765
Q ss_pred cCC------------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SSL------------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~~------------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... ...++.++||||+||+||+|++|+.||.+.+
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 321 1223457899999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-40 Score=336.95 Aligned_cols=184 Identities=26% Similarity=0.380 Sum_probs=161.7
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
+.|++++.||+|+||+||+|++ .+++.||||++..... ......+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS--CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc--cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 4699999999999999999997 6889999999875332 234456778999999999999999999999999999999
Q ss_pred EEeccccCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 408 FLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~-~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
|||||.+|+|..++. +..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 172 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCccc
Confidence 999999999877654 457999999999999999999999999999999999999999999999999999975432
Q ss_pred --------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 --------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 --------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++.++|||||||++|+|++|..||.+.+
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 11235668999999999999999999998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-40 Score=342.26 Aligned_cols=184 Identities=22% Similarity=0.358 Sum_probs=162.4
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.++++|++++.||+|+||+||+|++ .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 97 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4578999999999999999999998 689999999986422 2234678899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC--CCcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~--~g~vKI~DFGlAk~~~ 480 (514)
+|||||||++|+|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+.+.
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999999999999853 46999999999999999999999999999999999999964 6789999999999765
Q ss_pred cC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.. ....++.++|||||||++|+|++|++||.+.|
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 33 12345668999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=330.90 Aligned_cols=188 Identities=24% Similarity=0.401 Sum_probs=164.0
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc-hhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
+.++|++++.||+|+||+||+|++ .+|+.||||++....... ......+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 456799999999999999999998 689999999997533221 122235678899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC----cEEEEeccCceec
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKVF 479 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g----~vKI~DFGlAk~~ 479 (514)
+|||||||++|+|.+++.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999999865 4699999999999999999999999999999999999998776 5999999999876
Q ss_pred ccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 480 LSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 480 ~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... ....++.++|||||||++|+|++|+.||.+.+
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 433 12356678999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-41 Score=332.11 Aligned_cols=184 Identities=28% Similarity=0.414 Sum_probs=152.9
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC--CCe
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESK 404 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~--~~~ 404 (514)
.++|++++.||+|+||+||+|++ .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+ .+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC---HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC---HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence 36899999999999999999998 67899999998754322 3345678899999999999999999998854 567
Q ss_pred EEEEEeccccCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCCEEEcCCCcEEEEecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-----~~lse~~v~~i~~QIl~gL~yLHs~g-----IIHRDLKP~NILId~~g~vKI~DFG 474 (514)
+|||||||++|+|.+++.+ ..+++..++.|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 9999999999999998853 35999999999999999999999876 9999999999999999999999999
Q ss_pred CceecccC-------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 475 LAKVFLSS-------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 475 lAk~~~~~-------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
+|+.+... ....++.++|||||||++|+|+||++||.+.+
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 99865432 12355678999999999999999999998753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-40 Score=336.81 Aligned_cols=183 Identities=25% Similarity=0.361 Sum_probs=151.2
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
+.+.|+++++||+|+||+||+|++ .+++.||||++...... .....+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456799999999999999999998 57899999998753221 2235678999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEc---CCCcEEEEeccCceeccc
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId---~~g~vKI~DFGlAk~~~~ 481 (514)
|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+|||+. .++.+||+|||+|+....
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999999999865 4699999999999999999999999999999999999995 578999999999986542
Q ss_pred C------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 482 S------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 482 ~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
. ....++.++|||||||+||+|++|++||.+.
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 2 1235667899999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=337.23 Aligned_cols=183 Identities=19% Similarity=0.330 Sum_probs=161.0
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
.+.++|++++.||+|+||+||+|++ .+++.||||+++... .....+.+|+.+|+.++||||+++++++.+.++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 75 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 4567899999999999999999998 578999999987532 122457899999999999999999999999999
Q ss_pred EEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC--CcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~--g~vKI~DFGlAk~~~ 480 (514)
+|||||||.||+|.+++... .+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999999999999754 58999999999999999999999999999999999999854 489999999999765
Q ss_pred cC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.. ....++..+|||||||++|+|++|.+||.+.+
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 33 12345568899999999999999999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-40 Score=339.36 Aligned_cols=185 Identities=25% Similarity=0.373 Sum_probs=163.8
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
+++|++++.||+|+||+||+|++ .+|+.||||++..... ......+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 46899999999999999999998 6899999999874221 12233467889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
+||||+.+|+|..++.+ ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~ 197 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccccc
Confidence 99999999999988865 57999999999999999999999999999999999999999999999999999987543
Q ss_pred -------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||+||+|+||++||.+.+
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 12345668999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-40 Score=324.59 Aligned_cols=181 Identities=27% Similarity=0.461 Sum_probs=155.4
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC----CCe
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESK 404 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----~~~ 404 (514)
+|++.+.||+|+||+||+|++ .+++.||+|.+...... ....+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 467788999999999999998 57889999998754322 3345678999999999999999999998754 456
Q ss_pred EEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEc-CCCcEEEEeccCceecc
Q 010231 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAKVFL 480 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILId-~~g~vKI~DFGlAk~~~ 480 (514)
+||||||+++|+|.+++.+ ..+++..++.|+.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 8999999999999999876 46999999999999999999999998 99999999999997 57899999999998643
Q ss_pred cC----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SS----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ....++.++|||||||++|+|++|+.||.+.
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 22 1234556899999999999999999999763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.4e-40 Score=338.29 Aligned_cols=186 Identities=27% Similarity=0.370 Sum_probs=158.4
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccc-hhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
+++|+++++||+|+||+||+|++ .+|+.||||++....... ..........+++.+++.++||||+++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 56899999999999999999998 579999999986422111 1112222334557788888999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
|||||||.+|+|.+++.+ ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~ 162 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence 999999999999998865 46899999999999999999999999999999999999999999999999999976533
Q ss_pred ----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++.++|||||||+||+|+||+.||.+.
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 1234567899999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-40 Score=329.76 Aligned_cols=179 Identities=26% Similarity=0.382 Sum_probs=156.3
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeE
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l 405 (514)
..++|++++.||+|+||+||+|++ .+++.||||+++.... ..+++.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 356899999999999999999998 5788999998764221 235688999999999999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 406 YIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
|||||||++|+|..++.. ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999999999865 35889999999999999999999999999999999999999999999999999876433
Q ss_pred --------------------CCcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 483 --------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 483 --------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
....++.++|||||||++|+|++|..||.
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 11345568999999999999999655543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=330.62 Aligned_cols=181 Identities=29% Similarity=0.436 Sum_probs=151.7
Q ss_pred eeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEec
Q 010231 333 KGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (514)
Q Consensus 333 i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy 411 (514)
.+++||+|+||+||+|++ .+|+.||||+++............+.+.+|+.+|+.++||||+++++++...+++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468899999999999998 6799999999875433322223345688999999999999999999999999999999999
Q ss_pred cccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--------
Q 010231 412 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-------- 482 (514)
Q Consensus 412 ~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-------- 482 (514)
+.++++..++.. ..+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 999877766654 45899999999999999999999999999999999999999999999999999876432
Q ss_pred ------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++.++|||||||++|+|+||.+||.+.
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 1134566889999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=330.47 Aligned_cols=185 Identities=26% Similarity=0.431 Sum_probs=159.5
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHh-hcCCCceeEEEEEecCCCeE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS-RFEHENIVQYYGTDKDESKL 405 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~-~L~HpnIv~l~~~~~~~~~l 405 (514)
+++|++++.||+|+||+||+|++ .+++.||||++..... ........+..|+.++. .++||||+++++++.+.+.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 36899999999999999999998 6899999999974221 11223345566666654 68999999999999999999
Q ss_pred EEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 406 ~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
||||||+++|+|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999999999999966 46999999999999999999999999999999999999999999999999999865432
Q ss_pred -----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 -----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 -----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.+..++.++|||||||++|+|+||+.||.+.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 22455668999999999999999999998864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-39 Score=328.02 Aligned_cols=182 Identities=24% Similarity=0.398 Sum_probs=149.2
Q ss_pred ccceEeeeeecccCceeEEEEEcc-CCc---eEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD-DGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~-~g~---~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.++|++.++||+|+||+||+|++. +++ .||||.+... ......+.+.+|+.+|++++|||||++++++...+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 467999999999999999999873 333 5777766432 12334567899999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+|||||||++|+|.+++... .+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+..
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999999988763 589999999999999999999999999999999999999999999999999986542
Q ss_pred C------------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 S------------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~------------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
. ....++..+|||||||+||||+| |++||.+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 2 11344557899999999999998 89999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=324.44 Aligned_cols=180 Identities=25% Similarity=0.380 Sum_probs=153.3
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|+++++||+|+||+||+|++.. .||||+++..... ....+.+.+|+.+|++++||||+++++++.. +.+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 4678999999999999999998753 5999988654322 2345778999999999999999999998754 56899
Q ss_pred EEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC---
Q 010231 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS--- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~--- 482 (514)
|||||++|+|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999999999999864 35899999999999999999999999999999999999999999999999999765321
Q ss_pred ---------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 ---------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 ---------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++.++|||||||+||||+||+.||.+.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 0123456789999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=321.64 Aligned_cols=179 Identities=20% Similarity=0.311 Sum_probs=151.8
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
++|++++.||+|+||+||+|.+.+++.||||+++.... ..+.+.+|+.+++.++||||+++++++...+.+|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC------cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 47999999999999999999998888999998864221 124688999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC----
Q 010231 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS---- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~---- 482 (514)
|||+++|+|.+++.. ..+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999999999998865 45888999999999999999999999999999999999999999999999999865422
Q ss_pred ----------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 483 ----------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 483 ----------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
....++.++|||||||++|||+| |.+||...
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 12345567899999999999999 57777654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=325.20 Aligned_cols=184 Identities=29% Similarity=0.457 Sum_probs=155.5
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~ 406 (514)
+++|++++.||+|+||+||+|++ .+|+.||||+++.... .......+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence 36899999999999999999998 6899999999864322 1223467889999999999999999999999999999
Q ss_pred EEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
|||||+.++.+..+... .++++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 99999987644444332 469999999999999999999999999999999999999999999999999998664321
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
...++..+|+|||||++|+|++|++||.+.|
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 1233567999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.6e-39 Score=318.43 Aligned_cols=187 Identities=21% Similarity=0.299 Sum_probs=161.2
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~- 403 (514)
.+.++|++++.||+|+||+||+|++ .+|+.||||+++.... ........+.+|+.+++.++||||+++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT--TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 3457899999999999999999998 6899999999875332 22344567899999999999999999999886543
Q ss_pred ---eEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 404 ---KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 404 ---~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
.+||||||+.|++|..++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||+++..
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 48999999999999988865 46999999999999999999999999999999999999999999999999998765
Q ss_pred ccC----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 480 LSS----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 480 ~~~----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... .+..++.++|||||||++|+|+||++||.+.+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 322 12345678999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=320.99 Aligned_cols=179 Identities=25% Similarity=0.391 Sum_probs=153.5
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|++++.||+|+||+||+|+++++..||||+++.... ..+.+.+|+.++++++|||||++++++.+ +.+||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC------CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 468999999999999999999998889999999864222 23568899999999999999999998765 56799
Q ss_pred EEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-
Q 010231 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~- 483 (514)
||||+++|+|.+++.. ..+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999999987753 359999999999999999999999999999999999999999999999999999764321
Q ss_pred -------------------CcCcceeehhhhHHHHHHHHHhC-CCCCCCC
Q 010231 484 -------------------DFDLLLIFSIFLNGCKFFLIFLH-VLIFRPP 513 (514)
Q Consensus 484 -------------------~~~~~~~~DVwSlG~lLyeLltG-~~PF~g~ 513 (514)
...++.++|||||||++|||+|| .+||...
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 12344578999999999999995 5566543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-39 Score=320.59 Aligned_cols=183 Identities=27% Similarity=0.436 Sum_probs=161.1
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
++|+++++||+|+||+||+|++.+|+.||||++...... ....+.+.+|+.+|+.++||||+++++++...+.+|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 689999999999999999999999999999998654321 22346788999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC-----
Q 010231 409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS----- 482 (514)
Q Consensus 409 mEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~----- 482 (514)
|||+.++.+..+.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|..+...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 999999877777664 56999999999999999999999999999999999999999999999999999875432
Q ss_pred ---------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 483 ---------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 483 ---------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
....++..+|||||||++|+|++|++||.+.+
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~ 205 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence 12345678999999999999999999998753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-39 Score=320.30 Aligned_cols=181 Identities=22% Similarity=0.358 Sum_probs=154.4
Q ss_pred cceEeeee-ecccCceeEEEEEc---cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 329 TYWQKGDL-LGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 329 ~~Y~i~~~-LG~GsfG~Vyka~~---~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
++|.+.+. ||+|+||+||+|.+ .++..||||+++... .....+.+.+|+.+|++++|||||++++++.+ +.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc----CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 57888885 99999999999976 345679999986422 23445778999999999999999999999875 46
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
+||||||+++|+|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 8999999999999998854 45899999999999999999999999999999999999999999999999999876432
Q ss_pred C----------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 483 L----------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 483 ~----------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
. ...++.++|||||||++|||+| |+.||.+.+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 1 1233457899999999999998 999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-39 Score=325.74 Aligned_cols=182 Identities=26% Similarity=0.392 Sum_probs=153.5
Q ss_pred ccceEeeeeecccCceeEEEEEccC------CceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEec
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~------g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~ 400 (514)
.++|+++++||+|+||+||+|++.. ...||+|.+.... .......+.+|+.++.++ +|||||++++++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc----CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 4689999999999999999998732 2368888875322 123345678999999988 8999999999999
Q ss_pred CCCeEEEEEeccccCCHHHHHhhc------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 010231 401 DESKLYIFLELVTKGSLLNLYQRY------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456 (514)
Q Consensus 401 ~~~~l~LVmEy~~gGsL~~lL~~~------------------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLK 456 (514)
+.+.+|||||||++|+|.++++.. .+++..++.|+.||+.||.|||++||||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 999999999999999999998653 37888999999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 457 CANILVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 457 P~NILId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
|+|||++.++.+||+|||+|+...... ...++.++|||||||+||||+| |++||.+.
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998654321 1344557899999999999997 89999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-39 Score=316.21 Aligned_cols=180 Identities=24% Similarity=0.378 Sum_probs=158.8
Q ss_pred cceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV 408 (514)
++|+++++||+|+||+||+|++++++.||||.++.... ..+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS------CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC------CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 57889999999999999999998899999999875322 124688999999999999999999999999999999
Q ss_pred EeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 409 mEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
|||+.+|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+....
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999999988643 468999999999999999999999999999999999999999999999999998654321
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
+..++.++|||||||++|||+| |+.||.+.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 1344568999999999999998 899998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-39 Score=326.28 Aligned_cols=178 Identities=24% Similarity=0.313 Sum_probs=151.9
Q ss_pred ccccceEeee-eecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhh-cCCCceeEEEEEecC-
Q 010231 326 RIITYWQKGD-LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKD- 401 (514)
Q Consensus 326 ~~~~~Y~i~~-~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIv~l~~~~~~- 401 (514)
.++++|++.. +||+|+||+||+|++ .+++.||||+++.. ..+.+|+.++.+ .+||||++++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 3467888765 699999999999998 68999999998631 345688988654 589999999998864
Q ss_pred ---CCeEEEEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC---CCcEEEEe
Q 010231 402 ---ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLAD 472 (514)
Q Consensus 402 ---~~~l~LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~---~g~vKI~D 472 (514)
...+|||||||+||+|.+++... .+++..++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 46799999999999999999763 5899999999999999999999999999999999999985 56799999
Q ss_pred ccCceecccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 473 FGLAKVFLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 473 FGlAk~~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
||+|+..... ....++.++|||||||+||+|+||++||.+.
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 9999876432 1234556899999999999999999999764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=315.30 Aligned_cols=176 Identities=24% Similarity=0.378 Sum_probs=148.9
Q ss_pred eeecccCceeEEEEEc---cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEEEEec
Q 010231 335 DLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (514)
Q Consensus 335 ~~LG~GsfG~Vyka~~---~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy 411 (514)
++||+|+||+||+|.+ .+++.||||+++.... .....+.+.+|+.+|++++|||||++++++.++ ..||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC---CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEc
Confidence 4799999999999986 3457899999864322 223346789999999999999999999998754 57899999
Q ss_pred cccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC-------
Q 010231 412 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL------- 483 (514)
Q Consensus 412 ~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~------- 483 (514)
+++|+|.+++.+ ..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+....
T Consensus 89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999999999876 459999999999999999999999999999999999999999999999999998764321
Q ss_pred ---------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 484 ---------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 484 ---------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
...++.++|||||||++|||+| |++||.+.+
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 1233457899999999999997 899998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=314.52 Aligned_cols=186 Identities=25% Similarity=0.360 Sum_probs=155.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchh-HHHHHHHHHHHHHHhhcC--CCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE--HENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~-~~~~~~l~~Ei~iL~~L~--HpnIv~l~~~~~~~~ 403 (514)
.++|+++++||+|+||+||+|++ .+|+.||||++......... .....++.+|+.+|+++. ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999998 68999999998753221110 111233568999999986 899999999999999
Q ss_pred eEEEEEecccc-CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCC-CcEEEEeccCceecc
Q 010231 404 KLYIFLELVTK-GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKVFL 480 (514)
Q Consensus 404 ~l~LVmEy~~g-GsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~-g~vKI~DFGlAk~~~ 480 (514)
.+|+||||+.+ +++.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999975 578887754 579999999999999999999999999999999999999854 799999999998764
Q ss_pred cCCC------------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SSLD------------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~~~------------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.... ..++..+|||||||++|+|+||+.||.+.
T Consensus 163 ~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 163 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 3311 12235689999999999999999999763
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-38 Score=310.63 Aligned_cols=182 Identities=29% Similarity=0.434 Sum_probs=147.0
Q ss_pred ccceEeeeeecccCceeEEEEEcc----CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~----~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
.++|++++.||+|+||.||+|++. .+..||||.++.. ......+.+.+|+.+|++++||||+++++++. .+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 468999999999999999999873 2345777776432 22334567889999999999999999999986 46
Q ss_pred eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+||||||+.+|+|..++.. ..+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+.+..
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 78999999999999988754 3589999999999999999999999999999999999999999999999999986542
Q ss_pred C--------------------CCcCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 482 S--------------------LDFDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 482 ~--------------------~~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
. ....++.++|||||||++|||+| |.+||.+.+
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 2 11344567899999999999997 899998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=310.37 Aligned_cols=180 Identities=23% Similarity=0.376 Sum_probs=148.7
Q ss_pred cceEeeeeecccCceeEEEEEccCC-----ceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGISDDG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~~~g-----~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
+.|.+.++||+|+||+||+|.+... ..||||.+.... .......+.+|+.++++++|||||++++++.+.+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 4688999999999999999987432 479999886422 1233456889999999999999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
.+++||||+.+++|.+++.. ..+++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999999987765 3589999999999999999999999999999999999999999999999999986533
Q ss_pred C----------------------CCcCcceeehhhhHHHHHHHHHhC-CCCCCC
Q 010231 482 S----------------------LDFDLLLIFSIFLNGCKFFLIFLH-VLIFRP 512 (514)
Q Consensus 482 ~----------------------~~~~~~~~~DVwSlG~lLyeLltG-~~PF~g 512 (514)
. ....++.++|||||||++|||+++ .+||.+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~ 216 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc
Confidence 2 112445579999999999999985 555544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-38 Score=318.85 Aligned_cols=184 Identities=26% Similarity=0.422 Sum_probs=153.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC-
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~- 403 (514)
.+..+|++++.||+|+||+||+|++ .+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc----ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 3456799999999999999999997 689999999986422 2344567889999999999999999999986543
Q ss_pred ---eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 404 ---KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 404 ---~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
..+++|+|+.+|+|.++++..++++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 23444556668899999998899999999999999999999999999999999999999999999999999998653
Q ss_pred cC-----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 481 SS-----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 481 ~~-----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.. ....+..++||||+||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 21 1123446789999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-38 Score=318.35 Aligned_cols=184 Identities=22% Similarity=0.405 Sum_probs=155.5
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC--
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-- 403 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~-- 403 (514)
+.++|+++++||+|+||+||+|++ .+|+.||||+++... ......+.+.+|+.+|+.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh---cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 467899999999999999999998 679999999986422 22345577889999999999999999999987654
Q ss_pred ----eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 404 ----~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
.+||||||+ +.+|..+++...+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 568888888889999999999999999999999999999999999999999999999999999987
Q ss_pred ccCC-----------------CcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 480 LSSL-----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 480 ~~~~-----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.... ...++..+|||||||++|+|++|++||.+.+
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 5431 1344568999999999999999999998753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=306.12 Aligned_cols=180 Identities=27% Similarity=0.411 Sum_probs=159.5
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
++|++++.||+|+||+||+|++ .+++.||||+++.... ......++.+|+.+|+.++|+||+++++++.+...+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC---ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 5899999999999999999998 6889999999975432 23345778899999999999999999999999999999
Q ss_pred EEeccccCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC---
Q 010231 408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL--- 483 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~~-~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~--- 483 (514)
||+++.+++|..++... .+++..++.++.|++.||+|||++|||||||||+||||+.++.+||+|||+|+.+....
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 99999999988877654 68899999999999999999999999999999999999999999999999999765431
Q ss_pred -----------------CcCcceeehhhhHHHHHHHHHhCCCCCC
Q 010231 484 -----------------DFDLLLIFSIFLNGCKFFLIFLHVLIFR 511 (514)
Q Consensus 484 -----------------~~~~~~~~DVwSlG~lLyeLltG~~PF~ 511 (514)
...++.++|||||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 1234568999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=309.60 Aligned_cols=178 Identities=29% Similarity=0.401 Sum_probs=150.9
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCeEEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L 407 (514)
.++|++++.||+|+||+||+|++.++..||||+++.... ..+.+.+|+.++++++|+|||++++++.+ +.+|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC------CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence 468999999999999999999998888899999864322 12568899999999999999999999865 56899
Q ss_pred EEeccccCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 408 VmEy~~gGsL~~lL~~---~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
||||+.+|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999999988753 35999999999999999999999999999999999999999999999999999865322
Q ss_pred ------------------CCcCcceeehhhhHHHHHHHHHhC-CCCCCC
Q 010231 483 ------------------LDFDLLLIFSIFLNGCKFFLIFLH-VLIFRP 512 (514)
Q Consensus 483 ------------------~~~~~~~~~DVwSlG~lLyeLltG-~~PF~g 512 (514)
.+..++.++|||||||++|+|++| .+||.+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 113445688999999999999995 455544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-37 Score=314.93 Aligned_cols=175 Identities=29% Similarity=0.414 Sum_probs=148.4
Q ss_pred ceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec------CC
Q 010231 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK------DE 402 (514)
Q Consensus 330 ~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~------~~ 402 (514)
.|..+++||+|+||+||+|++ .+|+.||||++...... ..+|+.+|++++|+||++++++|. +.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 699999999999999999998 67999999998753221 237999999999999999999874 34
Q ss_pred CeEEEEEeccccCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-cEEEEeccCce
Q 010231 403 SKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAK 477 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~----~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-~vKI~DFGlAk 477 (514)
.++|||||||+++.+..+.. ...+++..++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 46899999998875444332 23699999999999999999999999999999999999999775 89999999998
Q ss_pred ecccC-------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 478 VFLSS-------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 478 ~~~~~-------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+... ....++..+|||||||++|+|++|.+||.+.
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 76432 1235667899999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=313.32 Aligned_cols=180 Identities=23% Similarity=0.389 Sum_probs=149.9
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCc----eEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~----~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~ 403 (514)
++|+++++||+|+||+||+|.+ .+|+ .||+|.++.. ......+.+.+|+.++++++|||||+++++|.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 4699999999999999999987 4554 4777766532 2223456789999999999999999999999875
Q ss_pred eEEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
..+++|+|+.+|+|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+..
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 57788999999999987764 3689999999999999999999999999999999999999999999999999987543
Q ss_pred CC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 482 SL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 482 ~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
.. ...++.++|||||||+||||+| |.+||.+.
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 21 1234568999999999999998 89999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=316.87 Aligned_cols=186 Identities=25% Similarity=0.389 Sum_probs=157.6
Q ss_pred ccceEeeeeecccCceeEEEEEc----cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC-CceeEEEEEecCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDE 402 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~----~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIv~l~~~~~~~ 402 (514)
+++|++++.||+|+||+||+|.+ .+|+.||||+++....... ....+.+.+|+.++++++| |||+++++++.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 57899999999999999999986 3688999999864321111 1123456789999999976 8999999999999
Q ss_pred CeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceeccc
Q 010231 403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLS 481 (514)
Q Consensus 403 ~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~ 481 (514)
..+|+||||+.+|+|.+++.. ..+.+..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999998865 4688999999999999999999999999999999999999999999999999987642
Q ss_pred C----------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 482 S----------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 482 ~----------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
. ....++.++|||||||+||+|++|..||.+.+
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 2 11234557899999999999999999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-37 Score=310.03 Aligned_cols=183 Identities=24% Similarity=0.335 Sum_probs=157.0
Q ss_pred ccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.++|++++.||+|+||+||+|++. ++..||||+++... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc----ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 468999999999999999999863 46789999876422 23345678999999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhhc-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~-------------------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLK 456 (514)
.+.+++||||+.+|+|.+++... .++...+..|+.||+.||+|||+++|||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 99999999999999999988642 37788899999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHhCC-CCCCCCC
Q 010231 457 CANILVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFLHV-LIFRPPN 514 (514)
Q Consensus 457 P~NILId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLltG~-~PF~g~n 514 (514)
|+||||+.++.+||+|||+|+.+.... ...++.++|||||||++|||++|. +||.+.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998653221 124456889999999999999995 6787653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-37 Score=313.88 Aligned_cols=185 Identities=26% Similarity=0.370 Sum_probs=155.8
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCC---
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--- 402 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~--- 402 (514)
+.++|+++++||+|+||+||+|++ .+|+.||||++..... .....+++.+|+.+|+.++|+||+++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 457899999999999999999998 6899999999874322 233446788999999999999999999988532
Q ss_pred --CeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecc
Q 010231 403 --SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFL 480 (514)
Q Consensus 403 --~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~ 480 (514)
...+++|+|+.+|+|.+++...++++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 344666777889999999988899999999999999999999999999999999999999999999999999998764
Q ss_pred cC-----------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 481 SS-----------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 481 ~~-----------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.. ....++..+|||||||++|+|++|++||.+.+
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 33 12345678999999999999999999998753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-37 Score=306.35 Aligned_cols=185 Identities=29% Similarity=0.470 Sum_probs=150.7
Q ss_pred cccceEeeeeecccCceeEEEEEc-cC-CceEEEEEEecccccchhHHHHHHHHHHHHHHhhc---CCCceeEEEEEec-
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDK- 400 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~-g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIv~l~~~~~- 400 (514)
..++|++++.||+|+||+||+|++ .+ ++.||||+++........ ...+.+|+.+|+.+ +||||++++++|.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH---HHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 357899999999999999999997 34 678999998753322111 12344666666554 8999999999874
Q ss_pred ----CCCeEEEEEeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEecc
Q 010231 401 ----DESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (514)
Q Consensus 401 ----~~~~l~LVmEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFG 474 (514)
....+|++|||+.++.+..... ...+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 3457999999999887654443 3468999999999999999999999999999999999999999999999999
Q ss_pred CceecccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 475 LAKVFLSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 475 lAk~~~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
+++..... ....++.++|||||||++|+|+||++||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 99865322 23556678999999999999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=307.25 Aligned_cols=183 Identities=24% Similarity=0.364 Sum_probs=147.3
Q ss_pred cceEeeeeecccCceeEEEEEc--cC--CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCCe
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS--DD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~--~~--g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 404 (514)
++|++.+.||+|+||.||+|++ .+ ...||||+++.... ......+.+.+|+.+|++++||||+++++++.+ ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 5799999999999999999986 22 34789998764322 223445678999999999999999999999976 46
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS 482 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~ 482 (514)
++|||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 7899999999999987654 45999999999999999999999999999999999999999999999999999986433
Q ss_pred CC----------------------cCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 483 LD----------------------FDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 483 ~~----------------------~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
.. ..++..+|||||||++|||+| |..||.+.|
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 11 223346899999999999998 899998764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-37 Score=307.47 Aligned_cols=184 Identities=25% Similarity=0.425 Sum_probs=153.0
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----- 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~----- 401 (514)
+++|++++.||+|+||+||+|++ .+|+.||||++...... ......+.+|+.+|+.++|+||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 57899999999999999999998 68999999988653322 2234567899999999999999999998754
Q ss_pred ---CCeEEEEEeccccCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCce
Q 010231 402 ---ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (514)
Q Consensus 402 ---~~~l~LVmEy~~gGsL~~lL~~-~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk 477 (514)
.+.+|+||||+.++.+..+... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 4568999999998766654433 468999999999999999999999999999999999999999999999999998
Q ss_pred ecccC------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 478 VFLSS------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 478 ~~~~~------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
.+... ....++.++|||||||++|+|++|++||.+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 65421 12346678999999999999999999998753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-37 Score=304.47 Aligned_cols=178 Identities=24% Similarity=0.376 Sum_probs=149.3
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-CCeEE
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLY 406 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~-~~~l~ 406 (514)
.++|+++++||+|+||.||+|.+. |..||||+++.. ...+.+.+|+.++++++||||+++++++.+ .+.+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 468999999999999999999984 778999988632 123568899999999999999999998854 56789
Q ss_pred EEEeccccCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccCC
Q 010231 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSSL 483 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~---~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~~ 483 (514)
|||||+++|+|.+++... .+++..+..|+.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC
Confidence 999999999999998653 38999999999999999999999999999999999999999999999999999754331
Q ss_pred ----------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 484 ----------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 484 ----------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
+..++.++|||||||++|||+| |++||.+.
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 2355668999999999999998 79988765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-37 Score=305.52 Aligned_cols=182 Identities=25% Similarity=0.359 Sum_probs=143.1
Q ss_pred ccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEec
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~ 400 (514)
.++|+++++||+|+||.||+|++ .+++.||||.++... .....+.+.+|..++.++ +|+||+.+++++.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 46899999999999999999986 245789999876322 223345667777777766 6899999999876
Q ss_pred C-CCeEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE
Q 010231 401 D-ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV 462 (514)
Q Consensus 401 ~-~~~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILI 462 (514)
. ...+|+|||||++|+|.+++... .+++..+..|+.||+.||.|||++|||||||||+||||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 5 45689999999999999998642 37889999999999999999999999999999999999
Q ss_pred cCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHhC-CCCCCCC
Q 010231 463 DANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFLH-VLIFRPP 513 (514)
Q Consensus 463 d~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLltG-~~PF~g~ 513 (514)
+.++.+||+|||+|+...... +..++.++|||||||++|+|++| .+||.+.
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999998653321 12345678999999999999986 5788764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-36 Score=307.28 Aligned_cols=176 Identities=24% Similarity=0.369 Sum_probs=152.2
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEec--CCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDK--DES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~--~~~ 403 (514)
.++|+++++||+|+||+||+|++ .+|+.||||+++... .+++.+|+.+|+.+. ||||++++++|. ...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 46899999999999999999998 689999999986421 246789999999995 999999999986 446
Q ss_pred eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC-cEEEEeccCceecccC
Q 010231 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKVFLSS 482 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g-~vKI~DFGlAk~~~~~ 482 (514)
.+|+|||||.+++|..+. ..+++..++.|++||+.||.|||++|||||||||+||||+.++ .+||+|||+|+.+...
T Consensus 106 ~~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp SEEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred ceeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 799999999999997664 3699999999999999999999999999999999999998655 6999999999876432
Q ss_pred -------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 483 -------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 483 -------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
....++..+|+|||||++|+|++|+.||...
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 1123566789999999999999999999754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-36 Score=304.45 Aligned_cols=183 Identities=25% Similarity=0.352 Sum_probs=157.8
Q ss_pred cccceEeeeeecccCceeEEEEEc------cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD 399 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~------~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~ 399 (514)
-.++|+++++||+|+||.||+|++ .++..||||+++.... ......+.+|+.+++.+ +|||||++++++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC----HHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 357999999999999999999975 4667999999875322 23345788999999999 699999999999
Q ss_pred cCCCeEEEEEeccccCCHHHHHhhc-------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCE
Q 010231 400 KDESKLYIFLELVTKGSLLNLYQRY-------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460 (514)
Q Consensus 400 ~~~~~l~LVmEy~~gGsL~~lL~~~-------------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI 460 (514)
.+.+.+|||||||++|+|.+++... .+++..+..|+.||+.||+|||+++||||||||+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 9999999999999999999998643 378899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCC
Q 010231 461 LVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPP 513 (514)
Q Consensus 461 LId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~ 513 (514)
|++.++.+||+|||+++...... ...++.++|||||||++|+|+| |.+||.+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999765331 1344568899999999999998 77777654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=304.30 Aligned_cols=187 Identities=25% Similarity=0.358 Sum_probs=152.9
Q ss_pred ccccccceEeeeeecccCceeEEEEEcc--------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeE
Q 010231 324 FKRIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394 (514)
Q Consensus 324 ~~~~~~~Y~i~~~LG~GsfG~Vyka~~~--------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~ 394 (514)
|..-.++|++++.||+|+||.||+|+.. ++..||||+++... .......+.+|...+.++ +|||||+
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc----ChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 3333579999999999999999999862 23579999876422 223356678888888887 8999999
Q ss_pred EEEEecCCCeEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 010231 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (514)
Q Consensus 395 l~~~~~~~~~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP 457 (514)
++++|.+++.+|+||||+.+|+|.+++... .+++..++.|+.||+.||+|||+++||||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 999999999999999999999999999643 378999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeccCceecccCC---------------------CcCcceeehhhhHHHHHHHHHh-CCCCCCCCC
Q 010231 458 ANILVDANGSVKLADFGLAKVFLSSL---------------------DFDLLLIFSIFLNGCKFFLIFL-HVLIFRPPN 514 (514)
Q Consensus 458 ~NILId~~g~vKI~DFGlAk~~~~~~---------------------~~~~~~~~DVwSlG~lLyeLlt-G~~PF~g~n 514 (514)
+|||++.++.+||+|||+++...... +..++.++|||||||++|+|++ |.+||.+.+
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999999999764331 2345568899999999999997 799998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-37 Score=307.06 Aligned_cols=183 Identities=24% Similarity=0.389 Sum_probs=152.7
Q ss_pred ccceEeeeeecccCceeEEEEEc-cCCc--eEEEEEEecccccchhHHHHHHHHHHHHHHhhc-CCCceeEEEEEecCCC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~-~~g~--~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 403 (514)
.++|++.++||+|+||+||+|++ .++. .||||.+.... .....+.+.+|+.+|+.+ +||||+++++++.+.+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc----ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 36899999999999999999998 4454 46777765322 223346788999999998 7999999999999999
Q ss_pred eEEEEEeccccCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCC
Q 010231 404 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~-----------------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g 466 (514)
.+||||||+++|+|.++++.. .+++..+..|+.||+.||.|||+++||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998642 488999999999999999999999999999999999999999
Q ss_pred cEEEEeccCceecccCC------------------CcCcceeehhhhHHHHHHHHHhC-CCCCCCCC
Q 010231 467 SVKLADFGLAKVFLSSL------------------DFDLLLIFSIFLNGCKFFLIFLH-VLIFRPPN 514 (514)
Q Consensus 467 ~vKI~DFGlAk~~~~~~------------------~~~~~~~~DVwSlG~lLyeLltG-~~PF~g~n 514 (514)
.+||+|||+|+...... +..++.++|||||||++|+|++| .+||.+.|
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 99999999998654221 23344578999999999999996 56787653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-36 Score=304.29 Aligned_cols=183 Identities=22% Similarity=0.341 Sum_probs=156.8
Q ss_pred ccceEeeeeecccCceeEEEEEcc------CCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~------~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~ 401 (514)
.++|++++.||+|+||+||+|.+. ++..||||+++... .......+.+|+.++++++||||+++++++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~----~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc----ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 478999999999999999999863 46789999886321 22344678899999999999999999999999
Q ss_pred CCeEEEEEeccccCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEE
Q 010231 402 ESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (514)
Q Consensus 402 ~~~l~LVmEy~~gGsL~~lL~~~-----------~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI 470 (514)
...++|||||+.+|+|.+++... .++...+..|+.||+.||.|||+++|+||||||+||||+.++++||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 99999999999999999987532 3678889999999999999999999999999999999999999999
Q ss_pred EeccCceecccC---------------------CCcCcceeehhhhHHHHHHHHHhC-CCCCCCCC
Q 010231 471 ADFGLAKVFLSS---------------------LDFDLLLIFSIFLNGCKFFLIFLH-VLIFRPPN 514 (514)
Q Consensus 471 ~DFGlAk~~~~~---------------------~~~~~~~~~DVwSlG~lLyeLltG-~~PF~g~n 514 (514)
+|||+|+.+... .+..++.++|||||||++|||+|| .+||.+.+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence 999999865432 113345578999999999999998 58887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-36 Score=300.82 Aligned_cols=178 Identities=29% Similarity=0.362 Sum_probs=149.2
Q ss_pred ccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecCCC----
Q 010231 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES---- 403 (514)
Q Consensus 328 ~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~~~---- 403 (514)
...|.+.+.||+|+||.||+|+. +|+.||||++.... ......+.|+..+.+++||||+++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 35789999999999999999986 58899999886421 11122345666677889999999999986543
Q ss_pred eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCCEEEcCCCcEEEEeccC
Q 010231 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD--------QDVVHRDIKCANILVDANGSVKLADFGL 475 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs--------~gIIHRDLKP~NILId~~g~vKI~DFGl 475 (514)
.+||||||+.+|+|.+++++..+++..+..++.|++.||.|||. +|||||||||+||||+.++.+||+|||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 68999999999999999999999999999999999999999996 5999999999999999999999999999
Q ss_pred ceecccCCC-----------------------c------CcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 476 AKVFLSSLD-----------------------F------DLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 476 Ak~~~~~~~-----------------------~------~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
++.+....+ . .++.++|||||||+||||+||..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 987643211 0 123467999999999999999988753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=303.92 Aligned_cols=183 Identities=25% Similarity=0.372 Sum_probs=151.0
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEec-----
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----- 400 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~----- 400 (514)
+.++|+++++||+|+||+||+|++ .+|+.||||++..... .......+.+|+.+++.++||||++++++|.
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence 457899999999999999999998 5799999999875332 2344567889999999999999999999985
Q ss_pred -CCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 401 -DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 401 -~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..+++|+|||||.++.+. .+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~~~~~~iv~Ey~~~~l~~-~~-~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 92 EEFQDVYLVMELMDANLCQ-VI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp TTCCEEEEEEECCSEEHHH-HH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ccCceeEEEEeccchHHHH-hh-hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 347899999999876554 44 346899999999999999999999999999999999999999999999999998865
Q ss_pred ccC------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCCC
Q 010231 480 LSS------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPPN 514 (514)
Q Consensus 480 ~~~------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~n 514 (514)
... .+..+...+||||+||++|+|++|.+||.+.+
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 432 23455678999999999999999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-35 Score=296.91 Aligned_cols=177 Identities=25% Similarity=0.396 Sum_probs=148.4
Q ss_pred EeeeeecccCceeEEEEEccC----CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCceeEEEEEecC-CCeEE
Q 010231 332 QKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLY 406 (514)
Q Consensus 332 ~i~~~LG~GsfG~Vyka~~~~----g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~~~~~-~~~l~ 406 (514)
+..++||+|+||+||+|++.. ...||||.++.. ......+.+.+|+.+|++++||||+++++++.. +..++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC----CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 346889999999999998732 236899988632 234456789999999999999999999998764 56899
Q ss_pred EEEeccccCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCceecccC--
Q 010231 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKVFLSS-- 482 (514)
Q Consensus 407 LVmEy~~gGsL~~lL~~~--~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~~~~-- 482 (514)
+|||||.+|+|.+++... .+....+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999999988754 4667788999999999999999999999999999999999999999999999875422
Q ss_pred ---------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCC
Q 010231 483 ---------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRP 512 (514)
Q Consensus 483 ---------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g 512 (514)
....++.++|||||||++|||+||..||..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 113444578999999999999998777753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.9e-35 Score=290.14 Aligned_cols=179 Identities=21% Similarity=0.298 Sum_probs=152.9
Q ss_pred cccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCC-CceeEEEEEecCCCe
Q 010231 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESK 404 (514)
Q Consensus 327 ~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIv~l~~~~~~~~~ 404 (514)
+.++|+++++||+|+||+||+|++ .+|+.||||++...... ..+.+|+.+++.+.| +||+.+++++.....
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 75 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 75 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence 346899999999999999999998 57899999988643221 235678888888865 899999999999999
Q ss_pred EEEEEeccccCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC-----CCcEEEEeccCce
Q 010231 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-----NGSVKLADFGLAK 477 (514)
Q Consensus 405 l~LVmEy~~gGsL~~lL~~--~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~-----~g~vKI~DFGlAk 477 (514)
.|+||||+ +++|.++++. ..++...+..++.|++.||+|||++|||||||||+||||+. ++.+||+|||+|+
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99999999 6799888865 35899999999999999999999999999999999999974 5789999999999
Q ss_pred ecccC--------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 478 VFLSS--------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 478 ~~~~~--------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
.+... ....++.++|||||||++|+|+||..||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 76432 1224556789999999999999999999764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-34 Score=288.97 Aligned_cols=180 Identities=23% Similarity=0.325 Sum_probs=148.6
Q ss_pred ccccceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCc-eeEEEEEecCCC
Q 010231 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES 403 (514)
Q Consensus 326 ~~~~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~ 403 (514)
++.++|++++.||+|+||+||+|++ .+|+.||||++...... ..+.+|+.+++.+.|+| |+.++.++.+.+
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 3456899999999999999999998 67899999988753221 23678999999998766 555666778888
Q ss_pred eEEEEEeccccCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcC---CCcEEEEeccCcee
Q 010231 404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKV 478 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~--~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~---~g~vKI~DFGlAk~ 478 (514)
..++||||+.+ +|...+. ...+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.
T Consensus 77 ~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 77 YNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99999999955 5655554 346999999999999999999999999999999999999864 45799999999997
Q ss_pred cccC--------------------------CCcCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 479 FLSS--------------------------LDFDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 479 ~~~~--------------------------~~~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+... .+..++.++|||||||++|+|+||..||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~ 216 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccccc
Confidence 6432 1124566899999999999999999999764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=4.1e-30 Score=261.05 Aligned_cols=179 Identities=25% Similarity=0.327 Sum_probs=140.6
Q ss_pred cceEeeeeecccCceeEEEEEc-cCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-----------CCceeEEE
Q 010231 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----------HENIVQYY 396 (514)
Q Consensus 329 ~~Y~i~~~LG~GsfG~Vyka~~-~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-----------HpnIv~l~ 396 (514)
++|+++++||+|+||+||+|++ .+|+.||||+++.. ....+.+.+|+.+++.+. |+||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 3599999999999999999998 68999999998742 122345677888887764 57899998
Q ss_pred EEec--CCCeEEEEEeccccCCHH-HHH---hhcCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEcCCCc--
Q 010231 397 GTDK--DESKLYIFLELVTKGSLL-NLY---QRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGS-- 467 (514)
Q Consensus 397 ~~~~--~~~~l~LVmEy~~gGsL~-~lL---~~~~lse~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILId~~g~-- 467 (514)
+++. .....+++|.++..+... ... ....+.+..++.+++||+.||.|||+ +||+||||||+||||+.++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 8764 345677777776655332 222 22468899999999999999999998 89999999999999987653
Q ss_pred ----EEEEeccCceecccCCC----------------cCcceeehhhhHHHHHHHHHhCCCCCCCC
Q 010231 468 ----VKLADFGLAKVFLSSLD----------------FDLLLIFSIFLNGCKFFLIFLHVLIFRPP 513 (514)
Q Consensus 468 ----vKI~DFGlAk~~~~~~~----------------~~~~~~~DVwSlG~lLyeLltG~~PF~g~ 513 (514)
+||+|||.+........ ..++.++|+||+||++++|++|+.||.+.
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp TEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 99999999987654321 33456799999999999999999999764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=4e-25 Score=206.13 Aligned_cols=141 Identities=18% Similarity=0.208 Sum_probs=112.2
Q ss_pred eEeeeeecccCceeEEEEEccCCceEEEEEEecccc-------------cchhHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 010231 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ-------------GSQAKQSISQLEQEIALLSRFEHENIVQYYG 397 (514)
Q Consensus 331 Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~-------------~~~~~~~~~~l~~Ei~iL~~L~HpnIv~l~~ 397 (514)
+.++++||+|+||+||+|++.+|+.||||+++.... ............+|...+..+.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 457899999999999999998899999998653111 0112223344567889999999999999887
Q ss_pred EecCCCeEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEcCCCcEEEEeccCce
Q 010231 398 TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (514)
Q Consensus 398 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILId~~g~vKI~DFGlAk 477 (514)
+... +++|||+.+..+. .+....+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|||+|+
T Consensus 82 ~~~~----~lvme~~~~~~~~------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~ 150 (191)
T d1zara2 82 WEGN----AVLMELIDAKELY------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150 (191)
T ss_dssp EETT----EEEEECCCCEEGG------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCE
T ss_pred ecCC----EEEEEeecccccc------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcc
Confidence 6432 7999999986543 35556677899999999999999999999999999999865 48999999998
Q ss_pred ecccC
Q 010231 478 VFLSS 482 (514)
Q Consensus 478 ~~~~~ 482 (514)
....+
T Consensus 151 ~~~~~ 155 (191)
T d1zara2 151 EVGEE 155 (191)
T ss_dssp ETTST
T ss_pred cCCCC
Confidence 87644
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=5.2e-07 Score=84.80 Aligned_cols=145 Identities=13% Similarity=0.119 Sum_probs=90.4
Q ss_pred cccccceEeeeeecccCceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCC
Q 010231 325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES 403 (514)
Q Consensus 325 ~~~~~~Y~i~~~LG~GsfG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 403 (514)
+..+..|+..+..+.++.+.||+... ++..+.+|......... ...+.+|..++..+. +--+.+++.++...+
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 44566778777666566678998864 44556778765322211 223567777776663 323566777777788
Q ss_pred eEEEEEeccccCCHHHHHhhcCCCHHHHHHHHHHHHHHH-----------------------------------------
Q 010231 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL----------------------------------------- 442 (514)
Q Consensus 404 ~l~LVmEy~~gGsL~~lL~~~~lse~~v~~i~~QIl~gL----------------------------------------- 442 (514)
..|+||++++|..+........ ....++.++...|
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~~----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDEQ----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTCS----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred ceEEEEEecccccccccccccc----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 8999999999887754321100 0111122222222
Q ss_pred ------------HHHHHC------CccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 443 ------------KYLHDQ------DVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 443 ------------~yLHs~------gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
..+.+. .++|+|+.|.|||++.++.+-|+||+.+...
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 222221 2789999999999987666679999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=4.8e-06 Score=77.59 Aligned_cols=136 Identities=18% Similarity=0.132 Sum_probs=83.9
Q ss_pred eecccCc-eeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCC--ceeEEEEEecCCCeEEEEEecc
Q 010231 336 LLGRGSF-GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDESKLYIFLELV 412 (514)
Q Consensus 336 ~LG~Gsf-G~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIv~l~~~~~~~~~l~LVmEy~ 412 (514)
.+..|.. +.||+....++..+.+|....... ..+..|..+++.+... .+.+++.+..+.+..|+||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence 4455553 679999888888888997653221 2345677777666332 2566777777888899999999
Q ss_pred ccCCHHH--------------HHhh-cCCC-------H--HH-HH----HHH---------------HHHHHHHHHHHHC
Q 010231 413 TKGSLLN--------------LYQR-YHLR-------D--SQ-VS----AYT---------------RQILLGLKYLHDQ 448 (514)
Q Consensus 413 ~gGsL~~--------------lL~~-~~ls-------e--~~-v~----~i~---------------~QIl~gL~yLHs~ 448 (514)
+|.++.. ++.+ ..++ . .. .. .+. ......+..+.+.
T Consensus 89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 8755411 1111 0110 0 00 00 000 0112234444432
Q ss_pred -------CccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 449 -------DVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 449 -------gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
.+||+|+.|.|||++.++.+-|+||+.+...
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 3799999999999988766789999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.77 E-value=4.5e-05 Score=76.85 Aligned_cols=81 Identities=14% Similarity=0.144 Sum_probs=47.1
Q ss_pred eeeecccCceeEEEEEcc-CCceEEEEEEeccc--ccchhHHHHHHHHHHHHHHhhcC---CCceeEEEEEecCCCeEEE
Q 010231 334 GDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLD--QGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYI 407 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~-~g~~vAIK~v~~~~--~~~~~~~~~~~l~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l~L 407 (514)
.+.||.|....||++... +++.+++|.-...- .+..-.....+...|...|+.+. ...+.+++.+..+ ..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~--~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--MAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--TTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC--CCEE
Confidence 456899999999999874 46788888643211 00000111223445777666552 2346667765443 4478
Q ss_pred EEeccccCC
Q 010231 408 FLELVTKGS 416 (514)
Q Consensus 408 VmEy~~gGs 416 (514)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.14 E-value=0.00035 Score=68.05 Aligned_cols=130 Identities=14% Similarity=0.080 Sum_probs=74.0
Q ss_pred ceeEEEEEccCCceEEEEEEecccccchhHHHHHHHHHHHHHHhhcCCCce--eEEEE-----EecCCCeEEEEEecccc
Q 010231 342 FGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI--VQYYG-----TDKDESKLYIFLELVTK 414 (514)
Q Consensus 342 fG~Vyka~~~~g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI--v~l~~-----~~~~~~~l~LVmEy~~g 414 (514)
.-.||++...+|..|++|+..... ....++..|+..+..|...+| +..+. .+......+.+++++.|
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~------~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER------WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT------SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC------CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999999999999999875321 123456677777776643222 11111 12335678899999876
Q ss_pred CCH-----HH------HH-------hhcC------CC-------------------HHHHHHHHHHHHHHHHHHHH----
Q 010231 415 GSL-----LN------LY-------QRYH------LR-------------------DSQVSAYTRQILLGLKYLHD---- 447 (514)
Q Consensus 415 GsL-----~~------lL-------~~~~------ls-------------------e~~v~~i~~QIl~gL~yLHs---- 447 (514)
..+ .. .+ .... +. ......+...+-..+..+..
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred cCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccc
Confidence 331 11 11 0000 11 11111222222223333322
Q ss_pred ---CCccccCCCCCCEEEcCCCcEEEEeccCceec
Q 010231 448 ---QDVVHRDIKCANILVDANGSVKLADFGLAKVF 479 (514)
Q Consensus 448 ---~gIIHRDLKP~NILId~~g~vKI~DFGlAk~~ 479 (514)
.++||+|+.+.|||++. + ..|+||+.|..-
T Consensus 189 ~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~g 221 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARNG 221 (325)
T ss_dssp CSCCEECCSSCSGGGEEESS-S-EEECCCTTCCEE
T ss_pred cCCceeecCCCCcccEEEeC-C-ceEEechhcccC
Confidence 36899999999999964 4 458999999863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.69 E-value=0.0018 Score=64.43 Aligned_cols=72 Identities=10% Similarity=-0.017 Sum_probs=46.0
Q ss_pred eeeecccCceeEEEEEccC--------CceEEEEEEecccccchhHHHHHHHHHHHHHHhhcC-CCceeEEEEEecCCCe
Q 010231 334 GDLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK 404 (514)
Q Consensus 334 ~~~LG~GsfG~Vyka~~~~--------g~~vAIK~v~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIv~l~~~~~~~~~ 404 (514)
++.|+.|-.-.+|++...+ ...|.+++... ... .....+|..+++.+. +.-..++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~------~idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET------ESHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC------HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch------hhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence 4678888888999987533 34455655431 111 123457888888774 3334577887764
Q ss_pred EEEEEeccccCC
Q 010231 405 LYIFLELVTKGS 416 (514)
Q Consensus 405 l~LVmEy~~gGs 416 (514)
.+||||++|..
T Consensus 117 -g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 -GRLEEYIPSRP 127 (395)
T ss_dssp -EEEECCCCEEE
T ss_pred -ceEEEEecccc
Confidence 78999998754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.42 E-value=0.0032 Score=60.05 Aligned_cols=31 Identities=26% Similarity=0.284 Sum_probs=27.9
Q ss_pred CCccccCCCCCCEEEcCCCcEEEEeccCcee
Q 010231 448 QDVVHRDIKCANILVDANGSVKLADFGLAKV 478 (514)
Q Consensus 448 ~gIIHRDLKP~NILId~~g~vKI~DFGlAk~ 478 (514)
.|+||+|+.++||+++.+...-|+||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999887778999999875
|